"Molecule ChEMBL ID";"Molecule Name";"Molecule Max Phase";"Molecular Weight";"#RO5 Violations";"AlogP";"Compound Key";"Smiles";"Standard Type";"Standard Relation";"Standard Value";"Standard Units";"pChEMBL Value";"Data Validity Comment";"Comment";"Uo Units";"Ligand Efficiency BEI";"Ligand Efficiency LE";"Ligand Efficiency LLE";"Ligand Efficiency SEI";"Potential Duplicate";"Assay ChEMBL ID";"Assay Description";"Assay Type";"BAO Format ID";"BAO Label";"Assay Organism";"Assay Tissue ChEMBL ID";"Assay Tissue Name";"Assay Cell Type";"Assay Subcellular Fraction";"Assay Parameters";"Assay Variant Accession";"Assay Variant Mutation";"Target ChEMBL ID";"Target Name";"Target Organism";"Target Type";"Document ChEMBL ID";"Source ID";"Source Description";"Document Journal";"Document Year";"Cell ChEMBL ID";"Properties"
"CHEMBL527507";"";"0";"315.98";"1";"-0.28";"GNF-Pf-677";"OP1(O)=NP(O)(O)=NP(O)(O)=NP(O)(O)=N1";"IFI";"'='";"1.515";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL581699";"";"0";"368.37";"0";"3.83";"GNF-Pf-597";"COc1ccccc1-c1nnc(Nc2nc3cc4c(cc3s2)OCO4)o1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL578065";"";"0";"461.56";"1";"5.10";"GNF-Pf-5591";"CCC(C)OC(=O)C1=C(C)NC2=C(C(=O)CC(c3ccc(OC)cc3)C2)C1c1ccc(O)cc1";"IFI";"'='";"4.545";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL533576";"";"0";"313.38";"0";"3.08";"GNF-Pf-5013";"CSc1ccc(C=CC(=O)NC(=O)c2ccccc2O)cc1";"IFI";"";"";"";"";"";"Not applicable";"";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600359";"";"0";"469.63";"1";"7.08";"GNF-Pf-5027";"Cc1ccn2c(NC(C)(C)CC(C)(C)C)c(-c3ccccc3OC(=O)Cc3ccccc3)nc2c1";"IFI";"'='";"3.738";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL601754";"";"0";"408.48";"0";"3.77";"GNF-Pf-5035";"CC(C)COc1nc(-c2ccccc2)n(S(=O)(=O)c2cccc3cccnc23)n1";"IFI";"'='";"4.167";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585829";"";"0";"375.26";"0";"4.86";"GNF-Pf-5038";"CCC(=O)NC(c1ccccc1Cl)c1cc(Cl)c2cccnc2c1O";"IFI";"'='";"15.38";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585048";"";"0";"531.67";"2";"5.55";"GNF-Pf-5081";"CCCCN(CC)CCNC(=O)C1c2ccccc2C(=O)N(Cc2ccc(F)cc2)C1c1ccc(OC)cc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL586006";"";"0";"423.53";"0";"4.68";"GNF-Pf-5095";"CCOC(=O)C1=C(C)NC2=C(C(=O)CC(c3ccc(OC)cc3)C2)C1c1cccs1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL583164";"";"0";"486.03";"1";"6.26";"GNF-Pf-5098";"COc1cc(NC(C)CCCN(Cc2ccc(F)cc2)C(=O)C(C)(C)CCl)c2ncccc2c1";"IFI";"'='";"1.053";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL603031";"";"0";"422.42";"1";"5.57";"GNF-Pf-5102";"Fc1cc(F)c(C2SCCN2C(=S)Nc2cccc(C(F)(F)F)c2)c(F)c1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL123292";"CYCLOHEXIMIDE";"0";"281.35";"0";"1.04";"GNF-Pf-5118";"C[C@H]1C[C@H](C)C(=O)[C@H]([C@H](O)CC2CC(=O)NC(=O)C2)C1";"IFI";"'='";"19.67";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL586023";"";"0";"512.40";"2";"5.00";"GNF-Pf-5119";"COC(=O)C1=C(C)NC2=C(C(=O)CC(c3ccc(OC)c(OC)c3)C2)C1c1ccc(Br)cc1";"IFI";"'='";"4.878";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL578957";"";"0";"436.51";"0";"3.73";"GNF-Pf-5135";"C=CC1CC23CC(C(OC(=O)CCC(=O)O)c4ccnc5ccc(OC)cc45)N2CCC13";"IFI";"'='";"5.455";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600725";"";"0";"501.46";"2";"6.21";"GNF-Pf-5142";"CC(C)CN(CC(=O)Nc1cc(C(C)(C)C)nn1-c1ccccc1)C(=O)c1cc(Cl)cc(Cl)c1";"IFI";"'='";"1.869";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL576812";"";"0";"520.65";"2";"6.55";"GNF-Pf-5146";"O=C(Cc1ccccc1)N1CCOc2c(cc(-c3csc4ccccc34)cc2OCCc2ccccn2)C1";"IFI";"'='";"4.04";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL536655";"";"0";"352.73";"0";"2.05";"GNF-Pf-5147";"COC(=O)C1=CNC=C(C(=O)OC)C1c1ccc(Cl)c([N+](=O)[O-])c1";"IFI";"'='";"2.353";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL548286";"";"0";"356.43";"0";"4.69";"GNF-Pf-5150";"COc1ccccc1C1CC(c2ccccc2)=NN1C(=O)c1ccccc1";"IFI";"'='";"2.299";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL602780";"";"0";"342.18";"0";"2.79";"GNF-Pf-5156";"COC(=O)C1=CNC=C(C(=O)OC)C1c1ccc(Cl)c(Cl)c1";"IFI";"'='";"6.098";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL580566";"";"0";"468.60";"0";"4.73";"GNF-Pf-5160";"C#CCNC(=O)c1ccc(OC2CCN(CC(c3ccccc3)c3ccccc3)CC2)c(OC)c1";"IFI";"'='";"2.74";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL601164";"";"0";"466.46";"0";"3.27";"GNF-Pf-5163";"COC(=O)[C@@H]1C[C@@H](NC(=O)c2ccc(OC)cc2OC)CN1Cc1ccc(C(F)(F)F)cc1";"IFI";"'='";"3.478";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL532611";"";"0";"573.74";"2";"9.18";"GNF-Pf-5172";"Cc1cc(C)c2c(c1)c(-c1ccccc1)c(-c1ccccc1)n2CC(O)Cn1cnc(-c2ccccc2)c1-c1ccccc1";"IFI";"'='";"2.299";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL577660";"";"0";"447.02";"0";"3.21";"GNF-Pf-5183";"Cc1cc(Cl)c(S(=O)(=O)N2CCSCC2)cc1OCC(=O)NC1CCCCC1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL152117";"";"0";"179.22";"0";"1.07";"GNF-Pf-5230";"CC(=O)NCCc1ccc(O)cc1";"IFI";"'='";"1.481";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL578105";"";"0";"397.91";"0";"4.37";"GNF-Pf-5237";"CN(CCCNc1ccnc2cc(Cl)ccc12)C(=O)COCc1ccccc1";"IFI";"'='";"0.9346";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL576403";"";"0";"396.28";"1";"5.84";"GNF-Pf-5250";"Oc1c(C(Nc2ccccn2)c2cccc(Cl)c2Cl)ccc2cccnc12";"IFI";"'='";"15.38";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL580648";"";"0";"425.33";"0";"4.94";"GNF-Pf-540";"Cc1cc(N2CCCCC2)nc2ccc(NC(=O)c3cncc(Br)c3)cc12";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL1744501";"";"0";"866.10";"3";"4.98";"GNF-Pf-556";"CC=C[C@H]1O[C@@](O)([C@@H](C)C(O)C(C)[C@H]2OC(=O)C(OC)=CC(C)=C[C@@H](C)[C@H](O)C(CC)[C@@H](O)[C@H](C)CC(C)=CC=C[C@@H]2OC)C[C@@H](O[C@H]2C[C@@H](O)[C@H](OC(N)=O)[C@@H](C)O2)[C@@H]1C";"IFI";"'='";"17.54";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600496";"";"0";"256.32";"0";"2.70";"GNF-Pf-580";"COc1ccc(/C=C\c2cc[n+](C)cc2)cc1OC";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600339";"";"0";"412.30";"1";"6.20";"GNF-Pf-630";"CC1(C)CC(=O)c2cc(-c3ccc(Br)cc3)n(-c3ccccc3F)c2C1";"IFI";"'='";"3.125";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL602964";"";"0";"325.44";"0";"3.81";"GNF-Pf-636";"CCN(CC)c1ccc2c(c1)OC(N)=C(C#N)C2c1ccsc1";"IFI";"'='";"9.091";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL597860";"";"0";"354.36";"0";"3.03";"GNF-Pf-654";"COc1cc(O)c2c(=O)cc(CCOC(=O)Nc3ccccc3)[nH]c2c1";"IFI";"'='";"1.22";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL2308884";"";"0";"420.41";"0";"-0.45";"GNF-Pf-1439";"COc1cccc2c1[C@@H](OC)[C@@]13O[C@]1(C2=O)[C@H](O)[C@@H](C)[C@](O)(C(=O)[C@@H]1O[C@H]1C)[C@H]3O";"IFI";"'='";"20.37";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600941";"";"0";"388.30";"1";"5.12";"GNF-Pf-2693";"CN(CCCNc1ccnc2cc(Cl)ccc12)C(=O)c1cccc(Cl)c1";"IFI";"'='";"1.852";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL581656";"";"0";"472.53";"1";"5.77";"GNF-Pf-343";"Cc1ccccc1Nc1sc(C(=O)c2ccc([N+](=O)[O-])cc2)c(N)c1C(=O)Nc1ccccc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL581658";"";"0";"563.72";"1";"2.34";"GNF-Pf-345";"O=C(CN(CCN1CCOCC1)S(=O)(=O)c1ccccn1)N1CCN(C(c2ccccc2)c2ccccc2)CC1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL579561";"";"0";"338.79";"0";"4.64";"GNF-Pf-403";"CCOC(=O)c1c(Cl)nnc(-c2ccccc2)c1-c1ccccc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL582732";"";"0";"380.88";"1";"5.20";"GNF-Pf-412";"Cc1ccc(C)c(Nc2nc(NCc3ccco3)c3ccccc3n2)c1.Cl";"IFI";"'='";"6.452";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL581273";"";"0";"416.61";"0";"3.75";"GNF-Pf-450";"CC(C)CNC(=O)c1cnc(NCCCN2CCCC2)nc1NCC1CCCCC1";"IFI";"'='";"0.9524";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL602815";"";"0";"404.27";"1";"5.34";"GNF-Pf-495";"Oc1ccccc1-c1nc(-c2ccccc2)nc(-c2ccc(Br)cc2)n1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL582735";"";"0";"543.66";"2";"6.19";"GNF-Pf-500";"COc1cccc(C(=O)N(CCCC(C)Nc2cc(OC)cc3cccnc23)Cc2ccc(OC)c(OC)c2)c1";"IFI";"'='";"3.81";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL611373";"";"0";"330.73";"0";"3.14";"GNF-Pf-726";"O=C(NCc1cc2cc3c(cc2nc1Cl)OCO3)c1ccco1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585077";"";"0";"390.49";"0";"4.42";"GNF-Pf-741";"Cc1ccc(C(=O)CSc2nc(N)c(C#N)c(-c3cccs3)c2C#N)cc1";"IFI";"'='";"7.143";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL530636";"";"0";"301.80";"0";"4.91";"GNF-Pf-748";"Cc1ccnc(Nc2nc(-c3ccc(Cl)cc3)cs2)c1";"IFI";"'='";"6.452";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585085";"";"0";"402.81";"1";"5.01";"GNF-Pf-750";"COC(=O)c1c(-c2c(F)cccc2Cl)noc1/C=C/Nc1ccc(OC)cc1";"IFI";"'='";"3.947";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL527732";"";"0";"204.27";"0";"0.96";"GNF-Pf-751";"O=S1(=O)CCC(O)c2ccsc21";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL2304386";"";"0";"380.44";"0";"3.37";"GNF-Pf-754";"COC(=O)C1=C(C)N/C(=C\c2cc(C)n(-c3cc(C)ccc3OC)c2C)C1=O";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL1576338";"";"0";"337.42";"0";"4.58";"GNF-Pf-763";"COc1ccc(C2C3=C(O)CC(C)(C)CC3=Nc3[nH]nc(C)c32)cc1";"IFI";"'='";"5.195";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL601960";"";"0";"624.72";"1";"4.47";"GNF-Pf-765";"CCOC(=O)c1ccc(N(C(=O)CSCC(=O)Nc2cc(C)on2)C(C(=O)NC2CCCCC2)c2ccc(O)c(O)c2)cc1";"IFI";"'='";"2.727";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL598261";"";"0";"481.98";"0";"3.20";"GNF-Pf-772";"CC1CN(C(=O)C(Cc2c[nH]c3ccccc23)NC(=O)CCl)CCN1C(=O)Nc1ccccc1";"IFI";"'='";"1.869";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600904";"";"0";"265.32";"0";"2.98";"GNF-Pf-780";"Oc1c2c(nc3cc(-c4ccccc4)nn13)CCCC2";"IFI";"'='";"7.143";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL599707";"";"0";"390.88";"0";"1.70";"GNF-Pf-782";"Cc1nc(Cl)cc(N2CCc3c(nc(N4CC(C)OC(C)C4)[nH]c3=O)C2)n1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL604122";"";"0";"489.52";"1";"6.19";"GNF-Pf-786";"Cc1oc2c(cc(NS(=O)(=O)c3ccc(F)cc3)c3ccccc32)c1C(=O)OCc1ccccc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL604311";"";"0";"419.51";"1";"5.58";"GNF-Pf-793";"CCCc1ccc(OCc2nc(-c3ccc(NC(=O)c4cccs4)cc3)no2)cc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL547101";"";"0";"283.76";"0";"0.88";"GNF-Pf-806";"COc1ccc(N2C(N)=NC(N)=NC2(C)C)cc1.Cl";"IFI";"'='";"4.545";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL596852";"";"0";"460.54";"1";"6.38";"GNF-Pf-812";"COc1ccc(-c2nc3cc(Cc4ccc5[nH]c(-c6ccc(OC)cc6)nc5c4)ccc3[nH]2)cc1";"IFI";"'='";"25.71";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL599515";"";"0";"616.19";"2";"5.76";"GNF-Pf-813";"CCOC(=O)c1c(NC(=O)CSc2nnc(CNC(=O)c3cccs3)n2-c2cccc(Cl)c2)sc2c1CCCC2";"IFI";"'='";"1.25";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL582955";"";"0";"410.57";"0";"3.37";"GNF-Pf-822";"CC(C)CNc1nc(NCCCN2CCCC2)ncc1C(=O)NCc1ccccc1";"IFI";"'='";"2.857";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL606023";"";"0";"467.60";"0";"2.38";"GNF-Pf-827";"Cc1ccc(-c2nnc(N3CCOCC3)c3ccccc23)cc1S(=O)(=O)N1CCN(C)CC1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL601381";"";"0";"358.36";"0";"3.18";"GNF-Pf-828";"Cc1cc(C)cc(OCC(=O)N2N=C(C(C)C)CC2(O)C(F)(F)F)c1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL582960";"";"0";"281.23";"0";"3.44";"GNF-Pf-829";"O=C(C1CC1)n1cc(C(=O)C(F)(F)F)c2ccccc21";"IFI";"'='";"1.538";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL410467";"";"0";"478.42";"0";"3.87";"GNF-Pf-835";"CCOC(=O)C(C)Oc1cccc2c(=O)n(CC(=O)Nc3ccc(OC(F)(F)F)cc3)ccc12";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL601321";"";"0";"327.47";"0";"4.32";"GNF-Pf-864";"CN1C2CCC1/C(=C\c1ccsc1)C(=O)/C2=C\c1ccsc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL584018";"";"0";"304.37";"0";"1.72";"GNF-Pf-882";"CC(C)n1nnnc1CN1CCN(c2ccccc2F)CC1";"IFI";"'='";"1.667";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL583809";"";"0";"310.27";"0";"1.49";"GNF-Pf-888";"CCOC(=O)NN=C1c2ccccc2-c2nc3nonc3nc21";"IFI";"'='";"15.38";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL602018";"";"0";"281.71";"0";"2.99";"GNF-Pf-893";"Clc1ccc2c(c1)c(-c1ccccc1)nc1nnnn12";"IFI";"'='";"3.077";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL583594";"";"0";"291.76";"0";"2.07";"GNF-Pf-900";"CCN(CC)S(=O)(=O)c1cc(C(=O)O)ccc1Cl";"IFI";"'='";"7.937";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585791";"";"0";"570.67";"2";"5.42";"GNF-Pf-920";"COC(=O)C1=C(C(=O)OC)SC(=C2C(=S)C(C)(C)N(C(=O)c3ccc([N+](=O)[O-])cc3)c3ccc(C)cc32)S1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL602600";"";"0";"314.36";"0";"2.96";"GNF-Pf-2705";"CC(C)[C@@H](CO)Nc1ccnc2c(-c3ccccc3F)cnn12";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL578505";"";"0";"377.53";"0";"3.54";"GNF-Pf-2709";"NCCC(=O)N1CC(c2ccccc2)c2ccccc2C1CN1CCCCC1";"IFI";"'='";"4.225";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL578718";"";"0";"307.35";"0";"2.80";"GNF-Pf-2712";"CC1CC(=O)NN=C1c1ccc(NC(=O)c2ccccc2)cc1";"IFI";"'='";"14.29";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600125";"";"0";"432.91";"1";"5.43";"GNF-Pf-2714";"COc1ccc(C(=O)NC(c2ccc(C)cc2)c2cc(Cl)c3cccnc3c2O)cc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL379386";"";"0";"395.26";"1";"5.34";"GNF-Pf-2722";"Brc1ccc(Nc2nc(NCc3ccco3)c3ccccc3n2)cc1";"IFI";"'='";"11.11";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL579149";"";"0";"344.42";"0";"3.53";"GNF-Pf-2726";"Oc1nnc(SCc2nc3ccccc3s2)n1Cc1ccco1";"IFI";"'='";"4.098";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL577136";"";"0";"494.62";"0";"2.38";"GNF-Pf-2734";"Cc1c(C(=O)N2CCC(C)CC2)sc2ncn(CC(=O)N3CCN(c4ccccn4)CC3)c(=O)c12";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL577388";"";"0";"323.37";"0";"0.66";"GNF-Pf-2747";"O=C(O)CSc1ccc(C(=O)NC2CCCCNC2=O)cn1";"IFI";"'='";"1.389";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL601989";"";"0";"440.24";"0";"4.25";"GNF-Pf-2749";"O=C(Nc1ccc(-c2cn3cccnc3n2)cc1)c1ccccc1I";"IFI";"'='";"7.692";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL578484";"";"0";"351.36";"0";"3.46";"GNF-Pf-2761";"CCC(=O)NC(c1cccc([N+](=O)[O-])c1)c1ccc2cccnc2c1O";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL578290";"";"0";"372.47";"0";"4.46";"GNF-Pf-2772";"CCCCOc1ccc(C2C3CCCC=C3C(C#N)=C(N)C2(C#N)C#N)cc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL603940";"";"0";"460.38";"0";"4.93";"GNF-Pf-2777";"CCN1C(=Cc2sc3ccccc3[n+]2C)C=Cc2ccc(C)cc21.[I-]";"IFI";"";"";"";"";"";"Not applicable";"";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL601792";"";"0";"534.70";"1";"5.11";"GNF-Pf-2794";"CCN1C(=Cc2sc3ccc(OC)cc3[n+]2CC)C=Cc2ccccc21.Cc1ccc(S(=O)(=O)[O-])cc1";"IFI";"'='";"25.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL578234";"";"0";"408.89";"1";"5.13";"GNF-Pf-2821";"COc1ccc(Nc2nc(Nc3ccc(OC)cc3)c3ccccc3n2)cc1.Cl";"IFI";"'='";"7.519";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL577151";"";"0";"462.59";"0";"4.67";"GNF-Pf-2825";"CC(C)CN(CC(=O)Nc1cc(C(C)(C)C)nn1-c1ccccc1)C(=O)COc1ccccc1";"IFI";"'='";"1.852";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL1744502";"";"0";"852.07";"3";"4.59";"GNF-Pf-2848";"CC=C[C@H]1O[C@@](O)([C@@H](C)C(O)C(C)[C@H]2OC(=O)C(OC)=CC(C)=C[C@@H](C)[C@@H](O)[C@@H](C)[C@@H](O)C(C)CC(C)=CC=C[C@@H]2OC)C[C@@H](O[C@H]2C[C@@H](O)[C@H](OC(N)=O)[C@@H](C)O2)[C@@H]1C";"IFI";"'='";"15.52";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL576767";"";"0";"278.27";"0";"1.82";"GNF-Pf-2855";"N#Cc1ccccc1Cn1nc(-c2cccnc2)oc1=O";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL579141";"";"0";"415.32";"1";"5.58";"GNF-Pf-2878";"COc1cccc(NCC(O)Cn2c3ccc(Cl)cc3c3cc(Cl)ccc32)c1";"IFI";"'='";"0.6757";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL536423";"";"0";"566.10";"2";"7.19";"GNF-Pf-2879";"CCC(c1nc2ccccc2c(=O)n1-c1ccc(Cl)cc1C)N(CCc1ccccc1)C(=O)c1cccc(OC)c1";"IFI";"'='";"2.83";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL576991";"";"0";"399.45";"0";"2.29";"GNF-Pf-2882";"C=CCNC(=O)c1cc2c(=O)n3ccccc3nc2n(CCc2ccccc2)c1=N";"IFI";"'='";"15.38";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL579357";"";"0";"301.46";"0";"4.05";"GNF-Pf-2887";"CC1CCN(c2ncnc3sc4c(c23)CCC(C)C4)CC1";"IFI";"'='";"2.353";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL603519";"";"0";"385.53";"1";"5.32";"GNF-Pf-2889";"O=C(C[n+]1cc(-c2ccccc2)n2c1CCC2)c1ccc(C2CCCCC2)cc1";"IFI";"'='";"12.5";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL599908";"";"0";"281.36";"0";"2.70";"GNF-Pf-2894";"Cc1cccc(CCNc2cc(C)nc3nc(C)nn23)c1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL524603";"";"0";"437.45";"0";"3.13";"GNF-Pf-2895";"COc1ccc(OCC(=O)Nc2cccc(NC(=O)COc3ccc(OC)cc3)n2)cc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL10835";"";"0";"350.03";"1";"5.94";"GNF-Pf-2903";"O=C(Nc1ccc(Cl)c(Cl)c1)Nc1ccc(Cl)c(Cl)c1";"IFI";"'='";"6.061";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL582694";"";"0";"268.32";"0";"2.24";"GNF-Pf-2905";"Cc1cc(Nc2ccc(N(C)C)cc2)n2ncnc2n1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL603017";"";"0";"360.37";"0";"2.52";"GNF-Pf-2908";"COC(=O)C1=C(C)N(C)C(C)=C(C(=O)OC)C1c1ccc([N+](=O)[O-])cc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL579966";"";"0";"412.49";"0";"3.85";"GNF-Pf-2916";"COc1ccccc1CNC(=O)C1c2ccccc2C(=O)N2CCc3ccccc3C12";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL579971";"";"0";"333.86";"0";"4.19";"GNF-Pf-2918";"CN(CCCNc1ccnc2cc(Cl)ccc12)C(=O)C(C)(C)C";"IFI";"'='";"1.869";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL531165";"";"0";"463.58";"1";"5.69";"GNF-Pf-2920";"COc1cc(OC)nc(C(Sc2ccc(NC(=O)c3cccs3)cc2)c2ccccc2)n1";"IFI";"'='";"0.7874";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL581678";"";"0";"298.77";"0";"4.95";"GNF-Pf-2948";"COc1ccc2nc(C)cc(Nc3cccc(Cl)c3)c2c1";"IFI";"'='";"3.261";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL581038";"";"0";"432.70";"0";"3.95";"GNF-Pf-2951";"CCCN1CCC(N2C[C@@H](NCCC3=C(C)CCCC3(C)C)C[C@H]2C(=O)NCC)CC1";"IFI";"'='";"3.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL601343";"";"0";"299.35";"0";"2.18";"GNF-Pf-2952";"O=C(c1cccc(F)c1)N1CCN(Cc2ccncc2)CC1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL582310";"";"0";"420.47";"1";"5.48";"GNF-Pf-2963";"CCOc1cc(/C=C(\C#N)c2nc3ccccc3[nH]2)ccc1OCc1ccccc1C#N";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL601372";"";"0";"513.73";"2";"8.06";"GNF-Pf-2964";"Cc1ccn2c(NC(C)(C)CC(C)(C)C)c(-c3ccccc3OC(=O)C34CC5CC(CC(C5)C3)C4)nc2c1";"IFI";"'='";"2.041";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL582059";"";"0";"405.46";"1";"6.27";"GNF-Pf-2965";"O=C(Nc1ccc(-c2nc3ccccc3[nH]2)cc1)c1ccccc1Oc1ccccc1";"IFI";"'='";"6.742";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL587819";"";"0";"405.26";"0";"4.71";"GNF-Pf-2967";"O=C(Nc1cccnc1)c1cc(-c2cccnc2)nc2ccc(Br)cc12";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL601977";"";"0";"342.55";"1";"5.03";"GNF-Pf-3342";"CC1(C)C2CCC1(C)C(OCC[N+]1(Cc3ccccc3)CCCC1)C2";"IFI";"'='";"9.615";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL535252";"";"0";"576.62";"2";"5.87";"GNF-Pf-3348";"O=C1c2cccc(N3CCCC(C(=O)N4CCCCC4c4cccnc4)C3)c2C(=O)N1Cc1ccc(C(F)(F)F)cc1";"IFI";"'='";"6.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL579731";"";"0";"430.98";"1";"6.36";"GNF-Pf-3356";"CCN(CC)CCNc1nc(/C=C/c2ccc(Cl)cc2)nc2cc3ccccc3cc12";"IFI";"'='";"8.772";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL582482";"";"0";"525.61";"1";"4.12";"GNF-Pf-3373";"COc1cc(C2c3[nH]c4ccccc4c3C[C@@H]3C(=O)N(CCc4ccccc4)CC(=O)N23)cc(OC)c1OC";"IFI";"'='";"2.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600500";"";"0";"294.14";"0";"3.48";"GNF-Pf-4215";"Cc1cc(Nc2ccc(Cl)c(Cl)c2)n2ncnc2n1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL584630";"";"0";"431.49";"0";"3.52";"GNF-Pf-5005";"CCc1cc2c3c(c1)C1(C(=O)N3C(C)(C)CC2C)C(C#N)=C(N)Oc2cc(C)oc(=O)c21";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL588175";"";"0";"383.54";"1";"6.23";"GNF-Pf-2601";"CCN1/C(=C/c2ccc3ccccc3[n+]2CC)Sc2c1ccc1ccccc21";"IFI";"";"";"";"";"";"Not applicable";"";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600525";"";"0";"313.41";"0";"2.87";"GNF-Pf-2616";"CCOc1ccc2[nH]c3c(NCCCN(C)C)ncnc3c2c1";"IFI";"'='";"3.333";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL578912";"";"0";"405.93";"0";"4.19";"GNF-Pf-2618";"Cc1nc(-c2nc3c(s2)CN(C(=O)COc2ccc(Cl)cc2)CC3)cs1";"IFI";"'='";"4.167";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL601150";"";"0";"408.53";"0";"3.82";"GNF-Pf-190";"Cc1sc2nc(C3CC3)n(C3CCN(C(=O)c4ccccn4)CC3)c(=O)c2c1C";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL579961";"";"0";"471.60";"0";"3.01";"GNF-Pf-207";"COC(=O)c1c(S(=O)(=O)NCCc2ccccc2)sc2c1CCN(Cc1cccnc1)C2";"IFI";"'='";"1.709";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL582698";"";"0";"434.50";"0";"3.98";"GNF-Pf-209";"O=C(NC1CC1)c1ccc(N2C(=O)C3C4c5ccccc5C(c5ccccc54)C3C2=O)cc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600717";"";"0";"315.33";"0";"2.50";"GNF-Pf-218";"COC(=O)c1ccccc1NC(=O)COc1cccc(OC)c1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL582299";"";"0";"389.50";"0";"4.53";"GNF-Pf-232";"COc1cccc(C2(NC(=O)CCn3ccnc3-c3ccccc3)CCCC2)c1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL581675";"";"0";"549.43";"2";"6.34";"GNF-Pf-237";"O=C(c1ccncc1)N1N=C(c2c(-c3ccccc3)c3cc(Br)ccc3[nH]c2=O)CC1c1ccccc1";"IFI";"'='";"4.11";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL578926";"";"0";"314.32";"0";"2.79";"GNF-Pf-161";"CCN(C(=O)Cn1c(=O)oc2ccccc21)c1ccc(F)cc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL579344";"";"0";"399.97";"1";"5.70";"GNF-Pf-166";"O=C(CCC1CCCC1)NC1CCC(Nc2ccnc3cc(Cl)ccc23)CC1";"IFI";"'='";"0.9009";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600944";"";"0";"492.62";"1";"6.03";"GNF-Pf-169";"COc1ccc(C(=O)N2C(C(=O)Nc3ccccc3F)CSC2c2ccc(C(C)(C)C)cc2)cc1";"IFI";"'='";"2.151";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL576998";"";"0";"269.74";"0";"3.97";"GNF-Pf-181";"Nc1ccc2[nH]c(/C=C/c3ccc(Cl)cc3)nc2c1";"IFI";"'='";"7.692";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585771";"";"0";"560.57";"2";"5.08";"GNF-Pf-183";"O=C(O)c1ccc(S(=O)(=O)c2ccc3c(c2)C(=O)N(c2ccc(Sc4ccc([N+](=O)[O-])cc4)cc2)C3=O)cc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL601980";"";"0";"265.25";"0";"1.88";"GNF-Pf-188";"N=C1NC(=O)C(=CC=Cc2ccc([N+](=O)[O-])o2)S1";"IFI";"";"";"";"";"";"Not applicable";"";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600515";"";"0";"274.41";"0";"3.41";"GNF-Pf-239";"CC(C)(C)c1ccc(NC(=O)CN2CCCCC2)cc1";"IFI";"'='";"2.655";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600546";"";"0";"320.39";"0";"4.68";"GNF-Pf-253";"O=C(Nc1ccc(N2CCCCC2)cc1)c1cc2ccccc2o1";"IFI";"'='";"10.94";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL581219";"";"0";"302.37";"0";"3.43";"GNF-Pf-255";"CCOC(=O)c1[nH]c(C)c(CNc2cccc(OC)c2)c1C";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL582062";"";"0";"281.35";"0";"1.04";"GNF-Pf-261";"C[C@@H]1C[C@@H](C)C(=O)[C@@H](C(O)CC2CC(=O)NC(=O)C2)C1";"IFI";"'='";"23.44";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL582688";"";"0";"407.30";"1";"6.77";"GNF-Pf-266";"Cc1ccc2nc(-c3ccccc3)cc(C(=O)Nc3ccc(Cl)c(Cl)c3)c2c1";"IFI";"'='";"1.504";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL579962";"";"0";"373.43";"0";"1.23";"GNF-Pf-277";"Cc1cccc(OCC(=O)NCCNC2=NS(=O)(=O)c3ccccc32)c1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600519";"";"0";"407.58";"1";"6.71";"GNF-Pf-15";"CN1/C(=C\C=C\C2=[N+](C)c3ccc4ccccc4c3C2(C)C)C(C)(C)c2ccccc21";"IFI";"'='";"23.08";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL532518";"";"0";"240.19";"0";"1.13";"GNF-Pf-23";"CCOC(=O)CC(C)(O)P(=O)(OC)OC";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585747";"";"0";"518.53";"1";"4.85";"GNF-Pf-31";"C=CC1CN2CCC1CC2[C@@H](OC(=O)c1cc([N+](=O)[O-])cc([N+](=O)[O-])c1)c1ccnc2ccc(OC)cc12";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL578488";"";"0";"522.68";"1";"4.87";"GNF-Pf-41";"O=C(NC(=S)Nc1ccc(-c2nc3ccccc3s2)cc1)c1ccc(S(=O)(=O)N2CCCC2)cc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585389";"";"0";"552.70";"2";"6.57";"GNF-Pf-45";"CCCCOc1cccc(NC(=O)CSC2=C(C#N)C(c3ccccc3)C(C(=O)Nc3ccccc3)=C(C)N2)c1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL577628";"";"0";"367.20";"0";"2.74";"GNF-Pf-49";"Cc1c(Br)c([N+](=O)[O-])nn1CC(=O)NC(C)c1ccccc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL601350";"";"0";"310.33";"0";"3.24";"GNF-Pf-55";"CN(C)c1ccc(/C=C2\N=C(c3ccccc3F)OC2=O)cc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL577860";"";"0";"530.11";"2";"7.45";"GNF-Pf-59";"CCCCCN(C(=O)CCc1ccccc1)C(CC)c1nc2ccccc2c(=O)n1-c1ccc(Cl)cc1C";"IFI";"'='";"2.913";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL578511";"";"0";"333.35";"0";"2.78";"GNF-Pf-65";"Oc1ccc(C=NN=C(Nc2ccccn2)c2ccccn2)c(O)c1";"IFI";"'='";"23.08";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585584";"";"0";"563.99";"2";"1.03";"GNF-Pf-69";"COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)C[C@](O)(C(C)=O)C[C@@H]3O[C@H]1C[C@@H](N)[C@H](O)[C@H](C)O1.Cl";"IFI";"'='";"19.67";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL578472";"";"0";"421.48";"0";"3.43";"GNF-Pf-72";"COc1ccc(SC2CCN(C3CCOCC3)CC2)cc1.O=C(O)C(F)(F)F";"IFI";"'='";"1.389";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL599930";"";"0";"315.44";"0";"3.24";"GNF-Pf-74";"COc1ccc(CN2CCC(Sc3ncccn3)CC2)cc1";"IFI";"'='";"1.389";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL578695";"";"0";"507.59";"1";"4.42";"GNF-Pf-82";"COc1ccc(CCN(C(=S)Nc2ccccc2)C2CC(=O)N(c3ccc(F)cc3)C2=O)cc1OC";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL602801";"";"0";"434.48";"0";"2.59";"GNF-Pf-83";"CC(C)CC(N)C(=O)NCCCNc1nsc2ccccc12.O=C(O)C(F)(F)F";"IFI";"'='";"20.83";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL582502";"";"0";"415.46";"0";"3.39";"GNF-Pf-305";"CCOCCCN(C(=O)C(F)(F)F)C(C(=O)NC1CCCCC1)c1ccncc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600745";"";"0";"331.42";"0";"0.94";"GNF-Pf-312";"Cc1ccc(N2C(=O)CC(NCCCN3CCOCC3)C2=O)cc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL604563";"";"0";"449.60";"0";"3.99";"GNF-Pf-314";"COc1ccc(C2C(C(=O)NCCN(C)C)c3ccccc3C(=O)N2C2CCCCC2)cc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL582514";"";"0";"520.72";"1";"3.80";"GNF-Pf-323";"CCCN1CCC(N2C[C@@H](NCc3cc(C)ccc3C)C[C@H]2C(=O)NCCc2ccc3c(c2)OCO3)CC1";"IFI";"'='";"6.25";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL582689";"";"0";"533.65";"2";"6.68";"GNF-Pf-338";"CCC(c1nc2ccccc2c(=O)n1-c1ccc(F)cc1)N(CCc1ccccc1)C(=O)CCc1ccccc1";"IFI";"'='";"3.158";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL601371";"";"0";"411.51";"0";"1.54";"GNF-Pf-342";"Cn1c(=O)c2c(nc3n(CCCO)c(C45CC6CC(CC(C6)C4)C5)cn23)n(C)c1=O";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL602809";"";"0";"421.91";"1";"5.58";"GNF-Pf-3140";"Cc1cccc(-c2nc3cc(NC(=S)NC(=O)c4ccc(Cl)cc4)ccc3o2)c1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL602415";"";"0";"342.75";"0";"4.80";"GNF-Pf-3153";"CC(Nc1ccccc1)C(=O)Nc1cc(C(F)(F)F)ccc1Cl";"IFI";"'='";"7.5";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL582681";"";"0";"546.11";"2";"7.53";"GNF-Pf-3177";"CCCCCCN(C(=O)c1cccc(OC)c1)C(CC)c1nc2ccccc2c(=O)n1-c1ccc(Cl)cc1C";"IFI";"'='";"0.9346";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL601808";"";"0";"465.59";"1";"5.88";"GNF-Pf-3178";"CCOC(=O)CCC(=O)Oc1ccccc1-c1nc2ccccn2c1NC(C)(C)CC(C)(C)C";"IFI";"'='";"2.83";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL580159";"";"0";"273.72";"0";"3.53";"GNF-Pf-3183";"Oc1ccc(Cl)cc1CNc1nc2ccccc2[nH]1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL527949";"";"0";"269.74";"0";"3.97";"GNF-Pf-3187";"Nc1ccc2nc(C=Cc3ccc(Cl)cc3)[nH]c2c1";"IFI";"";"";"";"";"";"Not applicable";"";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL588619";"CINCHONINE";"0";"294.40";"0";"3.16";"GNF-Pf-3189";"C=C[C@H]1CN2CC[C@H]1C[C@@H]2[C@@H](O)c1ccnc2ccccc12";"IFI";"'='";"4.688";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL603023";"";"0";"325.37";"0";"1.77";"GNF-Pf-3192";"O=C(c1ccncc1)N1CCN(Cc2ccc3c(c2)OCO3)CC1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL581871";"";"0";"322.15";"0";"2.21";"GNF-Pf-3200";"C[n+]1cccc2ccc3cccnc3c21.[I-]";"IFI";"'='";"1.389";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL581872";"";"0";"471.04";"1";"5.15";"GNF-Pf-3201";"COc1ccc(-c2n(C)c3ccccc3[n+]2CC(=O)OC2CC(C)CCC2C(C)C)cc1.[Cl-]";"IFI";"'='";"22.73";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL580397";"";"0";"478.00";"1";"6.00";"GNF-Pf-3221";"N#Cc1c(-c2ccccc2)cc(N2CCN(Cc3ccc(Cl)cc3)CC2)n2c1nc1ccccc12";"IFI";"'='";"7.5";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL581248";"";"0";"446.55";"0";"3.96";"GNF-Pf-3222";"COc1ccc(C=CC(=O)Nc2ccc3nc(N4CCN(C)CC4)cc(C)c3c2)cc1OC";"IFI";"";"";"";"";"";"Not applicable";"";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL581258";"";"0";"259.70";"0";"2.55";"GNF-Pf-3239";"Clc1ccc(NCn2nnc3ccccc32)nc1";"IFI";"'='";"1.587";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL602211";"";"0";"359.48";"0";"3.73";"GNF-Pf-3245";"Cc1cc(N2CCN(C3CCCC3)CC2)n2c(nc3ccccc32)c1C#N";"IFI";"'='";"4.706";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL601768";"";"0";"354.84";"0";"4.60";"GNF-Pf-3257";"CCCC(=O)NC(c1ccc(Cl)cc1)c1ccc2cccnc2c1O";"IFI";"'='";"16.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL582079";"";"0";"362.27";"0";"3.63";"GNF-Pf-3274";"CCN(CC)CCNc1ncnc2c1[nH]c1ccc(Br)cc12";"IFI";"'='";"5.66";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL582082";"";"0";"413.90";"0";"4.53";"GNF-Pf-3278";"COc1cccc(OC)c1C(=O)NCCCCNc1ccnc2cc(Cl)ccc12";"IFI";"'='";"0.9346";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL601769";"";"0";"349.41";"0";"2.87";"GNF-Pf-3282";"COc1ccc(S(=O)(=O)ON=C2C=C(C(C)C)C(=O)C=C2C)cc1";"IFI";"'='";"7.692";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600716";"";"0";"628.81";"2";"6.11";"GNF-Pf-3285";"COc1ccc(C2CC(c3cccs3)=NN2C(=O)CSc2nnc(CNC(=O)c3cccs3)n2-c2cccc(C)c2)cc1";"IFI";"'='";"3.571";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL548572";"";"0";"396.28";"1";"5.84";"GNF-Pf-3288";"Oc1c(C(Nc2ccccn2)c2ccc(Cl)cc2Cl)ccc2cccnc12";"IFI";"'='";"13.43";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL581672";"";"0";"375.94";"1";"5.56";"GNF-Pf-3292";"CCCCCC(=O)NCCCCCCNc1ccnc2cc(Cl)ccc12";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL486081";"";"0";"406.49";"1";"6.59";"GNF-Pf-3294";"c1ccc(OCCOc2ccc(Nc3ccnc4cc5ccccc5cc34)cc2)cc1";"IFI";"'='";"6.154";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL582286";"";"0";"426.59";"1";"6.09";"GNF-Pf-3312";"Cc1ccccc1OCCSc1nc2ccc(NC(=O)c3cccs3)cc2s1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL601362";"";"0";"438.61";"1";"5.35";"GNF-Pf-5599";"COc1ccc(OC)c(-c2ccc(O)c(CNCC3(N4CCCCC4)CCCCC3)c2)c1";"IFI";"'='";"0.885";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL601363";"";"0";"581.49";"1";"4.08";"GNF-Pf-5602";"CN(c1ccc(Br)cc1)S(=O)(=O)c1ccc2[nH]cc(C(=O)N3CCN(c4ccccc4)CC3)c(=O)c2c1";"IFI";"'='";"5.128";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL579135";"";"0";"417.51";"1";"5.73";"GNF-Pf-5604";"Cc1ccc(-c2c3c(nc4sc(C(=O)Nc5ccc(F)cc5)c(N)c24)CCC3)cc1";"IFI";"'='";"7.143";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL2092739";"DIHYDROQUINIDINE";"0";"326.44";"0";"3.40";"GNF-Pf-5606";"CCC1CN2CCC1CC2[C@@H](O)c1ccnc2ccc(OC)cc12";"IFI";"";"";"";"";"";"Not applicable";"";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL529837";"";"0";"267.28";"0";"2.86";"GNF-Pf-5613";"CCOC(=O)c1c[nH]c2c(ccc3ccccc32)c1=O";"IFI";"'='";"1.587";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL317364";"";"0";"277.80";"0";"3.64";"GNF-Pf-5623";"CCN(CC)CCNc1ccnc2cc(Cl)ccc12";"IFI";"'='";"7.143";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL611811";"";"0";"500.42";"2";"6.32";"GNF-Pf-5633";"CCCOC(=O)C1=C(C)NC2=C(C(=O)CC(c3ccc(OC)cc3)C2)C1c1ccc(Cl)cc1Cl";"IFI";"'='";"2.353";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585357";"";"0";"532.59";"2";"5.46";"GNF-Pf-5639";"COc1ccc(C2CC(=O)C3=C(C2)NC(C)=C(C(=O)OC2CCCC2)C3c2ccc([N+](=O)[O-])cc2)cc1OC";"IFI";"'='";"3.529";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL579309";"";"0";"451.49";"0";"4.38";"GNF-Pf-5642";"COC(=O)C1=C(C)NC2=C(C(=O)CC(c3ccc(OC)c(OC)c3)C2)C1c1ccc(F)cc1";"IFI";"'='";"7.059";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL579313";"";"0";"546.45";"2";"5.56";"GNF-Pf-5646";"COCCOC(=O)C1=C(C)NC2=C(C(=O)CC(c3ccc(OC)c(OC)c3)C2)C1c1ccc(Cl)cc1Cl";"IFI";"'='";"3.529";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL578479";"";"0";"465.52";"0";"4.77";"GNF-Pf-5651";"CCOC(=O)C1=C(C)NC2=C(C(=O)CC(c3ccc(OC)c(OC)c3)C2)C1c1ccc(F)cc1";"IFI";"'='";"8.333";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL578284";"";"0";"448.52";"0";"4.88";"GNF-Pf-5661";"CCOC(=O)c1cc(-c2ccc(OC)cc2)n(CCC(=O)Nc2cccc(C(C)=O)c2)c1C";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL577202";"";"0";"349.91";"0";"3.55";"GNF-Pf-5678";"CCCCN(CCCC)C(=O)Cn1ccc(=N)c2ccccc21.Cl";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL577426";"";"0";"443.59";"0";"4.94";"GNF-Pf-5680";"COC(=O)c1sc2nc(CN3CCC(C)CC3)ccc2c1NC(=O)c1ccc(C)s1";"IFI";"'='";"1.739";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL577429";"";"0";"390.36";"1";"5.18";"GNF-Pf-5684";"CCOC(=O)c1cnc2c(OC)cccc2c1Nc1cccc(C(F)(F)F)c1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL577646";"";"0";"249.34";"0";"3.17";"GNF-Pf-5685";"Cn1cc(/C=C/c2cc[n+](C)cc2)c2ccccc21";"IFI";"";"";"";"";"";"Not applicable";"";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL577435";"";"0";"494.47";"1";"5.79";"GNF-Pf-5695";"OC(CN1CCN(C/C=C/c2ccccc2)CC1)Cn1c2ccc(Cl)cc2c2cc(Cl)ccc21";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL582449";"";"0";"505.59";"2";"5.69";"GNF-Pf-5422";"COc1ccc(C2CC(=O)C3=C(C2)NC(C)=C(C(=O)OC2CCCC2)C3c2ccccc2F)cc1OC";"IFI";"'='";"5.882";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL582661";"";"0";"355.40";"1";"5.01";"GNF-Pf-5426";"COc1cncc(-c2cncc(-c3ccc(Oc4ccccc4)cc3)n2)c1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL601991";"";"0";"512.40";"2";"5.00";"GNF-Pf-5445";"COC(=O)C1=C(C)NC2=C(C(=O)CC(c3ccc(OC)c(OC)c3)C2)C1c1ccccc1Br";"IFI";"'='";"4.819";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL522825";"";"0";"390.53";"1";"5.04";"GNF-Pf-5454";"CCN1/C(=C/c2ccc3ccccc3[n+]2CC)Sc2cc(NC(C)=O)ccc21";"IFI";"";"";"";"";"";"Not applicable";"";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL121663";"DEQUALINIUM CHLORIDE";"4";"527.58";"1";"6.17";"GNF-Pf-5483";"Cc1cc(N)c2ccccc2[n+]1CCCCCCCCCC[n+]1c(C)cc(N)c2ccccc21.[Cl-].[Cl-]";"IFI";"'='";"5.789";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL532416";"";"0";"435.95";"1";"5.65";"GNF-Pf-5494";"CC1=C(C(=O)OC(C)C)C(c2ccccc2Cl)C2=C(CC(c3ccccc3)CC2=O)N1";"IFI";"'='";"2.353";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL579153";"";"0";"517.58";"1";"3.90";"GNF-Pf-5503";"CCCCNC(=O)C(c1cccc(OC)c1)N1C(=O)c2cc(Oc3ccccc3)ccc2NC(=O)C1CO";"IFI";"'='";"3.03";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL602169";"";"0";"316.50";"0";"1.48";"GNF-Pf-5507";"CC(C)(C)NC(=S)NN=CC=NNC(=S)NC(C)(C)C";"IFI";"'='";"4.724";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL578740";"";"0";"480.95";"1";"5.56";"GNF-Pf-5508";"CC1=C(C(=O)OC(C)C)C(c2ccc([N+](=O)[O-])cc2)C2=C(CC(c3ccc(Cl)cc3)CC2=O)N1";"IFI";"'='";"2.353";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL578323";"";"0";"356.45";"0";"4.27";"GNF-Pf-5512";"CC(CCc1ccccc1)N1CC(c2cccc([N+](=O)[O-])c2)OC1=S";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL601987";"";"0";"338.41";"0";"4.90";"GNF-Pf-5520";"Cc1cccc(Nc2c3c(c(C#N)c4nc5ccccc5n24)CCC3)c1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL577227";"";"0";"316.31";"0";"2.15";"GNF-Pf-5319";"O=[N+]([O-])c1cccc(C(O)CNCc2ccc3c(c2)OCO3)c1";"IFI";"'='";"0.813";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL576608";"";"0";"401.47";"0";"4.75";"GNF-Pf-5321";"COc1ccc(Cn2c(C)nc3cc(NC(=O)Nc4ccccc4)c(C)nc32)cc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL546917";"";"0";"354.49";"0";"4.15";"GNF-Pf-5323";"COc1ccccc1N1CCN(Cc2cc(C(C)C)c(C)cc2O)CC1";"IFI";"'='";"3.125";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL601795";"";"0";"559.09";"2";"6.45";"GNF-Pf-5327";"CCOc1ccccc1C1C(C#N)=C(SCC(=O)Nc2ccc(Cl)cc2)NC(C)=C1C(=O)Nc1ccccc1";"IFI";"'='";"3.614";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL578545";"";"0";"481.02";"1";"6.27";"GNF-Pf-5328";"COc1ccc(NC(=O)C2c3ccccc3C(=O)N(C3CCCC3)C2c2cccs2)cc1Cl";"IFI";"'='";"6.25";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL601397";"";"0";"447.56";"1";"7.13";"GNF-Pf-5338";"O=C1C2=C(Nc3ccccc3SC2c2ccc(OCc3ccccc3)cc2)c2ccccc21";"IFI";"'='";"18.18";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL582448";"";"0";"352.39";"0";"4.17";"GNF-Pf-5357";"CCOC(=O)c1cnc2ccccc2c1Nc1ccc(OC)c(OC)c1";"IFI";"'='";"14.29";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL599920";"";"0";"517.03";"0";"3.67";"GNF-Pf-5375";"Cl.O=C(Nc1ccc(C2=NCCCN2)cc1)c1ccc(C(=O)Nc2ccc(C3=NCCCN3)cc2)cc1";"IFI";"'='";"5.263";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL601318";"";"0";"345.25";"0";"3.26";"GNF-Pf-5008";"CCSc1ccc2ccccc2[n+]1CC.[I-]";"IFI";"'='";"0.7463";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL603891";"";"0";"521.66";"2";"6.83";"GNF-Pf-4245";"CC1=C(C(=O)OCC(C)C)C(c2ccc(OCc3ccccc3)cc2)C2=C(CC(c3ccccc3)CC2=O)N1";"IFI";"'='";"3.529";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL597854";"";"0";"337.89";"1";"5.32";"GNF-Pf-4249";"Cc1c2c(cc3c1ccc1ccccc13)C[N+]1(CCCCC1)C2.[Cl-]";"IFI";"'='";"1.515";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL528422";"";"0";"317.82";"0";"3.56";"GNF-Pf-4269";"CN(CCCNc1ccnc2cc(Cl)ccc12)C(=O)C1CC1";"IFI";"'='";"2.778";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600498";"";"0";"340.81";"0";"4.04";"GNF-Pf-4067";"CCc1ccc(-n2nnc(C(=O)Nc3ccccc3Cl)c2C)cc1";"IFI";"'='";"2.857";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL584675";"";"0";"363.29";"0";"3.15";"GNF-Pf-4076";"Cl.Clc1ccc2c(c1)nc(N1CCNCC1)n2Cc1ccccc1";"IFI";"'='";"0.8";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585133";"";"0";"464.35";"1";"5.01";"GNF-Pf-4089";"N#Cc1c(N)nc2sc(C(=O)Nc3ccc(Br)cc3)c(N)c2c1-c1ccccc1";"IFI";"'='";"1.515";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL578503";"";"0";"343.84";"0";"0.97";"GNF-Pf-104";"Cl.Nc1nc(N)c2cc(S(=O)(=O)N3CCCCC3)ccc2n1";"IFI";"'='";"16.41";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL578687";"";"0";"431.58";"0";"4.94";"GNF-Pf-133";"CCCCN(C)Cc1ccc2c(NC(=O)c3ccc(C)s3)c(C(=O)OC)sc2n1";"IFI";"'='";"1.724";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL601353";"";"0";"501.31";"2";"6.72";"GNF-Pf-2414";"Cc1cc(Nc2cccc(C(F)(F)F)c2)nc2ccc(NC(=O)c3cncc(Br)c3)cc12";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL578698";"";"0";"421.91";"1";"6.05";"GNF-Pf-2475";"Clc1cccc(CSc2nc(Nc3ccc4c(c3)OCO4)c3ccccc3n2)c1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL578077";"";"0";"263.34";"0";"4.24";"GNF-Pf-2496";"C=C1C=CN(Cc2ccccc2)c2ccc(OC)cc21";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL582460";"";"0";"277.36";"0";"3.05";"GNF-Pf-1876";"CCCN(Cc1cc(OC)c2c(c1)OCO2)CC1CC1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL599918";"";"0";"450.49";"0";"4.61";"GNF-Pf-1889";"CCC(=O)NCc1nnc(SCc2cccc(C(F)(F)F)c2)n1-c1cccc(OC)c1";"IFI";"'='";"0.885";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL577666";"";"0";"539.38";"0";"3.43";"GNF-Pf-1894";"COc1cc(C(=O)N2CCN(Cc3cccc(Br)c3)CC2)cc(OC)c1OC.O=C(O)C(=O)O";"IFI";"'='";"1.124";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL601550";"";"0";"265.34";"0";"2.62";"GNF-Pf-1904";"OCC[n+]1ccc(/C=C/c2c[nH]c3ccccc23)cc1";"IFI";"'='";"2.273";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL578333";"";"0";"427.51";"0";"1.92";"GNF-Pf-1912";"Cc1ccccc1OCC(O)Cn1c(NC2CCCCC2)nc2c1c(=O)[nH]c(=O)n2C";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL1197556";"";"0";"327.45";"1";"5.04";"GNF-Pf-1919";"CCN1/C(=C/c2ccc3ccccc3[n+]2CC)C=Cc2ccccc21";"IFI";"'='";"22.73";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585785";"";"0";"410.30";"1";"6.15";"GNF-Pf-5062";"Cc1ccnc(NC(c2ccc(Cl)cc2Cl)c2ccc3cccnc3c2O)c1";"IFI";"'='";"15.38";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL579265";"";"0";"381.51";"0";"3.49";"GNF-Pf-2660";"Cc1ncc(CN2CCC(C(=O)Nc3ccc(-n4cccn4)cc3)CC2)s1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL579287";"";"0";"319.38";"0";"2.17";"GNF-Pf-2663";"COC(=O)C1CCCN1S(=O)(=O)c1ccc2ccccc2c1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL602607";"";"0";"536.08";"2";"6.25";"GNF-Pf-2665";"CC(C)c1ccc(NC(=O)c2ccc(NCCCN3CCN(c4cccc(Cl)c4)CC3)c([N+](=O)[O-])c2)cc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL578878";"";"0";"335.41";"0";"2.63";"GNF-Pf-2671";"Cn1c(SCc2cccc([N+](=O)[O-])c2)nc2c(c1=O)SCC2";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL581695";"";"0";"552.50";"2";"7.24";"GNF-Pf-438";"CCCCCN(C(=O)COc1ccc(Cl)cc1)C(CC)c1nc2ccccc2c(=O)n1-c1cccc(Cl)c1";"IFI";"'='";"2.857";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600948";"";"0";"555.43";"2";"6.98";"GNF-Pf-465";"CC(C)N(CC(=O)Nc1cc(C(C)(C)C)nn1-c1ccc(Cl)c(Cl)c1)C(=O)c1ccc(C(F)(F)F)cc1";"IFI";"'='";"1.905";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL581265";"";"0";"395.87";"0";"2.90";"GNF-Pf-478";"O=[N+]([O-])c1cccc(Cl)c1N1CCN(S(=O)(=O)Cc2ccccc2)CC1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL588250";"";"0";"386.88";"0";"3.97";"GNF-Pf-1935";"COc1ccccc1Nc1nc(NCC2CCCO2)c2ccccc2n1.Cl";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL586455";"";"0";"494.30";"0";"2.93";"GNF-Pf-1942";"O=C(COC(c1ccccc1)c1c(Cl)cncc1Cl)N1CCNCC1.O=C(O)C(F)(F)F";"IFI";"'='";"3.96";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL577652";"";"0";"331.20";"1";"5.54";"GNF-Pf-2201";"O=Cc1c(OCc2ccc(Cl)cc2Cl)ccc2ccccc12";"IFI";"'='";"5.634";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL576526";"";"0";"366.21";"0";"4.33";"GNF-Pf-2209";"O=C1C(=O)N(Cc2cccc3ccccc23)c2ccc(Br)cc21";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL577154";"";"0";"439.56";"0";"4.16";"GNF-Pf-2214";"O=C(NC1CCN(Cc2ccccc2)CC1)[C@@H](c1ccccc1)N1Cc2ccccc2C1=O";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL578702";"";"0";"462.59";"1";"6.24";"GNF-Pf-2242";"CCN(CC)CCCC(C)Nc1cc(/C=C/c2ccc([N+](=O)[O-])cc2)nc2cc(OC)ccc12";"IFI";"'='";"3.614";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL576983";"";"0";"485.84";"1";"6.14";"GNF-Pf-2252";"CCCCN(C)CCCNC(=O)c1ccc(Cl)c(NC(=O)Nc2ccc(Cl)c(Cl)c2)c1";"IFI";"'='";"2.941";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL577861";"";"0";"372.42";"0";"2.42";"GNF-Pf-2261";"CO[C@H]1O[C@@H]2COC(c3ccccc3)O[C@H]2[C@@H](O)[C@@H]1OCc1ccccc1";"IFI";"'='";"1.587";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL602796";"";"0";"307.36";"0";"2.39";"GNF-Pf-2263";"OCCCNc1cc(-c2ccccn2)nc(-c2ccccn2)n1";"IFI";"'='";"15.38";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL601764";"";"0";"387.32";"0";"3.02";"GNF-Pf-2267";"O=S(=O)(c1ccc(Br)s1)N1CCN(c2ccccc2)CC1";"IFI";"'='";"0.7937";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL578268";"";"0";"376.46";"1";"6.58";"GNF-Pf-2294";"Cc1cc(Nc2cccc3ccccc23)nc(Nc2cccc3ccccc23)n1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL531611";"";"0";"282.55";"0";"2.73";"GNF-Pf-2296";"O=C(CCl)NCCOc1ccc(Cl)cc1Cl";"IFI";"'='";"7.692";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL582247";"";"0";"444.31";"0";"4.70";"GNF-Pf-2029";"CCOc1ccc(N=C2NC(=O)SC2=C2C(=O)Nc3ccc(Br)cc32)cc1";"IFI";"";"";"";"";"";"Not applicable";"";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL601145";"";"0";"351.41";"0";"2.92";"GNF-Pf-2333";"CCC(C)NC(=O)c1nn(-c2cccc(OC)c2)c(=O)c2ccccc12";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL578257";"";"0";"488.44";"1";"5.88";"GNF-Pf-2357";"CCCC[n+]1c(C=C2C=Cc3ccccc3N2CC)sc2ccccc21.[I-]";"IFI";"";"";"";"";"";"Not applicable";"";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL597458";"";"0";"467.53";"0";"2.47";"GNF-Pf-3712";"Nc1c(C(=O)Nc2ccc(C3=NCCN3)cc2)cccc1C(=O)Nc1ccc(C2=NCCN2)cc1";"IFI";"'='";"7.407";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL583825";"";"0";"306.34";"0";"3.90";"GNF-Pf-3738";"Fc1ccccc1CCNc1ncnc2c1[nH]c1ccccc12";"IFI";"'='";"12.5";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL583196";"";"0";"335.75";"0";"2.80";"GNF-Pf-3748";"O=C(c1ccc([N+](=O)[O-])o1)N1CCN(c2cccc(Cl)c2)CC1";"IFI";"'='";"4.706";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL432537";"";"0";"293.24";"0";"1.84";"GNF-Pf-3777";"O=C1c2cc([N+](=O)[O-])ccc2-n2c1nc1ccccc1c2=O";"IFI";"'='";"4.545";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL605753";"";"0";"319.41";"0";"2.59";"GNF-Pf-4276";"Cc1c2c(n3c(nc4ccccc43)c1C#N)N(CCN(C)C)CC2";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL528258";"";"0";"266.30";"0";"3.70";"GNF-Pf-4065";"Cc1cc(Nc2ccc(O)cc2)nc2cccc(O)c12";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL528984";"";"0";"350.45";"0";"3.56";"GNF-Pf-5079";"CCc1c(C#N)c(N)nc(SCC(=O)c2ccc(C)cc2C)c1C#N";"IFI";"'='";"7.143";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600552";"";"0";"483.66";"1";"7.47";"GNF-Pf-5104";"Cc1ccn2c(NC(C)(C)CC(C)(C)C)c(-c3ccccc3OC(=O)CCc3ccccc3)nc2c1";"IFI";"'='";"3.738";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585055";"";"0";"404.94";"0";"3.17";"GNF-Pf-4802";"CC1CN(C(=O)C(Cl)(Cl)Cl)C(C)CN1C(=O)C(Cl)(Cl)Cl";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL601189";"";"0";"566.46";"2";"7.32";"GNF-Pf-5209";"COc1cc2c(-c3cc(Br)ccc3O)nc3c(c(Cc4ccccc4)nn3-c3ccccc3)c2cc1OC";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585595";"";"0";"326.44";"0";"2.87";"GNF-Pf-4848";"Oc1ccc(-c2ccccc2)cc1CNCCCN1CCOCC1";"IFI";"'='";"0.8696";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL602564";"";"0";"637.62";"2";"9.19";"GNF-Pf-4860";"CC(C)c1cccc(C(C)C)c1NC(=O)N(Cc1ccccc1)C(C)c1nc2ccccc2c(=O)n1-c1ccc(Br)cc1";"IFI";"'='";"5.556";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL588732";"";"0";"444.60";"0";"4.99";"GNF-Pf-4877";"Cc1ccc(Cn2c(N3CCC(C(=O)NCc4cccs4)CC3)nc3ccccc32)cc1";"IFI";"'='";"2.703";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585830";"";"0";"316.40";"0";"2.32";"GNF-Pf-4897";"CCN(CC)Cc1cc2ccc(C)cc2n(CC(=O)OC)c1=O";"IFI";"'='";"1.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600350";"";"0";"368.51";"0";"3.81";"GNF-Pf-4938";"CCCCNC(=O)CSCc1cnn(-c2ccccc2)c1-n1cccc1";"IFI";"'='";"2.439";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600567";"";"0";"377.47";"0";"4.73";"GNF-Pf-4972";"COc1ccc(-n2c(COc3cccc4ccccc34)nnc2SC)cc1";"IFI";"'='";"2.83";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585968";"";"0";"509.62";"1";"4.78";"GNF-Pf-4983";"CCOC(=O)C1=C(C)NC2=C(C(=O)C(C(=O)OCC)C(c3ccccc3OC)C2)C1c1sccc1C";"IFI";"'='";"3.488";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL586545";"";"0";"338.41";"0";"2.98";"GNF-Pf-1777";"CC(C)COc1ccc(C(=O)N/C(=C/c2ccccc2)C(N)=O)cc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600957";"";"0";"457.49";"1";"6.45";"GNF-Pf-1792";"O=[N+]([O-])c1ccc(-c2nc3ccccc3n2-c2cc(-c3ccccc3)nn2-c2ccccc2)cc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL577876";"";"0";"397.95";"1";"5.76";"GNF-Pf-1808";"CCN1C(=Cc2sc3ccc(Cl)cc3[n+]2CC)C=Cc2cc(OC)ccc21";"IFI";"'='";"15.38";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585959";"";"0";"610.11";"2";"3.62";"GNF-Pf-1810";"CCOC(=O)c1sc(NC(=O)CSc2nnc(CNC(=O)COc3ccc(Cl)cc3)n2C)c(C(=O)OCC)c1C";"IFI";"'='";"1.19";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL601331";"";"0";"349.48";"0";"3.54";"GNF-Pf-1822";"CCc1cc(C(=O)OC)c(NC(=S)NC(C)c2ccncc2)s1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL579374";"";"0";"528.61";"2";"6.09";"GNF-Pf-1830";"CCCCCN(C(=O)c1cccc([N+](=O)[O-])c1)C(CC)c1nc2ccccc2c(=O)n1-c1ccccc1OC";"IFI";"'='";"0.9346";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL2021448";"";"0";"336.44";"0";"3.74";"GNF-Pf-1832";"C=C[C@H]1CN2CC[C@H]1C[C@H]2[C@H](OC(C)=O)c1ccnc2ccccc12";"IFI";"'='";"1.887";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL601988";"";"0";"480.43";"1";"6.37";"GNF-Pf-1837";"Cc1cc(C)cc(-n2c(C)cc(/C=C3/SC(=Nc4ccc(Br)cc4)NC3=O)c2C)c1";"IFI";"'='";"2.381";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL532177";"";"0";"279.30";"0";"3.37";"GNF-Pf-1839";"COc1ccc(/C=C\c2nc(=O)c3ccccc3o2)cc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL588918";"";"0";"490.49";"0";"2.73";"GNF-Pf-1840";"O=C(O)C(F)(F)F.c1ccc(-c2cc(NCCCN3CCOCC3)nc(-c3ccccn3)n2)nc1";"IFI";"'='";"15.38";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600711";"";"0";"165.22";"0";"1.72";"GNF-Pf-1850";"Nc1cc(-c2cccs2)n[nH]1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL582005";"";"0";"512.08";"0";"4.56";"GNF-Pf-1864";"Cl.Nc1nc(NCC2CCC(CNS(=O)(=O)c3cccc4ccccc34)CC2)nc2ccccc12";"IFI";"'='";"3.906";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL580129";"";"0";"404.56";"1";"5.37";"GNF-Pf-1869";"CCN1C(=Cc2sc3cc(NC(C)=O)ccc3[n+]2CC)C=Cc2cc(C)ccc21";"IFI";"'='";"7.692";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL582251";"";"0";"429.52";"0";"3.73";"GNF-Pf-1871";"CCCCn1c(=N)c(C(=O)NC(C)c2ccccc2)cc2c(=O)n3cccc(C)c3nc21";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL602013";"";"0";"538.74";"2";"8.34";"GNF-Pf-1875";"CCCN(C(=O)Nc1c(C(C)C)cccc1C(C)C)C(CC)c1nc2ccccc2c(=O)n1-c1cccc(C)c1";"IFI";"'='";"0.9434";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL1500740";"";"0";"313.38";"0";"3.10";"GNF-Pf-1878";"CCN1CCCC1CNc1[nH]cnc2c3cc(F)ccc3nc1-2";"IFI";"'='";"2.439";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL577882";"";"0";"415.88";"1";"5.87";"GNF-Pf-1896";"COc1cc(/C=C(\C#N)c2nc3ccccc3[nH]2)ccc1OCc1ccc(Cl)cc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL576807";"";"0";"412.56";"0";"3.08";"GNF-Pf-1897";"CN(C)CCNC(=O)COc1ccc(-c2nc3ccccc3s2)cc1CN(C)C";"IFI";"'='";"3.419";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL601542";"";"0";"198.24";"0";"0.97";"GNF-Pf-1921";"COC(=O)C[S+]([O-])c1ccccc1";"IFI";"'='";"2.105";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL602378";"";"0";"377.53";"1";"5.42";"GNF-Pf-1985";"CCN1/C(=C/c2sc3ccc(OC)cc3[n+]2CC)C=Cc2cc(C)ccc21";"IFI";"'='";"23.08";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL577451";"";"0";"436.58";"0";"3.89";"GNF-Pf-1994";"COc1ccc(CN2C[C@H](Sc3nc4ccccc4[nH]3)C[C@H]2C(=O)NC2CC2)cc1C";"IFI";"'='";"14.41";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL546464";"";"0";"534.96";"3";"5.03";"GNF-Pf-1995";"Cc1ccc(Nc2nc(NN=Cc3ccc(-c4ccc([N+](=O)[O-])cc4)o3)nc(N3CCOCC3)n2)cc1Cl";"IFI";"'='";"4.706";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL602984";"";"0";"288.14";"0";"1.53";"GNF-Pf-2007";"CC(=O)N1CCNC1=Nc1c(Cl)nc(C)nc1Cl";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL579479";"";"0";"432.75";"1";"5.27";"GNF-Pf-2022";"O=C(NCCCCNc1ccnc2cc(Cl)ccc12)c1ccccc1Br";"IFI";"'='";"1.852";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL576796";"";"0";"358.74";"0";"2.27";"GNF-Pf-2044";"O=C(CN1C(=O)c2ccccc2C1=O)Nc1cc(Cl)ccc1C(=O)O";"IFI";"'='";"7.692";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL601361";"";"0";"353.90";"0";"4.84";"GNF-Pf-2054";"Cc1ccc2nc3c(c(Nc4ccc(N(C)C)cc4)c2c1)CCC3.Cl";"IFI";"'='";"1.064";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600943";"";"0";"285.39";"0";"2.09";"GNF-Pf-2097";"O=C(CN1CCCC1)Nc1c2c(nc3c1CCC3)CCC2";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL578945";"";"0";"432.44";"0";"3.46";"GNF-Pf-2658";"O=C(C1=C(O)C(=O)N(CCCn2ccnc2)C1c1ccccc1[N+](=O)[O-])c1ccccc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL579305";"";"0";"525.10";"1";"4.54";"GNF-Pf-2672";"CN1CCc2c(sc3nc(SCC(=O)NCCc4ccccc4)n(-c4ccc(Cl)cc4)c(=O)c23)C1";"IFI";"'='";"12.5";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600537";"";"0";"403.53";"0";"4.22";"GNF-Pf-2694";"COc1cccc(-c2ccc(O)c(CNC3CCN(Cc4ccccc4)CC3)c2)n1";"IFI";"'='";"4.31";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL599902";"";"0";"303.23";"0";"2.85";"GNF-Pf-2727";"Cl.O=C(CCl)Nc1ccc(CN2CCCCC2)cc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL576327";"";"0";"419.98";"1";"5.97";"GNF-Pf-2738";"O=C(C[n+]1cc(-c2ccc(Cl)cc2)n2c1CCC2)c1ccc(C2CCCCC2)cc1";"IFI";"'='";"27.5";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL578879";"";"0";"257.30";"0";"2.26";"GNF-Pf-2739";"Cc1cc(C)nc(NC(=N)Nc2cccc(O)c2)n1";"IFI";"'='";"1.053";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL609156";"";"0";"245.28";"0";"2.27";"GNF-Pf-2742";"CCOC(=O)c1c[nH]c2c(CC)cccc2c1=O";"IFI";"'='";"1.587";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL601127";"";"0";"304.43";"0";"3.91";"GNF-Pf-2752";"CCCCN1C(=O)N(c2ccccc2C)C(C)(O)CC1(C)C";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL581245";"";"0";"524.96";"1";"4.30";"GNF-Pf-3079";"COc1cc(OC)c(NC(=O)c2ccc(N3CC4CC(C3)c3cccc(=O)n3C4)c([N+](=O)[O-])c2)cc1Cl";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL581255";"";"0";"545.06";"2";"6.06";"GNF-Pf-3096";"COc1ccc(Cl)cc1NC(=O)CSC1=C(C#N)C(c2ccccc2)C(C(=O)Nc2ccccc2)=C(C)N1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL602784";"";"0";"257.25";"0";"1.26";"GNF-Pf-3111";"O=C(NN=Cc1ccc(O)cc1O)c1ccncc1";"IFI";"'='";"2.727";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL535432";"";"0";"322.50";"0";"4.28";"GNF-Pf-3144";"CCN1CCC(NCCC(c2ccccc2)c2ccccc2)CC1";"IFI";"'='";"4.098";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL586554";"";"0";"348.19";"0";"3.14";"GNF-Pf-3169";"Cc1nc2ccccn2c1C1(O)C(=O)Nc2c(Cl)cc(Cl)cc21";"IFI";"'='";"9.375";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL582466";"";"0";"452.52";"0";"2.89";"GNF-Pf-3175";"O=C(Nc1cccc(C2=NCCN2)c1)c1ccc(C(=O)Nc2cccc(C3=NCCN3)c2)cc1";"IFI";"'='";"0.8929";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600140";"";"0";"449.86";"1";"5.18";"GNF-Pf-3206";"CC12CN(Cc3ccccc3)CC(C)(CN(Cc3cccc(Br)c3)C1)C2.Cl";"IFI";"'='";"15.38";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL601800";"";"0";"344.89";"0";"3.41";"GNF-Pf-3213";"OCCC1CN(Cc2cccc(Cl)c2)CCN1Cc1ccccc1";"IFI";"'='";"7.692";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL581857";"";"0";"321.85";"0";"2.77";"GNF-Pf-3253";"CC(C)N(C(=O)Cn1ccc(=N)c2ccccc21)C(C)C.Cl";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL582073";"";"0";"387.35";"0";"4.24";"GNF-Pf-3268";"Cc1ccc(-c2c[n+](-c3ccccc3)c3n2CCCS3)cc1.[Br-]";"IFI";"'='";"7.692";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL534573";"";"0";"718.89";"2";"6.22";"GNF-Pf-3304";"COc1cccc(CCOc2ccc3c(c2)C(=O)N(C(CC(C)C)C(=O)NC2CCN(Cc4ccccc4)CC2)[C@@H](Cc2ccc(O)cc2)C(=O)N3)c1";"IFI";"'='";"4.717";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL602207";"";"0";"433.60";"1";"6.44";"GNF-Pf-3326";"Cc1ccc(NC(=O)c2sc3nc4c(c(-c5cccs5)c3c2N)CCCCC4)cc1";"IFI";"'='";"2.41";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585781";"";"0";"530.11";"2";"7.53";"GNF-Pf-4911";"CCCCCCN(C(=O)CCc1ccccc1)C(CC)c1nc2ccccc2c(=O)n1-c1ccc(Cl)cc1";"IFI";"'='";"2.778";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL584830";"";"0";"436.51";"1";"5.49";"GNF-Pf-4917";"O=C(Nc1ccccc1)c1ccccc1OCC(O)Cn1c2ccccc2c2ccccc21";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585051";"";"0";"462.38";"0";"4.85";"GNF-Pf-4937";"CSC(Cl)=C(NC(C)=O)[P+](c1ccccc1)(c1ccccc1)c1ccccc1.[Cl-]";"IFI";"";"";"";"";"";"Not applicable";"";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL586008";"";"0";"472.61";"1";"5.96";"GNF-Pf-4957";"CC(C)C(=O)N1CCOc2c(cc(-c3csc4ccccc34)cc2OCCc2ccccn2)C1";"IFI";"'='";"1.923";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585834";"";"0";"492.45";"1";"5.54";"GNF-Pf-4975";"O=[N+]([O-])c1cc(C(F)(F)F)ccc1N1CCCN(C(=S)Nc2cccc(C(F)(F)F)c2)CC1";"IFI";"'='";"2.632";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600277";"";"0";"709.60";"1";"5.52";"GNF-Pf-4986";"Cc1onc(-c2ccccc2)c1C(=O)N1CCC(CNc2c(-c3ccoc3)nc3ccccn23)CC1.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F";"IFI";"'='";"4.167";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL533366";"";"0";"654.19";"2";"5.40";"GNF-Pf-5597";"O=C(Cc1c(F)cccc1Cl)Nc1cc(C(=O)N2CCN(Cc3ccccc3)CC2)ccc1N1CC2CC(C1)c1cccc(=O)n1C2";"IFI";"'='";"1.205";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL586203";"";"0";"409.55";"0";"4.75";"GNF-Pf-5610";"CCOC(=O)C(=O)N1c2ccc(OCC)cc2-c2c(ssc2=S)C1(C)C";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL579077";"";"0";"364.45";"0";"3.67";"GNF-Pf-5628";"COC(=O)C1=C(C)NC(=Cc2cc(C)n(-c3cc(C)ccc3C)c2C)C1=O";"IFI";"";"";"";"";"";"Not applicable";"";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL531808";"";"0";"561.70";"2";"7.82";"GNF-Pf-5632";"COc1cc(NC(C)CCCN(Cc2ccc(F)cc2)C(=O)C(c2ccccc2)c2ccccc2)c2ncccc2c1";"IFI";"'='";"4.673";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL532481";"";"0";"604.51";"2";"7.43";"GNF-Pf-5645";"CCC(c1nc2ccccc2c(=O)n1-c1ccc(F)c(Cl)c1)N(CCc1ccccc1)C(=O)COc1ccc(Cl)cc1";"IFI";"'='";"2.83";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL586020";"";"0";"439.60";"1";"5.31";"GNF-Pf-5044";"COC(=O)C1=C(C)NC2=C(C(=O)CC(c3ccccc3)C2)C1c1cc(C)sc1SC";"IFI";"'='";"4.706";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL601180";"";"0";"368.39";"0";"3.15";"GNF-Pf-5058";"CCOC(=O)c1ccc(Nc2nc(N)c3cc(OC)c(OC)cc3n2)cc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585810";"";"0";"391.51";"0";"4.77";"GNF-Pf-5087";"COc1ccc(OC)c(-c2ccc(O)c(CNCC3CC4C=CC3C43CC3)c2)c1";"IFI";"'='";"1.709";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL582953";"";"0";"462.47";"0";"4.67";"GNF-Pf-5108";"Cc1ccc(C)c(Oc2c(C(F)(F)F)oc3c(CN4CCN(C)CC4)c(O)ccc3c2=O)c1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585774";"";"0";"549.62";"1";"4.43";"GNF-Pf-5143";"CCOC(=O)C1=C(C)NC2=C(C(=O)C(C(=O)OCC)C(c3cccc(OC)c3)C2)C1c1ccc(OC)c(OC)c1";"IFI";"'='";"3.488";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL577453";"";"0";"458.60";"0";"4.62";"GNF-Pf-5144";"COCC(=O)NCc1ccc(OC2CCN(CC(c3ccccc3)c3ccccc3)CC2)cc1";"IFI";"'='";"1.408";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600329";"";"0";"462.47";"0";"4.76";"GNF-Pf-5158";"CCN1CCN(Cc2c(O)ccc3c(=O)c(Oc4cccc(C)c4)c(C(F)(F)F)oc23)CC1";"IFI";"'='";"1.176";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL607520";"";"0";"548.64";"2";"6.51";"GNF-Pf-5169";"COc1ccccc1NC(=O)N(Cc1ccccc1)C(C)c1nc2ccccc2c(=O)n1-c1cc(C)ccc1OC";"IFI";"'='";"2.5";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL603006";"";"0";"381.91";"0";"4.83";"GNF-Pf-5228";"O=C(CCc1ccccc1)NCCCCNc1ccnc2cc(Cl)ccc12";"IFI";"'='";"3.774";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL599655";"";"0";"347.80";"0";"4.02";"GNF-Pf-4284";"COc1cc(NC(=O)C=Cc2ccccc2Cl)cc(OC)c1OC";"IFI";"";"";"";"";"";"Not applicable";"";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL596651";"";"0";"452.26";"0";"4.46";"GNF-Pf-4285";"O=C(Cn1c2ccccc2c(=O)c2ccccc21)Nc1ccc([N+](=O)[O-])c(Br)c1";"IFI";"'='";"3.571";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL601108";"";"0";"382.24";"0";"3.25";"GNF-Pf-4306";"COC(=O)C1C(=O)C2=C(CC1C)NC(=O)CC2c1cccc(Cl)c1Cl";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600487";"";"0";"333.41";"0";"3.28";"GNF-Pf-4357";"COc1ccc(-c2c[n+](CC(=O)c3ccccc3)c3n2CCC3)cc1";"IFI";"'='";"2.381";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL597251";"";"0";"482.22";"0";"4.45";"GNF-Pf-4481";"OC(CNCC1CCCO1)Cn1c2ccc(Br)cc2c2cc(Br)ccc21";"IFI";"'='";"11.69";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL529837";"";"0";"267.28";"0";"2.86";"GNF-Pf-4388";"CCOC(=O)c1c[nH]c2c(ccc3ccccc32)c1=O";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL533195";"";"0";"490.52";"1";"5.35";"GNF-Pf-4389";"CN1CCN(Cc2c(O)ccc3c(=O)c(Oc4ccc(C(C)(C)C)cc4)c(C(F)(F)F)oc23)CC1";"IFI";"'='";"2.353";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL529773";"";"0";"328.20";"0";"2.53";"GNF-Pf-4408";"CCc1c(C)c(=N)c2ccccc2n1C.I";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL530445";"";"0";"294.19";"0";"4.35";"GNF-Pf-4409";"CCCCc1c(C)nc2ccc(Br)cc2c1O";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL604325";"";"0";"363.44";"0";"3.29";"GNF-Pf-4412";"COc1ccc(-c2c[n+](CC(=O)c3cccc(OC)c3)c3n2CCC3)cc1";"IFI";"'='";"2.5";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585419";"";"0";"308.34";"0";"2.81";"GNF-Pf-4524";"COc1ccc(-c2nc(-c3ccncc3)cnc2N)cc1OC";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL602563";"";"0";"323.85";"0";"4.28";"GNF-Pf-4812";"Clc1ccc(-c2c[n+](CCc3ccccc3)c3n2CCC3)cc1";"IFI";"'='";"5.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL586344";"";"0";"273.33";"0";"2.44";"GNF-Pf-4824";"CCCc1cc(O)c2c3c(c(=O)oc2c1)CN(C)CC3";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585452";"";"0";"467.55";"0";"4.31";"GNF-Pf-4825";"COc1ccc(-n2nc3c(c2NC(=O)C=Cc2cc(OC)c(OC)c(OC)c2)CSC3)cc1";"IFI";"";"";"";"";"";"Not applicable";"";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL584620";"";"0";"515.65";"2";"6.25";"GNF-Pf-4856";"COc1ccc(C2CC(=O)C3=C(C2)NC(C)=C(C(=O)OC2CCCCC2)C3c2cccc(C)c2)cc1OC";"IFI";"'='";"6.522";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL578466";"";"0";"363.51";"0";"4.36";"GNF-Pf-4946";"CC[n+]1c(/C=C2\Sc3ccccc3N2CCO)ccc2cc(C)ccc21";"IFI";"";"";"";"";"";"Not applicable";"";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600361";"";"0";"412.28";"0";"3.30";"GNF-Pf-4961";"COc1cc(C2CC(=O)NC(C)=C2C(=O)OC(C)C)c(OC)cc1Br";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL529870";"";"0";"320.21";"0";"2.69";"GNF-Pf-4962";"CN(C)c1cc[n+](CC(=O)c2ccc(Br)cc2)cc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL586013";"";"0";"404.30";"0";"3.72";"GNF-Pf-4963";"CCN1C=CC(=Cc2ccc3cc(C)ccc3[n+]2C)C=C1.[I-]";"IFI";"'='";"15.38";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585833";"";"0";"340.43";"0";"4.84";"GNF-Pf-4970";"CCc1c(C)c(C#N)c2nc3ccccc3n2c1NCc1ccccc1";"IFI";"'='";"5.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL400092";"LYCORINE";"0";"287.31";"0";"0.75";"GNF-Pf-4974";"O[C@H]1C=C2CCN3Cc4cc5c(cc4[C@H]([C@@H]1O)[C@@H]23)OCO5";"IFI";"";"";"";"";"";"Not applicable";"";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585601";"";"0";"381.45";"0";"4.55";"GNF-Pf-4990";"COc1ccc(OC)c(-c2ccc(O)c(CNCCc3ccc(F)cc3)c2)c1";"IFI";"'='";"2.586";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585602";"";"0";"402.07";"0";"3.44";"GNF-Pf-4991";"C[n+]1ccccc1C=Cc1ccc(Br)cc1.[I-]";"IFI";"";"";"";"";"";"Not applicable";"";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585587";"";"0";"524.62";"2";"5.12";"GNF-Pf-5249";"COC(=O)c1ccc(N(C(=O)Cc2c[nH]c3ccccc23)C(C(=O)NC2CCCCC2)c2cccnc2)cc1";"IFI";"'='";"3.636";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL579379";"";"0";"472.53";"1";"6.34";"GNF-Pf-5395";"CC(C)CN1C(=O)c2ccccc2C(C(=O)Nc2cccc(C(F)(F)F)c2)C1c1cccs1";"IFI";"'='";"3.03";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585435";"";"0";"449.64";"1";"7.42";"GNF-Pf-4537";"CCCCCC(=O)Oc1ccccc1-c1nc2cc(C)ccn2c1NC(C)(C)CC(C)(C)C";"IFI";"'='";"4.673";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585999";"";"0";"530.69";"1";"3.17";"GNF-Pf-4542";"CCOC(=O)c1c(C)[nH]c(C)c1S(=O)(=O)N1CCCC(C(=O)N2CCN(c3cc(C)ccc3C)CC2)C1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL586000";"";"0";"359.43";"1";"5.61";"GNF-Pf-4543";"O=C1c2ccccc2C2=Nc3ccccc3SC(c3cccc(F)c3)C12";"IFI";"'='";"3.226";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL12089";"BERBERINE CHLORIDE";"1";"371.82";"0";"3.10";"GNF-Pf-4545";"COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-]";"IFI";"'='";"1.84";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL583159";"";"0";"274.32";"0";"3.21";"GNF-Pf-4550";"CCOC(=O)c1[nH]c2ccc(C)cc2c1N=NN(C)C";"IFI";"'='";"5.455";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL579424";"";"0";"440.54";"0";"4.64";"GNF-Pf-4453";"COc1cccc(NC(=O)c2ccc(NCCCN3CC(C)CC(C)C3)c([N+](=O)[O-])c2)c1";"IFI";"'='";"7.692";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL583162";"";"0";"332.41";"1";"6.12";"GNF-Pf-4554";"c1ccc(-c2ccnc3c2ccc2c(-c4ccccc4)ccnc23)cc1";"IFI";"'='";"13.74";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL606473";"";"0";"343.41";"1";"5.37";"GNF-Pf-4465";"N#CC(=Cc1ccc(Sc2ccccc2)o1)c1nc2ccccc2[nH]1";"IFI";"";"";"";"";"";"Not applicable";"";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL547770";"";"0";"354.42";"0";"4.29";"GNF-Pf-4578";"c1ccc(-c2csc(Nc3nc4cc5c(cc4s3)OCO5)n2)nc1";"IFI";"'='";"17.78";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL584626";"";"0";"229.28";"0";"2.18";"GNF-Pf-4579";"CCCCNC1=CC(=O)C(=O)c2ccccc21";"IFI";"'='";"15.38";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL584226";"";"0";"471.60";"1";"6.86";"GNF-Pf-4587";"COc1ccccc1C(=O)Oc1ccccc1-c1nc2ccccn2c1NC(C)(C)CC(C)(C)C";"IFI";"'='";"3.774";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL584653";"";"0";"511.90";"1";"3.70";"GNF-Pf-4598";"O=C(c1ccc([N+](=O)[O-])cc1)N1CCC(c2nc(O)c3nnn(Cc4c(F)cccc4Cl)c3n2)CC1";"IFI";"'='";"7.895";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL584451";"";"0";"360.87";"1";"5.53";"GNF-Pf-4607";"COc1ccc(-c2csc(Nc3cccc(Cl)c3C)n2)cc1OC";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL583416";"";"0";"492.63";"1";"6.79";"GNF-Pf-4084";"Cc1cnc(NC(=O)Nc2ccc(-c3ccc(NC(=O)Nc4ncc(C)s4)c(C)c3)cc2C)s1";"IFI";"'='";"7.143";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL602568";"";"0";"243.74";"0";"2.70";"GNF-Pf-708";"O=C1CSC(=S)N1c1cccc(Cl)c1";"IFI";"'='";"3.077";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL603232";"";"0";"518.04";"1";"4.71";"GNF-Pf-730";"O=C1c2cccc(N3CCN(Cc4cccn4-c4nccs4)CC3)c2C(=O)N1Cc1ccc(Cl)cc1";"IFI";"'='";"2.586";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL602601";"";"0";"432.57";"0";"4.74";"GNF-Pf-2839";"CCn1ncc(CN2CCC(C(=O)Nc3ccccc3-c3cccc(OC)c3)CC2)c1C";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL579348";"";"0";"342.44";"0";"3.53";"GNF-Pf-2880";"CCN1CCC(NC2CCCc3c2[nH]c2ccc([N+](=O)[O-])cc32)CC1";"IFI";"'='";"7.143";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL535514";"";"0";"637.73";"2";"5.50";"GNF-Pf-2899";"CCOC(=O)C1=C(c2ccccc2)N=c2sc(=Cc3cc(C)n(-c4ccc(F)cc4)c3C)c(=O)n2C1c1cccc(OC)c1OC";"IFI";"'='";"2.41";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL601161";"";"0";"389.57";"1";"6.12";"GNF-Pf-638";"CCN1/C(=C/c2ccc3cc(C)ccc3[n+]2C)Sc2ccc3ccsc3c21";"IFI";"'='";"10.61";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL584616";"";"0";"443.34";"1";"6.94";"GNF-Pf-916";"N#C/C(=C\c1cn(Cc2ccc(Cl)cc2Cl)c2ccccc12)c1nc2ccccc2[nH]1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL7892";"";"0";"569.62";"1";"4.88";"GNF-Pf-934";"CC(=O)Nc1ccc2c(c1)C(=O)N(C(C(=O)NC1CCCCC1)c1ccc([N+](=O)[O-])cc1)[C@@H](c1ccccc1)C(=O)N2";"IFI";"'='";"1.22";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL581457";"";"0";"407.56";"1";"6.33";"GNF-Pf-2923";"CCCC(=O)Oc1ccccc1-c1nc2ccccn2c1NC(C)(C)CC(C)(C)C";"IFI";"'='";"3.67";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL580559";"";"0";"234.30";"0";"3.69";"GNF-Pf-2930";"CN1C=CC=C/C1=C\C=C1\C=Nc2ccccc21";"IFI";"'='";"7.143";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL602807";"";"0";"431.52";"0";"4.66";"GNF-Pf-2950";"COc1ccc2ccccc2c1C1CC(=O)N2CN(Cc3ccco3)CSC2=C1C#N";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL581453";"";"0";"409.74";"0";"4.75";"GNF-Pf-2994";"COc1ccc(-c2c[n+](Cc3ccc(Cl)cc3Cl)c3n2CCC3)cc1.[Cl-]";"IFI";"'='";"4.762";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL587334";"";"0";"339.35";"0";"3.89";"GNF-Pf-2997";"Cc1noc(-c2ccc(O)cc2O)c1-c1ccc2c(c1)OCCCO2";"IFI";"'='";"3.571";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL601349";"";"0";"476.58";"0";"1.45";"GNF-Pf-1485";"Cc1sc2ncn(CC(=O)N(C)Cc3ccccc3)c(=O)c2c1S(=O)(=O)N1CCOCC1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL599700";"";"0";"450.63";"0";"4.44";"GNF-Pf-640";"CC1CCCCN1CCCNc1ncc(C(=O)NCc2ccccc2)c(NC2CCCC2)n1";"IFI";"'='";"0.9434";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL598480";"";"0";"416.61";"0";"3.75";"GNF-Pf-649";"CC(C)CNC(=O)c1cnc(NCCC2CCCN2C)nc1NCC1CCCCC1";"IFI";"'='";"2.885";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL597859";"";"0";"380.39";"0";"3.15";"GNF-Pf-652";"O=C(CSc1nnc2c(n1)[nH]c1ccccc12)Nc1ccc([N+](=O)[O-])cc1";"IFI";"'='";"2.29";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL597460";"";"0";"446.55";"0";"3.96";"GNF-Pf-659";"COc1ccc(/C=C/C(=O)Nc2ccc3nc(N4CCN(C)CC4)cc(C)c3c2)cc1OC";"IFI";"'='";"8.333";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL530359";"";"0";"601.69";"1";"4.81";"GNF-Pf-541";"COc1ccccc1/C=C/CN(CCN1CCN(S(=O)(=O)c2cccc(C(F)(F)F)c2)CC1)C(=O)Cc1ccccc1";"IFI";"'='";"0.9259";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL580841";"";"0";"420.46";"1";"5.49";"GNF-Pf-558";"CCCc1cc2c(=O)c(-c3cc4ccccc4o3)coc2cc1OC(C)C(=O)OCC";"IFI";"'='";"4.762";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL587267";"";"0";"414.31";"1";"5.17";"GNF-Pf-3341";"Cn1nc(C(F)(F)F)c(-c2ccc(F)cc2)c1NC(=O)Nc1ccc(F)cc1F";"IFI";"'='";"2.479";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL582098";"";"0";"292.43";"0";"3.58";"GNF-Pf-3349";"N=c1c2c(n(CCc3ccccc3)c3c1CCC3)CCCC2";"IFI";"'='";"8.197";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600163";"";"0";"436.55";"0";"4.59";"GNF-Pf-4615";"CCC1CCCCN1C(=O)C1CC(=O)N(c2ccc(OC)cc2)C1c1ccc(OC)cc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL581855";"";"0";"319.41";"0";"2.81";"GNF-Pf-3360";"CCN1CCN(c2cc(C)c(C#N)c3nc4ccccc4n23)CC1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585783";"";"0";"461.63";"1";"7.22";"GNF-Pf-4619";"Cc1ccn2c(NC(C)(C)CC(C)(C)C)c(-c3ccccc3OC(=O)c3cccs3)nc2c1";"IFI";"'='";"3.738";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL599886";"";"0";"318.33";"0";"4.39";"GNF-Pf-4622";"Cc1cc(=O)oc2c1ccc1oc(C(=O)c3ccccc3)c(C)c12";"IFI";"'='";"5.505";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL582533";"";"0";"384.45";"1";"5.81";"GNF-Pf-4682";"O=C1CC(c2ccccc2)CC2=C1C(c1ccccc1F)Nc1ccccc1N2";"IFI";"'='";"1.176";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL530265";"";"0";"602.71";"2";"5.93";"GNF-Pf-4683";"COc1ccccc1N1CCN(C(=O)CCCCSc2nnc3c4cc(F)ccc4n(Cc4ccc(F)cc4)c3n2)CC1";"IFI";"'='";"0.9091";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585596";"";"0";"464.66";"0";"4.34";"GNF-Pf-4566";"O=C(NCCc1ccccc1)c1cnc(NCCCN2CCCC2)nc1NCC1CCCCC1";"IFI";"'='";"0.9524";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585597";"";"0";"516.66";"2";"6.73";"GNF-Pf-4567";"CCOC(=O)c1c(S(=O)(=O)Nc2ccc(C(C)(C)C)cc2)c(-c2ccccc2)n(-c2ccccc2)c1C";"IFI";"'='";"3.093";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL599951";"";"0";"476.02";"1";"7.50";"GNF-Pf-4580";"CC(C)(C)CC(C)(C)Nc1c(-c2ccccc2OC(=O)c2cccc(Cl)c2)nc2ccccn12";"IFI";"'='";"4.717";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL531190";"";"0";"310.42";"0";"2.65";"GNF-Pf-2459";"CCOC(=O)c1c(NC(C)=O)sc2c1CCN(C(C)C)C2";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL530049";"";"0";"237.26";"0";"3.08";"GNF-Pf-2460";"Oc1cccc2ccc(Nc3ccccn3)nc12";"IFI";"'='";"15.22";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL579323";"";"0";"337.49";"1";"5.66";"GNF-Pf-2467";"CCCCc1ccc(Nc2ncnc3sc4c(c23)CCCC4)cc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL602794";"";"0";"363.51";"1";"5.00";"GNF-Pf-2494";"CC[n+]1c(/C=C2\Sc3ccc(OC)cc3N2C)ccc2cc(C)ccc21";"IFI";"'='";"14.29";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL601358";"";"0";"441.54";"0";"3.35";"GNF-Pf-2503";"Cc1cccn2c(=O)c3cc(C(=O)NC4CCCC4)c(=N)n(CCc4ccccc4)c3nc12";"IFI";"'='";"6.757";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL602377";"";"0";"277.80";"0";"3.11";"GNF-Pf-5530";"CC(Cc1ccccc1)NCc1ccccc1O.Cl";"IFI";"'='";"3.125";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL601793";"";"0";"422.57";"1";"5.07";"GNF-Pf-5570";"Oc1ccc(-c2ccc3c(c2)OCO3)cc1CNCC1(N2CCCCC2)CCCCC1";"IFI";"'='";"0.8547";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL576800";"";"0";"373.93";"1";"5.17";"GNF-Pf-1483";"O=C(CCC1CCCC1)NCCCCNc1ccnc2cc(Cl)ccc12";"IFI";"'='";"1.869";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL577004";"";"0";"325.73";"0";"2.97";"GNF-Pf-1486";"O=C(NC(=S)Nc1ccc([N+](=O)[O-])cc1Cl)c1ccco1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL601758";"";"0";"327.27";"None";"None";"GNF-Pf-2426";"C[n+]1c2n(c3ccccc31)N=C(c1ccccc1)C[Se]2";"IFI";"'='";"3.704";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600322";"";"0";"329.88";"0";"4.97";"GNF-Pf-2429";"CC[n+]1c(C=CN(C)c2ccccc2)sc2ccc(Cl)cc21";"IFI";"'='";"9.091";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL578676";"";"0";"458.54";"0";"2.77";"GNF-Pf-2432";"COc1cccc(CNc2ncnc3sc(C(=O)NCC4COCCO4)c(C)c23)c1OC";"IFI";"'='";"1.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL578689";"";"0";"330.39";"0";"4.89";"GNF-Pf-2466";"Cc1ccccc1Nc1nc(NCc2ccco2)c2ccccc2n1";"IFI";"'='";"7.143";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL588589";"";"0";"355.42";"0";"3.49";"GNF-Pf-1776";"COc1ccc(CN(C=O)/C=C2\Sc3ccccc3C2=O)cc1OC";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL610216";"";"0";"333.44";"0";"3.88";"GNF-Pf-3623";"CC(C)NC(=O)c1ccc2c(c1)N=C(c1ccccc1)N(C1CC1)C2";"IFI";"'='";"2.469";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL597457";"";"0";"357.42";"0";"4.46";"GNF-Pf-3626";"COc1ccc2c(C)nc(Nc3nc(C)cc(-c4ccccc4)n3)nc2c1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL597047";"";"0";"284.79";"0";"3.47";"GNF-Pf-3631";"Cc1[nH]c2ccccc2c1/C=C/c1cc[n+](C)cc1.[Cl-]";"IFI";"'='";"4.444";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL579946";"";"0";"379.46";"0";"3.95";"GNF-Pf-3637";"O=C(NC1CC1)c1ccc(N2CCC(Cc3ccccc3)CC2)c([N+](=O)[O-])c1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL604516";"";"0";"370.41";"0";"3.51";"GNF-Pf-3647";"CC1=C(C(=O)OC(C)C)C(c2ccc([N+](=O)[O-])cc2)C2=C(CCCC2=O)N1";"IFI";"'='";"1.136";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL583823";"";"0";"378.40";"0";"3.57";"GNF-Pf-3664";"CC(=O)N(C1=C(N2CCCC2)C(=O)c2ccccc2C1=O)c1cccc(F)c1";"IFI";"'='";"7.692";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL583829";"";"0";"385.42";"0";"2.28";"GNF-Pf-3674";"COc1ccc(C2C(C(C)=O)=C(O)C(=O)N2CCCn2ccnc2)c(OC)c1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL55";"PENTAMIDINE";"4";"340.43";"0";"2.88";"GNF-Pf-3680";"N=C(N)c1ccc(OCCCCCOc2ccc(C(=N)N)cc2)cc1";"IFI";"'='";"2.614";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL3143972";"";"0";"251.20";"0";"-0.24";"GNF-Pf-3681";"NN1C(=O)NC(=O)C1Nc1cccc([N+](=O)[O-])c1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL597034";"";"0";"472.61";"0";"3.68";"GNF-Pf-3687";"CCOC(=O)N1CCC(n2c(SCC(=O)N3CCCCCC3)nc3ccccc3c2=O)CC1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL611371";"";"0";"284.32";"0";"2.75";"GNF-Pf-3711";"COc1ccc(C=CC(=O)Nc2ccncc2)cc1OC";"IFI";"";"";"";"";"";"Not applicable";"";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600497";"";"0";"230.27";"0";"1.84";"GNF-Pf-3722";"COc1ccc2c(c1)C(C)(CC#N)C(=O)N2C";"IFI";"'='";"1.515";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL609036";"";"0";"371.87";"0";"2.83";"GNF-Pf-3723";"CN1CCN(c2nc(Nc3ccc(O)cc3)nc3ccccc23)CC1.Cl";"IFI";"'='";"7.143";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL598076";"";"0";"480.61";"0";"2.80";"GNF-Pf-3729";"COc1ccc(CCN2C(=O)N(CCN(C)C)C(=O)C23CCN(Cc2ccc(O)cc2)CC3)cc1";"IFI";"'='";"2.41";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL584039";"";"0";"357.79";"0";"4.12";"GNF-Pf-3746";"COc1cc(NC(C)=C2C(=O)c3ccccc3C2=O)c(OC)cc1Cl";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL598282";"";"0";"443.34";"1";"6.94";"GNF-Pf-3765";"N#CC(=Cc1cn(Cc2ccc(Cl)cc2Cl)c2ccccc12)c1nc2ccccc2[nH]1";"IFI";"";"";"";"";"";"Not applicable";"";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL597875";"";"0";"267.29";"0";"1.56";"GNF-Pf-3772";"O=C(C=Cc1ccccc1)NNC(=O)c1cccnc1";"IFI";"";"";"";"";"";"Not applicable";"";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL584036";"";"0";"524.01";"2";"5.06";"GNF-Pf-3778";"CCOC(=O)C1=C(C)NC2=C(C(=O)C(C(=O)OCC)C(c3ccccc3OC)C2)C1c1ccc(Cl)cc1";"IFI";"'='";"3.75";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL601827";"";"0";"433.60";"1";"6.44";"GNF-Pf-3793";"Cc1cccc(NC(=O)c2sc3nc4c(c(-c5cccs5)c3c2N)CCCCC4)c1";"IFI";"'='";"3.797";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL582488";"";"0";"495.59";"0";"4.06";"GNF-Pf-3380";"O=C(Nc1ccc(NC(=O)c2ccc(C3=NCCCN3)cc2)cc1)Nc1ccc(C2=NCCCN2)cc1";"IFI";"'='";"0.9091";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585269";"";"0";"328.44";"0";"4.05";"GNF-Pf-4218";"CCCn1cc(SCC(=O)NCc2ccco2)c2ccccc21";"IFI";"'='";"1.149";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL598275";"";"0";"427.55";"0";"3.81";"GNF-Pf-4270";"COCCNC(=S)N(Cc1ccc(F)cc1)Cc1cc2ccc(C)c(C)c2[nH]c1=O";"IFI";"'='";"2.5";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL528165";"";"0";"255.36";"0";"3.68";"GNF-Pf-3815";"CC(C)(C)C1CCc2[nH]c3ccccc3c(=O)c2C1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL598062";"";"0";"303.43";"0";"4.96";"GNF-Pf-3820";"CCCCCCOc1ccc(NC(=O)c2cccs2)cc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL597661";"";"0";"358.46";"0";"3.06";"GNF-Pf-3822";"C=CC1CN2CCC1CC2[C@H](c1ccnc2ccccc12)S(=O)(=O)O";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL611070";"";"0";"378.49";"0";"4.12";"GNF-Pf-3825";"CCCCN(CCCC)S(=O)(=O)c1ccc(NC(=O)c2ccco2)cc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL530149";"";"0";"323.35";"0";"3.09";"GNF-Pf-3828";"COc1cc2cc(C(=O)Nc3ccccc3)c(N)nc2cc1OC";"IFI";"'='";"4.478";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL598493";"";"0";"445.68";"0";"3.11";"GNF-Pf-3841";"CCN(CC)CCN(Cc1cc2c(C)cc(C)cc2[nH]c1=O)C(=S)NCCCN(C)C";"IFI";"'='";"2.083";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL603756";"";"0";"372.48";"0";"3.53";"GNF-Pf-3845";"Cc1cccc(N2CCN(c3nc4ccccc4c4nnc(C)n34)CC2)c1C";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL601112";"";"0";"720.69";"2";"6.25";"GNF-Pf-3850";"COc1ccc(N2C(=O)C3C(C2=O)C2(c4ccccc4)C(=O)C3(c3ccccc3)C(c3ccc4c(c3)OCO4)=C2c2ccc3c(c2)OCO3)c([N+](=O)[O-])c1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL601177";"";"0";"519.77";"2";"9.45";"GNF-Pf-3852";"CCCCCCCCCCCC(=O)Oc1ccccc1-c1nc2ccccn2c1NC(C)(C)CC(C)(C)C";"IFI";"'='";"2.83";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL584253";"";"0";"269.35";"0";"2.47";"GNF-Pf-3857";"CN(C)CCCNc1ncnc2c1[nH]c1ccccc12";"IFI";"'='";"6.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL601384";"";"0";"525.74";"2";"8.89";"GNF-Pf-3858";"CCCCCc1ccc(C(=O)Oc2ccccc2-c2nc3cc(C)ccn3c2NC(C)(C)CC(C)(C)C)cc1";"IFI";"'='";"4.348";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL584257";"";"0";"435.58";"1";"5.48";"GNF-Pf-3861";"N#Cc1c(-c2ccccc2)cc(N2CCN(C3CCCCC3)CC2)n2c1nc1ccccc12";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585511";"";"0";"466.92";"1";"5.68";"GNF-Pf-3869";"O=C(Cn1c2ccccc2c(=O)c2ccccc21)Nc1ccc(Cl)cc1C(=O)c1ccccc1";"IFI";"'='";"6.024";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL602828";"";"0";"340.88";"0";"4.73";"GNF-Pf-2906";"CCn1c(/C=C/N(C)c2ccccc2)[n+](CC)c2cc(Cl)ccc21";"IFI";"'='";"6.25";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL583619";"";"0";"470.59";"1";"5.72";"GNF-Pf-3944";"O=C(C1CC1)N1CCOc2c(cc(-c3csc4ccccc34)cc2OCCc2ccccn2)C1";"IFI";"'='";"0.9524";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600095";"";"0";"347.89";"0";"4.63";"GNF-Pf-3986";"CC(C)(C)CC(=O)NCCCCNc1ccnc2cc(Cl)ccc12";"IFI";"'='";"1.869";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL584674";"";"0";"466.84";"1";"5.60";"GNF-Pf-4006";"COc1ccccc1Nc1nc2cc([N+](=O)[O-])c([N+](=O)[O-])cc2nc1Nc1cccc(Cl)c1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585319";"";"0";"418.45";"0";"3.82";"GNF-Pf-4015";"COc1cc(NC(=O)Cn2c3ccccc3c(=O)c3ccccc32)cc(OC)c1OC";"IFI";"'='";"3.614";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL597651";"";"0";"411.37";"0";"4.79";"GNF-Pf-4020";"C=CCN1C=CC(=Cc2sc3ccccc3[n+]2C)c2ccccc21.[Br-]";"IFI";"";"";"";"";"";"Not applicable";"";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL529062";"";"0";"198.23";"0";"2.12";"GNF-Pf-4043";"CC(Nc1cc(C)ccn1)=C(C#N)C#N";"IFI";"'='";"7.692";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL593726";"";"0";"371.57";"0";"3.97";"GNF-Pf-3411";"O=C(Nc1ccc([N+](=O)[O-])cc1Cl)c1cc(Br)ccc1O";"IFI";"'='";"7.692";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL582100";"";"0";"428.58";"0";"2.95";"GNF-Pf-3419";"CC(C)CN1C(=O)N(CCCc2cccnc2)C(=O)C12CCN(C1CCOCC1)CC2";"IFI";"'='";"6.329";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL602620";"";"0";"405.45";"0";"4.22";"GNF-Pf-3451";"CC(=O)c1ccc(OCc2cc(C(=O)N3CCCCC3c3cccnc3)no2)cc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL582705";"";"0";"271.32";"0";"3.03";"GNF-Pf-3458";"Cc1cccc(C)c1OCC(=O)Nc1ccccc1O";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL582708";"";"0";"367.54";"1";"5.12";"GNF-Pf-3463";"CCCCN(CCCC)CCCNc1ncnc2c1[nH]c1ccc(C)cc12";"IFI";"'='";"2.5";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL581693";"";"0";"293.45";"0";"4.30";"GNF-Pf-3469";"CC(=O)N1CCOC1C(C)(C)CC=C(C)CCC=C(C)C";"IFI";"";"";"";"";"";"Not applicable";"";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL529479";"";"0";"293.32";"0";"3.80";"GNF-Pf-3503";"COc1cc2c(cc1C=C(C#N)c1cccc(C)c1)OCO2";"IFI";"";"";"";"";"";"Not applicable";"";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL604982";"";"0";"393.49";"0";"2.91";"GNF-Pf-3517";"CCCn1c(=N)c(C(=O)NC2CCCCC2)cc2c(=O)n3cccc(C)c3nc21";"IFI";"'='";"8.333";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL598059";"";"0";"461.58";"0";"4.14";"GNF-Pf-3549";"CCN(CC)CCCNCC(=O)N1c2ccccc2Sc2ccccc21.O=CO.O=CO";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL606167";"";"0";"359.43";"1";"5.61";"GNF-Pf-3582";"O=C1c2ccccc2C2=Nc3ccccc3SC(c3ccccc3F)C12";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL601554";"";"0";"318.40";"0";"2.67";"GNF-Pf-3029";"CCCn1nc(NS(C)(=O)=O)c2cc3cccc(C)c3nc21";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL581448";"";"0";"496.64";"1";"5.62";"GNF-Pf-3057";"COc1cccc(-c2cn3c(n2)sc2cc(C(=O)NC4CCN(Cc5ccccc5)CC4)ccc23)c1";"IFI";"'='";"10.53";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL547775";"";"0";"430.52";"1";"5.22";"GNF-Pf-2793";"CCCN(CCC)CCCNc1ccc(C(=O)Nc2ccc(C)c(F)c2)cc1[N+](=O)[O-]";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL577571";"";"0";"410.51";"0";"3.37";"GNF-Pf-2798";"COc1ccc(C(=O)NCCc2ccc(C)cc2)cc1OC1CCN(C(C)=O)CC1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL578471";"";"0";"491.27";"1";"5.44";"GNF-Pf-2815";"Cc1ccc(O)c(NC(=O)c2cnn3c(C(F)(F)F)cc(-c4ccc(Br)cc4)nc23)c1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL610911";"";"0";"410.54";"1";"5.58";"GNF-Pf-2642";"CCCCN(C(=O)c1ccccc1C)c1nc(-c2cc(OC)ccc2OC)cs1";"IFI";"'='";"1.786";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL16476";"PRONETALOL";"4";"229.32";"0";"2.87";"GNF-Pf-2670";"CC(C)NCC(O)c1ccc2ccccc2c1";"IFI";"'='";"0.885";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585767";"";"0";"562.76";"2";"5.09";"GNF-Pf-2706";"Cc1ccc(CNC(=O)CSc2nc3ccsc3c(=O)n2CCCCCC(=O)NCCc2ccccc2)cc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600518";"";"0";"474.50";"1";"5.33";"GNF-Pf-2737";"COCCN1C(=O)c2ccccc2C(C(=O)Nc2cccc(C(F)(F)F)c2)C1c1cccs1";"IFI";"'='";"9.091";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL601152";"";"0";"399.36";"1";"5.40";"GNF-Pf-2740";"O=C(Nc1ccc2oc(-c3cccc4ccccc34)nc2c1)c1ccc([N+](=O)[O-])o1";"IFI";"'='";"7.143";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL535265";"";"0";"350.38";"0";"2.91";"GNF-Pf-2768";"COc1ccc2nc(NC(N)=NC(=O)Nc3ccccc3)nc(C)c2c1";"IFI";"'='";"6.452";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL582516";"";"0";"390.47";"0";"4.02";"GNF-Pf-3110";"COc1ccc(-n2c(CNC(=O)c3cccc4ccccc34)n[nH]c2=S)cc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL579517";"";"0";"563.55";"0";"3.68";"GNF-Pf-3119";"COc1ccc(C(OCC(=O)N2CCN(Cc3ccccc3)CC2)c2ccc(F)cc2)cn1.O=C(O)C(F)(F)F";"IFI";"'='";"2.885";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL581462";"";"0";"489.62";"0";"4.05";"GNF-Pf-3141";"CCCS(=O)(=O)c1c(S(=O)(=O)CCC)c2ccc(C(C)=O)cn2c1C(=O)c1ccc(C)cc1";"IFI";"'='";"3.03";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600746";"";"0";"471.40";"0";"4.24";"GNF-Pf-3160";"CCOc1ccc(C(=O)C(C)[n+]2cc(-c3ccc(OC)cc3)n3c2CCC3)cc1.[Br-]";"IFI";"'='";"8.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL581657";"";"0";"440.66";"0";"3.46";"GNF-Pf-3196";"CCN1CCN(CCCNC(=S)Nc2ccc3nc(N4CCCC4)cc(C)c3c2)CC1";"IFI";"'='";"7.692";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL581875";"";"0";"406.87";"1";"5.79";"GNF-Pf-3205";"COc1cc(-c2nc(-c3cccc(Cl)c3)c(-c3ccccc3)[nH]2)cc(OC)c1O";"IFI";"'='";"3.371";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL582083";"";"0";"460.53";"0";"4.32";"GNF-Pf-3210";"CC(C)CC(NC(=O)C(=Cc1ccco1)NC(=O)c1ccccc1)C(=O)OCc1ccccc1";"IFI";"";"";"";"";"";"Not applicable";"";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL602810";"";"0";"572.53";"2";"5.42";"GNF-Pf-3223";"O=C(Nc1cc(Cl)cc(Cl)c1)C1C2C=CC3(O2)C1C(=O)N(CCC1=CCCCC1)C3C(=O)NC1CCCCC1";"IFI";"'='";"2.128";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL582071";"";"0";"392.33";"0";"1.08";"GNF-Pf-3262";"COc1nc(C)nc(NC(=O)NC(=O)c2c(OC)ccc([N+](=O)[O-])c2OC)n1";"IFI";"'='";"2.609";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL597876";"";"0";"377.24";"0";"4.48";"GNF-Pf-3270";"O=C1NC(=Nc2ccccc2)S/C1=C/c1ccc(F)c(Br)c1";"IFI";"";"";"";"";"";"Not applicable";"";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL582281";"";"0";"295.39";"0";"3.01";"GNF-Pf-3309";"c1ccc2c(c1)[nH]c1c(NCCN3CCCCC3)ncnc12";"IFI";"'='";"3.846";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL577016";"";"0";"433.60";"1";"5.12";"GNF-Pf-5524";"CCSc1nc2sc3c(c2c(=O)n1-c1ccccc1)CCN(Cc1ccccc1)C3";"IFI";"'='";"2.837";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL533563";"";"0";"592.66";"2";"8.20";"GNF-Pf-5533";"CCCCCC(=O)N1c2ccccc2NC2=C(C(=O)CC(c3ccc(OC)c(OC)c3)C2)C1c1ccc(C(F)(F)F)cc1";"IFI";"'='";"3.371";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL530051";"";"0";"356.38";"0";"2.72";"GNF-Pf-5541";"O=C(c1ccco1)N1CCN(c2ccc([N+](=O)[O-])c(NC3CC3)c2)CC1";"IFI";"'='";"1.205";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL580353";"";"0";"360.89";"0";"3.32";"GNF-Pf-5561";"C=CC12CCN(CC1)C(C(O)c1ccnc3ccc(OC)cc13)C2.Cl";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL602360";"";"0";"336.18";"0";"2.70";"GNF-Pf-4936";"CC[n+]1cccc2ccc3cccnc3c21.[I-]";"IFI";"'='";"7.692";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL537716";"";"0";"519.01";"1";"2.93";"GNF-Pf-4940";"Cl.O=C(Nc1ccc(NC2=NCCN2)cc1)c1ccc(C(=O)Nc2ccc(NC3=NCCN3)cc2)cc1";"IFI";"'='";"2.609";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL602794";"";"0";"363.51";"1";"5.00";"GNF-Pf-4968";"CC[n+]1c(/C=C2\Sc3ccc(OC)cc3N2C)ccc2cc(C)ccc21";"IFI";"";"";"";"";"";"Not applicable";"";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL586782";"";"0";"403.96";"0";"1.70";"GNF-Pf-5201";"O=S(=O)(c1ccc(Cl)cc1)N1CCN(C(=S)NCC2CCCO2)CC1";"IFI";"'='";"4.545";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL582674";"";"0";"326.44";"0";"3.34";"GNF-Pf-5224";"COc1ccccc1N1CCN(Cc2cc(C)c(C)cc2O)CC1";"IFI";"'='";"2.941";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL586571";"";"0";"439.54";"0";"3.51";"GNF-Pf-1936";"CC(=O)c1ccc(NC(=O)CN(C)S(=O)(=O)c2ccc3[nH]c4c(c3c2)CCCC4)cc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL601165";"";"0";"326.40";"0";"4.69";"GNF-Pf-1966";"C=CCNc1ncnc2c1c(-c1ccccc1)cn2-c1ccccc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL493863";"";"0";"327.43";"1";"5.95";"GNF-Pf-1979";"CC(C)Nc1ccc(Nc2ccnc3cc4ccccc4cc23)cc1";"IFI";"'='";"14.29";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL582440";"";"0";"341.41";"0";"3.78";"GNF-Pf-2026";"CN(C)c1ccc(/C=C2\SC(=Nc3ccc(F)cc3)NC2=O)cc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL582268";"";"0";"355.87";"0";"4.49";"GNF-Pf-3041";"Cc1nc(-c2ccc[n+](C)c2)sc1C(=O)/C=C/c1ccc(Cl)cc1";"IFI";"'='";"5.714";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL584875";"";"0";"492.62";"0";"4.11";"GNF-Pf-673";"COCCN(CC(=O)Nc1cc(C(C)(C)C)nn1-c1ccc(C)cc1)C(=O)COCc1ccccc1";"IFI";"'='";"1.869";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585084";"";"0";"356.13";"0";"3.19";"GNF-Pf-683";"O=C(OCCOc1ccc([N+](=O)[O-])cc1)c1ccc(Br)o1";"IFI";"'='";"0.7692";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL601799";"";"0";"482.54";"0";"3.84";"GNF-Pf-3072";"CNC1CC2OC(C)(C1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4O";"IFI";"'='";"28.57";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL602399";"";"0";"453.68";"1";"7.78";"GNF-Pf-2835";"CCN1/C(=C/C2=C/C(=C/c3sc4ccccc4[n+]3CC)CC(C)(C)C2)C=Cc2ccccc21";"IFI";"'='";"9.434";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL602195";"";"0";"521.04";"2";"7.35";"GNF-Pf-5665";"COc1cc(NC(C)CCCN(Cc2ccc(Cl)cc2)C(=O)Nc2ccccc2F)c2ncccc2c1";"IFI";"'='";"3.67";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL586825";"";"0";"418.56";"1";"5.02";"GNF-Pf-5417";"C=C[C@H]1CN2CC[C@H]1C[C@@H]2[C@@H](OC(=O)Cc1cccs1)c1ccnc2ccccc12";"IFI";"";"";"";"";"";"Not applicable";"";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL582644";"";"0";"486.34";"0";"4.70";"GNF-Pf-5419";"Cc1cccc[n+]1CCCCCCCCCC[n+]1ccccc1C.[Br-].[Br-]";"IFI";"'='";"1.389";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600523";"";"0";"297.31";"0";"3.13";"GNF-Pf-5455";"CCOC(=O)c1c(C)nc2c(c1C)c(=O)oc1ccccc12";"IFI";"'='";"3.03";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL599720";"";"0";"499.42";"1";"5.46";"GNF-Pf-4129";"CC[n+]1c(C)n(-c2ccccc2)c2ccc(C3Nc4ccccc4S3)cc21.[I-]";"IFI";"'='";"3.175";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL577427";"";"0";"449.52";"1";"5.15";"GNF-Pf-5615";"COc1ccc(C2CC(=O)C3=C(C2)NC(C)=C(C(=O)OC(C)C)C3c2ccc(F)cc2)cc1";"IFI";"'='";"3.488";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL610453";"";"0";"318.17";"0";"3.48";"GNF-Pf-5686";"Cc1nc2cc(-c3ccc(Br)cc3)nn2c(O)c1C";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL577650";"";"0";"467.19";"1";"5.74";"GNF-Pf-5693";"Cc1nn(CC(O)Cn2c3ccc(Cl)cc3c3cc(Cl)ccc32)c(C)c1Br";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL582660";"";"0";"357.44";"0";"2.90";"GNF-Pf-5424";"O=[N+]([O-])c1ccc(N2CCCN(C(=S)Nc3ccccc3)CC2)nc1";"IFI";"'='";"1.667";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL580144";"";"0";"439.97";"1";"5.21";"GNF-Pf-5435";"O=S(=O)(NCCCCNc1ccnc2cc(Cl)ccc12)c1ccc2ccccc2c1";"IFI";"'='";"1.887";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL601564";"";"0";"502.45";"1";"4.71";"GNF-Pf-5457";"COc1cc(-c2cc(C(F)(F)F)n3ncc(C(=O)Nc4cc(C)ccc4O)c3n2)cc(OC)c1OC";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL599926";"";"0";"454.21";"1";"5.07";"GNF-Pf-5465";"CC(C)(C)NCC(O)Cn1c2ccc(Br)cc2c2cc(Br)ccc21";"IFI";"'='";"1.626";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL580145";"";"0";"506.56";"1";"4.93";"GNF-Pf-5497";"CCCOC(=O)C1=C(C)NC2=C(C(=O)CC(c3ccc(OC)c(OC)c3)C2)C1c1cccc([N+](=O)[O-])c1";"IFI";"'='";"2.439";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL601992";"";"0";"601.34";"2";"7.91";"GNF-Pf-5515";"OC(Cn1cnc(-c2ccccc2)c1-c1ccccc1)Cn1c2ccc(Br)cc2c2cc(Br)ccc21";"IFI";"'='";"0.7194";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL578066";"";"0";"403.52";"1";"5.46";"GNF-Pf-5659";"COc1ccc(OC)c(-c2ccc(O)c(CN3CCC(c4ccccc4)CC3)c2)c1";"IFI";"'='";"1.724";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL345083";"";"0";"282.34";"0";"2.39";"GNF-Pf-5671";"CC1CCC2C(C)C(=O)OC3OC4(C)CCC1C32OO4";"IFI";"'='";"7.143";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL601566";"";"0";"451.57";"1";"7.35";"GNF-Pf-5687";"CCCCCCc1cc2cc(-c3nc4ccccc4[nH]3)c(=Nc3ccccc3C)oc2cc1O";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600708";"";"0";"421.71";"0";"4.97";"GNF-Pf-5420";"CC[n+]1c(/C=C/c2ccc(Cl)cc2)ccc2ccccc21.[I-]";"IFI";"'='";"4.839";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL1630";"AMODIAQUINE HYDROCHLORIDE";"0";"392.33";"1";"5.18";"GNF-Pf-5648";"CCN(CC)Cc1cc(Nc2ccnc3cc(Cl)ccc23)ccc1O.Cl";"IFI";"'='";"2.591";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL577014";"";"0";"356.43";"1";"5.57";"GNF-Pf-5460";"Cc1cc(Nc2ccc(OCc3ccccc3)cc2)nc2cc(O)ccc12";"IFI";"'='";"9.091";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL197253";"";"0";"422.50";"0";"3.17";"GNF-Pf-5473";"C=CC1CN2CCC1CC2C(O)c1ccnc2ccc(OC)cc12.O=S(=O)(O)O";"IFI";"'='";"1.818";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL587636";"";"0";"489.85";"1";"6.50";"GNF-Pf-5334";"CN(CCCNc1ccnc2cc(Cl)ccc12)C(=O)c1cc(C(F)(F)F)cc(C(F)(F)F)c1";"IFI";"'='";"2.083";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600539";"";"0";"467.97";"1";"6.18";"GNF-Pf-5498";"CCC(C)OC(=O)C1=C(C)NC2=C(C(=O)CC(c3ccc(Cl)cc3)C2)C1c1ccccc1F";"IFI";"'='";"2.41";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600104";"";"0";"264.32";"0";"3.97";"GNF-Pf-5517";"C[n+]1ccc(/C=C/c2ccccc2F)c2ccccc21";"IFI";"'='";"14.29";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL530869";"";"0";"597.71";"2";"6.13";"GNF-Pf-5335";"CCOC(=O)c1ccc(N(C(=O)Cc2c[nH]c3ccccc23)C(C(=O)NC2CCCCC2)c2cccc(OC)c2OC)cc1";"IFI";"'='";"1.923";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL567597";"ARTEMISININ";"4";"282.34";"0";"2.39";"1";"C[C@@H]1CC[C@H]2[C@@H](C)C(=O)O[C@@H]3O[C@]4(C)CC[C@@H]1[C@]32OO4";"IFI";"'='";"3.185";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL586785";"";"0";"424.45";"0";"4.52";"GNF-Pf-5342";"O=[N+]([O-])c1cc(C(F)(F)F)ccc1N1CCCN(C(=S)Nc2ccccc2)CC1";"IFI";"'='";"3.361";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL587723";"AEE-788";"2";"440.60";"0";"4.94";"GNF-Pf-5343";"CCN1CCN(Cc2ccc(-c3cc4c(N[C@H](C)c5ccccc5)ncnc4[nH]3)cc2)CC1";"IFI";"'='";"6.667";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL587760";"";"0";"407.94";"0";"3.71";"GNF-Pf-5345";"CCN1C(=O)N(CCC(C)C)C2(CCN(Cc3cc(Cl)ccc3O)CC2)C1=O";"IFI";"'='";"3.704";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL581176";"";"0";"447.62";"1";"7.11";"GNF-Pf-5352";"CC(C)(C)CC(C)(C)Nc1c(-c2ccccc2OC(=O)C2CCCCC2)nc2ccccn12";"IFI";"'='";"2.83";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL579378";"";"0";"388.47";"0";"4.12";"GNF-Pf-5394";"CC(=O)N(C1=C(N2CCCCC2)C(=O)c2ccccc2C1=O)c1ccccc1C";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL576204";"";"0";"449.51";"0";"3.97";"GNF-Pf-5396";"CCOC(=O)c1cccc(NC(=O)CC2C(=O)N(c3ccccc3)C(=O)N2C2CCCC2)c1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL578753";"";"0";"421.47";"0";"4.37";"GNF-Pf-5397";"COC(=O)C1=C(C)NC2=C(C(=O)CC(c3ccc(OC)cc3)C2)C1c1ccccc1F";"IFI";"'='";"2.326";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL586748";"";"0";"392.43";"0";"3.96";"GNF-Pf-5337";"CC(=O)N(C1=C(N2CCCCC2)C(=O)c2ccccc2C1=O)c1ccc(F)cc1";"IFI";"'='";"8.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL597057";"";"0";"531.49";"2";"4.64";"GNF-Pf-4282";"COc1ccc(Nc2nc(NN=Cc3cccc([N+](=O)[O-])c3OC)nc(Nc3ccc([N+](=O)[O-])cc3)n2)cc1";"IFI";"'='";"6.494";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL596652";"";"0";"427.32";"0";"2.76";"GNF-Pf-4287";"O=C(NCc1ccco1)C1CCN(S(=O)(=O)c2ccc(Br)cc2)CC1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585499";"";"0";"367.36";"0";"4.34";"GNF-Pf-4308";"COc1ccc(C2Nc3ccc([N+](=O)[O-])cc3C3C=CCC32)cc1[N+](=O)[O-]";"IFI";"'='";"8.333";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL596841";"";"0";"408.84";"0";"4.47";"GNF-Pf-4333";"O=C(COc1ccccc1)NC(c1ccco1)c1cc(Cl)c2cccnc2c1O";"IFI";"'='";"4.167";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585648";"";"0";"412.48";"1";"5.20";"GNF-Pf-4366";"O=C1CN(C(=O)CCC2CCCCC2)C(c2ccc(F)cc2)c2cc(F)ccc2N1";"IFI";"'='";"5.882";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL602765";"";"0";"360.45";"0";"2.60";"GNF-Pf-4480";"COc1cc(C(=O)NC2CC3CCC(C2)N3C2CC2)cc(OC)c1OC";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL584496";"";"0";"286.36";"0";"3.18";"GNF-Pf-4386";"C=CCSc1nnc2c(n1)[nH]c1ccc(OCC)cc12";"IFI";"'='";"11.29";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL609313";"";"0";"368.32";"0";"3.83";"GNF-Pf-4486";"C#CC[N+]1(CC#Cc2cccc3ccccc23)CCCCC1.[Br-]";"IFI";"'='";"3.636";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL599507";"";"0";"417.51";"0";"3.19";"GNF-Pf-4488";"CC(=O)N(C1=C(N2CCN(C)CC2)C(=O)c2ccccc2C1=O)c1cc(C)cc(C)c1";"IFI";"'='";"7.143";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL586825";"";"0";"418.56";"1";"5.02";"GNF-Pf-5417";"C=C[C@H]1CN2CC[C@H]1C[C@@H]2[C@@H](OC(=O)Cc1cccs1)c1ccnc2ccccc12";"IFI";"'='";"2.5";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585973";"";"0";"403.49";"0";"2.57";"GNF-Pf-4519";"O=C(Nc1nc2ccccc2s1)c1ccc(S(=O)(=O)N2CCOCC2)cc1";"IFI";"'='";"5.344";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL602839";"";"0";"474.13";"1";"6.90";"GNF-Pf-4525";"CCCCCCCC(O)(c1ccc(OCC)cc1)C(CN1CCCCC1)c1ccccc1.Cl";"IFI";"'='";"2.857";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL583682";"";"0";"334.38";"0";"3.52";"GNF-Pf-4558";"COc1ccccc1C(=O)ON=C(N)Cc1cccc2ccccc12";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL530683";"";"0";"614.15";"2";"5.68";"GNF-Pf-4569";"CCOC(=O)c1c(NC(=O)C(C)Sc2nnc(CNC(=O)c3ccco3)n2-c2cccc(Cl)c2)sc2c1CCCC2";"IFI";"'='";"1.22";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600555";"";"0";"461.54";"0";"4.49";"GNF-Pf-4591";"CC(NC(=S)N(Cc1ccco1)Cc1cc2cc3c(cc2[nH]c1=O)OCO3)c1ccccc1";"IFI";"'='";"5.785";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL584240";"";"0";"347.84";"0";"4.08";"GNF-Pf-4603";"CCOc1cc2c(cc1OCC)C(c1cc(Cl)ccc1O)NCC2";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL579298";"";"0";"315.22";"1";"5.14";"GNF-Pf-124";"C[n+]1c(C=Cc2ccc(Cl)c(Cl)c2)ccc2ccccc21";"IFI";"";"";"";"";"";"Not applicable";"";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL578707";"";"0";"468.66";"1";"5.41";"GNF-Pf-152";"COc1ccc(C(=O)N2C(C(=O)NCCC(C)C)CSC2c2ccc(C(C)(C)C)cc2)cc1";"IFI";"'='";"2.174";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600715";"";"0";"284.35";"0";"2.19";"GNF-Pf-5580";"CC1CCC2C(C)C(O)OC3OC4(C)CCC1C32OO4";"IFI";"'='";"7.547";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL579131";"";"0";"423.68";"1";"6.17";"GNF-Pf-5600";"COC(=O)c1c(-c2c(Cl)cccc2Cl)noc1/C=C/Nc1ccc(Cl)cc1";"IFI";"'='";"5.333";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL578064";"";"0";"453.31";"0";"4.49";"GNF-Pf-5590";"O=C(N=CNNc1ccccc1F)c1cc(OCC(F)(F)F)ccc1OCC(F)(F)F";"IFI";"'='";"3.896";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL597452";"";"0";"318.18";"0";"3.25";"GNF-Pf-4328";"Cc1cc(Nc2ccc(Br)cc2)n2nc(C)nc2n1";"IFI";"'='";"1.961";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL529767";"";"0";"624.66";"2";"5.89";"GNF-Pf-4336";"COc1cc(C(=O)NCc2ccco2)ccc1OC1CCN(CC(c2ccccc2)c2ccccc2)CC1.O=C(O)C(F)(F)F";"IFI";"'='";"1.449";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL599095";"";"0";"350.37";"0";"2.60";"GNF-Pf-4343";"CC(=O)N(C1=C(N(C)C)C(=O)c2ccccc2C1=O)c1cccc(O)c1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL597264";"";"0";"435.61";"1";"7.03";"GNF-Pf-4359";"CCCCC(=O)Oc1ccccc1-c1nc2cc(C)ccn2c1NC(C)(C)CC(C)(C)C";"IFI";"'='";"4.673";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL602763";"";"0";"292.34";"0";"2.96";"GNF-Pf-4384";"Cc1cc(C)cc(NC2=C(N)C(=O)c3ccccc3C2=O)c1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL604587";"";"0";"363.36";"0";"3.15";"GNF-Pf-4483";"CCc1cc2c(NCCN3CCCCC3)ncnc2s1.Cl.Cl";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL584706";"";"0";"431.58";"0";"3.92";"GNF-Pf-4387";"COc1ccc(CNCCN2CCN(c3ccccc3)C[C@@H]2Cc2ccc(O)cc2)cc1";"IFI";"'='";"2.632";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL611068";"";"0";"301.37";"0";"3.00";"GNF-Pf-4402";"CCN(CC)CCNc1ncnc2c1[nH]c1ccc(F)cc12";"IFI";"'='";"5.882";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL605550";"";"0";"412.37";"0";"4.68";"GNF-Pf-4503";"Cc1ccc(O)c(NC(=O)c2cnn3c(C(F)(F)F)cc(-c4ccccc4)nc23)c1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL529111";"";"0";"295.39";"0";"2.96";"GNF-Pf-4532";"CCc1nc2nc(C)cc(NCCc3cccc(C)c3)n2n1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585035";"";"0";"549.62";"1";"4.43";"GNF-Pf-4993";"CCOC(=O)C1=C(C)NC2=C(C(=O)C(C(=O)OCC)C(c3ccc(OC)cc3)C2)C1c1ccc(OC)c(OC)c1";"IFI";"'='";"4.651";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL597850";"";"0";"531.49";"2";"4.64";"GNF-Pf-4092";"COc1ccc(Nc2nc(NN=Cc3cc([N+](=O)[O-])ccc3OC)nc(Nc3ccc([N+](=O)[O-])cc3)n2)cc1";"IFI";"'='";"2.857";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL598484";"";"0";"352.85";"1";"5.02";"GNF-Pf-4114";"Clc1ccc(-c2csc3ncnc(NCc4ccncc4)c23)cc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL597052";"";"0";"427.49";"0";"2.66";"GNF-Pf-4124";"CC(=O)Nc1ccc(S(=O)(=O)N2CCC(c3nc(-c4cccnc4)no3)CC2)cc1";"IFI";"'='";"15.79";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL599106";"";"0";"367.26";"0";"3.53";"GNF-Pf-4131";"O=c1sc(=NCC(O)c2ccc(Cl)c(Cl)c2)[nH]c2ccccc12";"IFI";"'='";"7.317";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL531401";"";"0";"444.27";"1";"6.03";"GNF-Pf-3333";"CC(Oc1ccc(Cl)cc1Cl)c1nc(-c2ccc(NC(=O)c3ccco3)cc2)no1";"IFI";"'='";"3.636";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600545";"";"0";"436.56";"0";"3.06";"GNF-Pf-3347";"COc1ccc(C2=Nc3cc(C(=O)NCCN4CCOCC4)ccc3CN2C(C)C)cc1";"IFI";"'='";"1.22";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL602393";"";"0";"506.56";"1";"4.93";"GNF-Pf-5588";"COc1ccc(C2CC(=O)C3=C(C2)NC(C)=C(C(=O)OC(C)C)C3c2ccc([N+](=O)[O-])cc2)cc1OC";"IFI";"'='";"4.301";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL577843";"";"0";"447.53";"0";"4.55";"GNF-Pf-5589";"COC(=O)C1=C(C)NC2=C(C(=O)CC(c3ccc(OC)c(OC)c3)C2)C1c1ccccc1C";"IFI";"'='";"4.651";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL579130";"";"0";"524.65";"2";"5.66";"GNF-Pf-5598";"Cc1cc(C(=O)N2CCOc3c(cc(-c4csc5ccccc45)cc3OCCc3ccccn3)C2)n(C)n1";"IFI";"'='";"1.923";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL577216";"";"0";"453.94";"1";"5.79";"GNF-Pf-5627";"CCCOC(=O)C1=C(C)NC2=C(C(=O)CC(c3ccc(Cl)cc3)C2)C1c1ccccc1F";"IFI";"'='";"3.529";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL602033";"";"0";"556.15";"2";"8.45";"GNF-Pf-5683";"CC(C)(C)c1cc(CCC(=O)Nc2c3c(nc4ccccc24)N(c2cccc(Cl)c2)CC3)cc(C(C)(C)C)c1O";"IFI";"'='";"4.545";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL584881";"";"0";"391.84";"0";"2.80";"GNF-Pf-679";"O=C(COc1ccccc1Cl)OCc1cc(=O)n2nc(C3CC3)sc2n1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL584884";"";"0";"467.57";"0";"4.25";"GNF-Pf-684";"COc1ccc(Cn2c(SCC(=O)Nc3ccccc3OC)nc3ccsc3c2=O)cc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585322";"";"0";"432.16";"0";"2.16";"GNF-Pf-692";"NC(=O)C1CCN(S(=O)(=O)c2cc(Br)c(Br)s2)CC1";"IFI";"'='";"7.143";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585893";"";"0";"420.27";"1";"5.42";"GNF-Pf-693";"O=C(Nc1ccc(-c2nnc(-c3ccccc3)o2)cc1)c1ccc(Br)cc1";"IFI";"'='";"4.688";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL604801";"";"0";"430.56";"0";"3.28";"GNF-Pf-699";"Cc1ccc(S(=O)(=O)NNC(=O)C2CCC(c3ccccc3)CC2)c2nsnc12";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL609030";"";"0";"278.41";"0";"2.85";"GNF-Pf-703";"CSc1nc(N)nc(SC2C=CCCC2)c1C#N";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL597260";"";"0";"473.64";"0";"3.93";"GNF-Pf-732";"CCCC(C(=O)NCCC(C)C)N(C(=O)c1snc(C(N)=O)c1N)c1ccc(C(C)C)cc1";"IFI";"'='";"4.839";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL598054";"";"0";"227.29";"0";"3.40";"GNF-Pf-769";"O=C1Nc2ccccc2Sc2ccccc21";"IFI";"'='";"2.4";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL605335";"";"0";"438.44";"1";"5.96";"GNF-Pf-775";"Cc1cc([N+](=O)[O-])ccc1-c1ccc(C(=O)Nc2ccc(-c3nc4ccccc4[nH]3)cc2)o1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL603897";"";"0";"425.47";"0";"2.90";"GNF-Pf-789";"Cc1cccc(-n2nc3c(c2NC(=O)c2ccc4c(c2)OCO4)CS(=O)(=O)C3)c1C";"IFI";"'='";"3.448";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585214";"";"0";"361.30";"0";"2.30";"GNF-Pf-842";"COC(F)(C(=O)Nc1c(C)n(C)n(-c2ccccc2)c1=O)C(F)(F)F";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585607";"";"0";"459.62";"1";"5.18";"GNF-Pf-850";"O=C(C1CCC(Cn2c(=S)[nH]c3ccccc3c2=O)CC1)N1CC=C(c2ccccc2)CC1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585231";"";"0";"542.64";"2";"6.39";"GNF-Pf-857";"COc1cc(NC(C)CCCN(Cc2ccccc2OC)C(=O)c2ccc(C)c([N+](=O)[O-])c2)c2ncccc2c1";"IFI";"'='";"1.835";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585431";"";"0";"357.41";"0";"2.07";"GNF-Pf-862";"CCOc1ccccc1NC(=O)CN1CCN(C(=O)c2ccco2)CC1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585808";"";"0";"466.31";"0";"3.83";"GNF-Pf-868";"N=C(NN=Cc1cccc([N+](=O)[O-])c1)SC1CC(=O)N(c2cc(Cl)ccc2Cl)C1=O";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL587041";"";"0";"370.41";"0";"3.63";"GNF-Pf-876";"COc1ccc(-c2cncc3ccc(C(=O)NCc4ccncc4)nc23)cc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL584020";"";"0";"312.28";"0";"2.80";"GNF-Pf-885";"O=C1CC(c2cccc([N+](=O)[O-])c2)c2cc3c(cc2N1)OCO3";"IFI";"'='";"4.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL583810";"";"0";"359.35";"1";"5.22";"GNF-Pf-890";"C[C@H](Nc1cncc(-c2cccc(OC(F)(F)F)c2)n1)c1ccccc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL529793";"";"0";"351.45";"0";"3.65";"GNF-Pf-897";"COc1cc(CNCCCn2ccnc2)ccc1OCc1ccccc1";"IFI";"'='";"0.9346";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL601382";"";"0";"511.45";"0";"4.98";"GNF-Pf-902";"CN(C)c1ccc(/C=C/c2cccc(/C=C/c3ccc(N(C)C)cc3)[n+]2C)cc1.[I-]";"IFI";"'='";"25.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL601389";"";"0";"446.33";"0";"4.89";"GNF-Pf-907";"O=C(Nc1ccccc1)Nc1ccc(S(=O)(=O)Nc2ccc(Br)cc2)cc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL584419";"";"0";"498.55";"1";"5.23";"GNF-Pf-921";"O=C(COc1ccc(-c2ncccn2)cc1CN1CCCCCC1)NCc1ccccc1C(F)(F)F";"IFI";"'='";"2.804";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585428";"";"0";"304.82";"0";"2.79";"GNF-Pf-929";"Cc1ccc(C(=O)C(C)[n+]2ccc(N(C)C)cc2)cc1.[Cl-]";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600974";"";"0";"502.45";"1";"4.70";"GNF-Pf-935";"COc1ccc(OC)c(NC(=O)c2cnn3c(C(F)(F)F)cc(-c4ccc(OC)c(OC)c4)nc23)c1";"IFI";"'='";"2.381";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL602212";"";"0";"312.37";"0";"4.85";"GNF-Pf-3454";"Cc1ccc(COc2ccc3c(C#N)c4ccccn4c3c2)cc1";"IFI";"'='";"7.292";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL582321";"";"0";"487.77";"1";"5.19";"GNF-Pf-3474";"C[n+]1c(C=CNc2ccccc2)n(-c2ccccc2)c2ccc(Cl)cc21.[I-]";"IFI";"";"";"";"";"";"Not applicable";"";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL581488";"";"0";"528.63";"1";"3.58";"GNF-Pf-3482";"COc1ccc(CCNC(=O)CN(c2ccc(OC)c(OC)c2)S(=O)(=O)c2ccc(C)cc2)cc1OC";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL582116";"";"0";"381.39";"0";"4.05";"GNF-Pf-3486";"O=C(O)C(F)(F)F.Oc1ccc(-c2ccccc2)cc1CN1CCCCC1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL531730";"";"0";"419.49";"0";"3.85";"GNF-Pf-3489";"CCN1CCN(c2cc(C)c3cc(NC(=O)c4cccc([N+](=O)[O-])c4)ccc3n2)CC1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL601173";"";"0";"495.49";"1";"5.55";"GNF-Pf-3526";"CC[N+]1(CCOc2ccc(C34CC5CC(CC(C5)C3)C4)cc2)CCCCC1.[I-]";"IFI";"'='";"7.692";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL548348";"";"0";"276.34";"0";"4.27";"GNF-Pf-3562";"Cc1cc(Nc2ccccc2)nc(Nc2ccccc2)n1";"IFI";"'='";"2.985";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL587899";"";"0";"421.50";"0";"4.19";"GNF-Pf-3584";"COc1cc2nc(NCCCOC(C)C)n3nc(-c4ccccc4)nc3c2cc1OC";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL598266";"";"0";"429.44";"0";"3.30";"GNF-Pf-3624";"CC(=NNC(=O)/C(=C/c1ccc([N+](=O)[O-])cc1)NC(=O)c1ccccc1)c1ccccn1";"IFI";"'='";"10.4";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL606381";"";"0";"499.68";"0";"3.01";"GNF-Pf-3632";"O=C(NC1CCN(CC(O)CN(Cc2ccccc2)S(=O)(=O)c2ccccc2)C1)C1CCCCC1";"IFI";"'='";"1.942";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL603898";"";"0";"523.66";"1";"2.75";"GNF-Pf-3642";"COc1ccccc1C(=O)NC1CCN(CC(O)CN(Cc2ccccc2)S(=O)(=O)c2ccccc2)C1";"IFI";"'='";"1.942";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL607972";"";"0";"267.34";"0";"2.40";"GNF-Pf-3705";"Cc1cccc(CCNc2cc(C)nc3ncnn23)c1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL599300";"";"0";"404.04";"1";"6.39";"GNF-Pf-3718";"CCCCCN(CCCCC)C(O)c1cc2c(c3ccccc13)CCCC2.Cl";"IFI";"'='";"1.818";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL597673";"";"0";"415.49";"1";"5.51";"GNF-Pf-3733";"Cc1ccc(-c2nc3ncccc3o2)cc1NC(=O)COc1ccc(C(C)(C)C)cc1";"IFI";"'='";"2.381";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL583830";"";"0";"419.42";"0";"3.87";"GNF-Pf-3744";"CCOC(=O)c1c(NC(=O)c2ccc([N+](=O)[O-])cc2[N+](=O)[O-])sc2c1CCCC2";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL604111";"";"0";"370.33";"0";"4.86";"GNF-Pf-3761";"Oc1ccccc1-c1nc2ncccn2c1Nc1cccc(C(F)(F)F)c1";"IFI";"'='";"14.29";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL598281";"";"0";"345.47";"0";"4.14";"GNF-Pf-3763";"CCc1ccc(C(=O)C[n+]2cc(-c3ccc(C)cc3)n3c2CCC3)cc1";"IFI";"'='";"9.524";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL583801";"";"0";"322.43";"0";"4.70";"GNF-Pf-3773";"CC(C)c1ccc(/C=C2/SC(=Nc3ccccc3)NC2=O)cc1";"IFI";"";"";"";"";"";"Not applicable";"";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL584034";"";"0";"398.56";"0";"4.02";"GNF-Pf-3775";"CCCN1CCc2c(sc3nc(SCC(=O)c4ccccc4)nc(N)c23)C1";"IFI";"'='";"8.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL527931";"";"0";"383.23";"0";"2.70";"GNF-Pf-3776";"COc1ccc(C=Cc2cc[n+](C)cc2)cc1OC.[I-]";"IFI";"";"";"";"";"";"Not applicable";"";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL584041";"";"0";"319.38";"0";"1.52";"GNF-Pf-3784";"O=C(COc1cccc2ccccc12)NC1CCS(=O)(=O)C1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL580076";"";"0";"362.48";"0";"4.05";"GNF-Pf-2998";"COc1ccc2nc(C)cc(Nc3ccc(N4CCN(C)CC4)cc3)c2c1";"IFI";"'='";"5.594";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL579980";"";"0";"433.55";"0";"4.74";"GNF-Pf-3004";"CC(=O)[O-].CCN(CC)c1cc2oc3cc(=[N+](CC)CC)ccc-3nc2c2ccccc12";"IFI";"'='";"14.55";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL602782";"";"0";"253.31";"0";"3.03";"GNF-Pf-3005";"Cc1nc2c(C)c(-c3ccccc3)nn2c(O)c1C";"IFI";"'='";"1.538";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL581890";"";"0";"364.51";"0";"4.35";"GNF-Pf-3021";"CSc1cccc([C@@H]2C[C@H]3CN(c4ccccc4)C(=O)[C@]34CCCN24)c1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL602005";"";"0";"296.41";"0";"3.97";"GNF-Pf-3022";"Cc1ccc(C)n1-c1ccc(C(=O)N2CCC(C)CC2)cc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL535331";"";"0";"275.31";"0";"3.49";"GNF-Pf-3023";"C(=NNc1nc2ccccc2[nH]1)c1c[nH]c2ccccc12";"IFI";"'='";"13.14";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL580414";"";"0";"331.85";"0";"3.95";"GNF-Pf-3024";"CN(CCCNc1ccnc2cc(Cl)ccc12)C(=O)C1CCC1";"IFI";"'='";"3.704";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL601809";"";"0";"454.51";"0";"4.15";"GNF-Pf-3042";"Cc1ncc([N+](=O)[O-])n1CCOC(=O)c1c(NC(=O)c2ccccc2)sc2c1CCCC2";"IFI";"'='";"1.504";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL529159";"";"0";"392.25";"0";"2.44";"GNF-Pf-5096";"O=C(CN1CCN(C(=O)c2ccco2)CC1)Nc1ccccc1Br";"IFI";"'='";"1.667";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL580571";"";"0";"379.53";"0";"4.66";"GNF-Pf-5562";"CCOC(=O)C(=O)N1c2ccc(C)cc2-c2c(ssc2=S)C1(C)C";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600495";"";"0";"234.34";"0";"2.88";"GNF-Pf-5103";"CC[n+]1c(SC)ccc2cc(OC)ccc21";"IFI";"'='";"7.937";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL603046";"";"0";"402.44";"1";"5.94";"GNF-Pf-4787";"O=C1CC(c2ccccc2)CC2=C1C(c1cc(F)ccc1F)Nc1ccccc1N2";"IFI";"'='";"1.205";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL583351";"";"0";"373.32";"0";"3.85";"GNF-Pf-4789";"Cc1ccc(-c2cn3c([n+]2-c2ccccc2)SCC3)cc1.[Br-]";"IFI";"'='";"5.185";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL576208";"";"0";"337.38";"0";"3.24";"GNF-Pf-5151";"Cc1oc2c(c1C(=O)N1CCC(C)CC1)C(=O)c1ccccc1C2=O";"IFI";"'='";"15.38";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585638";"";"0";"538.65";"2";"5.51";"GNF-Pf-4820";"CCOC(=O)c1ccc(N(C(=O)Cc2c[nH]c3ccccc23)C(C(=O)NC2CCCCC2)c2cccnc2)cc1";"IFI";"'='";"3.704";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL601611";"";"0";"334.46";"0";"3.74";"GNF-Pf-4898";"Cc1ccccc1CN1CCN(C/C=C/c2ccccc2)CCC1=O";"IFI";"'='";"0.9615";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL527626";"";"0";"710.60";"2";"6.49";"GNF-Pf-4948";"C(#Cc1ccccc1)C[N+]1(CC#Cc2ccc(C#CC[N+]3(CC#Cc4ccccc4)CCCCC3)cc2)CCCCC1.[Br-].[Br-]";"IFI";"'='";"14.29";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL601396";"";"0";"495.60";"0";"4.47";"GNF-Pf-4966";"CCOC(=O)C1=C(C)NC2=C(C(=O)C(C(=O)OCC)C(c3ccccc3OC)C2)C1c1cccs1";"IFI";"'='";"4.494";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600278";"";"0";"268.32";"0";"2.61";"GNF-Pf-4987";"OCc1nc2ccccc2n1CCOc1ccccc1";"IFI";"'='";"0.7937";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL584840";"";"0";"369.52";"0";"3.71";"GNF-Pf-5006";"C=CCSc1nc2sc3c(c2c(=O)n1-c1ccccc1)CCN(C)C3";"IFI";"'='";"7.547";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL604363";"";"0";"427.32";"0";"2.07";"GNF-Pf-5015";"Cc1ccc(N(C)C(=O)CCNS(=O)(=O)c2cc(Br)cnc2N)cc1";"IFI";"'='";"2.5";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585625";"";"0";"388.51";"0";"4.92";"GNF-Pf-5016";"COc1cccc(-c2ccc(O)c(CN3CCC(Cc4ccccc4)CC3)c2)n1";"IFI";"'='";"1.923";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL528059";"";"0";"352.39";"0";"4.07";"GNF-Pf-5017";"CSc1nc2nc(C)c(Cc3cccc(C(F)(F)F)c3)c(C)n2n1";"IFI";"'='";"1.25";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL586014";"";"0";"366.46";"0";"3.74";"GNF-Pf-5032";"C=CC1CN2CCC1CC2C(OC(C)=O)c1ccnc2ccc(OC)cc12";"IFI";"'='";"1.626";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL581346";"";"0";"323.85";"0";"4.40";"GNF-Pf-5054";"Cc1ccc(-c2c[n+](Cc3ccc(Cl)cc3)c3n2CCC3)cc1";"IFI";"'='";"10.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL584822";"";"0";"226.30";"0";"2.41";"GNF-Pf-5060";"CCn1c2ccccc2[n+]2c(C)cc(C)nc12";"IFI";"'='";"7.143";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600158";"";"0";"541.62";"2";"5.86";"GNF-Pf-5078";"COC(=O)c1ccc(N(C(=O)Cc2c[nH]c3ccccc23)C(C(=O)NC2CCCCC2)c2ccccc2F)cc1";"IFI";"'='";"5.455";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL577013";"";"0";"375.94";"1";"5.41";"GNF-Pf-5246";"CCCCC(CC)C(=O)NCCCCNc1ccnc2cc(Cl)ccc12";"IFI";"'='";"7.407";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL599925";"";"0";"300.37";"0";"3.79";"GNF-Pf-5256";"c1ccc(C2=NN(c3ccccc3)N(c3ccccc3)N2)cc1";"IFI";"'='";"9.091";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600317";"";"0";"382.24";"0";"3.25";"GNF-Pf-5259";"COC(=O)C1C(=O)C2=C(CC1C)NC(=O)CC2c1ccc(Cl)cc1Cl";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL3138494";"";"0";"467.14";"0";"4.30";"GNF-Pf-5264";"CC1CNC2C(C)C3C(CC4C5CCC6CC(N)CCC6(C)C5CCC43C)OC2(O)C1.Cl";"IFI";"'='";"5.263";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL586810";"";"0";"473.40";"1";"5.27";"GNF-Pf-5292";"CC12CCC(C(=O)N(CC(O)Cn3c4ccc(Cl)cc4c4cc(Cl)ccc43)C1=O)C2(C)C";"IFI";"'='";"2.027";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL578526";"";"0";"484.34";"0";"2.90";"GNF-Pf-5303";"CCN(CC)CCNc1ccnc2ccc([N+](=O)[O-])cc12.O=P(O)(O)O.O=P(O)(O)O";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600721";"";"0";"389.45";"0";"3.83";"GNF-Pf-5320";"CC(=O)Nc1ccc(NC2=C(N3CCCCC3)C(=O)c3ccccc3C2=O)cc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL602982";"";"0";"232.24";"0";"1.75";"GNF-Pf-5329";"N#Cc1ccc(NC(=O)CCCC(=O)O)cc1";"IFI";"'='";"2.542";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL578733";"";"0";"507.58";"1";"3.90";"GNF-Pf-5369";"CN1C(=O)N(C)C2(c3ccccc3)NN3C(=NC12c1ccccc1)SC1=C3C(=O)c2ccccc2C1=O";"IFI";"'='";"4.444";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL601532";"";"0";"737.63";"2";"6.07";"GNF-Pf-4613";"Cc1onc(-c2ccccc2)c1C(=O)N1CCC(CNc2c(-c3ccc(F)cc3)nc3ccccn23)CC1.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F";"IFI";"'='";"5.556";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL582132";"";"0";"357.37";"0";"1.26";"GNF-Pf-4614";"CCOc1cc(-c2nnc3[nH]c(=O)n(C)c(=O)c3n2)ccc1OC(C)C";"IFI";"'='";"4.444";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585778";"";"0";"531.59";"2";"5.87";"GNF-Pf-4617";"Cn1c(SCCCCNC(=O)c2cc([N+](=O)[O-])cc([N+](=O)[O-])c2)nc(-c2ccccc2)c1-c1ccccc1";"IFI";"'='";"1.869";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585784";"";"0";"461.66";"1";"5.75";"GNF-Pf-4621";"CC(C)CSc1nc2sc3c(c2c(=O)n1-c1ccccc1)CCN(Cc1ccccc1)C3";"IFI";"'='";"2.5";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL583345";"";"0";"379.50";"1";"5.55";"GNF-Pf-4627";"CC(=O)Oc1ccccc1-c1nc2ccccn2c1NC(C)(C)CC(C)(C)C";"IFI";"'='";"3.774";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585965";"";"0";"342.40";"0";"4.24";"GNF-Pf-4687";"Cc1ccnc(NC(c2ccncc2)c2ccc3cccnc3c2O)c1";"IFI";"'='";"9.524";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL602435";"";"0";"492.42";"0";"3.33";"GNF-Pf-4691";"COc1ccc(CNC(=O)C2CNCC2c2ccc(C(F)(F)F)cc2)cc1.O=C(O)C(F)(F)F";"IFI";"'='";"1.408";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585989";"";"0";"386.50";"0";"4.24";"GNF-Pf-4710";"O=C(Nc1ccc(-n2cccn2)cc1)C1CCN(CC=Cc2ccccc2)CC1";"IFI";"";"";"";"";"";"Not applicable";"";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL584645";"";"0";"592.53";"2";"6.72";"GNF-Pf-4728";"COc1cc(OC)c(Br)c(-n2c(C(C)N(CCC(C)C)C(=O)c3ccccc3C)nc3ccccc3c2=O)c1";"IFI";"'='";"2.804";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL579583";"";"0";"330.39";"0";"4.44";"GNF-Pf-4738";"CCc1c(C)c(C#N)c2nc3ccccc3n2c1NCc1ccco1";"IFI";"'='";"3.65";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL586184";"";"0";"349.26";"0";"3.65";"GNF-Pf-4739";"Br.Cc1ccnc(Nc2nc(-c3ccccn3)cs2)c1";"IFI";"'='";"24.62";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL584454";"";"0";"510.97";"1";"4.92";"GNF-Pf-4748";"COc1cc(OC)c(NC(=O)C2c3ccccc3C(=O)N(C)C2c2ccc(OC)c(OC)c2)cc1Cl";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL584455";"";"0";"395.46";"1";"5.52";"GNF-Pf-4749";"COc1cc(C=C(C#N)c2nc3ccccc3[nH]2)ccc1OCc1ccc(C)cc1";"IFI";"";"";"";"";"";"Not applicable";"";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585455";"";"0";"537.90";"2";"5.17";"GNF-Pf-4754";"O=C(CSc1nc2cc3c(cc2c(=O)n1Cc1ccco1)OCO3)Nc1cc(C(F)(F)F)ccc1Cl";"IFI";"'='";"4.348";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600768";"";"0";"423.56";"0";"3.89";"GNF-Pf-4755";"O=C(NC1CC1)C1CCN(c2cccc3c2C(=O)N(C2CCCCCCC2)C3=O)CC1";"IFI";"'='";"5.941";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL601316";"";"0";"307.39";"0";"3.88";"GNF-Pf-4761";"Cc1ccc(C[n+]2cc(-c3ccc(F)cc3)n3c2CCC3)cc1";"IFI";"'='";"2.381";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL579620";"";"0";"437.57";"0";"4.87";"GNF-Pf-4763";"CN1CCc2c(sc3nc(SCc4ccc(F)cc4)n(-c4ccccc4)c(=O)c23)C1";"IFI";"'='";"2.5";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL581109";"";"0";"458.59";"0";"4.68";"GNF-Pf-4764";"O=C(NCc1nnc(SCC2CCCO2)n1Cc1ccccc1)c1cccc2ccccc12";"IFI";"'='";"1.724";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585407";"";"0";"467.64";"1";"6.55";"GNF-Pf-4768";"CCCn1c(SCCNC(=O)/C=C/c2ccccc2)nc(-c2ccccc2)c1-c1ccccc1";"IFI";"'='";"0.9259";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL89445";"TERPYRIDINE";"0";"233.27";"0";"3.21";"GNF-Pf-4776";"c1ccc(-c2cccc(-c3ccccn3)n2)nc1";"IFI";"'='";"21.62";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL602577";"";"0";"300.38";"0";"4.37";"GNF-Pf-4777";"C=C(c1ccccc1)[n+]1ccc(/C=C/c2ccccc2O)cc1";"IFI";"";"";"";"";"";"Not applicable";"";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL602639";"";"0";"364.88";"0";"3.62";"GNF-Pf-4778";"Cc1cc2nc3ccc(N(C)C)cc3[n+](-c3ccccc3)c2cc1N.[Cl-]";"IFI";"'='";"9.524";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL603044";"";"0";"477.20";"1";"5.19";"GNF-Pf-4299";"Cc1cc(C)n(CC(O)Cn2c3ccc(Br)cc3c3cc(Br)ccc32)n1";"IFI";"'='";"2.041";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585658";"BIALAMICOL HYDROCHLORIDE";"0";"473.10";"1";"5.91";"GNF-Pf-4303";"C=CCc1cc(-c2cc(CC=C)c(O)c(CN(CC)CC)c2)cc(CN(CC)CC)c1O.Cl";"IFI";"'='";"2.353";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585847";"";"0";"495.67";"1";"7.65";"GNF-Pf-4382";"Cc1ccn2c(NC(C)(C)CC(C)(C)C)c(-c3ccccc3OC(=O)C3C[C@H]3c3ccccc3)nc2c1";"IFI";"'='";"3.738";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL597043";"";"0";"359.40";"0";"4.98";"GNF-Pf-4405";"Cc1cccc(NC(c2ccccc2F)c2ccc3cccnc3c2O)n1";"IFI";"'='";"4.545";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL599709";"";"0";"334.46";"0";"3.74";"GNF-Pf-4411";"Cc1ccccc1CN1CCN(CC=Cc2ccccc2)CCC1=O";"IFI";"";"";"";"";"";"Not applicable";"";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL604922";"";"0";"334.38";"0";"4.36";"GNF-Pf-4425";"CCOC(=O)c1cnc2ccccc2c1Nc1ccc(C(C)=O)cc1";"IFI";"'='";"6.154";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL603043";"";"0";"295.30";"0";"3.90";"GNF-Pf-4443";"Cc1cc(Nc2ccc([N+](=O)[O-])cc2O)nc2ccccc12";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600976";"";"0";"418.54";"0";"4.53";"GNF-Pf-4454";"CCN(CC)C(=O)COc1ccc(-c2nnc(N3CCCCC3)c3ccccc23)cc1";"IFI";"'='";"3.077";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL598476";"";"0";"326.38";"0";"3.62";"GNF-Pf-4471";"CSc1nnc(-c2cccc([N+](=O)[O-])c2)n1Cc1ccccc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585793";"";"0";"468.43";"1";"5.28";"GNF-Pf-4574";"OC(CN1CCN(Cc2ccccc2)CC1)Cn1c2ccc(Cl)cc2c2cc(Cl)ccc21";"IFI";"'='";"1.149";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL584627";"";"0";"409.96";"1";"5.81";"GNF-Pf-4581";"CCCCc1ccc(C(=O)N(C)CCCNc2ccnc3cc(Cl)ccc23)cc1";"IFI";"'='";"3.158";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL227704";"";"0";"478.52";"1";"5.65";"GNF-Pf-4599";"CC1CC(C)CN(CCCNc2ccc(C(=O)Nc3ccc(C(F)(F)F)cc3)cc2[N+](=O)[O-])C1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL601347";"";"0";"361.45";"0";"4.76";"GNF-Pf-2892";"COc1ccc(Nc2ccccc2NC(=O)c2cccc(N(C)C)c2)cc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL582684";"";"0";"375.41";"1";"6.50";"GNF-Pf-2972";"ClCCSc1ccc(Sc2ccc(SCCCl)cc2)cc1";"IFI";"'='";"1.515";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL580174";"";"0";"410.47";"1";"5.64";"GNF-Pf-2992";"CCOC(=O)c1ccc(NC(=O)c2cc(-c3ccccc3)nc3ccc(C)cc23)cc1";"IFI";"'='";"3.488";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL546693";"";"0";"403.91";"0";"2.98";"GNF-Pf-4013";"COc1cc(N)c(Cl)cc1C(=O)NCC1CCN(c2nc(C)cc(C)n2)CC1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL582099";"";"0";"379.42";"0";"4.24";"GNF-Pf-3418";"CCCCC(=O)NC(c1cccc([N+](=O)[O-])c1)c1ccc2cccnc2c1O";"IFI";"'='";"8.333";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL581685";"";"0";"454.61";"None";"None";"GNF-Pf-3423";"CC1CCCCN1CC(=O)N1CCN(C(=O)CN2CCCCC2C)CC1.CC=O.O=CO";"IFI";"'='";"3.704";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL582276";"";"0";"331.53";"0";"3.10";"GNF-Pf-3438";"CCNC(=S)NC1CC2CCCC(C1)N2CCc1ccccc1";"IFI";"'='";"2.597";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL601561";"";"0";"302.28";"0";"2.14";"GNF-Pf-3439";"Cc1nc(-c2cnccc2C(F)(F)F)sc1C(=O)NN";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL582696";"";"0";"334.34";"0";"2.80";"GNF-Pf-3444";"COc1ccc(-c2noc(CC(=O)Nc3ccccc3C#N)n2)cc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL601772";"";"0";"353.45";"0";"3.82";"GNF-Pf-3457";"COc1ccccc1N1C(=N)S/C(=C/c2ccc(N(C)C)cc2)C1=O";"IFI";"'='";"15.38";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL583653";"";"0";"478.50";"0";"4.15";"GNF-Pf-4163";"COC(=O)C1=C(C)NC2=C(C(=O)CC(c3ccc(OC)c(OC)c3)C2)C1c1ccc([N+](=O)[O-])cc1";"IFI";"'='";"1.19";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL597654";"";"0";"378.32";"0";"1.19";"GNF-Pf-4174";"O=C(Cn1cc([N+](=O)[O-])nc1[N+](=O)[O-])N1CCN(c2ccc(F)cc2)CC1";"IFI";"'='";"4.255";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL527593";"";"0";"361.23";"0";"4.16";"GNF-Pf-4188";"O=C(O)C1Cc2c([nH]c3ccccc23)C(c2ccc(Cl)cc2Cl)N1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL601114";"";"0";"289.40";"0";"3.63";"GNF-Pf-4195";"c1ccc(CC[n+]2cc(-c3ccccc3)n3c2CCC3)cc1";"IFI";"'='";"2.439";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL598068";"";"0";"268.36";"0";"3.04";"GNF-Pf-4198";"CNc1ccccc1C(=O)N(C)CCc1ccccc1";"IFI";"'='";"5.882";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL596853";"";"0";"354.29";"0";"3.17";"GNF-Pf-4206";"C[N+](C)(CC#Cc1ccccc1)CC#Cc1ccccc1.[Br-]";"IFI";"'='";"3.636";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585237";"";"0";"403.94";"0";"4.37";"GNF-Pf-5011";"Cc1ccc(S(=O)(=O)NCCCCNc2ccnc3cc(Cl)ccc23)cc1";"IFI";"'='";"2.105";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600898";"";"0";"450.97";"0";"4.36";"GNF-Pf-5023";"COc1cc2c(cc1OC)C1=NC(=O)C(C(C)C)N1C(SCc1csc(Cl)n1)=N2";"IFI";"'='";"3.659";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600566";"";"0";"379.26";"0";"3.21";"GNF-Pf-5041";"[Br-].c1ccc(-c2nn(-c3ccccc3)[n+](-c3ccccc3)n2)cc1";"IFI";"'='";"11.22";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585836";"";"0";"373.50";"0";"4.12";"GNF-Pf-5047";"Cc1cc(N2CCN(C3CCCCC3)CC2)n2c(nc3ccccc32)c1C#N";"IFI";"'='";"2.878";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585775";"";"0";"322.41";"1";"5.08";"GNF-Pf-5048";"CCOc1ccc(Nc2cc(C)nc3ccc(OCC)cc23)cc1";"IFI";"'='";"3.448";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL601385";"";"0";"345.20";"0";"4.76";"GNF-Pf-5061";"COc1ccc(N=Nc2nc3ccc(Br)cc3n2C)cc1";"IFI";"'='";"9.259";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL599955";"";"0";"410.42";"0";"4.09";"GNF-Pf-5066";"CC(=O)N(C1=C(N2CCCCC2)C(=O)c2ccccc2C1=O)c1ccc(F)c(F)c1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585225";"";"0";"322.43";"0";"2.06";"GNF-Pf-5068";"COCCNC(=O)CN1C(=O)CC(C)(C)Sc2ccccc21";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600565";"";"0";"496.00";"1";"5.67";"GNF-Pf-5070";"COc1ccc(C2CC(=O)C3=C(C2)NC(C)=C(C(=O)OC(C)C)C3c2cccc(Cl)c2)cc1OC";"IFI";"'='";"6.024";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585983";"";"0";"307.44";"0";"4.53";"GNF-Pf-5073";"CCN(CC)CCCNc1ccnc2cc3ccccc3cc12";"IFI";"'='";"4.839";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL1744513";"";"0";"340.40";"0";"3.60";"GNF-Pf-5083";"COc1ccc(/C=C2/SC(=Nc3ccccc3OC)NC2=O)cc1";"IFI";"";"";"";"";"";"Not applicable";"";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL583165";"";"0";"549.64";"1";"4.31";"GNF-Pf-5099";"COc1ccc2[nH]c(SCC(=O)Nc3cccc(NC(=O)CSc4nc5cc(OC)ccc5[nH]4)n3)nc2c1";"IFI";"'='";"13.1";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL582957";"";"0";"408.33";"1";"5.16";"GNF-Pf-5113";"CCOC(=O)C1=C(C)NC2=C(C(=O)CC(C)(C)C2)C1c1ccc(Cl)cc1Cl";"IFI";"'='";"5.814";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL584223";"";"0";"317.39";"0";"3.18";"GNF-Pf-4585";"Cc1c(C#N)c2ccccc2n1CC(=O)NCCc1ccccc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL529640";"";"0";"338.28";"0";"4.62";"GNF-Pf-4606";"CCC(C)NCC(O)(c1ccc(Cl)cc1)c1ccc(Cl)cc1";"IFI";"'='";"1.316";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL599104";"";"0";"493.63";"0";"2.74";"GNF-Pf-4060";"O=C(NC1CCN(CC(O)CN(Cc2ccccc2)S(=O)(=O)c2ccccc2)C1)c1ccccc1";"IFI";"'='";"2.941";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL586220";"";"0";"484.42";"1";"6.70";"GNF-Pf-5543";"CCC(C)OC(=O)C1=C(C)NC2=C(C(=O)CC(c3ccc(Cl)cc3)C2)C1c1ccc(Cl)cc1";"IFI";"'='";"7.692";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL416956";"MEFLOQUINE";"4";"378.32";"0";"4.45";"GNF-Pf-5544";"OC(c1cc(C(F)(F)F)nc2c(C(F)(F)F)cccc12)C1CCCCN1";"IFI";"'='";"2.419";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL586410";"";"0";"439.91";"1";"5.40";"GNF-Pf-5545";"CCOC(=O)C1=C(C)NC2=C(C(=O)CC(c3ccc(Cl)cc3)C2)C1c1ccc(F)cc1";"IFI";"'='";"3.488";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL580358";"";"0";"425.51";"0";"4.31";"GNF-Pf-5563";"N#Cc1c2c(c(N3CCN(Cc4ccc(F)cc4)CC3)n3c1nc1ccccc13)CCC2";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL579145";"";"0";"338.44";"1";"6.18";"GNF-Pf-2654";"c1ccc(-c2nc3cc4ccccc4cc3nc2-c2ccsc2)cc1";"IFI";"'='";"2.941";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL602193";"";"0";"389.57";"1";"6.29";"GNF-Pf-2667";"CCN1/C(=C/c2ccc3ccccc3[n+]2CC)Sc2sc3ccccc3c21";"IFI";"'='";"18.33";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL578275";"";"0";"337.30";"0";"4.73";"GNF-Pf-2684";"O=C(Nc1ccc(Oc2ccc(OC(F)(F)F)cc2)cc1)C1CC1";"IFI";"'='";"1.575";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL578277";"";"0";"476.04";"0";"3.84";"GNF-Pf-2687";"O=C(NC(CN1CCCC1)c1ccccc1)C1CCCCN1S(=O)(=O)c1ccc(Cl)cc1";"IFI";"'='";"0.9709";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL578880";"";"0";"414.46";"0";"3.94";"GNF-Pf-2741";"CN(C)c1ccc(/C=C/C(=O)NC(=O)c2ccccc2OC(=O)c2ccccc2)cc1";"IFI";"'='";"8.333";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL576951";"";"0";"413.34";"0";"2.92";"GNF-Pf-2746";"O=C(C1CC1)N1CCc2cc(Br)cc(S(=O)(=O)N3CCCCC3)c21";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585749";"";"0";"531.66";"2";"6.54";"GNF-Pf-2756";"CCC(c1nc2ccccc2c(=O)n1-c1ccccc1OC)N(CCc1ccccc1)C(=O)c1ccc(C)cc1";"IFI";"'='";"4.717";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL579122";"";"0";"469.63";"1";"7.41";"GNF-Pf-2763";"CCc1ccc(C(=O)Oc2ccccc2-c2nc3ccccn3c2NC(C)(C)CC(C)(C)C)cc1";"IFI";"'='";"5.66";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL602599";"";"0";"448.53";"1";"1.72";"GNF-Pf-2774";"O=C(NCCCNC(=O)Nc1cccc(C2=NCCN2)c1)Nc1cccc(C2=NCCN2)c1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL602612";"";"0";"441.55";"0";"3.23";"GNF-Pf-3001";"CCOc1ccc2ncc(S(=O)(=O)c3ccc(OC)cc3)c(N3CCN(C)CC3)c2c1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL601344";"";"0";"326.40";"0";"2.63";"GNF-Pf-3003";"CC(=O)N(C)C1=C(N2CCCCCC2)C(=O)c2ccccc2C1=O";"IFI";"'='";"22.47";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL580612";"";"0";"465.37";"0";"2.41";"GNF-Pf-3006";"Nc1ncc(Br)cc1S(=O)(=O)NCCC(=O)N1CC=C(c2ccccc2)CC1";"IFI";"'='";"1.961";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL582094";"";"0";"423.99";"1";"6.20";"GNF-Pf-3014";"CCCCCc1ccc(C(=O)N(C)CCCNc2ccnc3cc(Cl)ccc23)cc1";"IFI";"'='";"7.477";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL601342";"";"0";"643.68";"2";"5.86";"GNF-Pf-3026";"CCOc1ccc(CCN2C(=S)N(c3cccc(C(F)(F)F)c3)C(=O)C2CC(=O)Nc2ccc(C(=O)OC)cc2)cc1OCC";"IFI";"'='";"3.261";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL581254";"";"0";"484.56";"1";"6.53";"GNF-Pf-3027";"O=C(C=Cc1ccccc1)Nc1ccc(-c2nc3cc(NC(=O)C=Cc4ccccc4)ccc3[nH]2)cc1";"IFI";"";"";"";"";"";"Not applicable";"";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL579555";"";"0";"466.48";"0";"4.25";"GNF-Pf-3032";"CCN(CC)S(=O)(=O)c1ccc(C(=O)c2c(C)c(C(=O)C(F)(F)F)c3ccccn23)cc1";"IFI";"'='";"3.125";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL580161";"";"0";"484.55";"1";"5.93";"GNF-Pf-3047";"CCOC(=O)c1c(C)n(-c2ccccc2)c2ccc(OC(=O)c3ccccc3NC(=O)C(C)C)cc12";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL536013";"";"0";"570.62";"1";"3.68";"GNF-Pf-3053";"COC(=O)c1cn([C@@H]2C[C@@H](C(=O)NCc3cccc(C(F)(F)F)c3)N(C3CCN(Cc4ccccc4)CC3)C2)nn1";"IFI";"'='";"1.754";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL576990";"";"0";"424.50";"0";"4.13";"GNF-Pf-2103";"COc1ccccc1NC1=CC(=NS(=O)(=O)c2cccs2)c2ccccc2C1=O";"IFI";"'='";"7.692";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL577205";"";"0";"422.74";"1";"5.77";"GNF-Pf-2105";"CN(CCCNc1ccnc2cc(Cl)ccc12)C(=O)c1cc(Cl)cc(Cl)c1";"IFI";"'='";"1.709";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL587620";"";"0";"434.54";"0";"3.95";"GNF-Pf-2115";"CCN1CCN(c2cc(C)c3cc(NC(=O)c4cc(OC)cc(OC)c4)ccc3n2)CC1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL579307";"";"0";"509.09";"2";"6.61";"GNF-Pf-2137";"CC(C)N(CC(=O)Nc1cc(C(C)(C)C)nn1-c1ccc(Cl)cc1)C(=O)c1ccc(C(C)(C)C)cc1";"IFI";"'='";"1.887";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL530796";"";"0";"194.19";"0";"-0.34";"GNF-Pf-1528";"CNC(=O)NNC(=O)c1cccnc1";"IFI";"'='";"2.752";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600741";"";"0";"531.48";"1";"5.31";"GNF-Pf-2175";"CCN(CC)CCCC(C)Nc1ccnc2cc3ccccc3cc12.O=P(O)(O)O.O=P(O)(O)O";"IFI";"'='";"9.231";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600330";"";"0";"327.36";"0";"0.66";"GNF-Pf-3067";"O=C(O)CC(c1ccc2c(c1)OCO2)N1CCS(=O)(=O)CC1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL601135";"";"0";"282.39";"0";"3.39";"GNF-Pf-3084";"Cc1cc(N2CCCCC2)nc(NCc2ccccc2)n1";"IFI";"'='";"2.353";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL1744498";"";"0";"312.78";"0";"3.11";"GNF-Pf-3104";"O=c1c(=Cc2ccc(Cl)cc2)sc2nc3ccccc3n12";"IFI";"'='";"3.086";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600541";"";"0";"350.48";"0";"3.14";"GNF-Pf-3138";"CC(=O)Nc1ccc(S(=O)(=O)NC2C(C)(C)C3CC[C@]2(C)C3)cc1";"IFI";"'='";"1.695";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL581043";"";"0";"415.67";"1";"5.75";"GNF-Pf-3163";"Cc1cc(C)c(NC(=S)N(CCCN2CCCCC2)Cc2cccs2)c(C)c1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600923";"";"0";"278.15";"0";"3.74";"GNF-Pf-3170";"C=CCc1c(C)nc2ccc(Br)cc2c1O";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL579644";"";"0";"229.67";"0";"3.33";"GNF-Pf-3174";"O=c1c2ccccc2[nH]c2cc(Cl)ccc12";"IFI";"'='";"2.703";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL581865";"";"0";"537.86";"2";"5.06";"GNF-Pf-3191";"COC(=O)CNC(c1ccccc1Cl)c1cc(Br)ccc1NS(=O)(=O)c1ccc(C)cc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL581463";"";"0";"363.41";"0";"4.43";"GNF-Pf-3217";"CCOC(=O)c1c(C)n(-c2ccccc2)c2ccc(OC(=O)C3CC3)cc12";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600358";"";"0";"405.45";"0";"3.93";"GNF-Pf-4620";"O=C(NC(=CC=Cc1ccccc1)C(=O)N1CCCCC1)c1ccc([N+](=O)[O-])cc1";"IFI";"";"";"";"";"";"Not applicable";"";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL584414";"";"0";"418.32";"0";"4.88";"GNF-Pf-4631";"CN(CCCNc1ccnc2cc(Cl)ccc12)C(=O)COc1ccc(Cl)cc1";"IFI";"'='";"1.869";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL530038";"";"0";"285.40";"0";"2.82";"GNF-Pf-4637";"Cc1cc(N2CCC(C)CC2)nc(-n2nc(C)cc2C)n1";"IFI";"'='";"1.613";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL599961";"";"0";"455.51";"0";"4.44";"GNF-Pf-4641";"COc1cc(C=CC(=O)Nc2c3c(nn2-c2ccc(F)cc2)CSC3)cc(OC)c1OC";"IFI";"";"";"";"";"";"Not applicable";"";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL530733";"";"0";"480.24";"1";"5.60";"GNF-Pf-3240";"OC(CNC1CCCCC1)Cn1c2ccc(Br)cc2c2cc(Br)ccc21";"IFI";"'='";"5.303";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL584220";"";"0";"395.20";"0";"2.58";"GNF-Pf-4650";"Cn1c(-c2ccc([N+](=O)[O-])cc2)[n+](C)c2ccccc21.[I-]";"IFI";"'='";"1.299";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL533917";"";"0";"354.41";"0";"4.46";"GNF-Pf-4651";"O=C(NC(c1ccccc1)c1ccc2cccnc2c1O)c1ccccc1";"IFI";"'='";"7.692";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600346";"";"0";"280.38";"0";"0.04";"GNF-Pf-4652";"NC(=S)NN=CC(=NNC(N)=S)c1ccccc1";"IFI";"'='";"11.02";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL584434";"";"0";"394.43";"0";"4.61";"GNF-Pf-4653";"CCOC(=O)c1ccc2c(c1)[C@@H]1C=CC[C@@H]1[C@H](c1ccc(OC)c([N+](=O)[O-])c1)N2";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL602219";"";"0";"351.19";"0";"3.79";"GNF-Pf-4660";"Cc1cc(C(=O)Nc2cnn(Cc3ccc(Cl)cc3Cl)c2)no1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL584860";"";"0";"314.31";"0";"1.38";"GNF-Pf-4668";"CCOC(=O)c1nnn(-c2nonc2N)c1-c1ccc(C)cc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL584243";"";"0";"385.51";"0";"4.81";"GNF-Pf-4679";"CCOc1ccccc1-n1c(N)c(C(=O)Nc2ccc(C)cc2)sc1=S";"IFI";"'='";"1.163";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL602010";"";"0";"327.34";"0";"-0.05";"GNF-Pf-3281";"Cn1c(=O)c2c(nc3n2CC(O)CN3c2ccccc2)n(C)c1=O";"IFI";"'='";"2.41";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL601819";"";"0";"351.41";"0";"2.92";"GNF-Pf-4695";"CCC(C)NC(=O)c1nn(-c2ccc(OC)cc2)c(=O)c2ccccc12";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL581881";"";"0";"399.45";"1";"5.27";"GNF-Pf-3287";"CCOC(=O)c1cnc2c(ccc3ccccc32)c1Nc1ccc(NC(C)=O)cc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL534338";"";"0";"589.62";"2";"5.82";"GNF-Pf-3290";"O=C(c1cc2n(n1)C(C(F)(F)F)CC(c1ccc3c(c1)OCO3)N2)N1CCN(C(c2ccccc2)c2ccccc2)CC1";"IFI";"'='";"1.163";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL601770";"";"0";"318.83";"0";"4.13";"GNF-Pf-3298";"Cc1ccc(CNC(=O)c2cc3sc(Cl)cc3n2C)cc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL546215";"";"0";"378.48";"0";"4.53";"GNF-Pf-3299";"CCN(CC)c1nc(Nc2cc(C)ccc2C)nc(Nc2ccccc2O)n1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL1615701";"";"0";"381.44";"1";"5.21";"GNF-Pf-3302";"COc1cc(C=C(C#N)c2nc3ccccc3[nH]2)ccc1OCc1ccccc1";"IFI";"";"";"";"";"";"Not applicable";"";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL584641";"";"0";"324.42";"0";"3.30";"GNF-Pf-4726";"O=C1C(NC2CCCC2)=C(N2CCCCC2)C(=O)c2ccccc21";"IFI";"'='";"15.38";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL584651";"";"0";"420.53";"1";"6.02";"GNF-Pf-4733";"COc1cc(CNc2ccc(N3CCCCC3)cc2)ccc1OCc1ccccc1F";"IFI";"'='";"2.778";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL601315";"";"0";"630.92";"0";"3.25";"GNF-Pf-4757";"COC(=O)C1CCN(C(=O)COC(c2ccccc2)c2cccnc2Cl)CC1.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F";"IFI";"'='";"1.942";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL582370";"";"0";"470.04";"0";"4.91";"GNF-Pf-4766";"Cc1nc(N2CCCCC2)c2c(C)c(C(=O)N3CCN(c4cccc(Cl)c4)CC3)sc2n1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585241";"";"0";"439.34";"0";"4.78";"GNF-Pf-4804";"O=C(NCc1n[nH]c(=S)n1-c1ccc(Br)cc1)c1cccc2ccccc12";"IFI";"'='";"2.222";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585443";"";"0";"464.59";"0";"3.97";"GNF-Pf-4814";"O=C(c1ccc2nc(N3CCCCC3)sc2c1)N1CCN(Cc2ccc3c(c2)OCO3)CC1";"IFI";"'='";"2.857";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600356";"";"0";"314.43";"0";"4.75";"GNF-Pf-4816";"CCCCCCc1cc(O)c2c3c(c(=O)oc2c1)CCC(C)C3";"IFI";"'='";"7.246";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585824";"";"0";"598.23";"0";"2.15";"GNF-Pf-4823";"C[n+]1ccn(-c2ccc(C(=O)c3ccc(-n4cc[n+](C)c4)cc3)cc2)c1.[I-].[I-]";"IFI";"'='";"1.408";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600767";"";"0";"436.48";"0";"3.82";"GNF-Pf-4827";"CCN(CC)c1nc(NN=Cc2cccc([N+](=O)[O-])c2OC)nc(Nc2ccccc2)n1";"IFI";"'='";"5.195";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL527397";"";"0";"314.81";"0";"4.45";"GNF-Pf-4843";"Nc1c(Cl)c(Cl)nc(C(Cl)(Cl)Cl)c1Cl";"IFI";"'='";"1.389";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585422";"";"0";"456.53";"0";"3.86";"GNF-Pf-4861";"O=C(NC1CCN(Cc2ccccc2)CC1)c1cc(-c2ccc(F)cc2)cc(-n2cnnn2)c1";"IFI";"'='";"3.03";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL597049";"";"0";"520.61";"1";"4.36";"GNF-Pf-3827";"COc1cccc(C2C(C(=O)Nc3ccccc3)=C(C)N=c3sc(=Cc4c[nH]c5ccccc45)c(=O)n32)c1";"IFI";"'='";"2.439";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL599511";"";"0";"490.60";"1";"5.51";"GNF-Pf-3831";"Cc1c(/C=C2\SC(=Nc3ccccc3F)N(C3CCCCC3)C2=O)c2ccccc2n1CC(N)=O";"IFI";"'='";"2.439";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL579572";"";"0";"501.90";"2";"7.14";"GNF-Pf-3842";"CCN(CC)CCCC(C)Nc1nc(C=Cc2ccc(Br)cc2)nc2cc(Cl)ccc12";"IFI";"";"";"";"";"";"Not applicable";"";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL597876";"";"0";"377.24";"0";"4.48";"GNF-Pf-3846";"O=C1NC(=Nc2ccccc2)S/C1=C/c1ccc(F)c(Br)c1";"IFI";"'='";"2.299";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL597446";"";"0";"297.31";"0";"2.37";"GNF-Pf-3874";"COc1ccc(/C=C/C(=O)NC(=O)c2ccccc2O)cc1";"IFI";"'='";"8.333";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL481505";"";"0";"448.91";"0";"4.89";"GNF-Pf-3875";"COc1ccc(C(NC(=O)COc2ccccc2)c2cc(Cl)c3cccnc3c2O)cc1";"IFI";"'='";"15.38";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL604530";"";"0";"487.58";"1";"6.04";"GNF-Pf-3902";"CC1(C)CC(=O)C2=C(C1)Nc1ccccc1N(C(=O)Cc1ccccc1)C2c1ccc([N+](=O)[O-])s1";"IFI";"'='";"1.19";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL581891";"";"0";"369.43";"0";"2.85";"GNF-Pf-358";"COc1ccc(C2C(C(=O)OC3CCCCC3)=C(C)Nc3nnnn32)cc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL582678";"";"0";"521.35";"1";"4.14";"GNF-Pf-367";"Cc1cc(I)ccc1N1C(=O)C2C3c4ccccc4C(CO)(c4ccccc43)C2C1=O";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL581861";"";"0";"404.60";"0";"3.61";"GNF-Pf-382";"CC(C)CNC(=O)c1cnc(NCCCN2CCCCC2C)nc1NCC(C)C";"IFI";"'='";"1.923";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL588091";"";"0";"361.48";"1";"5.18";"GNF-Pf-387";"CCN(CC)c1ccc(C=Cc2cc[n+](Cc3ccc(F)cc3)cc2)cc1";"IFI";"";"";"";"";"";"Not applicable";"";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL581261";"";"0";"464.57";"0";"3.86";"GNF-Pf-392";"CCCC(C(=O)NC(C)(C)C)N1C(=O)c2cc(NC(C)=O)ccc2NC(=O)[C@@H]1c1ccccc1";"IFI";"'='";"1.282";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL582106";"";"0";"345.38";"0";"1.58";"GNF-Pf-395";"CCc1cccc(NS(=O)(=O)c2ccc3[nH]c(=O)c(=O)[nH]c3c2)c1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL580373";"";"0";"308.34";"0";"2.77";"GNF-Pf-404";"COCOc1ccc(-c2nc(-c3ccncc3)cnc2N)cc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL581263";"";"0";"425.53";"0";"4.23";"GNF-Pf-406";"O=C(CCCn1c(SCc2ccccc2F)nc2ccccc2c1=O)N1CCCC1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL581264";"";"0";"541.65";"2";"6.30";"GNF-Pf-407";"CCCCCCN(C(=O)c1ccc2c(c1)OCO2)C(CC)c1nc2ccccc2c(=O)n1-c1ccccc1OC";"IFI";"'='";"0.9709";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL581900";"";"0";"579.60";"2";"8.16";"GNF-Pf-408";"Cc1cccc(CSc2nnc(C(Cc3ccccc3)NC(=O)C3CCCCC3)n2-c2ccc(Cl)cc2Cl)c1";"IFI";"'='";"1.075";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL581901";"";"0";"486.70";"0";"4.35";"GNF-Pf-409";"CCNC(=O)N1CCN(CCN(C/C=C/c2ccccc2OC)C(=O)CC(C)CC(C)(C)C)CC1";"IFI";"'='";"2.542";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL581052";"";"0";"364.43";"0";"4.21";"GNF-Pf-416";"Cc1ccccc1Cn1cc(NC(=O)c2cc(-c3cccs3)on2)cn1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL581694";"";"0";"581.94";"2";"7.97";"GNF-Pf-422";"COc1cc(NC(C)CCCN(Cc2ccc(Cl)cc2)C(=O)Nc2ccc(Br)cc2)c2ncccc2c1";"IFI";"'='";"3.738";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL581696";"";"0";"369.79";"0";"1.80";"GNF-Pf-439";"O=C(Cc1ccc(Cl)cc1)NNS(=O)(=O)c1ccc([N+](=O)[O-])cc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL601978";"";"0";"359.90";"0";"4.78";"GNF-Pf-3371";"O=C(NCCCCNc1ccnc2cc(Cl)ccc12)C1CCCCC1";"IFI";"'='";"4.673";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL582111";"";"0";"432.53";"0";"3.81";"GNF-Pf-494";"O=c1c2sccc2nc(SCc2cc(=O)n3ccccc3n2)n1Cc1ccccc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL578934";"";"0";"424.38";"0";"2.68";"GNF-Pf-2783";"COc1ccc2nc3cc(Cl)ccc3c(NCCN(CCN)CCN)c2c1.Cl";"IFI";"'='";"14.46";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL610052";"";"0";"489.02";"1";"6.09";"GNF-Pf-2799";"C=CC1CN2CCC1CC2[C@@H](OC(=O)/C=C/c1ccc(Cl)cc1)c1ccnc2ccc(OC)cc12";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL125044";"";"0";"288.31";"0";"3.36";"GNF-Pf-2812";"COc1ccc(-c2cc3c(nn2)-c2ccccc2C3=O)cc1";"IFI";"'='";"8.046";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL601798";"";"0";"530.03";"1";"5.00";"GNF-Pf-433";"Cl.O=[N+]([O-])c1ccc(N2CCN(c3nc(NCCc4c[nH]c5ccccc45)c4ccccc4n3)CC2)cc1";"IFI";"'='";"6.173";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL607974";"";"0";"620.89";"2";"2.16";"GNF-Pf-520";"CC1(C)CN=C(N2CCN(CC(O)COc3ccc(OCC(O)CN4CCN(C5=NCC(C)(C)S5)CC4)cc3)CC2)S1";"IFI";"'='";"7.692";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL578913";"";"0";"445.64";"0";"4.49";"GNF-Pf-2619";"Cc1cc(N2CCCC2)nc2ccc(NC(=S)NCCN3CCc4ccccc4C3)cc12";"IFI";"'='";"5.882";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600719";"";"0";"302.34";"0";"2.26";"GNF-Pf-310";"CC1CC(C)CN(c2ccc([N+](=O)[O-])cc2-c2nnn[nH]2)C1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL579766";"";"0";"385.47";"0";"0.46";"GNF-Pf-316";"CCCN1CCN(C(=O)CCNC(=O)Cn2cnc3ccccc3c2=O)CC1";"IFI";"'='";"1.19";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL537607";"";"0";"273.36";"0";"2.11";"GNF-Pf-331";"O=C(c1cccs1)N1CCN(c2ccccn2)CC1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL582058";"";"0";"480.66";"0";"3.72";"GNF-Pf-333";"CC1CCCCN1CCCNc1ncc(C(=O)NCCc2ccccc2)c(NCC2CCCO2)n1";"IFI";"'='";"3.81";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL602417";"";"0";"420.58";"0";"4.71";"GNF-Pf-337";"CCN1CCN(c2cc(C)c3cc(NC(=O)/C=C/c4sccc4C)ccc3n2)CC1";"IFI";"'='";"7.692";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL581654";"";"0";"328.39";"0";"2.29";"GNF-Pf-341";"Cc1ccc(NC(=O)CN2CCN(c3ccccn3)CC2)cc1F";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL537500";"";"0";"592.15";"2";"8.87";"GNF-Pf-351";"COc1ccc(-c2cc(-c3ccccc3)nc(SCC(=O)N3c4ccccc4Sc4ccc(Cl)cc43)c2C#N)cc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600919";"";"0";"365.45";"0";"4.44";"GNF-Pf-389";"C=CCNC(=O)c1ccc2c(c1)N=C(c1ccc(F)cc1)N(CCCC)C2";"IFI";"'='";"1.22";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL582734";"";"0";"327.39";"0";"3.47";"GNF-Pf-484";"CCc1ccc2c(c1)C(c1ccncc1)=NNC(c1ccncc1)=N2";"IFI";"'='";"1.852";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600314";"";"0";"312.38";"0";"4.13";"GNF-Pf-1503";"Nc1ccc(-c2nc(-c3ccc(N)cc3)c3ccccc3n2)cc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600151";"";"0";"374.15";"0";"3.53";"GNF-Pf-1330";"O=C1C(=Cc2cc([N+](=O)[O-])cc(Br)c2O)C(=O)c2ccccc21";"IFI";"'='";"7.692";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL602223";"";"0";"351.42";"0";"4.54";"GNF-Pf-1343";"COc1ccccc1CCNCc1cc(-c2ccc(F)cc2)ccc1O";"IFI";"'='";"0.9091";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585451";"";"0";"341.43";"0";"1.10";"GNF-Pf-1354";"O=C(NCC1CCCO1)c1cc(S(=O)(=O)N2CCCCC2)c[nH]1";"IFI";"'='";"2.381";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600744";"";"0";"345.81";"0";"2.90";"GNF-Pf-3046";"O=C(CSc1ccc(Cl)cc1)NN=C1C(=O)Nc2ccccc21";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL608146";"";"0";"355.48";"0";"4.89";"GNF-Pf-3817";"COc1ccc(OC)c(-c2ccc(O)c(CNC3CCCCCC3)c2)c1";"IFI";"'='";"2.97";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL598061";"";"0";"367.86";"0";"3.93";"GNF-Pf-3818";"COc1cccc(C(=O)C[n+]2cc(-c3ccc(Cl)cc3)n3c2CCC3)c1";"IFI";"'='";"2.439";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL599100";"";"0";"453.33";"1";"5.78";"GNF-Pf-3837";"COc1ccc(C(=O)NC(c2ccccc2Cl)c2cc(Cl)c3cccnc3c2O)cc1";"IFI";"'='";"6.349";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL584247";"";"0";"399.43";"1";"5.35";"GNF-Pf-3851";"COc1cc(C=C(C#N)c2nc3ccccc3[nH]2)ccc1OCc1ccccc1F";"IFI";"";"";"";"";"";"Not applicable";"";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL584252";"";"0";"376.46";"0";"2.61";"GNF-Pf-3855";"Cn1nc(C(=O)NCc2ccccc2)c2c1CCN(Cc1cccc(O)c1)C2";"IFI";"'='";"1.22";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL598270";"";"0";"510.18";"1";"6.49";"GNF-Pf-3889";"CCCCCCC[N+](CC)(CC)CCCCc1ccc(Cl)cc1.Cc1ccc(S(=O)(=O)[O-])cc1";"IFI";"'='";"4.511";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL584245";"";"0";"511.42";"1";"3.98";"GNF-Pf-3922";"CCOC(=O)c1c(CN2CCN(CC#N)CC2)n(Cc2ccccc2)c2cc(Br)c(O)cc12";"IFI";"'='";"2.273";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL133276";"";"0";"400.48";"1";"5.42";"GNF-Pf-2664";"OC1(c2ccc3ccccc3c2)c2c(c3ccccc3c3ccccc23)C2=NCCN21";"IFI";"'='";"3.252";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL584464";"";"0";"323.23";"0";"2.74";"GNF-Pf-3934";"Br.CC(C)(C)C(=O)Cn1ccc(=N)c2ccccc21";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL579306";"";"0";"429.45";"1";"5.27";"GNF-Pf-2674";"FC(F)(F)COc1nc(N2CCCCC2)nc(N(c2ccccc2)c2ccccc2)n1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL577171";"";"0";"284.39";"0";"3.57";"GNF-Pf-2678";"Cc1cc(C)c(CSc2ncnc3[nH]cnc23)c(C)c1";"IFI";"'='";"1.562";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL597059";"";"0";"362.47";"0";"4.13";"GNF-Pf-4505";"C=CC1CN2CCC1CC2C(OC(=O)C1CC1)c1ccnc2ccccc12";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585418";"";"0";"374.49";"0";"3.60";"GNF-Pf-4523";"Oc1ccc(-c2cnccn2)cc1CNC1CCN(Cc2ccccc2)CC1";"IFI";"'='";"5.556";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL586030";"";"0";"482.41";"0";"4.11";"GNF-Pf-4447";"CC[n+]1c(C=C2Sc3ccccc3N2CCO)sc2ccccc21.[I-]";"IFI";"";"";"";"";"";"Not applicable";"";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL586031";"";"0";"362.43";"0";"3.88";"GNF-Pf-4450";"COc1ccccc1NC1=C(N2CCCCC2)C(=O)c2ccccc2C1=O";"IFI";"'='";"17.65";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600906";"";"0";"201.27";"0";"3.20";"GNF-Pf-4557";"CCCc1c(C)nc2ccccc2c1O";"IFI";"'='";"1.587";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL582807";"";"0";"472.41";"0";"4.79";"GNF-Pf-4460";"CCCCCCCCn1c(C)[n+](CC)c2cc(C(=O)OCC)ccc21.[I-]";"IFI";"'='";"7.143";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL583167";"";"0";"337.85";"0";"2.78";"GNF-Pf-4562";"CCOC(=O)c1cnc2ccccc2c1NCCCN(C)C.Cl";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585585";"";"0";"264.33";"0";"4.61";"GNF-Pf-4229";"Cc1ccc(N=Nc2nc3ccccc3n2C)c(C)c1";"IFI";"'='";"19.35";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL604719";"";"0";"457.41";"0";"3.87";"GNF-Pf-4248";"O=C(O)C(F)(F)F.O=C(O)c1ccc2c(c1)N=C(c1ccccc1)N(Cc1cccnc1)C2";"IFI";"'='";"1.22";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL603037";"";"0";"426.73";"0";"3.96";"GNF-Pf-4568";"O=C(c1ccccc1)N1CCN(c2ccccc2NC(=O)C(Cl)(Cl)Cl)CC1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600553";"";"0";"478.59";"1";"5.51";"GNF-Pf-4588";"COc1cc(C2C3=C(CC(C)(C)CC3=O)Nc3ccccc3N2C(=O)C(C)C)cc(OC)c1OC";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL584235";"";"0";"346.90";"0";"3.79";"GNF-Pf-4600";"CC(C)CCNCC(O)Cn1c2ccccc2c2ccccc21.Cl";"IFI";"'='";"1.408";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL580133";"";"0";"249.34";"0";"3.02";"GNF-Pf-4063";"CN1/C(=C/c2cccc[n+]2C)C=Cc2ccccc21";"IFI";"";"";"";"";"";"Not applicable";"";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL602831";"";"0";"448.50";"0";"4.07";"GNF-Pf-4079";"COc1ccc(S(=O)(=O)N=C2C=C(Nc3ccccc3OC)C(=O)c3ccccc32)cc1";"IFI";"'='";"23.08";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL533577";"";"0";"403.86";"1";"5.40";"GNF-Pf-4151";"O=C(CSc1nccn1C1CCCC1)Nc1cc(C(F)(F)F)ccc1Cl";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL602354";"";"0";"461.35";"0";"3.10";"GNF-Pf-4182";"Cc1cc(C)[n+](C)n1CC(O)Cn1c2ccccc2c2ccccc21.[I-]";"IFI";"'='";"1.031";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL604320";"";"0";"414.91";"1";"5.32";"GNF-Pf-4191";"O=C1CN(C(=O)CCC2CCCC2)C(c2ccc(F)cc2)c2cc(Cl)ccc2N1";"IFI";"'='";"2.941";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL601996";"";"0";"473.62";"1";"7.17";"GNF-Pf-4200";"Cc1cc(/C=C2\SC(=Nc3ccccc3)N(C3CCCCC3)C2=O)c(C)n1-c1ccc(F)cc1";"IFI";"";"";"";"";"";"Not applicable";"";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL597465";"";"0";"357.52";"0";"4.03";"GNF-Pf-4203";"CCc1n(CC(=O)OC2CC(C)CCC2C(C)C)c2ccccc2[n+]1C";"IFI";"'='";"7.143";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL581669";"";"0";"374.29";"0";"4.75";"GNF-Pf-3214";"COc1ccc(-c2c[n+](Cc3ccc(Cl)c(Cl)c3)c3n2CCC3)cc1";"IFI";"'='";"2.439";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL582280";"";"0";"448.52";"0";"3.40";"GNF-Pf-3372";"COC(=O)[C@@H]1C[C@@H](NC(=O)c2ccc(OC)cc2OC)CN1Cc1cccc2ccccc12";"IFI";"'='";"0.8475";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL582283";"";"0";"389.50";"0";"3.73";"GNF-Pf-3377";"Cc1cc(C)n(-c2ccc(NC(=O)C3CCN(Cc4ccncc4)CC3)cc2)n1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL602818";"";"0";"268.36";"0";"2.69";"GNF-Pf-3391";"Cc1cn2c3ccccc3n(CCN3CCCC3)c2n1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600920";"";"0";"330.82";"0";"4.39";"GNF-Pf-3397";"CCOc1ccc2nc(C)cc(Nc3cccc(O)c3)c2c1.Cl";"IFI";"'='";"1.064";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL582050";"";"0";"275.30";"0";"2.31";"GNF-Pf-3277";"CCc1ccc2ncc(C(=O)OCCOC)c(O)c2c1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL582713";"";"0";"386.43";"1";"5.48";"GNF-Pf-3009";"Fc1ccc(C(CCNc2ncnc3c2[nH]c2ccccc23)c2ccco2)cc1";"IFI";"'='";"16.67";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL581889";"";"0";"368.82";"0";"3.55";"GNF-Pf-3020";"CC(=O)N(C1=C(N(C)C)C(=O)c2ccccc2C1=O)c1cccc(Cl)c1";"IFI";"'='";"7.143";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL579553";"";"0";"438.02";"1";"6.59";"GNF-Pf-3028";"CCCCCCc1ccc(C(=O)N(C)CCCNc2ccnc3cc(Cl)ccc23)cc1";"IFI";"'='";"4.211";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL1615700";"";"0";"453.03";"1";"5.81";"GNF-Pf-3033";"CCN(CC)CCCC(C)N=c1[nH]c(C=Cc2ccccc2OC)nc2cc(Cl)ccc12";"IFI";"";"";"";"";"";"Not applicable";"";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL582267";"";"0";"319.32";"0";"2.65";"GNF-Pf-3040";"O=c1c2[nH]c3ccccc3c2ncn1Cc1ccc2c(c1)OCO2";"IFI";"'='";"3.077";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600304";"";"0";"405.54";"0";"3.04";"GNF-Pf-3052";"CCC(COC)NC(=O)c1cn(C2CCCCC2)cc(C(=O)NC(C)(C)C)c1=O";"IFI";"'='";"1.709";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL601370";"";"0";"400.45";"1";"5.14";"GNF-Pf-3054";"CCOC(=O)CCCSc1nc(-c2cccs2)cc(C(F)(F)F)c1C#N";"IFI";"'='";"7.273";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL581236";"";"0";"291.39";"0";"4.06";"GNF-Pf-3059";"C#CC(C)(C)NC(=O)c1ccc(-c2ccc(CC)cc2)cc1";"IFI";"'='";"3.101";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL581661";"";"0";"434.91";"0";"3.92";"GNF-Pf-3068";"CN(CCCNc1ccnc2cc(Cl)ccc12)S(=O)(=O)c1ccc([N+](=O)[O-])cc1";"IFI";"'='";"5.505";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL579759";"";"0";"356.48";"0";"2.93";"GNF-Pf-3085";"S=C(NN=CC=NNC(=S)Nc1ccccc1)Nc1ccccc1";"IFI";"'='";"14.29";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL531121";"";"0";"289.34";"0";"3.20";"GNF-Pf-3093";"C=CCNc1cc(-c2ccccn2)nc(-c2ccccn2)n1";"IFI";"'='";"7.692";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL536572";"";"0";"279.38";"0";"3.12";"GNF-Pf-3122";"O=C(O)C=CC(=O)N(C1CCCCC1)C1CCCCC1";"IFI";"";"";"";"";"";"Not applicable";"";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL601979";"";"0";"575.66";"1";"3.74";"GNF-Pf-3127";"COc1cccc(CCOc2ccc3c(c2)C(=O)N(C(C(=O)NC(C)(C)C)c2cccc(OC)c2)C(CO)C(=O)N3)c1";"IFI";"'='";"2.299";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL580158";"";"0";"264.78";"0";"4.02";"GNF-Pf-3182";"C=CCSc1ncc(-c2ccc(Cl)cc2)n1C";"IFI";"'='";"1.075";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL581466";"";"0";"620.95";"0";"3.43";"GNF-Pf-3404";"COc1ccc(C(OCC(=O)N2CCSCC2)c2ccncc2Cl)cc1.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F";"IFI";"'='";"0.9804";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL599719";"";"0";"377.53";"1";"5.39";"GNF-Pf-3412";"CCN1/C(=C/c2ccc3cc(OC)ccc3[n+]2CC)Sc2cc(C)ccc21";"IFI";"";"";"";"";"";"Not applicable";"";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL579550";"";"0";"375.86";"1";"5.50";"GNF-Pf-3416";"Cc1cccc(NC(c2cccc(Cl)c2)c2ccc3cccnc3c2O)n1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL602179";"";"0";"286.76";"0";"4.34";"GNF-Pf-3417";"COc1ccc(C(=O)C2CC2c2ccc(Cl)cc2)cc1";"IFI";"'='";"3.797";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL500142";"";"0";"338.37";"0";"3.31";"GNF-Pf-3422";"COc1cc(Nc2cncc(-c3ccncc3)n2)cc(OC)c1OC";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL582273";"";"0";"384.52";"0";"3.63";"GNF-Pf-3433";"CCCCNC(=O)NC(Cc1c[nH]c2ccccc12)C(=O)NC1CCCCC1";"IFI";"'='";"4.211";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL546828";"";"0";"326.14";"0";"4.41";"GNF-Pf-3435";"O=C(c1ccc(Cl)cc1Cl)N1CCCC(C(F)(F)F)C1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL582274";"";"0";"405.25";"0";"4.46";"GNF-Pf-3436";"CC[n+]1c(/C=C/c2ccc(F)cc2)ccc2ccccc21.[I-]";"IFI";"'='";"5.102";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL602619";"";"0";"341.41";"0";"4.65";"GNF-Pf-3442";"Oc1c2c(nc3cc(-c4ccc(-c5ccccc5)cc4)nn13)CCCC2";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL582695";"";"0";"416.52";"0";"1.98";"GNF-Pf-3443";"CC(C)(C)NC(=O)C(C1CC1)N1C(=O)c2cc(O)ccc2NC(=O)[C@@H]1CCCCN";"IFI";"'='";"0.8264";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL582697";"";"0";"403.53";"0";"3.59";"GNF-Pf-3445";"CC(C)OC(=O)CSc1nnc(CNc2nc(-c3ccccc3)cs2)n1C";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL604979";"";"0";"520.54";"1";"4.61";"GNF-Pf-3465";"CCOC(=O)c1ccc(OCC2c3cc(OC)c(OC)cc3CCN2C(=O)c2ccc([N+](=O)[O-])cc2)cc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL582296";"";"0";"346.34";"0";"3.90";"GNF-Pf-3466";"CCOC(=O)c1c(-c2ccccc2)oc2c1C(=O)c1ccccc1C2=O";"IFI";"'='";"1.471";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL579891";"";"0";"434.50";"0";"2.71";"GNF-Pf-3472";"COc1cc2nc(NCCN3CCOCC3)n3nc(-c4ccccc4)nc3c2cc1OC";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600488";"";"0";"280.17";"0";"3.96";"GNF-Pf-3473";"CCCc1c(C)nc2ccc(Br)cc2c1O";"IFI";"'='";"3.03";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL579787";"";"0";"381.50";"0";"4.58";"GNF-Pf-3492";"O=C(Nc1ccccc1F)NC1CC2CCCC(C1)N2CCc1ccccc1";"IFI";"'='";"1.299";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL581700";"";"0";"411.55";"0";"3.75";"GNF-Pf-3498";"CCNC(=O)C1CCN(c2cccc3c2C(=O)N(C2CCCCCCC2)C3=O)CC1";"IFI";"'='";"3.448";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600550";"";"0";"389.48";"0";"4.46";"GNF-Pf-3505";"N#CCSc1ncccc1C(=O)NCCc1ccc(Oc2ccccc2)cc1";"IFI";"'='";"2.778";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL601109";"";"0";"640.81";"2";"6.40";"GNF-Pf-3532";"CC(Sc1nnc2c3ccccc3n(Cc3ccccc3)c2n1)C(=O)N1CCN(C(=O)C(c2ccccc2)c2ccccc2)C(C)C1";"IFI";"'='";"1.887";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL598679";"";"0";"304.40";"0";"4.45";"GNF-Pf-3543";"Cc1ccc(Nc2cc(C)nc(NCc3ccccc3)n2)cc1";"IFI";"'='";"5.814";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL598680";"";"0";"377.40";"0";"3.92";"GNF-Pf-3546";"Cc1ccc(-c2noc(C3CCN(C(=O)Nc4ccc(C#N)cc4)CC3)n2)o1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL597858";"";"0";"267.74";"0";"2.01";"GNF-Pf-3547";"O=C1CSC2=NCN(c3cccc(Cl)c3)CN12";"IFI";"'='";"2.083";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL604326";"";"0";"444.55";"0";"3.78";"GNF-Pf-3563";"CCOC(=O)c1ccc(NC(=O)c2ccc(S(=O)(=O)N3CC(C)CC(C)C3)cc2)cc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL583601";"";"0";"409.49";"0";"3.92";"GNF-Pf-3590";"O=C(O)C(=O)O.c1ccc(CN2CCC(NCc3c[nH]c4ccccc34)CC2)cc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL583605";"";"0";"357.45";"0";"3.66";"GNF-Pf-3596";"O=C(CN1CCCC1)N1N=C(c2cccs2)CC1c1ccc(F)cc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL494668";"";"0";"434.54";"0";"4.11";"GNF-Pf-3622";"CCN(CC)CCCNc1nc2cc(OC)c(OC)cc2c2nc(-c3ccccc3)nn12";"IFI";"'='";"8.333";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL580702";"";"0";"358.73";"0";"4.35";"GNF-Pf-3628";"FC(F)(F)c1cnc(Sc2nnc(-c3ccncc3)o2)c(Cl)c1";"IFI";"'='";"10.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL525128";"";"0";"448.91";"1";"5.13";"GNF-Pf-3638";"COc1cccc(C(=O)NC(c2ccccc2OC)c2cc(Cl)c3cccnc3c2O)c1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL605423";"";"0";"424.89";"0";"4.69";"GNF-Pf-3639";"CCOC(=O)c1cnn(-c2ccnc3cc(Cl)ccc23)c1CNC(C)c1ccco1";"IFI";"'='";"2.586";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL599099";"";"0";"379.50";"0";"4.56";"GNF-Pf-3643";"COc1cc2ccccc2cc1C(=O)NCCOC12CC3CC(CC(C3)C1)C2";"IFI";"'='";"2.151";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL601957";"";"0";"228.34";"0";"3.17";"GNF-Pf-3651";"CCCc1c(CC)c(=N)c2ccccc2n1C";"IFI";"'='";"7.692";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL597873";"";"0";"389.41";"0";"4.93";"GNF-Pf-3652";"CCOC(=O)c1c(C)n(-c2ccccc2)c2ccc(OC(=O)c3ccco3)cc12";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL598074";"";"0";"515.72";"2";"6.56";"GNF-Pf-3654";"CC(C)CN1C(=O)c2ccccc2C(C(=O)Nc2ccc(CN3CCC(C)CC3)cc2)C1c1cccs1";"IFI";"'='";"3.03";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL609614";"";"0";"315.40";"0";"2.30";"GNF-Pf-3656";"CN1CCc2c(sc3c2C(=O)NC(c2ccc(O)cc2)N3)C1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL597473";"";"0";"284.27";"0";"1.94";"GNF-Pf-3659";"Nc1ccc(C(=O)NN=Cc2cccc([N+](=O)[O-])c2)cc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL583600";"";"0";"325.46";"0";"4.52";"GNF-Pf-3663";"CC1=C(C=CC(C)C=NNC(=O)c2ccncc2)C(C)(C)CCC1";"IFI";"";"";"";"";"";"Not applicable";"";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL583603";"";"0";"289.36";"0";"3.11";"GNF-Pf-3666";"CCc1ccc(NC(=O)COC(=O)c2cccs2)cc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL583610";"";"0";"496.59";"0";"1.73";"GNF-Pf-3675";"O=C(NCCCN1CCOCC1)c1c[nH]c2ccc(S(=O)(=O)N3CCc4ccccc43)cc2c1=O";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL1744510";"";"0";"340.40";"0";"3.60";"GNF-Pf-3684";"COc1cccc(/C=C2\SC(=Nc3ccccc3)NC2=O)c1OC";"IFI";"";"";"";"";"";"Not applicable";"";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL609025";"";"0";"299.80";"1";"5.12";"GNF-Pf-3689";"CC(C)c1ccc(NC(=O)/C=C/c2ccccc2Cl)cc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL598886";"";"0";"282.37";"0";"2.87";"GNF-Pf-3699";"Sc1nnc(-c2ccncc2)n1CCc1ccccc1";"IFI";"'='";"1.515";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL604723";"";"0";"415.32";"1";"5.20";"GNF-Pf-3701";"O=C(COc1ccc(Cl)cc1)N1CCCn2cccc2C1c1ccc(Cl)cc1";"IFI";"'='";"0.9709";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL598268";"";"0";"417.51";"0";"4.73";"GNF-Pf-3702";"COc1ccc(CN2CCC(C(=O)Nc3ccc(Oc4cccnc4)cc3)CC2)cc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL609606";"";"0";"404.30";"0";"3.81";"GNF-Pf-3716";"CC[n+]1c(C=C2C=CN(C)C=C2)ccc2cc(C)ccc21.[I-]";"IFI";"'='";"7.812";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL598694";"";"0";"446.28";"1";"6.15";"GNF-Pf-3724";"Cn1nc(C(F)(F)F)c(C(=O)Nc2ccc(Cl)cc2)c1Sc1ccc(Cl)cc1";"IFI";"'='";"4.11";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL604511";"";"0";"530.35";"1";"5.24";"GNF-Pf-3727";"[Br-].[Br-].c1cc2cc3c(cc2c2cc4c(cc12)C[N+]1(CCCC1)C4)C[N+]1(CCCC1)C3";"IFI";"'='";"1.538";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL597475";"";"0";"337.47";"0";"3.90";"GNF-Pf-3732";"CCN(CC)CCN1C(=O)c2ccccc2NC1c1ccc(C)cc1";"IFI";"'='";"6.977";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL606449";"";"0";"455.31";"0";"3.43";"GNF-Pf-3737";"CC(=O)N(C1=C(N2CCOCC2)C(=O)c2ccccc2C1=O)c1ccc(Br)cc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL602422";"";"0";"388.47";"0";"4.62";"GNF-Pf-3740";"C=C[C@H]1CN2CC[C@H]1C[C@@H]2[C@@H](OC(=O)c1ccco1)c1ccnc2ccccc12";"IFI";"'='";"1.653";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL584040";"";"0";"497.04";"1";"5.71";"GNF-Pf-3747";"CCCCN(CC(=O)Nc1cc(C(C)(C)C)nn1-c1ccc(Cl)cc1)C(=O)c1ccc(OC)cc1";"IFI";"'='";"1.923";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL597243";"";"0";"462.81";"1";"5.32";"GNF-Pf-3760";"Cc1ccc(Cn2c(=N)n(CC(O)c3ccc(Cl)c(Cl)c3)c3ccccc32)cc1.Cl";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL598284";"";"0";"277.23";"0";"2.50";"GNF-Pf-3767";"CN(C)CCN(C)Cc1cc(Br)cs1";"IFI";"'='";"5.833";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL601958";"";"0";"285.34";"0";"2.15";"GNF-Pf-3785";"OC(CNCC1COc2ccccc2O1)c1ccccc1";"IFI";"'='";"1.504";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL602366";"";"0";"199.25";"0";"2.41";"GNF-Pf-3796";"O=c1c2c([nH]c3ccccc13)CCCC2";"IFI";"'='";"2.158";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL597244";"";"0";"550.53";"2";"6.54";"GNF-Pf-3799";"CC(C)(C)OC(=O)N1CCC(c2c(C(=O)Nc3cccc(C(F)(F)F)c3)cnn2-c2ccc(F)cc2F)CC1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL599290";"";"0";"459.57";"1";"6.99";"GNF-Pf-3811";"CC(C)(C)CC(C)(C)Nc1c(-c2ccccc2OC(=O)c2ccccc2F)nc2ccccn12";"IFI";"'='";"2.83";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL602966";"";"0";"342.22";"0";"2.45";"GNF-Pf-3814";"CC(=O)NC1=NN(C(C)=O)C(c2ccc(Br)cc2)S1";"IFI";"'='";"2.128";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL526027";"";"0";"212.30";"0";"2.63";"GNF-Pf-3838";"CCn1c2c(c(=N)c3ccccc31)CCC2";"IFI";"'='";"7.143";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL3216426";"";"0";"385.30";"0";"2.10";"GNF-Pf-3839";"Cl.Cl.N=C(N)c1ccc(OCCCOc2ccc(C(=N)N)cc2)cc1";"IFI";"'='";"5.556";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL598078";"";"0";"531.59";"2";"6.50";"GNF-Pf-3848";"COc1ccc(C2C(C(=O)Nc3cnc4ccccc4c3)c3ccccc3C(=O)N2Cc2ccc(F)cc2)cc1";"IFI";"'='";"1.176";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL584251";"";"0";"282.77";"1";"5.25";"GNF-Pf-3854";"Cc1ccc2cc(C)c(Nc3ccc(Cl)cc3)nc2c1";"IFI";"'='";"4.545";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL584256";"";"0";"331.17";"0";"3.48";"GNF-Pf-3859";"Oc1ccc(Br)cc1C=NNc1nc2ccccc2[nH]1";"IFI";"'='";"1.429";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL599889";"";"0";"290.71";"0";"3.81";"GNF-Pf-3862";"Cc1cc(Cl)ccc1NC(=O)c1ccccc1[N+](=O)[O-]";"IFI";"'='";"0.8197";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL584715";"";"0";"468.19";"0";"4.01";"GNF-Pf-3867";"OC(CN1CCOCC1)Cn1c2ccc(Br)cc2c2cc(Br)ccc21";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL549275";"";"0";"315.80";"0";"4.01";"GNF-Pf-3868";"Cc1cc(OC(C)C(=O)N2CCc3ccccc32)ccc1Cl";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL598269";"";"0";"324.43";"0";"4.21";"GNF-Pf-3888";"c1ccc2[nH]c(Sc3ncnc4sc5c(c34)CCC5)nc2c1";"IFI";"'='";"1.515";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL597863";"";"0";"391.23";"0";"3.97";"GNF-Pf-3892";"C[n+]1c(/C=C/c2ccc(F)cc2)ccc2ccccc21.[I-]";"IFI";"'='";"8.772";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL599103";"";"0";"235.62";"0";"2.47";"GNF-Pf-3907";"O=C(CCl)Nc1ccc(OC(F)F)cc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL597259";"";"0";"397.57";"0";"4.49";"GNF-Pf-3976";"C=CCSc1nc2sc3c(c2c(=O)n1-c1ccccc1)CCN(CCC)C3";"IFI";"'='";"7.843";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585270";"";"0";"462.56";"1";"2.11";"GNF-Pf-4221";"O=C(NCCCCNC(=O)Nc1cccc(C2=NCCN2)c1)Nc1cccc(C2=NCCN2)c1";"IFI";"'='";"0.9009";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585469";"";"0";"419.58";"0";"4.73";"GNF-Pf-4226";"CN1CCc2c(sc3nc(SCc4ccccc4)n(-c4ccccc4)c(=O)c23)C1";"IFI";"'='";"10.2";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL578517";"";"0";"515.53";"1";"5.44";"GNF-Pf-2435";"O=C(Nc1ccc(Oc2ccccc2)cc1)NC(CN1CCCC1)c1ccccc1.O=C(O)C(F)(F)F";"IFI";"'='";"7.042";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL578310";"";"0";"475.03";"1";"7.42";"GNF-Pf-2438";"CCC(Oc1ccc(C(C)(C)CC)cc1C(C)(C)CC)C(=O)Nc1ccc(Cl)c([N+](=O)[O-])c1";"IFI";"'='";"2.479";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL610621";"";"0";"340.77";"0";"4.44";"GNF-Pf-2439";"O=C(Nc1ccc(NC(=O)c2ccco2)cc1Cl)c1ccccc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL605185";"";"0";"382.51";"0";"3.99";"GNF-Pf-552";"CCOc1ccc(Nc2nc(N3CCCCC3)nc(N3CCCCC3)n2)cc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL579125";"";"0";"370.50";"0";"3.49";"GNF-Pf-2481";"Cc1nc(-c2nc3c(s2)CN(C(=O)CCc2cccnc2)CC3)cs1";"IFI";"'='";"4.167";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL582115";"";"0";"417.46";"0";"4.58";"GNF-Pf-586";"COc1ccc(C2C(C(=O)O)c3ccccc3C(=O)N2c2ccc(C)cc2)cc1OC";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL576614";"";"0";"489.56";"0";"3.43";"GNF-Pf-1510";"Cc1ccc(C(C(=O)NCc2ccccc2)N(C(=O)c2snc(C(N)=O)c2N)c2ccccc2)o1";"IFI";"'='";"4.673";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL583169";"";"0";"327.81";"0";"4.08";"GNF-Pf-820";"Cc1ccc(C)c(N2C(=O)CC(Cc3ccc(Cl)cc3)C2=O)c1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL578079";"";"0";"442.61";"0";"2.92";"GNF-Pf-2564";"CCn1c(SCC(=O)NCCc2ccccc2)nc2sc3c(c2c1=O)CCN(C)C3";"IFI";"'='";"8.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600126";"";"0";"385.33";"0";"0.51";"GNF-Pf-2574";"CC1(C)O[C@@H]2OC([C@@H](O)CNc3ccc([N+](=O)[O-])cc3[N+](=O)[O-])C(O)[C@@H]2O1";"IFI";"'='";"0.7463";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL601785";"";"0";"430.25";"0";"2.39";"GNF-Pf-2582";"Cc1n(-c2ccccc2)c2c([n+]1C)C(=O)c1ccccc1C2=O.[I-]";"IFI";"'='";"33.33";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL578731";"";"0";"225.31";"0";"3.25";"GNF-Pf-2585";"CC[n+]1c(C)cc2c([nH]c3ccccc32)c1C";"IFI";"'='";"3.03";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585249";"";"0";"306.39";"0";"3.85";"GNF-Pf-1346";"COc1ccc(/C=C/c2ccc3ccccc3[n+]2C)cc1OC";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL605945";"";"0";"462.38";"1";"5.16";"GNF-Pf-4258";"CCCCCOC(=O)C1=C(C)NC2=C(C(=O)CCC2)C1c1ccc(OC)c(Br)c1";"IFI";"'='";"2.222";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL582249";"";"0";"421.55";"0";"3.22";"GNF-Pf-1795";"CC(C)CNC(=O)c1cnc(NCCCn2ccnc2)nc1NCCc1ccccc1";"IFI";"'='";"0.9615";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL582459";"";"0";"310.35";"0";"3.51";"GNF-Pf-1802";"COc1ccc2[nH]cc(CCNC(=O)Oc3ccccc3)c2c1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL601967";"";"0";"252.36";"0";"2.21";"GNF-Pf-1805";"O=C(NCSC1=NCCS1)c1ccccc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL577662";"";"0";"410.34";"0";"4.58";"GNF-Pf-1813";"CCCCCCCn1c2c(c(=N)c3ccccc31)CCC2.I";"IFI";"'='";"13.64";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL577663";"";"0";"312.84";"0";"2.76";"GNF-Pf-1814";"COc1ccccc1NC(=O)CCN1CCCC(C)C1.Cl";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL576805";"";"0";"362.48";"0";"4.29";"GNF-Pf-1824";"CC(C)N1CCCC(C(=O)Nc2ccc(-c3nc4ccccc4[nH]3)cc2)C1";"IFI";"'='";"7.692";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL601338";"";"0";"298.14";"0";"4.03";"GNF-Pf-1826";"Brc1ccc2[nH]c3nc4ccccc4nc3c2c1";"IFI";"'='";"3.774";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL602230";"";"0";"552.12";"2";"8.28";"GNF-Pf-1838";"CCCCCN(C(=O)c1ccc2ccccc2c1)C(CC)c1nc2ccccc2c(=O)n1-c1ccc(Cl)cc1C";"IFI";"'='";"1.887";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL587717";"";"0";"351.45";"0";"2.74";"GNF-Pf-1849";"O=C(NCCc1nc(-c2cccnc2)n[nH]1)C12CC3CC(CC(C3)C1)C2";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL587908";"";"0";"403.54";"0";"4.99";"GNF-Pf-1851";"CCCCCCC(NC(=O)OCc1ccccc1)S(=O)(=O)c1ccc(C)cc1";"IFI";"'='";"2.597";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL580945";"";"0";"430.36";"0";"4.82";"GNF-Pf-1862";"Cc1ccc(O)c(NC(=O)c2cnn3c(C(F)(F)F)cc(-c4ccc(F)cc4)nc23)c1";"IFI";"'='";"2.273";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600504";"";"0";"341.35";"0";"3.96";"GNF-Pf-1866";"O=C(/C=C/c1ccc(-c2cccc([N+](=O)[O-])c2)o1)Nc1nccs1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600103";"";"0";"262.35";"0";"3.01";"GNF-Pf-1872";"O=C(NC1CCCCC1)c1noc2c1CCCCC2";"IFI";"'='";"11.43";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL532857";"";"0";"573.74";"2";"7.57";"GNF-Pf-1879";"CCCCc1ccc(C(=O)N(CCc2ccccc2)C(CC)c2nc3ccccc3c(=O)n2-c2ccccc2OC)cc1";"IFI";"'='";"5.769";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL578099";"";"0";"315.33";"0";"0.68";"GNF-Pf-1885";"CCOC(=O)C1=NNC2C(=O)N(c3cccc(C)c3C)C(=O)C12";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL577881";"";"0";"411.57";"0";"4.47";"GNF-Pf-1891";"Cc1sc2nc(C3CC3)n(C3CCN(C(=O)C4CC=CCC4)CC3)c(=O)c2c1C";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL578963";"";"0";"393.53";"1";"5.12";"GNF-Pf-1908";"CCN1/C(=C/c2sc3ccc(OC)cc3[n+]2CC)C=Cc2cc(OC)ccc21";"IFI";"'='";"15.38";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL601391";"";"0";"535.66";"2";"7.85";"GNF-Pf-1914";"CCCCCCN(C(=O)c1ccc2ccccc2c1)C(CC)c1nc2ccccc2c(=O)n1-c1ccc(F)cc1";"IFI";"'='";"2.941";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL532674";"";"0";"634.50";"2";"8.00";"GNF-Pf-1916";"CCC(c1nc2ccccc2c(=O)n1-c1ccc(Br)cc1)N(CCc1ccccc1)C(=O)c1cccc(C(F)(F)F)c1";"IFI";"'='";"1.869";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL602997";"";"0";"269.35";"0";"2.33";"GNF-Pf-1918";"Cc1ccc(CN=C(N)Nc2nc(C)cc(C)n2)cc1";"IFI";"'='";"7.527";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL531777";"";"0";"163.22";"0";"2.21";"GNF-Pf-1926";"CCc1ccccc1NC(C)=O";"IFI";"'='";"1.042";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL6229";"";"0";"295.42";"0";"2.84";"GNF-Pf-1931";"CCc1cc2c(Sc3nnc(N)s3)ncnc2s1";"IFI";"'='";"3.077";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL581623";"";"0";"320.40";"0";"4.43";"GNF-Pf-1957";"Oc1ccccc1Nc1nc(NC2CCCC2)c2ccccc2n1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL582046";"";"0";"397.91";"0";"3.68";"GNF-Pf-1962";"Oc1ccc(-c2ccnc3cc(Cl)ccc23)cc1CNCCN1CCOCC1";"IFI";"'='";"1.724";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL531123";"";"0";"392.28";"0";"3.30";"GNF-Pf-1988";"CN(C)c1ccc(C=CC=Cc2cc[n+](C)cc2)cc1.[I-]";"IFI";"'='";"12.41";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585963";"";"0";"566.61";"1";"2.55";"GNF-Pf-1996";"CC(=O)Nc1ccc2c(c1)C(=O)N(C(CC(C)C)C(=O)NCC(=O)O)[C@@H](CCC(=O)OCc1ccccc1)C(=O)N2";"IFI";"'='";"2.439";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL577641";"";"0";"363.51";"1";"5.12";"GNF-Pf-1999";"CCN1C(=Cc2sc3ccc(O)cc3[n+]2CC)C=Cc2cc(C)ccc21";"IFI";"";"";"";"";"";"Not applicable";"";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL587519";"";"0";"433.53";"0";"4.54";"GNF-Pf-2010";"COc1ccc(-c2ccc3c(N)c(C(=O)NCCc4ccccc4)sc3n2)cc1OC";"IFI";"'='";"7.273";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL532935";"";"0";"636.71";"2";"10.45";"GNF-Pf-2015";"Oc1cccc(-c2nc(-c3ccccc3)c(-c3ccc4oc5ccc(-c6[nH]c(-c7cccc(O)c7)nc6-c6ccccc6)cc5c4c3)[nH]2)c1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL581190";"";"0";"358.40";"0";"3.92";"GNF-Pf-2023";"COc1ccccc1NC(=O)c1cnn(-c2ccccc2)c1-n1cccc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL532641";"";"0";"336.39";"0";"3.67";"GNF-Pf-2034";"Oc1cccc(Nc2nc(NCC3CCCO3)c3ccccc3n2)c1";"IFI";"'='";"1.587";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL599940";"";"0";"485.63";"1";"6.52";"GNF-Pf-3987";"C=CCN1C(=O)/C(=C2/Sc3ccc(OC)cc3N2C)SC1=Nc1ccccc1-c1ccccc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL582259";"";"0";"248.76";"0";"2.09";"GNF-Pf-2039";"CN(C)c1cc[n+](Cc2ccccc2)cc1.[Cl-]";"IFI";"'='";"1.538";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL579108";"";"0";"367.88";"0";"4.82";"GNF-Pf-2062";"Cc1ccccc1C(=O)NCCCCNc1ccnc2cc(Cl)ccc12";"IFI";"'='";"2.804";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL602171";"";"0";"582.71";"2";"7.76";"GNF-Pf-2081";"c1ccc(N=c2n(-c3ccccc3)c(=Nc3ccccc3)n(-c3ccccc3)c(=Nc3ccccc3)n2-c2ccccc2)cc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL578922";"";"0";"398.48";"0";"2.89";"GNF-Pf-2085";"CCc1cc(C(=O)N2CCC[C@@H]3CN(C(=O)c4ccc(F)cc4)CC[C@@H]32)n(C)n1";"IFI";"'='";"0.9804";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL578923";"";"0";"440.29";"1";"5.29";"GNF-Pf-2086";"O=C1CN=C(c2ccccc2Cl)c2cc(Cl)ccc2N1Cc1cccc([N+](=O)[O-])c1";"IFI";"'='";"1.923";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL578928";"";"0";"296.42";"0";"4.14";"1a";"Cc1cc(NC2CCCCC2)nc(NCc2ccccc2)n1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL602593";"";"0";"465.48";"0";"4.37";"GNF-Pf-2107";"O=C(c1cc2nc(-c3ccccc3)cc(C(F)(F)F)n2n1)N1CCN(Cc2ccccc2)CC1";"IFI";"'='";"1.176";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL578019";"";"0";"481.59";"0";"4.43";"GNF-Pf-2122";"CCN(CC)c1ccc(NC(=O)C2Cc3ccccc3CN2S(=O)(=O)c2ccc(F)cc2)cc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL578443";"";"0";"432.75";"1";"5.27";"GNF-Pf-2123";"O=C(NCCCCNc1ccnc2cc(Cl)ccc12)c1cccc(Br)c1";"IFI";"'='";"0.9524";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL579290";"";"0";"414.62";"1";"5.34";"GNF-Pf-2127";"CC[N+](C)(CC)CCSc1nc2ccccc2c(=S)n1-c1ccc(OC)cc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL579291";"";"0";"316.24";"0";"3.23";"GNF-Pf-2128";"CCCCNCCOCCOc1ccc(Br)cc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600303";"";"0";"340.87";"0";"4.18";"GNF-Pf-2135";"C/C(Cl)=C/C[N+]1(CC#Cc2cccc3ccccc23)CCOCC1";"IFI";"'='";"3.03";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL603941";"";"0";"332.39";"0";"1.37";"GNF-Pf-2136";"Cc1ccc(S(=O)(=O)Oc2ccc(C=NN=C(N)N)cc2)cc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600736";"";"0";"323.79";"0";"4.29";"GNF-Pf-2140";"Cc1ccc(Cl)cc1Nc1nc2ccccc2n2c(C)nnc12";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL576556";"";"0";"465.43";"0";"3.50";"GNF-Pf-2152";"Cl.N=c1n(CCN2CCCCC2)c2ccccc2n1CC(O)COc1ccc(Cl)cc1";"IFI";"'='";"9.434";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL601333";"";"0";"592.55";"3";"-0.80";"GNF-Pf-2160";"COc1ccc(-c2cc(=O)c3c(O)cc(OC4OC(COC5OC(C)C(O)C(O)C5O)C(O)C(O)C4O)cc3o2)cc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL583327";"";"0";"542.68";"2";"6.97";"GNF-Pf-1512";"CCCCCCN(C(=O)Nc1ccccc1OC)C(C)c1nc2ccccc2c(=O)n1-c1ccccc1OCC";"IFI";"'='";"2.778";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL601545";"";"0";"252.71";"0";"0.76";"GNF-Pf-2177";"CN1CCN(c2nc(Cl)nc3[nH]cnc23)CC1";"IFI";"'='";"0.6993";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL579340";"";"0";"491.66";"0";"4.37";"GNF-Pf-2178";"CCCN1CCN(CCCNC(=O)c2ccc3c(c2)sc2nc(-c4ccc(OC)cc4)cn23)CC1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL531160";"";"0";"659.58";"0";"3.54";"GNF-Pf-2183";"COc1ccc(C(OCC(=O)N2CCN(Cc3ccccc3)CC2)c2ccccc2)cn1.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F";"IFI";"'='";"0.9709";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL582654";"";"0";"430.94";"0";"4.53";"GNF-Pf-1536";"C=C(Cl)CSc1nnc(CCNC(=O)c2ccc(C)cc2)n1-c1ccc(F)cc1";"IFI";"'='";"1.724";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL580004";"";"0";"354.41";"0";"4.61";"GNF-Pf-2207";"Cc1ccc(O)c(Nc2c3c(c(C#N)c4nc5ccccc5n24)CCC3)c1";"IFI";"'='";"14.29";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL587142";"";"0";"475.38";"1";"8.55";"GNF-Pf-2230";"COc1ccc2nc(C)cc(Nc3ccc(Oc4ccc(Cl)c5ccccc45)c(Cl)c3)c2c1";"IFI";"'='";"10.11";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL576169";"";"0";"393.47";"0";"3.18";"GNF-Pf-2249";"CCOC(=O)CSC1=Nc2ccccc2C2=NC(Cc3ccccc3)C(=O)N12";"IFI";"'='";"3.614";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL577199";"";"0";"310.78";"0";"4.72";"GNF-Pf-2254";"Oc1ccc(-c2cncc(NCc3ccc(Cl)cc3)c2)cc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL578088";"";"0";"479.03";"1";"7.20";"GNF-Pf-2268";"Clc1ccc(-n2cc(-c3ccccc3)c3c(N4CCC(Cc5ccccc5)CC4)ncnc32)cc1";"IFI";"'='";"8.333";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL579080";"";"0";"429.43";"1";"5.23";"GNF-Pf-2276";"CC(C)(C)c1ccc(-c2c[n+](-c3ccccc3)c3n2CCCS3)cc1.[Br-]";"IFI";"'='";"23.08";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL573710";"ACANTHOSIDE B";"0";"580.58";"2";"0.68";"GNF-Pf-2316";"COc1cc([C@@H]2OC[C@@H]3[C@H]2CO[C@H]3c2cc(OC)c(O[C@@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O)c(OC)c2)cc(OC)c1O";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL578086";"";"0";"305.76";"0";"3.16";"GNF-Pf-2334";"COc1ccc(OCCNC(=O)c2ccccc2Cl)cc1";"IFI";"'='";"7.692";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL601146";"";"0";"441.02";"1";"5.14";"GNF-Pf-2335";"CC1CCC(C(C)C)C(OC(=O)Cn2c(-c3ccccc3)[n+](C)c3ccccc32)C1.[Cl-]";"IFI";"'='";"13.14";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL578876";"";"0";"517.10";"2";"5.13";"GNF-Pf-2353";"CCN(CC)CCCN(Cc1cc2cc(OC)c(OC)cc2[nH]c1=O)C(=S)Nc1cccc(Cl)c1";"IFI";"'='";"14.41";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL601547";"";"0";"386.88";"0";"3.97";"GNF-Pf-2356";"COc1cccc(Nc2nc(NCC3CCCO3)c3ccccc3n2)c1.Cl";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL610622";"";"0";"434.92";"0";"4.15";"GNF-Pf-2359";"Cn1cc(S(=O)(=O)c2cccc(Cl)c2)c(=O)c2cc(F)c(N3CCCCC3)cc21";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL578684";"";"0";"298.34";"0";"3.23";"GNF-Pf-2366";"CCOC(=O)c1cnc2ccc3c(c(C)c(C)n3C)c2c1O";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL578270";"";"0";"427.51";"0";"3.85";"GNF-Pf-2369";"O=C(NCc1ccccc1)c1cnc(NCCCn2ccnc2)nc1Nc1ccccc1";"IFI";"'='";"0.9709";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL577192";"";"0";"404.00";"1";"6.29";"GNF-Pf-2389";"CCCCCCCCCC(=O)N(C)CCCNc1ccnc2cc(Cl)ccc12";"IFI";"'='";"3.704";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL601549";"";"0";"351.15";"0";"2.78";"GNF-Pf-2403";"Cc1cc(Nc2ccc(I)cc2)n2ncnc2n1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL578303";"";"0";"409.51";"0";"3.79";"GNF-Pf-2407";"Cc1cc(C)cc(C(=O)Nc2c3c(nn2-c2cccc(C)c2C)CS(=O)(=O)C3)c1";"IFI";"'='";"4.706";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL488757";"";"0";"425.32";"1";"7.39";"GNF-Pf-1790";"COc1ccc2nc(C)cc(Nc3ccc(Oc4ccc(Cl)cc4)c(Cl)c3)c2c1";"IFI";"'='";"12.5";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL587249";"";"0";"419.87";"0";"3.98";"GNF-Pf-2661";"COc1ccccc1CNC(=O)c1nn(-c2ccc(Cl)cc2)c(=O)c2ccccc12";"IFI";"'='";"2.381";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL578671";"";"0";"460.44";"0";"0.25";"GNF-Pf-2668";"CC(=O)Nc1ccc2c(c1)C(=O)N(C(C(=O)NCC(=O)O)C1CC1)[C@@H](CCC(=O)O)C(=O)N2";"IFI";"'='";"1.235";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600737";"";"0";"331.46";"1";"5.27";"GNF-Pf-2681";"CC(NCCC(c1ccccc1)c1ccccc1O)c1ccccc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL602577";"";"0";"300.38";"0";"4.37";"GNF-Pf-2682";"C=C(c1ccccc1)[n+]1ccc(/C=C/c2ccccc2O)cc1";"IFI";"'='";"5.455";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL578504";"";"0";"380.27";"0";"3.23";"GNF-Pf-2708";"CC[n+]1ccccc1C=Cc1ccc(N(C)C)cc1.[I-]";"IFI";"'='";"5.882";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL579150";"";"0";"227.31";"0";"3.19";"GNF-Pf-2728";"O=c1c2c([nH]c3ccccc13)CCCCCC2";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL578043";"";"0";"347.92";"0";"4.35";"GNF-Pf-2748";"Clc1ccccc1CN1CCc2nc(N3CCCCC3)sc2C1";"IFI";"'='";"6.944";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL578265";"";"0";"283.33";"0";"2.55";"GNF-Pf-2750";"C=CCN1C(=O)/C(=C\c2ccccc2)C(C(=O)OC)=C1C";"IFI";"'='";"5.263";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585956";"";"0";"530.58";"2";"6.94";"GNF-Pf-2780";"Nc1cccc(C(=O)Nc2ccc(Oc3cccc(Oc4ccc(NC(=O)c5cccc(N)c5)cc4)c3)cc2)c1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL532318";"";"0";"1202.63";"None";"None";"GNF-Pf-2808";"CC=CC[C@@H](C)[C@@H](O)[C@H]1C(=O)N[C@@H](CC)C(=O)N(C)CC(=O)N(C)[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@H](C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N(C)[C@@H](C(C)C)C(=O)N1C";"IFI";"";"";"";"";"";"Not applicable";"";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL576187";"";"0";"366.36";"0";"3.80";"GNF-Pf-2819";"O=C(c1ccccc1F)N1CCN(Cc2ccccc2C(F)(F)F)CC1";"IFI";"'='";"1.176";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL577807";"";"0";"426.51";"0";"4.91";"GNF-Pf-2827";"CCN(c1ccccc1)S(=O)(=O)c1ccc(F)c(C(=O)Nc2c(C)cccc2C)c1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600101";"";"0";"568.68";"2";"7.73";"GNF-Pf-2840";"CCOc1ccccc1-n1c(C(C)N(Cc2ccccc2)C(=O)Nc2cccc3ccccc23)nc2ccccc2c1=O";"IFI";"'='";"1.887";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL578054";"";"0";"437.50";"0";"4.06";"GNF-Pf-2845";"CSc1nnc(CCNC(=O)c2c(-c3ccccc3)noc2C)n1-c1ccc(F)cc1";"IFI";"'='";"1.042";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585238";"";"0";"313.81";"1";"5.32";"GNF-Pf-5014";"O=C(Nc1ccc(-c2ccc(Cl)cc2)cc1)c1cccs1";"IFI";"'='";"5.405";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL586684";"";"0";"449.50";"0";"3.94";"GNF-Pf-5529";"COC(=O)C1=C(C)NC2=C(C(=O)CC(c3ccc(OC)c(OC)c3)C2)C1c1cccc(O)c1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL586007";"";"0";"393.48";"0";"4.24";"GNF-Pf-5097";"COc1ccc(OC)c(-c2ccc(O)c(CN(C)CC(O)c3ccccc3)c2)c1";"IFI";"'='";"0.9901";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL579280";"";"0";"273.35";"0";"3.94";"GNF-Pf-5631";"CC(C)CNCc1cc(-c2ccc(F)cc2)ccc1O";"IFI";"'='";"0.9804";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600117";"";"0";"326.23";"0";"3.44";"GNF-Pf-5681";"O=C(CCl)NCCCCNc1ccnc2cc(Cl)ccc12";"IFI";"'='";"2.041";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600311";"";"0";"421.57";"0";"4.22";"GNF-Pf-5697";"O=C(NCCc1ccccc1)C1CCC(Cn2c(=S)[nH]c3ccccc3c2=O)CC1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL587326";"";"0";"392.28";"0";"3.30";"GNF-Pf-5407";"CN(C)c1ccc(C=CC=Cc2cccc[n+]2C)cc1.[I-]";"IFI";"'='";"17.33";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL586178";"";"0";"348.40";"0";"4.67";"GNF-Pf-5409";"CCOC(=O)c1cnc2c(C)cccc2c1Nc1ccc(C(C)=O)cc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL605188";"";"0";"515.70";"2";"6.46";"GNF-Pf-5410";"Cc1ccc2c(c1)c(-c1ccccc1)c(-c1ccccc1)n2CC(O)CN1CCN(Cc2ccccc2)CC1";"IFI";"'='";"3.597";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL578735";"";"0";"282.34";"0";"2.05";"GNF-Pf-5437";"CC1CCC2C(C)C(=O)OC3OC(C)C4CC1C32OO4";"IFI";"'='";"7.143";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL578946";"";"0";"467.39";"0";"3.97";"GNF-Pf-5438";"CCOc1ccc(N(CC)S(=O)(=O)c2cc(Br)cc3c2N(C(C)=O)CC3)cc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600530";"";"0";"471.60";"1";"6.86";"GNF-Pf-5441";"COc1ccc(C(=O)Oc2ccccc2-c2nc3ccccn3c2NC(C)(C)CC(C)(C)C)cc1";"IFI";"'='";"2.857";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600108";"";"0";"295.81";"0";"3.61";"GNF-Pf-5449";"[Cl-].c1ccc(Cc2cc[n+](Cc3ccccc3)cc2)cc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL584669";"";"0";"353.47";"1";"6.06";"GNF-Pf-4069";"CC(NCc1cc(-c2ccccc2)ccc1O)c1cccc2ccccc12";"IFI";"'='";"1.695";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL587642";"";"0";"540.45";"2";"5.78";"GNF-Pf-5534";"CCCOC(=O)C1=C(C)NC2=C(C(=O)CC(c3ccc(OC)c(OC)c3)C2)C1c1ccc(Br)cc1";"IFI";"'='";"4.878";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL603744";"";"0";"401.27";"0";"3.50";"GNF-Pf-5180";"Cc1cc(C)n(-c2cc(NN=Cc3cc(Br)ccc3O)nc(C)n2)n1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL584841";"";"0";"338.28";"0";"4.62";"GNF-Pf-4934";"CCCCNCC(O)(c1ccc(Cl)cc1)c1ccc(Cl)cc1";"IFI";"'='";"1.266";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585050";"";"0";"519.05";"2";"6.69";"GNF-Pf-4935";"COc1ccccc1NC(=O)N(CCC(C)C)C(C)c1nc2ccccc2c(=O)n1-c1ccccc1Cl";"IFI";"'='";"0.9174";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585816";"";"0";"309.42";"0";"3.32";"GNF-Pf-4952";"Cc1ccc2[nH]c3c(NCCN4CCCCC4)ncnc3c2c1";"IFI";"'='";"10.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL582673";"";"0";"413.49";"0";"4.30";"GNF-Pf-5222";"O=C1N(Cc2cc3ccccc3s2)CC2CN(Cc3ccc(F)c(F)c3)CCN12";"IFI";"'='";"1.389";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL579858";"";"0";"436.51";"0";"3.55";"GNF-Pf-4981";"Cc1ccc(NC(=O)N(CCCN(C)C)Cc2cc3cc4c(cc3[nH]c2=O)OCO4)cc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL577226";"";"0";"322.35";"0";"1.77";"GNF-Pf-5248";"CC(=O)NC1=NN(C(C)=O)C(C)(c2ccc([N+](=O)[O-])cc2)S1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585626";"";"0";"526.68";"2";"6.61";"GNF-Pf-5019";"O=C(Cc1ccsc1)N1CCOc2c(cc(-c3csc4ccccc34)cc2OCCc2ccccn2)C1";"IFI";"'='";"1.942";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL584820";"";"0";"347.44";"0";"3.59";"GNF-Pf-5057";"COc1ccc(-c2c[n+](CC(=O)c3ccc(C)cc3)c3n2CCC3)cc1";"IFI";"'='";"2.381";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL601821";"";"0";"391.43";"0";"2.32";"GNF-Pf-5069";"NCC(=O)N1CCn2c(nc(-c3ccccc3)c2Nc2ccc3c(c2)OCO3)C1";"IFI";"'='";"4.167";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL601747";"";"0";"319.84";"0";"3.85";"GNF-Pf-5110";"CC(C)C(=O)NCCCCNc1ccnc2cc(Cl)ccc12";"IFI";"'='";"0.9346";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL586022";"";"0";"285.73";"0";"2.87";"GNF-Pf-5116";"Cc1cc(C)n(N=Cc2ccc(Cl)cc2)c(=O)c1C#N";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL578073";"";"0";"380.39";"0";"4.20";"GNF-Pf-2630";"COc1ccc(-n2c(S)nnc2CNc2cccc(C(F)(F)F)c2)cc1";"IFI";"'='";"1.695";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL578297";"";"0";"330.56";"0";"4.81";"GNF-Pf-2638";"CC(NCCCN(C)C)c1cc(C(C)(C)C)cc2c1CCC2(C)C";"IFI";"'='";"10.61";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL578509";"";"0";"438.51";"0";"-0.19";"GNF-Pf-2643";"COC(CNC(=O)c1c[nH]c2ccc(S(=O)(=O)N3CCN(C)CC3)cc2c1=O)OC";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL578510";"";"0";"379.89";"0";"4.86";"GNF-Pf-2644";"CN(CCCNc1ccnc2cc(Cl)ccc12)C(=O)/C=C/c1ccccc1";"IFI";"'='";"0.9346";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL579143";"";"0";"369.49";"0";"3.90";"GNF-Pf-2718";"CN(Cc1ccsc1)C(=O)CCc1nnc(CCCc2ccccc2)o1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL579328";"";"0";"423.51";"0";"4.27";"GNF-Pf-2765";"CCOC(=O)N1CCC(N2C(=O)c3ccccc3C2Nc2ccc(OCC)cc2)CC1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL575039";"";"0";"251.38";"0";"2.87";"GNF-Pf-2787";"CSc1nc(N)c2c3c(sc2n1)CCCC3";"IFI";"'='";"1.19";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL596854";"";"0";"322.45";"0";"3.52";"GNF-Pf-4208";"CCC(C(=O)N1CCN(Cc2ccccc2)CC1)c1ccccc1";"IFI";"'='";"1.613";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL604174";"";"0";"500.60";"2";"7.06";"GNF-Pf-4210";"Cc1ccc(C(=O)Oc2ccccc2-c2nc3ccccn3c2NC(C)(C)CC(C)(C)C)cc1[N+](=O)[O-]";"IFI";"'='";"2.83";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL76";"CHLOROQUINE";"4";"319.88";"0";"4.81";"GNF-Pf-4216";"CCN(CC)CCCC(C)Nc1ccnc2cc(Cl)ccc12";"IFI";"'='";"1.163";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585654";"";"0";"363.49";"0";"4.88";"GNF-Pf-4227";"CC1=CC(=C(C#N)c2nc3ccccc3s2)C=C(C)N1CC1CCCO1";"IFI";"'='";"3.125";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600524";"";"0";"328.37";"0";"4.39";"GNF-Pf-2846";"COc1ccc(/C=C(/C#N)C(=O)Nc2cccc3ccccc23)cc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL603942";"";"0";"524.86";"1";"5.76";"GNF-Pf-4073";"CCN1C(=Cc2sc3ccc(Cl)cc3[n+]2CC)C=Cc2cc(OC)ccc21.[I-]";"IFI";"";"";"";"";"";"Not applicable";"";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL599499";"";"0";"310.35";"0";"2.43";"GNF-Pf-4105";"CN(C)c1ccc(/C=C/C(=O)NC(=O)c2ccccc2O)cc1";"IFI";"'='";"10.59";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL601107";"";"0";"571.68";"2";"7.18";"GNF-Pf-4169";"Cc1cccc(N2C(=O)C3C(C2=O)C2(c4ccccc4)C(=O)C3(c3ccccc3)C(c3ccccc3)=C2c2ccccc2)c1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL597653";"";"0";"330.45";"0";"3.54";"GNF-Pf-4172";"COc1ccc(CCNC(=S)Nc2ccccc2C)cc1OC";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL605944";"";"0";"468.38";"0";"4.99";"GNF-Pf-4184";"Cc1c(-c2ccccc2)c2ccccc2n1CCc1ccc(C)[n+](C)c1.[I-]";"IFI";"'='";"1.22";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600309";"";"0";"320.35";"0";"1.25";"GNF-Pf-5149";"CCOC(=O)CCCCC(=O)c1[nH]c(=O)[nH]c1Cn1ccnc1";"IFI";"'='";"1.46";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL547238";"";"0";"391.60";"0";"3.85";"GNF-Pf-5170";"O=C(Nc1cc(C(F)(F)F)ccc1N1CCOCC1)C(Cl)(Cl)Cl";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL578544";"";"0";"452.52";"0";"2.89";"GNF-Pf-5262";"O=C(Nc1ccc(C(=O)Nc2cccc(C3=NCCN3)c2)cc1)c1ccc(C2=NCCN2)cc1";"IFI";"'='";"0.8696";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL586168";"";"0";"456.97";"1";"6.12";"GNF-Pf-5268";"CC(C)CN1C(=O)c2ccccc2C(C(=O)Nc2ccc(F)c(Cl)c2)C1c1cccs1";"IFI";"'='";"3.125";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL586214";"";"0";"492.02";"1";"6.20";"GNF-Pf-5274";"COc1ccc(C2CC(=O)C3=C(C2)NC(C)=C(C(=O)OC2CCCC2)C3c2ccc(Cl)cc2)cc1";"IFI";"'='";"4.706";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL601744";"";"0";"375.25";"0";"3.56";"GNF-Pf-4665";"Cc1c2ccccc2cc(Cc2ccccc2)[n+]1C.[I-]";"IFI";"'='";"6.299";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585222";"";"0";"296.33";"0";"3.03";"GNF-Pf-4697";"COc1ccc(C=NNc2nc3ccccc3[nH]2)cc1OC";"IFI";"'='";"7.692";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL601745";"";"0";"666.17";"2";"7.85";"GNF-Pf-4707";"COc1ccc(C2=C(c3ccc(OC)cc3)C3(c4ccccc4)C(=O)C2(c2ccccc2)C2C(=O)N(c4cc(Cl)ccc4C)C(=O)C23)cc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL531543";"";"0";"400.87";"0";"3.78";"GNF-Pf-4721";"O=C(c1cccc(Cl)c1)N1CCN(c2ccc([N+](=O)[O-])c(NC3CC3)c2)CC1";"IFI";"'='";"3.488";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL531798";"";"0";"353.42";"0";"4.47";"GNF-Pf-4724";"CCCc1c(C(=O)OCC)c2cc(O)ccc2n1-c1ccc(OC)cc1";"IFI";"'='";"6.25";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL584637";"";"0";"438.19";"0";"4.30";"GNF-Pf-4800";"Brc1ccc(-c2cn3c([n+]2-c2ccccc2)SCC3)cc1.[Br-]";"IFI";"'='";"0.7407";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL602972";"";"0";"654.39";"1";"5.32";"GNF-Pf-4839";"Cc1ccccc1Cn1c(=N)n(CC(O)c2ccc(Cl)c(Cl)c2)c2ccccc21.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F";"IFI";"'='";"3.226";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585820";"";"0";"453.33";"1";"5.78";"GNF-Pf-4883";"COc1cccc(C(=O)NC(c2ccc(Cl)cc2)c2cc(Cl)c3cccnc3c2O)c1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL528080";"";"0";"218.25";"0";"1.57";"GNF-Pf-4919";"OCC(O)COc1cccc2ccccc12";"IFI";"'='";"0.7752";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL601815";"";"0";"398.90";"0";"3.05";"GNF-Pf-4930";"CCN(CC)CCNC(=O)c1cc(-c2ccc(Cl)cc2)cc(-n2cnnn2)c1";"IFI";"'='";"1.724";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL577865";"";"0";"340.40";"0";"3.60";"GNF-Pf-4950";"COc1ccc(/C=C2/SC(=Nc3ccccc3)NC2=O)c(OC)c1";"IFI";"";"";"";"";"";"Not applicable";"";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL586018";"";"0";"336.25";"0";"4.35";"GNF-Pf-4971";"N#Cc1ccc(CNC(=S)Nc2cc(Cl)ccc2Cl)cc1";"IFI";"'='";"3.125";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL602434";"";"0";"435.55";"1";"5.75";"GNF-Pf-4982";"Cc1nc(N(C)c2ccc(C(C)C)cc2)c2c(C)c(C(=O)Nc3cc(C)on3)sc2n1";"IFI";"'='";"1.176";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL602020";"";"0";"398.53";"0";"3.41";"GNF-Pf-1362";"C=CCn1c2cc(C)sc2c2cnn(CC(=O)N3CC(C)CC(C)C3)c(=O)c21";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL587892";"";"0";"284.75";"0";"3.92";"GNF-Pf-1374";"Cc1ccc(Nc2nc(N)c3ccccc3n2)cc1Cl";"IFI";"'='";"7.692";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL579284";"";"0";"308.18";"0";"2.98";"GNF-Pf-2350";"Brc1ccc2ncnc(NCC3CCCO3)c2c1";"IFI";"'='";"2.632";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL1554";"DACTINOMYCIN";"4";"1255.44";"None";"None";"GNF-Pf-1977";"Cc1c2oc3c(C)ccc(C(=O)N[C@@H]4C(=O)N[C@H](C(C)C)C(=O)N5CCC[C@H]5C(=O)N(C)CC(=O)N(C)[C@@H](C(C)C)C(=O)O[C@@H]4C)c3nc-2c(C(=O)N[C@@H]2C(=O)N[C@H](C(C)C)C(=O)N3CCC[C@H]3C(=O)N(C)CC(=O)N(C)[C@@H](C(C)C)C(=O)O[C@@H]2C)c(N)c1=O";"IFI";"'='";"18.03";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585023";"";"0";"597.74";"2";"4.73";"GNF-Pf-1148";"CCOC(=O)c1c(NC(=O)CSc2nnc(CNC(=O)c3cccs3)n2-c2ccccc2OC)sc2c1CCC2";"IFI";"'='";"2.41";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL546437";"";"0";"361.53";"1";"5.82";"GNF-Pf-2402";"CCN(CC)CCCC(C)Nc1ccnc2ccc(-c3ccccc3)cc12";"IFI";"'='";"7.692";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL584834";"";"0";"442.48";"0";"0.48";"GNF-Pf-1162";"COCCn1nnnc1C(c1cc2cc3c(cc2[nH]c1=O)OCCO3)N1CCC(O)CC1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL583352";"";"0";"350.38";"0";"4.89";"GNF-Pf-1170";"Oc1ccc2cc(-c3nc4ccccc4[nH]3)c3nc4ccccc4n3c2c1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL584850";"";"0";"320.35";"0";"3.80";"GNF-Pf-1185";"Oc1ccc(-c2cncc(NCc3ccc4c(c3)OCO4)c2)cc1";"IFI";"'='";"3.333";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL599933";"";"0";"429.61";"0";"4.34";"GNF-Pf-362";"c1ccc(C[C@H]2CN(c3ccc4ccccc4c3)CCN2CCNCC2CCCO2)cc1";"IFI";"'='";"3.659";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL581437";"";"0";"395.46";"1";"5.52";"GNF-Pf-374";"COc1cc(/C=C(\C#N)c2nc3ccccc3[nH]2)ccc1OCc1ccc(C)cc1";"IFI";"'='";"5.185";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL1416605";"";"0";"222.20";"0";"0.32";"GNF-Pf-1227";"CCOC(=O)c1nc2nc(C)cc(O)n2n1";"IFI";"'='";"3.488";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL581727";"";"0";"273.73";"0";"3.14";"GNF-Pf-1247";"Cc1cc(Nc2ccc(C)c(Cl)c2)n2ncnc2n1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600152";"";"0";"377.81";"0";"2.57";"GNF-Pf-1254";"Nc1cc(OC(=O)c2ccccc2)nn1S(=O)(=O)c1ccc(Cl)cc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585450";"";"0";"260.36";"0";"4.14";"GNF-Pf-1278";"Cc1ccc(C=Cc2ccc3ccccc3[n+]2C)cc1";"IFI";"";"";"";"";"";"Not applicable";"";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600485";"";"0";"250.31";"0";"2.93";"GNF-Pf-609";"Cc1cc2ncn(N=Cc3cccnc3)c2cc1C";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL582731";"";"0";"515.62";"1";"3.78";"GNF-Pf-616";"COc1ccc(CCNc2nc(NCCCn3ccnc3)ncc2C(=O)NCc2ccccc2)cc1OC";"IFI";"'='";"0.9524";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL582523";"";"0";"434.97";"0";"4.99";"GNF-Pf-631";"CCN1CCN(c2cc(C)c3cc(NC(=O)/C=C/c4ccccc4Cl)ccc3n2)CC1";"IFI";"'='";"8.197";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL529270";"";"0";"343.43";"0";"2.65";"GNF-Pf-642";"COc1cccc(CN2CCN(C(=O)c3c(C)noc3C)[C@@H](C)C2)c1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL608145";"";"0";"308.34";"0";"2.57";"GNF-Pf-653";"CC1Cc2ccccc2N1C(=O)Cn1c(=O)oc2ccccc21";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL605752";"";"0";"408.82";"0";"4.44";"GNF-Pf-701";"Cc1nc(-c2ccncc2)nc(NCCNc2ccc(C(F)(F)F)cn2)c1Cl";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL597450";"";"0";"424.59";"0";"3.41";"GNF-Pf-705";"CC(C)CNC(=O)c1cnc(NCCC2CCCN2C)nc1NCCc1ccccc1";"IFI";"'='";"0.9524";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL599500";"";"0";"322.37";"0";"1.08";"GNF-Pf-711";"COCCCNc1nc2nonc2nc1N(C)C1CCOCC1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL582456";"";"0";"543.93";"2";"10.27";"GNF-Pf-1396";"CCCCN(CCCC)[P+](N(CCCC)CCCC)(N(CCCC)CCCC)N(CCCC)CCCC";"IFI";"'='";"27.27";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL548646";"";"0";"365.44";"0";"4.16";"GNF-Pf-1447";"c1cncc(-c2cc(N3CCc4ccccc4C3)nc(-c3ccncc3)n2)c1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL576603";"";"0";"410.40";"None";"None";"GNF-Pf-1488";"CCN1/C(=C/c2[se]c3ccccc3[n+]2CC)C=Cc2cc(OC)ccc21";"IFI";"";"";"";"";"";"Not applicable";"";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL579048";"";"0";"393.92";"0";"4.95";"GNF-Pf-2418";"CN(CCCNc1ccnc2cc(Cl)ccc12)C(=O)C1C[C@H]1c1ccccc1";"IFI";"'='";"8.491";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL581908";"";"0";"420.58";"1";"6.77";"GNF-Pf-510";"CCN1/C(=C\C=C\C2=[N+](C)c3ccccc3C2(C)C)N(c2ccccc2)c2ccccc21";"IFI";"'='";"28.57";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL579558";"";"0";"355.44";"1";"5.26";"GNF-Pf-532";"CCOc1ccccc1NC(=O)C1C(c2ccccc2)=C1c1ccccc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL582519";"";"0";"348.45";"0";"3.60";"GNF-Pf-539";"O=C(C1CC=CCC1)N1CCCC(c2ncncc2-c2ccncc2)C1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600338";"";"0";"519.69";"2";"6.19";"GNF-Pf-542";"Cc1ccc2nc(-c3ccc(NC(=O)c4ccc(S(=O)(=O)N5CC(C)CC(C)C5)cc4)cc3)sc2c1";"IFI";"'='";"2.299";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL601585";"";"0";"513.98";"1";"1.62";"GNF-Pf-544";"COc1ccc(-n2nc(C(=O)NCC(=O)NCCCN3CCOCC3)c3ccccc3c2=O)cc1Cl";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL580838";"";"0";"365.44";"0";"4.60";"GNF-Pf-546";"c1cncc(CCNc2nccn3c(-c4cccc5ccccc45)cnc23)c1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL580839";"";"0";"438.62";"0";"3.80";"GNF-Pf-547";"CN(C)CCCNc1ncc(C(=O)NCCc2ccccc2)c(NCC2CCCCC2)n1";"IFI";"'='";"0.9709";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600949";"";"0";"489.60";"1";"5.41";"GNF-Pf-551";"CC1CC(C)CN(S(=O)(=O)c2ccc(C(=O)Nc3ccc(-c4nc5ccccc5o4)cc3)cc2)C1";"IFI";"'='";"3.226";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL601954";"";"0";"285.26";"0";"2.74";"GNF-Pf-561";"O=C(O)c1ccc(C=NNc2ccc([N+](=O)[O-])cc2)cc1";"IFI";"'='";"4.317";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL581484";"";"0";"385.78";"0";"3.88";"GNF-Pf-564";"Cc1ccc2oc(=O)c3cnn(CC(=O)Nc4ccc(F)cc4Cl)c3c2c1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL1744493";"";"0";"423.84";"0";"4.28";"GNF-Pf-573";"O=c1c(=Cc2ccc(-c3ccc([N+](=O)[O-])cc3Cl)o2)sc2nc3ccccc3n12";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585837";"";"0";"540.56";"2";"5.73";"GNF-Pf-4438";"CC1=C(C(=O)Nc2ccc(C)cc2C)C(c2ccc([N+](=O)[O-])cc2)n2ncc(C(=O)Nc3ccc(F)cc3)c2N1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL601137";"";"0";"255.37";"0";"3.05";"GNF-Pf-4832";"CN1/C(=C/c2cccc[n+]2C)Sc2ccccc21";"IFI";"";"";"";"";"";"Not applicable";"";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585594";"";"0";"344.27";"0";"4.74";"GNF-Pf-4846";"Clc1ccc(C[n+]2cc(-c3ccccc3)n3c2CCC3)cc1Cl";"IFI";"'='";"3.774";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600159";"";"0";"386.15";"0";"2.49";"GNF-Pf-4859";"Cc1ccc(NC(=O)c2c(I)cnn2C)cc1[N+](=O)[O-]";"IFI";"'='";"2.353";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL601323";"";"0";"290.37";"0";"3.43";"GNF-Pf-4871";"Cc1ccccc1Cc1c(C)nc2c(C#N)c(C)nn2c1C";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL602431";"";"0";"469.01";"1";"5.99";"GNF-Pf-4875";"COc1ccc(Cl)cc1NC(=O)C1c2ccccc2C(=O)N(CC(C)C)C1c1cccs1";"IFI";"'='";"9.091";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585821";"";"0";"464.56";"1";"5.13";"GNF-Pf-4884";"CCC(CC)CN1CCC(O)(c2ccc3oc(C(=O)Nc4ccc5c(c4)OCO5)cc3c2)CC1";"IFI";"'='";"3.478";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585640";"";"0";"352.46";"0";"4.00";"GNF-Pf-4893";"CCn1c(SCC(=O)Nc2cccc(C)c2)nnc1-c1ccccc1";"IFI";"'='";"3.67";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585646";"";"0";"433.60";"1";"5.70";"GNF-Pf-4901";"CCOc1cccc(C2=Nc3cc(C(=O)NC(C)C)ccc3CN2CC2CCCCC2)c1";"IFI";"'='";"1.235";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL602836";"";"0";"377.40";"0";"4.12";"GNF-Pf-4902";"CC(=O)N1c2ccccc2NC2=C(C(=O)CCC2)C1c1ccc([N+](=O)[O-])cc1";"IFI";"'='";"5.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL582379";"";"0";"367.47";"0";"3.70";"GNF-Pf-4904";"O=C(CCn1c(=S)oc2ccccc21)N1CCN(c2ccccc2)CC1";"IFI";"'='";"4.412";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL601814";"";"0";"440.29";"0";"3.00";"GNF-Pf-4926";"CCOc1c(Br)cc(C2C(C(=O)OC)=CN(C)C=C2C(=O)OC)cc1OC";"IFI";"'='";"4.598";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL584633";"";"0";"308.59";"0";"3.29";"GNF-Pf-4932";"Cc1cc(C)c2c(c1)OC(N)(C(Cl)(Cl)Cl)CC2=O";"IFI";"'='";"2.273";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600354";"";"0";"366.89";"1";"5.68";"GNF-Pf-4941";"Oc1ccc(-c2ccnc3cc(Cl)ccc23)cc1CNC1CCCCC1";"IFI";"'='";"4.31";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585624";"";"0";"363.58";"0";"4.38";"GNF-Pf-4943";"COc1c2occc2c(OC)c2c(=O)cc(C(Cl)(Cl)Cl)oc12";"IFI";"'='";"4.054";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL604718";"";"0";"470.06";"1";"7.11";"GNF-Pf-4090";"Cc1ccn2c(NC(C)(C)CC(C)(C)C)c(-c3ccccc3OC(=O)C(C)(C)CCl)nc2c1";"IFI";"'='";"3.158";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL581588";"";"0";"263.77";"0";"3.25";"GNF-Pf-4091";"CN(C)CCCNc1ccnc2cc(Cl)ccc12";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL597039";"";"0";"304.27";"0";"2.35";"GNF-Pf-4094";"Cc1cc(C)nc(NNc2c([N+](=O)[O-])cccc2[N+](=O)[O-])n1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL597246";"";"0";"417.37";"0";"3.56";"GNF-Pf-4097";"CCCN(CCC)S(=O)(=O)c1cc(Br)cc2c1N(C(=O)CC)CC2";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL605943";"";"0";"427.50";"1";"5.83";"GNF-Pf-4100";"CCCCOC(=O)c1ccc(NC2=C(c3ccc(OC)cc3)C(=O)c3ccccc32)cc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL581049";"";"0";"366.38";"0";"2.44";"GNF-Pf-619";"Cc1nn(-c2cc(N3CCOCC3)ccc2[N+](=O)[O-])c(=O)c2ccccc12";"IFI";"'='";"1.176";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL604776";"";"0";"417.31";"0";"4.82";"GNF-Pf-622";"FC(F)(F)COc1ccc(OCC(F)(F)F)c(-c2ncnn2-c2ccccc2)c1";"IFI";"'='";"1.282";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL581691";"";"0";"304.32";"0";"2.75";"GNF-Pf-626";"O=C(O)c1c[nH]c2cc(N3CCCCCC3)c(F)cc2c1=O";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL602408";"";"0";"418.20";"0";"3.24";"GNF-Pf-633";"CC(=O)C1=C(O)C(=O)N(c2ccc(Br)cn2)C1c1ccccc1[N+](=O)[O-]";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL599699";"";"0";"458.61";"0";"3.96";"GNF-Pf-639";"O=C(NCc1ccccc1)c1cnc(NCCN2CCCCC2)nc1NCCc1ccccc1";"IFI";"'='";"0.9524";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL529496";"";"0";"215.25";"0";"2.47";"GNF-Pf-662";"CON(C)C(=O)c1cccc2ccccc12";"IFI";"'='";"3.252";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL584878";"";"0";"376.39";"0";"2.70";"GNF-Pf-676";"O=C1C=CC(=O)N1c1ccc(Sc2ccc(N3C(=O)C=CC3=O)cc2)cc1";"IFI";"'='";"12.77";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585086";"";"0";"446.98";"0";"3.89";"GNF-Pf-686";"COC(=O)c1[nH]c2ccc(Cl)cc2c1NC(=O)C(C)N1CCN(C2CCCCC2)CC1";"IFI";"'='";"10.2";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL597851";"";"0";"450.63";"0";"4.30";"GNF-Pf-697";"O=C(NCc1ccccc1)c1cnc(NCCCN2CCCC2)nc1NCC1CCCCC1";"IFI";"'='";"0.9709";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL604099";"";"0";"374.40";"0";"3.41";"GNF-Pf-698";"Cc1ccc(NC(=O)c2nc[nH]c2C(=O)Nc2nc3ccccc3[nH]2)c(C)c1";"IFI";"'='";"4.688";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL596837";"";"0";"422.53";"1";"5.19";"GNF-Pf-706";"CC1CCc2c(sc(NC(=O)c3ccccc3F)c2C(=O)NCc2ccccc2)C1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL599502";"";"0";"374.36";"0";"3.32";"GNF-Pf-713";"O=c1c(=O)n(Cc2cccc(C(F)(F)F)c2)ccn1CCc1ccccc1";"IFI";"'='";"2.222";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600903";"";"0";"335.38";"0";"4.59";"GNF-Pf-722";"COc1cccc2cc(-c3nc(-c4ccccc4)cs3)c(=O)oc12";"IFI";"'='";"6.452";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL598688";"";"0";"399.52";"0";"3.78";"GNF-Pf-724";"CCCCN(CC)C(=O)CSc1nc2ccccc2c(=O)n1Cc1ccco1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600977";"";"0";"303.33";"0";"2.36";"GNF-Pf-1450";"Cn1c2ccccc2c2nnc(NN=Cc3ccccn3)nc21";"IFI";"'='";"15.38";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL601335";"";"0";"309.41";"0";"3.55";"GNF-Pf-1465";"COc1ccc(-c2c[n+](-c3ccccc3)c3n2CCS3)cc1";"IFI";"'='";"7.692";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL576802";"";"0";"489.85";"1";"6.55";"GNF-Pf-1490";"O=C(NCCCCNc1ccnc2cc(Cl)ccc12)c1cc(C(F)(F)F)cc(C(F)(F)F)c1";"IFI";"'='";"1.852";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL578327";"";"0";"371.48";"0";"3.86";"GNF-Pf-1496";"COc1ccc(OC)c(-c2ccc(O)c(CNCC3(O)CCCCC3)c2)c1";"IFI";"'='";"1.709";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL610053";"";"0";"488.72";"1";"5.03";"GNF-Pf-2486";"Cc1cccc2cc(CNC34CC5CC(CC(C5)C3)C4)c(N3CCC(N4CCC(O)CC4)CC3)nc12";"IFI";"'='";"2.913";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL579256";"";"0";"349.39";"0";"3.78";"GNF-Pf-2514";"COC(=O)c1ccc(C=NNc2cc(C)nc3ccc(OC)cc23)cc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL576607";"";"0";"333.19";"0";"3.74";"GNF-Pf-1823";"Cc1occc1C(=O)NN=C/C(Br)=C/c1ccccc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL602198";"";"0";"501.03";"2";"6.03";"GNF-Pf-1828";"CC(C)(C)NC(=O)C(c1ccncc1)N(Cc1ccccc1Cl)C(=O)c1ccc(-c2ccccc2)[nH]1";"IFI";"'='";"5.405";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600735";"";"0";"469.35";"0";"4.57";"GNF-Pf-1831";"CN(CCCNc1ccnc2cc(Cl)ccc12)S(=O)(=O)c1ccc(Cl)c([N+](=O)[O-])c1";"IFI";"'='";"1.887";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL599895";"";"0";"397.26";"1";"5.10";"GNF-Pf-1834";"O=C(Cn1c2ccccc2c(=O)c2ccc(Cl)cc21)Nc1cccc(Cl)c1";"IFI";"'='";"4.819";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL581799";"";"0";"310.40";"0";"2.87";"GNF-Pf-1863";"C=CC1CN2CCC1CC2[C@H](O)c1ccnc2ccc(O)cc12";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL580128";"";"0";"486.20";"0";"2.97";"GNF-Pf-1868";"OCCN(CCO)CC(O)Cn1c2ccc(Br)cc2c2cc(Br)ccc21";"IFI";"'='";"2.083";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL577010";"";"0";"537.72";"1";"4.26";"GNF-Pf-1899";"CC(C)N1CC[C@@H](N2CCN(c3cccc(C(F)(F)F)c3)CC2)[C@@H](CCC(=O)N(C)C2CCN(C)CC2)C1";"IFI";"'='";"9.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL579375";"";"0";"495.96";"1";"5.23";"GNF-Pf-1902";"CCOC(=O)C1=C(N)N(c2cccc([N+](=O)[O-])c2)C2=C(C(=O)CC(C)(C)C2)C1c1ccc(Cl)cc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL578961";"";"0";"392.57";"0";"4.61";"GNF-Pf-1906";"O=C(Nc1ccc2c(c1)CN(C1CCSCC1)CC2)C1(c2ccccc2)CC1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL577421";"";"0";"271.22";"0";"1.85";"GNF-Pf-2186";"CC(=O)N/C(=C\c1ccc(OC(F)F)cc1)C(=O)O";"IFI";"'='";"1.01";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL531387";"";"0";"210.19";"0";"1.48";"GNF-Pf-2187";"O=C(O)CCNc1ccccc1[N+](=O)[O-]";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL24828";"VANDETANIB";"4";"475.36";"1";"5.00";"GNF-Pf-2188";"COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1";"IFI";"'='";"6.818";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL577865";"";"0";"340.40";"0";"3.60";"GNF-Pf-4950";"COc1ccc(/C=C2/SC(=Nc3ccccc3)NC2=O)c(OC)c1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585591";"";"0";"485.61";"1";"7.85";"GNF-Pf-1947";"CCN1/C(=C/C=C/c2oc3ccc(-c4ccccc4)cc3[n+]2CC)Oc2ccc(-c3ccccc3)cc21";"IFI";"";"";"";"";"";"Not applicable";"";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL581833";"";"0";"445.61";"0";"4.10";"GNF-Pf-1959";"COc1cccc(N2CCN(CCNCCOc3ccccc3)[C@@H](Cc3ccccc3)C2)c1";"IFI";"'='";"2.439";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL581841";"";"0";"342.91";"0";"4.18";"GNF-Pf-1960";"Clc1cccc(CCNC2CCN(CCc3ccccc3)CC2)c1";"IFI";"'='";"2.344";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL582052";"";"0";"373.88";"0";"4.49";"GNF-Pf-1965";"COc1ccc(C2(C(=O)NCc3ccccc3Cl)CCCC2)cc1OC";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL579157";"";"0";"461.36";"0";"4.68";"GNF-Pf-1974";"CON(C)C=C(C(=O)Nc1ccc(C(F)(F)F)cc1)C(=O)Nc1ccc(C(F)(F)F)cc1";"IFI";"'='";"3.896";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL601998";"";"0";"631.41";"2";"7.07";"GNF-Pf-1983";"OC(CN1CCN(C2c3ccccc3-c3ccccc32)CC1)Cn1c2ccc(Br)cc2c2cc(Br)ccc21";"IFI";"'='";"1.515";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600512";"";"0";"339.40";"0";"4.21";"GNF-Pf-100";"c1ccc(CNc2nc(-c3ccccn3)nnc2-c2ccccc2)cc1";"IFI";"'='";"15.38";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL578288";"";"0";"258.31";"0";"1.66";"GNF-Pf-150";"N#CN=C(N)c1sc(Nc2ccccc2)nc1N";"IFI";"'='";"15.38";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL601818";"";"0";"312.35";"0";"4.04";"GNF-Pf-1370";"CC(=NNc1nc2ccccc2s1)c1ccc([N+](=O)[O-])cc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600506";"";"0";"280.69";"0";"4.00";"GNF-Pf-1382";"O=[N+]([O-])c1cccc(CNc2ccc(F)c(Cl)c2)c1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL601348";"";"0";"334.39";"0";"3.58";"GNF-Pf-1405";"CCCCCCOC(=O)C1=C(C)NC(=O)NC1c1ccccc1F";"IFI";"'='";"0.7143";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL580820";"";"0";"453.87";"1";"5.13";"GNF-Pf-1431";"O=C(CSc1nc2ccccc2c(=O)n1C1CC1)Nc1cc(C(F)(F)F)ccc1Cl";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600970";"";"0";"402.46";"0";"3.26";"GNF-Pf-4219";"O=C(Nc1ccc(-n2cnnn2)cc1)C1CCN(Cc2cc3ccccc3o2)CC1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL530650";"";"0";"763.73";"2";"5.74";"GNF-Pf-4231";"COc1cc(C(=O)NCCc2ccccn2)ccc1OC1CCN(CC(c2ccccc2)c2ccccc2)CC1.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F";"IFI";"'='";"1.37";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585471";"";"0";"506.40";"0";"3.05";"GNF-Pf-4232";"O=C(NCc1ccc2c(c1)OCO2)C1CNCC1c1ccc(C(F)(F)F)cc1.O=C(O)C(F)(F)F";"IFI";"'='";"1.37";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL577446";"";"0";"277.39";"0";"3.71";"GNF-Pf-3835";"CCN1/C(=C/c2cccc[n+]2C)C=Cc2cc(C)ccc21";"IFI";"";"";"";"";"";"Not applicable";"";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL14435";"";"0";"209.64";"0";"1.78";"GNF-Pf-3836";"Nc1nc(Nc2cccc(Cl)c2)n[nH]1";"IFI";"'='";"1.075";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL611983";"";"0";"432.05";"1";"7.07";"GNF-Pf-3890";"CCCCCCCCCCCC(=O)N(C)CCCNc1ccnc2cc(Cl)ccc12";"IFI";"'='";"2.804";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL597864";"";"0";"373.46";"0";"4.29";"GNF-Pf-3893";"Cc1cccc(NC(=O)CCCn2c(=O)c3cccn3c3ccccc32)c1C";"IFI";"'='";"3.448";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL608431";"";"0";"356.42";"0";"3.59";"GNF-Pf-3894";"COc1cc(C(=O)C=CNc2ccc(N(C)C)cc2)cc(OC)c1OC";"IFI";"";"";"";"";"";"Not applicable";"";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL578727";"";"0";"277.39";"0";"3.71";"GNF-Pf-3901";"CCN1/C(=C/c2cccc[n+]2C)C=Cc2ccc(C)cc21";"IFI";"";"";"";"";"";"Not applicable";"";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL611382";"";"0";"394.32";"0";"3.97";"GNF-Pf-3913";"Br.Cc1nc2sccn2c1-c1csc(Nc2ccccn2)n1";"IFI";"'='";"6.767";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL527137";"";"0";"288.35";"0";"3.77";"GNF-Pf-3937";"c1ccc(CCNc2ncnc3c2[nH]c2ccccc23)cc1";"IFI";"'='";"21.95";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL584083";"";"0";"343.39";"0";"3.49";"GNF-Pf-3946";"O=C(Nc1ccccc1)C(=Cc1ccncc1)NC(=O)c1ccccc1";"IFI";"";"";"";"";"";"Not applicable";"";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL596833";"";"0";"482.89";"1";"5.15";"GNF-Pf-3953";"COc1ccc(-c2cc(C(F)(F)F)n3nc(C(=O)NC4CCCCC4)c(Cl)c3n2)cc1OC";"IFI";"'='";"1.22";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL598482";"";"0";"431.99";"0";"4.94";"GNF-Pf-3968";"Cc1cc(C)c(S(=O)(=O)N(C)CCCNc2ccnc3cc(Cl)ccc23)c(C)c1";"IFI";"'='";"4.717";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL605952";"";"0";"487.69";"1";"5.82";"GNF-Pf-3977";"CO/C(=C\C(N)=O)C(C)C(/C=C/c1csc(-c2csc(C(C)/C=C/C=C/C(C)C)n2)n1)OC";"IFI";"'='";"11.54";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL529143";"";"0";"283.38";"0";"2.78";"GNF-Pf-3978";"Cc1ccc2[nH]c3c(NCCCN(C)C)ncnc3c2c1";"IFI";"'='";"11.76";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL599940";"";"0";"485.63";"1";"6.52";"GNF-Pf-3987";"C=CCN1C(=O)/C(=C2/Sc3ccc(OC)cc3N2C)SC1=Nc1ccccc1-c1ccccc1";"IFI";"";"";"";"";"";"Not applicable";"";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL581037";"";"0";"316.74";"0";"2.63";"GNF-Pf-3409";"O=C(NN=Cc1cccc(Cl)c1)C1COc2ccccc2O1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL580638";"";"0";"457.60";"0";"2.00";"GNF-Pf-3477";"C=CCC(=O)NC1CCN(CC(O)CN(Cc2ccccc2)S(=O)(=O)c2ccccc2)C1";"IFI";"'='";"2.913";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL597252";"";"0";"308.39";"0";"2.67";"GNF-Pf-3553";"Cc1ccc(-c2cc(N3CCCC3CO)n3nccc3n2)cc1";"IFI";"'='";"3.03";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL583598";"";"0";"476.42";"0";"3.63";"GNF-Pf-3587";"Cc1ccc(CNC(=O)C2CNCC2c2ccc(C(F)(F)F)cc2)cc1.O=C(O)C(F)(F)F";"IFI";"'='";"2.817";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL583397";"";"0";"446.62";"1";"6.45";"GNF-Pf-3593";"CC(C)CN1C(=O)c2ccccc2C(C(=O)Nc2ccc(C(C)C)cc2)C1c1cccs1";"IFI";"'='";"6.061";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL606024";"";"0";"409.96";"1";"5.76";"GNF-Pf-3597";"CN(CCCNc1ccnc2cc(Cl)ccc12)C(=O)c1ccc(C(C)(C)C)cc1";"IFI";"'='";"7.477";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL583400";"";"0";"274.39";"0";"4.63";"GNF-Pf-3599";"CC[n+]1c(/C=C/c2ccc(C)cc2)ccc2ccccc21";"IFI";"'='";"11.43";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585311";"";"0";"385.12";"0";"3.79";"GNF-Pf-3608";"CCN1CCN(c2c(Cl)cccc2NC(=O)C(Cl)(Cl)Cl)CC1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL596832";"";"0";"355.53";"0";"4.17";"GNF-Pf-3612";"O=C(Nc1cccc(N2CCC(NCC3CCCCC3)CC2)c1)C1CC1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL604389";"";"0";"496.50";"1";"5.20";"GNF-Pf-3616";"Br.CCN(CC)S(=O)(=O)c1ccc(-c2csc(Nc3ccc(C)c(C)c3)n2)cc1";"IFI";"'='";"4.706";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL581244";"";"0";"435.64";"1";"6.94";"GNF-Pf-3002";"CSC1=NC(=Nc2ccccc2C)C2(CCC(C(C)(C)C)CC2)N1c1ccc(O)cc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL535101";"";"0";"1085.16";"None";"None";"GNF-Pf-3007";"CO[C@H](C(=O)[C@@H](O)[C@@H](C)O)[C@@H]1Cc2cc3cc(O[C@H]4C[C@@H](O[C@@H]5C[C@@H](O)[C@@H](O)[C@@H](C)O5)[C@@H](O)[C@H](C)O4)c(C)c(O)c3c(O)c2C(=O)[C@H]1O[C@H]1C[C@@H](O[C@H]2C[C@@H](O[C@H]3C[C@](C)(O)[C@@H](O)[C@H](C)O3)[C@H](O)[C@@H](C)O2)[C@H](O)[C@H](C)O1";"IFI";"'='";"9.375";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL581030";"";"0";"461.61";"0";"4.14";"GNF-Pf-3008";"O=C(NCCc1ccccc1)c1cnc(NCCCn2ccnc2)nc1NCC1CCCCC1";"IFI";"'='";"1.905";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL581040";"";"0";"346.18";"0";"3.12";"GNF-Pf-3025";"O=C(C=Cc1ccc(Br)cc1)NC(=O)c1ccccc1O";"IFI";"";"";"";"";"";"Not applicable";"";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL581884";"";"0";"488.42";"1";"5.55";"GNF-Pf-3330";"COc1ccc(C2C(C(=O)OC3CCCC3)=C(C)NC3=C2C(=O)CC(C)(C)C3)cc1Br";"IFI";"'='";"2.273";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL582089";"";"0";"398.91";"1";"6.32";"GNF-Pf-3331";"Cc1cc2c(cc1C)NC(c1ccc(Cl)c(F)c1)C1=C(CC(C)(C)CC1=O)N2";"IFI";"'='";"1.205";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL581465";"";"0";"466.58";"0";"2.70";"GNF-Pf-3334";"O=C1CC(N2CCCCCC2)C(=O)N1c1ccc(N2C(=O)CC(N3CCCCCC3)C2=O)cc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL580827";"";"0";"365.17";"0";"3.32";"GNF-Pf-3337";"Cc1nc2cc(-c3ccc(I)cc3)nn2c(O)c1C";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL581893";"";"0";"231.26";"0";"1.25";"GNF-Pf-3346";"COc1ccc2c(C)nc(NC(=N)N)nc2c1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL581645";"";"0";"326.40";"0";"4.76";"GNF-Pf-3358";"C(=Nc1cnc2ccccc2c1)c1c2n(c3ccccc13)CCCN2";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL582282";"";"0";"443.59";"1";"5.41";"GNF-Pf-3376";"CCOc1ccc(NC(=O)C(C)CSc2nc3ccc(NC(=O)CC)cc3s2)cc1";"IFI";"'='";"1.176";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL582717";"";"0";"378.50";"0";"4.25";"GNF-Pf-3224";"CCOC(=O)c1ccc2c(c1)[n+](CC)c(/C=C/N(C)c1ccccc1)n2CC";"IFI";"'='";"7.407";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL581474";"";"0";"431.24";"0";"3.41";"GNF-Pf-3233";"COc1cc(C2C(C#N)=C(N)Oc3cc4c(cc32)OCO4)cc(Br)c1OC";"IFI";"'='";"7.692";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL602992";"";"0";"334.40";"0";"2.18";"GNF-Pf-3236";"Cc1ccnc(NS(=O)(=O)c2ccc(NC(=O)C(C)C)cc2)n1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL581858";"";"0";"412.39";"0";"2.94";"GNF-Pf-3254";"CC(=O)N(C1=C(N2CCOCC2)C(=O)c2ccccc2C1=O)c1ccc(F)c(F)c1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL582289";"";"0";"415.88";"1";"5.87";"GNF-Pf-3317";"COc1cc(C=C(C#N)c2nc3ccccc3[nH]2)ccc1OCc1ccc(Cl)cc1";"IFI";"";"";"";"";"";"Not applicable";"";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL601995";"";"0";"389.57";"1";"6.03";"GNF-Pf-2621";"C=CCN1/C(=C/C=C/c2sc3ccccc3[n+]2CC=C)Sc2ccccc21";"IFI";"'='";"7.692";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585764";"";"0";"533.72";"2";"7.03";"GNF-Pf-2624";"O=C(NCc1ccccc1)c1cnc(NCCC(c2ccccc2)c2ccccc2)nc1NCC1CCCCC1";"IFI";"'='";"3.883";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL578004";"AMINOQUINOL";"0";"456.46";"1";"7.63";"GNF-Pf-2659";"CCN(CC)CCCC(C)Nc1cc(/C=C/c2ccccc2Cl)nc2cc(Cl)ccc12";"IFI";"'='";"8.065";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL579279";"";"0";"312.46";"0";"3.74";"GNF-Pf-5630";"CN(C)CC(C)(C)CNCc1cc(-c2ccccc2)ccc1O";"IFI";"'='";"1.739";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL579924";"";"0";"378.41";"0";"2.51";"GNF-Pf-1676";"COc1ccc([N+](=O)[O-])cc1N(CC1CO1)S(=O)(=O)c1ccc(C)cc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL582055";"";"0";"391.43";"0";"3.65";"GNF-Pf-1692";"CCOC(=O)c1ccc(N2C(=O)c3[nH]nc(C)c3C2c2ccccc2OC)cc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL577439";"";"0";"475.20";"0";"4.85";"GNF-Pf-1696";"O=C(Nc1ccc2oc(-c3ccc(I)cc3)nc2c1)c1ccc([N+](=O)[O-])o1";"IFI";"'='";"8.333";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL577440";"";"0";"331.42";"0";"2.60";"GNF-Pf-1701";"CN1CCN(c2c3c(c(C#N)c4nc5ccccc5n24)CCC3)CC1";"IFI";"'='";"0.6711";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL577441";"";"0";"292.34";"0";"2.24";"GNF-Pf-1703";"NC(=O)c1ccc2c(c1)N=C(c1cccnc1)N(C1CC1)C2";"IFI";"'='";"3.659";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL577442";"";"0";"309.41";"0";"3.55";"GNF-Pf-1705";"COc1ccc(-n2cc(-c3ccccc3)[n+]3c2SCC3)cc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL577224";"";"0";"411.46";"0";"4.43";"GNF-Pf-1707";"CC(=O)c1ccc(N2C(C)c3nc4ccccc4c(=O)n3C2c2cccc(O)c2)cc1";"IFI";"'='";"7.143";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL602792";"";"0";"355.41";"0";"3.31";"GNF-Pf-1708";"Cc1cnc(CNc2cc(-c3ccccn3)nc(-c3ccccn3)n2)nc1";"IFI";"'='";"11.76";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL577676";"";"0";"449.30";"1";"5.03";"GNF-Pf-1724";"COc1ccccc1-n1c(C=Cc2cc(Br)ccc2O)nc2ccccc2c1=O";"IFI";"";"";"";"";"";"Not applicable";"";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL602189";"";"0";"452.33";"1";"5.20";"GNF-Pf-1725";"CSc1c(C(=O)Nc2ccc(Br)cc2)ccc2c1C(=O)c1ccccc1C2=O";"IFI";"'='";"1.351";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL577891";"";"0";"393.50";"0";"3.30";"GNF-Pf-1727";"CC(C)CNC(=O)c1cnc(NCCCn2ccnc2)nc1Nc1ccccc1";"IFI";"'='";"1.923";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL593483";"";"0";"269.34";"0";"3.73";"GNF-Pf-1752";"CC(C)c1ccc(/C=C/C(=O)NCc2ccco2)cc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL603011";"";"0";"362.44";"0";"1.71";"GNF-Pf-1755";"OCCN1CCN(c2cc(-c3cccnc3)nc(-c3ccncc3)n2)CC1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL588175";"";"0";"383.54";"1";"6.23";"GNF-Pf-1767";"CCN1/C(=C/c2ccc3ccccc3[n+]2CC)Sc2c1ccc1ccccc21";"IFI";"'='";"14.29";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL602978";"";"0";"311.47";"0";"4.59";"GNF-Pf-2600";"CCN1C(C)=C(C)S/C1=C\c1ccc2cc(C)ccc2[n+]1C";"IFI";"'='";"11.36";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL579098";"";"0";"379.46";"1";"5.17";"GNF-Pf-2602";"CCOC(=O)c1c(C)oc2c1c1c(c3ccccc32)OCN(C2CCCC2)C1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL579310";"";"0";"399.59";"0";"4.57";"GNF-Pf-2606";"CCCCNC(=S)N(Cc1cccs1)Cc1cc2cc(C)ccc2[nH]c1=O";"IFI";"'='";"1.818";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL530609";"";"0";"316.79";"0";"3.35";"SJ000045621";"CCOc1ccc(Nc2nc(N)c3ccccc3n2)cc1.Cl";"IFI";"'='";"20.59";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL577846";"";"0";"464.57";"0";"2.72";"GNF-Pf-92";"CCN(CC)CCN1C(=O)c2ccc3c4c(ccc(c24)C1=O)C(=O)N(CCN(CC)CC)C3=O";"IFI";"'='";"15.18";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL578502";"";"0";"314.34";"0";"1.09";"GNF-Pf-103";"CC(=O)N(C)C1=C(N2CCOCC2)C(=O)c2ccccc2C1=O";"IFI";"'='";"22.11";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600938";"";"0";"457.92";"1";"6.03";"GNF-Pf-120";"CCOc1ccc2c(c1)c1nnc(-c3ccc4c(c3)OCO4)c-1cn2Cc1ccc(Cl)cc1";"IFI";"'='";"5.882";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL578872";"";"0";"389.50";"0";"4.54";"GNF-Pf-122";"O=C(O)C(=O)O.c1ccc2c(c1)CSc1sccc1C2=C1CCNCC1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL578055";"";"0";"283.37";"0";"3.91";"GNF-Pf-137";"CC(C)(C)c1ccc(C=CC(=O)NCc2ccco2)cc1";"IFI";"";"";"";"";"";"Not applicable";"";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL582729";"";"0";"333.50";"0";"2.48";"GNF-Pf-614";"CC1CC(C)(C)NC(=S)N1CCC(=O)NCCc1ccccc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL599302";"";"0";"496.85";"2";"-2.72";"GNF-Pf-665";"O=[N+]([O-])c1cc(NC2OC(CO)C(OC3OC(CO)C(O)C(O)C3O)C(O)C2O)ccc1Cl";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL604528";"";"0";"456.59";"1";"5.57";"GNF-Pf-668";"COc1ccc(CNC(=O)CCc2cn(Cc3cc(C)ccc3C)c3ccccc23)cc1OC";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585083";"";"0";"385.37";"0";"1.26";"GNF-Pf-681";"CC(=O)OC(OC(C)=O)C12C=CC(O1)C1C(=O)N(c3cccc(C)c3)C(=O)C12";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585426";"";"0";"382.28";"0";"3.60";"GNF-Pf-927";"COc1ccc(Br)cc1S(=O)(=O)N1CCCc2ccccc21";"IFI";"'='";"1.538";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585462";"";"0";"371.53";"0";"3.94";"GNF-Pf-4291";"CCCN1CCc2c(sc3nc(SC)n(-c4ccccc4)c(=O)c23)C1";"IFI";"'='";"11.54";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600702";"";"0";"375.25";"1";"5.83";"GNF-Pf-4294";"Cc1ccc(C)c(NC(=O)c2c(-c3c(Cl)cccc3Cl)noc2C)c1";"IFI";"'='";"4.598";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL584703";"";"0";"346.47";"1";"5.29";"GNF-Pf-4307";"Cc1cc(-c2ccc(O)c(CN3CCCCCC3)c2)c2ccccc2n1";"IFI";"'='";"5.128";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL602356";"";"0";"660.09";"2";"8.55";"GNF-Pf-4310";"O=C1C2C(C(=O)N1c1ccc(Cl)c(C(F)(F)F)c1)C1(c3ccccc3)C(=O)C2(c2ccccc2)C(c2ccccc2)=C1c1ccccc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL528644";"";"0";"663.75";"1";"2.96";"GNF-Pf-4332";"CCOC(=O)N1CCN(C(=O)c2ccc(N3CC4CC(C3)c3cccc(=O)n3C4)c(NS(=O)(=O)c3ccc4c(c3)OCCO4)c2)CC1";"IFI";"'='";"1.163";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL609628";"";"0";"384.31";"0";"3.95";"GNF-Pf-4338";"CCCCc1c(CCC)c(=N)c2ccccc2n1C.I";"IFI";"'='";"4.545";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL602572";"";"0";"662.70";"2";"6.80";"GNF-Pf-4345";"COc1ccc(C2=C(c3ccc(OC)cc3)C3(c4ccccc4)C(=O)C2(c2ccccc2)C2C(=O)N(c4ccccc4[N+](=O)[O-])C(=O)C23)cc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL597868";"";"0";"425.50";"0";"3.35";"GNF-Pf-4355";"O=C(CSc1ccc2nnc(-c3cccs3)n2n1)Nc1ccc2c(c1)OCCO2";"IFI";"'='";"4.167";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL597263";"";"0";"470.40";"1";"6.31";"GNF-Pf-4358";"CCCOC(=O)C1=C(C)NC2=C(C(=O)CC(c3ccc(Cl)cc3)C2)C1c1ccc(Cl)cc1";"IFI";"'='";"2.353";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL546930";"";"0";"303.80";"0";"3.13";"GNF-Pf-5033";"CN(C)CCCNc1ncnc2c1[nH]c1ccc(Cl)cc12";"IFI";"'='";"11.76";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585828";"";"0";"213.21";"0";"2.82";"GNF-Pf-5037";"O=c1c2ccccc2[nH]c2ccc(F)cc12";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585239";"";"0";"334.46";"0";"4.37";"GNF-Pf-5082";"Oc1ccc(-c2cccnc2)cc1CNC1C2CC3CC(C2)CC1C3";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL586017";"";"0";"420.52";"0";"3.98";"GNF-Pf-5106";"CCc1c(C)nc2cc(-c3cc(OC)cc(OC)c3)nn2c1NCCCn1ccnc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL582954";"";"0";"499.28";"0";"3.25";"GNF-Pf-5109";"CCOC(=O)c1c(CNCCN(CC)CC)n(C)c2cc(Br)c(O)cc12.Cl.Cl";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL603039";"";"0";"361.45";"0";"1.96";"GNF-Pf-5126";"N#Cc1c2c(c(N3CCN(CCO)CC3)n3c1nc1ccccc13)CCC2";"IFI";"'='";"2.326";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600143";"";"0";"532.60";"1";"2.94";"GNF-Pf-5164";"CCOC(=O)C1CCN(C(c2cc3cc(OC)c(OC)cc3[nH]c2=O)c2nnnn2Cc2ccccc2)CC1";"IFI";"'='";"1.031";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL582262";"";"0";"436.51";"0";"3.20";"GNF-Pf-5166";"Cc1ccc(NC(=O)N(CCN(C)C)Cc2cc3cc4c(cc3[nH]c2=O)OCCO4)cc1";"IFI";"'='";"6.349";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585106";"";"0";"578.46";"1";"4.04";"GNF-Pf-689";"COc1ccc(/C=C(\NC(=O)c2ccccc2Br)C(=O)N2CC3CC(C2)c2cccc(=O)n2C3)cc1OC";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL7077";"";"0";"174.21";"0";"1.10";"GNF-Pf-690";"Cc1cccc2nc(N)nc(N)c12";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL611659";"";"0";"400.53";"0";"4.61";"GNF-Pf-707";"Cc1cccc(-c2ccc(NC(=O)C3CCN(Cc4cnc(C)nc4)CC3)cc2)c1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL596839";"";"0";"257.72";"0";"3.67";"GNF-Pf-710";"Cc1cc(C)n2nc(-c3ccc(Cl)cc3)cc2n1";"IFI";"'='";"5.517";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL598892";"";"0";"404.52";"0";"2.59";"GNF-Pf-719";"CCOc1ccc2nc(SCc3nc(N)nc(N4CCOCC4)n3)sc2c1";"IFI";"'='";"3.659";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL593255";"";"0";"589.74";"2";"5.27";"GNF-Pf-881";"CCOC(=O)c1c(NC(=O)CSc2nnc(CNC(=O)c3cccc(C)c3)n2-c2cccc(C)c2)sc2c1CCC2";"IFI";"'='";"2.326";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL597855";"";"0";"293.32";"0";"3.78";"GNF-Pf-4475";"CCOC(=O)c1ccc2nc(-c3ccccc3)cc(O)c2c1";"IFI";"'='";"15.65";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585772";"";"0";"296.11";"0";"4.13";"GNF-Pf-4379";"O=C(c1ccc([N+](=O)[O-])cc1)c1ccc(Cl)c(Cl)c1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL583449";"";"0";"345.24";"0";"2.66";"GNF-Pf-4391";"Cc1n(C)c2ccccc2[n+]1CC(=O)c1ccccc1.[Br-]";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL607519";"";"0";"231.40";"0";"2.37";"GNF-Pf-4407";"CCCCSCC(O)CN1CCCCC1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585840";"";"0";"498.38";"0";"3.44";"GNF-Pf-4444";"COc1ccc(C(=O)C[n+]2ccc3c(c2)nc(-c2ccc(OC)cc2OC)n3C)cc1.[Br-]";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL529901";"";"0";"344.27";"0";"4.74";"GNF-Pf-4546";"Clc1ccc(-c2c[n+](Cc3ccccc3Cl)c3n2CCC3)cc1";"IFI";"'='";"2.381";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL610623";"";"0";"339.44";"1";"5.23";"GNF-Pf-2778";"Cc1ccc(NC(=O)C2CC3c4ccccc4C2c2ccccc23)cc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL579360";"";"0";"444.47";"0";"3.91";"GNF-Pf-2797";"O=C(NCc1ccccc1)C(c1ccc(F)cc1)N(Cc1ccco1)C(=O)c1cnccn1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL583900";"";"0";"559.62";"1";"4.26";"GNF-Pf-2804";"COc1ccccc1CNC(=O)CCC1N=C2c3ccccc3N=C(SCC(=O)Nc3ccc(F)cc3)N2C1=O";"IFI";"'='";"6.667";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL601185";"";"0";"535.62";"2";"6.37";"GNF-Pf-2816";"CCC(c1nc2ccccc2c(=O)n1-c1ccccc1OC)N(CCc1ccccc1)C(=O)c1ccc(F)cc1";"IFI";"'='";"3.191";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL579297";"";"0";"439.62";"1";"5.18";"GNF-Pf-2832";"COc1ccc(-c2c[n+](CC(=O)O[C@H]3C[C@H](C)CC[C@@H]3C(C)C)c3n2CCCCC3)cc1";"IFI";"'='";"21.85";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL578685";"";"0";"521.68";"2";"5.09";"GNF-Pf-2838";"COc1ccc(S(=O)(=O)Nc2ccc(N3CCC(Cc4ccccc4)CC3)c(C(=O)NC(C)C)c2)cc1";"IFI";"'='";"2.083";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL576353";"";"0";"236.27";"0";"3.31";"GNF-Pf-2844";"Cc1cc(O)ccc1-c1cnc2ccccc2n1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL583161";"";"0";"384.44";"0";"1.31";"GNF-Pf-4553";"O=C(CC(=O)N1CCOCC1)Nc1ccc2nc3n(c(=O)c2c1)CCCCC3";"IFI";"'='";"7.692";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL587296";"";"0";"398.72";"0";"4.15";"GNF-Pf-4608";"C=CCn1c(=N)n(CC(O)c2ccc(Cl)c(Cl)c2)c2ccccc21.Cl";"IFI";"'='";"9.524";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL584241";"";"0";"388.94";"0";"4.13";"GNF-Pf-4611";"C#CCNC(=O)c1ccc(OC2CCN(CC3CCCCC3)CC2)c(Cl)c1";"IFI";"'='";"9.722";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585777";"";"0";"472.92";"1";"5.48";"GNF-Pf-4616";"Cc1c(Cl)cccc1NC(=S)N1CCCN(c2ccc(C(F)(F)F)cc2[N+](=O)[O-])CC1";"IFI";"'='";"2.5";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL548097";"";"0";"328.40";"0";"4.70";"GNF-Pf-4628";"Fc1cccc2sc(Nc3nc(-c4ccccn4)cs3)nc12";"IFI";"'='";"16.67";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL583550";"";"0";"437.57";"1";"6.27";"GNF-Pf-4629";"Nc1c(C(=O)Nc2ccc(F)cc2)sc2nc3c(c(-c4cccs4)c12)CCCCC3";"IFI";"'='";"8.974";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600287";"";"0";"326.36";"0";"3.03";"GNF-Pf-4630";"COc1cc(C=NNc2nc3ccccc3[nH]2)cc(OC)c1OC";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL602160";"";"0";"598.63";"2";"9.00";"GNF-Pf-4642";"Cc1ccccc1Oc1cc(NC(=O)c2cc3n(n2)C(C(F)(F)F)CC(c2ccccc2)N3)cc(Oc2ccccc2C)c1";"IFI";"'='";"0.8065";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL584435";"";"0";"301.46";"0";"4.34";"GNF-Pf-4654";"CN(c1ncnc2sc3c(c12)CCCC3)C1CCCCC1";"IFI";"'='";"1.176";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL584650";"";"0";"327.81";"0";"4.23";"GNF-Pf-4662";"Fc1ccc(-c2c[n+](Cc3ccc(Cl)cc3)c3n2CCC3)cc1";"IFI";"'='";"9.756";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL584448";"";"0";"326.40";"0";"2.14";"GNF-Pf-4671";"O=C1C(NC2CCCC2)=C(N2CCOCC2)C(=O)c2ccccc21";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600763";"";"0";"371.46";"1";"5.56";"GNF-Pf-4677";"COc1cccc(C2Sc3ccccc3NC3=C2C(=O)c2ccccc23)c1";"IFI";"'='";"3.571";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585966";"";"0";"394.43";"0";"3.54";"GNF-Pf-4689";"COc1cc(C(=O)ON=C(N)Cc2cccc3ccccc23)cc(OC)c1OC";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL548209";"";"0";"430.52";"1";"5.53";"GNF-Pf-4694";"Nc1ccc(-c2nc3cc(Cc4ccc5[nH]c(-c6ccc(N)cc6)nc5c4)ccc3[nH]2)cc1";"IFI";"'='";"10.29";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585229";"";"0";"497.68";"1";"8.04";"GNF-Pf-4705";"CCC(C(=O)Oc1ccccc1-c1nc2cc(C)ccn2c1NC(C)(C)CC(C)(C)C)c1ccccc1";"IFI";"'='";"3.738";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL602217";"";"0";"492.55";"0";"2.73";"GNF-Pf-4723";"CCOC(=O)C1=C(C)N=c2sc(=Cc3ccccc3OC(C)=O)c(=O)n2C1c1ccc(OC)cc1";"IFI";"'='";"7.059";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600349";"";"0";"391.50";"0";"3.91";"GNF-Pf-4729";"COc1ccccc1C1CC(=O)N2CN(Cc3ccccc3)CSC2=C1C#N";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL533794";"";"0";"402.88";"1";"5.04";"GNF-Pf-4730";"O=C(Cc1ccccc1)NC(c1ccc(Cl)cc1)c1ccc2cccnc2c1O";"IFI";"'='";"9.375";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL584857";"";"0";"355.87";"0";"3.91";"GNF-Pf-4734";"CN(C)CCNCc1cc(-c2ccnc3cc(Cl)ccc23)ccc1O";"IFI";"'='";"1.754";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL535261";"";"0";"480.95";"0";"4.92";"GNF-Pf-4736";"COc1ccc(C2C(C(=O)Nc3cc(Cl)c(OC)cc3OC)c3ccccc3C(=O)N2C)cc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL584655";"";"0";"484.60";"1";"5.96";"GNF-Pf-4741";"COc1ccc(C2C(C(=O)Nc3cccc(OC)c3)c3ccccc3C(=O)N2C2CCCCC2)cc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL584661";"";"0";"449.55";"1";"5.20";"GNF-Pf-4750";"CCOC(=O)C1=CN(c2cc(C)ccc2C)C=C(C(=O)OCC)C1c1ccccc1OCC";"IFI";"'='";"2.353";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL582742";"";"0";"321.89";"0";"3.94";"GNF-Pf-4752";"CC1(CNCc2ccccc2O)C2CC3CC(C2)CC1C3.Cl";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585593";"";"0";"282.68";"0";"3.38";"GNF-Pf-4770";"O=C(NNc1ccccc1F)c1c(F)cccc1Cl";"IFI";"'='";"0.8";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL489770";"";"0";"254.32";"0";"3.34";"GNF-Pf-4773";"c1ccc(Nc2nc(-c3ccccn3)cs2)nc1";"IFI";"'='";"18.05";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL603730";"";"0";"427.50";"0";"3.99";"GNF-Pf-4797";"O=C1[C@@H]2CCCN2C(=O)C(c2ccc(Oc3ccccc3)cc2)N1CCc1ccccn1";"IFI";"'='";"2.74";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL604155";"";"0";"303.83";"1";"5.18";"GNF-Pf-4801";"CCCCCC1CCCc2c1[nH]c1cc(Cl)ccc1c2=O";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL586465";"";"0";"285.39";"0";"3.06";"GNF-Pf-4803";"COc1ccc2c(c1)N(C)/C(=C/c1cccc[n+]1C)S2";"IFI";"";"";"";"";"";"Not applicable";"";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600355";"";"0";"404.39";"0";"4.07";"GNF-Pf-4810";"COC(=O)C1=C(C)N/C(=C\c2cc(C)n(-c3ccccc3C(F)(F)F)c2C)C1=O";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL526210";"";"0";"476.50";"1";"5.06";"GNF-Pf-4817";"CCN1CCN(Cc2c(O)ccc3c(=O)c(Oc4cc(C)cc(C)c4)c(C(F)(F)F)oc23)CC1";"IFI";"'='";"3.488";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585633";"";"0";"571.20";"1";"4.88";"GNF-Pf-4818";"Cc1cc(C)n(CC(O)Cn2c3ccc(I)cc3c3cc(I)ccc32)n1";"IFI";"'='";"0.7246";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585634";"";"0";"551.52";"1";"4.39";"GNF-Pf-4819";"OC(CN1CCN(c2ccnc3cc(Cl)ccc23)CC1)CN1CCN(c2ccnc3cc(Cl)ccc23)CC1";"IFI";"'='";"6.667";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL579624";"";"0";"280.29";"0";"2.74";"GNF-Pf-4838";"C(=NNc1nc2ccccc2[nH]1)c1ccc2c(c1)OCO2";"IFI";"'='";"8.333";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL580054";"";"0";"404.52";"0";"3.76";"GNF-Pf-4841";"O=C(/C=C/c1c[nH]cn1)N1CCC(n2c(CC3CCCC3)nc3cccnc32)CC1";"IFI";"'='";"0.9709";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585218";"";"0";"397.28";"0";"3.95";"GNF-Pf-4850";"CC1=CC(=Cc2sc3ccccc3[n+]2C)C=C(C)O1.[I-]";"IFI";"'='";"16.67";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL583558";"";"0";"269.39";"0";"3.36";"GNF-Pf-4864";"Cc1ccc2c(c1)N(C)/C(=C/c1cccc[n+]1C)S2";"IFI";"";"";"";"";"";"Not applicable";"";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585440";"";"0";"419.92";"0";"4.36";"GNF-Pf-4872";"O=C(CSc1nc(-c2ccccc2Cl)ns1)Nc1ccc2c(c1)OCCO2";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585441";"";"0";"485.61";"1";"5.87";"GNF-Pf-4874";"CCN(CC)c1ccc(C=NNC(=O)c2ccc(Nc3nc(-c4ccccc4)cs3)cc2)c(O)c1";"IFI";"'='";"27.27";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585444";"";"0";"357.54";"0";"4.14";"GNF-Pf-4876";"CC(C)(C)CC(C)(C)c1ccc(O)c(CN2CCN(CCC#N)CC2)c1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL602634";"";"0";"407.34";"0";"3.97";"GNF-Pf-4881";"O=C(Nc1cccc(OC(=O)c2ccc([N+](=O)[O-])cc2)c1)c1ccc([N+](=O)[O-])cc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585635";"";"0";"447.35";"1";"5.91";"GNF-Pf-4882";"FC(F)(F)c1cccc(NC(=S)N2CCSC2c2ccc(Br)cc2)c1";"IFI";"'='";"4.545";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585825";"";"0";"411.45";"1";"5.00";"GNF-Pf-4888";"O=C(ON(C(=O)c1ccc(F)cc1)C1C2CC3CC(C2)CC1C3)c1ccc(F)cc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585639";"";"0";"413.46";"0";"3.34";"GNF-Pf-4891";"Cc1ccccc1OCc1nnc(SCC(=O)Nc2ccc([N+](=O)[O-])cc2)n1C";"IFI";"'='";"5.941";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585641";"";"0";"331.42";"0";"2.19";"GNF-Pf-4894";"CCN(CC)C(=O)c1cn(C2CCN(Cc3ccco3)CC2)nn1";"IFI";"'='";"1.77";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL581467";"";"0";"514.99";"1";"3.17";"GNF-Pf-4921";"CCOC(=O)C1=C(C)N=c2sc(=Cc3cc(Cl)ccc3O)c(=O)n2C1c1ccc(OC)c(OC)c1";"IFI";"'='";"3.571";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL605422";"";"0";"548.66";"2";"7.71";"GNF-Pf-4922";"COC(=O)c1ccc(C2C3=C(O)CC(c4ccc(C)cc4)CC3=Nc3ccccc3N2C(=O)c2cccs2)cc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585794";"";"0";"319.36";"0";"4.03";"GNF-Pf-4925";"CCOc1ccc(C=C(C#N)c2nc3ccccc3[nH]2)cc1OC";"IFI";"";"";"";"";"";"Not applicable";"";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL584421";"";"0";"481.90";"1";"7.14";"GNF-Pf-4927";"CCCCN(CCCC)CC(O)c1cc(-c2ccc(Cl)cc2)nc2cc(Cl)ccc12.Cl";"IFI";"'='";"3.279";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL602012";"";"0";"402.34";"0";"4.36";"GNF-Pf-5219";"CCN(CC)CCN1C(=O)c2ccccc2NC1c1ccc(Br)cc1";"IFI";"'='";"4.706";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL582672";"";"0";"497.02";"0";"3.81";"GNF-Pf-5221";"CC(c1nc2ccc(Cl)cc2c(=O)n1C)N1CCN(S(=O)(=O)c2cccc3ccccc23)CC1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585827";"";"0";"334.42";"0";"4.34";"GNF-Pf-4967";"CCCCC(=O)NC(c1ccccc1)c1ccc2cccnc2c1O";"IFI";"'='";"12.5";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL601569";"";"0";"329.36";"0";"4.45";"GNF-Pf-5235";"Oc1ccccc1Nc1nc(-c2ccccc2O)nc2ccccc12";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600120";"";"0";"460.60";"0";"4.21";"GNF-Pf-5239";"COCCNC(=O)[C@@H]1C[C@@H](Sc2nc3ccccc3[nH]2)CN1Cc1ccc2ccccc2c1";"IFI";"'='";"8.824";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL593485";"";"0";"646.86";"2";"7.96";"GNF-Pf-5241";"COc1ccc(-c2nc(SCCCCC(=O)N3CCN(C(c4ccccc4)c4ccccc4)CC3)[nH]c2-c2ccc(OC)cc2)cc1";"IFI";"'='";"0.9259";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL586171";"";"0";"405.54";"0";"4.64";"GNF-Pf-5270";"CC(=O)c1cccc(NC(=O)NC2CC3CCCC(C2)N3CCc2ccccc2)c1";"IFI";"'='";"1.266";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL601378";"";"0";"420.33";"1";"6.70";"GNF-Pf-5290";"OC1=C2C(=Nc3ccccc3SC2c2ccc(Br)cc2)c2ccccc21";"IFI";"'='";"1.075";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL578313";"";"0";"437.49";"0";"3.73";"GNF-Pf-5296";"COc1ccc(OC)c(C2CC(=O)C3=C(C2)NC(=O)CC3c2ccc(OC)c(OC)c2)c1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL578319";"";"0";"347.29";"0";"4.05";"GNF-Pf-5306";"COC1=C(Nc2cccc(C(F)(F)F)c2)C(=O)c2ccccc2C1=O";"IFI";"'='";"4.651";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL587829";"";"0";"422.35";"1";"5.55";"GNF-Pf-5535";"CCOC(=O)C1=C(CC)NC2=C(C(=O)CC(C)(C)C2)C1c1ccc(Cl)cc1Cl";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL587693";"";"0";"351.45";"0";"2.74";"GNF-Pf-5538";"O=C(NCCc1nc(-c2ccncc2)n[nH]1)C12CC3CC(CC(C3)C1)C2";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600714";"";"0";"341.84";"0";"3.85";"GNF-Pf-5549";"O=S(=O)(ON=C1CCCc2sc(Cl)cc21)c1ccccc1";"IFI";"'='";"2.239";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL580785";"";"0";"368.04";"None";"None";"GNF-Pf-5565";"Cl.O[Si](CCCN1CCCCC1)(c1ccccc1)C1CCCCC1";"IFI";"'='";"2.778";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL582051";"";"0";"533.69";"2";"6.27";"GNF-Pf-5566";"COc1ccc(C2CC(=O)C3=C(C2)NC(C)=C(C(=O)OC2CCCC2)C3c2ccc(SC)cc2)cc1OC";"IFI";"'='";"5.882";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL579361";"";"0";"453.94";"1";"5.79";"GNF-Pf-5571";"CC1=C(C(=O)OC(C)C)C(c2ccccc2F)C2=C(CC(c3ccc(Cl)cc3)CC2=O)N1";"IFI";"'='";"2.222";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL534999";"ETHYLHYDROCUPREINE HYDROCHLORIDE";"0";"376.93";"0";"3.79";"GNF-Pf-5574";"CCOc1ccc2nccc([C@@H](O)[C@@H]3C[C@@H]4CCN3C[C@@H]4CC)c2c1.Cl";"IFI";"'='";"3.822";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL1198140";"";"0";"249.34";"0";"3.47";"GNF-Pf-5029";"Cc1[nH]c2ccccc2c1/C=C/c1cc[n+](C)cc1";"IFI";"";"";"";"";"";"Not applicable";"";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL528534";"";"0";"402.07";"0";"3.44";"GNF-Pf-5043";"C[n+]1ccc(C=Cc2ccc(Br)cc2)cc1.[I-]";"IFI";"";"";"";"";"";"Not applicable";"";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL526955";"";"0";"381.30";"0";"3.82";"GNF-Pf-5050";"CCC(CO)NCC(O)Cn1c2ccc(Cl)cc2c2cc(Cl)ccc21";"IFI";"'='";"6.452";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL578110";"";"0";"484.69";"1";"7.09";"GNF-Pf-5138";"Cc1cc(C)c2c(c1)-c1c(ssc1=S)C(C)(C)N2C(=O)COc1nc2ccccc2s1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL582049";"";"0";"334.72";"0";"1.73";"GNF-Pf-5162";"CCOC(=O)c1nnn(-c2nonc2N)c1-c1ccc(Cl)cc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL602777";"";"0";"366.51";"0";"3.66";"GNF-Pf-5167";"CCN(CC)CCN1C(=O)c2ccccc2NC1c1ccc(N(C)C)cc1";"IFI";"'='";"5.263";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600145";"";"0";"377.87";"0";"3.49";"GNF-Pf-5168";"CCOC(=O)CCC(=O)N(C)CCCNc1ccnc2cc(Cl)ccc12";"IFI";"'='";"2.752";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL596630";"";"0";"413.48";"0";"2.60";"GNF-Pf-3807";"C=CCNC(=O)c1cc2c(=O)n3cccc(C)c3nc2n(CCc2ccccc2)c1=N";"IFI";"'='";"5.882";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL584035";"";"0";"490.05";"1";"7.81";"GNF-Pf-3849";"Cc1ccn2c(NC(C)(C)CC(C)(C)C)c(-c3ccccc3OC(=O)c3ccc(Cl)cc3)nc2c1";"IFI";"'='";"3.738";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL584266";"";"0";"489.02";"1";"6.60";"GNF-Pf-3863";"COc1ccc(C2C(C(=O)Nc3cccc(Cl)c3)c3ccccc3C(=O)N2C2CCCCC2)cc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL598887";"";"0";"404.47";"0";"3.28";"GNF-Pf-3884";"CC(=O)N(C1=C(N2CCOCC2)C(=O)c2ccccc2C1=O)c1cc(C)cc(C)c1";"IFI";"'='";"7.143";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL598495";"";"0";"329.36";"0";"4.33";"GNF-Pf-3910";"Nc1ccc(C(=O)Nc2ccc(-c3nc4ccccc4o3)cc2)cc1";"IFI";"'='";"7.692";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600094";"";"0";"280.33";"0";"4.48";"GNF-Pf-3914";"CCn1c(N=Nc2ccc(OC)cc2)nc2ccccc21";"IFI";"'='";"7.692";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL584254";"";"0";"403.27";"0";"4.20";"GNF-Pf-3930";"CC(=O)N(C1=C(N(C)C)C(=O)c2ccccc2C1=O)c1ccc(Cl)c(Cl)c1";"IFI";"'='";"7.692";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL584462";"";"0";"455.21";"1";"5.44";"GNF-Pf-3931";"CCCCCCCC[n+]1c(C)n(C)c2cc(Cl)c(Cl)cc21.[I-]";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL584463";"";"0";"507.59";"1";"1.71";"GNF-Pf-3933";"COC(=O)c1c(NC(=O)c2ccc(S(=O)(=O)N3CCOCC3)cc2)sc2c1CCN(C(C)=O)C2";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL597447";"";"0";"365.55";"1";"5.60";"GNF-Pf-3950";"CCCC(=O)N1c2ccc(OC)cc2-c2c(ssc2=S)C1(C)C";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL599088";"";"0";"588.48";"2";"6.89";"GNF-Pf-3964";"CC1=C(C(=O)Nc2ccc(C)cc2C)C(c2cc(Br)ccc2F)n2ncc(C(=O)Nc3ccc(C)cc3)c2N1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL529284";"";"0";"634.82";"1";"2.56";"GNF-Pf-3970";"OC(COc1ccc(OCC(O)CN2CCN(CCOc3ccccc3)CC2)cc1)CN1CCN(CCOc2ccccc2)CC1";"IFI";"'='";"7.143";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL604101";"";"0";"339.42";"0";"3.32";"GNF-Pf-3974";"COc1cccc(Cn2c3cc(C)sc3c3cnn(C)c(=O)c32)c1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600561";"";"0";"491.61";"1";"5.52";"GNF-Pf-3979";"C/C(C=C1Sc2ccc3ccoc3c2N1CCO)=C\c1sc2ccc3occc3c2[n+]1CCO";"IFI";"'='";"14.29";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL584457";"";"0";"381.48";"0";"3.99";"GNF-Pf-3994";"Cc1cc(N2CCN(Cc3ccccc3)CC2)n2c(nc3ccccc32)c1C#N";"IFI";"'='";"4.615";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL584667";"";"0";"393.92";"0";"2.85";"GNF-Pf-4000";"CCOC(=O)c1cnc2ccc(C)cc2c1NCCCN1CCOCC1.Cl";"IFI";"'='";"4.762";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL584304";"";"0";"418.23";"0";"4.01";"GNF-Pf-4241";"Cc1c(C=O)c2ccccc2n1CC(=O)Nc1cccc(I)c1";"IFI";"'='";"7.692";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL584514";"";"0";"380.27";"0";"3.06";"GNF-Pf-4242";"Cc1ccc(C=Cc2ccc(N(C)C)cc2)[n+](C)c1.[I-]";"IFI";"";"";"";"";"";"Not applicable";"";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL598055";"";"0";"442.91";"0";"4.05";"GNF-Pf-4250";"N#CC(=Cc1cn(Cc2ccccc2Cl)c2ccccc12)c1nn(CCO)c(N)c1C#N";"IFI";"";"";"";"";"";"Not applicable";"";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL609035";"";"0";"420.31";"1";"5.61";"GNF-Pf-4034";"Cc1ccc2ccc(C(Nc3ccccn3)c3ccc(Br)cc3)c(O)c2n1";"IFI";"'='";"8.333";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL547606";"";"0";"362.89";"0";"3.25";"GNF-Pf-4253";"CN(C)CCNC(=O)c1cc2c(-c3ccc(Cl)cc3)nn(C)c2s1";"IFI";"'='";"7.692";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600096";"";"0";"368.82";"1";"5.01";"GNF-Pf-4056";"CCOC(=O)c1cnc2c(Cl)cccc2c1Nc1cccc(C(C)=O)c1";"IFI";"'='";"3.279";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL527976";"";"0";"633.67";"2";"5.66";"GNF-Pf-4261";"CCOC(=O)c1c(NC(=O)C(C)Sc2nnc(CNC(=O)c3ccco3)n2-c2cccc(C(F)(F)F)c2)sc2c1CCC2";"IFI";"'='";"2.5";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL597467";"";"0";"329.40";"0";"3.37";"GNF-Pf-4275";"COC(=O)C1=C(C)NC2=C(C(=O)CC(C)(C)C2)C1c1ccc(C)o1";"IFI";"'='";"0.8621";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL584664";"";"0";"450.54";"0";"4.36";"GNF-Pf-4062";"CCOC(=O)c1cc(-c2ccc(OC)cc2)n(CCC(=O)NCc2ccc(OC)cc2)c1C";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL2021322";"";"0";"358.44";"1";"6.34";"GNF-Pf-4075";"c1ccc(/C2=N/c3ccccc3/N=C(/c3ccccc3)c3ccccc32)cc1";"IFI";"'='";"1.149";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585112";"";"0";"309.41";"0";"3.55";"GNF-Pf-4161";"COc1ccc(-c2cn3c([n+]2-c2ccccc2)SCC3)cc1";"IFI";"'='";"2.727";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL598262";"";"0";"464.95";"0";"3.84";"GNF-Pf-4166";"COc1ccc(N2C(=O)[C@@H]3C[C@H]2CN3C(=O)c2cccc(Cn3nc(C)cc3C)c2)cc1Cl";"IFI";"'='";"1.869";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL599294";"";"0";"366.37";"0";"4.30";"GNF-Pf-4190";"COc1ccc(CNc2cc(-c3ccc(F)c(F)c3)nc3ccnn23)cc1";"IFI";"'='";"3.03";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL611662";"";"0";"351.41";"0";"2.92";"GNF-Pf-4201";"CCCCNC(=O)c1nn(-c2ccc(OC)cc2)c(=O)c2ccccc12";"IFI";"'='";"2.353";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL579259";"";"0";"225.29";"0";"2.38";"GNF-Pf-2676";"CCN1c2ccccc2N=C2C=CC(N)=CC21";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL36633";"OXIRACETAM";"2";"158.16";"0";"-1.94";"GNF-Pf-1005";"NC(=O)CN1CC(O)CC1=O";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL584445";"";"0";"360.80";"0";"3.69";"GNF-Pf-1009";"COc1cc(C=NNc2nc3cc(Cl)ccc3[nH]2)cc(OC)c1OC";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL583805";"";"0";"269.39";"0";"3.44";"GNF-Pf-1023";"CCN1/C(=C/c2cccc[n+]2C)Sc2ccccc21";"IFI";"'='";"7.692";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL601608";"";"0";"376.51";"0";"4.65";"GNF-Pf-1035";"CC[n+]1c(/C=C2\Sc3cc(NC(C)=O)ccc3N2C)ccc2ccccc21";"IFI";"'='";"7.692";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585981";"";"0";"449.30";"1";"5.03";"GNF-Pf-1045";"COc1ccccc1-n1c(/C=C/c2cc(Br)ccc2O)nc2ccccc2c1=O";"IFI";"'='";"8.065";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL530252";"";"0";"251.80";"0";"4.38";"GNF-Pf-1046";"C=CCC1(Nc2ccccc2)CCCCC1.Cl";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600973";"";"0";"451.57";"1";"5.41";"GNF-Pf-1057";"C=CCNC(=O)c1ccc2c(c1)N=C(/C=C/c1ccccc1)N(CCc1cccc(OC)c1)C2";"IFI";"'='";"8.642";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600341";"";"0";"554.79";"1";"3.65";"GNF-Pf-1062";"CCOC(=O)C1=C(C)N=c2sc(=Cc3ccc(I)o3)c(=O)n2C1c1ccccc1Cl";"IFI";"'='";"4.819";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL602562";"";"0";"641.84";"2";"5.01";"GNF-Pf-1065";"CCC(/C=C1\Sc2ccc(OC)cc2N1CCCS(=O)(=O)O)=C\c1sc2ccc(OC)cc2[n+]1CCCS(=O)(=O)O";"IFI";"'='";"22.73";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL602625";"";"0";"415.45";"0";"3.77";"GNF-Pf-1066";"COc1cccc(OC)c1C(=O)Nn1c(-c2cccc(C)c2)nc2ccccc2c1=O";"IFI";"'='";"1.163";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600345";"";"0";"459.55";"1";"5.24";"GNF-Pf-1067";"COc1ccc(C2C(C(=O)Nc3cc(C)on3)c3ccccc3C(=O)N2C2CCCCC2)cc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL580843";"";"0";"345.20";"0";"3.84";"GNF-Pf-632";"Cc1ccc(N=C2C(=O)Nc3ccc(C)c(Br)c32)c(O)c1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL598682";"";"0";"514.33";"2";"5.44";"GNF-Pf-650";"O=C(COC(=O)c1ccc2c(c1)C(=O)N(c1ccc3ccccc3c1)C2=O)c1ccc(Br)cc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL584882";"";"0";"329.40";"0";"3.84";"GNF-Pf-680";"COc1ccc(NC(=O)COc2ccccc2C(C)C)c(OC)c1";"IFI";"'='";"1.493";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL584275";"";"0";"485.57";"0";"3.83";"GNF-Pf-688";"O=C(CSc1nc2ccccc2c(=O)n1-c1ccc(C(=O)N2CCOCC2)cc1)c1ccccc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL597448";"";"0";"499.04";"0";"4.89";"GNF-Pf-702";"CCOC(=O)N1CCN(C(=O)CSc2nc(-c3ccc(Cl)cc3)cn2-c2ccc(C)cc2)CC1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL601533";"";"0";"384.48";"0";"2.92";"GNF-Pf-942";"COc1ccc(N2CCN(C(=O)C3=C(C)C(=O)OC34CCCCC4)CC2)cc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL529349";"";"0";"736.94";"3";"6.02";"GNF-Pf-956";"CC1CC2CCC(O2)C(C)C(=O)O[C@H](C)CC2CCC(O2)C(C)C(=O)OC(C)CC2CCC(O2)C(C)C(=O)O[C@H](C)CC2CCC(O2)C(C)C(=O)O1";"IFI";"'='";"19.23";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL583815";"";"0";"447.31";"0";"4.32";"GNF-Pf-964";"Cc1cc(C)nc(SCc2cc(=O)c(OC(=O)c3ccccc3Br)co2)n1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL602215";"";"0";"385.51";"0";"3.38";"GNF-Pf-967";"CCOC(=O)c1c(NC(=O)CCC(=O)OC)sc2c1CC(C)(C)SC2";"IFI";"'='";"1.22";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585403";"";"0";"386.29";"1";"5.39";"GNF-Pf-976";"CCCOc1ccc(Cc2c(C)nc3ccc(Br)cc3c2O)cc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585615";"";"0";"543.62";"1";"4.71";"GNF-Pf-978";"CC(=O)Nc1cccc(N(C(=O)C2COc3ccccc3O2)C(C(=O)NC2CCCCC2)c2ccc(O)cc2)c1";"IFI";"'='";"2.083";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL602221";"";"0";"385.37";"0";"2.59";"GNF-Pf-1123";"CN1C(=O)NC(c2cccnc2)C(C(=O)c2cccs2)C1(O)C(F)(F)F";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585613";"";"0";"556.92";"2";"8.13";"GNF-Pf-1167";"COc1cc(NC(C)CCCN(Cc2ccc(Cl)cc2)C(=O)c2ccc(Cl)cc2Cl)c2ncccc2c1";"IFI";"'='";"6.481";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL606022";"";"0";"336.44";"0";"4.28";"GNF-Pf-1175";"CCOc1ccc2nc(C)c(CN(C)Cc3ccccc3)c(O)c2c1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600695";"";"0";"619.63";"1";"4.24";"GNF-Pf-1179";"CC1CCCC(NC(=O)C2N(CCN3CCCCC3C)C(=O)C3C(C(=O)Nc4cccc(Cl)c4)C4C=CC32O4)C1C.Cl";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585063";"";"0";"369.51";"1";"5.28";"GNF-Pf-1195";"COc1ccc(OC)c(-c2ccc(O)c(CNC3CCCCCCC3)c2)c1";"IFI";"'='";"1.724";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585251";"";"0";"261.31";"0";"0.82";"GNF-Pf-1202";"Cc1ccc(NC=C2C(=O)NC(=S)NC2=O)cc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585073";"";"0";"416.46";"0";"3.57";"GNF-Pf-1212";"COc1ccc(N2C(=O)/C(=C3/C(=O)Nc4ccc(F)cc43)SC2=S)c(OC)c1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL584870";"";"0";"306.28";"0";"3.68";"GNF-Pf-1214";"N#C/C(=C\C=C\c1ccc([N+](=O)[O-])o1)c1nc2ccccc2[nH]1";"IFI";"'='";"28.57";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600089";"";"0";"717.41";"2";"8.44";"GNF-Pf-1274";"O=C1c2ccccc2C(=O)C12C(c1ccc(Br)cc1)N(c1ccccc1)C1(C(=O)c3ccccc3C1=O)C2c1ccc(Br)cc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585261";"";"0";"371.46";"0";"4.09";"GNF-Pf-1285";"CCOc1ccc(NC(=O)CSc2nc3cc(OCC)ccc3[nH]2)cc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585074";"";"0";"380.56";"0";"3.86";"GNF-Pf-1290";"O=C(CN1CCCC1C(c1ccccc1)c1ccccc1)N1CCSCC1";"IFI";"'='";"0.9615";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL601141";"";"0";"426.52";"0";"4.09";"GNF-Pf-2484";"COc1ccc(-c2ncc([C@@H]3C[C@H]4CN(c5ccccc5)C(=O)[C@]45CCCN35)cn2)cc1";"IFI";"'='";"7.692";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL577629";"";"0";"432.75";"1";"5.27";"GNF-Pf-2485";"O=C(NCCCCNc1ccnc2cc(Cl)ccc12)c1ccc(Br)cc1";"IFI";"'='";"3.03";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL581690";"";"0";"398.56";"0";"2.88";"GNF-Pf-625";"CC(C)CNC(=O)c1cnc(NCCCN(C)C)nc1NCCc1ccccc1";"IFI";"'='";"0.9615";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL602404";"";"0";"258.28";"0";"0.53";"GNF-Pf-2515";"Cn1c(NN=Cc2ccccc2)cc(=O)n(C)c1=O";"IFI";"'='";"2.29";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL596847";"";"0";"371.87";"0";"2.29";"GNF-Pf-663";"COc1ccc(Cn2nnnc2CN2CCc3ccccc3C2)cc1.Cl";"IFI";"'='";"1.515";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600535";"";"0";"426.99";"1";"6.23";"GNF-Pf-2766";"CCCC(CCC)C(=O)Nc1ccc2c(c1)N(C(=O)CCCl)c1ccccc1CC2";"IFI";"'='";"1.887";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL577626";"";"0";"488.61";"0";"4.67";"GNF-Pf-2769";"Cc1ccc(-c2nnc(NCc3ccccc3)c3ccccc23)cc1S(=O)(=O)NCC1CCCO1";"IFI";"'='";"2.941";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL578294";"";"0";"320.40";"0";"4.15";"GNF-Pf-2776";"COc1ccc(Nc2cc(C)nc(NCc3ccccc3)n2)cc1";"IFI";"'='";"4.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL534144";"";"0";"230.22";"0";"1.02";"GNF-Pf-2822";"COC(=O)c1ccnn(-c2ccccc2)c1=O";"IFI";"'='";"2.597";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL577374";"";"0";"292.39";"0";"2.96";"GNF-Pf-2826";"CN1CCN(Nc2ccnc3cc4ccccc4cc23)CC1";"IFI";"'='";"7.143";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL531888";"";"0";"234.22";"0";"-0.38";"GNF-Pf-2842";"O=C(O)Cn1cnc2nc3n(c2c1=O)CCC3";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL602586";"";"0";"309.41";"0";"3.34";"GNF-Pf-2865";"CN(C)c1ccc(N=Cc2ccc(N3CCOCC3)cc2)cc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL601577";"";"0";"476.38";"1";"6.35";"GNF-Pf-2874";"Cn1nc(-c2ccccc2)c2c(C(=O)C(F)(F)F)cc(C(=O)C(F)(F)F)c-2c1-c1ccccc1";"IFI";"'='";"1.538";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL534139";"";"0";"449.51";"0";"3.85";"GNF-Pf-2924";"CCN1CCN(c2cc(C)c3cc(NC(=O)c4ccc(OC)c([N+](=O)[O-])c4)ccc3n2)CC1";"IFI";"'='";"11.48";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL580163";"";"0";"336.31";"0";"2.14";"GNF-Pf-2979";"O=C(NN=Cc1ccncc1)c1cc(-c2cccc([N+](=O)[O-])c2)[nH]n1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL580168";"";"0";"544.72";"1";"3.18";"GNF-Pf-2984";"CCOC(=O)c1c(S(=O)(=O)N2CCCC(C(=O)N3CCN(c4cccc(C)c4C)CC3)C2)c(C)n(C)c1C";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL580171";"";"0";"515.62";"1";"3.42";"GNF-Pf-2989";"CC(C)NC(=O)N1CCN(C(=O)C(Cc2c[nH]c3ccccc23)NC(=O)Nc2cccc(C#N)c2)CC1C";"IFI";"'='";"1.835";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL603012";"";"0";"432.48";"0";"3.87";"GNF-Pf-125";"CC(C)(C)C1=NN(CC(=O)Nc2ccc3c(c2)OCO3)C(=O)c2cc3ccccc3n2C1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL578890";"";"0";"388.86";"1";"5.59";"GNF-Pf-130";"Cc1cc(Nc2cccc(Cl)c2)nc2ccc(NC(=O)c3cccnc3)cc12";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585977";"";"0";"424.50";"1";"6.55";"GNF-Pf-1315";"C=CCc1cc([N+](=O)[O-])cc2c1OC1(C=C2)N(c2ccccc2)c2ccccc2C1(C)C";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL578458";"";"0";"385.52";"0";"2.92";"GNF-Pf-2597";"CC(C)CNC(=O)c1cnc(NCCCn2ccnc2)nc1NC1CCCC1";"IFI";"'='";"2.885";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600279";"";"0";"413.23";"0";"4.14";"GNF-Pf-1732";"Cc1n[nH]c2c1C(c1ccc([N+](=O)[O-])cc1)N(c1ccc(Br)cc1)C2=O";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL588728";"";"0";"444.48";"0";"2.02";"GNF-Pf-1772";"O=C(O)C(=O)O.O=C(c1ccccc1)N1CCN(CC(O)COCc2ccccc2)CC1";"IFI";"'='";"2.703";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600536";"";"0";"419.37";"1";"5.32";"GNF-Pf-2552";"Cc1c(Cc2ccccc2)sc(N=Cc2ccc(Br)s2)c1C(N)=O";"IFI";"'='";"5.556";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL534578";"";"0";"395.22";"0";"4.30";"GNF-Pf-2565";"O=C(Nc1ccon1)c1cc(-c2cccnc2)nc2ccc(Br)cc12";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL578291";"";"0";"552.67";"2";"6.04";"GNF-Pf-96";"COc1cc(C(=O)N2C(C(=O)Nc3ccccc3F)CSC2c2ccc(C(C)(C)C)cc2)cc(OC)c1OC";"IFI";"'='";"1.053";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL601149";"";"0";"382.69";"1";"6.02";"GNF-Pf-101";"O=C(Nc1cccc(Cl)c1)Nc1cc(C(F)(F)F)cc(C(F)(F)F)c1";"IFI";"'='";"12.5";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL578501";"";"0";"411.81";"0";"3.57";"GNF-Pf-102";"COc1ccc(Nc2nc3nonc3nc2NN=Cc2cc(Cl)ccc2O)cc1";"IFI";"'='";"7.143";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL602371";"";"0";"233.27";"0";"3.21";"GNF-Pf-112";"c1ccc(-c2ccc(-c3ccccn3)nc2)nc1";"IFI";"'='";"15.91";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL601156";"";"0";"335.32";"0";"3.56";"GNF-Pf-119";"CC1=C(CC(=O)c2cccc([N+](=O)[O-])c2)C(=O)c2ccccc2C1=O";"IFI";"'='";"2.439";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL579299";"";"0";"439.54";"0";"4.51";"GNF-Pf-126";"COc1cc(C(=O)Nc2c3c(nn2-c2cc(C)cc(C)c2)CSC3)cc(OC)c1OC";"IFI";"'='";"3.529";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585571";"";"0";"615.91";"0";"2.56";"GNF-Pf-140";"NC(=O)C1CCCN(C(=O)COC(c2ccccc2)c2cccnc2Cl)C1.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F";"IFI";"'='";"1.942";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL581639";"";"0";"527.67";"2";"6.08";"GNF-Pf-1623";"COc1cc(NC(C)CCCN(Cc2ccccc2OC)C(=O)COCc2ccccc2)c2ncccc2c1";"IFI";"'='";"2.804";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL587421";"";"0";"332.41";"0";"2.35";"GNF-Pf-1625";"CN1CCN(c2cc(-c3cccnc3)nc(-c3ccncc3)n2)CC1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL576401";"";"0";"330.40";"0";"2.62";"GNF-Pf-1639";"Oc1ccc(-c2ccc(F)cc2)cc1CNCCN1CCOCC1";"IFI";"'='";"0.8547";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL581905";"";"0";"384.53";"0";"2.84";"GNF-Pf-493";"CC(C)CNc1nc(NCCCN(C)C)ncc1C(=O)NCc1ccccc1";"IFI";"'='";"2.02";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL578670";"";"0";"415.49";"0";"3.38";"GNF-Pf-2599";"Cc1ccc(C)c(S(=O)(=O)N=C2C=C(SCC(=O)O)C(=O)c3ccccc32)c1";"IFI";"'='";"6.25";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL581055";"";"0";"352.46";"0";"1.04";"GNF-Pf-505";"CC(C(=O)NN=C1CCN(C)CC1)N(c1ccccc1)S(C)(=O)=O";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL578058";"";"0";"419.55";"0";"4.70";"GNF-Pf-2614";"CC(C)NC(=O)c1cc(NC(=O)c2cccs2)ccc1N1CCc2ccccc2C1";"IFI";"'='";"3.125";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL579315";"";"0";"358.39";"0";"3.93";"GNF-Pf-2150";"COc1ccc(C=C2SC(Nc3ccc(F)cc3)=NC2=O)c(OC)c1";"IFI";"";"";"";"";"";"Not applicable";"";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL579892";"";"0";"338.36";"0";"1.75";"GNF-Pf-1786";"Cc1oc2c(c1C(=O)N1CCN(C)CC1)C(=O)c1ccccc1C2=O";"IFI";"'='";"10.81";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL588091";"";"0";"361.48";"1";"5.18";"GNF-Pf-1853";"CCN(CC)c1ccc(C=Cc2cc[n+](Cc3ccc(F)cc3)cc2)cc1";"IFI";"'='";"16.81";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL582256";"";"0";"370.38";"0";"3.38";"GNF-Pf-1799";"COc1ccc(C2=NN(C(=O)CCC(=O)O)C(c3ccccc3F)C2)cc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL577446";"";"0";"277.39";"0";"3.71";"GNF-Pf-1819";"CCN1/C(=C/c2cccc[n+]2C)C=Cc2cc(C)ccc21";"IFI";"'='";"15.38";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL578118";"";"0";"348.41";"0";"4.46";"GNF-Pf-1836";"c1ccc2c(NC3CCCC3)nc(Nc3ccc4c(c3)OCO4)nc2c1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL588667";"";"0";"499.44";"0";"3.24";"GNF-Pf-1860";"COc1ccc(OCC(O)CNC2CCN(CC(O)COc3ccc(Cl)c(Cl)c3)CC2)cc1";"IFI";"'='";"3.361";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL530562";"";"0";"427.32";"0";"1.75";"GNF-Pf-2416";"CN(Cc1ccccc1)C(=O)CCNS(=O)(=O)c1cc(Br)cnc1N";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL579295";"";"0";"329.32";"0";"3.37";"GNF-Pf-2451";"N#Cc1cc2[nH]c3ccccc3c2n(-c2ccc([N+](=O)[O-])cc2)c1=N";"IFI";"'='";"1.587";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL579104";"";"0";"325.42";"0";"3.02";"GNF-Pf-2458";"COc1ccc2[nH]c3c(NCCN4CCCCC4)ncnc3c2c1";"IFI";"'='";"9.756";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL576561";"";"0";"372.31";"1";"5.29";"GNF-Pf-2470";"CC(=O)N1c2ccccc2C(C)(c2ccc(Br)cc2)CC1(C)C";"IFI";"'='";"1.613";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL533534";"";"0";"272.44";"0";"3.92";"GNF-Pf-2477";"CCCCCCn1c2c(c(=N)c3c1CCC3)CCCC2";"IFI";"'='";"14.29";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL577848";"";"0";"486.62";"0";"4.30";"GNF-Pf-2487";"COc1ccc(OC)c(-c2ccc(C(=O)N3CCN(C/C=C/c4ccccc4)CC3)c(N(C)C)n2)c1";"IFI";"'='";"2.542";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL582253";"";"0";"400.55";"1";"5.43";"GNF-Pf-2032";"c1ccc(CN2CCC(Nc3ncnc4cc(-c5ccccc5)sc34)CC2)cc1";"IFI";"'='";"3.472";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL582254";"";"0";"353.51";"0";"3.09";"GNF-Pf-2033";"COCCNCCN1CCN(c2ccc(C)cc2)C[C@@H]1c1ccccc1";"IFI";"'='";"1.235";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL579365";"";"0";"419.93";"0";"4.07";"GNF-Pf-2048";"COc1ccc(S(=O)(=O)NCCCCNc2ccnc3cc(Cl)ccc23)cc1";"IFI";"'='";"3.738";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL578461";"";"0";"284.36";"0";"2.83";"GNF-Pf-2051";"Cc1ccccc1-c1cnnc(NCC2CCCCO2)n1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL578272";"";"0";"305.43";"0";"4.28";"GNF-Pf-2066";"CCN1CCC(Nc2ccnc3cc4ccccc4cc23)CC1";"IFI";"'='";"9.091";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL578496";"";"0";"326.40";"0";"4.50";"GNF-Pf-2084";"Oc1ccccc1-c1nc2sc(-c3ccccc3O)nc2s1";"IFI";"'='";"10.99";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL602594";"";"0";"425.62";"0";"4.24";"GNF-Pf-2114";"CN1CCC(N2CCC(Oc3cccc(C(=O)NCCC4=CCCCC4)c3)CC2)CC1";"IFI";"'='";"7.692";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL601351";"";"0";"344.54";"0";"3.83";"GNF-Pf-2260";"CC1CC2(C)Oc3ccccc3CC2C(C)C1CNCCCN(C)C";"IFI";"'='";"9.231";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL603001";"";"0";"409.56";"0";"3.84";"GNF-Pf-2271";"CCc1ccc2[nH]c(=O)c(CN(CCO)C(=S)Nc3ccccc3CC)cc2c1";"IFI";"'='";"6.481";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL578030";"";"0";"357.89";"0";"4.75";"GNF-Pf-2277";"CCOc1ccc2nc(C)cc(Nc3ccc(N(C)C)cc3)c2c1.Cl";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600526";"";"0";"280.33";"0";"2.38";"GNF-Pf-2302";"CCc1[nH]nc2c1C(Cc1ccccc1)C(C#N)=C(N)O2";"IFI";"'='";"1.538";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL421088";"";"0";"258.28";"0";"3.36";"GNF-Pf-2307";"O=C1c2ccccc2-c2nnc(-c3ccccc3)cc21";"IFI";"'='";"10.98";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL603729";"";"0";"561.01";"1";"4.18";"GNF-Pf-1556";"COc1cc(OC)c(N(C)S(=O)(=O)c2cccc(C(=O)OCC(=O)Nc3ccccc3C(C)=O)c2)cc1Cl";"IFI";"'='";"9.677";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL601993";"";"0";"359.79";"0";"2.63";"GNF-Pf-1569";"Nc1c(C(=O)NCc2ccccc2)nnn1Cc1ccc(F)cc1Cl";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600150";"";"0";"450.63";"0";"4.30";"GNF-Pf-3783";"CN1CCCC1CCNc1ncc(C(=O)NCc2ccccc2)c(NCC2CCCCC2)n1";"IFI";"'='";"3.883";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL611971";"";"0";"271.34";"0";"3.48";"GNF-Pf-4207";"C[n+]1cccc(C=C2c3ccccc3-c3ncccc32)c1";"IFI";"";"";"";"";"";"Not applicable";"";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL597250";"";"0";"459.56";"1";"6.06";"GNF-Pf-4254";"CC1=C(C(=O)OC2CCCCC2)C(c2ccc(F)cc2)C2=C(CC(c3ccccc3)CC2=O)N1";"IFI";"'='";"5.882";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL586279";"";"0";"233.70";"0";"3.06";"GNF-Pf-4265";"O=c1c2c([nH]c3cc(Cl)ccc13)CCCC2";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL601794";"";"0";"398.25";"0";"3.48";"GNF-Pf-1901";"C[n+]1cccc(/C=C2/c3ccccc3-c3ncccc32)c1.[I-]";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL578962";"";"0";"383.88";"0";"4.47";"GNF-Pf-1907";"COc1ccc(C(=O)N(C)CCCNc2ccnc3cc(Cl)ccc23)cc1";"IFI";"'='";"0.9346";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL577229";"";"0";"307.74";"0";"3.32";"GNF-Pf-1913";"O=C(NN=CC1CC=CCC1)c1ccc([N+](=O)[O-])cc1Cl";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL586896";"";"0";"537.30";"None";"None";"GNF-Pf-1933";"CCN1/C(=C/c2[se]c3ccccc3[n+]2CC)C=Cc2cc(OC)ccc21.[I-]";"IFI";"'='";"19.55";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL582649";"";"0";"449.60";"1";"5.52";"GNF-Pf-1951";"COc1cc(NC(C)CCCN(Cc2ccccc2OC)C(=O)C(C)C)c2ncccc2c1";"IFI";"'='";"5.714";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL531351";"";"0";"641.83";"2";"5.32";"GNF-Pf-1953";"COCCN(CC(=O)NCc1ccc(OC2CCN(CC(c3ccccc3)c3ccccc3)CC2)cc1)S(=O)(=O)c1ccccc1";"IFI";"'='";"1.408";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL581203";"";"0";"253.37";"0";"3.23";"GNF-Pf-1955";"CC[n+]1ccc(C=Cc2ccc(N(C)C)cc2)cc1";"IFI";"";"";"";"";"";"Not applicable";"";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL602771";"";"0";"586.83";"2";"9.47";"GNF-Pf-1956";"c1ccc(N=c2sc(-c3ccccc3)cn2CCCCCCn2cc(-c3ccccc3)sc2=Nc2ccccc2)cc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL582252";"";"0";"375.78";"0";"4.29";"GNF-Pf-1963";"N#CCCN(CC1CCCO1)C(=O)Nc1ccc(Cl)c(C(F)(F)F)c1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL531562";"";"0";"263.36";"0";"3.41";"GNF-Pf-1964";"CCN1/C(=C/c2cccc[n+]2C)C=Cc2ccccc21";"IFI";"'='";"8.333";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL579362";"";"0";"437.53";"0";"2.03";"GNF-Pf-1970";"CN(Cc1ccccc1)c1nc2c(c(=O)[nH]c(=O)n2C)n1CCCSc1ncccn1";"IFI";"'='";"2.703";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600297";"";"0";"612.73";"2";"8.77";"GNF-Pf-2371";"O=C(Nc1ccc(-c2nc3cc(NC(=O)C(c4ccccc4)c4ccccc4)ccc3[nH]2)cc1)C(c1ccccc1)c1ccccc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL586516";"";"0";"419.36";"0";"3.44";"GNF-Pf-2006";"OC(CNC1CCN(Cc2ccccc2)CC1)COc1ccc(Br)cc1";"IFI";"'='";"0.8264";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL602395";"";"0";"498.29";"1";"5.43";"GNF-Pf-2379";"O=c1c(NCc2ccco2)nc2cc(Cl)ccc2n1CCNc1ncc(C(F)(F)F)cc1Cl";"IFI";"'='";"2.469";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL588616";"";"0";"442.56";"1";"6.34";"GNF-Pf-2011";"CCN(Cc1ccccc1)Cc1c(O)ccc2oc(C)c(C(=O)Nc3ccc(C)cc3C)c12";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL586602";"";"0";"314.52";"1";"5.09";"GNF-Pf-2017";"CCCCCCCCCn1c2c(c(=N)c3c1CCC3)CCCC2";"IFI";"'='";"21.26";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL601398";"";"0";"468.54";"1";"5.83";"GNF-Pf-2018";"C=CCSc1oc(-c2ccco2)nc1[P+](c1ccccc1)(c1ccccc1)c1ccccc1";"IFI";"'='";"23.08";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL582246";"";"0";"464.11";"1";"6.59";"GNF-Pf-2028";"O=[N+]([O-])c1cc(C(F)(F)F)c(Cl)c([N+](=O)[O-])c1Nc1cc(C(F)(F)F)ccc1Cl";"IFI";"'='";"21.21";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL531569";"";"0";"263.36";"0";"3.41";"GNF-Pf-2038";"CCN1C=CC(=Cc2ccc3ccccc3[n+]2C)C=C1";"IFI";"'='";"3.077";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL579364";"";"0";"345.87";"0";"4.39";"GNF-Pf-2046";"O=C(NCCCCNc1ccnc2cc(Cl)ccc12)C1CCCC1";"IFI";"'='";"0.9174";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL578892";"";"0";"520.05";"2";"7.27";"GNF-Pf-2055";"CCCCCN(C(=O)c1cccc(F)c1)C(CC)c1nc2ccccc2c(=O)n1-c1ccc(Cl)cc1C";"IFI";"'='";"1.905";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL578057";"";"0";"286.29";"0";"3.16";"GNF-Pf-2065";"COc1ccc(NC(=O)c2cccc([N+](=O)[O-])c2C)cc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL577841";"";"0";"395.93";"0";"3.78";"GNF-Pf-2076";"CC(C)CC(N)C(=O)N1CCc2nc(Cc3ccc(F)cc3Cl)sc2C1";"IFI";"'='";"4.225";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL579346";"";"0";"356.38";"0";"3.73";"GNF-Pf-2098";"CCOc1cccc2oc(=O)c(C(=O)Nc3cc(C(C)(C)C)on3)cc12";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL576175";"";"0";"296.39";"0";"1.41";"GNF-Pf-2100";"CC(NS(=O)(=O)c1ccccc1)C(=O)NC1CCCC1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL124006";"";"0";"279.39";"0";"3.75";"GNF-Pf-2110";"CN(C)CCCNc1c2ccccc2nc2ccccc12";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL578674";"";"0";"363.37";"0";"1.51";"GNF-Pf-2130";"COC(=O)C1=CNC=C(C(=O)OC)C1c1cc(OC)c(OC)c(OC)c1";"IFI";"'='";"2.381";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL577873";"";"0";"466.61";"0";"3.89";"GNF-Pf-1804";"CC1CCN(C(=O)C2CCCN(S(=O)(=O)c3ccc4[nH]c(-c5ccccc5)nc4c3)C2)CC1";"IFI";"'='";"3.125";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL531947";"";"0";"204.06";"0";"2.52";"GNF-Pf-1811";"O=C(CCl)Nc1ccc(Cl)cc1";"IFI";"'='";"3.54";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL601985";"";"0";"458.34";"1";"5.24";"GNF-Pf-1812";"CCOC(=O)C1=C(N)OC2=C(C(=O)CC(c3ccccc3)C2)C1c1ccc(Cl)cc1Cl";"IFI";"'='";"1.176";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL577878";"";"0";"329.40";"0";"2.92";"GNF-Pf-1815";"COC(=O)C1=C(C)N(C)C(C)=C(C(=O)OC)C1c1ccc(C)cc1";"IFI";"'='";"2.353";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL531726";"";"0";"222.72";"0";"2.04";"GNF-Pf-1835";"C/C=C/c1n(C)c2ccccc2[n+]1C.[Cl-]";"IFI";"'='";"4.348";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL586685";"";"0";"248.32";"0";"2.01";"GNF-Pf-1841";"C=C(C)[C@@]12O[C@@H]1[C@@]1(C)C(=CC2=O)CC[C@@H](O)[C@@H]1C";"IFI";"'='";"5.172";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL1520837";"";"0";"337.57";"1";"5.56";"GNF-Pf-1859";"CCCCCCCCN[C@@H](C)[C@H](O)c1ccc(SC(C)C)cc1";"IFI";"'='";"3.106";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL531956";"";"0";"625.86";"2";"10.44";"GNF-Pf-1870";"Cc1ccc(C2(C)CC(C)(C)N(C(=O)Cc3ccccc3)c3ccc(C(c4ccccc4)(c4ccccc4)c4ccccc4)cc32)cc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL532858";"";"0";"583.77";"2";"7.92";"GNF-Pf-1880";"CCCCCc1ccc(C(=O)N(CCCC(C)Nc2cc(OC)cc3cccnc23)Cc2ccc(OC)c(OC)c2)cc1";"IFI";"'='";"3.704";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL578097";"";"0";"432.95";"1";"5.68";"GNF-Pf-1881";"C=C[C@H]1CN2CC[C@H]1C[C@H]2[C@H](OC(=O)c1ccc(Cl)cc1)c1ccnc2ccccc12";"IFI";"'='";"1.042";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL533134";"";"0";"332.36";"0";"4.28";"GNF-Pf-1882";"Oc1ccc(Nc2nc(NCc3ccco3)c3ccccc3n2)cc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL578101";"";"0";"442.51";"0";"3.39";"GNF-Pf-1888";"COc1ccc(N(CC(=O)NCCc2ccc(F)cc2)S(=O)(=O)c2ccccc2)cc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL601986";"";"0";"485.10";"1";"5.10";"GNF-Pf-1893";"CCN(CC)CCCNC(=S)N(Cc1ccccc1)Cc1cc2cc(C)c(Cl)cc2[nH]c1=O";"IFI";"'='";"16.39";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL599909";"";"0";"259.31";"0";"1.78";"GNF-Pf-153";"CC(=O)Nn1c(C(C)(C)C)nc2ccccc2c1=O";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL579349";"";"0";"406.31";"1";"5.37";"GNF-Pf-167";"O=C(Nc1cc(C(F)(F)F)cc(C(F)(F)F)c1)Nc1ccc2nnsc2c1";"IFI";"'='";"12.82";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL576994";"";"0";"498.54";"0";"4.98";"GNF-Pf-176";"Cl.O=C(NCCN1CCCCC1)c1ccc(OC2CCN(CC3CCCCC3)CC2)c(Cl)c1";"IFI";"'='";"8.571";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL50588";"EMETINE";"0";"480.65";"0";"4.94";"GNF-Pf-196";"CC[C@H]1CN2CCc3cc(OC)c(OC)cc3[C@@H]2C[C@@H]1C[C@H]1NCCc2cc(OC)c(OC)cc21";"IFI";"'='";"23.81";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL582709";"";"0";"478.64";"1";"7.65";"GNF-Pf-221";"CCOc1ccc(CN(CCC(c2ccccc2)c2ccccc2)C(=O)Nc2ccccc2C)cc1";"IFI";"'='";"0.9259";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL579755";"";"0";"365.42";"0";"3.30";"GNF-Pf-222";"Cc1cccc(Nc2nc3nonc3[nH]c2=NN=Cc2cccs2)c1C";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL603027";"";"0";"448.48";"0";"4.18";"GNF-Pf-226";"CC1=C(C(=O)OCCOc2ccccc2)C(c2cccc([N+](=O)[O-])c2)C2=C(CCCC2=O)N1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL602380";"";"0";"302.37";"0";"2.61";"GNF-Pf-234";"CCCNC(=O)N1CCC2(CC1)CC(=O)c1ccccc1O2";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL581674";"";"0";"359.86";"0";"3.78";"GNF-Pf-235";"Cc1ccccc1NC(=O)N(CCCNC(=O)CCl)c1ccccc1";"IFI";"'='";"2.778";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL602381";"";"0";"272.40";"0";"4.47";"GNF-Pf-257";"CCSc1ncnc2scc(-c3ccccc3)c12";"IFI";"'='";"1.19";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL602812";"";"0";"466.49";"0";"3.81";"GNF-Pf-259";"COc1ccccc1NC(=O)Cn1cnc2sc(C(=O)Nc3ccc(F)cc3)c(C)c2c1=O";"IFI";"'='";"3.529";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL602418";"";"0";"339.35";"0";"2.68";"GNF-Pf-265";"COc1ccc(-c2cc(C(=O)NCc3cccnc3)no2)cc1OC";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL582692";"";"0";"327.77";"0";"2.71";"GNF-Pf-271";"N#Cc1c(NC(=O)CCl)c(C(=O)c2ccccc2)n2c1CCC2";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL579746";"";"0";"436.47";"0";"2.88";"GNF-Pf-282";"CCCCC(=O)Nc1ccccc1-c1nnn(CC(=O)Nc2ccc3c(c2)OCCO3)n1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL582501";"";"0";"309.37";"0";"2.15";"GNF-Pf-298";"COc1ccc(C2N=C(N)N=C(N)N2c2ccc(C)cc2)cc1";"IFI";"'='";"1.37";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL577669";"";"0";"334.85";"0";"4.76";"GNF-Pf-6";"CCCCN(CCCC)c1nc(=O)cc(-c2ccc(Cl)cc2)o1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL578678";"";"0";"409.44";"0";"4.17";"GNF-Pf-21";"CC12C(=O)N(c3cccc(C(=O)O)c3)C(=O)C1C1c3ccccc3C2c2ccccc21";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL22148";"";"0";"214.27";"0";"1.87";"GNF-Pf-26";"CCc1nc(N)nc(N)c1-c1ccccc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL578487";"";"0";"295.45";"0";"4.26";"GNF-Pf-39";"CC(C)CC[n+]1ccccc1C=Cc1ccc(N(C)C)cc1";"IFI";"'='";"15.38";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL586061";"";"0";"362.48";"1";"5.79";"GNF-Pf-57";"O=C(Nc1cccc(-c2csc(-c3ccccc3)n2)c1)c1cccs1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600100";"";"0";"253.37";"0";"3.06";"GNF-Pf-58";"Cc1ccc(C=Cc2ccc(N(C)C)cc2)[n+](C)c1";"IFI";"'='";"15.38";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL578512";"";"0";"193.17";"0";"-1.63";"GNF-Pf-67";"Cn1ncnc2c(=O)n(C)c(=O)nc1-2";"IFI";"'='";"26.67";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600527";"";"0";"452.51";"0";"3.70";"GNF-Pf-70";"CN[C@H]1C[C@@H]2O[C@](C)([C@H]1O)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4";"IFI";"'='";"46.22";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL602988";"";"0";"568.67";"1";"4.62";"GNF-Pf-80";"CC(=O)Nc1ccc2c(c1)C(=O)N(C(C(=O)NCc1ccccc1)C1CCCCC1)[C@@H](Cc1ccc(O)cc1)C(=O)N2";"IFI";"'='";"2.439";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL586226";"";"0";"247.28";"0";"2.84";"GNF-Pf-1383";"Cc1cnc(Sc2ccccn2)c([N+](=O)[O-])c1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL582451";"";"0";"533.71";"2";"6.84";"GNF-Pf-1395";"COc1cc(NC(C)CCCN(Cc2ccc(OC)c(OC)c2)C(=O)CCC2CCCC2)c2ncccc2c1";"IFI";"'='";"3.008";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL313938";"";"0";"221.21";"0";"0.57";"GNF-Pf-1401";"NC1(C(=O)O)CCc2cc(C(=O)O)ccc21";"IFI";"'='";"1.481";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL582260";"";"0";"357.15";"0";"3.54";"GNF-Pf-1402";"CCOc1ccc(NC(=O)c2ccc(I)o2)cc1";"IFI";"'='";"7.692";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL579366";"";"0";"320.78";"0";"2.75";"GNF-Pf-1409";"COc1ccc(/C=C/C(=O)Nc2ccncc2)cc1OC.Cl";"IFI";"'='";"2.899";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL601974";"";"0";"339.22";"0";"2.56";"GNF-Pf-1419";"Cc1nc(N)sc1C(=O)NN=Cc1cccc(Br)c1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL579165";"";"0";"488.61";"0";"4.93";"GNF-Pf-1420";"Cc1ccc(NC(=O)N2CCN(CCN(Cc3ccc(F)cc3)C(=O)c3ccccc3C)CC2)cc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL601999";"";"0";"469.41";"1";"5.55";"GNF-Pf-1421";"CC(C)CCNC(=O)C1CSC(c2ccc(F)cc2)N1C(=O)c1ccc(Cl)cc1Cl";"IFI";"'='";"3.226";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL577019";"";"0";"415.89";"1";"5.42";"GNF-Pf-1433";"O=C(Nc1ccc(Cl)c(C(F)(F)F)c1)NC1CC2CCC(C1)N2C1CCCC1";"IFI";"'='";"1.282";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL577148";"";"0";"367.46";"0";"3.58";"GNF-Pf-2444";"O=C(CSc1ccc2nnc(-c3cccs3)n2n1)Nc1ccccc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL268584";"";"0";"350.40";"0";"2.78";"GNF-Pf-2448";"Nc1nc(N)c2cc(S(=O)(=O)c3ccc4ccccc4c3)ccc2n1";"IFI";"'='";"12.4";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL602804";"";"0";"431.54";"0";"3.49";"GNF-Pf-2449";"COC(=O)c1sccc1S(=O)(=O)N1CCCC(c2[nH]ncc2-c2ccccc2)C1";"IFI";"'='";"3.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL578887";"";"0";"369.45";"0";"2.83";"GNF-Pf-2456";"COc1ccc(NC(=O)C2=C(C)NC(=S)NC2c2ccc(O)cc2)cc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600529";"";"0";"314.39";"0";"3.75";"GNF-Pf-2464";"CCC1CCCCN1C(=O)c1cc(-c2ccccc2OC)on1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL576154";"";"0";"374.42";"0";"1.43";"GNF-Pf-2469";"NS(=O)(=O)c1ccc(CCNC(=O)C=Cc2ccc3c(c2)OCO3)cc1";"IFI";"";"";"";"";"";"Not applicable";"";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL611213";"";"0";"372.47";"0";"3.38";"GNF-Pf-2483";"Cc1cc(/C=C2/SC(=S)N(CC(=O)O)C2=O)c(C)n1-c1ccccc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL578722";"";"0";"367.88";"0";"4.44";"GNF-Pf-2504";"O=C(Cc1ccccc1)NCCCCNc1ccnc2cc(Cl)ccc12";"IFI";"'='";"4.808";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL602368";"";"0";"344.46";"0";"3.12";"GNF-Pf-2557";"COc1ccc(OC)c(-c2ccc(O)c(CNCCCN(C)C)c2)c1";"IFI";"'='";"2.564";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL578106";"";"0";"206.27";"0";"2.56";"GNF-Pf-2147";"CC(=O)Nc1ccc2nc(C)sc2c1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL576359";"";"0";"386.84";"0";"4.83";"GNF-Pf-2158";"CCOC(=O)c1cnc2ccc(Cl)cc2c1Nc1ccc(OC)c(OC)c1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL578285";"";"0";"291.17";"0";"3.15";"GNF-Pf-2166";"C[n+]1ccccc1C=Cc1cc(Br)ccc1O";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL579126";"";"0";"428.29";"0";"3.38";"GNF-Pf-2174";"Br.O=C(Cn1ccc(=NCc2ccccc2)cc1)c1cccc([N+](=O)[O-])c1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL579343";"";"0";"368.52";"1";"7.10";"GNF-Pf-2179";"CN(C)c1ccc(-c2cc(-c3ccccc3)[s+]c(-c3ccccc3)c2)cc1";"IFI";"'='";"31.43";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL588176";"";"0";"289.77";"0";"2.74";"GNF-Pf-2180";"CN(C)CCNc1ncnc2c1[nH]c1ccc(Cl)cc12";"IFI";"'='";"7.843";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600502";"";"0";"558.73";"2";"8.43";"GNF-Pf-1542";"CC(C)c1cccc(C(C)C)c1NC(=O)N(Cc1ccccc1)C(C)c1nc2ccccc2c(=O)n1-c1ccccc1";"IFI";"'='";"1.869";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL579719";"";"0";"446.59";"1";"1.89";"GNF-Pf-1543";"Nc1nnc(SCC(=O)Nc2nnc(SCC(=O)Nc3nccs3)s2)s1";"IFI";"'='";"3.371";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL577218";"";"0";"242.25";"0";"3.53";"GNF-Pf-1551";"O=C1CC(c2ccccc2)Oc2ccc(F)cc21";"IFI";"'='";"2.273";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL577437";"";"0";"543.54";"2";"7.26";"GNF-Pf-1553";"CC(C)N(CC(=O)Nc1cc(C(C)(C)C)nn1-c1ccc(Cl)c(Cl)c1)C(=O)c1ccc(C(C)(C)C)cc1";"IFI";"'='";"2.913";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL576803";"";"0";"452.65";"0";"4.19";"GNF-Pf-1559";"CC(C)CNc1nc(NCCCN2CCCCC2C)ncc1C(=O)NCCc1ccccc1";"IFI";"'='";"3.846";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL1198336";"";"0";"314.41";"0";"1.87";"GNF-Pf-1560";"O=C(C[n+]1ccc(/C=N/O)cc1)NC12CC3CC(CC(C3)C1)C2";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL602173";"";"0";"333.46";"0";"3.34";"GNF-Pf-1564";"CCCSCCCNC(=O)c1oc2c(c1C)-c1[nH]ncc1CC2";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL528734";"";"0";"290.25";"0";"3.79";"GNF-Pf-1568";"FC(F)(F)c1ccc(Nc2nnnc3ccccc23)cc1";"IFI";"'='";"2.439";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL578113";"";"0";"407.90";"0";"4.20";"GNF-Pf-1578";"O=S(=O)(NCCCCNc1ccnc2cc(Cl)ccc12)c1ccc(F)cc1";"IFI";"'='";"1.852";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL577455";"";"0";"507.63";"1";"2.92";"GNF-Pf-1582";"C=C1[C@@H](O)[C@@H]2C=CC[C@H](C)C(=O)[C@](C)(O)C=CC(OC(C)=O)[C@]23C(=O)N[C@@H](Cc2ccccc2)[C@@H]3[C@@H]1C";"IFI";"'='";"6.897";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600726";"";"0";"363.46";"0";"4.03";"GNF-Pf-1584";"CN(C)c1ccc(Nc2nc(NCC3CCCO3)c3ccccc3n2)cc1";"IFI";"'='";"7.692";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL588954";"";"0";"410.48";"0";"3.16";"GNF-Pf-1591";"Cc1ccc(S(=O)(=O)N=C2C=C(Sc3nnc[nH]3)C(=O)c3ccccc32)cc1";"IFI";"'='";"25.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL531478";"";"0";"567.77";"2";"8.30";"GNF-Pf-1598";"CCCCCCN(C(=O)c1ccc(CCCCC)cc1)C(CC)c1nc2ccccc2c(=O)n1-c1ccccc1OC";"IFI";"'='";"1.942";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL582655";"";"0";"540.42";"1";"3.90";"GNF-Pf-1608";"O=C(Nn1c(SCc2cc(=O)n3ccccc3n2)nc2ccsc2c1=O)c1cccc(Br)c1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL579944";"";"0";"463.51";"0";"4.87";"GNF-Pf-1622";"COC(=O)c1c(C)oc2ccc(N(C(=O)c3ccc(C)cc3)S(=O)(=O)c3ccccc3)cc12";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL577009";"";"0";"520.70";"1";"4.42";"GNF-Pf-1635";"CC(C)CN(C(C(=O)NC(CN1CCCC1)c1ccccc1)c1ccccc1)S(=O)(=O)c1ccccn1";"IFI";"'='";"1.961";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL578747";"";"0";"330.30";"0";"2.01";"GNF-Pf-1643";"NC(=O)C(Cc1ccccc1)Nc1ccc([N+](=O)[O-])cc1[N+](=O)[O-]";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600734";"";"0";"428.46";"0";"4.25";"GNF-Pf-1644";"CC(=O)N(Cc1ccc(F)cc1)C1=C(NCc2ccccc2)C(=O)c2ccccc2C1=O";"IFI";"'='";"23.08";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL578114";"";"0";"371.82";"0";"3.44";"GNF-Pf-1645";"CCn1c(C)cc(/C=C2\C(=O)NC(=O)N(c3cccc(Cl)c3)C2=O)c1C";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL588397";"";"0";"348.41";"0";"3.92";"GNF-Pf-1658";"COc1ccc(C=NNc2cc(C)nc(-c3ccccc3)n2)cc1OC";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL588631";"";"0";"551.61";"2";"7.20";"GNF-Pf-1663";"CCCCCN(C(=O)c1cccc(C(F)(F)F)c1)C(CC)c1nc2ccccc2c(=O)n1-c1ccccc1OC";"IFI";"'='";"0.9259";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL588291";"";"0";"332.49";"0";"3.40";"GNF-Pf-1667";"COc1cccc(CN2CCN(C3CCCC(C)C3)CC2)c1OC";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL599906";"";"0";"711.84";"3";"5.62";"GNF-Pf-1677";"CCOc1cccc2c1N(C(=O)c1ccc(C)cc1)C(C)(C)C1=C2C2(SC(C(=O)OC)=C(C(=O)OC)S2)C(C(=O)OC)=C(C(=O)OC)S1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL581251";"";"0";"465.67";"1";"7.91";"GNF-Pf-1731";"CCC(/C=C1\Sc2ccc3ccccc3c2N1C)=C\c1sc2ccc3ccccc3c2[n+]1C";"IFI";"";"";"";"";"";"Not applicable";"";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL531710";"";"0";"225.25";"0";"3.51";"GNF-Pf-1737";"Cc1ccc2nc(-c3ccc(O)cc3)oc2c1";"IFI";"'='";"7.143";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL586396";"";"0";"444.30";"1";"5.35";"GNF-Pf-1738";"CC1Cc2ccc(F)cc2CN1C(=O)c1ccc(COc2ccccc2Br)o1";"IFI";"'='";"2.857";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL578266";"";"0";"400.52";"1";"5.90";"GNF-Pf-2751";"COc1ccc(C(=O)N2c3cc(C)ccc3C(Nc3ccc(C)cc3)CC2C)cc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL601128";"";"0";"287.47";"0";"4.05";"GNF-Pf-2759";"CCCCCCc1ccc(/C(C=[N+](C)C)=C\N(C)C)cc1";"IFI";"'='";"21.43";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL576533";"";"0";"455.57";"0";"3.76";"GNF-Pf-2803";"O=C(NCc1ccccc1)c1cnc(NCCCn2ccnc2)nc1NCCc1ccccc1";"IFI";"'='";"2.913";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600324";"";"0";"420.55";"1";"5.75";"GNF-Pf-2831";"O=C(Nc1ccccc1O)c1ccc(C(=O)N(C2CCCCC2)C2CCCCC2)cc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL578467";"";"0";"404.53";"0";"3.57";"GNF-Pf-2833";"Cc1ccc(-c2nc(CS(=O)(=O)CC(=O)NC3CCC(C)CC3)c(C)o2)cc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL578679";"";"0";"482.57";"1";"5.31";"GNF-Pf-2834";"CN(c1ccccc1)S(=O)(=O)c1ccc(C(=O)Nc2ccc(-c3nc4ccccc4[nH]3)cc2)cc1";"IFI";"'='";"7.692";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL578930";"";"0";"231.03";"0";"2.81";"GNF-Pf-2871";"O=c1ccc2cc(Cl)c(O)c(Cl)c2o1";"IFI";"'='";"7.143";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL602621";"";"0";"343.50";"0";"3.70";"GNF-Pf-2956";"COc1cccc(CN2CCc3nc(N4CCCCC4)sc3C2)c1";"IFI";"'='";"9.722";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL601558";"";"0";"230.29";"0";"3.73";"GNF-Pf-2960";"c1ccc2c(c1)ccc1cc3cccc[n+]3cc12";"IFI";"'='";"9.091";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL602596";"";"0";"401.47";"1";"6.67";"GNF-Pf-93";"Cc1ccccc1N=c1oc2ccc3ccccc3c2cc1-c1nc2ccccc2[nH]1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL579354";"";"0";"474.59";"0";"3.66";"GNF-Pf-113";"COc1ccc(N2CCN(c3ncnc4sc(C(=O)NCc5cccnc5)c(C)c34)CC2)cc1";"IFI";"'='";"1.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL578536";"";"0";"310.42";"0";"3.38";"GNF-Pf-1497";"CCc1ccccc1N1C(=O)CN(Cc2ccccc2)C1=S";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL235891";"";"0";"323.42";"0";"3.36";"GNF-Pf-1319";"CCc1ccc2c(c1)C1(NN=C(c3ccc(C)cc3)S1)C(=O)N2";"IFI";"'='";"9.302";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585244";"";"0";"357.59";"0";"3.76";"GNF-Pf-1340";"CC(NCCN1CCNCC1)c1cc(C(C)(C)C)cc2c1CCC2(C)C";"IFI";"'='";"6.667";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL529852";"";"0";"574.70";"1";"4.11";"GNF-Pf-1349";"COc1ccc(CCn2c(SCC(=O)N3CCN(c4ccccc4OC)CC3)nc3ccccc3c2=O)cc1OC";"IFI";"'='";"1.19";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL581458";"";"0";"502.62";"2";"5.16";"GNF-Pf-2999";"O=C1[C@H]2Cc3c([nH]c4ccccc34)C(CCc3ccccc3)N2C(=O)CN1CCc1c[nH]c2ccccc12";"IFI";"'='";"12.24";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL581873";"";"0";"271.36";"0";"2.84";"GNF-Pf-3128";"CCCCN1Cc2ccc(C(N)=O)cc2N=C1C1CC1";"IFI";"'='";"2.439";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL581910";"";"0";"313.38";"0";"3.08";"GNF-Pf-3501";"CSc1ccc(/C=C/C(=O)NC(=O)c2ccccc2O)cc1";"IFI";"'='";"7.692";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL582531";"";"0";"247.25";"0";"2.13";"GNF-Pf-3504";"CCOC(=O)c1cnc2ccc(OC)cc2c1O";"IFI";"'='";"1.562";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600748";"";"0";"527.71";"2";"8.33";"GNF-Pf-3511";"CCCCOc1ccc(C(=O)Oc2ccccc2-c2nc3cc(C)ccn3c2NC(C)(C)CC(C)(C)C)cc1";"IFI";"'='";"4.673";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600894";"";"0";"231.26";"0";"0.85";"GNF-Pf-3520";"COc1cccc2c(C)nc(N=C(N)N)nc12";"IFI";"'='";"4.615";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL583396";"";"0";"377.28";"0";"2.52";"GNF-Pf-3522";"COc1ccc(C(=O)C[N+]2=C(C)c3ccc(C)n3CC2)cc1.[Br-]";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL584523";"";"0";"348.24";"0";"2.87";"GNF-Pf-3534";"Oc1ccc(Br)cc1CN1CCN(c2ccccn2)CC1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL599084";"";"0";"387.27";"1";"5.23";"GNF-Pf-3539";"Cl.Clc1cccc(Nc2nc(NCc3ccco3)c3ccccc3n2)c1";"IFI";"'='";"9.677";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL597455";"";"0";"434.01";"1";"6.76";"GNF-Pf-3555";"COc1ccc2c(c1)-c1c(ssc1=S)C(C)(C)N2C(=O)c1cccc(Cl)c1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL599712";"";"0";"518.60";"1";"2.77";"GNF-Pf-3561";"COc1cccc(NC(=O)c2sc3ncn(CC(=O)N4CCN(c5ccccn5)CC4)c(=O)c3c2C)c1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL529033";"";"0";"555.68";"2";"5.37";"GNF-Pf-3581";"COc1ccc(CN(Cc2cc3cccc(C)c3nc2N2CCCC(O)C2)C(=O)c2ccc(OC)c(OC)c2)cc1";"IFI";"'='";"2.941";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL583602";"";"0";"354.62";"0";"3.48";"GNF-Pf-3591";"CC(C)C(=O)NC(Nc1cccc([N+](=O)[O-])c1)C(Cl)(Cl)Cl";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL601599";"";"0";"355.48";"0";"4.75";"GNF-Pf-3592";"COc1ccc(OC)c(-c2ccc(O)c(CNCC3CCCCC3)c2)c1";"IFI";"'='";"5.882";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL605817";"";"0";"310.36";"0";"4.77";"GNF-Pf-3595";"c1ccc(-c2nc3cc4nc(-c5ccccc5)[nH]c4cc3[nH]2)cc1";"IFI";"'='";"8.871";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600486";"";"0";"289.79";"0";"4.71";"GNF-Pf-3598";"Cc1cc2c(Nc3cccc(Cl)c3C)ncnc2s1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600895";"";"0";"236.28";"0";"3.01";"GNF-Pf-3602";"C(=NNc1nc2ccccc2[nH]1)c1ccccc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL584894";"";"0";"325.37";"0";"2.26";"GNF-Pf-3865";"Cc1ccc(Cn2c(C)c3cnn(CC(=O)O)c(=O)c3c2C)cc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL581666";"";"0";"437.58";"0";"4.61";"GNF-Pf-3131";"COc1cccc(-c2nc3c(OC)ccc(OC)c3cc2CNCC(C)(C)CN(C)C)c1";"IFI";"'='";"2.609";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL582468";"";"0";"328.39";"0";"4.36";"GNF-Pf-3244";"C[n+]1ccccc1/C=C/C1=C(c2ccccc2)Oc2ccccc2O1";"IFI";"'='";"11.11";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL581868";"";"0";"418.07";"1";"6.61";"GNF-Pf-3265";"CCCCCc1ccc(OCCCC[n+]2cccc(C)c2)c(CCCCC)c1.[Cl-]";"IFI";"'='";"14.73";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600322";"";"0";"329.88";"0";"4.97";"GNF-Pf-3297";"CC[n+]1c(C=CN(C)c2ccccc2)sc2ccc(Cl)cc21";"IFI";"";"";"";"";"";"Not applicable";"";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600953";"";"0";"441.48";"0";"3.67";"GNF-Pf-3316";"CC(OC(=O)c1ccccc1N1C(=O)C2C3C=CC(C4CC34)C2C1=O)C(=O)c1ccccc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600333";"";"0";"438.02";"1";"6.63";"GNF-Pf-3328";"CCCCCCc1ccc(C(=O)NCCCCNc2ccnc3cc(Cl)ccc23)cc1";"IFI";"'='";"2.128";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL586019";"";"0";"370.41";"0";"4.54";"GNF-Pf-5042";"CC(=NNc1nc(-c2ccccc2O)nc2ccccc12)c1ccccc1O";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585787";"";"0";"445.54";"0";"3.56";"GNF-Pf-5065";"CCOC(=O)C1(Cc2ccc(OC)cc2)CCN(C(=O)c2scc3c2OCCO3)CC1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL598686";"";"0";"253.31";"0";"2.79";"GNF-Pf-4036";"Cc1cc(Nc2ccc(C)c(C)c2)n2cnnc2n1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL611076";"";"0";"264.37";"0";"2.99";"GNF-Pf-4037";"N=c1c2c(n(Cc3ccccc3)c3c1CCC3)CCC2";"IFI";"'='";"4.545";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL598066";"";"0";"465.54";"0";"2.87";"GNF-Pf-4040";"COc1ccc2cc(C)c3nnc(SCC(=O)N4CCN(C(=O)c5ccco5)CC4)n3c2c1";"IFI";"'='";"3.54";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL532909";"";"0";"253.74";"0";"0.87";"GNF-Pf-3611";"CC1(C)N=C(N)N=C(N)N1c1ccccc1.Cl";"IFI";"'='";"5.303";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600489";"";"0";"642.83";"2";"6.42";"GNF-Pf-3644";"COc1ccc(C2CC(c3cccs3)=NN2C(=O)CSc2nnc(CNC(=O)c3cccs3)n2-c2cc(C)ccc2C)cc1";"IFI";"'='";"2.41";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL202969";"";"0";"259.31";"0";"3.24";"GNF-Pf-3645";"CCOC(=O)c1cnc2ccc(C(C)C)cc2c1O";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL583607";"";"0";"380.96";"0";"4.46";"GNF-Pf-3672";"CCCCCCCCCCOC(=O)Cn1c(C)[n+](C)c2ccccc21.[Cl-]";"IFI";"'='";"1.527";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL597474";"";"0";"311.82";"0";"4.53";"GNF-Pf-3731";"Clc1ccc2c(N3CCC(n4cccc4)CC3)ccnc2c1";"IFI";"'='";"1.681";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL599949";"";"0";"459.70";"0";"3.51";"GNF-Pf-3779";"CCN(CC)CCCN(Cc1cc2c(C)cc(C)cc2[nH]c1=O)C(=S)NCCCN(C)C";"IFI";"'='";"2.542";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585478";"";"0";"397.57";"0";"2.21";"GNF-Pf-3787";"COc1ccc(S(=O)(=O)N2CCN(C(=S)NC3CCCCC3)CC2)cc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL586041";"";"0";"547.08";"1";"3.00";"GNF-Pf-3791";"Cc1noc(C)c1S(=O)(=O)N(Cc1ccccc1)CC(O)CN1CCC(NC(=O)c2ccccc2Cl)C1";"IFI";"'='";"1.942";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL605750";"";"0";"449.33";"0";"4.81";"GNF-Pf-3798";"N#Cc1c(N)nc(SCC(=O)c2ccc(Br)cc2)c(C#N)c1-c1ccccc1";"IFI";"'='";"5.747";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL609312";"";"0";"258.32";"0";"3.19";"GNF-Pf-3806";"O=C(O)c1ccc2c(c1)N=CN(C1CCCCC1)C2";"IFI";"'='";"1.25";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL599288";"";"0";"363.51";"0";"4.44";"GNF-Pf-3808";"O=C(Nc1ccccc1)NC1CC2CCCC(C1)N2CCc1ccccc1";"IFI";"'='";"1.316";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL261693";"";"0";"272.31";"0";"3.66";"GNF-Pf-3832";"Cc1ccc(-c2cc3c(nn2)-c2ccccc2C3=O)cc1";"IFI";"'='";"11.63";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL599715";"";"0";"478.57";"0";"4.49";"GNF-Pf-3833";"O=C(CC1N=C2c3ccccc3N=C(SCc3cccc(F)c3)N2C1=O)NCc1cccs1";"IFI";"'='";"14.29";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL586830";"";"0";"235.31";"0";"3.16";"GNF-Pf-3834";"C[n+]1ccc(/C=C/c2c[nH]c3ccccc23)cc1";"IFI";"'='";"7.463";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL601383";"";"0";"375.38";"0";"3.92";"GNF-Pf-3856";"COc1ccc(OCC(=O)Nc2cccc(-c3nc4ncccc4o3)c2)cc1";"IFI";"'='";"2.151";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL597462";"";"0";"263.25";"0";"3.24";"GNF-Pf-4047";"CC(=O)c1ccc2c3c(onc13)-c1ccccc1C2=O";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL605548";"";"0";"397.37";"1";"6.33";"GNF-Pf-4048";"Cc1ccc(NC2=C(c3ccc(C(F)(F)F)cc3)C(=O)c3ccccc32)cc1F";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL609607";"";"0";"345.79";"0";"2.60";"GNF-Pf-4049";"Cc1c2cnn(CC(=O)O)c(=O)c2c(C)n1Cc1cccc(Cl)c1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL598904";"";"0";"449.64";"1";"7.50";"GNF-Pf-4058";"CCCCCCC(=O)Oc1ccccc1-c1nc2ccccn2c1NC(C)(C)CC(C)(C)C";"IFI";"'='";"4.587";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL602633";"";"0";"321.85";"0";"2.77";"GNF-Pf-4223";"CCCN(CCC)C(=O)Cn1ccc(=N)c2ccccc21.Cl";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL587884";"";"0";"319.24";"None";"None";"GNF-Pf-5539";"c1ccc([B-](c2ccccc2)(c2ccccc2)c2ccccc2)cc1";"IFI";"'='";"1.266";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL580130";"";"0";"369.85";"0";"3.89";"GNF-Pf-5554";"CC(=O)NC(c1ccc(N(C)C)cc1)c1cc(Cl)c2cccnc2c1O";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL579175";"";"0";"534.52";"2";"7.79";"GNF-Pf-1925";"Cc1cc(/C=C2\SC(=Nc3ccccc3)N(C3CCCCC3)C2=O)c(C)n1-c1ccc(Br)cc1";"IFI";"'='";"1.176";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL601796";"";"0";"514.65";"2";"6.37";"GNF-Pf-2001";"COc1cc(NC(C)CCCN(Cc2ccc(N(C)C)cc2)C(=O)c2ccc(F)cc2)c2ncccc2c1";"IFI";"'='";"5.607";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL587779";"";"0";"450.95";"1";"5.82";"GNF-Pf-2019";"COc1cc(/C=C2/SC(=Nc3ccccc3)NC2=O)ccc1OCc1ccccc1Cl";"IFI";"'='";"2.299";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL581821";"";"0";"382.42";"0";"4.18";"GNF-Pf-2025";"CCOC(=O)c1cnc2c(OC)cccc2c1Nc1ccc(OC)c(OC)c1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL601575";"";"0";"353.83";"0";"2.96";"GNF-Pf-2061";"COc1cc(OC)nc(CSc2ccc(NC(=O)CCl)cc2)n1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL582302";"";"0";"373.41";"0";"4.52";"GNF-Pf-3016";"Cc1ccc(OCC(=O)Nc2cccc(-c3nc4ncccc4o3)c2)cc1C";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL580162";"";"0";"298.34";"0";"1.85";"GNF-Pf-3049";"CC(=O)N(C)C1=C(N2CCCC2)C(=O)c2ccccc2C1=O";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL578289";"";"0";"364.40";"0";"4.63";"GNF-Pf-2771";"COc1ccc(C2Nc3ccc(C(C)=O)cc3C3C=CCC32)cc1[N+](=O)[O-]";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600293";"";"0";"245.28";"0";"3.32";"GNF-Pf-2849";"CCCOc1ccc(NC(=O)c2ccco2)cc1";"IFI";"'='";"6.061";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL578665";"";"0";"381.47";"0";"4.71";"GNF-Pf-2901";"FC(F)(F)c1ccccc1CN1CCc2nc(N3CCCCC3)sc2C1";"IFI";"'='";"9.859";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL582693";"";"0";"271.22";"0";"1.85";"GNF-Pf-2904";"CC(=O)NC(=Cc1ccc(OC(F)F)cc1)C(=O)O";"IFI";"";"";"";"";"";"Not applicable";"";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL587004";"";"0";"407.48";"0";"2.81";"GNF-Pf-2926";"CN1CCN(c2nc(NCCNc3ccc([N+](=O)[O-])cc3)c3ccccc3n2)CC1";"IFI";"'='";"19.05";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL582093";"";"0";"534.34";"2";"6.44";"GNF-Pf-2942";"CC12CCC(CN(CC(O)Cn3c4ccc(Br)cc4c4cc(Br)ccc43)C1)C2(C)C";"IFI";"'='";"1.389";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL581039";"";"0";"408.55";"0";"2.92";"GNF-Pf-2953";"Cc1c[nH]c(CCNCc2ccc(OCC(O)CN(C)Cc3ccccc3)cc2)n1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL577020";"";"0";"478.69";"1";"5.08";"GNF-Pf-1504";"CC1CCCCN1CCCNc1ncc(C(=O)NCc2ccccc2)c(NCC2CCCCC2)n1";"IFI";"'='";"0.9709";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585053";"";"0";"594.55";"1";"4.72";"GNF-Pf-1335";"COc1ccccc1N1CCN(c2ccc(NC(=O)c3ccc(Br)cc3)cc2C(=O)NCCCN(C)C)CC1";"IFI";"'='";"3.093";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL597660";"";"0";"332.43";"0";"1.51";"GNF-Pf-651";"Cc1c(NC(=S)N2CCOCC2)c(=O)n(-c2ccccc2)n1C";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL604157";"";"0";"534.08";"2";"5.59";"GNF-Pf-1316";"CCOC(=O)CSc1nc2c(sc(=S)n2-c2ccc(Cl)c(C)c2)c(=O)n1-c1ccccc1OC";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL602359";"";"0";"281.34";"0";"4.70";"GNF-Pf-1317";"c1ccc(N=Nc2nnc(Nc3ccccc3)s2)cc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL583559";"";"0";"307.34";"0";"0.53";"GNF-Pf-1327";"COc1cc(C=NNC(=O)Cc2nnc(N)s2)ccc1O";"IFI";"'='";"7.692";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL584213";"";"0";"442.23";"1";"5.32";"GNF-Pf-1329";"Cc1ccc(-c2nc3cc(NC(=O)c4ccc([N+](=O)[O-])o4)ccc3o2)cc1Br";"IFI";"'='";"18.18";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL602163";"";"0";"234.28";"0";"2.16";"GNF-Pf-1253";"CSc1oc(-c2ccccc2)nc1C(N)=O";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600281";"";"0";"284.45";"0";"4.97";"GNF-Pf-1276";"CC[n+]1c(/C=C2\C=C(C)CC(C)C2)sc2ccccc21";"IFI";"'='";"7.143";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585262";"";"0";"285.73";"0";"2.87";"GNF-Pf-1286";"Cc1cc(C)n(N=Cc2cccc(Cl)c2)c(=O)c1C#N";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600969";"";"0";"408.51";"0";"3.67";"GNF-Pf-1291";"O=[N+]([O-])c1ccc(NN=Cc2cccs2)c(S(=O)(=O)N2CCCCCC2)c1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL580891";"";"0";"281.27";"0";"2.60";"GNF-Pf-1297";"Cc1nc2ccccc2c(=O)n1-c1ccc([N+](=O)[O-])cc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL581742";"";"0";"481.64";"1";"6.65";"GNF-Pf-1298";"CCCCCN(C(=O)c1ccc(C)cc1)C(C)c1nc2ccccc2c(=O)n1-c1ccccc1CC";"IFI";"'='";"3.704";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585212";"";"0";"313.43";"0";"2.83";"GNF-Pf-1300";"Cn1c(C(C#N)C(=S)NC2CCCCC2)nc2cccnc21";"IFI";"'='";"7.143";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL584825";"";"0";"373.79";"0";"3.86";"GNF-Pf-1305";"COc1ccc(OC)c(C(=O)c2oc3ccccc3c2NC(=O)CCl)c1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL527237";"";"0";"351.45";"0";"2.55";"GNF-Pf-608";"CCNC(=O)NS(=O)(=O)c1cnccc1Sc1cccc(C)c1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL581688";"";"0";"405.28";"0";"4.36";"GNF-Pf-610";"COC(=O)C1=C(C)N/C(=C/c2cc(C)n(-c3ccc(Cl)c(Cl)c3)c2C)C1=O";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600549";"";"0";"586.75";"2";"5.63";"GNF-Pf-512";"COc1ccc(CCNC(=O)c2cc(S(=O)(=O)N3CC(C)CC(C)C3)ccc2Sc2ccc(F)cc2)cc1OC";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL582529";"";"0";"441.60";"0";"3.18";"GNF-Pf-513";"O=C(NC(CN1CCCC1)c1ccccc1)C1CCCCN1S(=O)(=O)c1ccccc1";"IFI";"'='";"2.913";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL580848";"";"0";"311.47";"0";"4.74";"GNF-Pf-518";"CCCCN1C=CC=C/C1=C\c1sc2ccccc2[n+]1CC";"IFI";"'='";"18.18";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL582118";"";"0";"425.50";"1";"5.20";"GNF-Pf-525";"CCOc1ccccc1C=NNc1nc(Nc2ccccc2)nc(Nc2ccccc2)n1";"IFI";"'='";"3.896";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL579557";"";"0";"342.42";"0";"2.61";"GNF-Pf-530";"Cc1ccccc1N1C(=O)N(c2ccccc2)C2CS(=O)(=O)CC21";"IFI";"'='";"4.762";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL602201";"";"0";"318.79";"0";"3.65";"GNF-Pf-531";"COc1ccc(Cl)cc1-n1c(-c2cccnc2)n[nH]c1=S";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL599891";"";"0";"277.33";"0";"3.46";"GNF-Pf-534";"Oc1ccc(-c2cncc(NCc3ccccc3)n2)cc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL581481";"";"0";"328.39";"0";"3.16";"GNF-Pf-548";"C=CCOC(=O)C1=C(C)N2CCSC2=C(C#N)C1c1ccco1";"IFI";"'='";"1.064";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL581892";"";"0";"492.42";"0";"3.33";"GNF-Pf-3345";"COc1cccc(CNC(=O)C2CNCC2c2ccc(C(F)(F)F)cc2)c1.O=C(O)C(F)(F)F";"IFI";"'='";"1.389";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL581854";"";"0";"427.50";"1";"5.47";"GNF-Pf-3359";"O=C(Nc1ccc(Oc2cccnc2)cc1)C1CCN(Cc2cc3ccccc3o2)CC1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL601161";"";"0";"389.57";"1";"6.12";"GNF-Pf-3362";"CCN1/C(=C/c2ccc3cc(C)ccc3[n+]2C)Sc2ccc3ccsc3c21";"IFI";"";"";"";"";"";"Not applicable";"";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL602821";"";"0";"310.38";"0";"4.22";"GNF-Pf-4645";"COc1ccc(/C=C2\SC(=O)NC2=Nc2ccccc2)cc1";"IFI";"";"";"";"";"";"Not applicable";"";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL584438";"";"0";"483.03";"1";"6.29";"GNF-Pf-4658";"COc1cc(Cl)c(C)cc1NC(=O)C1c2ccccc2C(=O)N(CC(C)C)C1c1cccs1";"IFI";"'='";"9.091";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL527800";"";"0";"558.63";"2";"6.70";"GNF-Pf-4667";"COC(=O)c1ccc(C2C3=C(CC(c4ccc(OC)cc4)CC3=O)Nc3ccccc3N2C(=O)c2ccccc2)cc1";"IFI";"'='";"3.659";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600961";"";"0";"304.40";"0";"4.06";"GNF-Pf-4669";"CCCCNc1c2c(c(C#N)c3nc4ccccc4n13)CCC2";"IFI";"'='";"3.125";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL604980";"";"0";"400.48";"0";"3.51";"GNF-Pf-4688";"Oc1c(CN2CCN(Cc3ccc4cccnc4c3O)CC2)ccc2cccnc12";"IFI";"'='";"12.8";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL583119";"";"0";"486.57";"1";"6.76";"GNF-Pf-4690";"CC(C)(C)CC(C)(C)Nc1c(-c2ccccc2OC(=O)c2ccc([N+](=O)[O-])cc2)nc2ccccn12";"IFI";"'='";"2.885";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL527131";"";"0";"382.87";"0";"2.65";"GNF-Pf-4692";"O=C(NCc1ccco1)C1CCN(S(=O)(=O)c2ccc(Cl)cc2)CC1";"IFI";"'='";"0.885";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600693";"";"0";"575.64";"2";"7.01";"GNF-Pf-4713";"O=C1C2C(C(=O)N1c1ccccc1F)C1(c3ccccc3)C(=O)C2(c2ccccc2)C(c2ccccc2)=C1c1ccccc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585994";"";"0";"347.33";"0";"4.18";"GNF-Pf-4714";"O=[N+]([O-])c1cccc(-c2ccc(C=NNc3nc4ccccc4[nH]3)o2)c1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL602426";"";"0";"365.39";"0";"2.26";"GNF-Pf-4737";"CCOC(=O)C(Cc1ccc(O)cc1)NC1=CC(=O)C(=O)c2ccccc21";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL602429";"";"0";"282.25";"0";"2.32";"GNF-Pf-4753";"O=C1C(=O)N(Cc2ccccc2[N+](=O)[O-])c2ccccc21";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL581537";"";"0";"381.48";"0";"3.75";"GNF-Pf-4765";"CCOC(=O)c1c(CC)nc(-c2ccccc2)nc1C(=O)N1CCC(C)CC1";"IFI";"'='";"2.247";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL603042";"";"0";"422.44";"0";"3.62";"GNF-Pf-4767";"COc1ccc(OC)c(C2CC(=O)C3=C(C2)NC(=O)CC3c2ccc([N+](=O)[O-])cc2)c1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL601750";"";"0";"692.72";"2";"6.81";"GNF-Pf-4771";"COc1ccc(C2=C(c3ccc(OC)cc3)C3(c4ccccc4)C(=O)C2(c2ccccc2)C2C(=O)N(c4ccc(OC)cc4[N+](=O)[O-])C(=O)C23)cc1";"IFI";"'='";"0.7299";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585978";"";"0";"379.80";"0";"4.56";"GNF-Pf-4780";"O=C(COc1ccc(Cl)cc1)Nc1cccc(-c2nc3ncccc3o2)c1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL583555";"";"0";"287.37";"0";"4.44";"GNF-Pf-4791";"Cc1ccc2cc3c(N)c4c(C)ccc(C)c4nc3nc2c1";"IFI";"'='";"7.207";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL584214";"";"0";"479.41";"1";"5.06";"GNF-Pf-4793";"O=S(=O)(NCCNc1ncnc2scc(-c3ccccc3)c12)c1ccc(Cl)c(Cl)c1";"IFI";"'='";"1.667";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585246";"";"0";"298.39";"0";"3.45";"GNF-Pf-4807";"COc1ccc(-c2nc(CN3CCCCC3)ccc2O)cc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585247";"";"0";"365.30";"0";"4.85";"GNF-Pf-4808";"CC(C)(C)NCC(O)Cn1c2ccc(Cl)cc2c2cc(Cl)ccc21";"IFI";"'='";"2.4";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585453";"";"0";"412.58";"0";"3.75";"GNF-Pf-4826";"CCCCC(CC)C(=O)N1CCN(C(CC)c2nc3ccccc3c(=O)n2C)CC1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585458";"";"0";"525.00";"2";"5.74";"GNF-Pf-4833";"CCOC(=O)c1ccc(OCC2c3cc(OC)c(OC)cc3CCN2C(=O)Nc2ccc(Cl)cc2)cc1";"IFI";"'='";"4.839";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585459";"";"0";"313.40";"1";"5.37";"GNF-Pf-4834";"Oc1ccc(C2Nc3ccc4ccccc4c3C3C=CCC32)cc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL530308";"";"0";"546.60";"2";"7.48";"GNF-Pf-4836";"COC(=O)c1ccc(C2C3=C(O)CC(c4ccc(F)cc4)CC3=Nc3ccccc3N2C(=O)c2ccccc2)cc1";"IFI";"'='";"4.762";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600769";"";"0";"402.49";"0";"3.74";"GNF-Pf-4837";"COc1ccc2c(c1)C=C([C@@H]1C[C@H]3CN(c4ccccc4)C(=O)[C@]34CCCN14)CO2";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585219";"";"0";"540.45";"2";"5.78";"GNF-Pf-4851";"COc1ccc(C2CC(=O)C3=C(C2)NC(C)=C(C(=O)OC(C)C)C3c2cccc(Br)c2)cc1OC";"IFI";"'='";"3.529";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585411";"";"0";"540.52";"2";"3.05";"GNF-Pf-4852";"COc1cc2c(OC3OCC(OC)C(OC)C3O)c3c(c(-c4ccc5c(c4)OCO5)c2cc1OC)C(=O)OC3";"IFI";"'='";"27.69";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL599950";"";"0";"355.44";"1";"5.49";"GNF-Pf-4855";"COc1ccc(C2=C(Nc3ccc(C)c(C)c3)c3ccccc3C2=O)cc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585421";"";"0";"495.59";"0";"4.06";"GNF-Pf-4858";"O=C(Nc1ccc(C(=O)Nc2ccc(C3=NCCCN3)cc2)cc1)Nc1ccc(C2=NCCCN2)cc1";"IFI";"'='";"3.509";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585436";"";"0";"511.29";"2";"5.99";"GNF-Pf-4869";"COc1ccc(-c2cc(C(F)(F)F)n3ncc(C(=O)Nc4cccc(Cl)c4Cl)c3n2)cc1OC";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL601753";"";"0";"607.20";"2";"9.47";"GNF-Pf-4885";"CCC(c1nc2ccccc2c(=O)n1-c1ccc(Cl)cc1)N(Cc1ccccc1)C(=O)Nc1c(C(C)C)cccc1C(C)C";"IFI";"'='";"0.9174";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL586011";"";"0";"340.22";"0";"3.67";"GNF-Pf-4889";"CC(=O)C(=NNc1cc(C(F)(F)F)cc(C(F)(F)F)c1)C(C)=O";"IFI";"'='";"1.449";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL602835";"";"0";"413.52";"0";"2.57";"GNF-Pf-4895";"CCN(CC)C(=O)c1cn(C2CCN(C(=O)CCc3cccc(OC)c3)CC2)nn1";"IFI";"'='";"0.8772";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL601320";"";"0";"240.35";"0";"3.67";"GNF-Pf-4279";"CC(C)N1CC=C(c2c[nH]c3ccccc23)CC1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL606166";"";"0";"331.40";"1";"5.53";"GNF-Pf-4283";"OC1=C2C(=Nc3ccccc3SC2c2ccco2)c2ccccc21";"IFI";"'='";"1.504";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL604778";"";"0";"447.33";"0";"3.59";"GNF-Pf-4290";"COc1ccc(Br)cc1CNC(=O)CCCN1C(=O)COc2ccc(C)cc21";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL603045";"";"0";"458.56";"0";"3.87";"GNF-Pf-4304";"COC(=O)[C@@H]1C[C@@H](NC(=O)c2ccc(OC)cc2)CN1CC(c1ccccc1)c1ccccc1";"IFI";"'='";"1.653";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585659";"";"0";"450.58";"1";"5.41";"GNF-Pf-4305";"CCC(CC)CN1CCC(O)(c2ccc3oc(C(=O)Nc4ccc(OC)cc4)cc3c2)CC1";"IFI";"'='";"1.695";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585706";"";"0";"341.41";"1";"5.18";"GNF-Pf-4312";"Cc1ccc(-n2c(C)c(C(=O)c3ccccc3)c3cc(O)ccc32)cc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL527980";"";"0";"602.86";"2";"9.04";"GNF-Pf-4314";"CCNC(=O)N(CCCCOc1ccc(C(C)(C)CC)cc1C(C)(C)CC)Cc1ccc(OC)c(OCc2ccccc2)c1";"IFI";"'='";"0.9434";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL610788";"";"0";"282.17";"0";"4.42";"GNF-Pf-4316";"Cc1nc2c(C)cccc2c(O)c1CC=C(Cl)Cl";"IFI";"'='";"7.143";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL598263";"";"0";"265.31";"0";"0.50";"GNF-Pf-4325";"COc1ccc(CC2NCC(O)C2OC(C)=O)cc1";"IFI";"";"";"";"";"";"Not applicable";"";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL528212";"";"0";"324.83";"0";"3.69";"GNF-Pf-4327";"CC(=C(Cl)Cl)/C(Br)=C(\Br)CO";"IFI";"'='";"5.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL596842";"";"0";"476.02";"1";"7.50";"GNF-Pf-4335";"CC(C)(C)CC(C)(C)Nc1c(-c2ccccc2OC(=O)c2ccccc2Cl)nc2ccccn12";"IFI";"'='";"4.717";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL598488";"";"0";"629.53";"1";"4.15";"GNF-Pf-4350";"C=CCOc1c(Br)cc(C=c2sc3n(c2=O)C(c2ccc(OC)c(OC)c2)C(C(=O)OCC)=C(C)N=3)cc1OC";"IFI";"'='";"1.46";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL596856";"";"0";"341.42";"0";"4.76";"GNF-Pf-4363";"Cc1ccc2c(C)nc(Nc3nc(C)cc(-c4ccccc4)n3)nc2c1";"IFI";"'='";"15.38";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585653";"";"0";"517.50";"2";"7.05";"GNF-Pf-4373";"CCN(CC)CCCC(C)Nc1nc(C=Cc2cc(OC)c(OC)cc2Cl)nc2cc(Cl)ccc12";"IFI";"";"";"";"";"";"Not applicable";"";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL582784";"";"0";"448.56";"0";"4.58";"GNF-Pf-4383";"CCOc1ccc(NC(=O)c2ccc(F)c(S(=O)(=O)NC3CCCC(C)C3C)c2)cc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL583219";"";"0";"267.38";"0";"3.34";"GNF-Pf-4385";"CN(C)c1ccc(C2N(C)c3ccccc3N2C)cc1";"IFI";"'='";"5.732";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL596640";"";"0";"348.79";"0";"5.00";"GNF-Pf-4485";"O=C(Nc1c2ccccc2nc2ccccc12)c1cc(Cl)ccc1O";"IFI";"'='";"3.03";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL598264";"";"0";"515.65";"2";"7.17";"GNF-Pf-4397";"COc1cc(OC)cc(C(=O)Oc2ccccc2-c2nc3cc(C)ccn3c2NC(C)(C)CC(C)(C)C)c1";"IFI";"'='";"2.804";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL526418";"";"0";"413.50";"0";"3.83";"GNF-Pf-4401";"Cc1cc(NC(=O)c2ccc(S(=O)(=O)N(Cc3ccccc3)C(C)C)cc2)no1";"IFI";"'='";"2.778";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL597044";"";"0";"510.44";"1";"6.26";"GNF-Pf-4406";"CCN1C(=Cc2ccc3ccccc3[n+]2CC)C=Cc2sc3ccccc3c21.[I-]";"IFI";"";"";"";"";"";"Not applicable";"";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL597060";"";"0";"366.85";"0";"4.53";"GNF-Pf-4507";"O=C1C(Nc2ccc(Cl)cc2)=C(N2CCCCC2)C(=O)c2ccccc21";"IFI";"'='";"5.333";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL537336";"";"0";"379.33";"1";"5.10";"GNF-Pf-4508";"CC(C)CCNCC(O)Cn1c2ccc(Cl)cc2c2cc(Cl)ccc21";"IFI";"'='";"5.882";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL599298";"";"0";"416.61";"0";"3.89";"GNF-Pf-4416";"CC(C)CNC(=O)c1cnc(NCCCN2CCCCC2C)nc1NC1CCCC1";"IFI";"'='";"1.905";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL604321";"";"0";"366.39";"0";"3.47";"GNF-Pf-4418";"CCCNC1=C(N(C(C)=O)c2cccc(F)c2)C(=O)c2ccccc2C1=O";"IFI";"'='";"21.43";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL611077";"";"0";"399.93";"0";"2.31";"GNF-Pf-4422";"O=S(=O)(c1ccc(Cl)cc1)N1CCN(C(=S)NCc2ccco2)CC1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585588";"";"0";"279.36";"0";"3.03";"GNF-Pf-4423";"COc1ccc2c(ccc(/C=C3\C=CC=CN3C)[n+]2C)c1";"IFI";"";"";"";"";"";"Not applicable";"";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL598071";"";"0";"353.43";"0";"4.25";"GNF-Pf-4427";"N#Cc1c2c(c(NCc3ccccn3)n3c1nc1ccccc13)CCCC2";"IFI";"'='";"4.762";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL494669";"";"0";"319.45";"0";"4.59";"GNF-Pf-4431";"Cc1cc(NCCN2CCCCC2)c2ccc3ccccc3c2n1";"IFI";"'='";"7.018";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL597469";"";"0";"317.27";"0";"4.08";"GNF-Pf-4432";"O=C1C=C(Nc2cccc(C(F)(F)F)c2)C(=O)c2ccccc21";"IFI";"'='";"7.042";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL597058";"";"0";"327.77";"0";"1.92";"GNF-Pf-4437";"O=[N+]([O-])c1cc(Cl)c(N2CCOCC2)cc1N1CCOCC1";"IFI";"'='";"1.439";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL602027";"";"0";"522.04";"2";"6.20";"GNF-Pf-4536";"COc1ccc(C2CC(=O)C3=C(C2)NC(C)=C(C(=O)OC2CCCC2)C3c2cccc(Cl)c2)cc1OC";"IFI";"'='";"8.235";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585621";"";"0";"441.39";"0";"3.70";"GNF-Pf-4538";"CCC1CCCCN1S(=O)(=O)c1cc(Br)cc2c1N(C(=O)C1CC1)CC2";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL601612";"";"0";"445.52";"0";"3.51";"GNF-Pf-4442";"CCOC(=O)C1CCN(C(=O)CN2C(=O)c3ccccc3C2c2c[nH]c3ccccc23)CC1";"IFI";"'='";"6.667";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585812";"";"0";"447.04";"1";"5.76";"GNF-Pf-4541";"O=C(NCc1cccs1)c1ccc(OC2CCN(CC3CCCCC3)CC2)c(Cl)c1";"IFI";"'='";"4.167";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600164";"";"0";"486.62";"0";"4.30";"GNF-Pf-4544";"COc1ccc(OC)c(-c2ccc(C(=O)N3CCN(CC=Cc4ccccc4)CC3)c(N(C)C)n2)c1";"IFI";"";"";"";"";"";"Not applicable";"";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585118";"";"0";"324.40";"0";"1.89";"GNF-Pf-4457";"Cc1cc2c(cc1S(=O)(=O)N1CCCCC1C)OCC(=O)N2";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL603759";"";"0";"361.51";"1";"5.17";"GNF-Pf-4459";"CCN(CC)c1ccc(/C=C/c2ccc3ccc(OC)cc3[n+]2CC)cc1";"IFI";"";"";"";"";"";"Not applicable";"";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600692";"";"0";"422.35";"0";"4.26";"GNF-Pf-4464";"CC(C)CC[n+]1ccccc1C=Cc1ccc(N(C)C)cc1.[I-]";"IFI";"";"";"";"";"";"Not applicable";"";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL610248";"";"0";"413.86";"0";"3.19";"GNF-Pf-4564";"COc1ccc(-c2c[n+](CC(=O)c3ccc([N+](=O)[O-])cc3)c3n2CCC3)cc1.[Cl-]";"IFI";"'='";"2.5";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600966";"";"0";"309.37";"0";"3.18";"GNF-Pf-4066";"COc1ccc2c(c1)CC1c3c(cc4c(c3-2)OCO4)CCN1C";"IFI";"'='";"25.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL584676";"";"0";"274.39";"0";"3.85";"GNF-Pf-4077";"CCN(CC)c1ccc(NC(=O)c2cccs2)cc1";"IFI";"'='";"7.092";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL584511";"";"0";"246.35";"0";"3.29";"GNF-Pf-4088";"CN(C)c1ccc(NC=CC(=O)C(C)(C)C)cc1";"IFI";"";"";"";"";"";"Not applicable";"";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL605751";"";"0";"453.55";"1";"8.40";"GNF-Pf-4095";"c1ccc(Cn2c(N=Nc3c(Nc4ccccc4)ccc4ccccc34)nc3ccccc32)cc1";"IFI";"'='";"15.08";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL604109";"";"0";"392.41";"0";"3.81";"GNF-Pf-4107";"Cc1cccc(C(=O)NCc2nnc(S)n2-c2cccc(C(F)(F)F)c2)c1";"IFI";"'='";"1.176";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL604531";"";"0";"429.38";"0";"3.56";"GNF-Pf-4126";"CCCN(CCC)S(=O)(=O)c1cc(Br)cc2c1N(C(=O)C1CC1)CC2";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585472";"";"0";"351.27";"0";"4.96";"GNF-Pf-4233";"Brc1ccc(/C=C/c2cc[n+](Cc3ccccc3)cc2)cc1";"IFI";"'='";"10.61";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585302";"";"0";"436.58";"0";"4.60";"GNF-Pf-4235";"CC(=O)c1cc(CN2CCC(C(=O)Nc3ccc(-n4nc(C)cc4C)cc3)CC2)cs1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL598474";"";"0";"346.40";"0";"3.99";"GNF-Pf-4246";"CCOc1ccc(CCNC(=O)Nc2ccc(F)cc2)cc1OCC";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL598676";"";"0";"436.51";"0";"4.35";"GNF-Pf-4247";"CC(C)CN1CCC(O)(c2ccc3oc(C(=O)Nc4ccc5c(c4)OCO5)cc3c2)CC1";"IFI";"'='";"0.8475";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL596635";"";"0";"433.26";"0";"2.54";"GNF-Pf-4183";"CCOC(=O)c1c(CNC)n(C)c2cc(Br)c(O)cc12.O=CO.O=CO";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL597451";"";"0";"297.31";"0";"2.37";"GNF-Pf-4255";"COc1ccc(C=CC(=O)NC(=O)c2ccccc2O)cc1";"IFI";"";"";"";"";"";"Not applicable";"";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL598067";"";"0";"441.33";"0";"3.64";"GNF-Pf-4197";"O=C(NC(=CC=Cc1ccccc1)C(=O)N1CCOCC1)c1ccc(Br)cc1";"IFI";"";"";"";"";"";"Not applicable";"";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL599082";"";"0";"431.54";"0";"3.91";"GNF-Pf-4468";"COc1ccc(C2c3[nH]c4ccccc4c3C[C@H]3C(=O)N(CCC(C)C)CC(=O)N23)cc1";"IFI";"";"";"";"";"";"Not applicable";"";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585792";"";"0";"480.61";"1";"5.42";"GNF-Pf-4573";"CCC(CC)CN1CCC(O)(c2ccc3oc(C(=O)Nc4ccc(OC)c(OC)c4)cc3c2)CC1";"IFI";"'='";"3.448";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL584028";"";"0";"370.33";"0";"4.38";"GNF-Pf-4610";"C=CC[N+]1(CC#Cc2cccc3ccccc23)CCCCC1.[Br-]";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL578688";"";"0";"346.50";"1";"5.27";"GNF-Pf-2465";"Cc1ccccc1NC(=S)NC(Cc1ccccc1)c1ccccc1";"IFI";"'='";"6.818";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL577180";"";"0";"257.34";"0";"2.45";"GNF-Pf-2472";"CC(C)C1=Nc2cc(C(N)=O)ccc2CN1C1CC1";"IFI";"'='";"4.938";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL1615738";"";"0";"309.18";"0";"2.43";"GNF-Pf-2473";"O=C(C[n+]1ccccc1)NN=Cc1ccc(Cl)c(Cl)c1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL578083";"";"0";"483.52";"1";"6.66";"GNF-Pf-2498";"CC(C)(C)c1ccc(C(=O)Nc2ccc(NC(=O)c3ccc(-c4ccc([N+](=O)[O-])cc4)o3)cc2)cc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL531198";"";"0";"275.17";"0";"3.44";"GNF-Pf-2517";"C[n+]1ccccc1/C=C/c1ccc(Br)cc1";"IFI";"'='";"4.255";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL579083";"";"0";"461.01";"1";"5.56";"GNF-Pf-2523";"C=CC1(C)CC23CC(C(OC(=O)c4ccccc4)c4ccnc5ccccc45)N2CCC13.Cl";"IFI";"'='";"3.636";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL578251";"";"0";"532.13";"1";"4.29";"GNF-Pf-2526";"O=C(NCc1cccnc1)[C@@H]1C[C@H](NC2CCN(CCc3ccccc3)CC2)CN1Cc1ccc(Cl)cc1";"IFI";"'='";"2.885";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL577834";"";"0";"395.48";"0";"3.70";"GNF-Pf-2541";"COCCN1C(=O)c2[nH]nc(-c3ccccc3O)c2C1c1ccc(SC)cc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL601126";"";"0";"311.17";"0";"3.71";"GNF-Pf-2577";"Cc1ccc(NC(=O)COc2ccc(Cl)cc2Cl)nc1";"IFI";"'='";"8.333";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL601118";"";"0";"1882.33";"None";"None";"GNF-Pf-2578";"CC(C)C[C@@H](NC(=O)[C@H](C)NC(=O)CNC(=O)[C@@H](NC=O)C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C(=O)N[C@H](C(=O)N[C@@H](C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)NCCO)C(C)C)C(C)C)C(C)C";"IFI";"'='";"27.64";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600320";"";"0";"406.92";"1";"5.38";"GNF-Pf-2586";"CCOc1ccc(Nc2nc(NCc3ccccc3)c3ccccc3n2)cc1.Cl";"IFI";"'='";"7.143";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL577211";"";"0";"476.57";"0";"4.02";"GNF-Pf-2113";"CCC(C)NC(=O)C1CSC(c2cccc(F)c2)N1C(=O)c1cc(OC)c(OC)c(OC)c1";"IFI";"'='";"1.923";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL529844";"";"0";"430.81";"1";"5.47";"GNF-Pf-2120";"O=C(Cn1c2ccccc2c(=O)c2ccc(Cl)cc21)Nc1ccc(C(F)(F)F)cc1";"IFI";"'='";"3.571";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL579103";"";"0";"396.40";"0";"2.61";"GNF-Pf-2134";"COC(=O)c1ccccc1NC(=O)CN(C)c1nc(-c2ccc(OC)cc2)no1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL579095";"";"0";"384.47";"0";"4.39";"GNF-Pf-2141";"O=C(C1CCN(C(c2ccc(F)cc2)c2ccc(F)cc2)CC1)N1CCCC1";"IFI";"'='";"1.961";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL579096";"";"0";"319.50";"0";"3.75";"GNF-Pf-2142";"c1csc(CN2CCc3nc(N4CCCCC4)sc3C2)c1";"IFI";"'='";"6.944";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL578261";"";"0";"432.52";"0";"4.08";"GNF-Pf-2146";"Cc1ccccc1C(=O)N1CCC(n2nccc2NC(=O)CCOc2ccccc2)CC1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL602773";"";"0";"294.33";"0";"3.26";"GNF-Pf-2155";"Cc1nc2c(C#N)c(C)nn2c(C)c1Cc1cccc(F)c1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL578481";"IMILOXAN HYDROCHLORIDE";"0";"280.75";"0";"2.29";"GNF-Pf-2156";"CCn1ccnc1CC1COc2ccccc2O1.Cl";"IFI";"'='";"1.176";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL577837";"";"0";"311.38";"0";"3.21";"GNF-Pf-2162";"Cn1cnc2cc(OC3CCN(Cc4ccco4)CC3)ccc21";"IFI";"'='";"2.778";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL602396";"";"0";"450.58";"0";"3.45";"GNF-Pf-2165";"CCCCN1Cc2ccc(C(=O)NCCN3CCOCC3)cc2N=C1c1ccc(OC)cc1";"IFI";"'='";"1.22";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL578491";"";"0";"357.37";"1";"5.03";"GNF-Pf-2168";"O=[N+]([O-])c1ccc2nc(Nc3ccccc3)c(Nc3ccccc3)nc2c1";"IFI";"'='";"14.29";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585768";"";"0";"617.57";"2";"5.76";"GNF-Pf-2181";"CC(c1nc2ccccc2c(=O)n1-c1ccc(Br)cc1)N1CCN(S(=O)(=O)c2ccc3ccccc3c2)C(C)C1";"IFI";"'='";"1.869";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL588032";"";"0";"173.17";"0";"1.66";"GNF-Pf-1514";"N#Cc1cccc(/C=C/C(=O)O)c1";"IFI";"'='";"0.9524";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL537778";"";"0";"470.17";"1";"6.64";"GNF-Pf-2233";"Brc1ccc(Nc2nc3ccccc3nc2Nc2ccc(Br)cc2)cc1";"IFI";"'='";"14.18";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL586200";"";"0";"397.90";"1";"5.06";"GNF-Pf-1519";"COc1ccc(OC)c(-c2ccc(O)c(CNCCc3ccc(Cl)cc3)c2)c1";"IFI";"'='";"4.31";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL588288";"";"0";"330.43";"0";"4.07";"GNF-Pf-1525";"CCN(CC)CCCC(C)Nc1ccnc2ccc([N+](=O)[O-])cc12";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL588655";"";"0";"410.45";"0";"4.69";"GNF-Pf-1526";"COc1ccc(Nc2nc(-c3cc4cc(OC)ccc4oc3=O)cs2)c(OC)c1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL530801";"";"0";"214.27";"0";"2.15";"GNF-Pf-1573";"NC(=O)c1ccc2[nH]c3c(c2c1)CCCC3";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL601121";"";"0";"589.83";"1";"3.69";"GNF-Pf-1580";"CCCN1CCC(N2C[C@@H](NC3CCN(CCc4ccccc4)CC3)C[C@H]2C(=O)NCCc2ccc3c(c2)OCO3)CC1";"IFI";"'='";"1.98";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL602999";"";"0";"271.16";"0";"3.68";"GNF-Pf-1581";"CC(=O)Nc1cc(C(F)(F)F)cc(C(F)(F)F)c1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL601139";"";"0";"497.59";"0";"3.29";"GNF-Pf-1588";"CCCCNC(=O)C(c1cccc(OC)c1)N1C(=O)c2cc(OCCCC)ccc2NC(=O)C1CO";"IFI";"'='";"0.9804";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL587788";"";"0";"430.49";"0";"4.81";"GNF-Pf-1603";"COc1cc(/C=C2/SC(=Nc3ccccc3)NC2=O)ccc1OC(=O)c1ccccc1";"IFI";"'='";"1.136";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL195575";"";"0";"361.53";"1";"5.88";"GNF-Pf-1613";"CCCC[n+]1c(C=C2C=Cc3ccccc3N2CC)sc2ccccc21";"IFI";"'='";"11.11";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL579721";"";"0";"490.40";"0";"4.47";"GNF-Pf-1617";"CCN(CC(=O)N1CCc2cc(OC)c(OC)cc2C1C)C(=O)Nc1ccc(Br)cc1";"IFI";"'='";"2.83";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600312";"";"0";"399.88";"1";"5.05";"GNF-Pf-1626";"Cc1c(Cl)cccc1N1C(=O)C2C3c4ccccc4C(c4ccccc43)C2C1=O";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL578701";"";"0";"381.50";"1";"6.03";"GNF-Pf-2325";"CC[n+]1c(C=CN(C)c2ccccc2)oc(-c2ccccc2)c1-c1ccccc1";"IFI";"";"";"";"";"";"Not applicable";"";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL577222";"";"0";"549.68";"1";"1.94";"GNF-Pf-1631";"CCOC(=O)N1CCN(S(=O)(=O)c2ccc(C(=O)Nc3sc4c(c3C(N)=O)CCN(CC)C4)cc2)CC1";"IFI";"'='";"1.205";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL579045";"";"0";"447.54";"0";"3.56";"GNF-Pf-2347";"O=C(CN1CCCC1)Nc1ccc(-c2nc3cc(NC(=O)CN4CCCC4)ccc3o2)cc1";"IFI";"'='";"5.405";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600298";"";"0";"481.40";"0";"4.18";"GNF-Pf-2374";"CCCCN1C(=Cc2cccc[n+]2C)Sc2cc(NC(C)=O)ccc21.[I-]";"IFI";"";"";"";"";"";"Not applicable";"";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL576773";"";"0";"439.97";"1";"5.16";"GNF-Pf-2388";"CN(CCCNc1ccnc2cc(Cl)ccc12)S(=O)(=O)c1ccc2ccccc2c1";"IFI";"'='";"10.19";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL578302";"";"0";"301.43";"0";"2.55";"GNF-Pf-2405";"CC1CCCN(C(=O)C2CCN(Cc3ccccn3)CC2)C1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL604319";"";"0";"517.67";"2";"7.79";"GNF-Pf-4103";"COc1cc(CN(CC[C@H](c2ccccc2)c2c(O)ccc3ccccc23)Cc2ccccc2)cc(OC)c1";"IFI";"'='";"3.636";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL532879";"";"0";"281.28";"0";"2.92";"GNF-Pf-4119";"O=[N+]([O-])c1ccc(C=NNc2nc3ccccc3[nH]2)cc1";"IFI";"'='";"1.471";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585267";"";"0";"394.49";"0";"4.49";"GNF-Pf-4138";"CCOC(=O)c1c(C)[n+](-c2ccc(C)cc2)c(CC)c2cc(OC)c(OC)cc12";"IFI";"'='";"2.29";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585268";"";"0";"510.47";"2";"8.15";"GNF-Pf-4139";"CC(C)(C)CC(C)(C)Nc1c(-c2ccccc2OC(=O)c2ccc(Cl)c(Cl)c2)nc2ccccn12";"IFI";"'='";"4.717";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585277";"";"0";"336.39";"0";"3.80";"GNF-Pf-4152";"COc1cccc(NC(=O)Cn2c(C)c(C(C)=O)c3ccccc32)c1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL597849";"";"0";"435.98";"1";"6.26";"GNF-Pf-4164";"Cc1cc(C)cc(-n2c(C)cc(/C=C3\SC(=Nc4ccc(Cl)cc4)NC3=O)c2C)c1";"IFI";"";"";"";"";"";"Not applicable";"";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL584089";"";"0";"474.46";"0";"4.86";"GNF-Pf-4165";"COc1ccc(Nc2nc(NN=Cc3cccc(F)c3)nc(Nc3ccc([N+](=O)[O-])cc3)n2)cc1";"IFI";"'='";"3.947";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL604514";"";"0";"344.47";"0";"4.59";"GNF-Pf-4167";"CC(=O)Nc1nc(C)c(-c2csc(Nc3ccc(C)cc3)n2)s1";"IFI";"'='";"3.333";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL596636";"";"0";"433.39";"1";"1.88";"GNF-Pf-4185";"Cc1ccc(C=NNC(=O)c2nnn(-c3nonc3N)c2-c2ccc([N+](=O)[O-])cc2)cc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL599093";"";"0";"440.53";"1";"5.25";"GNF-Pf-4187";"CC(=O)Nc1ccc(C2NC(=O)NC3=Nc4ccccc4SC(c4ccccc4)=C32)cc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL598069";"";"0";"373.50";"0";"4.21";"GNF-Pf-4199";"Oc1ccc(-c2ccccn2)cc1CNC1CCN(Cc2ccccc2)CC1";"IFI";"'='";"0.8547";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600328";"";"0";"420.52";"0";"1.98";"GNF-Pf-5558";"O=[N+]([O-])c1ccc(S(=O)(=O)N2CCN(C(=S)NCc3ccccc3)CC2)cc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL602030";"";"0";"362.39";"0";"4.07";"GNF-Pf-1051";"Cc1cccc(NC(=O)Nc2cccnc2)c1NC(=O)Nc1cccnc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585801";"";"0";"260.26";"0";"-0.22";"GNF-Pf-1055";"CC(=O)Nc1ccccc1-c1nnn(CC(N)=O)n1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585805";"";"0";"268.36";"1";"5.97";"GNF-Pf-1056";"Cc1c2ccccc2c(-c2ccccc2)c2ccccc12";"IFI";"'='";"3.008";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL583151";"";"0";"447.59";"0";"4.10";"GNF-Pf-1061";"O=C(NCc1ccccc1)c1cnc(NCCCn2ccnc2)nc1NCC1CCCCC1";"IFI";"'='";"2.913";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL580008";"";"0";"411.81";"0";"3.57";"GNF-Pf-1071";"COc1cc(C=NNc2nc3nonc3nc2Nc2ccc(Cl)cc2)ccc1O";"IFI";"'='";"7.692";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL602436";"";"0";"354.36";"0";"3.09";"GNF-Pf-1079";"CC(=O)Oc1ccc(C(=O)C(C(C)=O)c2ccccc2)c(OC(C)=O)c1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585414";"";"0";"375.47";"1";"5.23";"GNF-Pf-1082";"CC(C)(C)c1ccc(Oc2ccc(N3C(=O)C4CC=CCC4C3=O)cc2)cc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585423";"";"0";"578.78";"1";"3.65";"GNF-Pf-1091";"CS(=O)(=O)N(CCc1ccccc1)CC(O)CN1CCC(CNC(=O)NC(c2ccccc2)c2ccccc2)CC1";"IFI";"'='";"2.913";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL584858";"";"0";"464.01";"1";"7.15";"GNF-Pf-1121";"O=C(COC(=O)c1c2c(nc3ccccc13)CCCCCCCCCC2)c1ccc(Cl)cc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585066";"";"0";"551.59";"2";"7.88";"GNF-Pf-1126";"Cc1c(Cl)cccc1NC(=S)N(CCCN(C)c1ccccc1)Cc1cccn1Cc1ccc(Cl)cc1";"IFI";"'='";"6.452";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585604";"";"0";"441.55";"0";"2.13";"GNF-Pf-1158";"COc1ccc(CNC(=O)C(Cc2c[nH]c3ccccc23)N2CCS(=O)(=O)CC2)cc1";"IFI";"'='";"1.282";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL527599";"";"0";"230.40";"0";"3.38";"GNF-Pf-1169";"CCSc1sc2sccc2[n+]1CC";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL583354";"";"0";"275.35";"0";"2.25";"GNF-Pf-1173";"CCN1CCN(CC=Cc2ccccc2[N+](=O)[O-])CC1";"IFI";"";"";"";"";"";"Not applicable";"";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600347";"";"0";"298.44";"0";"4.81";"GNF-Pf-1184";"Cc1ccccc1CSc1ccc(-c2cccs2)nn1";"IFI";"'='";"12.5";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL602025";"";"0";"357.42";"0";"3.30";"GNF-Pf-1189";"c1cncc(-c2cc(NCCCn3ccnc3)nc(-c3ccncc3)n2)c1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL602220";"";"0";"443.53";"0";"2.52";"GNF-Pf-1190";"O=C(Cn1c(=O)oc2cc(S(=O)(=O)NCc3ccccc3)ccc21)NC1CCCCC1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL584854";"";"0";"343.39";"0";"3.49";"GNF-Pf-1192";"O=C(Nc1ccccc1)/C(=C\c1ccncc1)NC(=O)c1ccccc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL584856";"";"0";"341.45";"0";"4.50";"GNF-Pf-1194";"COc1ccc(OC)c(-c2ccc(O)c(CNC3CCCCC3)c2)c1";"IFI";"'='";"1.739";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL584871";"";"0";"521.66";"2";"6.11";"GNF-Pf-1217";"CC(=O)Nc1ccc(C(=O)N2CCC(Oc3cccc(CN(C)Cc4cccc5ccccc45)c3)CC2)cc1";"IFI";"'='";"2.941";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL582781";"";"0";"413.46";"0";"2.21";"GNF-Pf-1221";"COCCNC(=O)c1ccc2c(=O)n(Cc3ccc4c(c3)OCO4)c(=S)[nH]c2c1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585211";"";"0";"411.03";"1";"5.19";"GNF-Pf-1225";"CCOc1ccc(CN(C(=O)C(C)(C)CCl)C(C)CCCN(CC)CC)cc1";"IFI";"'='";"1.835";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL584823";"";"0";"404.43";"0";"3.45";"GNF-Pf-1226";"Cc1ccc([N+](=O)[O-])cc1-c1ccc(/C=C2/SC(=S)N(CC(=O)O)C2=O)o1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL584824";"";"0";"350.42";"0";"3.76";"GNF-Pf-1229";"COc1cccc(-c2ccc(O)c(CNCc3ccccc3OC)c2)n1";"IFI";"'='";"1.754";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585039";"";"0";"313.35";"0";"2.60";"GNF-Pf-1237";"C=CCOc1cccc(/C=C2/NC(C)=C(C(=O)OCC)C2=O)c1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600156";"";"0";"466.65";"0";"4.15";"GNF-Pf-1239";"CCN(CC)CCCN(Cc1cc2ccc(OC)cc2[nH]c1=O)C(=S)NCc1ccccc1";"IFI";"'='";"3.419";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL547833";"";"0";"342.83";"0";"3.68";"GNF-Pf-1251";"Cl.Oc1ccc(Nc2nc(N3CCCC3)c3ccccc3n2)cc1";"IFI";"'='";"4.545";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL584847";"";"0";"492.54";"1";"5.75";"GNF-Pf-1257";"COc1ccc(C(=O)Nc2ccc(-c3nc4ccc(NC(=O)c5ccc(OC)cc5)cc4[nH]3)cc2)cc1";"IFI";"'='";"12.79";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585058";"";"0";"337.38";"0";"2.37";"GNF-Pf-1265";"CCOc1ccc(C=NNC(=O)CCn2nnc3ccccc32)cc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585069";"";"0";"377.28";"0";"3.68";"GNF-Pf-1281";"Fc1ccc(-n2cc(-c3ccccc3)[n+]3c2SCC3)cc1.[Br-]";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL602358";"";"0";"710.62";"2";"7.96";"GNF-Pf-1289";"COc1ccc(C2=C(c3ccc(OC)cc3)C3(c4ccccc4)C(=O)C2(c2ccccc2)C2C(=O)N(c4ccc(C)c(Br)c4)C(=O)C23)cc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600493";"";"0";"616.72";"2";"10.35";"GNF-Pf-1302";"O=C1c2ccc(-c3nc(-c4ccccc4)[nH]c3-c3ccccc3)cc2-c2cc(-c3[nH]c(-c4ccccc4)nc3-c3ccccc3)ccc21";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585030";"";"0";"405.45";"0";"3.93";"GNF-Pf-1307";"O=C(N/C(=C/C=C/c1ccccc1)C(=O)N1CCCCC1)c1ccc([N+](=O)[O-])cc1";"IFI";"'='";"0.6849";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL527162";"";"0";"581.07";"2";"7.01";"GNF-Pf-1311";"Cc1ccc(C(=O)N(CCc2ccccc2)C(C)c2nc3ccccc3c(=O)n2-c2cccc(Cl)c2C)cc1[N+](=O)[O-]";"IFI";"'='";"1.923";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL578921";"";"0";"361.49";"0";"4.97";"GNF-Pf-2172";"CN(C)c1ccc(C2Nc3ccccc3NC3=C2C(=O)CC(C)(C)C3)cc1";"IFI";"'='";"5.594";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL533926";"";"0";"618.73";"2";"9.57";"GNF-Pf-1524";"CC(=O)Nc1ccc(Oc2ccc(C(c3ccccc3)(c3ccccc3)c3ccc(Oc4ccc(NC(C)=O)cc4)cc3)cc2)cc1";"IFI";"'='";"1.562";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL601805";"";"0";"307.42";"1";"5.61";"GNF-Pf-1533";"CCN(CC)c1ccc2c(C)cc(Nc3ccccc3)[o+]c2c1";"IFI";"'='";"7.692";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL582443";"";"0";"299.37";"0";"3.79";"GNF-Pf-1535";"CCCCOc1ccc(/C=C/C(=O)NCc2ccco2)cc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL601328";"";"0";"259.26";"0";"2.39";"GNF-Pf-1537";"CC(C)C1Oc2cc3oc(=O)ccc3cc2C1=NO";"IFI";"'='";"3.125";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL582676";"";"0";"467.01";"1";"5.62";"GNF-Pf-1547";"Cc1ccccc1C(=O)N(CC(=O)Nc1cc(C(C)(C)C)nn1-c1ccccc1Cl)C(C)C";"IFI";"'='";"2.778";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL227959";"";"0";"434.97";"0";"4.99";"GNF-Pf-1549";"CCN1CCN(c2cc(C)c3cc(NC(=O)/C=C/c4cccc(Cl)c4)ccc3n2)CC1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL532918";"";"0";"352.41";"0";"3.93";"GNF-Pf-1554";"COc1cccc(-c2ccc(O)c(CNCCc3cccc(F)c3)c2)n1";"IFI";"'='";"0.9009";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL601329";"";"0";"279.38";"0";"3.12";"GNF-Pf-1587";"O=C(O)/C=C\C(=O)N(C1CCCCC1)C1CCCCC1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL588216";"";"0";"512.70";"1";"4.21";"GNF-Pf-1590";"COc1ccc(CCNc2nc(NCCCN3CCCCC3C)ncc2C(=O)NCC(C)C)cc1OC";"IFI";"'='";"2.857";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL587791";"";"0";"480.62";"0";"4.88";"GNF-Pf-1605";"O=C(Nc1ccc(-c2cn3ccsc3n2)cc1)c1ccc(S(=O)(=O)N2CCCCCC2)cc1";"IFI";"'='";"3.125";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL608558";"";"0";"298.25";"0";"0.80";"GNF-Pf-1607";"O=c1[nH]nc(SCc2c(F)cccc2[N+](=O)[O-])c(=O)[nH]1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL582656";"";"0";"342.45";"0";"1.23";"GNF-Pf-1610";"COc1cncc(-c2cncc(N3CCN(CCN(C)C)CC3)n2)c1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL579485";"";"0";"339.35";"0";"2.27";"GNF-Pf-1611";"Cc1oc2c(c1C(=O)NCC1CCCO1)C(=O)c1ccccc1C2=O";"IFI";"'='";"17.02";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL577438";"";"0";"453.03";"1";"6.38";"GNF-Pf-1624";"CCN(CC)CCCC(C)Nc1nc(/C=C/c2ccccc2OC)nc2cc(Cl)ccc12";"IFI";"'='";"9.091";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600102";"";"0";"263.36";"0";"3.41";"GNF-Pf-1633";"CCN1C=C/C(=C\c2cccc[n+]2C)c2ccccc21";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL578746";"";"0";"441.58";"1";"5.28";"GNF-Pf-1642";"COc1cccc(CCN2Cc3ccc(C(=O)NC(C)C)cc3N=C2c2ccc(C)cc2)c1";"IFI";"'='";"3.659";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL578115";"";"0";"417.65";"0";"4.92";"GNF-Pf-1647";"Clc1ccccc1Nc1nc2nonc2nc1Nc1cccc(Br)c1";"IFI";"'='";"15.38";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL577456";"";"0";"437.95";"1";"6.23";"GNF-Pf-1649";"Cc1ccc(-c2c3c(nc4sc(C(=O)Nc5ccc(Cl)cc5)c(N)c24)CCCC3)o1";"IFI";"'='";"2.299";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL577675";"";"0";"335.37";"0";"2.05";"GNF-Pf-1652";"Cc1nnc2sc(SCc3cccc([N+](=O)[O-])c3)nn2c1=O";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL534243";"";"0";"377.48";"0";"4.97";"GNF-Pf-1664";"COc1ccc(OC)c(-c2ccc(O)c(CNCC(C)c3ccccc3)c2)c1";"IFI";"'='";"3.509";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL586608";"";"0";"520.47";"2";"7.61";"GNF-Pf-1666";"CC(C)(C)CC(C)(C)Nc1c(-c2ccccc2OC(=O)c2ccc(Br)cc2)nc2ccccn12";"IFI";"'='";"2.83";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL588907";"";"0";"271.34";"0";"2.06";"GNF-Pf-1675";"COc1ccc(C(=O)C[n+]2ccc(N)c(C)c2C)cc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL577658";"";"0";"556.01";"2";"5.19";"GNF-Pf-1698";"COCCNC(=O)c1ccc(NCCc2ccc(Cl)cc2)c(S(=O)(=O)Nc2cccc(C(F)(F)F)c2)c1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL577659";"";"0";"337.60";"0";"4.11";"GNF-Pf-1699";"CC1=C(CCN(CCCN(C)C)CCCN(C)C)C(C)(C)CCC1";"IFI";"'='";"3.937";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600709";"";"0";"298.25";"0";"3.17";"GNF-Pf-1700";"CC1=NOC(=O)C1=Cc1ccc(-c2ccc([N+](=O)[O-])cc2)o1";"IFI";"";"";"";"";"";"Not applicable";"";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL578959";"";"0";"529.64";"2";"5.01";"GNF-Pf-1717";"Cc1cccc(C)c1NC(=O)N1CCN(C(=O)c2nc(-c3ccccc3)nc(C)c2C(=O)OC(C)C)CC1C";"IFI";"'='";"2.804";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL533947";"";"0";"545.73";"2";"8.67";"GNF-Pf-1719";"Cc1ccn2c(NC(C)(C)CC(C)(C)C)c(-c3ccccc3OC(=O)C(c3ccccc3)c3ccccc3)nc2c1";"IFI";"'='";"2.151";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL578540";"";"0";"352.52";"0";"4.62";"GNF-Pf-1723";"CC1CCCCN1CCCNCc1ccc(OCc2ccccc2)cc1";"IFI";"'='";"6.481";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL579672";"";"0";"314.43";"0";"2.16";"GNF-Pf-1730";"CCCn1c(C(CC)N2CCNCC2)nc2ccccc2c1=O";"IFI";"'='";"2.804";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL588400";"";"0";"370.45";"0";"1.69";"GNF-Pf-1733";"CN(C(=O)CCNC(=O)Cn1cnc2ccccc2c1=O)C1CCCCC1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL587533";"";"0";"394.95";"1";"5.96";"GNF-Pf-1740";"CC1(C)CC(N=c2cc(-c3ccccc3)oc3ccc(Cl)cc23)CC(C)(C)N1";"IFI";"'='";"11.43";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL586232";"";"0";"491.66";"0";"4.50";"GNF-Pf-1741";"CC(=O)N1CCN(C(=O)CCCSc2nnc(-c3ccc(C)cc3)n2-c2cccc(C)c2)CC1C";"IFI";"'='";"2.752";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL601969";"";"0";"405.28";"0";"4.36";"GNF-Pf-1745";"COC(=O)C1=C(C)NC(=Cc2cc(C)n(-c3ccc(Cl)c(Cl)c3)c2C)C1=O";"IFI";"";"";"";"";"";"Not applicable";"";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL578960";"";"0";"460.53";"0";"4.32";"GNF-Pf-1756";"CC(C)CC(NC(=O)/C(=C\c1ccco1)NC(=O)c1ccccc1)C(=O)OCc1ccccc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL578541";"";"0";"307.36";"0";"2.66";"GNF-Pf-1760";"COCCNc1cc(-c2ccccn2)nc(-c2ccccn2)n1";"IFI";"'='";"15.38";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL577892";"";"0";"319.38";"0";"3.49";"GNF-Pf-1763";"COc1ccc(C(=O)C(C)[n+]2ccccc2-c2ccccn2)cc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL583801";"";"0";"322.43";"0";"4.70";"GNF-Pf-945";"CC(C)c1ccc(/C=C2/SC(=Nc3ccccc3)NC2=O)cc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL584232";"";"0";"381.40";"0";"0.99";"GNF-Pf-951";"CCCCn1c(NN=C2C(=O)Nc3ccccc32)nc2c1c(=O)[nH]c(=O)n2C";"IFI";"'='";"1.307";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL584234";"";"0";"268.40";"0";"4.19";"GNF-Pf-954";"CCCCCCn1c2c(c(=N)c3ccccc31)CCC2";"IFI";"'='";"7.143";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL601964";"";"0";"720.83";"2";"10.84";"GNF-Pf-965";"CC(=O)Nc1ccc(-c2nc(-c3ccc(Oc4ccc(-c5[nH]c(-c6ccc(NC(C)=O)cc6)nc5-c5ccccc5)cc4)cc3)c(-c3ccccc3)[nH]2)cc1";"IFI";"'='";"1.538";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585803";"";"0";"424.34";"0";"3.48";"GNF-Pf-981";"O=C(c1cc([N+](=O)[O-])cc([N+](=O)[O-])c1)N1CCN(c2cccc(C(F)(F)F)c2)CC1";"IFI";"'='";"5.042";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600772";"";"0";"314.35";"0";"2.35";"GNF-Pf-982";"COc1ccccc1C(c1c(C)n[nH]c1O)c1c(C)n[nH]c1O";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL526069";"";"0";"350.38";"0";"3.31";"GNF-Pf-987";"COc1ccc(C=NNc2nc(O)cc(-c3ccccc3)n2)cc1OC";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL584013";"";"0";"441.51";"0";"1.79";"GNF-Pf-997";"Cc1ccc(CNC(=O)c2cc(=O)[nH]c3ccc(S(=O)(=O)N4CCOCC4)cc23)cc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL602626";"";"0";"404.52";"0";"3.81";"GNF-Pf-998";"Cc1cc(-c2cnc(N3CCCC3)nc2C2CCN(Cc3cccnc3)CC2)on1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL584444";"";"0";"347.42";"0";"2.83";"GNF-Pf-1007";"CCCCCCOc1ccc(C(C)=NNC2=NCCN2)cc1[N+](=O)[O-]";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL584239";"";"0";"438.96";"0";"3.12";"GNF-Pf-1018";"Cc1ccc(CN2C[C@H](n3cnnn3)C[C@H]2C(=O)NCCc2cccc(Cl)c2)c(C)c1";"IFI";"'='";"1.942";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL599947";"";"0";"368.89";"0";"4.65";"GNF-Pf-1027";"CCn1c(C=CN(C(C)=O)c2ccccc2)[n+](CC)c2cc(Cl)ccc21";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585591";"";"0";"485.61";"1";"7.85";"GNF-Pf-1031";"CCN1/C(=C/C=C/c2oc3ccc(-c4ccccc4)cc3[n+]2CC)Oc2ccc(-c3ccccc3)cc21";"IFI";"'='";"15.38";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL584837";"";"0";"501.83";"2";"6.16";"GNF-Pf-1050";"COc1ccccc1Cn1c(SCc2ccc(Cl)cc2)nc2ccc(Br)cc2c1=O";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL1744500";"";"0";"347.19";"0";"3.98";"GNF-Pf-1773";"O=C(NN=CC(Br)=Cc1ccccc1)c1ccc(F)cc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600276";"";"0";"596.71";"2";"6.10";"GNF-Pf-1313";"COc1ccc(-c2nnc(NC(=O)CCN(CCc3ccc(OC)c(OC)c3)C(=O)c3cccc4ccccc34)s2)cc1";"IFI";"'='";"3.81";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL602369";"";"0";"591.94";"None";"None";"GNF-Pf-2593";"c1ccc([Si]2(c3ccccc3)N[Si](c3ccccc3)(c3ccccc3)N[Si](c3ccccc3)(c3ccccc3)N2)cc1";"IFI";"'='";"1.98";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL602370";"";"0";"227.22";"0";"2.63";"GNF-Pf-2595";"Cn1c2ccncc2c2cc([N+](=O)[O-])ccc21";"IFI";"'='";"7.692";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL578669";"";"0";"393.60";"0";"4.91";"GNF-Pf-2598";"Cc1cccc(NC(=S)NC2CC3CCCC(C2)N3CCc2ccccc2)c1";"IFI";"'='";"2.564";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL579311";"";"0";"299.36";"0";"2.94";"GNF-Pf-2608";"COc1ccccc1-n1c(S)nnc1-c1ccccc1O";"IFI";"'='";"3.571";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL601576";"";"0";"404.54";"1";"5.09";"GNF-Pf-2611";"C=C[C@H]1CN2CC[C@H]1C[C@@H]2[C@@H](OC(=O)c1cccs1)c1ccnc2ccccc12";"IFI";"'='";"2.778";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL578498";"";"0";"386.40";"None";"None";"GNF-Pf-97";"CCN1C(=Cc2sc3ccccc3[n+]2CC)[Se]c2ccccc21";"IFI";"";"";"";"";"";"Not applicable";"";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL579140";"";"0";"488.65";"1";"6.20";"GNF-Pf-111";"COc1ccc(C(=O)N2C(C(=O)Nc3ccc(C)cc3)CSC2c2ccc(C(C)(C)C)cc2)cc1";"IFI";"'='";"2.198";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585583";"";"0";"522.48";"2";"5.55";"GNF-Pf-116";"O=C(Nc1ccc(-c2nc3cc(NC(=O)c4cccc([N+](=O)[O-])c4)ccc3[nH]2)cc1)c1cccc([N+](=O)[O-])c1";"IFI";"'='";"16.88";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL602587";"";"0";"328.89";"0";"4.14";"GNF-Pf-145";"Clc1cccc(CNC2CCN(CCc3ccccc3)CC2)c1";"IFI";"'='";"0.7812";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL578304";"";"0";"460.54";"1";"6.35";"GNF-Pf-64";"Cc1ccc(C(=O)Nc2ccc(-c3nc4ccc(NC(=O)c5ccc(C)cc5)cc4[nH]3)cc2)cc1";"IFI";"'='";"17.44";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL300389";"";"0";"355.83";"0";"3.73";"GNF-Pf-88";"OCCCNc1cc(-c2ccnc(Nc3cccc(Cl)c3)n2)ccn1";"IFI";"'='";"30.82";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL581660";"";"0";"346.23";"0";"1.83";"GNF-Pf-3198";"Cc1n(N)c2ccccc2[n+]1CC(=O)c1ccccc1.[Br-]";"IFI";"'='";"1.562";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL602009";"";"0";"405.57";"1";"5.48";"GNF-Pf-3209";"c1ccc(Oc2cccc(CN3CCc4nc(N5CCCCC5)sc4C3)c2)cc1";"IFI";"'='";"18.31";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL601136";"";"0";"316.30";"0";"3.71";"GNF-Pf-3216";"CCOC(=O)c1sc(-c2cnccc2C(F)(F)F)nc1C";"IFI";"'='";"5.682";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL579763";"";"0";"382.37";"0";"2.82";"GNF-Pf-3227";"COCCN1C(=O)C(O)=C(C(=O)c2ccccc2)C1c1ccccc1[N+](=O)[O-]";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL602785";"";"0";"223.30";"0";"3.09";"GNF-Pf-3228";"CCC[n+]1cccc2ccc3cccnc3c21";"IFI";"'='";"1.587";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL582306";"";"0";"531.70";"2";"8.37";"GNF-Pf-3231";"CC(C)(C)CC(C)(C)Nc1c(-c2ccccc2OC(=O)C(c2ccccc2)c2ccccc2)nc2ccccn12";"IFI";"'='";"4.762";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL581681";"";"0";"402.43";"0";"1.41";"GNF-Pf-3235";"O=C(Cn1c(=O)oc2cc(S(=O)(=O)N3CCCC3)ccc21)Nc1cccnc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL579950";"";"0";"442.52";"0";"3.80";"GNF-Pf-3249";"COc1cc2c(c(OC)c1CN1CCN(c3ccccc3)CC1)C(=O)c1ccccc1C2=O";"IFI";"'='";"15.38";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL580153";"";"0";"350.46";"0";"4.13";"GNF-Pf-3250";"C=C[C@H]1CN2CC[C@H]1C[C@H]2[C@H](OC(=O)CC)c1ccnc2ccccc12";"IFI";"'='";"1.869";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL588495";"";"0";"352.44";"0";"2.30";"GNF-Pf-3256";"CC(C)Cc1nc(N2CCOCC2)c2nnn(Cc3ccccc3)c2n1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL582070";"";"0";"274.32";"0";"2.76";"GNF-Pf-3261";"COc1nc(Nc2ccc(C(C)C)cc2)nc(OC)n1";"IFI";"'='";"2.273";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL582072";"";"0";"524.58";"2";"7.52";"GNF-Pf-3264";"Nc1ccc(-c2nc3cc(Oc4ccc(Oc5ccc6[nH]c(-c7ccc(N)cc7)nc6c5)cc4)ccc3[nH]2)cc1";"IFI";"'='";"5.797";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL599936";"";"0";"529.73";"1";"0.57";"GNF-Pf-3267";"CC(C)C[C@@H]1NC(=O)[C@@H](CC(C)C)NC(=O)[C@H](C(C)C)NC(=O)[C@H]2CSSC[C@@H](NC1=O)C(=O)N2";"IFI";"'='";"25.93";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL602008";"";"0";"333.86";"0";"4.19";"GNF-Pf-3273";"CC(C)CC(=O)N(C)CCCNc1ccnc2cc(Cl)ccc12";"IFI";"'='";"0.9346";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL1615737";"";"0";"358.83";"0";"3.40";"GNF-Pf-3301";"O=[N+]([O-])c1ccc(C=NN2CCN(Cc3ccccc3Cl)CC2)cc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL582075";"";"0";"435.22";"0";"3.28";"GNF-Pf-3306";"COc1ccc(-c2noc(CNC(=O)c3cccc(I)c3)n2)cc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL582293";"";"0";"445.30";"0";"3.97";"GNF-Pf-3321";"CC(=O)N(C1=C(N2CCOCC2)C(=O)c2ccccc2C1=O)c1ccc(Cl)c(Cl)c1";"IFI";"'='";"15.38";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600142";"";"0";"399.24";"0";"3.31";"GNF-Pf-3324";"CNC1=C(N(C(C)=O)c2ccc(Br)cc2)C(=O)c2ccccc2C1=O";"IFI";"'='";"14.29";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL581045";"";"0";"365.89";"0";"3.66";"GNF-Pf-3507";"CCC(CC)C(=O)Nc1c2c(nn1-c1cccc(Cl)c1)C[S+]([O-])C2";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL530144";"";"0";"617.73";"1";"4.68";"GNF-Pf-3518";"COc1cc(C(C(=O)NCc2ccccc2)N(C(=O)c2snc(C(N)=O)c2N)c2ccc(C(C)C)cc2)cc(OC)c1OC";"IFI";"'='";"5.455";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL597266";"";"0";"424.88";"0";"4.15";"GNF-Pf-3578";"COc1cc(OC)cc(C(=O)NCC2Cc3cc(Cl)cc(-c4ccncc4)c3O2)c1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL1186409";"";"0";"487.65";"1";"7.32";"GNF-Pf-3619";"CC[n+]1c(/C=C/N(C)c2ccccc2)n(-c2ccccc2)c2ccc(-c3nc4ccccc4s3)cc21";"IFI";"";"";"";"";"";"Not applicable";"";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL528368";"";"0";"455.21";"1";"5.53";"GNF-Pf-3630";"CCCCCn1c(C)[n+](CCCC)c2cc(Cl)c(Cl)cc21.[I-]";"IFI";"'='";"7.143";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL597048";"";"0";"351.86";"0";"4.23";"GNF-Pf-3633";"Cc1ccc(-c2c[n+](CC(=O)c3ccccc3Cl)c3n2CCC3)cc1";"IFI";"'='";"4.762";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL583604";"";"0";"306.34";"0";"3.90";"GNF-Pf-3667";"Fc1ccc(CCNc2ncnc3c2[nH]c2ccccc23)cc1";"IFI";"'='";"14.63";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL583827";"";"0";"425.50";"0";"4.64";"GNF-Pf-3669";"COCCN(Cc1cc2ccc(F)cc2nc1N1CCCCCC1)C(=O)c1ccoc1";"IFI";"'='";"2.941";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL583606";"";"0";"333.31";"0";"3.19";"GNF-Pf-3671";"CC(C)(C)C(=O)NCCNc1ccc([N+](=O)[O-])cc1C(F)(F)F";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL604118";"";"0";"502.52";"1";"1.42";"GNF-Pf-3692";"CC(=O)Nc1ccc2c(c1)C(=O)N(C(C(=O)NCC(=O)O)C1CCCCC1)[C@@H](CCC(=O)O)C(=O)N2";"IFI";"'='";"1.22";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL584712";"";"0";"521.41";"1";"4.20";"GNF-Pf-3753";"O=C(Nc1ccc(C2=NCCN2)c(Cl)c1)c1cccc(C(=O)Nc2ccc(C3=NCCN3)c(Cl)c2)c1";"IFI";"'='";"0.9174";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL598283";"";"0";"433.36";"1";"5.04";"GNF-Pf-3766";"CC[n+]1c(/C=C/c2ccc(SC)cc2)ccc2ccccc21.[I-]";"IFI";"'='";"8.421";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL584016";"";"0";"376.33";"0";"4.18";"GNF-Pf-3780";"CC(Cl)=CC[N+]1(CC#Cc2cccc3ccccc23)CCOCC1.[Cl-]";"IFI";"";"";"";"";"";"Not applicable";"";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600336";"";"0";"444.54";"1";"5.86";"GNF-Pf-3037";"O=C(Nc1ccc(-c2nc3cc(NC(=O)c4cccs4)ccc3[nH]2)cc1)c1cccs1";"IFI";"'='";"8.333";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL579615";"";"0";"334.78";"0";"2.92";"GNF-Pf-4111";"Cl.OCCNc1nc(Nc2ccc(F)cc2)nc2ccccc12";"IFI";"'='";"2.941";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL53034";"";"0";"341.46";"1";"5.03";"GNF-Pf-4133";"CN(C)CCNc1cc(-c2ccc3ccccc3c2)nc2ccccc12";"IFI";"'='";"4.511";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL581034";"";"0";"333.86";"0";"4.34";"GNF-Pf-3338";"CCCCC(=O)N(C)CCCNc1ccnc2cc(Cl)ccc12";"IFI";"'='";"1.869";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL582496";"";"0";"425.86";"1";"5.58";"GNF-Pf-3393";"Cc1cccc(-n2ccnc2SCC(=O)Nc2cc(C(F)(F)F)ccc2Cl)c1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL599896";"";"0";"350.85";"0";"3.24";"GNF-Pf-5576";"CC(CCc1ccccc1)NCC(O)c1cccc([N+](=O)[O-])c1.Cl";"IFI";"'='";"2.381";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL578705";"";"0";"516.42";"2";"5.94";"GNF-Pf-5595";"CCOC(=O)C1=C(C)NC2=C(C(=O)CC(c3ccc(OC)c(OC)c3)C2)C1c1cccc(Cl)c1Cl";"IFI";"'='";"3.571";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL577210";"";"0";"472.63";"1";"5.51";"GNF-Pf-5614";"COc1cc(C(=O)NC(C)C)ccc1OC1CCN(CC(c2ccccc2)c2ccccc2)CC1";"IFI";"'='";"2.778";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL577430";"";"0";"506.56";"1";"4.93";"GNF-Pf-5622";"CCCOC(=O)C1=C(C)NC2=C(C(=O)CC(c3ccc(OC)c(OC)c3)C2)C1c1ccc([N+](=O)[O-])cc1";"IFI";"'='";"2.381";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL531809";"";"0";"545.68";"2";"6.79";"GNF-Pf-5635";"CCc1ccc(C(=O)N(CCc2ccccc2)C(CC)c2nc3ccccc3c(=O)n2-c2ccccc2OC)cc1";"IFI";"'='";"3.846";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600133";"";"0";"418.42";"0";"4.46";"GNF-Pf-5654";"CCOC(=O)C1=C(C)NC(=Cc2cc(C)n(-c3ccccc3C(F)(F)F)c2C)C1=O";"IFI";"";"";"";"";"";"Not applicable";"";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL587581";"";"0";"543.69";"1";"3.90";"GNF-Pf-5414";"O=C(NC1CCN(CC(O)CN(Cc2ccccc2)S(=O)(=O)c2ccccc2)C1)c1cccc2ccccc12";"IFI";"'='";"2.97";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL581393";"";"0";"413.55";"1";"5.90";"GNF-Pf-5418";"Cc1ccc(-c2c3c(nc4sc(C(=O)Nc5cccc(C)c5)c(N)c24)CCC3)cc1";"IFI";"'='";"4.706";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL603015";"";"0";"378.47";"0";"4.06";"GNF-Pf-5432";"CCOC(=O)C1=C(C)NC(=Cc2cc(C)n(-c3ccc(C)cc3C)c2C)C1=O";"IFI";"";"";"";"";"";"Not applicable";"";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL579173";"";"0";"433.56";"0";"4.28";"GNF-Pf-5467";"CC(C)c1nc(N2CCN(C(=O)Nc3ccccc3)CC2)c(C#N)c2c1COC(C)(C)C2";"IFI";"'='";"2.41";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL588455";"";"0";"434.92";"1";"5.57";"GNF-Pf-5480";"COc1ccc(CNCc2cc(-c3ccnc4cc(Cl)ccc34)ccc2O)c(OC)c1";"IFI";"'='";"3.478";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL589018";"";"0";"307.85";"0";"4.67";"GNF-Pf-5481";"CC1CC(C)CN(C(=O)c2sc3ccccc3c2Cl)C1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600538";"";"0";"311.38";"0";"4.13";"GNF-Pf-5496";"CCN1c2ccc([N+](=O)[O-])cc2N(CC)C1(C)c1ccccc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL602576";"";"0";"515.08";"1";"4.69";"GNF-Pf-5499";"CC(C)OCCCNc1sc(S(=O)(=O)c2ccccc2)nc1S(=O)(=O)c1ccc(Cl)cc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL586793";"";"0";"407.47";"0";"3.80";"GNF-Pf-5509";"CCOCCCNc1nc2cc(OC)c(OC)cc2c2nc(-c3ccccc3)nn12";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL578952";"";"0";"469.01";"1";"5.99";"GNF-Pf-5511";"COc1ccc(NC(=O)C2c3ccccc3C(=O)N(CC(C)C)C2c2cccs2)cc1Cl";"IFI";"'='";"3.125";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL578533";"";"0";"421.47";"0";"4.37";"GNF-Pf-5513";"COC(=O)C1=C(C)NC2=C(C(=O)CC(c3ccc(OC)cc3)C2)C1c1ccc(F)cc1";"IFI";"'='";"2.326";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL577667";"";"0";"455.47";"0";"0.62";"GNF-Pf-5519";"NCCCC[C@H]1C(=O)Nc2ccc(O)cc2C(=O)N1C(C(=O)NCC(=O)O)c1cccnc1";"IFI";"'='";"1.176";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL1615694";"";"0";"264.32";"0";"3.97";"GNF-Pf-5370";"C[n+]1ccc(C=Cc2ccccc2F)c2ccccc21";"IFI";"";"";"";"";"";"Not applicable";"";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL578321";"";"0";"369.92";"0";"3.75";"GNF-Pf-5382";"CCCCS(=O)(=O)N(C)CCCNc1ccnc2cc(Cl)ccc12";"IFI";"'='";"3.704";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL533779";"";"0";"229.32";"0";"3.04";"GNF-Pf-5393";"c1ccc2c(c1)OC13CCCCC1C2NCC3";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL601190";"";"0";"473.59";"1";"7.29";"GNF-Pf-5402";"Cc1ccn2c(NC(C)(C)CC(C)(C)C)c(-c3ccccc3OC(=O)c3ccc(F)cc3)nc2c1";"IFI";"'='";"2.804";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL586560";"";"0";"464.03";"1";"6.90";"GNF-Pf-5405";"Cc1ccc2nc(Cl)c3cc(C(=O)Nc4ccc(CN5CCC(C)CC5)cc4)sc3c2c1";"IFI";"'='";"8.108";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL577431";"";"0";"344.42";"0";"3.24";"GNF-Pf-5689";"CCOC(=O)c1sc2nc(N)c(C#N)c(-c3cccs3)c2c1N";"IFI";"'='";"1.351";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL534001";"";"0";"277.33";"0";"3.52";"GNF-Pf-5406";"COc1cncc(-c2cncc(-c3ccc(C)cc3)n2)c1";"IFI";"'='";"4.167";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL588796";"";"0";"433.51";"0";"2.98";"GNF-Pf-5408";"CCOc1ccc(N(C(C)=O)C2=C(N3CCN(C)CC3)C(=O)c3ccccc3C2=O)cc1";"IFI";"'='";"9.091";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL582090";"";"0";"382.25";"0";"4.59";"GNF-Pf-3402";"N#Cc1c(N)n(CCc2ccc(Cl)cc2Cl)c2nc3ccccc3nc12";"IFI";"'='";"3.125";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL602421";"";"0";"432.75";"1";"5.22";"GNF-Pf-3413";"CN(CCCNc1ccnc2cc(Cl)ccc12)C(=O)c1cccc(Br)c1";"IFI";"'='";"1.869";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600540";"";"0";"429.48";"0";"4.26";"GNF-Pf-3425";"O=C(Nc1ccc(Oc2cccnc2)cc1)C1CCN(Cc2ccc3nonc3c2)CC1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL273081";"";"0";"357.87";"0";"4.30";"GNF-Pf-3428";"CN(C)c1ccc(/C=C2/SC(=Nc3ccccc3Cl)NC2=O)cc1";"IFI";"";"";"";"";"";"Not applicable";"";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600548";"";"0";"551.67";"1";"3.99";"GNF-Pf-3437";"COc1cccc(C(C(=O)NC2CCCCC2)N(C(=O)c2snc(C(N)=O)c2N)c2ccc(C)cc2)c1OC";"IFI";"'='";"3.704";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL582277";"";"0";"501.62";"2";"5.86";"GNF-Pf-3440";"COc1ccc(C2CC(=O)C3=C(C2)NC(C)=C(C(=O)OC2CCCC2)C3c2cccc(C)c2)cc1OC";"IFI";"'='";"10.71";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL605394";"";"0";"436.51";"0";"3.72";"GNF-Pf-3449";"O=C(CNCCc1ccccc1)NC(c1ccccc1)c1ccccc1.O=CO.O=CO";"IFI";"'='";"1.818";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL582702";"";"0";"426.51";"0";"2.87";"GNF-Pf-3453";"COC(=O)[C@@H]1C[C@@H](NC(=O)c2ccc(C)cc2)CN1Cc1ccc(OC)c(C)c1OC";"IFI";"'='";"0.885";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL582686";"";"0";"445.68";"0";"3.11";"GNF-Pf-3045";"CCN(CC)CCCNC(=S)N(CCN(C)C)Cc1cc2cc(C)cc(C)c2[nH]c1=O";"IFI";"'='";"3.39";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600102";"";"0";"263.36";"0";"3.41";"GNF-Pf-3065";"CCN1C=C/C(=C\c2cccc[n+]2C)c2ccccc21";"IFI";"";"";"";"";"";"Not applicable";"";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL601982";"";"0";"272.25";"0";"2.05";"GNF-Pf-3090";"O=C1NC(=S)NC1=Cc1ccc(C(F)(F)F)cc1";"IFI";"";"";"";"";"";"Not applicable";"";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600335";"";"0";"438.24";"0";"4.82";"GNF-Pf-3092";"O=c1c2ccccc2nc(C=Cc2ccc([N+](=O)[O-])o2)n1-c1ccc(Br)cc1";"IFI";"";"";"";"";"";"Not applicable";"";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL582095";"";"0";"412.45";"0";"3.97";"GNF-Pf-3094";"COc1cc2nc(NCc3ccccn3)n3nc(-c4ccccc4)nc3c2cc1OC";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL581256";"";"0";"296.35";"0";"2.82";"GNF-Pf-3099";"O=C1NC(=S)N/C1=C/c1cccc(Oc2ccccc2)c1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL580156";"";"0";"385.42";"0";"4.75";"GNF-Pf-3120";"CCCc1cc(-c2onc(C)c2-c2ccc(C(=O)OCC)o2)c(O)cc1OC";"IFI";"'='";"3.509";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL601556";"";"0";"585.70";"1";"3.87";"GNF-Pf-3129";"Cc1cccc(NC(=O)C2C3C=CC4(O3)C2C(=O)N(CC2COc3ccccc3O2)C4C(=O)NC2CCCC(C)C2C)c1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL602181";"";"0";"267.76";"0";"1.18";"GNF-Pf-3179";"Cc1cccc(N2C(N)=NC(N)=NC2(C)C)c1.Cl";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL581225";"";"0";"410.43";"0";"1.58";"GNF-Pf-3184";"O=C1c2ccc3c4c(ccc(c24)C(=O)N1CCCCO)C(=O)N(CCCCO)C3=O";"IFI";"'='";"11.29";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL581651";"";"0";"476.04";"0";"3.69";"GNF-Pf-3188";"O=C(NC(CN1CCCC1)c1ccccc1)C1CCN(S(=O)(=O)c2ccc(Cl)cc2)CC1";"IFI";"'='";"1.942";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL579178";"";"0";"323.42";"0";"4.04";"GNF-Pf-1653";"Cc1ccc(Sc2c(C)nn(C(=O)c3cccnc3)c2C)cc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL587111";"";"0";"420.39";"0";"4.44";"GNF-Pf-1660";"CC(O)c1ccc(NC(=O)c2cnn3c2NC(c2ccco2)CC3C(F)(F)F)cc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL587984";"";"0";"254.25";"0";"1.89";"GNF-Pf-1672";"COc1ccc(N2C(=O)c3cccnc3C2=O)cc1";"IFI";"'='";"1.149";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL580134";"";"0";"497.64";"1";"6.57";"GNF-Pf-1684";"CCCCCCN(C(=O)c1ccccc1)C(CC)c1nc2ccccc2c(=O)n1-c1ccccc1OC";"IFI";"'='";"1.031";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL580135";"";"0";"369.42";"0";"3.62";"GNF-Pf-1685";"COc1ccccc1NC(=O)CCCC(=O)OC(C)C(=O)c1ccccc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL580142";"";"0";"306.45";"0";"3.95";"GNF-Pf-1688";"C(=C/c1ccccc1)\CNC1CCN(Cc2ccccc2)CC1";"IFI";"'='";"14.29";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL576604";"";"0";"314.37";"0";"2.76";"GNF-Pf-1713";"CCOC(=O)CN1C(=O)c2ccccc2Sc2ncccc21";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL578748";"";"0";"559.45";"1";"5.31";"GNF-Pf-1715";"CSc1oc(C(C)(C)C)nc1[P+](c1ccccc1)(c1ccccc1)c1ccccc1.[I-]";"IFI";"'='";"23.2";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL578330";"";"0";"408.19";"0";"4.03";"GNF-Pf-1721";"COc1ccc(-c2noc(-c3cccc(I)c3)n2)cc1OC";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600124";"";"0";"498.71";"0";"3.70";"GNF-Pf-1722";"CCCN1CCC(N2C[C@@H](NC3CCCCCC3)C[C@H]2C(=O)NCCc2ccc3c(c2)OCO3)CC1";"IFI";"'='";"2.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL602574";"";"0";"283.37";"0";"3.91";"GNF-Pf-1726";"CC(C)(C)c1ccc(/C=C/C(=O)NCc2ccco2)cc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL525864";"";"0";"460.58";"1";"5.90";"GNF-Pf-2528";"CC(C)c1ccc(NC(=O)c2ccc(NCCCN(C)Cc3ccccc3)c([N+](=O)[O-])c2)cc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL588583";"";"0";"459.61";"0";"4.12";"GNF-Pf-1734";"CC(NS(=O)(=O)c1ccccc1)C(c1cccs1)N1CCN(c2ccccc2F)CC1";"IFI";"'='";"6.061";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL610912";"";"0";"497.66";"1";"8.62";"GNF-Pf-1758";"CN(C)c1ccc(C(=Cc2cc(-c3ccccc3)cc(-c3ccccc3)[o+]2)c2ccc(N(C)C)cc2)cc1";"IFI";"'='";"12.73";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL578117";"";"0";"512.61";"1";"4.40";"GNF-Pf-1766";"Cc1nc(-c2ccccc2)nc(C(=O)N2CCN(C(=O)/C=C/c3ccccc3)C(C)C2)c1C(=O)OC(C)C";"IFI";"'='";"1.887";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL601125";"";"0";"698.89";"2";"4.19";"GNF-Pf-1770";"CCC(=O)OC(C(C)C(=O)O)C(C)C1OC2(CCC(C)(C3CCC(C)(C4OC(C5OC(O)(CO)C(C)CC5C)CC4C)O3)O2)CC(O)C1C";"IFI";"'='";"8.621";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL587671";"";"0";"309.43";"0";"3.60";"GNF-Pf-1774";"CCCC1=[N+](CC(=O)c2ccc(C)cc2)CCn2c(C)ccc21";"IFI";"'='";"5.747";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL583584";"";"0";"231.30";"0";"1.42";"GNF-Pf-2559";"Cc1cccc(NC2=NC(N)=NC(C)(C)N2)c1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600713";"";"0";"227.31";"0";"2.87";"GNF-Pf-1801";"CC1CCN(c2nncc3ccccc23)CC1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL588661";"";"0";"374.40";"1";"5.51";"GNF-Pf-1784";"N#Cc1cc(Oc2ccc(-c3cnc4ccccc4n3)cc2)nc2ccccc12";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL586548";"";"0";"297.30";"0";"0.58";"GNF-Pf-1848";"NC(=S)NN=C1c2ccccc2-c2nc3nonc3nc21";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL589021";"";"0";"327.79";"0";"2.41";"GNF-Pf-2014";"Cc1nn(C(=O)NS(=O)(=O)c2ccccc2Cl)c(C)c1C";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL601968";"";"0";"259.31";"0";"3.39";"SID7972771";"Fc1ccc(CSc2nc3cccnc3[nH]2)cc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL576939";"";"0";"393.41";"1";"6.50";"GNF-Pf-2213";"Cc1ccc(C)c(NC2=C(c3ccc(C(F)(F)F)cc3)C(=O)c3ccccc32)c1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL577622";"";"0";"336.82";"0";"4.13";"GNF-Pf-2074";"O=C(Cn1ccc(=NCc2ccccc2)cc1)c1ccc(Cl)cc1";"IFI";"'='";"4.412";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL602197";"";"0";"380.29";"0";"3.51";"GNF-Pf-2089";"Br.N#Cc1ccccc1Cn1ccc(=NCc2ccccc2)cc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL577839";"";"0";"501.60";"2";"6.31";"GNF-Pf-2236";"COc1cccc(C(=O)N(CCCC(C)Nc2cc(OC)cc3cccnc23)Cc2ccc(F)cc2)c1";"IFI";"'='";"2.804";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL579129";"";"0";"349.18";"0";"3.55";"GNF-Pf-2247";"Ic1ccc(NCc2cn3ccccc3n2)cc1";"IFI";"'='";"8.209";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL576576";"";"0";"328.28";"0";"2.66";"GNF-Pf-2250";"CC(=NNC(=O)c1ccc([N+](=O)[O-])cc1)c1cccc([N+](=O)[O-])c1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL577639";"";"0";"445.68";"0";"3.06";"GNF-Pf-2259";"CCc1ccc2[nH]c(=O)c(CN(CCN(CC)CC)C(=S)NCCCN(C)C)cc2c1";"IFI";"'='";"5.357";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL601757";"";"0";"207.19";"0";"-1.32";"GNF-Pf-2272";"Cc1nc2c(=O)n(C)c(=O)nc-2n(C)n1";"IFI";"'='";"25.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL578039";"";"0";"396.52";"0";"2.79";"GNF-Pf-2284";"CC(=O)N1CCN(c2ccc(NC(=S)NC(=O)c3ccc(C)cc3)cc2)CC1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL602774";"";"0";"301.39";"0";"3.73";"GNF-Pf-2293";"CCC(Nc1ccc(OC)cc1)=C1C(=O)CC(C)(C)CC1=O";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL593486";"";"0";"613.76";"2";"5.47";"GNF-Pf-2310";"CC1CN(C(=O)C(Cc2c[nH]c3ccccc23)NC(=O)C(c2ccccc2)c2ccccc2)CCN1C(=O)NCc1ccccc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600740";"";"0";"433.97";"0";"2.89";"GNF-Pf-2314";"O=C(NCCc1ccc(Cl)cc1)C1CCCN(c2nnc(N3CCCC3=O)s2)C1";"IFI";"'='";"2.041";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585954";"";"0";"520.55";"2";"6.59";"GNF-Pf-2318";"Cc1ccc(Nc2nc(NN=Cc3ccc(-c4ccc([N+](=O)[O-])cc4)o3)nc(Nc3ccccc3)n2)c(C)c1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL49055";"";"0";"291.40";"0";"3.88";"GNF-Pf-2323";"CN(C)CCNc1cc(-c2ccccc2)nc2ccccc12";"IFI";"'='";"1.6";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL603004";"";"0";"214.27";"0";"2.86";"GNF-Pf-2412";"CN1c2ccccc2N(C)C1c1ccco1";"IFI";"'='";"1.429";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL587528";"";"0";"292.37";"0";"3.80";"GNF-Pf-1521";"c1ccc(CSc2nnc3c(n2)[nH]c2ccccc23)cc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL602573";"";"0";"1255.44";"None";"None";"GNF-Pf-1594";"Cc1c2oc3c(C)ccc(C(=O)NC4C(=O)N[C@@H](C(C)C)C(=O)N5CCCC5C(=O)N(C)CC(=O)N(C)C(C(C)C)C(=O)OC4C)c3nc-2c(C(=O)NC2C(=O)N[C@H](C(C)C)C(=O)N3CCCC3C(=O)N(C)CC(=O)N(C)C(C(C)C)C(=O)OC2C)c(N)c1=O";"IFI";"'='";"21.67";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL589027";"";"0";"522.94";"1";"4.87";"GNF-Pf-1600";"COc1cc(C(=O)NC(c2ccc3c(c2)OCO3)c2cc(Cl)c3cccnc3c2O)cc(OC)c1OC";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL587049";"";"0";"515.63";"2";"6.71";"GNF-Pf-1606";"CCCCCCN(C(=O)c1cccc(F)c1)C(CC)c1nc2ccccc2c(=O)n1-c1ccccc1OC";"IFI";"'='";"2.727";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL579930";"";"0";"429.48";"0";"4.19";"GNF-Pf-1614";"Cc1cccc(Nc2ccccc2C(=O)OCC(=O)N2CC(=O)Nc3ccccc32)c1C";"IFI";"'='";"4.348";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL589010";"";"0";"326.44";"0";"2.65";"GNF-Pf-1854";"c1ccc(-c2ccccc2OCCNCCN2CCOCC2)cc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL194986";"";"0";"442.52";"0";"4.04";"GNF-Pf-2322";"CCN1CCN(c2cc(C)c3cc(NC(=O)c4cc(=O)c5ccccc5o4)ccc3n2)CC1";"IFI";"'='";"9.195";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL577641";"";"0";"363.51";"1";"5.12";"GNF-Pf-2327";"CCN1C(=Cc2sc3ccc(O)cc3[n+]2CC)C=Cc2cc(C)ccc21";"IFI";"'='";"15.38";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL578877";"";"0";"433.51";"1";"6.12";"GNF-Pf-2354";"N#CC(C#N)C(C(Sc1ccc([N+](=O)[O-])cc1)=C(O)c1ccccc1)c1cccs1";"IFI";"";"";"";"";"";"Not applicable";"";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL579088";"";"0";"433.44";"0";"3.10";"GNF-Pf-2355";"COc1cc2c(cc1OC)-c1cc3ccc4c(c3c[n+]1CC2)OCO4.O=S(=O)([O-])O";"IFI";"'='";"4.065";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL602190";"";"0";"350.46";"0";"4.13";"GNF-Pf-2368";"C=C[C@H]1CN2CC[C@H]1C[C@@H]2[C@@H](OC(=O)CC)c1ccnc2ccccc12";"IFI";"'='";"1.02";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL579115";"";"0";"482.67";"1";"7.30";"GNF-Pf-2373";"CCN1/C(=C\C=C2/SC(=S)N(c3ccccc3)C2=O)C(C)(C)c2cc(-c3ccccc3)ccc21";"IFI";"'='";"25.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL601765";"";"0";"562.67";"2";"6.63";"GNF-Pf-2376";"CCC(c1nc2ccccc2c(=O)n1-c1ccccc1OC)N(CCc1ccccc1)C(=O)Nc1ccccc1OC";"IFI";"'='";"0.9434";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL578280";"";"0";"349.90";"0";"3.89";"GNF-Pf-2377";"Cl.OC(CCNC1CCCCC1)COc1cccc2ccccc12";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL576573";"";"0";"413.48";"0";"4.32";"GNF-Pf-2387";"Cc1cc(-c2cnc(C)nc2C2CCN(C(=O)c3ccc4ncccc4c3)CC2)on1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL599914";"";"0";"398.51";"1";"5.50";"GNF-Pf-2393";"Cc1cc(C)cc(NC(=O)CCCn2c3ccccc3c(=O)c3cc(C)ccc32)c1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL578087";"";"0";"464.44";"1";"6.12";"GNF-Pf-2404";"O=C(Nc1ccc(SC(F)(F)F)cc1)Nc1cccnc1N1CCC(C(F)(F)F)CC1";"IFI";"'='";"7.339";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL607976";"";"0";"475.98";"1";"5.83";"GNF-Pf-1517";"Cc1ccc(-n2c(C(C)N(Cc3ccco3)C(=O)C3CCC3)nc3cc(Cl)ccc3c2=O)cc1";"IFI";"'='";"3.093";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL577219";"";"0";"490.65";"0";"4.92";"GNF-Pf-1552";"CCn1c(SCC(=O)N(c2ccccc2)c2ccccc2)nc2sc3c(c2c1=O)CCN(C)C3";"IFI";"'='";"2.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL577006";"";"0";"368.50";"0";"1.94";"GNF-Pf-1557";"CCOCCCNC(=O)C1CCCN(S(=O)(=O)c2ccc(C)cc2)C1";"IFI";"'='";"6.757";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL576804";"";"0";"414.51";"1";"6.61";"GNF-Pf-1561";"c1ccc2c(NCCNc3c4ccccc4nc4ccccc34)c3ccccc3nc2c1";"IFI";"'='";"7.317";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL578538";"";"0";"444.31";"0";"4.70";"GNF-Pf-1570";"CCOc1ccc(N=C2NC(=O)S/C2=C2/C(=O)Nc3ccc(Br)cc32)cc1";"IFI";"'='";"1.22";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL586968";"";"0";"552.07";"2";"6.56";"GNF-Pf-1595";"Cc1c(Cl)cccc1-n1c(C(C)N(CCc2ccccc2)C(=O)COc2ccccc2)nc2ccccc2c1=O";"IFI";"'='";"5.556";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL602980";"";"0";"670.39";"0";"4.91";"GNF-Pf-1602";"O=C(COC(c1ccccc1)c1c(Cl)cncc1Cl)N1CCC(c2ccccn2)C1.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F";"IFI";"'='";"0.9709";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL579931";"";"0";"376.49";"0";"3.63";"GNF-Pf-1615";"O=C1N(c2ccccc2)C[C@@H]2C[C@@H](c3ccc4nsnc4c3)N3CCC[C@@]123";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL579943";"";"0";"500.98";"2";"5.91";"GNF-Pf-1621";"Cc1ccc(NC(=O)c2cc(C(=O)c3cc(Cl)ccc3O)cn(-c3ccc(C)c(C)c3)c2=O)cc1C";"IFI";"'='";"6.25";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL588175";"";"0";"383.54";"1";"6.23";"GNF-Pf-1636";"CCN1/C(=C/c2ccc3ccccc3[n+]2CC)Sc2c1ccc1ccccc21";"IFI";"'='";"24.06";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL581054";"";"0";"323.44";"0";"3.09";"GNF-Pf-504";"CCOC(=O)c1sc(=S)n(-c2ccc(N(C)C)cc2)c1N";"IFI";"'='";"1.538";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL579099";"";"0";"338.39";"0";"4.10";"GNF-Pf-2603";"Fc1ccc(Nc2nc(NCC3CCCO3)c3ccccc3n2)cc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585588";"";"0";"279.36";"0";"3.03";"GNF-Pf-1312";"COc1ccc2c(ccc(/C=C3\C=CC=CN3C)[n+]2C)c1";"IFI";"'='";"6.667";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585976";"";"0";"393.24";"0";"1.64";"GNF-Pf-1314";"CCOc1nc2c(c(=O)n(C)c(=O)n2C)n1Cc1cccc(Br)c1";"IFI";"'='";"4.545";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585228";"";"0";"543.75";"2";"6.06";"GNF-Pf-1318";"COc1ccc(CNC2CCN(CCN3CCCCC3)C(c3ccc(OCc4ccccc4)cc3)C2)cc1OC";"IFI";"'='";"11.11";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL612129";"";"0";"255.39";"0";"2.22";"GNF-Pf-1320";"CCN(CC)c1nc(S)nc(NC(C)(C)C)n1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585799";"";"0";"286.74";"0";"4.64";"GNF-Pf-1321";"Fc1ccc(CNc2ccnc3cc(Cl)ccc23)cc1";"IFI";"'='";"6.329";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585985";"";"0";"472.67";"0";"4.86";"GNF-Pf-1323";"COc1cc(C)c(CCNCCCCCCNCCc2cc(OC)c(OC)cc2C)cc1OC";"IFI";"'='";"2.381";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL584427";"";"0";"284.70";"0";"2.16";"GNF-Pf-1331";"O=C(NCC1CCCO1)c1ccc([N+](=O)[O-])cc1Cl";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL584428";"";"0";"381.91";"1";"5.02";"GNF-Pf-1332";"CCc1ccc(C(=O)N(C)CCCNc2ccnc3cc(Cl)ccc23)cc1";"IFI";"'='";"7.339";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585054";"";"0";"386.54";"0";"3.73";"GNF-Pf-1336";"CC(C)(C)CC(=O)N1CCC[C@@H]2CN(C(=O)CCOc3ccccc3)CC[C@@H]21";"IFI";"'='";"1.923";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL195024";"";"0";"446.55";"0";"3.96";"GNF-Pf-1338";"COc1ccc(OC)c(/C=C/C(=O)Nc2ccc3nc(N4CCN(C)CC4)cc(C)c3c2)c1";"IFI";"'='";"11.67";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600561";"";"0";"491.61";"1";"5.52";"GNF-Pf-1350";"C/C(C=C1Sc2ccc3ccoc3c2N1CCO)=C\c1sc2ccc3occc3c2[n+]1CCO";"IFI";"";"";"";"";"";"Not applicable";"";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL583600";"";"0";"325.46";"0";"4.52";"GNF-Pf-1351";"CC1=C(C=CC(C)C=NNC(=O)c2ccncc2)C(C)(C)CCC1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585446";"";"0";"363.51";"0";"4.36";"GNF-Pf-1352";"CC[n+]1c(/C=C2\Sc3cc(C)ccc3N2CCO)ccc2ccccc21";"IFI";"'='";"15.38";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL602635";"";"0";"369.53";"1";"5.99";"GNF-Pf-1356";"CCN1/C(=C/C=C/C2=[N+](C)c3ccc(C)cc3C2(C)C)C=Cc2ccccc21";"IFI";"'='";"28.57";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585637";"";"0";"552.34";"2";"5.32";"GNF-Pf-1357";"O=[N+]([O-])c1ccc(Nc2nc(NN=Cc3ccccc3I)nc(Nc3ccccc3)n2)cc1";"IFI";"'='";"2.632";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585258";"";"0";"347.47";"0";"3.13";"GNF-Pf-1359";"CCNc1ncnc2sc(C(=O)NCc3csc(C)n3)c(C)c12";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL588811";"";"0";"317.44";"1";"5.44";"GNF-Pf-1376";"CC(C)c1ccc(-c2cncc(N[C@@H](C)c3ccccc3)n2)cc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL601129";"";"0";"266.30";"0";"3.99";"GNF-Pf-1387";"Cc1ccc(C(=O)c2c(C)oc3ccc(O)cc23)cc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL576797";"";"0";"445.52";"0";"3.41";"GNF-Pf-1406";"CCN(c1ccc(F)cc1)S(=O)(=O)c1ccc2[nH]cc(C(=O)NC(C)(C)C)c(=O)c2c1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL577001";"";"0";"565.55";"2";"8.29";"GNF-Pf-1407";"CCc1ccc(-n2c(C(CC)N(CCC(C)C)C(=O)Nc3ccc(Cl)c(Cl)c3)nc3ccccc3c2=O)cc1";"IFI";"'='";"6.667";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL576600";"";"0";"373.46";"0";"4.24";"GNF-Pf-1413";"CCc1cccc(NC(=O)CCCn2c(=O)c3cccn3c3ccccc32)c1";"IFI";"'='";"3.704";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL529407";"";"0";"495.15";"1";"7.64";"GNF-Pf-1416";"O=[N+]([O-])c1ccc2nc(Nc3ccc(Cl)c(Cl)c3)c(Nc3ccc(Cl)c(Cl)c3)nc2c1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL578325";"";"0";"390.58";"0";"3.22";"GNF-Pf-1425";"CC(C)CNC(=O)c1cnc(NCCCN(C)C)nc1NCC1CCCCC1";"IFI";"'='";"3.883";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL578326";"";"0";"475.46";"0";"3.80";"GNF-Pf-1426";"COC(=O)c1cccc(NC(=O)/C(=C\c2cccc([N+](=O)[O-])c2)NC(=O)c2ccccc2OC)c1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL602775";"";"0";"643.78";"2";"9.16";"GNF-Pf-1452";"CC(C)c1ccc(C2N(c3ccccc3)C3(C(=O)c4ccccc4C3=O)C(c3ccc(C(C)C)cc3)C23C(=O)c2ccccc2C3=O)cc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL587924";"";"0";"565.64";"2";"7.59";"GNF-Pf-1454";"CCCCCCN(C(=O)c1cccc(C(F)(F)F)c1)C(CC)c1nc2ccccc2c(=O)n1-c1ccccc1OC";"IFI";"'='";"0.9174";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL586465";"";"0";"285.39";"0";"3.06";"GNF-Pf-1459";"COc1ccc2c(c1)N(C)/C(=C/c1cccc[n+]1C)S2";"IFI";"'='";"15.38";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL582653";"";"0";"294.35";"0";"3.95";"GNF-Pf-1461";"CCOc1ccc(NCc2ccc(O)c3ncccc23)cc1";"IFI";"'='";"13.04";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL582441";"";"0";"425.58";"1";"5.09";"GNF-Pf-1463";"Cc1csc(NC(=O)C2c3ccccc3C(=O)N(CC(C)C)C2c2cccs2)n1";"IFI";"'='";"3.03";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL603939";"";"0";"322.22";"0";"3.89";"GNF-Pf-1480";"Cn1c(COc2ccc(Cl)cc2Cl)[n+](C)c2ccccc21";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL577217";"";"0";"420.30";"1";"6.51";"GNF-Pf-1481";"N#C/C(=C\c1ccccc1OCc1ccc(Cl)cc1Cl)c1nc2ccccc2[nH]1";"IFI";"'='";"9.231";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL576602";"";"0";"491.73";"0";"0.93";"GNF-Pf-1487";"CCOC(=O)N1CCN(C(=O)C(=O)NNC(=O)COc2ccc(Cl)cc2Br)CC1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL579372";"";"0";"407.49";"1";"6.53";"GNF-Pf-1494";"CCN1C(=Cc2ccc3c4ccoc4ccc3[n+]2CC)C=Cc2c1ccc1occc21";"IFI";"'='";"28.57";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600501";"";"0";"341.44";"0";"4.08";"GNF-Pf-1502";"CCOc1ccc(NC(=O)C(C)Sc2nc3ccccc3[nH]2)cc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL579765";"";"0";"359.43";"0";"3.99";"GNF-Pf-352";"O=c1c2sccc2nc(SCc2cccc([N+](=O)[O-])c2)n1C1CC1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL472879";"";"0";"324.81";"0";"4.16";"GNF-Pf-359";"Cc1nc(-c2ccccn2)nc(NCCc2ccccc2)c1Cl";"IFI";"'='";"5.405";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL581476";"";"0";"309.48";"0";"4.79";"GNF-Pf-365";"CCCCCC[n+]1ccccc1C=Cc1ccc(N(C)C)cc1";"IFI";"";"";"";"";"";"Not applicable";"";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL582327";"";"0";"411.60";"1";"5.18";"GNF-Pf-603";"O=c1c2c3c(sc2[nH]c(=S)n1C1CCCCC1)CN(Cc1ccccc1)CC3";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL580835";"";"0";"406.53";"0";"3.66";"GNF-Pf-605";"COc1cc2c(cc1OC)C(=NN=C1NC(C)(C)Cc3ccccc31)NC(C)(C)C2";"IFI";"'='";"1.639";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600308";"";"0";"435.50";"0";"4.76";"GNF-Pf-5525";"CCOC(=O)C1=C(C)NC2=C(C(=O)CC(c3ccc(OC)cc3)C2)C1c1cccc(F)c1";"IFI";"'='";"4.651";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL605396";"";"0";"456.37";"1";"5.92";"GNF-Pf-5550";"CCOC(=O)C1=C(C)NC2=C(C(=O)CC(c3ccc(Cl)cc3)C2)C1c1ccccc1Cl";"IFI";"'='";"3.226";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL602363";"";"0";"320.07";"0";"3.03";"GNF-Pf-4786";"Oc1nc(-c2ccccn2)nc(C(F)(F)F)c1Br";"IFI";"'='";"8.772";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL576811";"";"0";"505.59";"2";"5.69";"GNF-Pf-5145";"COc1ccc(C2CC(=O)C3=C(C2)NC(C)=C(C(=O)OC2CCCC2)C3c2ccc(F)cc2)cc1OC";"IFI";"'='";"8.434";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL582446";"";"0";"546.72";"1";"4.75";"GNF-Pf-5157";"COc1ccc(CCNc2nc(NCCCN3CCCCC3C)ncc2C(=O)NCc2ccccc2)cc1OC";"IFI";"'='";"3.81";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585457";"";"0";"361.49";"0";"2.98";"GNF-Pf-4828";"CN(C)CCN1CCN(c2cccc(-c3cccc4cccnc34)n2)CC1";"IFI";"'='";"4.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL602770";"";"0";"281.42";"0";"4.01";"GNF-Pf-4835";"CCN(CC)c1ccc(C=Cc2cccc[n+]2CC)cc1";"IFI";"";"";"";"";"";"Not applicable";"";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600323";"";"0";"296.36";"0";"2.55";"GNF-Pf-2809";"O=C1CSC(=NN=Cc2cccnc2)N1c1ccccc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL531656";"";"0";"351.41";"0";"4.02";"GNF-Pf-4257";"COc1ccc(C=NNc2cc(C)nc3ccc(OC)cc23)c(OC)c1";"IFI";"'='";"7.692";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600492";"";"0";"648.73";"2";"9.58";"GNF-Pf-4272";"O=C(Nc1ccc(-c2nc3ccc(-c4nc5ccc(NC(=O)c6cccc7ccccc67)cc5[nH]4)cc3[nH]2)cc1)c1cccc2ccccc12";"IFI";"'='";"5.97";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL606046";"";"0";"303.43";"0";"4.05";"GNF-Pf-4173";"Cc1ccc(C[n+]2cc(-c3ccc(C)cc3)n3c2CCC3)cc1";"IFI";"'='";"4.878";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL584010";"";"0";"296.35";"0";"3.92";"GNF-Pf-1073";"O=C1NC(=Nc2ccccc2)/C(=C/c2ccc(O)cc2)S1";"IFI";"";"";"";"";"";"Not applicable";"";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL584642";"";"0";"388.40";"0";"1.73";"GNF-Pf-1109";"COc1ccc2oc(=O)c(C(=O)N(C)c3ccc(S(N)(=O)=O)cc3)cc2c1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL584647";"";"0";"376.53";"0";"1.35";"GNF-Pf-1117";"Cc1nc(N2CCN(C)CC2)c2c(C)c(C(=O)NCCN(C)C)sc2n1";"IFI";"'='";"1.124";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL602427";"";"0";"460.98";"0";"4.53";"GNF-Pf-1132";"COc1cccc(C2CC3(CC(C)(C)NC(=S)N3)Oc3cc(OC(C)=O)c(Cl)cc32)c1";"IFI";"'='";"3.125";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL586712";"";"0";"459.55";"0";"4.92";"GNF-Pf-2008";"Cc1ccc(S(=O)(=O)N=C2C=C(Sc3nc4ccccc4[nH]3)C(=O)c3ccccc32)cc1";"IFI";"'='";"12.66";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL533855";"";"0";"662.87";"1";"3.60";"GNF-Pf-2381";"CCOc1ccc(CN2CCN(CC(O)COc3ccc(OCC(O)CN4CCN(Cc5ccc(OCC)cc5)CC4)cc3)CC2)cc1";"IFI";"'='";"7.143";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585024";"";"0";"363.40";"0";"3.67";"GNF-Pf-1150";"O=C(NNc1nc(-c2cc3ccccc3oc2=O)cs1)c1ccccc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL583353";"";"0";"449.51";"0";"3.79";"GNF-Pf-1171";"CSc1nccc(-c2cc(F)cc3c2OC(CNC(=O)C2CC(=O)c4ccccc42)C3)n1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600560";"";"0";"318.42";"0";"4.76";"GNF-Pf-1198";"Cc1ccc(Nc2cc(C)nc(NCc3ccccc3)n2)c(C)c1";"IFI";"'='";"10.45";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL582573";"";"0";"335.40";"0";"4.60";"GNF-Pf-1220";"CCCCCOc1ccc(/C=C2/N=C(c3ccccc3)OC2=O)cc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL582313";"";"0";"480.49";"1";"5.59";"GNF-Pf-398";"O=C(Nc1ccc(F)c(F)c1)c1cc2cc(C3(O)CCN(Cc4ccccc4F)CC3)ccc2o1";"IFI";"'='";"2.97";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL579560";"";"0";"342.83";"0";"2.86";"GNF-Pf-402";"NS(=O)(=O)c1ccc(N/C=C/C(=O)c2ccc(Cl)s2)cc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL581902";"";"0";"294.38";"0";"3.89";"GNF-Pf-411";"Cc1ccccc1/C=C1/SC(=Nc2ccccc2)NC1=O";"IFI";"'='";"3.448";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585060";"";"0";"528.65";"2";"6.58";"GNF-Pf-1267";"CCCCCN(C(=O)Nc1ccccc1OC)C(C)c1nc2ccccc2c(=O)n1-c1ccccc1OCC";"IFI";"'='";"3.704";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL579111";"";"0";"478.64";"0";"3.62";"GNF-Pf-2680";"CCN1CCN(C(=O)Nc2ccc(Cc3ccc(NC(=O)N4CCN(CC)CC4)cc3)cc2)CC1";"IFI";"'='";"1.124";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL306946";"TRYPTANTHRIN";"0";"248.24";"0";"1.93";"GNF-Pf-2691";"O=C1c2ccccc2-n2c1nc1ccccc1c2=O";"IFI";"'='";"2.19";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL602797";"";"0";"455.54";"0";"2.27";"GNF-Pf-2707";"COC(=O)c1cn([C@H]2C[C@@H](C(=O)NCc3ccc(OC)cc3)N(Cc3ccsc3)C2)nn1";"IFI";"'='";"1.98";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL601579";"";"0";"443.98";"0";"3.97";"GNF-Pf-2720";"COCCCNC(=O)c1cc(NC(=O)CCCCl)ccc1N1CCc2ccccc2C1";"IFI";"'='";"2.174";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL578483";"";"0";"443.60";"0";"2.45";"GNF-Pf-2758";"CCN1CCN(c2nc3ccccn3c(=O)c2/C=C2\SC(=S)N(C(C)C)C2=O)CC1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL579327";"";"0";"325.46";"0";"3.95";"GNF-Pf-2764";"Cc1ccc2[nH]c3c(NCCN(C(C)C)C(C)C)ncnc3c2c1";"IFI";"'='";"5.128";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL578933";"";"0";"480.59";"1";"7.28";"GNF-Pf-2782";"COc1cc(-c2nc(-c3ccc(Sc4ccccc4)cc3)c(-c3ccccc3)[nH]2)cc(OC)c1O";"IFI";"'='";"4.651";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL579092";"";"0";"440.96";"0";"4.56";"GNF-Pf-2810";"CN(CCCNc1ccnc2cc(Cl)ccc12)S(=O)(=O)c1cccc2cccnc12";"IFI";"'='";"6.481";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL599721";"";"0";"398.20";"0";"3.58";"GNF-Pf-4211";"COc1ccc(C(=O)ON=C(N)Cc2ccc(Cl)cc2Cl)cc1[N+](=O)[O-]";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL527972";"";"0";"625.79";"2";"5.86";"GNF-Pf-4220";"Cc1ccc(N(C(=O)c2snc(C(=O)NC3CCCCC3)c2N)C(C(=O)NCCc2ccccc2)c2ccc(O)cc2)c(C)c1";"IFI";"'='";"5.208";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL601325";"";"0";"332.51";"0";"4.23";"GNF-Pf-4228";"OC1CCCCC1C1(NC(=S)Nc2ccccc2)CCCCC1";"IFI";"'='";"2.128";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585496";"";"0";"459.70";"0";"3.45";"GNF-Pf-4236";"CCc1ccc2[nH]c(=O)c(CN(CCCN(CC)CC)C(=S)NCCCN(C)C)cc2c1";"IFI";"'='";"2.727";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL528462";"";"0";"448.78";"1";"5.01";"GNF-Pf-4240";"Cl.N=c1n(Cc2ccccc2)c2ccccc2n1CC(O)c1ccc(Cl)c(Cl)c1";"IFI";"'='";"14.29";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL274189";"PALMATINE CHLORIDE";"0";"387.86";"0";"3.38";"GNF-Pf-4086";"COc1cc2c(cc1OC)-c1cc3ccc(OC)c(OC)c3c[n+]1CC2.[Cl-]";"IFI";"'='";"1.613";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL597247";"";"0";"383.33";"0";"4.47";"GNF-Pf-4098";"Cc1ccc(-[n+]2c(-c3ccccc3)cn3c2CCCCC3)cc1.[Br-]";"IFI";"'='";"6.422";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585467";"";"0";"490.91";"1";"5.38";"GNF-Pf-4148";"COc1ccc(Nc2nc(NN=Cc3cccc(Cl)c3)nc(Nc3ccc([N+](=O)[O-])cc3)n2)cc1";"IFI";"'='";"3.947";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL597249";"";"0";"507.03";"2";"6.10";"GNF-Pf-4181";"CCOC(=O)c1ccc(N2CCN(c3cc(C)ccc3C)CC2)c(NC(=O)Nc2ccc(Cl)cc2)c1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL601319";"";"0";"282.80";"0";"1.98";"GNF-Pf-4189";"CN(C)c1cc[n+](CC(=O)c2cccs2)cc1.[Cl-]";"IFI";"'='";"3.226";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600122";"";"0";"364.45";"0";"3.75";"GNF-Pf-5137";"CCOC(=O)C1=C(C)NC(=Cc2cc(C)n(-c3ccc(C)cc3)c2C)C1=O";"IFI";"";"";"";"";"";"Not applicable";"";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL601783";"";"0";"531.61";"1";"4.40";"GNF-Pf-5139";"COc1ccccc1NC(=O)N1CCN(C(=O)c2nc(-c3ccccc3)nc(C)c2C(=O)OC(C)C)CC1C";"IFI";"'='";"0.9434";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL601817";"";"0";"393.42";"0";"2.01";"GNF-Pf-5010";"COC(=O)CC(NS(=O)(=O)c1ccc(OC)cc1)c1ccc2c(c1)OCO2";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL599945";"";"0";"384.85";"1";"5.89";"GNF-Pf-5111";"FC(F)(F)c1cccc(NC(=S)N2CCCC2c2ccccc2Cl)c1";"IFI";"'='";"3.636";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL582956";"";"0";"313.57";"0";"3.42";"GNF-Pf-5112";"N#Cc1c(N)nc(C(Cl)(Cl)Cl)nc1-c1ccccc1";"IFI";"'='";"1.471";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL582392";"";"0";"367.36";"0";"3.11";"GNF-Pf-5121";"CCOC(=O)c1c(-c2ccc3c(c2)OCO3)[nH]c2cc(OC)ccc2c1=O";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585028";"";"0";"396.92";"1";"5.05";"GNF-Pf-5128";"Oc1ccc(-c2ccnc3cc(Cl)ccc23)cc1CNCC1(O)CCCCC1";"IFI";"'='";"2.586";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL579369";"";"0";"492.65";"1";"6.05";"GNF-Pf-5131";"Cc1ccc(Cn2c(SCc3ccc(C(=O)NCCc4ccccc4)cc3)nc3ccncc32)cc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600291";"";"0";"295.35";"0";"2.76";"GNF-Pf-4656";"CCOc1cccc(Nc2c3c(nc4ncnn24)CCC3)c1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL584649";"";"0";"465.98";"1";"5.75";"GNF-Pf-4661";"CCC(C)OC(=O)C1=C(C)NC2=C(C(=O)CC(c3ccc(Cl)cc3)C2)C1c1cccc(O)c1";"IFI";"'='";"2.439";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL584654";"";"0";"421.59";"1";"6.72";"GNF-Pf-4664";"CCCCC(=O)Oc1ccccc1-c1nc2ccccn2c1NC(C)(C)CC(C)(C)C";"IFI";"'='";"4.717";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL584447";"";"0";"535.05";"1";"5.54";"GNF-Pf-4670";"CCC(C)CNC(=O)c1ccc(OC2CCN(CC3CCCCC3)CC2)c(Cl)c1.O=C(O)C(F)(F)F";"IFI";"'='";"2.778";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL603030";"";"0";"407.56";"0";"3.87";"GNF-Pf-4686";"CC(C)(C)c1csc(NC(=O)c2ccc(S(=O)(=O)N3CCCCC3)cc2)n1";"IFI";"'='";"3.371";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585221";"";"0";"378.49";"0";"4.41";"GNF-Pf-4696";"CCOc1ccc(-c2cc(C)[n+](CCO)c(-c3ccc(OCC)cc3)c2)cc1";"IFI";"'='";"7.273";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL602628";"";"0";"483.66";"1";"7.73";"GNF-Pf-4747";"CCC(C(=O)Oc1ccccc1-c1nc2ccccn2c1NC(C)(C)CC(C)(C)C)c1ccccc1";"IFI";"'='";"4.717";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL599953";"";"0";"314.39";"0";"3.93";"GNF-Pf-4772";"O=C(c1c2c(nc3ccccc13)CCC2)N1CCc2ccccc21";"IFI";"'='";"2.857";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585217";"";"0";"310.46";"0";"3.93";"GNF-Pf-4775";"CCCCCSc1scc(-c2ccc(O)c(O)c2)[n+]1C";"IFI";"'='";"6.504";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL531495";"";"0";"527.21";"0";"4.05";"GNF-Pf-4785";"Br.CCOC(=O)c1c(CNc2ccncc2)n(C)c2cc(Br)c(OC(C)=O)cc12";"IFI";"'='";"3.03";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL583554";"";"0";"538.37";"2";"7.07";"GNF-Pf-4790";"CC(C)CCN(CCC(C)C)CC(O)Cn1c2ccc(Br)cc2c2cc(Br)ccc21";"IFI";"'='";"5.505";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL584430";"";"0";"276.36";"0";"3.84";"GNF-Pf-4796";"COc1ccc(/C=C/c2ccc3ccccc3[n+]2C)cc1";"IFI";"'='";"10.58";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL584636";"";"0";"362.43";"0";"3.64";"GNF-Pf-4799";"CCCNC1=C(N(C(C)=O)c2ccc(C)cc2)C(=O)c2ccccc2C1=O";"IFI";"'='";"18.4";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL532545";"";"0";"297.79";"1";"5.09";"GNF-Pf-4811";"CC(Cl)=CCc1c(C)nc2c(ccc3ccccc32)c1O";"IFI";"";"";"";"";"";"Not applicable";"";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585823";"";"0";"378.40";"0";"3.57";"GNF-Pf-4821";"CC(=O)N(C1=C(N2CCCC2)C(=O)c2ccccc2C1=O)c1ccc(F)cc1";"IFI";"'='";"8.108";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585642";"";"0";"371.40";"0";"1.23";"GNF-Pf-4830";"CCOc1cc(-c2nc3c(=O)n(C)c(=O)nc-3n(C)n2)ccc1OC(C)C";"IFI";"'='";"30.77";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL581118";"";"0";"422.57";"1";"6.00";"GNF-Pf-4844";"Cc1ccn2c(NC(C)(C)CC(C)(C)C)c(-c3ccccc3OC(=O)N(C)C)nc2c1";"IFI";"'='";"4.717";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585454";"";"0";"429.98";"0";"4.91";"GNF-Pf-4890";"CCn1c(CNc2ccc(Cl)cc2)nnc1SCC(=O)Nc1cccc(C)c1C";"IFI";"'='";"2.885";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL587356";"";"0";"423.56";"1";"5.49";"GNF-Pf-5202";"COCC(=O)Oc1ccccc1-c1nc2cc(C)ccn2c1NC(C)(C)CC(C)(C)C";"IFI";"'='";"3.738";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL582215";"";"0";"391.23";"0";"3.97";"GNF-Pf-5213";"C[n+]1c(/C=C\c2ccc(F)cc2)ccc2ccccc21.[I-]";"IFI";"'='";"3.488";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL602981";"";"0";"285.33";"0";"3.19";"GNF-Pf-5220";"CCc1nc2nc(C)cc(Nc3ccc(C)c(F)c3)n2n1";"IFI";"'='";"1.818";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL579905";"";"0";"305.43";"0";"4.28";"GNF-Pf-5260";"CCN1CCCC(Nc2ccnc3cc4ccccc4cc23)C1";"IFI";"'='";"11.76";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL587633";"";"0";"516.25";"2";"2.47";"GNF-Pf-5263";"Nc1nonc1-n1nnc(C(=O)NN=Cc2ccc(F)c(Br)c2)c1-c1ccc([N+](=O)[O-])cc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL588827";"";"0";"426.51";"0";"2.87";"GNF-Pf-5272";"COC(=O)[C@@H]1C[C@@H](NC(=O)c2ccc(OC)cc2OC)CN1Cc1ccc(C)cc1C";"IFI";"'='";"0.8772";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600118";"";"0";"362.47";"0";"4.15";"GNF-Pf-5616";"COc1cccc(-c2ccc(O)c(CNCC3CC4C=CC3C43CC3)c2)n1";"IFI";"'='";"4.31";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL602595";"";"0";"299.39";"0";"4.57";"GNF-Pf-5626";"Oc1ccc(-c2ccc(F)cc2)cc1CN1CCCCCC1";"IFI";"'='";"1.709";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL579292";"";"0";"324.42";"0";"3.03";"GNF-Pf-5637";"C=CC1CN2CCC1C(C(O)c1ccnc3ccc(OC)cc13)C2";"IFI";"'='";"2.29";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL609153";"";"0";"545.68";"2";"6.55";"GNF-Pf-5643";"CCC(c1nc2ccccc2c(=O)n1-c1ccccc1OC)N(CCc1ccccc1)C(=O)CCc1ccccc1";"IFI";"'='";"2.247";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL580284";"";"0";"384.30";"0";"4.08";"GNF-Pf-5650";"CCOc1cc2c(cc1OCC)C(c1ccc(O)c(Cl)c1)NCC2.Cl";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL579940";"";"0";"434.54";"0";"2.02";"GNF-Pf-5365";"O=[N+]([O-])c1ccc(S(=O)(=O)N2CCN(C(=S)NCCc3ccccc3)CC2)cc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL578528";"";"0";"530.45";"2";"6.33";"GNF-Pf-5374";"CCCOC(=O)C1=C(C)NC2=C(C(=O)CC(c3ccc(OC)c(OC)c3)C2)C1c1ccc(Cl)c(Cl)c1";"IFI";"'='";"4.706";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL577850";"";"0";"296.11";"0";"4.13";"GNF-Pf-5379";"O=C(c1cccc([N+](=O)[O-])c1)c1ccc(Cl)c(Cl)c1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL530432";"";"0";"499.03";"1";"5.99";"GNF-Pf-5386";"COc1cc(OC)c(NC(=O)C2c3ccccc3C(=O)N(CC(C)C)C2c2cccs2)cc1Cl";"IFI";"'='";"6.061";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL576808";"";"0";"389.46";"0";"4.07";"GNF-Pf-5391";"CC(=NO)c1ccc(NC2=C(N3CCCCC3)C(=O)c3ccccc3C2=O)cc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL576809";"";"0";"466.51";"0";"4.98";"GNF-Pf-5392";"CCOC(=O)c1cccc(NC(=O)CCn2c(-c3ccc(F)cc3)cc(C(=O)OCC)c2C)c1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL547476";"";"0";"370.49";"0";"3.80";"GNF-Pf-5523";"CCCN(CCC)CC(O)COc1ccccc1C(=O)Nc1ccccc1";"IFI";"'='";"1.515";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL576407";"";"0";"462.55";"0";"3.90";"GNF-Pf-5527";"CCCN(C(=O)C(=O)Nc1ccc2nc3n(c(=O)c2c1)CCCCC3)c1ccc(OCC)cc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL576408";"";"0";"364.49";"0";"4.52";"GNF-Pf-5528";"COc1cccc(-c2ccc(O)c(CNC34CC5CC(CC(C5)C3)C4)c2)n1";"IFI";"'='";"3.448";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL602403";"";"0";"477.56";"0";"4.64";"GNF-Pf-5531";"CCOC(=O)C1=C(C)NC2=C(C(=O)CC(c3ccc(OC)c(OC)c3)C2)C1c1ccccc1OC";"IFI";"'='";"2.326";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL588749";"";"0";"332.21";"0";"3.56";"GNF-Pf-5536";"Cc1cc(Nc2ccc(Br)c(C)c2)n2nc(C)nc2n1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL588690";"";"0";"388.49";"0";"3.44";"GNF-Pf-5548";"CCC(=O)Nc1cc(NC(=O)CSc2nc(C)c(CC)c(O)n2)ccc1C";"IFI";"'='";"5.455";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL532209";"";"0";"536.42";"1";"4.03";"GNF-Pf-5553";"CCOC(=O)C1=C(C)NC2=C(C(=O)C(C(=O)OC)C(C)C2)C1c1cc(Br)c(OCC)c(OC)c1";"IFI";"'='";"5.814";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL531221";"";"0";"301.39";"0";"3.22";"GNF-Pf-5555";"CCCCCc1cc(O)c2c3c(c(=O)oc2c1)CN(C)CC3";"IFI";"'='";"2.29";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585220";"";"0";"367.83";"0";"4.05";"GNF-Pf-4625";"O=C1CC(c2ccc(O)cc2)C2=C(CC(c3ccccc3Cl)CC2=O)N1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL602627";"";"0";"488.47";"1";"6.03";"GNF-Pf-4675";"CN1CCc2c(sc3nc(SCc4ccc(Cl)cc4)n(-c4cccc(Cl)c4)c(=O)c23)C1";"IFI";"'='";"11.54";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600086";"";"0";"350.64";"1";"5.06";"GNF-Pf-4712";"Cc1cc(NC(=O)C=Cc2ccccc2Cl)ccc1Br";"IFI";"";"";"";"";"";"Not applicable";"";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL584868";"";"0";"464.97";"0";"4.83";"GNF-Pf-4746";"Cc1ccc(NC(=O)c2ccc(NCCCN3CCC(C)CC3)c([N+](=O)[O-])c2)cc1F.Cl";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585643";"";"0";"484.40";"1";"6.00";"GNF-Pf-4831";"Cc1ccc(C2CC(C(F)(F)F)n3ncc(C(=O)Nc4ccc(OC(F)(F)F)cc4)c3N2)cc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL584829";"";"0";"335.84";"0";"3.43";"GNF-Pf-4857";"CCOC(=O)c1cnc2ccc(Cl)cc2c1NCCCN(C)C";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL608259";"";"0";"367.54";"0";"3.95";"GNF-Pf-4887";"CCCCNCCN1CCN(c2ccc(OC)cc2)C[C@@H]1c1ccccc1";"IFI";"'='";"2.439";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL527850";"";"0";"634.78";"1";"3.92";"GNF-Pf-4903";"CCN(CC)S(=O)(=O)c1ccc(C(=O)NCc2nnc(SCC(=O)N3CCc4ccccc43)n2-c2ccccc2OC)cc1";"IFI";"'='";"3.571";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL580480";"";"0";"319.38";"0";"1.30";"GNF-Pf-4907";"O=C(CN1CCC(NC(=O)c2cccc(F)c2)CC1)NC1CC1";"IFI";"'='";"1.587";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL580636";"";"0";"363.51";"0";"4.36";"GNF-Pf-4918";"CC[n+]1c(/C=C2\Sc3ccc(C)cc3N2CCO)ccc2ccccc21";"IFI";"";"";"";"";"";"Not applicable";"";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL601602";"";"0";"323.76";"0";"2.69";"GNF-Pf-4920";"CN(C)C=Nc1nn(C)cc1C(=O)Nc1ccc(F)c(Cl)c1";"IFI";"'='";"0.8197";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585052";"";"0";"342.91";"0";"4.89";"GNF-Pf-4939";"CCCN1CCC(NC(c2ccccc2)c2ccc(Cl)cc2)CC1";"IFI";"'='";"1.613";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL602636";"";"0";"499.61";"1";"6.88";"GNF-Pf-4964";"Cc1ccn2c(NC(C)(C)CC(C)(C)C)c(-c3ccccc3OC(=O)c3ccc4c(c3)OCO4)nc2c1";"IFI";"'='";"2.804";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585832";"";"0";"458.37";"0";"4.99";"GNF-Pf-4969";"CN(C=Cc1sc2ccc3ccccc3c2[n+]1C)c1ccccc1.[I-]";"IFI";"";"";"";"";"";"Not applicable";"";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585647";"";"0";"365.44";"0";"4.60";"GNF-Pf-4973";"c1cncc(CCNc2nccn3c(-c4ccc5ccccc5c4)cnc23)c1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL583539";"";"0";"374.88";"1";"5.94";"GNF-Pf-4985";"CCc1c(C)c(C#N)c2nc3ccccc3n2c1Nc1ccc(C)c(Cl)c1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL577643";"";"0";"379.59";"0";"3.11";"GNF-Pf-2190";"COCCNC(=O)[C@@H]1C[C@@H](NCCC2=C(C)CCCC2(C)C)CN1C(C)C";"IFI";"'='";"1.923";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL577654";"";"0";"378.71";"1";"5.40";"GNF-Pf-2205";"Clc1ccc(-c2c[n+](Cc3ccccc3Cl)c3n2CCC3)cc1Cl";"IFI";"'='";"7.317";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL579300";"";"0";"396.92";"0";"4.96";"GNF-Pf-2217";"O=c1cc(NC2CCN(CCCc3ccccc3)CC2)c2cc(Cl)ccc2o1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL603013";"";"0";"317.46";"0";"4.78";"GNF-Pf-2219";"Cc1ccc(-c2cn3c([n+]2-c2ccc(C)cc2)CCCCC3)cc1";"IFI";"'='";"15.38";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL183";"1,3-DIPROPYL-8-CYCLOPENTYLXANTHINE [DPCPX]";"0";"304.39";"0";"2.36";"GNF-Pf-2224";"CCCn1c(=O)c2[nH]c(C3CCCC3)nc2n(CCC)c1=O";"IFI";"'='";"1.408";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL578693";"";"0";"454.54";"0";"4.48";"GNF-Pf-2232";"CCOc1ccc(C2C(=O)N(C3CCCCC3)CC(=O)N2Cc2ccc(F)cc2)cc1OC";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL601151";"";"0";"445.61";"0";"3.97";"GNF-Pf-2280";"COc1cccc(N2CCN(CCNCCc3ccccc3)[C@@H](Cc3ccc(O)cc3)C2)c1";"IFI";"'='";"2.469";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL578470";"";"0";"409.51";"0";"3.25";"GNF-Pf-2289";"Cc1ccccc1[S+]([O-])Cc1ccc(C(=O)N2CCN(c3ccccn3)CC2)o1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL4298702";"";"0";"474.64";"1";"8.80";"GNF-Pf-2299";"c1ccc(C2CC(C3CC(c4ccccc4)OC(c4ccccc4)C3)CC(c3ccccc3)O2)cc1";"IFI";"'='";"13.33";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL578061";"";"0";"262.32";"0";"3.96";"GNF-Pf-2301";"c1ccc(Nc2ccnc(Nc3ccccc3)n2)cc1";"IFI";"'='";"5.195";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL578063";"ALAZANINE";"0";"365.55";"1";"5.70";"GNF-Pf-2304";"CCN1/C(=C/C=C/c2sc3ccccc3[n+]2CC)Sc2ccccc21";"IFI";"";"";"";"";"";"Not applicable";"";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL579336";"";"0";"394.49";"1";"5.06";"GNF-Pf-2313";"O=C1CN(C(=O)CCC2CCCCC2)C(c2ccccc2)c2cc(F)ccc2N1";"IFI";"'='";"5.882";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL533623";"";"0";"209.28";"0";"0.14";"GNF-Pf-2320";"CC(=NNC(=S)NN)c1ccccn1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL599915";"";"0";"463.56";"0";"4.60";"GNF-Pf-2321";"CCOc1ccc(S(=O)(=O)c2cn(Cc3ccccc3C)c3ccc(OC)cc3c2=O)cc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL601352";"";"0";"381.51";"0";"3.44";"GNF-Pf-2328";"Cc1sc2nc3c4ccccc4c(NCCCN(C)C)nn3c(=O)c2c1C";"IFI";"'='";"12.5";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL536118";"";"0";"312.84";"0";"4.04";"GNF-Pf-2341";"N=c1c2c(n(Cc3cccc(Cl)c3)c3c1CCC3)CCCC2";"IFI";"'='";"14.29";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600899";"";"0";"650.57";"2";"7.95";"GNF-Pf-421";"Cc1ccc(N2C(=O)C3C(C2=O)C2(c4ccccc4)C(=O)C3(c3ccccc3)C(c3ccccc3)=C2c2ccccc2)cc1Br";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL602362";"";"0";"595.79";"2";"5.79";"GNF-Pf-427";"CCOC(=O)c1c(NC(=O)CSc2nnc(CNC(=O)c3ccc(C)c(C)c3)n2C2CCCCC2)sc2c1CCC2";"IFI";"'='";"2.41";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600340";"";"0";"321.42";"0";"3.52";"GNF-Pf-431";"c1ccc2cc3c(NCCCN4CCOCC4)ccnc3cc2c1";"IFI";"'='";"12.73";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL601593";"";"0";"402.95";"0";"3.39";"GNF-Pf-442";"Cc1ccc2nc(Cl)c3cc(C(=O)NCCN4CCN(C)CC4)sc3c2c1";"IFI";"'='";"2.439";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL581478";"";"0";"481.45";"1";"8.04";"GNF-Pf-463";"Cc1ccc(N=C2S/C(=C\c3c(Cl)cccc3Cl)C(=O)N2c2ccc(C)c(C)c2)cc1C";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL582112";"";"0";"246.31";"0";"1.65";"GNF-Pf-497";"CCC(=O)N1CCN(C(=O)c2ccc(C)cc2)C1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL582730";"";"0";"410.57";"0";"3.37";"GNF-Pf-615";"CC(C)CNc1nc(NCCN2CCCCC2)ncc1C(=O)NCc1ccccc1";"IFI";"'='";"2.857";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL602623";"";"0";"374.45";"0";"2.18";"GNF-Pf-617";"CN1CCN(C(=O)c2cccc(-c3nc(-c4ccncc4)cnc3N)c2)CC1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL581048";"";"0";"296.37";"0";"3.89";"GNF-Pf-618";"CCOc1ccc(N2C(=O)c3ccccc3NC2(C)C)cc1";"IFI";"'='";"4.615";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL604121";"";"0";"418.52";"0";"4.35";"GNF-Pf-641";"CC1(C)CC(=O)C(=CNc2nc3c(s2)CCc2c-3cnn2-c2ccccc2)C(=O)C1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL604106";"";"0";"390.44";"0";"4.47";"GNF-Pf-648";"Cc1ccc2c(nc3sc(=Cc4ccc(-c5ccccc5F)o4)c(=O)n32)c1C";"IFI";"'='";"3.571";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL599509";"";"0";"377.46";"0";"3.56";"GNF-Pf-666";"Cc1ccccc1Oc1ccc(S(=O)(=O)NC(CC(C)C)C(=O)O)cc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL596838";"";"0";"309.35";"0";"2.09";"GNF-Pf-709";"CCC(=O)N=c1sc2cc([N+](=O)[O-])ccc2n1CCOC";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL599501";"";"0";"391.47";"1";"6.00";"GNF-Pf-712";"Cc1ccnc(NC(c2ccc3ccccc3c2)c2ccc3cccnc3c2O)c1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL599705";"";"0";"305.38";"0";"0.17";"GNF-Pf-714";"Cc1ccc(C(=O)NCCNC(=O)CN2CCOCC2)cc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL597666";"";"0";"394.47";"1";"5.49";"GNF-Pf-727";"CCCc1cc2c(=O)c(-c3ccc4c(c3)OCO4)c(CC)oc2cc1OC(C)C";"IFI";"'='";"4.819";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL604156";"";"0";"356.25";"0";"3.56";"GNF-Pf-744";"O=C(CCCOc1ccc(Cl)cc1Cl)NCCCn1ccnc1";"IFI";"'='";"1.562";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL3144827";"";"0";"421.45";"0";"2.94";"GNF-Pf-746";"Cc1[nH]n(-c2ccccc2)c(=O)c1C(=O)CN(C(=O)c1ccc2c(c1)OCO2)C(C)C";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL536695";"";"0";"360.80";"0";"4.60";"GNF-Pf-756";"O=C(Nc1cccnc1)c1cc(-c2cccnc2)nc2ccc(Cl)cc12";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL272911";"";"0";"339.42";"0";"3.35";"GNF-Pf-774";"CN(C)c1ccc(/C=C2/SC(=Nc3ccc(O)cc3)NC2=O)cc1";"IFI";"";"";"";"";"";"Not applicable";"";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL599092";"";"0";"539.72";"2";"7.48";"GNF-Pf-790";"CCCCCN(C(=O)c1ccc(C(C)(C)C)cc1)C(CC)c1nc2ccccc2c(=O)n1-c1ccccc1OC";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL535267";"";"0";"379.63";"0";"1.48";"GNF-Pf-809";"CC1(C)N=C(N)N=C(N)N1c1ccc(I)cc1.Cl";"IFI";"'='";"5.97";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL582958";"";"0";"498.66";"1";"5.07";"GNF-Pf-825";"CC(C)CC(=O)OC1C(N2CCCCC2)c2c(ccc(C=CC(=O)N3CCCCC3)c2O)OC1(C)C";"IFI";"";"";"";"";"";"Not applicable";"";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL582961";"";"0";"499.41";"1";"5.01";"GNF-Pf-830";"COC(=O)C1=C(C)N(c2ccc(N(C)C)cc2)C(C)=C(C(=O)OC)C1c1ccc(Br)cc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL258137";"TYLOPHORINE";"0";"393.48";"0";"4.55";"GNF-Pf-838";"COc1cc2c3c(c4cc(OC)c(OC)cc4c2cc1OC)CN1CCC[C@@H]1C3";"IFI";"'='";"5.263";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600093";"";"0";"433.42";"0";"0.60";"GNF-Pf-849";"Cn1c(=O)c2c(nc(N3CCN(C(=O)Nc4ccc(F)cc4F)CC3)n2C)n(C)c1=O";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL583137";"";"0";"293.45";"0";"4.30";"GNF-Pf-852";"CC(=O)N1CCOC1C(C)(C)C/C=C(\C)CCC=C(C)C";"IFI";"'='";"1.471";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL583158";"";"0";"518.06";"2";"6.83";"GNF-Pf-873";"CCCCCN(C(=O)c1ccc(Cl)cc1)C(CC)c1nc2ccccc2c(=O)n1-c1ccccc1OC";"IFI";"'='";"1.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL583812";"";"0";"292.33";"0";"2.70";"GNF-Pf-892";"COC(=O)N(C)C(C)(C)C(C)=NOC(=O)c1ccccc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL583813";"";"0";"258.25";"0";"3.25";"GNF-Pf-895";"CCOP(=O)(OCC)C(O)c1ccc(C)cc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL583595";"";"0";"564.10";"1";"4.33";"GNF-Pf-901";"CN1CCC(N[C@@H]2C[C@@H](C(=O)N3CCN(c4cccc(C(F)(F)F)c4)CC3)N(Cc3ccccc3Cl)C2)CC1";"IFI";"'='";"1.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL530679";"";"0";"241.32";"0";"3.25";"GNF-Pf-919";"c1ccc(CSc2nc3ccncc3[nH]2)cc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL583362";"";"0";"443.55";"0";"3.10";"GNF-Pf-938";"CCN1CCCC1CNC(=O)CN1N=C(c2ccccc2)Cn2c(cc3ccccc32)C1=O";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL584228";"";"0";"327.34";"0";"2.38";"GNF-Pf-950";"COc1ccc(/C=C/C(=O)NC(=O)c2ccccc2O)cc1OC";"IFI";"'='";"8.333";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL602825";"";"0";"428.54";"0";"3.42";"GNF-Pf-958";"Cc1ccc(S(=O)(=O)N=C(NS(=O)(=O)c2ccc(C)cc2)c2ccccc2)cc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL583819";"";"0";"365.44";"0";"4.16";"GNF-Pf-970";"c1ccc(-c2cc(N3CCc4ccccc4C3)nc(-c3ccccn3)n2)nc1";"IFI";"'='";"7.692";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL583820";"";"0";"431.54";"0";"3.91";"GNF-Pf-971";"COc1ccc(C2c3[nH]c4ccccc4c3C[C@@H]3C(=O)N(CCC(C)C)CC(=O)N23)cc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL584008";"";"0";"359.88";"1";"5.73";"GNF-Pf-990";"CC[n+]1c(C=C2C=CN(c3ccc(Cl)cc3)C=C2)ccc2ccccc21";"IFI";"'='";"15.38";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL584009";"";"0";"401.92";"0";"3.99";"GNF-Pf-993";"CCC(C)NC(=O)CSc1nnc(-c2cccnc2)n1-c1ccc(Cl)cc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL528241";"";"0";"548.56";"2";"5.31";"GNF-Pf-996";"COC(=O)c1ccc(C(=O)Nc2ccc(-c3nc4cc(NC(=O)c5ccc(C(=O)OC)cc5)ccc4[nH]3)cc2)cc1";"IFI";"'='";"1.515";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL584014";"";"0";"549.76";"2";"7.33";"GNF-Pf-999";"COc1cc(NC(C)CCCN(Cc2ccc(OC)c(OC)c2)C(=O)CC(C)CC(C)(C)C)c2ncccc2c1";"IFI";"'='";"3.636";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL584026";"";"0";"285.30";"0";"2.10";"GNF-Pf-1016";"CN(C)c1ccc(NC(=O)c2cccnc2C(=O)O)cc1";"IFI";"'='";"6.024";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL6625";"";"0";"334.35";"0";"3.40";"GNF-Pf-1021";"N#Cc1c(NC(=O)COc2ccc(F)cc2F)sc2c1CCC2";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL284377";"DEXFOSFOSERINE";"0";"185.07";"0";"-1.49";"GNF-Pf-1028";"N[C@@H](COP(=O)(O)O)C(=O)O";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL601392";"";"0";"384.41";"0";"3.49";"GNF-Pf-1030";"COc1ccc(/C=C2\SC(=N)N(c3ccc4c(c3)OCO4)C2=O)cc1OC";"IFI";"'='";"2.439";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL584828";"";"0";"609.49";"2";"10.14";"GNF-Pf-1040";"CCCCCN1/C(=C\C=C\c2n(CCCCC)c3cc(Cl)c(Cl)cc3[n+]2CC)N(CC)c2cc(Cl)c(Cl)cc21";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL599954";"";"0";"433.87";"0";"3.20";"GNF-Pf-1042";"COc1cc2nc(C3CCC3)n(NC(=O)c3cccc(F)c3)c(=O)c2cc1OC.Cl";"IFI";"'='";"8.333";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL584836";"";"0";"431.95";"1";"5.47";"GNF-Pf-1048";"O=C1C(Cc2ccccc2)N=C2c3ccccc3N=C(SCc3ccc(Cl)cc3)N12";"IFI";"'='";"2.41";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL532582";"";"0";"602.76";"2";"6.29";"GNF-Pf-1506";"CCCCc1ccc(C(=O)N(CCC(=O)Nc2nnc(-c3ccc(OC)cc3)s2)CCc2ccc(OC)c(OC)c2)cc1";"IFI";"'='";"2.804";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL602998";"";"0";"328.38";"0";"4.54";"GNF-Pf-1507";"O=C(NNc1c2ccccc2nc2ccccc12)Nc1ccccc1";"IFI";"'='";"7.692";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL602003";"";"0";"477.65";"0";"2.46";"GNF-Pf-517";"COC(=O)c1c(S(=O)(=O)N2CCN(C)CC2)sc2c1CCN(CCCc1ccccc1)C2";"IFI";"'='";"1.961";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL587714";"3',4' DICHLOROBENZAMIL";"0";"388.65";"0";"1.85";"GNF-Pf-1778";"N/C(=N\C(=O)c1nc(Cl)c(N)nc1N)NCc1ccc(Cl)c(Cl)c1";"IFI";"'='";"2.817";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL211589";"";"0";"339.42";"0";"3.35";"GNF-Pf-1788";"CN(C)c1ccc(/C=C2\SC(=Nc3ccc(O)cc3)NC2=O)cc1";"IFI";"'='";"7.955";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL582416";"";"0";"270.36";"0";"3.75";"GNF-Pf-1789";"CCC(C(=O)Nc1sccc1C#N)c1ccccc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL599939";"";"0";"532.08";"2";"7.22";"GNF-Pf-1797";"CCCCCCN(C(=O)c1ccc(Cl)cc1)C(CC)c1nc2ccccc2c(=O)n1-c1ccccc1OC";"IFI";"'='";"1.923";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL582257";"";"0";"461.59";"1";"6.28";"GNF-Pf-1800";"CCN1/C(=C\C=C\c2n(CC)c3ccc(C#N)cc3[n+]2CC)Oc2ccc(-c3ccccc3)cc21";"IFI";"";"";"";"";"";"Not applicable";"";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL603002";"";"0";"446.58";"0";"3.41";"GNF-Pf-1803";"Cc1c(C(=O)N2CCC3(CCN(C)C3)C2)cnn1-c1ncc2c(n1)-c1ccccc1SC2";"IFI";"'='";"3.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL580636";"";"0";"363.51";"0";"4.36";"GNF-Pf-576";"CC[n+]1c(/C=C2\Sc3ccc(C)cc3N2CCO)ccc2ccccc21";"IFI";"'='";"15.38";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL602811";"";"0";"436.47";"0";"3.62";"GNF-Pf-598";"CC(=O)Nc1cccc(NC(=O)CSc2ccc3nnc(-c4ccc(F)cc4)n3n2)c1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL599916";"";"0";"333.86";"0";"4.24";"GNF-Pf-2189";"CC(C)CC(=O)NCCCCNc1ccnc2cc(Cl)ccc12";"IFI";"'='";"1.852";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL577648";"";"0";"448.32";"0";"2.67";"GNF-Pf-2194";"COc1ccc(CCNC(=O)CC(=O)NN=Cc2ccc(Br)cc2)cc1OC";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585259";"";"0";"438.62";"0";"4.15";"GNF-Pf-1360";"CC(C)CNc1nc(NCCCN2CCCCC2C)ncc1C(=O)NCc1ccccc1";"IFI";"'='";"3.922";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600153";"";"0";"454.01";"1";"6.16";"GNF-Pf-1366";"COc1cc(NC(C)CCCN(Cc2ccc(Cl)cc2)C(=O)C(C)C)c2ncccc2c1";"IFI";"'='";"5.607";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585971";"";"0";"294.34";"0";"1.70";"GNF-Pf-1077";"CCCSc1nc(N)c(NC(=O)c2ccco2)c(=O)[nH]1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600958";"";"0";"486.64";"1";"6.70";"GNF-Pf-1102";"CCC(CC)C(=O)N1CCOc2c(cc(-c3csc4ccccc34)cc2OCc2ccccn2)C1";"IFI";"'='";"1.739";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL602606";"";"0";"415.58";"0";"4.09";"GNF-Pf-2349";"c1ccc(C[C@H]2CN(c3ccccc3)CCN2CCNCCOc2ccccc2)cc1";"IFI";"'='";"1.235";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585065";"";"0";"399.39";"0";"1.38";"GNF-Pf-1125";"Cc1[nH]c(=O)[nH]c(=O)c1S(=O)(=O)Nc1ccc2oc(-c3ccncc3)nc2c1";"IFI";"'='";"2.381";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL578281";"";"0";"441.55";"0";"3.50";"GNF-Pf-2378";"CCC(C)NC(=O)c1c[nH]c2ccc(S(=O)(=O)N(C)c3cc(C)ccc3C)cc2c1=O";"IFI";"'='";"7.692";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL580221";"";"0";"312.80";"0";"4.82";"GNF-Pf-1144";"COc1cccc2c(C)cc(NCc3ccccc3Cl)nc12";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600753";"";"0";"495.34";"1";"6.15";"GNF-Pf-1146";"O=C(NC(=C(Cl)Cl)[P+](c1ccccc1)(c1ccccc1)c1ccccc1)c1ccc(F)cc1";"IFI";"'='";"27.27";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL578916";"";"0";"345.40";"0";"3.93";"GNF-Pf-2384";"CCOC(=O)c1sc2ncnc(NCc3ccc(F)cc3)c2c1C";"IFI";"'='";"4.706";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585071";"";"0";"290.37";"0";"3.94";"GNF-Pf-1209";"CC1CC(=Cc2ccncc2)C(=O)C(=Cc2ccncc2)C1";"IFI";"";"";"";"";"";"Not applicable";"";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL603686";"";"0";"434.49";"1";"5.47";"GNF-Pf-3700";"COc1ccccc1N1C(=N)SC(=Cc2ccc(OCc3ccccc3F)cc2)C1=O";"IFI";"";"";"";"";"";"Not applicable";"";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL604526";"";"0";"435.53";"0";"3.63";"GNF-Pf-3721";"CCOC(=O)N1CCC(NC(=O)c2c(C)nn(-c3cccc(C)c3)c2-n2cccc2)CC1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL598075";"";"0";"381.45";"0";"4.55";"GNF-Pf-3728";"COc1ccc(OC)c(-c2ccc(O)c(CNCCc3cccc(F)c3)c2)c1";"IFI";"'='";"1.923";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600896";"";"0";"319.39";"0";"2.53";"GNF-Pf-3730";"C=CCn1c(COc2ccccc2C)nnc1SCC(=O)O";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL597674";"";"0";"398.47";"0";"1.74";"GNF-Pf-3735";"CCOc1ccc2[nH]c(=O)c(C(c3nnnn3CCOC)N3CCCC3)cc2c1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL583828";"";"0";"544.37";"2";"2.89";"GNF-Pf-3741";"CN1CCN(c2nc(NN=Cc3cc(Br)c(O)cc3O)nc(Nc3ccc([N+](=O)[O-])cc3)n2)CC1";"IFI";"'='";"7.692";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585694";"";"0";"513.64";"2";"6.18";"GNF-Pf-3755";"COc1cc(NC(C)CCCN(Cc2ccc(OC)c(OC)c2)C(=O)c2ccccc2)c2ncccc2c1";"IFI";"'='";"0.9174";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL597036";"";"0";"367.50";"0";"2.95";"GNF-Pf-3757";"CC(CN1CCC(n2cc(C(=O)N3CCCC3)nn2)CC1)c1ccccc1";"IFI";"'='";"0.885";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL2368644";"";"0";"526.38";"0";"4.85";"GNF-Pf-3786";"CS/C(Cl)=C(/NC(C)=O)[P+](c1ccccc1)(c1ccccc1)c1ccccc1.[O-][Cl+3]([O-])([O-])[O-]";"IFI";"'='";"5.344";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL584296";"";"0";"370.19";"0";"2.25";"GNF-Pf-3797";"CNCC(O)c1ccc(Cl)c(Cl)c1.O=C(O)C(O)C(O)C(=O)O";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL599894";"";"0";"224.18";"0";"0.13";"GNF-Pf-3800";"O=C1c2ccccc2-c2nc3nnnn3nc21";"IFI";"'='";"42.86";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL597444";"";"0";"298.77";"1";"5.03";"GNF-Pf-3801";"CCOc1ccc(Nc2ccnc3cc(Cl)ccc23)cc1";"IFI";"'='";"5.172";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL1744506";"";"0";"432.51";"1";"5.20";"GNF-Pf-3803";"Cc1ccc(N=C2NC(=O)/C(=C/c3cc(C)n(-c4cccc([N+](=O)[O-])c4)c3C)S2)cc1";"IFI";"";"";"";"";"";"Not applicable";"";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL547603";"";"0";"415.45";"0";"3.33";"GNF-Pf-4626";"COc1ccc(-n2nc(C(=O)NCc3ccccc3OC)c3ccccc3c2=O)cc1";"IFI";"'='";"3.614";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL603944";"";"0";"511.40";"0";"2.67";"GNF-Pf-4632";"C=CCn1c(=O)c(C(=O)NCC[N+](CC)(CC)CC=C)c(O)c2ccccc21.[I-]";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL579851";"";"0";"398.45";"0";"4.81";"GNF-Pf-4639";"O=C1CN(C(=O)CCC2CCCC2)C(c2ccc(F)cc2)c2cc(F)ccc2N1";"IFI";"'='";"2.632";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL584442";"";"0";"319.86";"0";"4.43";"GNF-Pf-4659";"CC[n+]1c(C=C2C=C(C)OC(C)=C2)sc2ccccc21.[Cl-]";"IFI";"'='";"12.73";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL602425";"";"0";"396.49";"1";"7.51";"GNF-Pf-4673";"C(=C1/C(c2ccccc2)=Nc2ccccc21)\c1c(-c2ccccc2)[nH]c2ccccc12";"IFI";"'='";"21.43";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL601175";"";"0";"480.42";"0";"4.72";"GNF-Pf-4680";"CCSCCOC(=O)C1=C(C)NC2=C(C(=O)CCC2)C1c1ccc(OC)c(Br)c1";"IFI";"'='";"2.326";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585970";"";"0";"461.57";"0";"3.70";"GNF-Pf-4693";"CCOC(=O)CN(C)Cc1ccc2c(NC(=O)c3ccc(C)s3)c(C(=O)OC)sc2n1";"IFI";"'='";"1.724";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL603047";"";"0";"428.88";"0";"3.73";"GNF-Pf-4711";"O=C1CN=C(c2ccccc2)c2cc(Cl)ccc2N1Cc1cc(=O)n2ccccc2n1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL584221";"";"0";"361.45";"0";"4.08";"GNF-Pf-4722";"Cc1nc(NN=Cc2c(O)ccc3ccccc23)cc(N2CCCCC2)n1";"IFI";"'='";"7.692";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL584436";"";"0";"384.87";"1";"5.91";"GNF-Pf-4725";"O=C(Nc1ccc(Cl)cc1)c1c2c(nc3ccccc13)-c1ccccc1CC2";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL586310";"";"0";"346.40";"0";"3.33";"GNF-Pf-4731";"CCOC(=O)c1cn(CC)c2cc(N3CCCCC3)c(F)cc2c1=O";"IFI";"'='";"6.557";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL1744512";"";"0";"310.38";"0";"3.59";"GNF-Pf-4742";"COc1ccc(/C=C2/SC(=Nc3ccccc3)NC2=O)cc1";"IFI";"";"";"";"";"";"Not applicable";"";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL584867";"";"0";"381.65";"1";"5.86";"GNF-Pf-4745";"Cc1onc(-c2ccccc2Cl)c1C(=O)Nc1cc(Cl)ccc1Cl";"IFI";"'='";"1.149";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585456";"";"0";"528.48";"0";"3.33";"GNF-Pf-4756";"COc1cccc(CNC(=O)[C@@H]2CNC[C@H]2c2ccc(C(F)(F)F)cc2)c1.O=C(O)C(O)C(O)C(=O)O";"IFI";"";"";"";"";"";"Not applicable";"";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585592";"";"0";"357.22";"0";"4.77";"GNF-Pf-4769";"COc1ccc2c(Cl)c(C(=O)Nc3cc(C)on3)sc2c1Cl";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL603522";"";"0";"299.42";"0";"3.45";"GNF-Pf-4798";"CCN1/C(=C/c2cccc[n+]2C)Sc2ccc(OC)cc21";"IFI";"";"";"";"";"";"Not applicable";"";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585243";"";"0";"287.79";"0";"4.31";"GNF-Pf-4806";"Cc1cc(C)c2c(c1)OCN(Cc1ccccc1Cl)C2";"IFI";"'='";"3.333";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL545872";"";"0";"683.52";"2";"6.88";"GNF-Pf-4840";"COc1cc(C(=O)N2N=C(c3c(-c4ccccc4)c4cc(Br)ccc4[nH]c3=O)CC2c2cccc([N+](=O)[O-])c2)cc(OC)c1OC";"IFI";"'='";"1.111";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL547194";"";"0";"424.42";"1";"5.65";"GNF-Pf-3872";"O=C(Nc1ccc(-c2nc3ccccc3[nH]2)cc1)c1ccc(-c2cccc([N+](=O)[O-])c2)o1";"IFI";"'='";"5.769";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL217366";"";"0";"382.51";"1";"5.27";"GNF-Pf-3878";"CCN1CCN(c2ccc(Nc3c4ccccc4nc4ccccc34)cc2)CC1";"IFI";"'='";"21.43";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL587449";"";"0";"308.34";"0";"2.99";"GNF-Pf-3886";"CCc1ccc(O)c(-c2cc(C(=O)Nc3cccnc3)[nH]n2)c1";"IFI";"'='";"6.667";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL597051";"";"0";"364.45";"0";"3.63";"GNF-Pf-3896";"COc1cccc(-c2ccc(O)c(CN(C)CC(O)c3ccccc3)c2)n1";"IFI";"'='";"2.564";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL584248";"";"0";"327.34";"0";"1.20";"GNF-Pf-3925";"CCOC(=O)c1cc(S(=O)(=O)NCc2ccc(F)cc2)n[nH]1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL599702";"";"0";"373.48";"0";"4.99";"GNF-Pf-3958";"Cc1cc(/C=C2\SC(=Nc3ccccc3)NC2=O)c(C)n1-c1ccccc1";"IFI";"'='";"8.434";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL590647";"";"0";"491.58";"1";"5.87";"GNF-Pf-5552";"COc1ccc(C2CC3=NC(C)=C(C(=O)OC(C)C)C(c4ccccc4OC)C3=C(O)C2)cc1OC";"IFI";"'='";"3.488";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL1606";"";"0";"414.78";"0";"4.45";"GNF-Pf-5559";"Cl.O[C@@H](c1cc(C(F)(F)F)nc2c(C(F)(F)F)cccc12)[C@H]1CCCCN1";"IFI";"'='";"1.818";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL579155";"";"0";"299.39";"0";"4.62";"GNF-Pf-5568";"Oc1ccc(-c2ccc(F)cc2)cc1CNC1CCCCC1";"IFI";"'='";"1.739";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL579147";"";"0";"413.86";"1";"6.40";"GNF-Pf-2724";"O=C(Nc1ccc(-c2nc3ccccc3[nH]2)cc1)c1ccc(-c2ccc(Cl)cc2)o1";"IFI";"'='";"11.94";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL579066";"";"0";"436.58";"0";"4.69";"GNF-Pf-2731";"CCOc1ccc(-c2cn3c(n2)sc2cc(C(=O)NCCN(CC)CC)ccc23)cc1";"IFI";"'='";"10.34";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL579359";"";"0";"358.40";"0";"3.11";"GNF-Pf-2796";"COc1ccc([N+](=O)[O-])cc1NC(=O)C(C)Nc1ccc(N(C)C)cc1";"IFI";"'='";"6.25";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL601327";"";"0";"1204.65";"None";"None";"GNF-Pf-2802";"CCCC[C@@H](C)C(O)[C@H]1C(=O)N[C@@H](CC)C(=O)N(C)CC(=O)N(C)[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N(C)[C@@H](C(C)C)C(=O)N1C";"IFI";"'='";"3.448";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL578465";"";"0";"587.71";"1";"1.74";"GNF-Pf-2811";"Cc1ccc(S(=O)(=O)Nn2c(SCC(=O)NCCc3ccc(S(N)(=O)=O)cc3)nc3ccccc3c2=O)cc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL578466";"";"0";"363.51";"0";"4.36";"GNF-Pf-2814";"CC[n+]1c(/C=C2\Sc3ccccc3N2CCO)ccc2cc(C)ccc21";"IFI";"'='";"6.349";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600728";"";"0";"353.45";"0";"3.82";"GNF-Pf-2859";"COc1ccccc1N1C(=N)SC(=Cc2ccc(N(C)C)cc2)C1=O";"IFI";"";"";"";"";"";"Not applicable";"";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL582712";"";"0";"534.66";"1";"3.95";"GNF-Pf-2931";"CCOc1ccc(NC(=O)NC(Cc2c[nH]c3ccccc23)C(=O)N2CCN(C(=O)NC(C)C)C(C)C2)cc1";"IFI";"'='";"0.9346";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL579979";"";"0";"457.53";"0";"2.88";"GNF-Pf-2933";"CC(C)NC(=O)c1cn(Cc2ccccc2)cc(C(=O)NCCc2nc3ccccc3[nH]2)c1=O";"IFI";"'='";"4.545";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL609461";"";"0";"292.51";"0";"4.25";"GNF-Pf-2944";"CC(C)=CCCC1=CCC(CNCCCN(C)C)C(C)C1";"IFI";"'='";"8.955";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL582690";"";"0";"371.84";"0";"4.60";"GNF-Pf-2974";"CN(CCCNc1ccnc2cc(Cl)ccc12)C(=O)c1ccc(F)cc1";"IFI";"'='";"0.9346";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600516";"";"0";"548.56";"2";"6.82";"GNF-Pf-2990";"COc1ccc(-c2cc(C(=O)Nc3cc(Oc4ccc(NC(C)=O)cc4)cc([N+](=O)[O-])c3)c3ccccc3n2)cc1";"IFI";"'='";"3.409";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL586504";"";"0";"484.68";"1";"6.41";"GNF-Pf-5401";"CC(C)(C)CC(=O)NCc1ccc(OC2CCN(CC(c3ccccc3)c3ccccc3)CC2)cc1";"IFI";"'='";"7.042";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600556";"";"0";"397.59";"1";"6.72";"GNF-Pf-4663";"Cc1cc(C)c2c(c1)-c1c(ssc1=S)C(C)(C)N2C(=O)c1ccccc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL584452";"";"0";"431.33";"0";"2.31";"GNF-Pf-4674";"C[N+]1(CC(=O)NNc2c3ccccc3nc3ccccc23)CCOCC1.[Br-]";"IFI";"'='";"7.143";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL601601";"";"0";"476.62";"1";"6.33";"GNF-Pf-4702";"Cc1ccc(NC(=O)C2CSC(c3cccc(F)c3)N2C(=O)c2ccc(C(C)(C)C)cc2)cc1";"IFI";"'='";"3.061";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585995";"";"0";"286.71";"0";"3.82";"GNF-Pf-4715";"O=C(CC1OC(=O)c2ccccc21)c1ccc(Cl)cc1";"IFI";"'='";"5.333";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL602769";"";"0";"263.38";"0";"3.12";"GNF-Pf-4732";"CCCN(CCC)C1=CC(=O)C(C(C)(C)C)=CC1=O";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL601751";"";"0";"250.31";"0";"3.32";"GNF-Pf-4953";"Cc1ccccc1C=NNc1nc2ccccc2[nH]1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL586009";"";"0";"314.35";"0";"2.38";"GNF-Pf-4958";"O=[N+]([O-])c1cccc2c1nnn2C12CC3CC(CC(O)(C3)C1)C2";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL584618";"";"0";"476.57";"1";"5.28";"GNF-Pf-4781";"O=C(Nc1ccc2c(c1)OCO2)c1cc2cc(C3(O)CCN(CC4CCCCC4)CC3)ccc2o1";"IFI";"'='";"4.237";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL584619";"";"0";"371.44";"0";"3.72";"GNF-Pf-4782";"O=C(NC(=S)Nc1ccc(NC(=O)c2cccs2)cc1)c1ccco1";"IFI";"'='";"7.692";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL532872";"";"0";"456.95";"0";"4.97";"GNF-Pf-4784";"COc1cc(OC)c(NC(=O)C2c3ccccc3C(=O)N(C)C2c2cccs2)cc1Cl";"IFI";"'='";"2.703";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL583141";"";"0";"468.39";"0";"3.47";"GNF-Pf-4788";"CCOC(=O)c1c(CNCCN(CC)CC)n(C)c2cc(Br)c(OC(C)=O)cc12";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL608261";"";"0";"418.07";"0";"3.15";"GNF-Pf-4792";"C[n+]1ccccc1C=Cc1cc(Br)ccc1O.[I-]";"IFI";"";"";"";"";"";"Not applicable";"";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL584424";"";"0";"453.94";"1";"5.79";"GNF-Pf-4794";"CC1=C(C(=O)OC(C)C)C(c2ccc(F)cc2)C2=C(CC(c3ccc(Cl)cc3)CC2=O)N1";"IFI";"'='";"7.059";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL579846";"";"0";"517.45";"2";"5.24";"GNF-Pf-4842";"CCOC(=O)C1=C(C)NC2=C(C(=O)CC(C)(C)C2)C1c1cc(I)sc1SC";"IFI";"'='";"1.46";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL599957";"";"0";"454.47";"0";"4.47";"GNF-Pf-4853";"CCc1c(C(C)S(=O)(=O)c2ccc(C)cc2)[nH]c(=O)n1-c1ccc(OC(F)(F)F)cc1";"IFI";"'='";"1.22";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL601317";"";"0";"251.76";"0";"3.82";"GNF-Pf-4854";"Clc1ccc2c(c1)CN(C1CCCCC1)CO2";"IFI";"'='";"1.538";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL601380";"";"0";"440.29";"0";"3.05";"GNF-Pf-4865";"CCOc1cc(C2C(C(=O)OC)=CNC=C2C(=O)OC)cc(Br)c1OCC";"IFI";"'='";"2.353";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL579085";"";"0";"442.64";"0";"2.71";"GNF-Pf-191";"CC[C@@H]1CCC[C@H](C)CC[C@@H](O[C@@H]2O[C@@H](C)[C@@H](O)[C@@H](N)[C@H]2O)[C@H](CC)CCCNC1=O";"IFI";"'='";"1.515";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL602016";"";"0";"418.48";"0";"4.72";"GNF-Pf-210";"O=[N+]([O-])c1ccc(-n2cccc2C=NNc2ncnc3sc4c(c23)CCCC4)cc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL602407";"";"0";"487.67";"1";"6.16";"GNF-Pf-214";"CCOC(=O)NC(=O)N1CCC(c2nc(-c3cc(C(C)(C)C)c(O)c(C(C)(C)C)c3)cs2)CC1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL579973";"";"0";"525.05";"1";"3.44";"GNF-Pf-219";"COc1ccc(CCN(Cc2ccc(Cl)cc2)S(=O)(=O)c2ccc(S(N)(=O)=O)cc2)cc1OC";"IFI";"'='";"1.852";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL582297";"";"0";"335.15";"0";"3.19";"GNF-Pf-224";"O=C(COC(=O)c1ccccc1O)c1ccc(Br)cc1";"IFI";"'='";"4.651";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL582499";"";"0";"433.00";"0";"4.01";"GNF-Pf-227";"CCCCC(CC)C(=O)N1CCN(C(C)c2nc3ccc(Cl)cc3c(=O)n2C)CC1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL602006";"";"0";"504.59";"2";"5.64";"GNF-Pf-233";"c1ccc(C2=NN(c3ccccc3)C(c3ccc4c(c3)OCO4)N2c2ccc(N3CCOCC3)cc2)cc1";"IFI";"'='";"23.08";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL603018";"";"0";"595.51";"1";"6.05";"GNF-Pf-238";"[I-].c1ccc(CSc2scnc2[P+](c2ccccc2)(c2ccccc2)c2ccccc2)cc1";"IFI";"'='";"27.78";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL581895";"";"0";"418.53";"0";"2.68";"GNF-Pf-251";"CN1CCN(N/C=C2/C(=O)N(c3nc4ccccc4s3)N=C2c2ccccc2)CC1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL602014";"";"0";"387.41";"0";"4.20";"GNF-Pf-273";"CN(C)CCNc1cc(-c2cccc(C(F)(F)F)c2)nc(-c2ccncc2)n1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL579747";"";"0";"306.28";"0";"2.60";"GNF-Pf-284";"N#CC1=C(N)Oc2c(c(=O)oc3ccccc23)C1c1ccoc1";"IFI";"'='";"3.448";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL601981";"";"0";"335.37";"0";"2.05";"GNF-Pf-296";"Cc1nnc2sc(SCc3ccc([N+](=O)[O-])cc3)nn2c1=O";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600135";"";"0";"395.57";"1";"5.06";"GNF-Pf-297";"CC[n+]1c(/C=C(C)/C=C2\Sc3ccccc3N2CCO)sc2ccccc21";"IFI";"'='";"7.692";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL602214";"";"0";"413.56";"1";"5.10";"GNF-Pf-301";"CC1=C(C(=O)OCCC(C)C)C(c2ccccc2)C(C(=O)OCCC(C)C)=C(C)N1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL601374";"";"0";"321.19";"0";"2.18";"GNF-Pf-381";"CCOC(=O)CCS(=O)(=O)c1ccc(Br)cc1";"IFI";"'='";"1.538";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL582107";"";"0";"363.37";"0";"2.38";"GNF-Pf-396";"Cc1oc2c(c1C(=O)NCCCn1ccnc1)C(=O)c1ccccc1C2=O";"IFI";"'='";"24.32";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL602622";"";"0";"464.66";"0";"4.34";"GNF-Pf-458";"CN1CCCC1CCNc1ncc(C(=O)NCCc2ccccc2)c(NCC2CCCCC2)n1";"IFI";"'='";"0.9615";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL602597";"";"0";"514.61";"1";"4.17";"GNF-Pf-2492";"CCN1C(C(=O)c2ccccc2)=C(Nc2c(C)n(C)n(-c3ccccc3)c2=O)c2ccccc2S1(=O)=O";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL578299";"";"0";"463.62";"1";"6.05";"GNF-Pf-2499";"CCCCC(=O)N(CCCC(C)Nc1cc(OC)cc2cccnc12)Cc1ccccc1OC";"IFI";"'='";"5.263";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL602772";"";"0";"294.27";"0";"1.96";"GNF-Pf-1961";"Oc1ncnc2c1C(c1ccccc1)c1c(O)ncnc1O2";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL601994";"";"0";"326.34";"0";"1.57";"GNF-Pf-2547";"Cc1ccc(N2C(=O)c3sc4nnc(C)c(=O)n4c3C2=O)cc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL601565";"";"0";"477.69";"1";"8.00";"GNF-Pf-2191";"CC(CC(=O)Oc1ccccc1-c1nc2ccccn2c1NC(C)(C)CC(C)(C)C)CC(C)(C)C";"IFI";"'='";"2.83";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL602989";"";"0";"764.99";"3";"6.80";"GNF-Pf-90";"CCC1CC2CCC(O2)C(C)C(=O)OC(C)CC2CCC(O2)C(C)C(=O)OC(CC)CC2CCC(O2)C(C)C(=O)OC(C)CC2CCC(O2)C(C)C(=O)O1";"IFI";"'='";"24.07";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL578675";"";"0";"244.30";"0";"2.37";"GNF-Pf-107";"COc1cnc(-c2ccccn2)nc1NC(C)C";"IFI";"'='";"2.5";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL601155";"";"0";"272.25";"0";"2.05";"GNF-Pf-114";"O=C1NC(=S)N/C1=C/c1ccc(C(F)(F)F)cc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL14120";"";"0";"251.29";"0";"3.62";"GNF-Pf-117";"COc1ccc2nc(-c3ccccc3)cc(O)c2c1";"IFI";"'='";"14.16";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL578896";"";"0";"311.38";"0";"3.05";"GNF-Pf-134";"CN1CCN(c2ccc(NC(=O)Oc3ccccc3)cc2)CC1";"IFI";"'='";"1.205";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL581885";"";"0";"354.41";"0";"3.00";"GNF-Pf-306";"COc1ccc(-c2cnc3ccc(NC4CCOCC4)nn23)cc1OC";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL582101";"";"0";"407.42";"0";"1.77";"GNF-Pf-326";"CN1[C@@H](C(=O)Nc2ccc3c(c2)OCO3)C[C@@H](c2ccc(F)cc2)NS1(=O)=O";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL602616";"";"0";"522.22";"2";"5.50";"GNF-Pf-328";"Fc1ccc(Nc2nc(OC(C(F)(F)F)C(F)(F)F)nc(OC(C(F)(F)F)C(F)(F)F)n2)cc1";"IFI";"'='";"1.538";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL582057";"";"0";"283.42";"0";"3.40";"GNF-Pf-332";"Cc1ccc2nc3c(c(NCCCN(C)C)c2c1)CCC3";"IFI";"'='";"15.38";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL582511";"";"0";"384.47";"0";"4.16";"GNF-Pf-355";"N#CCSc1nc2ccccc2c2nc(CCc3c[nH]c4ccccc34)nn12";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL602585";"";"0";"329.31";"0";"1.14";"GNF-Pf-356";"CCOC(=O)CN(N=O)C1=C(N2CC2)C(=O)c2ccccc2C1=O";"IFI";"'='";"30.84";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL581475";"";"0";"501.37";"2";"7.04";"GNF-Pf-364";"O=C(Nc1ccc(-c2nc3cc(NC(=O)c4ccc(Cl)cc4)ccc3[nH]2)cc1)c1ccc(Cl)cc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL1615697";"";"0";"468.11";"1";"8.20";"GNF-Pf-366";"CSC1=NC(=Nc2c(C)cccc2C)C2(CCC(C(C)(C)C)CC2)N1c1ccc(Cl)cc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600918";"";"0";"226.12";"0";"2.91";"GNF-Pf-378";"Nc1cc2c(cc1Br)CCCC2";"IFI";"'='";"7.143";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL576329";"";"0";"448.37";"0";"3.74";"GNF-Pf-13";"CNc1nc(NN=Cc2cc([N+](=O)[O-])ccc2O)nc(Nc2cccc(C(F)(F)F)c2)n1";"IFI";"'='";"2.299";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600532";"";"0";"349.48";"0";"4.81";"GNF-Pf-18";"CCN1/C(=C\c2sc3ccc(O)cc3[n+]2CC)C=Cc2ccccc21";"IFI";"'='";"23.08";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL602398";"";"0";"515.00";"2";"5.16";"GNF-Pf-20";"CC1=NN(c2ccccc2)C(=O)C1=NNc1c(Br)cc(Br)cc1Br";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL579321";"";"0";"426.40";"0";"4.35";"GNF-Pf-37";"COc1ccc(-c2cc(C(F)(F)F)n3ncc(C(=O)NCc4ccccc4)c3n2)cc1";"IFI";"'='";"2.174";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL577634";"";"0";"431.40";"0";"3.66";"GNF-Pf-54";"CC(=O)N1CCc2cc(Br)cc(S(=O)(=O)N(CC(C)C)CC(C)C)c21";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL577855";"";"0";"436.58";"1";"7.72";"GNF-Pf-56";"CCCCOc1ccc(/C=C(/C#N)c2nc(-c3ccc(-c4ccccc4)cc3)cs2)cc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL578485";"";"0";"349.14";"1";"5.66";"GNF-Pf-81";"O=C(Nc1cc(Cl)cc(Cl)c1)Nc1cccc(C(F)(F)F)c1";"IFI";"'='";"17.29";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL599924";"";"0";"309.33";"0";"1.03";"GNF-Pf-159";"CCn1nc(/C=C/c2ccccc2)nc2c(=O)n(C)c(=O)nc1-2";"IFI";"'='";"16.67";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600513";"";"0";"295.34";"0";"3.42";"GNF-Pf-162";"COc1cccc2c1OCC(C(=O)Nc1ccc(C)cc1)=C2";"IFI";"'='";"11.43";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL2310931";"";"0";"439.43";"0";"0.42";"GNF-Pf-173";"Nc1nc(N)c2nc(CCc3ccc(C(=O)N[C@H](CCC(=O)O)C(=O)O)cc3)cnc2n1";"IFI";"'='";"15.97";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL576997";"";"0";"324.42";"0";"3.17";"GNF-Pf-180";"C=C[C@H]1CN2CC[C@H]1C[C@@H]2[C@H](O)c1ccnc2ccc(OC)cc12";"IFI";"'='";"2.013";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL94657";"PATUPILONE";"3";"507.69";"1";"4.48";"GNF-Pf-193";"C/C(=C\c1csc(C)n1)[C@@H]1C[C@@H]2O[C@]2(C)CCC[C@H](C)[C@H](O)[C@@H](C)C(=O)C(C)(C)[C@@H](O)CC(=O)O1";"IFI";"'='";"4.688";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL582476";"";"0";"362.45";"0";"4.04";"GNF-Pf-194";"Cc1cc(N(C)C)cc(C)[n+]1OC(=O)N(c1ccccc1)c1ccccc1";"IFI";"'='";"16.67";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL580978";"";"0";"407.48";"0";"4.52";"GNF-Pf-197";"c1ccc2[nH]c(CN(Cc3nc4ccccc4[nH]3)Cc3nc4ccccc4[nH]3)nc2c1";"IFI";"'='";"13.73";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL582703";"";"0";"484.39";"1";"7.15";"GNF-Pf-212";"Cc1ccc2[nH]c(/C(C#N)=C/c3cn(Cc4ccc(Cl)cc4Cl)nc3-c3ccccc3)nc2c1";"IFI";"'='";"2.308";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL581468";"";"0";"312.37";"0";"2.70";"GNF-Pf-242";"O=C(NC(C(=O)c1ccccc1)N1CCCCC1)c1ccco1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL579552";"";"0";"373.41";"0";"4.93";"GNF-Pf-245";"CCCOc1ccc(C(=O)Nc2cccc(-c3nc4ncccc4o3)c2)cc1";"IFI";"'='";"1.163";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL601373";"";"0";"398.47";"0";"1.04";"GNF-Pf-260";"CC(C)CCn1c(NCc2ccccc2)nc2c1c(=O)n(CC(N)=O)c(=O)n2C";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600337";"";"0";"572.51";"2";"6.68";"GNF-Pf-263";"CCN1C(=O)NC(c2cccc(NC(=O)Nc3cc(C(F)(F)F)cc(C(F)(F)F)c3)c2)C(C(=O)OC(C)C)=C1C";"IFI";"'='";"6.452";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL582478";"";"0";"420.51";"0";"3.92";"SJ000111745";"CCOC(=O)c1cnc2ccc(OC)cc2c1Nc1ccc(N2CCN(C)CC2)cc1";"IFI";"'='";"1.408";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL579967";"";"0";"235.68";"0";"2.31";"GNF-Pf-289";"CNc1nc(Cl)nc(Nc2ccccc2)n1";"IFI";"'='";"3.226";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL581456";"";"0";"337.45";"0";"3.95";"GNF-Pf-293";"Cc1cccc(N=C2NC(=O)/C(=C\c3ccc(N(C)C)cc3)S2)c1";"IFI";"'='";"11.76";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL582066";"";"0";"332.41";"0";"4.25";"GNF-Pf-385";"CCc1ccc(C(C)=NNc2nc(O)cc(-c3ccccc3)n2)cc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL601956";"";"0";"256.28";"0";"2.72";"GNF-Pf-391";"OCc1nc2ccccc2n1Cc1ccccc1F";"IFI";"'='";"1.587";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600749";"";"0";"325.39";"0";"3.57";"GNF-Pf-410";"Oc1ccc(-c2ccc(F)cc2)cc1CNCCCn1ccnc1";"IFI";"'='";"0.9901";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL602409";"";"0";"268.32";"0";"3.00";"GNF-Pf-420";"CN1c2ccccc2N(C)C1c1ccc2c(c1)OCO2";"IFI";"'='";"0.6211";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL581904";"";"0";"335.34";"0";"2.35";"GNF-Pf-424";"CC(=O)Nc1ccc(S(=O)(=O)Nc2ccccc2[N+](=O)[O-])cc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL582526";"";"0";"379.94";"0";"4.25";"GNF-Pf-429";"C1=C(c2ccc(CN3CCCCC3)cc2)N2CCN=C2c2ccccc21.Cl";"IFI";"'='";"2.985";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL602565";"";"0";"331.80";"0";"3.50";"GNF-Pf-430";"Cc1c(Cl)cccc1NC(=O)C1C(C(=O)O)C2C=CC1C21CC1";"IFI";"'='";"7.692";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL580846";"";"0";"371.44";"0";"4.00";"GNF-Pf-434";"Cc1ccc(CN2C(=O)C(O)(CC(=O)c3ccccc3)c3ccccc32)cc1";"IFI";"'='";"1.163";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL582324";"";"0";"335.81";"0";"3.84";"GNF-Pf-443";"O=C(O)CSC(C(=O)Nc1ccc(Cl)cc1)c1ccccc1";"IFI";"'='";"0.8";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600282";"";"0";"270.12";"0";"3.52";"GNF-Pf-460";"O=C(NCc1ccco1)c1cccc(Cl)c1Cl";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL601377";"";"0";"391.56";"1";"5.15";"GNF-Pf-466";"CCCCCc1c(C)c(C#N)c2nc3ccccc3n2c1NCCN(CC)CC";"IFI";"'='";"2.381";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL582518";"";"0";"401.33";"0";"2.78";"GNF-Pf-470";"CC(=O)N1CCc2cc(Br)cc(S(=O)(=O)N3CCCC(C)C3)c21";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL54804";"PRISTIMERIN";"0";"464.65";"1";"6.79";"GNF-Pf-476";"COC(=O)[C@]1(C)CC[C@]2(C)CC[C@]3(C)C4=CC=C5C(=CC(=O)C(O)=C5C)[C@]4(C)CC[C@@]3(C)[C@@H]2C1";"IFI";"'='";"21.43";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL529464";"";"0";"342.24";"0";"4.42";"GNF-Pf-477";"CCN(Cc1ccccc1)c1ncnc2ccc(Br)cc12";"IFI";"'='";"1.562";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL604359";"";"0";"512.74";"1";"4.09";"GNF-Pf-487";"CCCN1CCC(N2C[C@@H](NC3CCCCCCC3)C[C@H]2C(=O)NCCc2ccc3c(c2)OCO3)CC1";"IFI";"'='";"0.9901";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL581266";"";"0";"474.39";"1";"5.50";"GNF-Pf-489";"CCOC(=O)c1cc(-c2ccc(Cl)cc2Cl)[nH]c1N1CCN(c2ccc(OC)cc2)CC1";"IFI";"'='";"0.7937";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL601755";"";"0";"249.27";"0";"2.91";"GNF-Pf-491";"Oc1cccc(-c2cncc(-c3cccnc3)n2)c1";"IFI";"'='";"7.692";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL602975";"";"0";"297.79";"1";"5.09";"GNF-Pf-502";"C/C(Cl)=C/Cc1c(C)nc2c(ccc3ccccc32)c1O";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL602410";"";"0";"384.41";"0";"2.65";"GNF-Pf-503";"COCCNCc1cc2cc3c(cc2n(Cc2cccc(F)c2)c1=O)OCO3";"IFI";"'='";"5.455";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL605186";"";"0";"470.60";"1";"5.35";"GNF-Pf-601";"C#CC(C)(C)NS(=O)(=O)c1cc(-c2nnc(Nc3cccc(C)c3)c3ccccc23)ccc1C";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL582326";"";"0";"408.57";"0";"4.08";"GNF-Pf-602";"O=c1c2c3c(sc2ncn1CC1CCCCC1)CC(NCc1cccnc1)CC3";"IFI";"'='";"1.709";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL582114";"";"0";"462.55";"0";"1.33";"GNF-Pf-585";"COCCn1c(=S)[nH]c2cc(C(=O)NCCc3ccc(S(N)(=O)=O)cc3)ccc2c1=O";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL548176";"";"0";"358.37";"1";"5.16";"GNF-Pf-2419";"Cc1cc(Nc2cccc(C(F)(F)F)c2)nc(NCc2ccccc2)n1";"IFI";"'='";"5.882";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600130";"";"0";"236.27";"0";"2.91";"GNF-Pf-2427";"CC(=O)Nc1nc(-c2ccc(F)cc2)cs1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL579090";"";"0";"383.88";"0";"4.47";"GNF-Pf-2430";"COc1cccc(C(=O)N(C)CCCNc2ccnc3cc(Cl)ccc23)c1";"IFI";"'='";"1.852";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL601760";"";"0";"284.79";"0";"3.17";"GNF-Pf-2433";"Cn1cc(/C=C/c2cc[n+](C)cc2)c2ccccc21.[Cl-]";"IFI";"'='";"5.556";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL578309";"";"0";"273.42";"0";"4.27";"GNF-Pf-2436";"CCCCCCCCNC(=O)C1CC1c1ccccc1";"IFI";"'='";"1.818";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL587058";"";"0";"553.75";"2";"7.87";"GNF-Pf-2440";"CCCCCCN(C(=O)c1ccc(C(C)(C)C)cc1)C(CC)c1nc2ccccc2c(=O)n1-c1ccccc1OC";"IFI";"'='";"0.9259";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL602976";"";"0";"635.69";"2";"7.03";"GNF-Pf-2482";"COc1ccc(C2=C(c3ccc(OC)cc3)C3(c4ccccc4)C(=O)C2(c2ccccc2)C2C(=O)N(c4ccc(F)cc4)C(=O)C23)cc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL577856";"";"0";"402.54";"0";"3.49";"GNF-Pf-2493";"CC(C)NC(=O)[C@@H]1C[C@@H](NCc2cccnc2)CN1Cc1ccc2ccccc2c1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL576334";"";"0";"465.26";"1";"6.28";"GNF-Pf-2524";"Cc1ccc(-c2cc(C(F)(F)F)n3nc(C(=O)Nc4cccc(Cl)c4Cl)cc3n2)cc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL601762";"";"0";"356.88";"0";"4.82";"GNF-Pf-2527";"Cc1cc(C)cc(NC(=S)NNc2ccnc3cc(Cl)ccc23)c1";"IFI";"'='";"2.941";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL578888";"";"0";"368.31";"0";"4.46";"GNF-Pf-2529";"CC(C)(CCl)C(=O)NCCCCNc1ccnc2cc(Cl)ccc12";"IFI";"'='";"1.869";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL577849";"";"0";"536.76";"2";"5.02";"GNF-Pf-2556";"CCCCC(=O)N(C/C=C/c1ccccc1OC)CCN1CCN(C(=O)NC23CC4CC(CC(C4)C2)C3)CC1";"IFI";"'='";"2.752";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL602032";"";"0";"538.42";"2";"5.90";"GNF-Pf-2560";"O=C(Nc1cc(Oc2ccc(F)cc2)cc([N+](=O)[O-])c1)c1nc2nc(-c3ccccc3)cc(C(F)(F)F)n2n1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL577852";"";"0";"418.32";"0";"4.93";"GNF-Pf-2561";"O=C(COc1ccc(Cl)cc1)NCCCCNc1ccnc2cc(Cl)ccc12";"IFI";"'='";"2.97";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL532308";"";"0";"275.44";"0";"2.67";"GNF-Pf-2567";"CCN1CCN(Cc2ccc(N(CC)CC)cc2)CC1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL578724";"";"0";"502.66";"1";"3.78";"GNF-Pf-2573";"COc1ccc(CCN2CC(CNC(=O)Cc3cccnc3)C(c3ccc(N(C)C)cc3)C2)cc1OC";"IFI";"'='";"4.286";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL602405";"";"0";"537.49";"2";"7.12";"GNF-Pf-2589";"CC(C)N(CC(=O)Nc1cc(C(C)(C)C)nn1-c1ccc(Cl)c(Cl)c1)C(=O)c1ccc2ccccc2c1";"IFI";"'='";"2.857";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL1765";"";"0";"340.42";"0";"2.29";"GNF-Pf-2744";"C=CC1(O)CN2CCC1CC2[C@@H](O)c1ccnc2ccc(OC)cc12";"IFI";"'='";"3.571";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL601122";"";"0";"357.25";"1";"5.45";"GNF-Pf-2807";"CCOc1ccc2nc(C)cc(Nc3ccc(Br)cc3)c2c1";"IFI";"'='";"5.556";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL533327";"";"0";"332.36";"0";"4.28";"GNF-Pf-2841";"Oc1cccc(Nc2nc(NCc3ccco3)c3ccccc3n2)c1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL578711";"";"0";"412.56";"0";"4.76";"GNF-Pf-2866";"Cc1oc(-c2cccs2)nc1CN1CCC(CO)(CCOc2ccccc2)CC1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL579978";"";"0";"419.57";"1";"6.05";"GNF-Pf-2932";"Cc1ccc(NC(=O)c2sc3nc4c(c(-c5cccs5)c3c2N)CCCC4)cc1";"IFI";"'='";"2.41";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL580160";"";"0";"338.39";"0";"4.10";"GNF-Pf-2977";"Fc1cccc(Nc2nc(NCC3CCCO3)c3ccccc3n2)c1";"IFI";"'='";"4.545";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL582715";"";"0";"409.92";"0";"4.59";"GNF-Pf-3012";"Cc1cc(N2CCN(C)CC2)nc2ccc(NC(=O)Nc3ccccc3Cl)cc12";"IFI";"'='";"7.143";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL601376";"";"0";"436.56";"1";"6.64";"GNF-Pf-3034";"COc1cc(NCCCC(C)Nc2ccnc3cc4ccccc4cc23)c2ncccc2c1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL582312";"";"0";"341.41";"0";"2.06";"GNF-Pf-3035";"COc1ccc(CN2CCN(C(=O)c3cccnc3)CC2)cc1OC";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL582685";"";"0";"363.45";"1";"6.30";"GNF-Pf-3044";"FC(F)(F)c1ccc(-c2nc(C34CC5CC(CC(C5)C3)C4)cs2)cc1";"IFI";"'='";"4.255";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL581450";"";"0";"309.39";"0";"4.18";"GNF-Pf-3061";"CC(=O)N(C=C1Sc2ccccc2C1=O)c1ccc(C)cc1";"IFI";"";"";"";"";"";"Not applicable";"";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL581665";"";"0";"430.55";"0";"4.54";"GNF-Pf-3073";"CC(=O)c1cccc(CN2CCC(C(=O)Nc3ccc(-n4nc(C)cc4C)cc3)CC2)c1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600332";"";"0";"287.39";"0";"2.03";"GNF-Pf-3077";"O=C(Cc1cccs1)N1CCN(c2ccccn2)CC1";"IFI";"'='";"2.353";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL2368649";"";"0";"324.72";"0";"1.57";"GNF-Pf-3080";"Cc1cc(C)[n+]2nc(N)c3ccccc3c2n1.[O-][Cl+3]([O-])([O-])[O-]";"IFI";"'='";"1.835";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL579760";"";"0";"265.40";"0";"2.82";"GNF-Pf-3086";"Cc1ccc(OCCCCCCNCCO)c(C)c1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL602609";"";"0";"536.63";"1";"4.33";"GNF-Pf-3087";"CCCC(C)C(C(=O)Nc1c(C)cccc1C)N1C(=O)c2cc(NC(C)=O)ccc2NC(=O)[C@@H]1CCC(=O)O";"IFI";"'='";"3.659";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL603019";"";"0";"372.78";"1";"5.00";"GNF-Pf-3098";"COC(=O)c1c(-c2c(F)cccc2Cl)noc1/C=C/Nc1ccccc1";"IFI";"'='";"4.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL534971";"";"0";"634.76";"1";"4.01";"GNF-Pf-3101";"Cc1ccc(C(C(=O)NC2CCCCC2)N(C(=O)Cn2nnc3ccccc32)c2ccc(S(=O)(=O)NCC3CCCO3)cc2)o1";"IFI";"'='";"1.802";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600921";"";"0";"559.55";"2";"5.59";"GNF-Pf-3113";"O=C(c1ccc([N+](=O)[O-])cc1)C1C(C(=O)c2ccc(F)cc2)C2(C(=O)Nc3ccccc32)C2C=Cc3ccccc3N12";"IFI";"'='";"14.29";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600922";"";"0";"242.37";"0";"3.98";"GNF-Pf-3115";"CC[n+]1c(C)cc2c(sc3ccccc32)c1C";"IFI";"'='";"9.259";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL602416";"";"0";"524.65";"2";"5.51";"GNF-Pf-3116";"Cc1ccn(CC(=O)N2CCOc3c(cc(-c4csc5ccccc45)cc3OCCc3ccccn3)C2)n1";"IFI";"'='";"4.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL604564";"";"0";"362.43";"0";"3.51";"GNF-Pf-3126";"CC(=O)N(C1=C(N(C)C)C(=O)c2ccccc2C1=O)c1cc(C)cc(C)c1";"IFI";"'='";"15.38";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600543";"";"0";"383.83";"0";"3.07";"GNF-Pf-3335";"CN(C)c1ccc(C=C2C(=O)NC(=O)N(Cc3ccccc3Cl)C2=O)cc1";"IFI";"";"";"";"";"";"Not applicable";"";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL582680";"";"0";"505.66";"2";"8.31";"GNF-Pf-3354";"Cc1ccn2c(NC(C)(C)CC(C)(C)C)c(-c3ccccc3OC(=O)c3ccc4ccccc4c3)nc2c1";"IFI";"'='";"5.263";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL582065";"";"0";"339.40";"0";"3.00";"GNF-Pf-3363";"CC(C)CCNC(=O)CN1C(=O)c2cccnc2Oc2ccccc21";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL601589";"";"0";"360.46";"1";"5.66";"GNF-Pf-3369";"c1ccc(C2=Nc3ccccc3C(c3ccccc3)(c3ccccc3)N2)cc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL582483";"";"0";"307.44";"0";"4.84";"GNF-Pf-3374";"CC(=O)N1c2ccc(C)cc2C(C)(c2ccccc2)CC1(C)C";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL602817";"";"0";"565.78";"2";"7.04";"GNF-Pf-3387";"Cc1ccn2c(NC(C)(C)CC(C)(C)C)c(-c3ccccc3OS(=O)(=O)CC34CCC(CC3=O)C4(C)C)nc2c1";"IFI";"'='";"3.774";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL536384";"";"0";"243.35";"0";"3.18";"GNF-Pf-3390";"CC(C)Cc1ccc(C=CC(=O)NC2CC2)cc1";"IFI";"";"";"";"";"";"Not applicable";"";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL536846";"";"0";"576.63";"2";"5.80";"GNF-Pf-3392";"COc1ccc(NC(=O)N(CCCNS(=O)(=O)c2ccc([N+](=O)[O-])cc2)c2ccc(Oc3ccccc3)cc2)cc1";"IFI";"'='";"0.9009";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL581467";"";"0";"514.99";"1";"3.17";"GNF-Pf-3405";"CCOC(=O)C1=C(C)N=c2sc(=Cc3cc(Cl)ccc3O)c(=O)n2C1c1ccc(OC)c(OC)c1";"IFI";"'='";"3.529";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL581036";"";"0";"425.96";"1";"5.64";"GNF-Pf-3408";"CCCCOc1ccc(C(=O)N(C)CCCNc2ccnc3cc(Cl)ccc23)cc1";"IFI";"'='";"2.752";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL1744499";"";"0";"957.28";"None";"None";"GNF-Pf-3410";"CC(=Cc1sc2ccc3occc3c2[n+]1CCO)C=C1Sc2ccc3ccoc3c2N1CCO.CCC(=Cc1sc2ccc3ccccc3c2[n+]1C)C=C1Sc2ccc3ccccc3c2N1C";"IFI";"'='";"11.11";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL580152";"";"0";"531.61";"1";"4.40";"GNF-Pf-3426";"COc1ccc(NC(=O)N2CCN(C(=O)c3nc(-c4ccccc4)nc(C)c3C(=O)OC(C)C)CC2C)cc1";"IFI";"'='";"1.869";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL582060";"";"0";"499.39";"0";"3.27";"GNF-Pf-3431";"CCOC(=O)C1=C(C)N=c2sc(=Cc3cc(Br)ccc3O)c(=O)n2C1c1ccccc1";"IFI";"'='";"1.176";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL582484";"";"0";"327.34";"0";"2.38";"GNF-Pf-3441";"COc1ccc(C=CC(=O)NC(=O)c2ccccc2O)cc1OC";"IFI";"";"";"";"";"";"Not applicable";"";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL582486";"";"0";"357.81";"0";"2.13";"GNF-Pf-3446";"O=C(Nc1ccc(Cl)cc1)N1CCN(c2ccc3nncn3n2)CC1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600109";"";"0";"305.40";"0";"3.22";"GNF-Pf-3450";"CCN(c1ccc(OC)cc1)S(=O)(=O)c1ccc(C)cc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL602819";"";"0";"389.44";"0";"0.81";"GNF-Pf-3460";"CC(=O)Nc1ccc(S(=O)(=O)N(C)CC(=O)NN=Cc2ccncc2)cc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL601774";"";"0";"299.38";"0";"2.48";"GNF-Pf-3467";"CCOc1ccc2[nH]c3c(NCCN(C)C)ncnc3c2c1";"IFI";"'='";"3.125";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL236695";"";"0";"277.80";"0";"3.82";"GNF-Pf-3491";"NCCCCCCNc1ccnc2cc(Cl)ccc12";"IFI";"'='";"1.905";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL581272";"";"0";"434.47";"0";"0.14";"GNF-Pf-3497";"O=C(O)CS(=O)(=O)c1ccc(C(=O)NCC(c2cccnc2)N2CCOCC2)cn1";"IFI";"'='";"1.37";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL581899";"";"0";"271.30";"0";"2.93";"GNF-Pf-3513";"Cc1cc(Nc2ccc(C)c(F)c2)n2nc(C)nc2n1";"IFI";"'='";"2.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL586034";"";"0";"508.63";"1";"4.06";"GNF-Pf-3523";"O=C(Nc1ccc(CC2=NCCCN2)cc1)c1ccc(C(=O)Nc2ccc(CC3=NCCCN3)cc2)cc1";"IFI";"'='";"1.77";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL603688";"";"0";"413.95";"1";"5.11";"GNF-Pf-3540";"CCC(C)NC(=O)c1cc(NC(=O)c2cccc(Cl)c2)ccc1N1CCCCC1";"IFI";"'='";"1.887";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL405668";"";"0";"337.45";"0";"3.95";"GNF-Pf-3556";"Cc1ccc(N=C2NC(=O)/C(=C\c3ccc(N(C)C)cc3)S2)cc1";"IFI";"";"";"";"";"";"Not applicable";"";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL598280";"";"0";"484.96";"1";"5.20";"GNF-Pf-3571";"COc1cc(C(=O)NC(c2cccs2)c2cc(Cl)c3cccnc3c2O)cc(OC)c1OC";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL581876";"";"0";"401.56";"0";"3.94";"GNF-Pf-3132";"COc1ccc(-n2c(SC(C)C)nc3sc4c(c3c2=O)CCN(C)C4)cc1";"IFI";"'='";"2.439";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL581460";"";"0";"409.43";"0";"3.53";"GNF-Pf-3135";"Cc1ccc(-n2nnnc2SCc2nc(-c3cccc([N+](=O)[O-])c3)no2)c(C)c1";"IFI";"'='";"1.504";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL581667";"";"0";"389.97";"1";"5.90";"GNF-Pf-3139";"CCCCCCCCC(=O)N(C)CCCNc1ccnc2cc(Cl)ccc12";"IFI";"'='";"5.376";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL579762";"";"0";"413.35";"1";"6.19";"GNF-Pf-3146";"Cc1cc(C)cc(NCC(O)Cn2c3ccc(Cl)cc3c3cc(Cl)ccc32)c1";"IFI";"'='";"5.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL81782";"";"0";"492.45";"1";"5.70";"GNF-Pf-3148";"CCN1/C(=C/C=C/c2sc3ccccc3[n+]2CC)Sc2ccccc21.[I-]";"IFI";"'='";"21.67";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL582508";"";"0";"367.84";"0";"3.76";"GNF-Pf-3150";"Cc1nc2ccc(NC(=O)C3CC3)cc2c(=O)n1Cc1ccc(Cl)cc1";"IFI";"'='";"3.39";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL528933";"";"0";"353.47";"1";"6.12";"GNF-Pf-3154";"c1ccc2cc3c(Nc4ccc(N5CCCCC5)cc4)ccnc3cc2c1";"IFI";"'='";"7.143";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL582097";"";"0";"507.66";"2";"6.04";"GNF-Pf-3155";"C=CCn1c(SCC(=O)c2cc(C)n(-c3ccccc3F)c2C)nc2sc3c(c2c1=O)CCCC3";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL582304";"";"0";"485.07";"1";"7.55";"GNF-Pf-3156";"CC1CCCCN1CCCN(Cc1c2ccccc2cc2ccccc12)C(=O)c1ccccc1Cl";"IFI";"'='";"2.083";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL582263";"";"0";"360.50";"0";"3.49";"GNF-Pf-3171";"CCOC(=O)C1(CC2CCCCO2)CCN(Cc2cccc(C)n2)CC1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL582471";"";"0";"350.78";"0";"3.11";"GNF-Pf-3176";"COc1cc2nc(Nc3cccc(F)c3)nc(N)c2cc1OC.Cl";"IFI";"'='";"6.25";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL580157";"";"0";"417.56";"0";"3.18";"GNF-Pf-3181";"COCCSc1nc2sc3c(c2c(=O)n1-c1ccc(OC)cc1)CCN(C)C3";"IFI";"'='";"4.545";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL581650";"";"0";"322.36";"0";"3.41";"GNF-Pf-3186";"COc1ccc(NC(=O)Cn2c(C)c(C=O)c3ccccc32)cc1";"IFI";"'='";"7.692";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL537062";"";"0";"212.27";"0";"2.39";"GNF-Pf-3194";"C[n+]1ccc(C=Cc2ccc(O)cc2)cc1";"IFI";"'='";"2.206";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL581867";"";"0";"423.61";"1";"6.08";"GNF-Pf-3197";"CCCCN1C(=O)/C(=C2/Sc3ccccc3N2C)SC1=Nc1cc(C)ccc1C";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL581874";"";"0";"500.19";"2";"5.13";"GNF-Pf-3204";"OC(Cn1nnc2ccccc21)Cn1c2ccc(Br)cc2c2cc(Br)ccc21";"IFI";"'='";"2.013";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL581671";"";"0";"423.54";"1";"5.88";"GNF-Pf-3220";"Nc1c(C(=O)Nc2ccc(F)cc2)sc2nc3c(c(-c4cccs4)c12)CCCC3";"IFI";"'='";"3.529";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL603020";"";"0";"320.40";"0";"3.96";"GNF-Pf-3238";"c1ccc(Nc2nc(NCC3CCCO3)c3ccccc3n2)cc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL582467";"";"0";"307.35";"0";"3.36";"GNF-Pf-3243";"CCCC(C(=O)OCC)C(C)=NNc1ccccc1[N+](=O)[O-]";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL535684";"";"0";"601.14";"2";"6.73";"GNF-Pf-3246";"CCCCCCCC(=O)N1CCN(CCN(Cc2ccc(F)cc2)C(=O)c2c(-c3c(F)cccc3Cl)noc2C)CC1";"IFI";"'='";"4.808";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL547588";"";"0";"440.18";"0";"4.68";"GNF-Pf-3279";"CC(C)NCC(O)Cn1c2ccc(Br)cc2c2cc(Br)ccc21";"IFI";"'='";"3.191";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL601801";"";"0";"536.68";"2";"5.84";"GNF-Pf-3291";"Cc1ccc(CNC(=O)CCCCCn2c(SCc3cccc([N+](=O)[O-])c3)nc3ccsc3c2=O)cc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL586016";"";"0";"363.50";"1";"6.71";"GNF-Pf-5040";"Cc1ccc(NC(c2ccccc2)(c2ccccc2)c2ccccc2)cc1C";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL601367";"";"0";"420.31";"1";"5.94";"GNF-Pf-5052";"COc1ccc(C2=C(Nc3ccc(Br)c(C)c3)c3ccccc3C2=O)cc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL601816";"";"0";"534.50";"2";"7.92";"GNF-Pf-5077";"Cc1ccn2c(NC(C)(C)CC(C)(C)C)c(-c3ccccc3OC(=O)c3ccc(Br)cc3)nc2c1";"IFI";"'='";"5.263";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL586005";"";"0";"507.59";"2";"5.69";"GNF-Pf-5094";"COc1cccc(C2C(C(=O)Nc3ccc(C)cc3C)=C(C)Nc3c(C(=O)Nc4ccccc4)cnn32)c1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL533732";"";"0";"853.92";"2";"3.74";"GNF-Pf-5184";"CC(=O)O[C@H]1C(=O)[C@@]2(C)C([C@H](OC(=O)c3ccccc3)[C@]3(O)C[C@H](OC(=O)[C@@H](O)[C@@H](NC(=O)c4ccccc4)c4ccccc4)C(C)=C1C3(C)C)[C@]1(OC(C)=O)CO[C@@H]1C[C@@H]2O";"IFI";"";"";"";"";"";"Not applicable";"";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL577661";"";"0";"339.39";"0";"3.69";"GNF-Pf-5185";"C=CCNC(=S)N1CCc2c([nH]c3ccccc23)C1C(F)(F)F";"IFI";"'='";"2.439";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL587500";"";"0";"474.56";"1";"5.28";"GNF-Pf-5198";"O=C1CC(C(=O)N2CCC(c3nc(-c4cccnc4)ncc3-c3ccccc3)CC2)c2ccccc21";"IFI";"'='";"2.609";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL549210";"";"0";"340.40";"0";"3.76";"GNF-Pf-5225";"COc1ccc(C=C2SC(=N)N(c3ccccc3OC)C2=O)cc1";"IFI";"";"";"";"";"";"Not applicable";"";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL578312";"";"0";"421.85";"1";"5.53";"GNF-Pf-5227";"O=C(NCCCCNc1ccnc2cc(Cl)ccc12)c1cccc(C(F)(F)F)c1";"IFI";"'='";"0.9346";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL577011";"";"0";"301.41";"0";"3.91";"GNF-Pf-5244";"Cc1ccc(CSCc2ccc(C(=O)NC3CC3)o2)cc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL576404";"";"0";"359.86";"0";"3.29";"GNF-Pf-5251";"Cl.N=c1c2c(n(Cc3ccc([N+](=O)[O-])cc3)c3c1CCC3)CCCC2";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL602199";"";"0";"440.52";"1";"5.60";"GNF-Pf-5258";"CC(C)CN1C(=O)c2ccccc2C(C(=O)Nc2ccc(F)cc2F)C1c1cccs1";"IFI";"'='";"6.061";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL587942";"";"0";"484.04";"1";"7.70";"GNF-Pf-5275";"Cc1ccc2c(c1)C(C)(c1ccc(Cl)cc1)CC(C)(C)N2C(=O)COc1ccc2ccccc2c1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL533094";"";"0";"620.78";"3";"6.42";"GNF-Pf-5283";"CCOc1ccc(-n2c(=S)sc3c(=O)n(-c4ccc(C)cc4)c(SCC(=O)Nc4cc(OC)ccc4OC)nc32)cc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL582666";"";"0";"355.44";"0";"4.97";"GNF-Pf-5288";"c1ccc2cc3c(Nc4ccc(N5CCOCC5)cc4)ccnc3cc2c1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL579725";"";"0";"266.35";"0";"2.29";"GNF-Pf-5294";"CCNc1nc(NC(C)CC)nc(ON=C(C)C)n1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL578523";"";"0";"493.99";"1";"5.56";"GNF-Pf-5298";"COc1cc(OC)c(N(C)C(=O)c2cn(C3CCCC3)c(=O)c3c2c2ccccc2n3C)cc1Cl";"IFI";"'='";"6.667";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL601786";"";"0";"389.36";"1";"5.79";"GNF-Pf-5300";"Br.Cc1ccc(C)c(-c2csc(Nc3ccc(C)c(C)c3)n2)c1";"IFI";"'='";"5.882";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL601782";"";"0";"372.45";"0";"3.12";"GNF-Pf-5312";"COc1ccccc1NC(=S)N1CCN(c2ccc([N+](=O)[O-])cc2)CC1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL547227";"";"0";"308.17";"0";"3.79";"GNF-Pf-5315";"Cc1cc(Nc2ccc(Cl)c(Cl)c2)n2nc(C)nc2n1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL605745";"";"0";"394.54";"0";"4.65";"GNF-Pf-3877";"CCNC(=O)NCCSc1nc(-c2ccccc2)c(-c2ccccc2)n1CC";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL2368645";"";"0";"566.02";"1";"5.89";"GNF-Pf-3891";"Cc1nc([P+](c2ccccc2)(c2ccccc2)c2ccccc2)c(SCc2ccccc2)o1.[O-][Cl+3]([O-])([O-])[O-]";"IFI";"'='";"21.64";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL596645";"";"0";"291.34";"0";"2.55";"GNF-Pf-3903";"CN(C)CCNC(=S)Nc1cccc(C(F)(F)F)c1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL599102";"";"0";"326.23";"0";"2.33";"GNF-Pf-3906";"CN(C)c1cc[n+](CC(=O)Nc2ccc(Cl)cc2)cc1.[Cl-]";"IFI";"'='";"6.422";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL599303";"";"0";"421.57";"0";"4.06";"GNF-Pf-3908";"O=C(Nc1ccc(-n2cccn2)cc1)C1CCN(Cc2nc3c(s2)CCCC3)CC1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL584246";"";"0";"238.31";"0";"3.32";"GNF-Pf-3924";"C#CCN1c2ccccc2Sc2cccnc21";"IFI";"'='";"6.173";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL584459";"";"0";"362.26";"0";"4.88";"GNF-Pf-3929";"Fc1ccc(-c2c[n+](Cc3ccc(Cl)cc3Cl)c3n2CCC3)cc1";"IFI";"'='";"4.762";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL531637";"";"0";"348.25";"0";"3.24";"GNF-Pf-3941";"CN(C)CCCNc1ncnc2c1[nH]c1ccc(Br)cc12";"IFI";"'='";"4.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL598481";"";"0";"370.41";"0";"3.51";"GNF-Pf-3967";"CC1=C(C(=O)OC(C)C)C(c2cccc([N+](=O)[O-])c2)C2=C(CCCC2=O)N1";"IFI";"'='";"1.149";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL598065";"";"0";"437.48";"0";"3.98";"GNF-Pf-3973";"CCN1CCN(c2cc(C)c3cc(NC(=O)c4ccc(F)c([N+](=O)[O-])c4)ccc3n2)CC1";"IFI";"'='";"6.667";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL584456";"";"0";"388.38";"0";"1.59";"GNF-Pf-3993";"COc1cc([N+](=O)[O-])ccc1NC(=O)CN1CCN(C(=O)c2ccco2)CC1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL584671";"";"0";"445.66";"1";"5.07";"GNF-Pf-4002";"Cc1nc(C(C)N(C)Cc2c(C(=O)N3CCCCCCC3)nc3sccn23)c(C)s1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL602154";"";"0";"363.44";"0";"3.29";"GNF-Pf-4007";"COc1ccc(C(=O)C[n+]2cc(-c3ccc(OC)cc3)n3c2CCC3)cc1";"IFI";"'='";"4.878";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL596633";"";"0";"418.99";"0";"4.81";"GNF-Pf-4029";"CCCCN(CC)CCNC(=O)c1cc2c(-c3ccc(Cl)cc3)nn(C)c2s1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL581454";"";"0";"460.63";"1";"5.07";"GNF-Pf-2995";"Cc1cccc2cc(C(c3nnnn3C3CCCC3)N3CCCC4(CCCCC4)C3)c(=O)[nH]c12";"IFI";"'='";"3.883";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL598681";"";"0";"408.89";"0";"4.47";"GNF-Pf-3620";"CC(=O)N(C1=C(N2CCCCC2)C(=O)c2ccccc2C1=O)c1cccc(Cl)c1";"IFI";"'='";"7.692";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL599893";"";"0";"323.26";"0";"2.95";"GNF-Pf-3657";"Cc1ccccc1Cn1c(C)c[n+]2ccsc12.[Br-]";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL601597";"";"0";"302.17";"0";"3.34";"GNF-Pf-3660";"O=C(c1ccccc1)C1NC1c1ccc(Br)cc1";"IFI";"'='";"1.562";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL530381";"";"0";"252.79";"0";"2.57";"GNF-Pf-3665";"CN1CCC(NCCc2ccc(Cl)cc2)CC1";"IFI";"'='";"2.941";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL583826";"";"0";"413.52";"0";"4.58";"GNF-Pf-3668";"CCC(=O)Nc1ccc2nc(SCC(=O)Nc3ccc(C(C)=O)cc3)sc2c1";"IFI";"'='";"2.326";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL599493";"";"0";"440.46";"1";"5.47";"GNF-Pf-3691";"Cc1ccc(-c2cc(C(=O)OCC(=O)c3cccc([N+](=O)[O-])c3)c3cc(C)ccc3n2)cc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL597659";"";"0";"377.28";"0";"3.68";"GNF-Pf-3707";"Fc1ccc(-c2c[n+](-c3ccccc3)c3n2CCS3)cc1.[Br-]";"IFI";"'='";"1.923";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL596641";"";"0";"380.38";"0";"3.74";"GNF-Pf-3713";"O=C1CC(c2ccc([N+](=O)[O-])cc2)C2=C(CC(c3ccc(F)cc3)CC2=O)N1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL598695";"";"0";"340.40";"0";"3.60";"GNF-Pf-3725";"COc1ccc(/C=C2\SC(=Nc3ccccc3OC)NC2=O)cc1";"IFI";"'='";"7.692";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL527700";"";"0";"260.30";"0";"2.90";"GNF-Pf-3743";"CCOC(=O)c1[nH]c2ccccc2c1N=NN(C)C";"IFI";"'='";"1.361";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL584891";"";"0";"440.88";"0";"4.13";"GNF-Pf-3749";"COC(=O)c1cccc(-c2cc(Cl)c3c(c2)CC(CNC(=O)c2c(C)noc2C)O3)c1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL597874";"";"0";"395.52";"1";"5.78";"GNF-Pf-3770";"CCCCOc1cccc(C(=O)N(Cc2cccs2)c2ccc(OC)cc2)c1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL597662";"";"0";"432.93";"0";"2.21";"GNF-Pf-3823";"COc1ccccc1C(c1nnnn1Cc1ccc(F)cc1)N1CCN(C)CC1.Cl";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585036";"";"0";"327.81";"0";"3.94";"GNF-Pf-4994";"CC1CN(C(=O)c2sc3cccc(F)c3c2Cl)CC(C)O1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL527416";"";"0";"575.78";"1";"4.79";"GNF-Pf-5000";"CS(=O)(=O)N1CCCCC1C(=O)NCc1ccc(OC2CCN(CC(c3ccccc3)c3ccccc3)CC2)cc1";"IFI";"'='";"2.857";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL602985";"";"0";"324.41";"0";"3.14";"GNF-Pf-2501";"O=C1N=C(N2CCOCC2)S/C1=C/c1cccc2ccccc12";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL579082";"";"0";"352.44";"0";"3.27";"GNF-Pf-2521";"CCCOc1ccc2c(c1)C(=NN=C(N)N)c1cc(OCCC)ccc1-2";"IFI";"'='";"7.692";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL611212";"";"0";"385.38";"0";"3.21";"GNF-Pf-2531";"COc1cc(NC(=O)Cn2ccc3ccc([N+](=O)[O-])cc32)cc(OC)c1OC";"IFI";"'='";"3.03";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL533423";"";"0";"267.23";"0";"0.84";"GNF-Pf-2538";"O=C(NNC(=S)NCc1ccco1)C(F)(F)F";"IFI";"'='";"2.02";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL577835";"";"0";"312.37";"0";"2.27";"GNF-Pf-2542";"CCOc1cc(C=NN=C(N)N)ccc1OCc1ccccc1";"IFI";"'='";"2.239";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL578300";"";"0";"412.88";"0";"4.73";"GNF-Pf-2568";"Cc1ccc(C(=O)NCCCCNc2ccnc3cc(Cl)ccc23)cc1[N+](=O)[O-]";"IFI";"'='";"2.105";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL601952";"";"0";"226.75";"0";"2.65";"GNF-Pf-5114";"Cl.Nc1ccc(N2CCCCCC2)cc1";"IFI";"'='";"5.455";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL601580";"";"0";"371.46";"1";"5.95";"GNF-Pf-5129";"COc1ccc(C2Sc3ccccc3N=C3C2=C(O)c2ccccc23)cc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL579368";"";"0";"349.31";"0";"4.04";"GNF-Pf-5130";"Cl.N=c1c2c(n(Cc3ccccc3Cl)c3c1CCC3)CCCC2";"IFI";"'='";"6.25";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL603010";"";"0";"482.24";"0";"4.70";"GNF-Pf-5133";"COc1ccc(-[n+]2cc(-c3ccc(Br)cc3)n3c2SCCC3)cc1.[Br-]";"IFI";"'='";"7.692";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL1744504";"";"0";"429.44";"0";"3.30";"GNF-Pf-5136";"CC(=NNC(=O)/C(=C\c1ccc([N+](=O)[O-])cc1)NC(=O)c1ccccc1)c1ccccn1";"IFI";"";"";"";"";"";"Not applicable";"";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL529205";"";"0";"348.40";"0";"3.67";"GNF-Pf-5140";"COc1cccc(NC(=O)c2cccc3c(=O)c4c([nH]c23)CCCC4)c1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL577452";"";"0";"320.49";"0";"3.32";"GNF-Pf-5141";"C=CCSc1nc(N)c2c3c(sc2n1)CN(CCC)CC3";"IFI";"'='";"14.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL587468";"";"0";"313.42";"0";"0.30";"GNF-Pf-5155";"CC(C(=O)NCCCN)N(Cc1ccccc1)S(C)(=O)=O";"IFI";"'='";"3.922";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL582255";"";"0";"477.61";"1";"5.62";"GNF-Pf-5165";"O=C(NCc1ccccc1)c1cnc(NCCC(c2ccccc2)c2ccccc2)nc1NC1CC1";"IFI";"'='";"5.825";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL533765";"";"0";"515.58";"1";"4.40";"GNF-Pf-5187";"Cc1ncc([N+](=O)[O-])n1CCOC(=O)NC(Nc1ccc(Br)cc1)C(Cl)(Cl)Cl";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL586430";"";"0";"302.33";"0";"1.35";"GNF-Pf-5208";"CN(C)c1ccc(NC(=O)C2C3C=CC(O3)C2C(=O)O)cc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL582455";"";"0";"410.47";"0";"4.42";"GNF-Pf-5218";"Fc1ccc(C2(CCCSc3nnc4c(n3)[nH]c3ccccc34)OCCO2)cc1";"IFI";"'='";"4.673";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL532987";"";"0";"377.87";"0";"4.09";"GNF-Pf-5254";"CCOc1cc2c(cc1OCC)C(c1cc(OC)c(O)cc1Cl)NCC2";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL586500";"";"0";"378.41";"0";"3.60";"GNF-Pf-5266";"Cc1cc(F)ccc1NC(=O)C(C)n1c2ccccc2c2nc(=O)cc(C)n21";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL602575";"";"0";"1111.34";"None";"None";"GNF-Pf-5297";"CC1OC(=O)C(C(C)C)NC(=O)C(C(C)C)OC(=O)C(C(C)C)NC(=O)C(C)OC(=O)C(C(C)C)NC(=O)C(C(C)C)OC(=O)C(C(C)C)NC(=O)C(C)OC(=O)C(C(C)C)NC(=O)C(C(C)C)OC(=O)C(C(C)C)NC1=O";"IFI";"'='";"27.71";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL578524";"";"0";"500.82";"2";"6.03";"GNF-Pf-5299";"CCOC(=O)C1=C(C)NC2=C(C(=O)CC(c3ccc(Cl)cc3)C2)C1c1ccc(Br)cc1";"IFI";"'='";"5.882";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL533994";"";"0";"658.61";"0";"4.31";"GNF-Pf-5316";"COc1cccc(CN2CCN(C(c3ccccc3)c3ccccc3)CC2)c1O.O=C(O)C(=O)O.O=C(O)C(=O)O.O=C(O)C(=O)O";"IFI";"'='";"4.762";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL579281";"";"0";"438.44";"0";"3.32";"GNF-Pf-5698";"COC(=O)C1=CN(Cc2ccc(OC)cc2)C=C(C(=O)OC)C1c1cccc([N+](=O)[O-])c1";"IFI";"'='";"1.163";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL602176";"";"0";"945.19";"3";"5.22";"GNF-Pf-5428";"CO[C@H]1CC[C@H](O[C@H]2[C@H](C)[C@@](O)([C@@H](C)C(=O)O)O[C@@H](C[C@@H]3C[C@@H](OC)[C@@H](C)[C@]4(O3)O[C@](C)([C@H]3CC[C@@H]([C@H]5CC[C@H]([C@H]6O[C@](C)(O)[C@H](C)[C@@H](OC)[C@@H]6C)O5)O3)[C@H](OC)[C@H]4C)[C@]2(C)OC)O[C@@H]1C";"IFI";"'='";"15.52";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL579941";"";"0";"526.64";"1";"4.90";"GNF-Pf-5433";"CCCC(C)C(C(=O)NCc1ccccc1)N1C(=O)c2cc(NC(C)=O)ccc2NC(=O)[C@@H]1c1ccccc1";"IFI";"'='";"2.439";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL601541";"";"0";"353.51";"0";"4.19";"GNF-Pf-5347";"Cc1cccc2cc(CNC3CCOC(C)(C)C3)c(N3CCCC3)nc12";"IFI";"'='";"1.724";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL531982";"";"0";"588.58";"2";"8.88";"GNF-Pf-5368";"COc1cc(C2Nc3ccc4ccccc4c3C3=C2C(=O)CC(C)(C)C3)ccc1Oc1ccc([N+](=O)[O-])cc1C(F)(F)F";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL601787";"";"0";"456.56";"0";"3.42";"GNF-Pf-5371";"COc1ccc(C(OCCS(=O)(=O)CCO)(c2ccccc2)c2ccc(OC)cc2)cc1";"IFI";"'='";"0.7463";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL528471";"";"0";"454.32";"0";"3.80";"GNF-Pf-5388";"O=[N+]([O-])c1ccc(N2CCCN(C(=S)Nc3ccc(F)cc3Br)CC2)nc1";"IFI";"'='";"0.8403";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600138";"";"0";"382.44";"0";"4.24";"GNF-Pf-3480";"COC(=O)c1c(NC(=O)c2c(-c3ccccc3)noc2C)sc2c1CCC2";"IFI";"'='";"1.449";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL529448";"";"0";"334.47";"0";"3.44";"GNF-Pf-3484";"CN1CCN(CCCNc2ccnc3cc4ccccc4cc23)CC1";"IFI";"'='";"18.8";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL599887";"";"0";"367.15";"0";"2.16";"GNF-Pf-3490";"NC(=NOC(=O)c1ccccc1I)c1ccccn1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL602611";"";"0";"311.77";"0";"4.34";"GNF-Pf-3496";"COc1ccc(C=NNc2ccnc3cc(Cl)ccc23)cc1";"IFI";"'='";"4.8";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL104";"CLOTRIMAZOLE";"4";"344.85";"1";"5.38";"Clotrimazole";"Clc1ccccc1C(c1ccccc1)(c1ccccc1)n1ccnc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL527465";"";"0";"737.98";"0";"2.04";"GNF-Pf-3521";"O=C(COC(c1cccs1)c1cccnc1Cl)N1CCN(CCO)CC1.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F";"IFI";"'='";"3.922";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL583222";"";"0";"521.61";"2";"5.12";"GNF-Pf-3528";"CCCOC(=O)C1=C(C)NC2=C(C(=O)CC(c3ccc(OC)c(OC)c3)C2)C1c1ccc(O)c(OCC)c1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL599083";"";"0";"340.42";"0";"3.25";"GNF-Pf-3538";"CCOC(=O)C1=C(C)NC2=C(C(=O)CC(C)(C)C2)C1c1ccccn1";"IFI";"'='";"2.299";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL527230";"";"0";"364.45";"1";"5.07";"GNF-Pf-3541";"CCOc1ccc(Nc2cc(C)nc(Nc3ccc(OCC)cc3)n2)cc1";"IFI";"'='";"4.615";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL610790";"";"0";"281.32";"0";"1.86";"GNF-Pf-3544";"CN(C)c1ccc(C=NNc2ncnc3nc[nH]c23)cc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL598058";"";"0";"345.45";"0";"3.85";"GNF-Pf-3548";"C1=C(c2ccccc2)CCN(c2ncnc3c2nc2n3CCCCC2)C1";"IFI";"'='";"7.692";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL598060";"";"0";"347.42";"0";"3.94";"GNF-Pf-3550";"Cc1ccc2nc(Nc3ncc4c(n3)CC(C)(C)CC4=O)nc(C)c2c1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL597253";"";"0";"415.58";"0";"4.66";"GNF-Pf-3554";"COc1ccc(CNCCN2CCN(c3ccc(C)cc3)C[C@@H]2c2ccccc2)cc1";"IFI";"'='";"3.75";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL605947";"";"0";"401.47";"0";"4.75";"GNF-Pf-3557";"COc1cccc(Cn2c(C)nc3cc(NC(=O)Nc4ccccc4)c(C)nc32)c1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL593252";"";"0";"263.75";"0";"2.90";"GNF-Pf-3564";"Nc1ccc2nc3ccc(N)cc3[s+]c2c1.[Cl-]";"IFI";"'='";"9.091";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL598898";"";"0";"323.42";"0";"3.38";"GNF-Pf-3568";"CCCc1c2ccc(C)n2cc[n+]1CC(=O)c1ccc(OC)cc1";"IFI";"'='";"4.545";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL597871";"";"0";"342.38";"0";"2.71";"GNF-Pf-3575";"CCCOC(=O)CSc1nc(N)c(C#N)c(-c2ccco2)c1C#N";"IFI";"'='";"6.154";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL602566";"";"0";"350.47";"0";"2.66";"GNF-Pf-3577";"CCOC(=O)C1CCN(C(=S)Nc2ccc3nsnc3c2)CC1";"IFI";"'='";"12.96";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL597267";"";"0";"173.17";"0";"1.66";"GNF-Pf-3579";"N#Cc1cccc(C=CC(=O)O)c1";"IFI";"";"";"";"";"";"Not applicable";"";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600774";"";"0";"477.36";"0";"4.70";"GNF-Pf-3585";"N#CC(=Cn1cc(Cc2ccc(Cl)cc2Cl)c2ccccc21)c1nn(CCO)c(N)c1C#N";"IFI";"";"";"";"";"";"Not applicable";"";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL586026";"";"0";"387.49";"1";"6.34";"GNF-Pf-3586";"CN1C=C(c2ccc3ccccc3n2)C(c2c[nH]c3ccccc23)c2ccccc21";"IFI";"'='";"6.569";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600775";"";"0";"326.40";"0";"2.18";"GNF-Pf-3589";"COc1cc(CN2CC3CC(C2)c2cccc(=O)n2C3)ccc1O";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL583401";"";"0";"352.37";"0";"3.03";"GNF-Pf-3600";"CC(=O)N(C1=C(N(C)C)C(=O)c2ccccc2C1=O)c1ccc(F)cc1";"IFI";"'='";"31.08";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL584074";"";"0";"315.38";"0";"4.15";"GNF-Pf-3604";"C=CCn1cc(C=NNc2nc3ccccc3[nH]2)c2ccccc21";"IFI";"'='";"15.38";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL602965";"";"0";"585.63";"2";"7.25";"GNF-Pf-3613";"CCC(c1nc2ccccc2c(=O)n1-c1ccccc1OC)N(CCc1ccccc1)C(=O)c1cccc(C(F)(F)F)c1";"IFI";"'='";"3.261";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL599287";"";"0";"539.76";"2";"9.28";"GNF-Pf-3617";"CCCCCCc1ccc(C(=O)Oc2ccccc2-c2nc3cc(C)ccn3c2NC(C)(C)CC(C)(C)C)cc1";"IFI";"'='";"2.105";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL528150";"";"0";"342.87";"1";"5.30";"GNF-Pf-3618";"CCOc1ccc(Nc2cc(C)nc3c(C)cc(C)cc23)cc1.Cl";"IFI";"'='";"1.111";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL599098";"";"0";"338.12";"0";"4.01";"GNF-Pf-3641";"O=[N+]([O-])c1cc(Br)c(Nc2ccccc2)c([N+](=O)[O-])c1";"IFI";"'='";"7.692";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL598491";"";"0";"281.36";"0";"3.35";"GNF-Pf-3649";"Cc1cccc(OC(C)C(=O)N2CCc3ccccc32)c1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL605630";"";"0";"522.57";"2";"6.97";"GNF-Pf-3655";"COc1ccc(C2C(C(=O)Nc3cccc(C(F)(F)F)c3)c3ccccc3C(=O)N2C2CCCCC2)cc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL528609";"";"0";"470.21";"0";"4.04";"GNF-Pf-3658";"CCC(CO)NCC(O)Cn1c2ccc(Br)cc2c2cc(Br)ccc21";"IFI";"'='";"4.651";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL601598";"";"0";"471.48";"0";"4.00";"GNF-Pf-3662";"O=C(NC1CC1)C1CCN(c2cccc3c2C(=O)N(Cc2cccc(C(F)(F)F)c2)C3=O)CC1";"IFI";"'='";"4.237";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL7961";"";"0";"653.76";"3";"5.49";"GNF-Pf-3678";"CCOC(=O)c1sc(NC(=O)C(C)Sc2nnc(CNC(=O)c3cccc(F)c3)n2-c2cccc(C)c2)c(C(=O)OCC)c1C";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL602152";"";"0";"431.40";"0";"3.95";"GNF-Pf-3688";"CCCCN(CCCC)S(=O)(=O)c1cc(Br)cc2c1N(C(C)=O)CC2";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL527923";"";"0";"646.79";"2";"5.84";"GNF-Pf-3690";"COc1cc(OC)cc(C(=O)Nc2cc(C(=O)N3CCC(Cc4ccccc4)CC3)ccc2N2CC3CC(C2)c2cccc(=O)n2C3)c1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL608736";"";"0";"233.26";"0";"3.06";"GNF-Pf-3698";"NCC(c1ccc(F)cc1)c1ccc(F)cc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL607577";"";"0";"190.23";"0";"1.78";"GNF-Pf-3719";"O=C1CSc2nc3ccccc3n21";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL584033";"";"0";"502.62";"2";"5.16";"GNF-Pf-3739";"O=C1[C@@H]2Cc3c([nH]c4ccccc34)C(CCc3ccccc3)N2C(=O)CN1CCc1c[nH]c2ccccc12";"IFI";"";"";"";"";"";"Not applicable";"";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585094";"";"0";"419.57";"1";"6.33";"GNF-Pf-3750";"CC(C)(C)CC(C)(C)Nc1c(-c2ccccc2OC(=O)C2CCC2)nc2ccccn12";"IFI";"'='";"3.846";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585508";"";"0";"381.82";"0";"3.42";"GNF-Pf-3754";"CN(C)c1nnc(C(C#N)=Cc2cc(C(=O)c3cccc(Cl)c3)cn2C)o1";"IFI";"";"";"";"";"";"Not applicable";"";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL597035";"";"0";"327.44";"0";"4.27";"GNF-Pf-3756";"Cc1ccnc(Nc2nc(-c3c(C)nc4sccn34)cs2)c1";"IFI";"'='";"4.225";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL605950";"";"0";"418.47";"0";"4.07";"GNF-Pf-3758";"COc1ccc(S(=O)(=O)N=C2C=C(Nc3ccccc3)C(=O)c3ccccc32)cc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL605131";"";"0";"474.36";"1";"5.41";"GNF-Pf-3764";"O=c1c2sccc2nc(SCc2cccc([N+](=O)[O-])c2)n1-c1ccc(Br)cc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL599948";"";"0";"395.93";"0";"4.83";"GNF-Pf-3774";"CN1CCCC1CCNCc1cc(-c2ccnc3cc(Cl)ccc23)ccc1O";"IFI";"'='";"5.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL584038";"";"0";"238.33";"0";"3.44";"GNF-Pf-3782";"CN1CC=C(/C=C/c2c[nH]c3ccccc23)CC1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585665";"";"0";"403.27";"0";"3.85";"GNF-Pf-3788";"CNC1=C(N(Cc2ccc(Cl)c(Cl)c2)C(C)=O)C(=O)c2ccccc2C1=O";"IFI";"'='";"14.29";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL582983";"";"0";"339.39";"0";"0.73";"GNF-Pf-3792";"CC(=O)OC1(C)CC(C)C(=O)C(C(O)CC2CC(=O)NC(=O)C2)C1";"IFI";"'='";"22.64";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600756";"";"0";"374.49";"1";"5.40";"GNF-Pf-3794";"Nc1ccc2nc(-c3cccc(-c4nc5ccc(N)cc5s4)c3)sc2c1";"IFI";"'='";"11.94";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL584080";"";"0";"275.31";"0";"1.27";"GNF-Pf-3795";"COc1cc(NCc2cnc(N)nc2N)cc(OC)c1";"IFI";"'='";"0.8";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL530391";"";"0";"624.77";"2";"5.86";"GNF-Pf-3804";"O=C(Cc1ccccc1)NCc1nnc(SCC(=O)N2N=C(c3cccs3)CC2c2ccc(F)cc2)n1Cc1ccccc1";"IFI";"'='";"2.41";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL610331";"";"0";"449.52";"1";"5.15";"GNF-Pf-5583";"CCCOC(=O)C1=C(C)NC2=C(C(=O)CC(c3ccc(OC)cc3)C2)C1c1cccc(F)c1";"IFI";"'='";"2.353";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL578704";"";"0";"445.52";"0";"2.41";"GNF-Pf-5593";"O=C(Nc1ccc2nc3n(c(=O)c2c1)CCCCC3)C(=O)N1CCN(c2ccccc2)CC1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL579133";"";"0";"510.43";"2";"5.77";"GNF-Pf-5601";"COc1ccc(C2CC(=O)C3=C(C2)NC(C)=C(C(=O)OC(C)C)C3c2ccccc2Br)cc1";"IFI";"'='";"4.598";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL576783";"";"0";"526.43";"2";"5.39";"GNF-Pf-5608";"CCOC(=O)C1=C(C)NC2=C(C(=O)CC(c3ccc(OC)c(OC)c3)C2)C1c1ccccc1Br";"IFI";"'='";"3.529";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL577424";"";"0";"477.55";"1";"5.08";"GNF-Pf-5612";"CC(=O)c1ccc(NC(=O)CSc2nnc3c4c(-c5ccc(F)cc5)csc4ncn23)cc1";"IFI";"'='";"5.882";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600509";"";"0";"426.97";"0";"4.16";"GNF-Pf-5620";"CCOC(=O)c1c(NC(C)=O)sc2c(O)c(CNC3CCCCC3)ccc12.Cl";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL534056";"";"0";"636.73";"2";"5.12";"GNF-Pf-5682";"CCOC(=O)C1=C(c2ccccc2)N=c2sc(=Cc3cc(OC)c(OC)c(OC)c3)c(=O)n2C1c1c(OC)ccc2ccccc12";"IFI";"'='";"3.488";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL601553";"";"0";"304.38";"0";"2.59";"GNF-Pf-5696";"C[n+]1c2ccccc2nc2ccc(NCCc3cnc[nH]3)cc21";"IFI";"'='";"15.38";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL578942";"";"0";"304.44";"0";"1.81";"GNF-Pf-2653";"CNC(=O)c1nn(C)c2c1CC(NCC1CCCCC1)CC2";"IFI";"'='";"4.878";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL375673";"";"0";"270.72";"0";"4.34";"GNF-Pf-1310";"Oc1ccc(Nc2ccnc3cc(Cl)ccc23)cc1";"IFI";"'='";"1.316";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL588571";"";"0";"532.08";"2";"6.73";"GNF-Pf-1373";"CCCCCN(C(=O)COCc1ccccc1)C(CC)c1nc2ccccc2c(=O)n1-c1cccc(Cl)c1";"IFI";"'='";"1.887";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL582248";"";"0";"528.65";"2";"6.58";"GNF-Pf-1393";"CCCCCN(C(=O)Nc1ccccc1OC)C(CC)c1nc2ccccc2c(=O)n1-c1ccccc1OC";"IFI";"'='";"1.961";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL582457";"";"0";"596.53";"2";"6.99";"GNF-Pf-1397";"CCOc1ccccc1-n1c(C(C)N(CCc2ccccc2)C(=O)c2ccc(Br)cc2)nc2ccccc2c1=O";"IFI";"'='";"5.714";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL582261";"";"0";"324.45";"0";"2.10";"GNF-Pf-1403";"CC1CCN(C(=O)C(C)N(c2ccccc2)S(C)(=O)=O)CC1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL576798";"";"0";"392.54";"0";"3.25";"GNF-Pf-1414";"CC(=O)OC1CCC2(C)C(CCC3C2CCC2(C)C3CC(O)C2(O)C(C)=O)C1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL601581";"";"0";"348.45";"0";"4.58";"GNF-Pf-1415";"Cc1ccc(C)c(Nc2nc(NCC3CCCO3)c3ccccc3n2)c1";"IFI";"'='";"2.985";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL577888";"";"0";"491.52";"0";"3.79";"GNF-Pf-1501";"CCn1c2ccccc2c2cc(C=NNC(=O)c3nnn(-c4nonc4N)c3-c3ccccc3)ccc21";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL529626";"";"0";"617.79";"2";"7.68";"GNF-Pf-1345";"CCc1ccc(-n2c(C(CC)N(CCc3ccc(OC)c(OC)c3)C(=O)C(CC)c3ccccc3)nc3ccccc3c2=O)cc1";"IFI";"'='";"2.885";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL583808";"";"0";"540.76";"2";"7.24";"GNF-Pf-887";"O=C(Nc1ccc(Br)cn1)c1ccc(Oc2cc(Oc3cccc(Cl)c3)cc([N+](=O)[O-])c2)cc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585209";"";"0";"367.41";"0";"2.51";"GNF-Pf-906";"COc1ccc(OCC(=O)Nc2c(C)n(C)n(-c3ccccc3)c2=O)cc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585608";"";"0";"319.79";"0";"1.92";"GNF-Pf-918";"NCCNC(=O)COC(c1cccnc1)c1ccccc1Cl";"IFI";"'='";"0.9709";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL584420";"";"0";"281.14";"0";"3.95";"GNF-Pf-923";"Cc1c(Cl)cccc1NC(=O)c1cccnc1Cl";"IFI";"'='";"15.38";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600688";"";"0";"251.40";"0";"2.07";"GNF-Pf-933";"Cc1c(C)c(C)c(CNC(=S)NN)c(C)c1C";"IFI";"'='";"2.02";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL579294";"";"0";"268.36";"0";"3.67";"GNF-Pf-2450";"CCOc1ccc(C2N(C)c3ccccc3N2C)cc1";"IFI";"'='";"2.74";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL584759";"";"0";"579.99";"3";"0.00";"GNF-Pf-2453";"COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)CC(O)(C(=O)CO)CC3OC1CC(N)C(O)C(C)O1.Cl";"IFI";"";"";"";"";"";"Not applicable";"";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL578895";"";"0";"409.53";"1";"6.32";"GNF-Pf-2457";"Cc1cccc(NC(=O)c2ccc(NCCCC3CCCCCC3)c([N+](=O)[O-])c2)c1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL578490";"";"0";"433.64";"0";"4.00";"GNF-Pf-2167";"CC(C)N1CCC(N2CCN(Cc3ccc4c(c3)Cc3ccccc3-4)CC2CCO)CC1";"IFI";"'='";"8.333";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL534063";"";"0";"629.51";"2";"6.53";"GNF-Pf-2169";"CCc1ccc(C(=O)N(CC(=O)Nc2cc(C(C)(C)C)nn2-c2ccc(Cl)c(Cl)c2)C(C)C)cc1.O=C(O)C(F)(F)F";"IFI";"'='";"2.105";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL601171";"";"0";"540.62";"1";"4.34";"GNF-Pf-1539";"COc1cc(/C=C/C(=O)Nc2ccc3nc(N4CCN(c5ncccn5)CC4)cc(C)c3c2)cc(OC)c1OC";"IFI";"'='";"11.48";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL582671";"";"0";"340.38";"0";"4.43";"GNF-Pf-1541";"O=C1C(O)=CC(=Nc2ccc(Cc3ccncc3)cc2)c2ccccc21";"IFI";"'='";"7.143";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL578539";"";"0";"303.28";"0";"2.38";"GNF-Pf-1571";"CCOC(=O)N1CCN(c2ccc(C(F)(F)F)cn2)CC1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL577889";"";"0";"386.88";"1";"6.42";"GNF-Pf-1574";"Cc1cc(C)cc(NC(=O)c2cc(-c3ccc(Cl)cc3)nc3ccccc23)c1";"IFI";"'='";"2.703";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL577890";"";"0";"318.40";"0";"3.44";"GNF-Pf-1575";"CCOC(=O)c1c(NC(=O)c2cccnc2)sc(C)c1CC";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL576616";"";"0";"283.28";"0";"2.88";"GNF-Pf-1589";"COC(=O)c1ccc(Cn2cc(C=O)c3ccccc32)o1";"IFI";"'='";"8.333";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL601966";"";"0";"336.37";"0";"1.69";"GNF-Pf-1592";"CN=C1S/C(=C\c2ccc(OCC(=O)O)c(OC)c2)C(=O)N1C";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL587902";"";"0";"575.07";"1";"5.66";"GNF-Pf-1597";"CCOc1ccc(CN(C(=O)COc2ccc(Cl)cc2)C(C)CCCN(CC)CC)cc1.O=C(O)C(F)(F)F";"IFI";"'='";"2.703";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL588841";"";"0";"541.70";"1";"3.20";"GNF-Pf-1599";"O=C(NCCCN1CCCC1=O)c1cnc(N2CCN(Cc3ccccc3)CC2)nc1NCCc1ccccc1";"IFI";"'='";"0.9804";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL587974";"";"0";"421.55";"0";"3.22";"GNF-Pf-1604";"CC(C)CNc1nc(NCCCn2ccnc2)ncc1C(=O)NCCc1ccccc1";"IFI";"'='";"1.905";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600956";"";"0";"381.50";"0";"4.84";"GNF-Pf-1609";"Cc1ccc(CN2C3CCCC2CC(NC(=O)Nc2cccc(F)c2)C3)cc1";"IFI";"'='";"1.316";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL580794";"";"0";"379.44";"0";"3.06";"GNF-Pf-1616";"CCCS(=O)(=O)N1CCC(CO)(Cc2ccccc2C(F)(F)F)CC1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL602791";"";"0";"502.53";"1";"2.80";"GNF-Pf-1629";"COc1ccc(N(C)C(=O)CNC(=O)c2nn(-c3ccc(OC)cc3OC)c(=O)c3ccccc23)cc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL608556";"";"0";"617.79";"1";"3.44";"GNF-Pf-1659";"CC(C)[C@@]1(NC(=O)[C@@H]2C[C@@H]3c4cccc5[nH]cc(c45)C[C@H]3N(C)C2)O[C@@]2(O)[C@@H]3CCCN3C(=O)[C@H](CC3CCCCC3)N2C1=O";"IFI";"'='";"9.524";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL534172";"";"0";"218.08";"0";"3.26";"GNF-Pf-1679";"CC(=O)Nc1c(C)cc(Cl)cc1Cl";"IFI";"'='";"3.226";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL582047";"";"0";"378.43";"0";"3.12";"GNF-Pf-1689";"CCOc1ccc(NC2=C(N3CCOCC3)C(=O)c3ccccc3C2=O)cc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL582054";"";"0";"349.48";"0";"3.67";"GNF-Pf-1691";"CC(=O)N1CCc2cc(NC3CCN(Cc4ccccc4)CC3)ccc21";"IFI";"'='";"1.493";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL582056";"";"0";"339.40";"0";"3.74";"GNF-Pf-1693";"CC1N=C2c3ccccc3N=C(SCc3ccc(F)cc3)N2C1=O";"IFI";"'='";"3.529";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL577657";"";"0";"370.41";"0";"3.37";"GNF-Pf-1697";"COC(=O)C1=C(C)NC2=C(C(=O)CC(C)(C)C2)C1c1ccccc1[N+](=O)[O-]";"IFI";"'='";"2.299";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600520";"";"0";"294.81";"0";"4.97";"GNF-Pf-1710";"CC[n+]1c(C=Cc2ccc(Cl)cc2)ccc2ccccc21";"IFI";"";"";"";"";"";"Not applicable";"";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL587859";"";"0";"502.59";"1";"4.65";"GNF-Pf-1735";"COc1ccccc1N1CCN(c2ccc(NC(=O)c3cccc(F)c3)cc2C(=O)N2CCCC2)CC1";"IFI";"'='";"0.9174";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL588294";"";"0";"440.55";"1";"5.21";"GNF-Pf-1744";"CCCc1nc2ccc(NC(=O)NCC)cc2c(=O)n1Cc1ccc(-c2ccccc2)cc1";"IFI";"'='";"7.273";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600928";"";"0";"418.42";"0";"4.46";"GNF-Pf-1753";"CCOC(=O)C1=C(C)N/C(=C/c2cc(C)n(-c3ccccc3C(F)(F)F)c2C)C1=O";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL578542";"";"0";"363.63";"None";"None";"GNF-Pf-1761";"CCN(CC)[P+](N(C)C[Si](C)(C)C)(N(CC)CC)N(CC)CC";"IFI";"'='";"9.091";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL578749";"";"0";"450.65";"0";"4.62";"GNF-Pf-1762";"CCN(CC)CCN(Cc1cc2ccc(C)cc2[nH]c1=O)C(=S)NC(C)c1ccccc1";"IFI";"'='";"8.411";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL577893";"";"0";"247.34";"0";"1.61";"GNF-Pf-1764";"Cc1ccc(C(=O)NCCN2CCCCC2)cn1";"IFI";"'='";"0.6897";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL602162";"";"0";"229.24";"0";"1.42";"GNF-Pf-1118";"COc1ccc2[nH]c3c(=O)n(C)cnc3c2c1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL584853";"";"0";"256.35";"0";"1.91";"GNF-Pf-1120";"CC12CN3CC(C)(CN(C1)C3c1ccccc1)C2=O";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL601535";"";"0";"602.53";"2";"8.60";"GNF-Pf-1141";"CC(C)(c1ccc(Oc2ccc(NC(=O)C(F)(F)F)cc2)cc1)c1cccc(Oc2ccc(NC(=O)C(F)(F)F)cc2)c1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL581166";"";"0";"403.48";"0";"4.01";"GNF-Pf-1149";"COc1ccc(-n2nc(C(=O)NCCC3=CCCCC3)c3ccccc3c2=O)cc1";"IFI";"'='";"3.571";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL603522";"";"0";"299.42";"0";"3.45";"GNF-Pf-1151";"CCN1/C(=C/c2cccc[n+]2C)Sc2ccc(OC)cc21";"IFI";"'='";"15.38";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL530610";"";"0";"496.66";"0";"4.37";"GNF-Pf-1161";"CC1(C)Cc2c(oc3ncn(CCn4cnc5oc6c(c5c4=N)CC(C)(C)SC6)c(=N)c23)CS1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585612";"";"0";"374.35";"0";"4.98";"GNF-Pf-1165";"O=C(Oc1ccc(-c2ccc(OC(=O)c3ccco3)cc2)cc1)c1ccco1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL296622";"";"0";"293.35";"0";"0.58";"GNF-Pf-1178";"Nc1nc(N)c2cc(S(=O)(=O)N3CCCC3)ccc2n1";"IFI";"'='";"11.72";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL584851";"";"0";"445.91";"0";"4.73";"GNF-Pf-1187";"O=C1C2CN(C(=O)Nc3ccccc3)C(c3ccc(Cl)cc3)C2C(=O)N1c1ccccc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600968";"";"0";"343.41";"1";"5.37";"GNF-Pf-1211";"N#C/C(=C\c1ccc(Sc2ccccc2)o1)c1nc2ccccc2[nH]1";"IFI";"'='";"6.742";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585788";"";"0";"329.43";"0";"3.88";"GNF-Pf-1233";"CCCOc1ncnc2c1sc1nc3c(cc12)COC(C)(C)C3";"IFI";"'='";"1.802";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585790";"";"0";"334.38";"0";"-1.03";"GNF-Pf-1236";"Cn1c(=O)c2c(ncn2CC(O)CN=C2CCCCN2)n(C)c1=O";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL530293";"";"0";"294.40";"0";"1.07";"GNF-Pf-1261";"CCN1CCN(CC(O)COc2ccc(OC)cc2)CC1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL579304";"";"0";"371.46";"0";"3.78";"GNF-Pf-2605";"COCCn1c(SCC(=O)c2ccc(C)cc2C)nnc1-c1ccco1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL599928";"";"0";"549.04";"2";"9.03";"GNF-Pf-2607";"CCCCCCCN(CCCCCCC)CC(O)c1cc2ccccc2c2cc(Br)ccc12.Cl";"IFI";"'='";"0.885";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL602582";"";"0";"292.80";"0";"3.39";"GNF-Pf-2610";"CCc1cc2c(Nc3ccncc3)ncnc2s1.Cl";"IFI";"'='";"1.515";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL578902";"";"0";"396.49";"0";"4.88";"GNF-Pf-2613";"Cc1ccc(-n2cc(C(=O)N(C)Cc3ccccc3)c3ccccc3c2=O)cc1C";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL578709";"";"0";"309.39";"0";"4.18";"GNF-Pf-155";"CC(=O)N(/C=C1/Sc2ccccc2C1=O)c1ccc(C)cc1";"IFI";"'='";"7.692";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL579350";"";"0";"348.37";"0";"3.76";"GNF-Pf-168";"O=C(Nc1ccncc1)Nc1cccc(NC(=O)Nc2ccncc2)c1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600517";"";"0";"281.35";"0";"1.04";"GNF-Pf-170";"C[C@H]1C[C@H](C)C(=O)[C@@H]([C@@H](O)CC2CC(=O)NC(=O)C2)C1";"IFI";"'='";"23.87";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL576996";"";"0";"331.38";"0";"4.09";"GNF-Pf-178";"CN1C=C(c2ccc3ccccc3n2)C(C[N+](=O)[O-])c2ccccc21";"IFI";"'='";"16.67";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL576724";"";"0";"474.57";"0";"3.86";"GNF-Pf-185";"CC(=O)Nc1ccc(C(C)=NNc2nc(Nc3cc(C)ccc3C)nc(N3CCOCC3)n2)cc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL534382";"";"0";"600.62";"2";"5.08";"GNF-Pf-203";"Cc1ccc(-c2nn(CC(=O)Nc3ccc(OC(F)(F)F)cc3)c(=O)c3ccccc23)cc1S(=O)(=O)N1CCCCC1";"IFI";"'='";"2.353";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL582699";"";"0";"458.48";"1";"5.10";"GNF-Pf-211";"O=C(Nc1ccc(C(F)(F)F)cc1)c1cc(S(=O)(=O)NC2CCCCCC2)ccc1F";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL582500";"";"0";"350.64";"1";"5.06";"GNF-Pf-228";"Cc1cc(NC(=O)/C=C/c2ccccc2Cl)ccc1Br";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL582309";"";"0";"378.47";"0";"4.06";"GNF-Pf-250";"CCOC(=O)C1=C(C)N/C(=C\c2cc(C)n(-c3ccc(C)cc3C)c2C)C1=O";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL581852";"";"0";"504.23";"2";"7.84";"GNF-Pf-258";"Brc1cc(Br)c2c(-c3ccccc3)n(-c3ccccc3)nc(-c3ccccc3)c1-2";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL582269";"";"0";"479.99";"1";"5.82";"GNF-Pf-262";"CCOC(=O)c1ccc(-n2c(C)cc(/C=C3\SC(=Nc4ccc(Cl)cc4)NC3=O)c2C)cc1";"IFI";"'='";"1.176";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL530565";"";"0";"193.10";"0";"3.72";"GNF-Pf-267";"CSc1ccc(Cl)c(Cl)c1";"IFI";"'='";"6.173";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL535760";"";"0";"608.72";"1";"4.18";"GNF-Pf-278";"Cc1ccc(S(=O)(=O)NC(Cc2ccccc2)C(=O)N2CCC(C3CCN(C(=O)c4ccc([N+](=O)[O-])o4)CC3)CC2)cc1";"IFI";"'='";"7.692";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL579968";"";"0";"372.44";"0";"3.69";"GNF-Pf-285";"Cc1ccc(Nc2nc3c(N)nnc(N)c3nc2Nc2ccc(C)cc2)cc1";"IFI";"'='";"2.985";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL579970";"";"0";"290.34";"0";"3.56";"GNF-Pf-288";"CCOC(=O)c1[nH]c(C)c(CNc2cccc(F)c2)c1C";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL579975";"";"0";"490.99";"1";"5.83";"GNF-Pf-294";"COc1cccc(CN2CCC(O)(c3ccc4oc(C(=O)Nc5ccc(Cl)cc5)cc4c3)CC2)c1";"IFI";"'='";"3.81";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL579976";"";"0";"438.24";"0";"4.82";"GNF-Pf-295";"O=c1c2ccccc2nc(/C=C/c2ccc([N+](=O)[O-])o2)n1-c1ccc(Br)cc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL599910";"";"0";"351.48";"0";"3.59";"GNF-Pf-304";"N#C/C(=C\NC1CCN(Cc2ccccc2)CC1)C(=O)c1cccs1";"IFI";"'='";"2.5";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL577847";"";"0";"406.51";"0";"3.84";"GNF-Pf-94";"Cc1ccc(S(=O)(=O)N2CCN(C(=O)c3ccccc3)C2c2ccccc2)cc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL244023";"";"0";"440.49";"0";"4.57";"GNF-Pf-98";"COc1cc(/C=C2\CC/C(=C\c3cc(OC)c(OC)c(OC)c3)C2=O)cc(OC)c1OC";"IFI";"'='";"2.703";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600110";"";"0";"271.80";"0";"3.11";"GNF-Pf-123";"Nc1nnc(CCSc2ccc(Cl)cc2)s1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL578908";"";"0";"407.26";"0";"3.39";"GNF-Pf-142";"CCOc1cc(Br)cc(C=NNC(=O)COc2cccc(C)c2)c1O";"IFI";"'='";"5.147";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL577620";"";"0";"498.61";"1";"5.76";"GNF-Pf-144";"COc1ccc2[nH]c3c(c2c1)CCNC3c1ccc(OC)c(CSc2nnc(-c3ccccc3)o2)c1";"IFI";"'='";"2.308";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL578287";"";"0";"534.70";"2";"6.39";"GNF-Pf-148";"COc1cc(NC(C)CCCN(Cc2ccc(OC)c(OC)c2)C(=O)NC2CCCCC2)c2ncccc2c1";"IFI";"'='";"3.191";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL578535";"";"0";"356.34";"0";"2.41";"GNF-Pf-1";"CCC(=O)Nc1ccc(C(=O)NN=Cc2cc([N+](=O)[O-])ccc2O)cc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL578743";"";"0";"455.60";"1";"5.75";"GNF-Pf-3";"CCN1/C(=C/c2sc3ccc(-c4ccccc4)cc3[n+]2CCO)C=Cc2cc(OC)ccc21";"IFI";"'='";"7.143";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL578677";"";"0";"325.86";"0";"5.00";"GNF-Pf-19";"CN(/C=C/C1=[N+](C)c2ccc(Cl)cc2C1(C)C)c1ccccc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600934";"";"0";"434.54";"1";"5.78";"GNF-Pf-40";"COc1ccc2ccccc2c1C1NC(SCc2ccc(F)cc2)=NC(C)=C1C(C)=O";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL577631";"";"0";"355.83";"0";"3.57";"GNF-Pf-50";"CCC(C)NC(=O)c1nn(-c2ccc(Cl)cc2)c(=O)c2ccccc12";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL577632";"";"0";"260.34";"0";"4.50";"GNF-Pf-51";"Cc1cc2cc3c(cc2c(C)n1)c1ccccc1n3C";"IFI";"'='";"15.38";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL601571";"";"0";"306.37";"0";"4.07";"GNF-Pf-68";"CCN(CC)c1ccc(/C=C(/C#N)c2nc3ccccc3[nH]2)o1";"IFI";"'='";"7.692";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL602583";"";"0";"297.36";"0";"2.09";"GNF-Pf-73";"O=C(Cc1cccnc1)N1CCC(Oc2ccncc2)CC1";"IFI";"'='";"5.556";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL579317";"";"0";"417.56";"0";"4.55";"GNF-Pf-76";"CCN(CC)Cc1ccc2c(NC(=O)c3ccc(C)s3)c(C(=O)OC)sc2n1";"IFI";"'='";"0.8621";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL528006";"";"0";"313.38";"0";"3.15";"GNF-Pf-3897";"Fc1ccc2[nH]c3c(NCCN4CCCCC4)ncnc3c2c1";"IFI";"'='";"5.882";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL597257";"";"0";"359.38";"0";"1.87";"GNF-Pf-3898";"COc1cccc(OCC(=O)NN=C(C)CC(=O)NCc2ccco2)c1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL606159";"";"0";"468.34";"0";"3.78";"GNF-Pf-3904";"CCOC(=O)C1=CN(C)C=C(C(=O)OCC)C1c1cc(Br)c(OCC)c(OC)c1";"IFI";"'='";"3.448";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL1744507";"";"0";"418.48";"0";"4.89";"GNF-Pf-3905";"Cc1cc(/C=C2\SC(=Nc3ccccc3)NC2=O)c(C)n1-c1cccc([N+](=O)[O-])c1";"IFI";"";"";"";"";"";"Not applicable";"";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL598697";"";"0";"412.28";"1";"5.09";"GNF-Pf-3911";"COc1cc(Br)c(C2CC(=O)Nc3ccc4ccccc4c32)cc1OC";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL596834";"";"0";"391.29";"0";"4.19";"GNF-Pf-3954";"CC(=O)Nc1ccc(N2C(=O)CSC2c2ccc(Br)cc2)cc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL598684";"";"0";"546.11";"2";"7.12";"GNF-Pf-3816";"CCCCCCN(C(=O)COCc1ccccc1)C(CC)c1nc2ccccc2c(=O)n1-c1cccc(Cl)c1";"IFI";"'='";"0.9434";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL599514";"";"0";"352.37";"0";"3.03";"GNF-Pf-4055";"CC(=O)N(C1=C(N(C)C)C(=O)c2ccccc2C1=O)c1cccc(F)c1";"IFI";"'='";"15.38";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL599723";"";"0";"362.43";"0";"4.97";"GNF-Pf-4214";"CCOC(=O)c1cnc2c(C)cc(C)cc2c1Nc1ccc(C(C)=O)cc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL601594";"";"0";"471.56";"1";"6.59";"GNF-Pf-5223";"Cc1ccc(-n2c(-c3ccccc3)cc(C=NNC(=O)c3cccc(O)c3)c2-c2ccccc2)cc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL578315";"";"0";"371.48";"0";"4.12";"GNF-Pf-5234";"CCOc1cc(C2CC(=O)NC3=C2C(=O)CC(C)(C)C3)ccc1OC(C)C";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585796";"";"0";"389.48";"0";"4.64";"GNF-Pf-4999";"CCOc1ccccc1-n1c(N)c(C(=O)Nc2ccc(F)cc2)sc1=S";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL36";"PYRIMETHAMINE";"4";"248.72";"0";"2.52";"GNF-Pf-5586";"CCc1nc(N)nc(N)c1-c1ccc(Cl)cc1";"IFI";"'='";"4.118";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL578884";"";"0";"475.59";"1";"5.33";"GNF-Pf-5640";"COc1ccc(C2CC(=O)C3=C(C2)NC(C)=C(C(=O)OC(C)C)C3c2ccccc2C)cc1OC";"IFI";"'='";"4.762";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL602376";"";"0";"309.80";"0";"4.97";"GNF-Pf-5430";"C[C@H](Nc1cncc(-c2ccc(Cl)cc2)n1)c1ccccc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL533783";"";"0";"247.34";"0";"4.49";"GNF-Pf-5440";"c1ccc(CCNc2cccc3ccccc23)cc1";"IFI";"'='";"1.786";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL578736";"";"0";"481.98";"1";"5.28";"GNF-Pf-5442";"CCOC(=O)C1=C(C)NC2=C(C(=O)CC(c3ccc(OC)c(OC)c3)C2)C1c1cccc(Cl)c1";"IFI";"'='";"3.529";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL586830";"";"0";"235.31";"0";"3.16";"GNF-Pf-5485";"C[n+]1ccc(/C=C/c2c[nH]c3ccccc23)cc1";"IFI";"";"";"";"";"";"Not applicable";"";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL582662";"";"0";"547.54";"0";"5.00";"GNF-Pf-5490";"O=C(Cc1ccccc1)NCc1ccc(Nc2c(-c3cccnc3)nc3ccccn23)cc1.O=C(O)C(F)(F)F";"IFI";"'='";"4.167";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL601552";"";"0";"338.41";"0";"4.44";"GNF-Pf-5491";"CC(=O)N1c2ccc([N+](=O)[O-])cc2C(C)(c2ccccc2)CC1(C)C";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL580138";"";"0";"465.52";"0";"4.39";"GNF-Pf-5495";"COCCOC(=O)C1=C(C)NC2=C(C(=O)CC(c3ccc(OC)cc3)C2)C1c1ccc(F)cc1";"IFI";"'='";"3.448";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL601138";"";"0";"467.53";"0";"2.47";"GNF-Pf-5322";"Nc1cc(C(=O)Nc2cccc(C3=NCCN3)c2)ccc1C(=O)Nc1cccc(C2=NCCN2)c1";"IFI";"'='";"2.679";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL588864";"";"0";"388.47";"0";"0.42";"GNF-Pf-5348";"COCCNC(=S)N1CCN(S(=O)(=O)c2ccc([N+](=O)[O-])cc2)CC1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL601608";"";"0";"376.51";"0";"4.65";"GNF-Pf-5354";"CC[n+]1c(/C=C2\Sc3cc(NC(C)=O)ccc3N2C)ccc2ccccc21";"IFI";"";"";"";"";"";"Not applicable";"";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL578525";"";"0";"445.93";"1";"5.84";"GNF-Pf-5366";"O=C(Nc1ccc(F)c(Cl)c1)c1c2c(nc3ccccc13)CCN(Cc1ccccc1)C2";"IFI";"'='";"3.03";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL534190";"";"0";"292.34";"0";"3.42";"GNF-Pf-5367";"CN(C)c1ccc(C=Cc2nc(=O)c3ccccc3o2)cc1";"IFI";"";"";"";"";"";"Not applicable";"";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL582023";"";"0";"323.85";"0";"4.11";"GNF-Pf-5450";"Cc1ccc2c(Cl)c(C(=O)N3CC(C)OC(C)C3)sc2c1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL586181";"";"0";"562.69";"1";"3.50";"GNF-Pf-5476";"Cc1noc(C)c1S(=O)(=O)N(Cc1ccccc1)CC(O)CN1CCC(NC(=O)c2cccc3ccccc23)C1";"IFI";"'='";"2.913";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL583593";"";"0";"345.47";"0";"2.30";"GNF-Pf-899";"CCCNC(=O)CSc1nc(C)c(Cc2ccccc2)c(=O)n1C";"IFI";"'='";"0.9259";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL531643";"";"0";"294.36";"0";"3.09";"GNF-Pf-2627";"Cc1ccccc1Nc1nc(NCCO)c2ccccc2n1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL3216654";"";"0";"332.28";"0";"2.78";"GNF-Pf-2629";"COc1cc(NCCCC(C)N)c2ncccc2c1.Cl.Cl";"IFI";"'='";"10.2";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL578943";"";"0";"478.99";"0";"4.70";"GNF-Pf-2655";"CCCC(=O)O[C@]1(C(=O)CCl)[C@@H](C)CC2C3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)C(=O)C[C@@]21C";"IFI";"'='";"3.876";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL578719";"";"0";"215.26";"0";"1.55";"GNF-Pf-2713";"Cc1nc(NC(=N)N)nc2c(C)cccc12";"IFI";"'='";"4.545";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL586668";"";"0";"347.46";"1";"6.00";"GNF-Pf-5669";"OC1=C2C(=Nc3ccccc3SC2c2cccs2)c2ccccc21";"IFI";"'='";"2.273";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600942";"";"0";"530.45";"2";"6.33";"GNF-Pf-5672";"CCCOC(=O)C1=C(C)NC2=C(C(=O)CC(c3ccc(OC)c(OC)c3)C2)C1c1ccc(Cl)cc1Cl";"IFI";"'='";"3.571";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL602389";"";"0";"395.53";"0";"4.36";"GNF-Pf-5676";"CCOC(=O)C(=O)N1c2ccc(OC)cc2-c2c(ssc2=S)C1(C)C";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL577201";"";"0";"379.20";"0";"3.34";"GNF-Pf-5677";"CCc1nc2nc(C)cc(Nc3ccc(I)cc3)n2n1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL577432";"";"0";"386.52";"0";"3.19";"GNF-Pf-5690";"Cc1cc(C)c(S(=O)(=O)N2CCC(NC(=O)c3ccccc3)CC2)c(C)c1";"IFI";"'='";"3.797";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL15134";"";"0";"294.40";"0";"3.16";"GNF-Pf-5411";"C=CC1CN2CCC1CC2C(O)c1ccnc2ccccc12";"IFI";"'='";"0.7812";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL586788";"";"0";"473.59";"1";"7.29";"GNF-Pf-5413";"Cc1ccn2c(NC(C)(C)CC(C)(C)C)c(-c3ccccc3OC(=O)c3cccc(F)c3)nc2c1";"IFI";"'='";"2.83";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL579690";"";"0";"416.50";"1";"5.17";"GNF-Pf-5421";"C=C[C@H]1CN2CC[C@H]1C[C@H]2[C@H](OC(=O)c1ccc(F)cc1)c1ccnc2ccccc12";"IFI";"'='";"0.8403";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL576810";"";"0";"316.47";"0";"3.09";"GNF-Pf-5458";"CC1(C)C2CCC(C2)C1(C)NC(=S)NN=Cc1ccccn1";"IFI";"'='";"25.97";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600909";"";"0";"389.24";"1";"5.52";"GNF-Pf-5469";"COC(=O)c1c(-c2c(Cl)cccc2Cl)noc1/C=C/Nc1ccccc1";"IFI";"'='";"2.667";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL579929";"";"0";"375.94";"1";"5.51";"GNF-Pf-5492";"CCCCCCCC(=O)N(C)CCCNc1ccnc2cc(Cl)ccc12";"IFI";"'='";"6.316";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL578737";"";"0";"461.56";"0";"4.94";"GNF-Pf-5504";"CCOC(=O)C1=C(C)NC2=C(C(=O)CC(c3ccc(OC)c(OC)c3)C2)C1c1cccc(C)c1";"IFI";"'='";"8.75";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL609748";"";"0";"404.51";"1";"5.05";"GNF-Pf-5318";"CCCCOc1ccc(NC2=C(N3CCCCC3)C(=O)c3ccccc3C2=O)cc1";"IFI";"'='";"10.96";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL578752";"";"0";"452.89";"0";"4.78";"GNF-Pf-5331";"COC(=O)C1=C(C)NC2=C(C(=O)CC(c3ccccc3Cl)C2)C1c1ccc([N+](=O)[O-])cc1";"IFI";"'='";"5.435";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL578498";"";"0";"386.40";"None";"None";"GNF-Pf-5372";"CCN1C(=Cc2sc3ccccc3[n+]2CC)[Se]c2ccccc21";"IFI";"'='";"22.58";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600568";"";"0";"343.47";"1";"5.44";"GNF-Pf-5045";"Oc1ccc(-c2ccccc2)cc1CN1CCC(c2ccccc2)CC1";"IFI";"'='";"2.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL612128";"";"0";"456.03";"1";"6.86";"GNF-Pf-5055";"Cc1ccn2c(NC(C)(C)CC(C)(C)C)c(-c3ccccc3OC(=O)CCCCl)nc2c1";"IFI";"'='";"4.673";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585224";"";"0";"553.20";"1";"6.48";"GNF-Pf-5067";"Br.O=c1c(-c2ccc(Cl)cc2Cl)c(C(F)(F)F)oc2c(CN3CCCCC3)c(O)ccc12";"IFI";"'='";"1.22";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL601528";"";"0";"232.71";"0";"3.49";"GNF-Pf-5088";"Clc1ccc2c(N3CCCC3)ccnc2c1";"IFI";"'='";"5.714";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL584310";"";"0";"446.48";"0";"4.76";"GNF-Pf-4462";"COc1ccccc1-n1c(C(C)N(C)C(=O)Nc2ccccc2F)nc2ccccc2c1=O";"IFI";"'='";"4.902";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL584827";"";"0";"463.54";"1";"5.91";"GNF-Pf-4572";"CCCc1nc2ccc(NC(=O)c3ccco3)cc2c(=O)n1Cc1ccc(-c2ccccc2)cc1";"IFI";"'='";"5.455";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL584450";"";"0";"356.51";"0";"3.04";"GNF-Pf-4605";"C=CCn1nc(C(=O)N2CCCC2)c2c1CCC(N1CCCCCC1)C2";"IFI";"'='";"2.41";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL609027";"";"0";"301.82";"0";"2.74";"GNF-Pf-4280";"CN(C)c1ccc(-c2n(C)c3ccccc3[n+]2C)cc1.[Cl-]";"IFI";"'='";"6.25";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL529315";"";"0";"654.74";"2";"3.88";"GNF-Pf-4286";"O=C(Nc1ccc(C2=NCCN2)cc1)Nc1cc(C(=O)Nc2ccc(C3=NCCN3)cc2)ccc1C(=O)Nc1ccc(C2=NCCN2)cc1";"IFI";"'='";"1.802";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL580642";"";"0";"287.34";"0";"2.61";"GNF-Pf-4295";"CN(C)CCCNc1ncnc2c1[nH]c1ccc(F)cc12";"IFI";"'='";"5.556";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL605333";"";"0";"394.84";"0";"4.30";"GNF-Pf-4326";"N#Cc1c(N)nc(SCC(=O)c2ccc(Cl)cc2)c(C#N)c1-c1ccco1";"IFI";"'='";"0.7143";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL609319";"";"0";"387.27";"1";"5.23";"GNF-Pf-4331";"Cl.Clc1ccc(Nc2nc(NCc3ccco3)c3ccccc3n2)cc1";"IFI";"'='";"14.29";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL605946";"";"0";"435.35";"1";"6.97";"GNF-Pf-4334";"O=C1CC(c2ccccc2)CC2=C1C(c1cccc(Cl)c1Cl)Nc1ccccc1N2";"IFI";"'='";"4.706";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL599708";"";"0";"305.36";"0";"3.64";"GNF-Pf-4342";"CN1/C(=C/C=C/c2oc3ccccc3[n+]2C)Oc2ccccc21";"IFI";"'='";"21.15";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL602767";"";"0";"326.44";"0";"3.40";"GNF-Pf-4347";"CC[C@H]1CN2CC[C@@H]1C[C@@H]2[C@@H](O)c1ccnc2ccc(OC)cc12";"IFI";"'='";"2.158";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585652";"";"0";"430.36";"1";"6.01";"GNF-Pf-4372";"O=C(NCc1c(Cl)cccc1Sc1ccc(Cl)cc1)c1ccc2c(c1)CCO2";"IFI";"'='";"7.895";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL606474";"";"0";"427.36";"0";"3.31";"GNF-Pf-3990";"O=C(C1CC1)N1CCc2cc(Br)cc(S(=O)(=O)N3CCCCCC3)c21";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL602967";"";"0";"409.24";"0";"3.77";"GNF-Pf-4014";"O=C1NN(c2ccc(Br)cc2)C(=O)C1=Cc1c(O)ccc2ccccc12";"IFI";"";"";"";"";"";"Not applicable";"";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600165";"";"0";"453.01";"1";"6.29";"GNF-Pf-5092";"Cc1ccc(NC(=O)C2c3ccccc3C(=O)N(CC(C)C)C2c2cccs2)c(Cl)c1";"IFI";"'='";"3.226";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL586004";"";"0";"529.65";"1";"3.81";"GNF-Pf-5093";"CCCCNC(=O)N1CCN(C(=O)C(Cc2c[nH]c3ccccc23)NC(=O)Nc2cccc(C#N)c2)CC1C";"IFI";"'='";"2.778";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL582383";"";"0";"439.56";"0";"4.32";"GNF-Pf-5107";"Cc1ccc(Cn2c(N3CCC(C(=O)NCc4ccccn4)CC3)nc3ccccc32)cc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL602761";"";"0";"273.42";"0";"4.47";"GNF-Pf-5124";"CC(C)(C)c1ccc2c(c1)CN(C1CCCCC1)CO2";"IFI";"'='";"1.818";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585026";"";"0";"429.54";"1";"6.73";"GNF-Pf-5125";"CCCOc1ccc(C2Sc3ccccc3N=C3C2=C(O)c2ccccc23)cc1OC";"IFI";"'='";"3.333";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL577656";"";"0";"511.50";"0";"3.64";"GNF-Pf-5173";"COCCOC(=O)NCc1ccc(Nc2c(C(C)(C)C)nc3cnccn23)cc1.O=C(O)C(F)(F)F";"IFI";"'='";"1.37";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL577875";"";"0";"399.52";"0";"3.14";"GNF-Pf-5178";"Cc1ccc(C)c(NC(=O)C2CCCN(c3nnc(N4CCCC4=O)s3)C2)c1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL588004";"";"0";"371.45";"0";"4.38";"GNF-Pf-5193";"CCOC(=O)C1=C(CC)NC2=C(C(=O)CC(C)(C)C2)C1c1ccccc1F";"IFI";"'='";"4.598";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL587452";"";"0";"540.41";"2";"5.34";"GNF-Pf-5196";"CCOC(=O)C1=C(N)N(c2cccc([N+](=O)[O-])c2)C2=C(C(=O)CC(C)(C)C2)C1c1ccc(Br)cc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600327";"";"0";"484.64";"1";"6.34";"GNF-Pf-5214";"C=CC1CN2CCC1CC2[C@@H](OC(=O)c1ccc(C(C)(C)C)cc1)c1ccnc2ccc(OC)cc12";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL601570";"";"0";"452.52";"0";"2.89";"GNF-Pf-5238";"O=C(Nc1ccc(C2=NCCN2)cc1)c1ccc(NC(=O)c2ccc(C3=NCCN3)cc2)cc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL608858";"";"0";"275.76";"0";"2.58";"GNF-Pf-5247";"CN(C)c1cc[n+](CC(=O)c2ccc(Cl)cc2)cc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL579170";"";"0";"569.41";"1";"5.61";"GNF-Pf-5257";"CC(C)(C)c1nn(-c2ccc(Cl)cc2)c2[nH]c(=O)c(CNCc3ccc(Cl)cc3)cc12.O=C(O)C(F)(F)F";"IFI";"'='";"5.556";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL581173";"";"0";"445.44";"0";"4.73";"GNF-Pf-5282";"COc1ccc(C2CC(=O)C3=C(C2)NC(=O)CC3c2ccc(C(F)(F)F)cc2)cc1OC";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL580769";"";"0";"495.59";"0";"3.25";"GNF-Pf-5284";"Nc1cc(C(=O)Nc2ccc(C3=NCCCN3)cc2)ccc1C(=O)Nc1ccc(C2=NCCCN2)cc1";"IFI";"'='";"2.632";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL582667";"";"0";"480.57";"0";"3.58";"GNF-Pf-5291";"CN1CCN=C1c1ccc(NC(=O)c2ccc(C(=O)Nc3ccc(C4=NCCN4C)cc3)cc2)cc1";"IFI";"'='";"2.521";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL602229";"";"0";"532.64";"2";"6.81";"GNF-Pf-5307";"COc1ccccc1NC(=O)N(Cc1ccccc1)C(C)c1nc2ccccc2c(=O)n1-c1cc(C)ccc1C";"IFI";"'='";"3.774";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL533772";"";"0";"622.84";"1";"4.69";"GNF-Pf-5311";"COC1=CC(C)=C[C@@H](C)[C@@H](O)[C@H](C)CC(C)=CC=C[C@H](OC)[C@@H](C(C)C(O)[C@H](C)[C@@]2(O)C[C@@H](O)[C@H](C)[C@@H](C(C)C)O2)OC1=O";"IFI";"'='";"19.64";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL578108";"";"0";"475.59";"1";"5.33";"GNF-Pf-5313";"CCCOC(=O)C1=C(C)NC2=C(C(=O)CC(c3ccc(OC)c(OC)c3)C2)C1c1cccc(C)c1";"IFI";"'='";"4.706";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL537724";"";"0";"463.65";"0";"4.12";"GNF-Pf-5314";"CC(C)c1nc(N2CCN(C(=S)NCc3ccccc3)CC2)c(C#N)c2c1COC(C)(C)C2";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600905";"";"0";"575.66";"1";"3.74";"GNF-Pf-4556";"CCCCNC(=O)C(c1cccc(OC)c1)N1C(=O)c2cc(OCCc3cccc(OC)c3)ccc2NC(=O)C1CO";"IFI";"'='";"1.163";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL584440";"";"0";"514.85";"2";"6.42";"GNF-Pf-4592";"CC1=C(C(=O)OC(C)C)C(c2ccc(Br)cc2)C2=C(CC(c3ccc(Cl)cc3)CC2=O)N1";"IFI";"'='";"3.614";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL602390";"";"0";"465.52";"0";"4.77";"GNF-Pf-5609";"CCOC(=O)C1=C(C)NC2=C(C(=O)CC(c3ccc(OC)c(OC)c3)C2)C1c1ccccc1F";"IFI";"'='";"2.353";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL577215";"";"0";"449.52";"1";"5.15";"GNF-Pf-5624";"CCCOC(=O)C1=C(C)NC2=C(C(=O)CC(c3ccc(OC)cc3)C2)C1c1ccccc1F";"IFI";"'='";"3.529";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL579132";"";"0";"421.52";"0";"3.75";"GNF-Pf-5667";"O=C1N(Cc2cc3ccccc3s2)CC2CN(Cc3cccc4c3OCO4)CCN12";"IFI";"'='";"1.389";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL577450";"";"0";"380.44";"0";"3.37";"GNF-Pf-5456";"COC(=O)C1=C(C)NC(=Cc2cc(C)n(-c3cc(C)ccc3OC)c2C)C1=O";"IFI";"";"";"";"";"";"Not applicable";"";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL586701";"ZSTK-474";"2";"355.46";"1";"6.25";"GNF-Pf-5468";"Cc1ccc(C2Sc3ccccc3N=C3C2=C(O)c2ccccc23)cc1";"IFI";"'='";"2.174";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL602028";"";"0";"377.48";"0";"4.85";"GNF-Pf-5012";"Oc1ccc(-c2ccc3c(c2)OCO3)cc1CNC12CC3CC(CC(C3)C1)C2";"IFI";"'='";"1.786";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL581349";"";"0";"335.45";"0";"3.89";"GNF-Pf-5056";"CC(=O)NCCc1nc2ccccc2n1Cc1ccc(C(C)C)cc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL586002";"";"0";"515.61";"1";"4.70";"GNF-Pf-5091";"Cc1ccccc1NC(=O)N1CCN(C(=O)c2nc(-c3ccccc3)nc(C)c2C(=O)OC(C)C)CC1C";"IFI";"'='";"1.887";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL525333";"";"0";"304.27";"0";"4.03";"GNF-Pf-5117";"FC(F)(F)c1cccc(C=NNc2nc3ccccc3[nH]2)c1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL582182";"";"0";"447.45";"0";"4.22";"GNF-Pf-5120";"CN(Cc1cc(-c2ccccc2)ccc1O)CC(O)c1ccccc1.O=C(O)C(F)(F)F";"IFI";"'='";"1.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585027";"";"0";"397.50";"0";"3.30";"GNF-Pf-5127";"CCN(CC)C(=O)CSc1nnc(-c2ccccn2)n1-c1ccc(OC)cc1";"IFI";"'='";"3.636";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL602969";"";"0";"252.36";"0";"3.84";"GNF-Pf-5134";"CCN1c2ccccc2N(C)C1(C)c1ccccc1";"IFI";"'='";"6.557";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL576209";"";"0";"369.47";"1";"5.41";"GNF-Pf-5153";"CCc1ccc(C(Nc2cc(C)ccn2)c2ccc3cccnc3c2O)cc1";"IFI";"'='";"14.29";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL602781";"";"0";"488.22";"1";"5.47";"GNF-Pf-5206";"OC(CNCc1ccccc1)Cn1c2ccc(Br)cc2c2cc(Br)ccc21";"IFI";"'='";"5.263";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL588308";"";"0";"330.78";"0";"3.68";"GNF-Pf-5276";"COc1ccc(C=NNc2nc3cc(Cl)ccc3[nH]2)cc1OC";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL582036";"";"0";"362.43";"0";"2.87";"GNF-Pf-5286";"O=C(NC(=CC=Cc1ccccc1)C(=O)N1CCOCC1)c1ccccc1";"IFI";"";"";"";"";"";"Not applicable";"";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL578316";"";"0";"422.53";"1";"5.46";"GNF-Pf-5301";"CC(C)CN1C(=O)c2ccccc2C(C(=O)Nc2ccccc2F)C1c1cccs1";"IFI";"'='";"3.03";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL581692";"";"0";"392.52";"0";"3.67";"GNF-Pf-3468";"COc1cc(C(=O)OCCC2CCC[N+]3(C)CCCCC23)cc(OC)c1OC";"IFI";"'='";"1.852";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL580637";"";"0";"331.46";"0";"4.79";"GNF-Pf-3476";"C=CCN1C=CC(=Cc2sc3ccccc3[n+]2C)c2ccccc21";"IFI";"'='";"17.65";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL601583";"";"0";"459.79";"1";"7.69";"GNF-Pf-3478";"O=C(Nc1ccc(Cl)cc1Cl)c1ccc(-c2nc(-c3ccccc3Cl)cs2)cc1";"IFI";"'='";"6.667";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL578954";"";"0";"481.98";"0";"4.90";"GNF-Pf-5579";"COCCOC(=O)C1=C(C)NC2=C(C(=O)CC(c3ccc(OC)cc3)C2)C1c1ccc(Cl)cc1";"IFI";"'='";"4.651";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL577212";"";"0";"465.98";"1";"5.66";"GNF-Pf-5619";"CCCOC(=O)C1=C(C)NC2=C(C(=O)CC(c3ccc(OC)cc3)C2)C1c1ccccc1Cl";"IFI";"'='";"2.353";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL576157";"";"0";"475.59";"1";"5.33";"GNF-Pf-5657";"CCCOC(=O)C1=C(C)NC2=C(C(=O)CC(c3ccc(OC)c(OC)c3)C2)C1c1ccccc1C";"IFI";"'='";"3.529";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL601326";"";"0";"219.16";"0";"2.54";"GNF-Pf-2421";"CC(=O)Nc1ccccc1OC(F)(F)F";"IFI";"'='";"2.128";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL581492";"";"0";"365.47";"0";"4.38";"GNF-Pf-524";"CCOC(=O)C(=O)N1c2ccc(C)cc2C(C)(c2ccccc2)CC1(C)C";"IFI";"'='";"1.075";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL582316";"";"0";"414.52";"0";"1.51";"GNF-Pf-554";"COc1ccc(S(=O)(=O)NCC2CCC(C(=O)NCC(OC)OC)CC2)cc1";"IFI";"'='";"2.174";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL599306";"";"0";"269.31";"0";"2.58";"GNF-Pf-4134";"CCOc1cccc(Nc2cc(C)nc3ncnn23)c1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585279";"";"0";"326.58";"0";"4.14";"GNF-Pf-4156";"O=C(Nc1ccc(Cl)cc1)Nc1ccc(Br)cn1";"IFI";"'='";"4.167";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL584465";"";"0";"521.02";"1";"5.15";"GNF-Pf-3935";"CC(C)CNC(=O)c1ccc(OC2CCN(CC3CCCCC3)CC2)c(Cl)c1.O=C(O)C(F)(F)F";"IFI";"'='";"2.778";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL602826";"";"0";"578.41";"2";"5.97";"GNF-Pf-3995";"COc1ccccc1Cn1c(SCC(=O)Nc2cccc(C(F)(F)F)c2)nc2ccc(Br)cc2c1=O";"IFI";"'='";"4.348";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600531";"";"0";"536.42";"1";"4.03";"GNF-Pf-5447";"CCOC(=O)C1=C(C)NC2=C(C(=O)C(C(=O)OC)C(C)C2)C1c1cc(Br)c(OC)c(OCC)c1";"IFI";"'='";"4.651";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL527446";"";"0";"261.09";"0";"2.90";"GNF-Pf-449";"Ic1nc2ccccc2s1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL603895";"";"0";"530.63";"1";"4.86";"GNF-Pf-3883";"COc1cc(-c2cc(C)c3c(OC)ccc(OC)c3n2)cc2c1OCCN(C(=O)CCn1nc(C)cc1C)C2";"IFI";"'='";"12.5";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL598079";"";"0";"288.37";"0";"4.44";"GNF-Pf-3916";"C[n+]1oc(/C=C/c2ccccc2)cc1/C=C/c1ccccc1";"IFI";"'='";"19.4";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL584718";"";"0";"364.32";"0";"2.35";"GNF-Pf-3948";"N#Cc1ccc2c(c1)nc1c3ccc4c5c(ccc(c(=O)n21)c53)C(=O)NC4=O";"IFI";"'='";"16.42";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL597649";"";"0";"350.39";"0";"4.01";"GNF-Pf-3951";"O=C1C(Nc2ccc(F)cc2)=C(N2CCCCC2)C(=O)c2ccccc21";"IFI";"'='";"12.5";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL529057";"";"0";"573.74";"2";"6.82";"GNF-Pf-3957";"COc1cc(C(=O)NCCc2cc3ccccc3[nH]2)ccc1OC1CCN(CC(c2ccccc2)c2ccccc2)CC1";"IFI";"'='";"5.556";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL611085";"";"0";"417.29";"0";"4.33";"GNF-Pf-3961";"CC[n+]1c(/C=C/c2ccc(OC)cc2)ccc2ccccc21.[I-]";"IFI";"'='";"5.109";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL598064";"";"0";"470.58";"0";"4.29";"GNF-Pf-3972";"CC(C)(C)c1ccc(Cn2nnc3c(O)nc(C4CCN(C(=O)c5ccccc5)CC4)nc32)cc1";"IFI";"'='";"10.81";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL530401";"";"0";"624.79";"2";"5.13";"GNF-Pf-3988";"COc1ccc(NC(=O)CCCCCn2c(SCC(=O)NCCc3ccc(OC)c(OC)c3)nc3ccsc3c2=O)cc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL602827";"";"0";"514.70";"1";"4.81";"GNF-Pf-3998";"Cc1ccc(C)c(N2CCN(CCCNC(=O)c3ccc(CSc4nc5cnccc5[nH]4)cc3)CC2)c1";"IFI";"'='";"8.571";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL601179";"";"0";"437.57";"0";"4.69";"GNF-Pf-4003";"COc1ccc2[nH]c(=O)c(CN(C(=S)Nc3ccccc3OC)C3CCCC3)cc2c1";"IFI";"'='";"2.174";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL597037";"";"0";"412.45";"0";"3.97";"GNF-Pf-4022";"COc1cc2nc(NCc3ccccc3)n3nc(-c4cccnc4)nc3c2cc1OC";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL602632";"";"0";"418.86";"0";"4.15";"GNF-Pf-4217";"Cn1ccnc1C1CCCCN1C(=O)c1cc(COc2ccc(F)cc2Cl)on1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL578314";"";"0";"324.42";"0";"3.25";"GNF-Pf-5232";"O=C1C(N2CCCCC2)=C(N2CCCCC2)C(=O)c2ccccc21";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL578543";"";"0";"478.64";"0";"3.89";"GNF-Pf-5261";"CC(C)(C)NC(=O)c1cn(C2CCCCC2)cc(C(=O)NC2CCN(Cc3ccccc3)C2)c1=O";"IFI";"'='";"0.9709";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585037";"";"0";"387.31";"1";"5.04";"GNF-Pf-4995";"CN1CCN(c2ccc(Nc3ccnc4cc(Cl)ccc34)cc2Cl)CC1";"IFI";"'='";"8.333";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL579935";"";"0";"384.48";"1";"5.47";"GNF-Pf-5429";"COc1cccc(-c2ccc(O)c(CNC(C)c3cccc4ccccc34)c2)n1";"IFI";"'='";"2.564";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL533556";"";"0";"584.64";"1";"5.26";"GNF-Pf-5431";"COc1cc(C(=O)NC2CC2)ccc1OC1CCN(CC(c2ccccc2)c2ccccc2)CC1.O=C(O)C(F)(F)F";"IFI";"'='";"2.778";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL578531";"";"0";"365.50";"0";"4.35";"GNF-Pf-5444";"CCOC(=O)C(=O)N1c2ccccc2-c2c(ssc2=S)C1(C)C";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL582524";"";"0";"270.34";"0";"-0.07";"GNF-Pf-426";"CCNc1nc(NC(C)C)nc(NC(N)NOC)n1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL578067";"";"0";"538.71";"1";"4.63";"GNF-Pf-95";"Cc1noc(C)c1S(=O)(=O)N(CC(C)C)C(C(=O)NC(CN1CCCC1)c1ccccc1)c1ccccc1";"IFI";"'='";"1.98";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL579139";"";"0";"472.62";"0";"4.79";"GNF-Pf-110";"COC(=O)c1sc2nc(CN(C)Cc3nccs3)ccc2c1NC(=O)c1ccc(C)s1";"IFI";"'='";"1.709";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL601789";"";"0";"347.36";"1";"5.69";"GNF-Pf-141";"O=C(Nc1cccc(C(F)(F)F)c1)c1ccc(-c2cccs2)cc1";"IFI";"'='";"5.882";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL578909";"";"0";"415.95";"0";"4.67";"GNF-Pf-143";"O=S(=O)(/C=C/c1ccccc1)NCCCCNc1ccnc2cc(Cl)ccc12";"IFI";"'='";"6.41";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL578494";"";"0";"524.59";"0";"2.23";"GNF-Pf-151";"CC(C)CN(CC(=O)N1CCC(Nc2nsc3ccccc23)C1)S(C)(=O)=O.O=C(O)C(F)(F)F";"IFI";"'='";"20.83";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL599091";"";"0";"420.53";"0";"3.08";"GNF-Pf-787";"COc1cccc(-c2nc(CS(=O)(=O)CC(=O)N3CC(C)CC(C)C3)c(C)o2)c1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL604921";"";"0";"387.57";"1";"6.46";"GNF-Pf-797";"CC(C)(C)C(=O)Nc1ccc(C23CC4CC(CC(c5ccccc5)(C4)C2)C3)cc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL605395";"";"0";"447.52";"0";"4.63";"GNF-Pf-604";"COc1ccc(-n2c(=S)[nH]c3cc(C(=O)Nc4cccc(C)c4)ccc3c2=O)cc1OC";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL581689";"";"0";"379.89";"0";"3.46";"GNF-Pf-624";"O=C(Nc1ccccc1Cl)NC1(C(=O)NCC2CCCO2)CCCCC1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL597459";"";"0";"315.37";"0";"3.91";"GNF-Pf-656";"O=C(O)CC12CC3CC(C1)CC(c1ccc([N+](=O)[O-])cc1)(C3)C2";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL583210";"";"0";"476.62";"0";"4.52";"GNF-Pf-691";"CCCCNC(=O)c1ccc2c(c1)N=C(c1cccc(OCC)c1)N(CCCN1CCCC1=O)C2";"IFI";"'='";"1.235";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL597865";"";"0";"500.65";"2";"7.14";"GNF-Pf-728";"CCOc1ccc2nc(Sc3nc(Nc4cccc(C)c4)nc(Nc4cccc(C)c4)n3)sc2c1";"IFI";"'='";"1.205";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL597053";"";"0";"429.36";"0";"2.76";"GNF-Pf-729";"O=C(CCNS(=O)(=O)c1ccc(Br)s1)N1CCc2ccccc2C1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL597054";"";"0";"401.29";"0";"3.89";"GNF-Pf-731";"CCc1c(C#N)c(N)nc2sc(C(=O)c3ccc(Br)cc3)c(N)c12";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL553098";"";"0";"396.28";"0";"2.51";"GNF-Pf-764";"COc1ccc(C2N=C(N)N=C(N)N2c2ccc(Cl)cc2)cc1OC.Cl";"IFI";"'='";"1.429";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL598260";"";"0";"287.32";"0";"1.61";"GNF-Pf-770";"CCOc1ccc2c(C)nc(NC(N)=NC(C)=O)nc2c1";"IFI";"'='";"5.797";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL606164";"";"0";"513.69";"1";"2.73";"GNF-Pf-781";"O=C(Cc1cccs1)NC1CCN(CC(O)CN(Cc2ccccc2)S(=O)(=O)c2ccccc2)C1";"IFI";"'='";"1.923";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL611812";"";"0";"354.43";"0";"3.99";"GNF-Pf-798";"CCOc1ccc(/C=C2/SC(=Nc3ccccc3)NC2=O)cc1OC";"IFI";"";"";"";"";"";"Not applicable";"";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL530195";"";"0";"550.49";"2";"5.72";"GNF-Pf-799";"O=C(Nc1ccc(-c2nnc(-c3ccc(NC(=O)c4ccccc4[N+](=O)[O-])cc3)o2)cc1)c1ccccc1[N+](=O)[O-]";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL597449";"";"0";"318.77";"0";"1.96";"GNF-Pf-704";"CN(C)c1nc(Cl)nc(N(C#N)CCOc2ccccc2)n1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL604742";"";"0";"377.36";"0";"3.08";"GNF-Pf-733";"COc1ccc(C(=O)n2nc(N)c3cc4ccc(C)cc4nc32)cc1[N+](=O)[O-]";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL577872";"";"0";"437.49";"0";"3.81";"GNF-Pf-5175";"CCOc1cc(C2CC(=O)NC3=C2C(=O)CC(c2ccc(OC)c(OC)c2)C3)ccc1O";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL577874";"";"0";"391.41";"0";"4.14";"GNF-Pf-5177";"CCN(CC)CCNc1ccnc2cc3ccccc3cc12.O=P(O)(O)O";"IFI";"'='";"7.447";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL579542";"";"0";"302.38";"0";"3.19";"GNF-Pf-5191";"CSc1nc2nc(C)c(Cc3cccc(F)c3)c(C)n2n1";"IFI";"'='";"1.282";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL588788";"";"0";"440.52";"1";"5.60";"GNF-Pf-5200";"CC(C)CN1C(=O)c2ccccc2C(C(=O)Nc2cc(F)ccc2F)C1c1cccs1";"IFI";"'='";"6.452";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL580314";"";"0";"420.54";"0";"3.07";"GNF-Pf-5212";"Cc1c(C(=O)NCCN2CCCC2)cnn1-c1ncc2c(n1)-c1ccccc1SC2";"IFI";"'='";"2.586";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL580343";"";"0";"529.64";"1";"4.96";"GNF-Pf-5215";"CCc1cccc(NC(=O)N2CCN(C(=O)c3nc(-c4ccccc4)nc(C)c3C(=O)OC(C)C)CC2C)c1";"IFI";"'='";"1.887";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL1744497";"";"0";"602.48";"2";"6.53";"GNF-Pf-5216";"CCSC(Cl)=C(NC(=O)c1ccccc1)[P+](c1ccccc1)(c1ccccc1)c1ccccc1.[O-][Cl+3]([O-])([O-])[O-]";"IFI";"";"";"";"";"";"Not applicable";"";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL601551";"";"0";"592.77";"2";"5.88";"GNF-Pf-5253";"O=C(Nc1cc(C(=O)N2CCC(Cc3ccccc3)CC2)ccc1N1CC2CC(C1)c1cccc(=O)n1C2)c1cccs1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL529493";"";"0";"333.39";"0";"3.72";"GNF-Pf-5267";"CCc1cccc2c(C#N)cn(CC(=O)Nc3ccc(OC)cc3)c12";"IFI";"'='";"7.692";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL532079";"";"0";"261.41";"0";"4.11";"GNF-Pf-5310";"CC(C)(C)c1ccc(O)c(CNC2CCCCC2)c1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600283";"";"0";"242.06";"0";"2.64";"GNF-Pf-562";"O=C1OC(c2ccccc2)=NC1=C(Cl)Cl";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL581485";"";"0";"340.40";"0";"3.60";"GNF-Pf-565";"COc1cccc(/C=C2/SC(=Nc3ccccc3)NC2=O)c1OC";"IFI";"'='";"4.545";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL602971";"";"0";"293.12";"0";"2.81";"GNF-Pf-571";"O=C(NN=Cc1ccc(Br)cc1)c1ccco1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL581898";"";"0";"359.81";"0";"2.83";"GNF-Pf-613";"Cc1c(Cl)cccc1NC(=O)CCC(=O)NNC(=O)c1ccccc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL577002";"";"0";"361.88";"0";"0.53";"GNF-Pf-1408";"Cl.Nc1nc(N)c2cc(S(=O)(=O)N3CCSCC3)ccc2n1";"IFI";"'='";"17.74";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL587291";"";"0";"501.47";"2";"6.11";"GNF-Pf-1441";"CCCNC(=O)c1cc(NC(=O)c2cc(C(F)(F)F)cc(C(F)(F)F)c2)ccc1N1CCCCC1";"IFI";"'='";"3.67";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL193627";"";"0";"333.48";"0";"4.93";"GNF-Pf-1442";"CCN1C(=Cc2sc3ccccc3[n+]2C)C=Cc2cccc(C)c21";"IFI";"'='";"23.08";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL588436";"";"0";"380.44";"0";"2.69";"GNF-Pf-1444";"COc1ccc(CCNC(=O)Cn2c(C)cc3ccccc3c2=O)cc1OC";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL586389";"";"0";"414.72";"0";"4.78";"GNF-Pf-1446";"O=C(CCl)NCCCN(C(=O)Nc1ccc(Cl)c(Cl)c1)c1ccccc1";"IFI";"'='";"4.167";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL601123";"";"0";"267.29";"0";"1.56";"GNF-Pf-1448";"O=C(/C=C/c1ccccc1)NNC(=O)c1cccnc1";"IFI";"'='";"2.239";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585987";"";"0";"359.92";"0";"2.60";"GNF-Pf-1325";"CC(C)N1CCc2c(sc(NC(=O)C(C)(C)C)c2C(N)=O)C1.Cl";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL602021";"";"0";"312.38";"0";"2.03";"GNF-Pf-1333";"Cc1nn(C)cc1-c1nc2cnccn2c1NCC1CCCO1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL603307";"";"0";"562.51";"2";"6.94";"GNF-Pf-1334";"COc1cc(NC(C)CCCN(Cc2ccccc2OC)C(=O)c2cccc(Br)c2)c2ncccc2c1";"IFI";"'='";"3.81";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL601116";"";"0";"338.08";"0";"3.93";"GNF-Pf-1341";"CC1C(Br)C(=O)C(Br)C(C)C12CCCC2";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585245";"";"0";"319.43";"0";"3.63";"GNF-Pf-1342";"O=C(O)CCCCCNc1ncnc2sc3c(c12)CCCC3";"IFI";"'='";"0.7407";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585636";"";"0";"462.52";"0";"4.97";"GNF-Pf-1355";"CCOC(=O)c1ccc(N2CCN(c3ccc(F)cc3)CC2)c(NC(=O)Nc2ccccc2)c1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL578515";"";"0";"324.81";"0";"4.79";"GNF-Pf-2413";"Cc1cc(Nc2cccc(Cl)c2)nc(NCc2ccccc2)n1";"IFI";"'='";"4.545";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL601117";"";"0";"222.32";"0";"1.24";"GNF-Pf-2471";"CC(=NNC(=S)N(C)C)c1ccccn1";"IFI";"'='";"19.83";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL602375";"";"0";"1202.63";"None";"None";"GNF-Pf-2490";"C/C=C/C[C@@H](C)C(O)[C@H]1C(=O)N[C@@H](CC)C(=O)N(C)CC(=O)N(C)[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@H](C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N(C)[C@@H](C(C)C)C(=O)N1C";"IFI";"'='";"3.125";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL578521";"";"0";"352.51";"0";"4.17";"GNF-Pf-2513";"c1cc2cc(CN3CCc4nc(N5CCCCC5)sc4C3)ccc2[nH]1";"IFI";"'='";"4.167";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL356687";"";"0";"340.81";"0";"4.60";"GNF-Pf-2620";"CN(C)c1cc(NC(=O)Nc2cccc(Cl)c2)c2ccccc2n1";"IFI";"'='";"7.639";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL488954";"";"0";"440.93";"1";"7.89";"GNF-Pf-2622";"COc1ccc2nc(C)cc(Nc3ccc(Oc4ccc5ccccc5c4)c(Cl)c3)c2c1";"IFI";"'='";"7.143";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600511";"";"0";"577.75";"1";"2.73";"GNF-Pf-2640";"CC(C(=O)N1CCN(C(c2ccccc2)c2ccccc2)CC1)N(CCN1CCOCC1)S(=O)(=O)c1ccccn1";"IFI";"'='";"0.9901";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL602402";"";"0";"364.49";"0";"4.52";"GNF-Pf-2645";"C=C[C@H]1CN2CC[C@H]1C[C@H]2[C@H](OC(=O)CCC)c1ccnc2ccccc12";"IFI";"'='";"0.9174";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL578276";"";"0";"368.44";"0";"3.39";"GNF-Pf-2686";"Cc1cc(N2CCN(c3ccccn3)CC2)n2c(nc3ccccc32)c1C#N";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL581682";"";"0";"515.57";"2";"5.40";"GNF-Pf-357";"COc1ccc(C2=C(c3ccc(OC)cc3)C3C(=O)C2C2C(=O)N(c4cccc5ccccc45)C(=O)C32)cc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600544";"";"0";"265.27";"0";"1.39";"GNF-Pf-361";"CC(=O)Nc1cc([N+](=O)[O-])ccc1N1CCOCC1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL601596";"";"0";"352.80";"0";"1.87";"GNF-Pf-368";"C=CCN1C(=O)/C(=C\c2cc(Cl)c(O)c(OC)c2)C(=O)NC1=S";"IFI";"'='";"7.692";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL528533";"";"0";"298.77";"0";"4.95";"GNF-Pf-376";"COc1ccc2nc(C)cc(Nc3ccc(Cl)cc3)c2c1";"IFI";"'='";"3.371";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL581260";"";"0";"482.22";"1";"5.97";"GNF-Pf-390";"Cc1ccc(NC(=O)CCCCC(=O)Nc2ccc(C)c(Br)c2)cc1Br";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL602617";"";"0";"325.38";"0";"4.34";"GNF-Pf-397";"c1ccc(-c2nc(Nc3ccncc3)cc(-c3cccnc3)n2)cc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL582733";"";"0";"364.45";"0";"2.99";"GNF-Pf-414";"CC(=O)N1CC(=NNC(=O)C(C)Nc2c(C)cccc2C)c2ccccc21";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL580461";"";"0";"382.85";"0";"4.59";"GNF-Pf-415";"COc1ccc(Nc2nc(NCc3ccco3)c3ccccc3n2)cc1.Cl";"IFI";"'='";"12.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL581243";"";"0";"344.84";"0";"4.69";"GNF-Pf-437";"CCOc1ccc2nc(C)cc(Nc3ccc(OC)cc3)c2c1.Cl";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL582323";"";"0";"490.72";"0";"4.90";"GNF-Pf-441";"O=c1c2c3c(sc2ncn1CCCc1ccccc1)CC(N1CCC(N2CCCCC2)CC1)CC3";"IFI";"'='";"2.239";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL587528";"";"0";"292.37";"0";"3.80";"GNF-Pf-472";"c1ccc(CSc2nnc3c(n2)[nH]c2ccccc23)cc1";"IFI";"'='";"3.817";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL582108";"";"0";"393.72";"0";"4.93";"GNF-Pf-479";"Cc1ccc(C2=NC(C(F)(F)F)(C(F)(F)F)N=C3C=CC(Cl)=CN32)cc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600697";"";"0";"600.81";"2";"9.17";"GNF-Pf-483";"CCC(c1nc2ccccc2c(=O)n1-c1cccc(C)c1)N(CCc1ccccc1)C(=O)Nc1c(C(C)C)cccc1C(C)C";"IFI";"'='";"0.9434";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL1201100";"";"0";"422.50";"0";"3.17";"GNF-Pf-506";"C=C[C@H]1CN2CC[C@H]1C[C@H]2[C@H](O)c1ccnc2ccc(OC)cc12.O=S(=O)(O)O";"IFI";"'='";"2.632";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600319";"";"0";"410.86";"0";"3.32";"GNF-Pf-2288";"CC(=O)N(C1=C(N2CCOCC2)C(=O)c2ccccc2C1=O)c1cccc(Cl)c1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600316";"";"0";"407.52";"0";"4.50";"GNF-Pf-2292";"Cc1cc(N2CCN(C/C=C/c3ccccc3)CC2)n2c(nc3ccccc32)c1C#N";"IFI";"'='";"2.778";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL578462";"";"0";"342.42";"0";"4.09";"GNF-Pf-2358";"CCOC(=O)c1cnc2ccc(OC)cc2c1NCc1cccs1";"IFI";"'='";"1.852";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL599897";"";"0";"564.66";"2";"5.12";"GNF-Pf-2064";"CCOC(=O)C1=C(C)N=c2sc(=Cc3c4ccccc4cc4ccccc34)c(=O)n2C1c1cc(OC)ccc1OC";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL2305514";"";"0";"326.44";"0";"3.40";"GNF-Pf-2067";"CC[C@@H]1CN2CC[C@H]1C[C@H]2[C@H](O)c1ccnc2ccc(OC)cc12";"IFI";"'='";"1.316";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL601790";"";"0";"435.96";"1";"5.23";"GNF-Pf-2070";"O=C(Nc1ccc(N2CCCCC2)cc1)N1CCc2nc[nH]c2C1c1ccc(Cl)cc1";"IFI";"'='";"2.299";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600929";"";"0";"638.27";"2";"8.49";"GNF-Pf-2075";"O=C(Nc1ccc(Oc2cccc(Oc3ccc(NC(=O)c4ccc(Br)o4)cc3)c2)cc1)c1ccc(Br)o1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL577637";"";"0";"499.01";"0";"2.73";"GNF-Pf-2398";"COC(=O)c1c(S(=O)(=O)NCc2cccc(Cl)c2)sc2c1CCN(C(=O)C1CCCO1)C2";"IFI";"'='";"8.333";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL579345";"";"0";"417.53";"0";"2.47";"GNF-Pf-2096";"CN(Cc1cc2ccc(F)cc2n(CCN2CCCCC2)c1=O)CC1COCCO1";"IFI";"'='";"1.961";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL577204";"";"0";"466.24";"0";"4.75";"GNF-Pf-2104";"Brc1ccc(-c2cn3c([n+]2Cc2ccccc2)SCCC3)cc1.[Br-]";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL579087";"";"0";"386.50";"0";"3.36";"GNF-Pf-2126";"O=C1N(c2ccccc2)C[C@@H]2C[C@@H](c3ccc(C#CCCO)cc3)N3CCC[C@@]123";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL578883";"";"0";"431.56";"0";"2.89";"GNF-Pf-2133";"CCn1cc(C(=O)NCCC2=CCCCC2)c(=O)c2cc(S(=O)(=O)N(C)C)ccc21";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL531383";"";"0";"218.28";"0";"2.70";"GNF-Pf-2144";"CCSC1=CC(=O)c2ccccc2C1=O";"IFI";"'='";"24.32";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL578692";"";"0";"407.52";"0";"3.17";"GNF-Pf-2157";"CC(C)CNc1nc(NCCCn2ccnc2)ncc1C(=O)NCc1ccccc1";"IFI";"'='";"1.942";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL532267";"";"0";"231.34";"0";"3.13";"GNF-Pf-2164";"CCNC(=O)/C=C/c1ccc(C(C)(C)C)cc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL588574";"";"0";"571.59";"2";"8.09";"GNF-Pf-1515";"CCCCCCc1ccc(C(=O)N(CC(=O)Nc2cc(C(C)(C)C)nn2-c2ccc(Cl)c(Cl)c2)C(C)C)cc1";"IFI";"'='";"1.905";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL599904";"";"0";"334.68";"0";"4.51";"GNF-Pf-1523";"O=C1c2ccccc2-c2nc3c(Cl)cc(C(F)(F)F)cc3nc21";"IFI";"'='";"6.364";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL579662";"";"0";"278.40";"0";"3.38";"GNF-Pf-1545";"N=c1c2c(n(Cc3ccccc3)c3c1CCC3)CCCC2";"IFI";"'='";"7.692";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL579720";"";"0";"179.61";"0";"1.87";"GNF-Pf-1546";"Nc1nc(Cl)nc2ccccc12";"IFI";"'='";"0.625";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL196573";"";"0";"430.55";"0";"4.35";"GNF-Pf-1550";"CCN1CCN(c2cc(C)c3cc(NC(=O)/C=C/c4ccc(OC)cc4)ccc3n2)CC1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL1197554";"";"0";"245.29";"0";"1.30";"GNF-Pf-1566";"C/N=C(\N)Nc1nc(C)c2cc(OC)ccc2n1";"IFI";"'='";"3.623";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL576400";"";"0";"342.91";"0";"4.18";"GNF-Pf-1567";"Clc1ccc(CCNC2CCN(CCc3ccccc3)CC2)cc1";"IFI";"'='";"1.575";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL599905";"";"0";"272.14";"0";"1.66";"GNF-Pf-1572";"Clc1cc(C=NNC2=NCCCN2)cc(Cl)n1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL577235";"";"0";"421.52";"0";"1.74";"GNF-Pf-1579";"CCN1CCN(C(=O)CS(=O)(=O)Cc2nc(-c3cccc(OC)c3)oc2C)CC1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL274986";"";"0";"199.26";"0";"2.59";"GNF-Pf-1583";"Nc1ccc(Nc2ccc(N)cc2)cc1";"IFI";"'='";"3.937";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL587611";"";"0";"328.40";"0";"4.70";"GNF-Pf-1585";"Fc1ccc2nc(Nc3nc(-c4ccccn4)cs3)sc2c1";"IFI";"'='";"17.65";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL576615";"";"0";"394.28";"0";"4.24";"GNF-Pf-1586";"O=C(CC1SC(=Nc2ccccc2)NC1=O)Nc1cc(Cl)ccc1Cl";"IFI";"'='";"3.448";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL578870";"";"0";"402.41";"0";"3.98";"GNF-Pf-2520";"COc1ccc(NC(=O)c2cnn(-c3ccccc3)c2NC(=O)c2ccco2)cc1";"IFI";"'='";"1.176";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL578900";"";"0";"455.58";"1";"5.09";"GNF-Pf-2540";"CCCCN1C(=O)NC(c2ccc(NC(=O)c3cccs3)cc2)C(C(=O)OC(C)C)=C1C";"IFI";"'='";"6.41";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL602391";"";"0";"475.61";"1";"5.71";"GNF-Pf-2544";"CCCCCn1c(SCc2ccc(C)cc2)nc2cc(C(=O)NCc3ccco3)ccc2c1=O";"IFI";"'='";"2.381";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL388886";"";"0";"225.25";"0";"2.69";"GNF-Pf-2549";"COc1ccc2[nH]c3ccccc3c(=O)c2c1";"IFI";"'='";"4.444";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL529675";"";"0";"275.17";"0";"3.44";"GNF-Pf-2554";"C[n+]1ccc(/C=C/c2ccc(Br)cc2)cc1";"IFI";"'='";"5.455";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585200";"";"0";"528.62";"1";"4.56";"GNF-Pf-2558";"O=C(Nc1ccc(C2=NCCN2)cc1)c1ccc(-c2ccc(C(=O)Nc3ccc(C4=NCCN4)cc3)cc2)cc1";"IFI";"'='";"4.396";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL578078";"";"0";"492.58";"0";"4.95";"GNF-Pf-2563";"Cc1ccc(-c2nnc(Nc3ccc(F)cc3)c3ccccc23)cc1S(=O)(=O)NCC1CCCO1";"IFI";"'='";"6.061";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL578728";"";"0";"494.71";"0";"4.71";"GNF-Pf-2576";"CCc1ccc2[nH]c(=O)c(CN(Cc3ccc(OC)cc3)C(=S)NCCCN(CC)CC)cc2c1";"IFI";"'='";"8.271";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL578636";"";"0";"247.68";"0";"3.30";"GNF-Pf-2588";"O=C(Nc1ccccc1O)c1ccc(Cl)cc1";"IFI";"'='";"5.128";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL580095";"";"0";"466.65";"0";"4.78";"GNF-Pf-1787";"CCN(CC)CCCN(Cc1cc2cc(OC)ccc2[nH]c1=O)C(=S)Nc1ccc(C)cc1";"IFI";"'='";"5.405";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL577664";"";"0";"361.53";"0";"1.79";"GNF-Pf-1820";"CCN(CC)CCN(C)C1CCc2c(c(C(=O)N3CCCC3)nn2C)C1";"IFI";"'='";"1.099";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL579168";"";"0";"251.33";"0";"4.57";"GNF-Pf-1827";"CCCCOc1c2ccccc2nc2ccccc12";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL601595";"";"0";"342.42";"0";"4.17";"GNF-Pf-1620";"Cc1sc2c(c1C)CN(Cc1ccco1)CN2C(=O)c1ccco1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL577220";"";"0";"415.58";"1";"5.96";"GNF-Pf-1628";"CC(C)NC(=O)c1ccc2c(c1)N=C(/C=C/c1ccccc1)N(CC1CCCCC1)C2";"IFI";"'='";"6.173";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL577008";"";"0";"404.54";"0";"2.15";"GNF-Pf-1632";"CCCCNC(=O)CCCNC(=O)Cn1cnc2sc3c(c2c1=O)CCCC3";"IFI";"'='";"3.529";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL601984";"";"0";"500.60";"1";"3.13";"GNF-Pf-1634";"Cc1ccc(NC(=O)C2C3C=CC4(O3)C2C(=O)N(Cc2cccnc2)C4C(=O)NC2CCCCC2)cc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL576619";"";"0";"410.47";"0";"3.05";"GNF-Pf-1655";"COc1ccc(C2SCCN2S(=O)(=O)c2cccc([N+](=O)[O-])c2)cc1OC";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL588467";"";"0";"301.77";"0";"4.33";"GNF-Pf-1668";"COc1ccc(C(=NO)C2CC2c2ccc(Cl)cc2)cc1";"IFI";"'='";"1.351";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL582444";"";"0";"337.57";"1";"5.56";"GNF-Pf-1681";"CCCCCCCCN[C@@H](C)[C@@H](O)c1ccc(SC(C)C)cc1";"IFI";"'='";"1.351";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL602808";"";"0";"397.95";"0";"4.94";"GNF-Pf-1683";"CN(C)CC(C)(C)CNCc1cc(-c2ccnc3cc(Cl)ccc23)ccc1O";"IFI";"'='";"4.425";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL533491";"";"0";"750.50";"2";"11.47";"GNF-Pf-1704";"Brc1ccc(C=Nc2ccc(-c3nc4cc(-c5ccc6[nH]c(-c7ccc(N=Cc8ccc(Br)cc8)cc7)nc6c5)ccc4[nH]3)cc2)cc1";"IFI";"'='";"23.08";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL577225";"";"0";"456.59";"0";"4.22";"GNF-Pf-1709";"CCN(CC)CCN(Cc1cc2cc(OC)ccc2[nH]c1=O)C(=S)Nc1ccc(F)cc1";"IFI";"'='";"3.67";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL576402";"";"0";"389.97";"1";"5.66";"GNF-Pf-1711";"CC(CC(=O)NCCCCNc1ccnc2cc(Cl)ccc12)CC(C)(C)C";"IFI";"'='";"3.738";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL578958";"";"0";"400.98";"1";"6.93";"GNF-Pf-1716";"C=CCSc1nc(Sc2ccc(Cl)cc2)c2sc3ccccc3c2n1";"IFI";"'='";"1.333";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600106";"";"0";"362.24";"0";"3.40";"GNF-Pf-1718";"CCOCc1nnc(NC(=O)COc2ccc(Cl)cc2Cl)s1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL578329";"";"0";"404.46";"0";"1.80";"GNF-Pf-1720";"O=C(C1Cc2ccccc2CN1S(=O)(=O)c1ccc(F)cc1)N1CCOCC1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL576054";"";"0";"441.62";"0";"3.20";"GNF-Pf-1729";"CCNC(=O)[C@@H]1C[C@@H](NC2C3CC4CC(C3)CC2C4)CN1Cc1cccc(OC)c1OC";"IFI";"'='";"0.9804";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL586206";"";"0";"461.61";"0";"4.24";"GNF-Pf-1736";"COc1cc(OC)cc(N2CCN(CCNCCOc3ccccc3)[C@@H](c3ccccc3)C2)c1";"IFI";"'='";"4.938";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL587159";"";"0";"273.34";"0";"1.41";"GNF-Pf-1739";"COc1ccc(N2C(N)=NC(N)=NC23CCCC3)cc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL586801";"";"0";"337.38";"0";"2.63";"GNF-Pf-1742";"COC(CNc1cc(-c2ccccn2)nc(-c2ccccn2)n1)OC";"IFI";"'='";"7.692";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL582445";"";"0";"466.60";"0";"4.95";"GNF-Pf-1751";"CCCCCC(=O)N(CCN(C)C)C(CC)c1nc2ccccc2c(=O)n1-c1ccc(F)cc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL579167";"";"0";"526.61";"2";"6.40";"GNF-Pf-1757";"CCCCN(CC(=O)N1c2ccccc2-n2cccc2C1c1ccc(OC)cc1)C(=O)Nc1cccc(F)c1";"IFI";"'='";"6.731";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL577894";"";"0";"436.02";"0";"4.22";"GNF-Pf-1765";"COc1cccc(CC2(CO)CCCN(Cc3sc(N4CCCC4)nc3Cl)C2)c1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL607255";"";"0";"434.61";"1";"5.61";"GNF-Pf-3019";"CCCCNC(=O)C(CC)Sc1nnc(-c2ccc(C)cc2)c(-c2ccc(C)cc2)n1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL582266";"";"0";"269.34";"0";"3.73";"GNF-Pf-3038";"CC(C)c1ccc(C=CC(=O)NCc2ccco2)cc1";"IFI";"";"";"";"";"";"Not applicable";"";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL270726";"";"0";"323.42";"0";"3.64";"GNF-Pf-3039";"CN(C)c1ccc(/C=C2/SC(=Nc3ccccc3)NC2=O)cc1";"IFI";"'='";"3.448";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL602783";"";"0";"333.39";"0";"4.57";"GNF-Pf-3043";"CCOc1ccc2nc3cc(NCc4ccco4)ccc3c(N)c2c1";"IFI";"'='";"7.463";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL580598";"";"0";"484.60";"1";"5.78";"GNF-Pf-3055";"COc1ccc(NC(=O)c2cc3cc(C4(O)CCN(CC(C)c5ccccc5)CC4)ccc3o2)cc1";"IFI";"'='";"3.922";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL581015";"";"0";"458.52";"1";"5.07";"GNF-Pf-3056";"COC(C)(C)CNCc1cc2cc3c(cc2n(Cc2cccc(C(F)(F)F)c2)c1=O)CCC3";"IFI";"'='";"2.941";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL581452";"";"0";"330.41";"0";"2.95";"GNF-Pf-3064";"COc1cccc(C=NNC(=O)CSc2ccccc2C)c1O";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL581247";"";"0";"414.76";"0";"4.76";"GNF-Pf-3081";"CCCCn1c(=N)n(CC(O)c2ccc(Cl)c(Cl)c2)c2ccccc21.Cl";"IFI";"'='";"7.692";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL524786";"";"0";"311.35";"0";"4.17";"GNF-Pf-3082";"c1cc(-c2nc3ccccc3[nH]2)nc(-c2nc3ccccc3[nH]2)c1";"IFI";"'='";"2.985";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL601168";"";"0";"426.43";"0";"3.26";"GNF-Pf-3089";"CCOc1ccc(C(=O)CN2C(=O)c3ccccc3OC(C(C)C)C2=O)cc1[N+](=O)[O-]";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL601163";"";"0";"382.50";"0";"4.42";"GNF-Pf-3124";"CCCCCOC(=O)C1=C(C)NC2=C(C(=O)CC(C)(C)C2)C1c1ccncc1";"IFI";"'='";"2.381";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL602156";"";"0";"357.91";"0";"3.81";"GNF-Pf-767";"CCCCN(CCCC)S(=O)(=O)c1nc(C)c(Cl)c(C)c1C#N";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL609318";"";"0";"345.81";"0";"2.71";"GNF-Pf-773";"NC(=O)c1ccc(-n2nnnc2SCc2ccc(Cl)cc2)cc1";"IFI";"'='";"1.587";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL119315";"";"0";"289.38";"0";"2.05";"GNF-Pf-784";"CCCCOc1ccc(N2C(N)=NC(N)=NC2(C)C)cc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL609608";"";"0";"292.34";"0";"3.77";"GNF-Pf-811";"Oc1ccc(-c2cncc(NCc3cccc(O)c3)c2)cc1";"IFI";"'='";"4.706";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL527552";"";"0";"193.23";"0";"2.06";"GNF-Pf-819";"CC1=NOC(=O)/C1=C\c1cccs1";"IFI";"'='";"2.4";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585022";"";"0";"315.21";"0";"4.88";"GNF-Pf-836";"CCCn1c(-c2cccc(Br)c2)nc2ccccc21";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL583339";"";"0";"376.46";"0";"2.73";"GNF-Pf-845";"c1cncc(-c2cc(NCCCN3CCOCC3)nc(-c3ccncc3)n2)c1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL604566";"";"0";"478.57";"0";"1.43";"GNF-Pf-847";"COc1cccc(CNc2cc(C(=O)NCCNC(C)=O)cc(S(=O)(=O)N(C)C)c2)c1OC";"IFI";"'='";"6.024";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL584418";"";"0";"475.46";"1";"6.20";"GNF-Pf-854";"O=C(Nc1ccc(-c2nc3cc(-c4nc5ccccc5o4)ccc3[nH]2)cc1)c1ccc([N+](=O)[O-])cc1";"IFI";"'='";"5.882";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL602026";"";"0";"366.29";"1";"6.97";"GNF-Pf-858";"Clc1ccc(C2Nc3ccc4ccccc4c3C3C=CCC32)c(Cl)c1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585430";"";"0";"453.57";"0";"3.31";"GNF-Pf-861";"CCn1c(-c2ccc(O)cc2)nn(CN2CCN(Cc3ccc4c(c3)OCO4)CC2)c1=S";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL580847";"";"0";"335.40";"0";"3.99";"GNF-Pf-515";"O=C1/C(=C/c2ccccc2)Oc2c1ccc(O)c2CN1CCCCC1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL581483";"";"0";"356.42";"0";"3.59";"GNF-Pf-550";"COc1cc(C(=O)/C=C/Nc2ccc(N(C)C)cc2)cc(OC)c1OC";"IFI";"'='";"7.692";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL601797";"";"0";"446.56";"0";"4.36";"GNF-Pf-559";"Cc1ccc(-n2c(SCc3cc(=O)n4ccccc4n3)nc3ccsc3c2=O)cc1C";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL579569";"";"0";"472.64";"0";"4.87";"GNF-Pf-575";"CC1CCCCN1CCCNc1ncc(C(=O)NCCc2ccccc2)c(Nc2ccccc2)n1";"IFI";"'='";"2.885";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL580850";"";"0";"293.32";"0";"3.80";"GNF-Pf-591";"COc1cc2c(cc1/C=C(/C#N)c1cccc(C)c1)OCO2";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600960";"";"0";"327.38";"0";"2.06";"GNF-Pf-943";"COc1cc(OC)cc(C(=O)N2CCN(c3ccccn3)CC2)c1";"IFI";"'='";"7.692";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL583816";"";"0";"401.42";"0";"3.02";"GNF-Pf-966";"O=C(NN=Cc1ccc(O)c(O)c1)/C(=C/c1ccccc1)NC(=O)c1ccccc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL599962";"";"0";"460.61";"0";"3.88";"GNF-Pf-986";"CN1CCCC(CNC(=O)c2cnn(-c3ncc4c(n3)-c3ccccc3SC4)c2C2CC2)C1";"IFI";"'='";"1.786";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL602624";"";"0";"431.40";"0";"4.39";"GNF-Pf-991";"CCOc1ccc(-c2cn3c([n+]2Cc2ccccc2)SCCC3)cc1.[Br-]";"IFI";"'='";"15.38";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL369895";"";"0";"412.38";"1";"5.87";"GNF-Pf-1001";"CCN1/C(=C/c2sc3ccc(Br)cc3[n+]2CC)C=Cc2ccccc21";"IFI";"'='";"15.38";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL530468";"";"0";"325.62";"0";"3.93";"GNF-Pf-1012";"CC(C)OC(=O)NC(Nc1ccccc1)C(Cl)(Cl)Cl";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL584031";"";"0";"388.49";"0";"2.90";"GNF-Pf-1025";"COc1ccccc1N(CC(=O)N1CCCCC1)S(=O)(=O)c1ccccc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL528683";"";"0";"615.67";"2";"4.38";"GNF-Pf-1032";"CCOC(=O)c1sc(NC(=O)CSc2nnc(CNC(=O)c3ccco3)n2-c2ccc(F)cc2)c(C(=O)OCC)c1C";"IFI";"'='";"2.353";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL527297";"";"0";"367.54";"0";"3.56";"GNF-Pf-1037";"COc1ccc(CCN2CCC(NCc3cccc(N(C)C)c3)CC2)cc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL528926";"";"0";"667.50";"0";"-0.02";"GNF-Pf-1069";"O=C(O)C(F)(F)F.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F.O=S(=O)(c1ccccc1)N1CCN(CC2CNCCO2)CC1";"IFI";"'='";"1.408";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL583753";"";"0";"408.57";"1";"5.04";"GNF-Pf-1075";"CCCn1c(SCCNC(=O)NCC)nc(-c2ccccc2)c1-c1ccccc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL582924";"";"0";"325.45";"0";"4.23";"GNF-Pf-1100";"CC1(C)CC(=O)C2=C(C1)NC(=O)CC2c1ccc(C(C)(C)C)cc1";"IFI";"'='";"9.091";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL602161";"";"0";"720.78";"2";"11.23";"GNF-Pf-1116";"O=C1c2cccc3cccc(c23)C(=O)N1c1ccc(-c2c3ccccc3c(-c3ccc(N4C(=O)c5cccc6cccc(c56)C4=O)cc3)c3ccccc23)cc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL584859";"";"0";"374.53";"0";"3.71";"GNF-Pf-1122";"COc1ccc(CN(C)C(C)C)cc1OC1CCN(C(=O)C2CCC2)CC1";"IFI";"'='";"0.9804";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL584869";"";"0";"377.40";"0";"2.48";"GNF-Pf-1135";"COc1cc(C=NNC(=O)c2cccc3ccccc23)ccc1OCC(N)=O";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600965";"";"0";"307.18";"0";"4.81";"GNF-Pf-1142";"O=C1CCC(c2ccc(Cl)c(Cl)c2)c2ccc(O)cc21";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585416";"";"0";"396.40";"0";"5.00";"GNF-Pf-1155";"O=C(/C=C/c1ccccc1)c1c(-c2ccccc2)c2cc([N+](=O)[O-])ccc2[nH]c1=O";"IFI";"'='";"7.143";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL601610";"";"0";"364.62";"0";"4.47";"GNF-Pf-1157";"NC12CC3CC(C1)CC(SSC14CC5CC(CC(N)(C5)C1)C4)(C3)C2";"IFI";"'='";"8.197";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL584638";"";"0";"559.49";"2";"6.48";"GNF-Pf-1181";"CCCCCN(CC(=O)Nc1cc(C(C)(C)C)nn1-c1ccc(Cl)c(Cl)c1)C(=O)c1ccc2c(c1)OCO2";"IFI";"'='";"1.887";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL584855";"";"0";"264.33";"0";"3.51";"GNF-Pf-1193";"CC(C)Nc1nc(-c2cccnc2)nc2ccccc12";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600559";"";"0";"259.35";"0";"2.97";"GNF-Pf-1196";"COc1ccc2c(c1)sc1nc(C)c(C)c(C)[n+]12";"IFI";"'='";"2.759";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585255";"";"0";"356.81";"0";"3.45";"GNF-Pf-1200";"COCC(=O)NC(c1ccccc1)c1cc(Cl)c2cccnc2c1O";"IFI";"'='";"7.692";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL584866";"";"0";"473.04";"0";"4.73";"GNF-Pf-1206";"CCN(CC)CCN(Cc1cc2cc(OC)ccc2[nH]c1=O)C(=S)Nc1cccc(Cl)c1";"IFI";"'='";"7.143";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL601386";"";"0";"545.62";"2";"6.36";"GNF-Pf-1230";"CCn1c(SCCCCNC(=O)c2cc([N+](=O)[O-])cc([N+](=O)[O-])c2)nc(-c2ccccc2)c1-c1ccccc1";"IFI";"'='";"1.852";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL2079780";"";"0";"776.98";"3";"5.27";"GNF-Pf-1231";"CO[C@@H]1[C@H](C)[C@](O)([C@H](C)C(=O)[O-])O[C@H]([C@H](C)C2O[C@@]3(CC[C@@](C)([C@H]4CC[C@@](C)([C@@H]5O[C@@H]([C@H]6O[C@](C)(O)[C@H](C)C[C@@H]6C)C[C@@H]5C)O4)O3)C[C@H](O)[C@@H]2C)[C@@H]1C.[Na+]";"IFI";"'='";"6.349";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL601822";"";"0";"337.38";"0";"3.62";"GNF-Pf-1232";"Fc1ccc(CSc2ccc3nnc(-c4cccnc4)n3n2)cc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585040";"";"0";"274.80";"0";"4.88";"GNF-Pf-1238";"CC1CCC(Nc2ccnc3cc(Cl)ccc23)CC1";"IFI";"'='";"6.173";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585227";"";"0";"598.56";"2";"6.49";"GNF-Pf-1240";"COc1cc(NC(C)CCCN(Cc2ccccc2OC)S(=O)(=O)c2ccc(Br)cc2)c2ncccc2c1";"IFI";"'='";"4.255";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL528724";"";"0";"229.29";"0";"1.86";"GNF-Pf-1241";"Cc1cc2nc(NC(=N)N)nc(C)c2cc1C";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL529171";"";"0";"620.73";"2";"5.55";"GNF-Pf-1248";"CCOC(=O)C1=C(C)N=c2sc(=Cc3cccc(OCc4cccc5ccccc45)c3)c(=O)n2C1c1ccc(OC)cc1OC";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL584217";"";"0";"363.72";"0";"2.47";"GNF-Pf-1255";"O=C(CCl)Nc1ccc(S(=O)(=O)OCC(F)(F)C(F)F)cc1";"IFI";"'='";"7.692";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL584848";"";"0";"464.50";"0";"0.34";"GNF-Pf-1258";"CCOC(=O)C1=C(N)n2c(sc(=Cc3cccnc3)c2=O)=C(C(=O)OC)C1c1cccnc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600352";"";"0";"245.33";"0";"1.53";"GNF-Pf-1263";"O=C(C1CCC1)N1CCN(c2ccccn2)CC1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600558";"";"0";"358.39";"0";"3.93";"GNF-Pf-1268";"COc1ccc(/C=C2/SC(Nc3ccc(F)cc3)=NC2=O)c(OC)c1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585253";"";"0";"329.38";"0";"2.31";"GNF-Pf-1271";"CC(=O)c1ccc(OCCSc2nc3c(N)ncnc3[nH]2)cc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600765";"";"0";"307.53";"0";"3.34";"GNF-Pf-1280";"CC(C)=CCC/C(C)=C/CCC(C)NCCN1CCNCC1";"IFI";"'='";"3.333";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL610249";"";"0";"296.42";"0";"4.00";"GNF-Pf-1282";"CCN(CC)C1SC=C(c2ccc([N+](=O)[O-])cc2)S1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL602430";"";"0";"479.45";"1";"5.07";"GNF-Pf-1288";"O=C(Nc1ccc(Nc2cc([N+](=O)[O-])ccc2O)c2c1C(=O)c1ccccc1C2=O)c1ccccc1";"IFI";"'='";"7.692";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585405";"";"0";"413.55";"1";"5.90";"GNF-Pf-1301";"Cc1ccc(NC(=O)c2sc3nc4c(c(-c5ccc(C)cc5)c3c2N)CCC4)cc1";"IFI";"'='";"7.407";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL529403";"";"0";"232.11";"0";"2.77";"GNF-Pf-1303";"Clc1cc(N2CCCCC2)c(Cl)nn1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL578727";"";"0";"277.39";"0";"3.71";"GNF-Pf-2508";"CCN1/C(=C/c2cccc[n+]2C)C=Cc2ccc(C)cc21";"IFI";"'='";"7.792";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL606450";"";"0";"504.50";"2";"5.55";"GNF-Pf-947";"N#CC1=C(N)Oc2c3c(c4ccccc4c2C1c1ccc(F)cc1)C(c1ccc(F)cc1)C(C#N)=C(N)O3";"IFI";"'='";"6.78";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL584233";"";"0";"429.55";"1";"5.50";"GNF-Pf-952";"c1ccc(Cc2nc(NCc3ccc4c(c3)OCO4)c3c4c(sc3n2)CCCC4)cc1";"IFI";"'='";"1.163";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL603033";"";"0";"402.41";"0";"2.95";"GNF-Pf-962";"O=C(O)c1ccc(NC(=O)c2ccc(N3C(=O)C4C5C=CC(C5)C4C3=O)cc2)cc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL530023";"";"0";"351.19";"0";"3.78";"GNF-Pf-963";"Cc1ccc(CC(=O)Nc2ccc(I)cc2)cc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL602216";"";"0";"508.69";"1";"4.56";"GNF-Pf-972";"CC(C)(C)NC(=O)C(c1cccs1)N(CCCN1CCOCC1)C(=O)c1ccc(-c2ccccc2)[nH]1";"IFI";"'='";"3.261";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL602561";"";"0";"346.18";"0";"3.12";"GNF-Pf-992";"O=C(/C=C/c1ccc(Br)cc1)NC(=O)c1ccccc1O";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL584446";"";"0";"358.39";"0";"2.01";"GNF-Pf-1010";"COc1ccccc1NC(=O)C(=O)NCCc1ccc(OC)c(OC)c1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL584023";"";"0";"319.39";"0";"1.43";"GNF-Pf-1013";"CN1CCN(C(c2ccco2)c2sc3ncnn3c2O)CC1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL584238";"";"0";"517.63";"2";"5.40";"GNF-Pf-1017";"CCCCCCN(C(=O)Nc1cccc(C#N)c1)C(CC)c1nc2ccccc2c(=O)n1CCC(=O)OC";"IFI";"'='";"1.852";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585590";"";"0";"309.32";"0";"2.60";"GNF-Pf-1029";"Cc1oc2c(c1C(=O)N1CCCC1)C(=O)c1ccccc1C2=O";"IFI";"'='";"6.667";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL584835";"";"0";"540.04";"2";"7.01";"GNF-Pf-1047";"CCC(c1nc2ccccc2c(=O)n1-c1cccc(Cl)c1)N(CCc1ccccc1)C(=O)c1ccc(F)cc1";"IFI";"'='";"1.818";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585617";"";"0";"397.26";"1";"6.36";"GNF-Pf-1052";"Cc1ccc(-c2nc3cc(NC(=O)c4ccc(Cl)cc4Cl)ccc3o2)cc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585800";"";"0";"349.54";"1";"5.33";"GNF-Pf-1053";"CCCCCc1ccc(-c2ccc(/C(C=[N+](C)C)=C\N(C)C)cc2)cc1";"IFI";"'='";"14.29";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL583358";"";"0";"327.37";"0";"3.02";"GNF-Pf-1063";"O=C(CSc1nc2ccccc2[nH]1)Nc1ccc2c(c1)OCO2";"IFI";"'='";"1.176";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL582743";"";"0";"284.34";"0";"0.31";"GNF-Pf-1070";"CCc1c(C)nc(SCC(=O)NNC(C)=O)nc1O";"IFI";"'='";"1.613";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585415";"";"0";"427.55";"0";"4.70";"GNF-Pf-1084";"CCCNC(=O)CCCCCSc1nc2ccccc2c(=O)n1-c1ccc(F)cc1";"IFI";"'='";"0.9259";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL584623";"";"0";"508.02";"1";"3.83";"GNF-Pf-1087";"O=C(C1CCN(c2cccc3c2C(=O)N(C2CC2)C3=O)CC1)N1CCC(O)(c2ccc(Cl)cc2)CC1";"IFI";"'='";"8.824";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600087";"";"0";"671.04";"2";"8.17";"GNF-Pf-1090";"CC(C)CC1C(c2ccc(Cl)cc2)C(C(=O)c2ccccc2)C2(C(=O)Nc3ccc(Br)cc32)N1C(=O)NCc1ccccc1";"IFI";"'='";"3.636";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL583356";"";"0";"442.76";"1";"7.38";"GNF-Pf-1101";"N#C/C(=C\c1cc2ccccc2nc1Cl)c1nc(-c2ccc(Cl)c(Cl)c2)cs1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL583560";"";"0";"510.12";"2";"7.54";"GNF-Pf-1104";"CCCCCCN(C(=O)c1ccc(C(C)(C)C)cc1)C(CC)c1nc2cc(Cl)ccc2c(=O)n1CC";"IFI";"'='";"1.869";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL529833";"";"0";"1218.63";"None";"None";"GNF-Pf-1112";"CCC(=O)CC(O)C[C@@H](C)C[C@H](NC(=O)[C@@H]1C[C@H](C)CN1C(=O)/C=C/[C@@H](C)CC)C(=O)N[C@H](C(=O)NC(C)(C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)NC(C)(C)C(=O)NC(C)(C)C(=O)NCCC(=O)N[C@@H](C)CN(C)C)[C@H](O)C(C)C";"IFI";"'='";"12.07";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600088";"";"0";"285.14";"0";"1.43";"GNF-Pf-1129";"O=C(NN1CCOCC1)c1ccc(Br)cc1";"IFI";"'='";"3.03";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600694";"";"0";"290.37";"0";"3.94";"GNF-Pf-1134";"CC1C/C(=C/c2ccncc2)C(=O)/C(=C/c2ccncc2)C1";"IFI";"'='";"33.33";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600964";"";"0";"364.45";"0";"3.75";"GNF-Pf-1137";"CCOC(=O)C1=C(C)N/C(=C\c2cc(C)n(-c3ccc(C)cc3)c2C)C1=O";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL584663";"";"0";"396.92";"1";"5.18";"GNF-Pf-1139";"O=C1CN(C(=O)CC2CCCCC2)C(c2ccccc2)c2cc(Cl)ccc2N1";"IFI";"'='";"2.273";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL601536";"";"0";"267.31";"0";"1.44";"GNF-Pf-1147";"O=S(=O)(NC1CCCC1)c1cccc2nonc12";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL605818";"";"0";"452.51";"0";"4.16";"GNF-Pf-1249";"CC(C)(C)CC(C)(C)c1ccc(OCC(=O)NN=C2C(=O)Nc3ccccc32)c([N+](=O)[O-])c1";"IFI";"'='";"2.19";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585448";"";"0";"408.32";"0";"3.45";"GNF-Pf-1275";"CCOc1ccccc1C1NC(=O)NC(C)=C1C(=O)OCC(F)(F)C(F)(F)F";"IFI";"'='";"1.163";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585263";"";"0";"478.02";"1";"5.38";"GNF-Pf-1287";"Cc1c(C(=O)N2CCN(c3cccc(Cl)c3)CC2)sc2ncnc(N(C)c3ccccc3)c12";"IFI";"'='";"3.488";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL528950";"";"0";"210.26";"0";"0.15";"GNF-Pf-1294";"CN(C)C(=O)O[n+]1ccc(N(C)C)cc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL579837";"";"0";"378.86";"0";"4.69";"GNF-Pf-1295";"Cl.Oc1ccccc1Nc1nc(NCc2ccccc2)c2ccccc2n1";"IFI";"'='";"2.703";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL601390";"";"0";"462.53";"0";"1.27";"GNF-Pf-1299";"COCCN(CC(O)CNC(=O)c1ccc2ccccc2n1)S(=O)(=O)c1c(C)noc1C";"IFI";"'='";"1.961";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL611499";"";"0";"418.49";"0";"4.35";"GNF-Pf-2045";"COc1cc(OC)cc(C(=O)N2CCC(C(=O)Nc3cccc4ccccc34)CC2)c1";"IFI";"'='";"1.923";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL578898";"";"0";"435.47";"0";"4.92";"GNF-Pf-2060";"CCOC(=O)C1CSC(c2ccc(C(F)(F)F)cc2)N1C(=O)/C=C/c1ccccc1";"IFI";"'='";"2.83";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL532239";"";"0";"359.23";"0";"3.54";"GNF-Pf-2078";"OCCNc1nc(Nc2ccc(Br)cc2)nc2ccccc12";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL530263";"";"0";"268.24";"0";"3.13";"GNF-Pf-2079";"Cc1cc(Nc2cccc(C(F)(F)F)c2)nc(N)n1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL599944";"";"0";"447.97";"1";"5.84";"GNF-Pf-821";"CCC(c1nc2cc(Cl)ccc2c(=O)n1CC)N(CC)C(=O)c1ccc2ccccc2c1";"IFI";"'='";"1.852";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL583173";"";"0";"400.86";"1";"5.13";"GNF-Pf-823";"CCOC(=O)c1cnc2c(OC)cccc2c1Nc1cc(C)c(Cl)cc1OC";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585207";"";"0";"384.39";"0";"2.90";"GNF-Pf-837";"O=C(NC1CCN(Cc2ccccc2)CC1)c1cc([N+](=O)[O-])cc([N+](=O)[O-])c1";"IFI";"'='";"1.504";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL601605";"";"0";"369.44";"0";"4.08";"GNF-Pf-840";"COc1cc(/C=C2\SC(c3ccc(C)cc3)=NC2=O)cc(OC)c1OC";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL583553";"";"0";"342.44";"0";"2.98";"GNF-Pf-853";"CC(CCCC(C)(C)O)Nc1cncc(-c2ccc(C(N)=O)cc2)n1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585046";"";"0";"415.58";"1";"5.26";"GNF-Pf-855";"CCN(CC)c1ccc(C2N(Cc3ccccc3)CCN2Cc2ccccc2)c(O)c1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL602823";"";"0";"369.43";"0";"2.46";"GNF-Pf-878";"COc1cc(CN(C)c2ccc3nc(N)nc(N)c3c2)cc(OC)c1OC";"IFI";"'='";"15.38";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL602768";"";"0";"309.41";"0";"2.93";"GNF-Pf-913";"COc1ccccc1/C=C/CN1CCN(c2ccccn2)CC1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL608555";"";"0";"267.08";"0";"-0.36";"GNF-Pf-2579";"Br.Cc1onc(O)c1CC(N)C(=O)O";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL578729";"";"0";"343.50";"0";"3.70";"GNF-Pf-2583";"COc1ccc(CN2CCc3nc(N4CCCCC4)sc3C2)cc1";"IFI";"'='";"9.722";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL577649";"";"0";"411.59";"0";"3.13";"GNF-Pf-2195";"CN(Cc1ccccc1)CC(O)COc1ccc(CNCCCN2CCCC2)cc1";"IFI";"'='";"7.692";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL577864";"";"0";"452.45";"0";"2.64";"GNF-Pf-2196";"COc1nccnc1NS(=O)(=O)c1ccc(NC(=O)c2cc3ccccc3oc2=O)cc1";"IFI";"'='";"1.149";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL532723";"";"0";"213.24";"0";"2.85";"GNF-Pf-2208";"Oc1cccc(C=Nc2ccccc2)c1O";"IFI";"'='";"2.439";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL577145";"";"0";"394.59";"1";"5.24";"GNF-Pf-2211";"CCN1/C(=C/C(=C/c2sc3ccccc3[n+]2CC)NC)Sc2ccccc21";"IFI";"'='";"7.143";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL602800";"";"0";"444.60";"1";"5.23";"GNF-Pf-2231";"CC[n+]1c(/C=C/C=C2\N(C)c3ccccc3C2(C)C)n(CCCOC(C)=O)c2ccccc21";"IFI";"'='";"14.29";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL576777";"";"0";"375.48";"0";"3.22";"GNF-Pf-2251";"CCn1c(SCC(=O)Nc2ccc(OC)cc2)nc2ccsc2c1=O";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL577866";"";"0";"325.46";"0";"4.32";"GNF-Pf-2266";"CC[n+]1c(C=CN(C)c2ccccc2)sc2ccc(OC)cc21";"IFI";"'='";"9.375";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL578903";"";"0";"487.07";"1";"5.12";"GNF-Pf-2295";"CCN(CC)CCCN(Cc1cc2cc(OC)ccc2[nH]c1=O)C(=S)Nc1cccc(Cl)c1";"IFI";"'='";"8.036";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL578905";"";"0";"332.40";"0";"3.88";"GNF-Pf-2298";"O=C1C(Nc2ccccc2)=C(N2CCCCC2)C(=O)c2ccccc21";"IFI";"'='";"10.81";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL578279";"";"0";"398.50";"1";"5.04";"GNF-Pf-2305";"CCOC(=O)COC1=C(CCCCC2CCCCC2)C(=O)c2ccccc2C1=O";"IFI";"'='";"2.273";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL533851";"";"0";"206.29";"0";"4.61";"GNF-Pf-2329";"Cc1c2ccccc2c(C)c2ccccc12";"IFI";"'='";"3.759";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL577870";"";"0";"374.42";"0";"3.28";"GNF-Pf-2339";"Fc1ccc(N2CCN(c3ncnc4c3cnn4-c3ccccc3)CC2)cc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL602166";"";"0";"266.32";"0";"2.42";"GNF-Pf-2340";"CCOC(=O)c1[nH]c(CSC#N)c(C(C)=O)c1C";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL579285";"";"0";"312.34";"0";"3.06";"GNF-Pf-2352";"c1cncc(-c2ncc(-c3cnccn3)c(-c3cccnc3)n2)c1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL578463";"";"0";"319.37";"0";"2.44";"GNF-Pf-2360";"c1ccc(-c2cc(N3CCOCC3)nc(-c3ccccn3)n2)nc1";"IFI";"'='";"15.38";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL578682";"";"0";"435.45";"1";"5.19";"GNF-Pf-2362";"O=C1C(=Nc2cccc(C(F)(F)F)c2)c2ccccc2N1CN1CCc2ccccc2C1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL602635";"";"0";"369.53";"1";"5.99";"GNF-Pf-2370";"CCN1/C(=C/C=C/C2=[N+](C)c3ccc(C)cc3C2(C)C)C=Cc2ccccc21";"IFI";"";"";"";"";"";"Not applicable";"";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL601766";"";"0";"271.73";"0";"1.01";"GNF-Pf-2380";"CC1(C)N=C(N)N=C(N)N1c1ccc(F)cc1.Cl";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL579337";"";"0";"434.85";"1";"5.76";"GNF-Pf-2386";"Cc1ccc(C2CC(C(F)(F)F)n3ncc(C(=O)Nc4ccc(Cl)cc4)c3N2)cc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL577414";"";"0";"394.54";"0";"4.59";"GNF-Pf-2390";"CCCCN(C)C(=O)CSc1nc(NCc2ccccc2)c2ccccc2n1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL577858";"";"0";"323.44";"1";"5.31";"GNF-Pf-2399";"CCC[P+](CCC)(CCC)CC1OCc2ccccc2CO1";"IFI";"'='";"3.704";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL578307";"";"0";"556.32";"2";"7.27";"GNF-Pf-2411";"CC(C)N(CC(=O)Nc1cc(C(C)(C)C)nn1-c1ccc(Cl)c(Cl)c1)C(=O)c1ccc(Cl)c(Cl)c1";"IFI";"'='";"1.852";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL587862";"";"0";"360.41";"0";"4.55";"GNF-Pf-1775";"O=C(NCCC(c1ccccc1)c1ccccc1)c1cccc([N+](=O)[O-])c1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL582658";"";"0";"475.52";"0";"3.79";"GNF-Pf-1793";"O=C(NCc1ccco1)C1CCCN(c2cccc3c2C(=O)N(CCc2cccc(F)c2)C3=O)C1";"IFI";"'='";"6.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL578096";"";"0";"416.97";"1";"5.46";"GNF-Pf-1807";"CSC1=NC(C)(C)CC2(CC(c3ccc(C)cc3)c3cc(Cl)c(O)cc3O2)N1";"IFI";"'='";"10.42";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL601355";"";"0";"355.42";"0";"3.87";"GNF-Pf-1809";"Cc1ccc(NC(=O)C(C)Sc2nnc(-c3ccc(O)cc3)o2)cc1";"IFI";"'='";"6.14";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL601330";"";"0";"548.64";"2";"6.59";"GNF-Pf-1817";"CCOc1ccccc1-n1c(C(C)N(Cc2ccccc2)C(=O)Nc2ccccc2OC)nc2ccccc2c1=O";"IFI";"'='";"1.887";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL579169";"";"0";"366.46";"1";"5.42";"GNF-Pf-1829";"OC(CNc1cccc2ccccc12)Cn1c2ccccc2c2ccccc21";"IFI";"'='";"3.676";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL533293";"";"0";"604.73";"1";"6.82";"GNF-Pf-1852";"CCN1/C(=C/C=C/c2oc3ccc4ccccc4c3[n+]2CC)Oc2ccc3ccccc3c21.Cc1ccc(S(=O)(=O)[O-])cc1";"IFI";"'='";"19.71";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL579675";"";"0";"457.56";"1";"5.06";"GNF-Pf-1861";"CCC1=NN2C(=N)/C(=C/c3cn(CCOc4cccc(C)c4)c4ccccc34)C(=O)N=C2S1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL578311";"";"0";"508.55";"1";"2.50";"GNF-Pf-1884";"CCN1CCC(N2C[C@H](n3cc(C(=O)OC)nn3)C[C@H]2C(=O)NCc2cccc(C(F)(F)F)c2)CC1";"IFI";"'='";"0.9901";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL533302";"";"0";"996.25";"3";"9.36";"GNF-Pf-1905";"COc1c(N2CCN(Cc3c(C)cc(C)cc3C)CC2)c2nc3oc2c2c(OC(=O)C(C)(C)C)c(C)c4c(c12)[C@@H](O)[C@@](C)(OC=C[C@H](OC)[C@@H](C)[C@@H](OC(C)=O)C(C)[C@H](O)[C@H](C)[C@@H](O)C(C)C=CC=C3C)O4";"IFI";"'='";"2.128";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL577231";"";"0";"283.42";"0";"3.75";"GNF-Pf-1917";"CCN1/C(=C/c2cccc[n+]2C)Sc2ccc(C)cc21";"IFI";"'='";"7.692";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL576612";"";"0";"358.39";"0";"3.73";"GNF-Pf-1923";"COc1ccc(/C=C2\SC(=Nc3ccc(F)cc3)NC2=O)c(OC)c1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL579380";"";"0";"349.84";"0";"4.60";"GNF-Pf-1927";"COc1ccc(Cn2c(-c3ccc(Cl)cc3)c[n+]3ccccc23)cc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL587832";"";"0";"488.97";"0";"4.65";"GNF-Pf-1930";"CCOCCCNC(=O)c1cc(NC(=O)c2ccc(Cl)c([N+](=O)[O-])c2)ccc1N1CCCCC1";"IFI";"'='";"2.778";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL586761";"";"0";"253.35";"0";"1.73";"GNF-Pf-1937";"CCC(CC)=NNC(=O)C(=O)NC1CCCCC1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL535468";"";"0";"332.63";"0";"1.63";"GNF-Pf-1945";"CC1(C)N=C(N)N=C(N)N1c1ccc(Br)cc1.Cl";"IFI";"'='";"4.918";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL531119";"";"0";"573.65";"1";"3.41";"GNF-Pf-1946";"COc1cccc(NC(=O)C2C3C=CC4(O3)C2C(=O)N(Cc2ccc3c(c2)OCO3)C4C(=O)NC2CCCCC2C)c1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL580133";"";"0";"249.34";"0";"3.02";"GNF-Pf-1954";"CN1/C(=C/c2cccc[n+]2C)C=Cc2ccccc21";"IFI";"'='";"8.333";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL374744";"";"0";"503.62";"1";"4.77";"GNF-Pf-1967";"CCN(CC)CCNC(=O)C1c2ccccc2C(=O)N(Cc2ccc(F)cc2)C1c1ccc(OC)cc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL601364";"";"0";"361.53";"1";"5.53";"GNF-Pf-1969";"CC[n+]1c(C=CC=C2N(C)c3ccccc3C2(C)C)sc2ccccc21";"IFI";"'='";"28.57";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL579158";"";"0";"353.43";"0";"4.24";"GNF-Pf-1975";"CN(Cc1ccccc1)c1cc(-c2ccccn2)nc(-c2ccccn2)n1";"IFI";"'='";"7.692";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585562";"";"0";"583.11";"2";"5.28";"GNF-Pf-2462";"Cc1ccc(NC(=O)CSc2nc3cc(C(=O)NCCCOC(C)C)ccc3c(=O)n2Cc2ccco2)cc1Cl";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL601761";"";"0";"223.13";"0";"1.23";"GNF-Pf-2463";"O=C(NNc1cccc(F)n1)C(F)(F)F";"IFI";"'='";"1.25";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL587229";"";"0";"226.32";"0";"3.28";"GNF-Pf-2468";"CCN1CC=C(c2c[nH]c3ccccc23)CC1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL532141";"";"0";"636.71";"2";"10.45";"GNF-Pf-1410";"Oc1ccc(-c2nc(-c3ccc4oc5ccc(-c6[nH]c(-c7ccc(O)cc7)nc6-c6ccccc6)cc5c4c3)c(-c3ccccc3)[nH]2)cc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600310";"";"0";"394.40";"0";"2.80";"GNF-Pf-1435";"CC(=O)N(C1=C(N2CCOCC2)C(=O)c2ccccc2C1=O)c1ccc(F)cc1";"IFI";"'='";"24.68";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL576410";"";"0";"360.59";"1";"6.13";"GNF-Pf-1436";"CCCN(CCC)[P+](CC)(N(CCC)CCC)N(CCC)CCC";"IFI";"'='";"12.73";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL588513";"";"0";"422.23";"1";"5.36";"GNF-Pf-1455";"COC(=O)C(Nc1ccc(Cl)c(Cl)c1)(c1cc(C)c(O)c(C)c1)C(F)(F)F";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL582663";"";"0";"382.21";"0";"2.26";"GNF-Pf-1468";"COC(=O)C1=CNC=C(C(=O)OC)C1c1cc(Br)ccc1OC";"IFI";"'='";"6.25";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL582669";"";"0";"530.11";"2";"7.78";"GNF-Pf-1470";"CCCCCCN(C(=O)c1ccc(CC)cc1)C(CC)c1nc2ccccc2c(=O)n1-c1cccc(Cl)c1";"IFI";"'='";"1.887";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL602210";"";"0";"383.50";"1";"6.09";"GNF-Pf-1475";"CCCCOc1ccc(-c2nnc(-c3ccc(C)cc3)n2-c2ccccc2)cc1";"IFI";"'='";"1.613";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL528954";"";"0";"711.69";"0";"4.05";"GNF-Pf-1322";"CCN(CC)C(CN1CCN(CC(C)C(=O)c2ccc(O)cc2)CC1)c1ccc(F)cc1.O=C(O)C(=O)O.O=C(O)C(=O)O.O=C(O)C(=O)O";"IFI";"'='";"1.053";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585986";"";"0";"296.41";"0";"3.39";"GNF-Pf-1324";"CC[C@H]1CN2CC[C@H]1C[C@H]2[C@H](O)c1ccnc2ccccc12";"IFI";"'='";"5.172";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600351";"";"0";"307.39";"0";"1.49";"GNF-Pf-1337";"CN1CCN(C(=S)NC(=O)/C=C/c2ccc(F)cc2)CC1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585248";"";"0";"517.21";"1";"4.15";"GNF-Pf-1344";"COc1cc(Br)c(CCNC(=O)Cc2cc(OC)c(OC)cc2Br)cc1OC";"IFI";"'='";"3.008";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL602224";"";"0";"499.64";"1";"6.26";"GNF-Pf-1348";"CCC1=NN2C(=N)/C(=C/c3cn(CCOc4ccccc4C(C)CC)c4ccccc34)C(=O)N=C2S1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL530300";"";"0";"251.40";"0";"2.49";"GNF-Pf-1358";"NCCCCCCNC(=S)Nc1ccccc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL580845";"";"0";"307.40";"0";"2.33";"GNF-Pf-432";"O=C(c1nccs1)C1CCN(C(=O)c2cscn2)CC1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600690";"";"0";"300.41";"0";"2.45";"GNF-Pf-4996";"Cc1nc2c(c(C)nn2C)c(C)c1CCC(=O)N1CCCC1";"IFI";"'='";"5.556";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585795";"";"0";"379.17";"0";"1.84";"GNF-Pf-4998";"CCOC(=O)c1nnn(-c2nonc2N)c1-c1ccc(Br)cc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL603521";"";"0";"420.56";"1";"5.04";"GNF-Pf-5001";"CCN1/C(=C/c2ccc3cc(OC)ccc3[n+]2CC)Sc2ccc(NC(C)=O)cc21";"IFI";"";"";"";"";"";"Not applicable";"";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL588187";"";"0";"493.63";"1";"5.35";"GNF-Pf-5265";"CCOC(=O)C1=C(C)NC2=C(C(=O)CC(c3ccc(OC)c(OC)c3)C2)C1c1ccc(SC)cc1";"IFI";"'='";"5.882";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL588640";"";"0";"390.18";"0";"2.11";"GNF-Pf-5271";"CCOC(=O)C(=CNc1ccc(I)cn1)C(=O)OCC";"IFI";"'='";"2.532";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL578320";"";"0";"465.59";"0";"3.90";"GNF-Pf-5376";"COc1ccc(CCN2C(=O)N(CC(C)C)C(=O)C23CCN(Cc2ccccc2O)CC3)cc1";"IFI";"'='";"7.317";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL533105";"";"0";"624.96";"2";"9.94";"GNF-Pf-5380";"CCCN(CCC)[P+](CCC)(c1ccc([P+](CCC)(N(CCC)CCC)N(CCC)CCC)cc1)N(CCC)CCC";"IFI";"'='";"3.704";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL578754";"";"0";"524.49";"2";"8.46";"GNF-Pf-5399";"Cc1ccn2c(NC(C)(C)CC(C)(C)C)c(-c3ccccc3OC(=O)c3ccc(Cl)cc3Cl)nc2c1";"IFI";"'='";"5.66";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL601550";"";"0";"265.34";"0";"2.62";"GNF-Pf-4612";"OCC[n+]1ccc(/C=C/c2c[nH]c3ccccc23)cc1";"IFI";"";"";"";"";"";"Not applicable";"";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585964";"";"0";"255.36";"0";"2.70";"GNF-Pf-4618";"CN(C)CCNc1c2c(nc3ccccc13)CCC2";"IFI";"'='";"2.299";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585041";"";"0";"443.60";"0";"2.45";"GNF-Pf-4633";"CCN1CCN(c2nc3ccccn3c(=O)c2C=C2SC(=S)N(C(C)C)C2=O)CC1";"IFI";"";"";"";"";"";"Not applicable";"";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL587259";"";"0";"293.37";"0";"3.60";"GNF-Pf-4634";"Cc1ccc(-c2nn3c(O)c4c(nc3c2C)CCCC4)cc1";"IFI";"'='";"10.91";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL580801";"";"0";"368.44";"0";"4.39";"GNF-Pf-4638";"O=C(Cc1ccccc1)NC(c1ccccc1)c1ccc2cccnc2c1O";"IFI";"'='";"13.04";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL612130";"";"0";"359.56";"0";"4.41";"GNF-Pf-4640";"CSc1ccccc1CN1CCc2nc(N3CCCCC3)sc2C1";"IFI";"'='";"5.556";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL583360";"";"0";"285.41";"0";"1.87";"GNF-Pf-4647";"Cc1cc(C(C)(C)C)cc(S(=O)(=O)NCCO)c1C";"IFI";"'='";"2.985";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL602218";"";"0";"291.31";"0";"2.70";"GNF-Pf-4657";"O=C(NN=Cc1c(O)ccc2ccccc12)c1cccnc1";"IFI";"'='";"14.71";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL584242";"";"0";"477.31";"1";"6.10";"GNF-Pf-4678";"CC(=O)Nc1ccc(-c2nc3c4ccccc4c4ccc(I)cc4c3[nH]2)cc1";"IFI";"'='";"4.688";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL580879";"";"0";"310.35";"0";"2.43";"GNF-Pf-4684";"CN(C)c1ccc(C=CC(=O)NC(=O)c2ccccc2O)cc1";"IFI";"";"";"";"";"";"Not applicable";"";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL601820";"";"0";"406.46";"0";"4.20";"GNF-Pf-4698";"CC(=O)N(C1=C(N2CCC(C)CC2)C(=O)c2ccccc2C1=O)c1cccc(F)c1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL584621";"";"0";"519.61";"2";"6.08";"GNF-Pf-4703";"COc1ccc(C2CC(=O)C3=C(C2)NC(C)=C(C(=O)OC2CCCCC2)C3c2ccc(F)cc2)cc1OC";"IFI";"'='";"4.706";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585230";"";"0";"501.59";"2";"6.89";"GNF-Pf-4708";"CCOC(=O)c1c(C)n(Cc2ccccc2)c2c1cc(O)c1c2c(-c2ccccc2)nn1-c1ccccc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL582543";"";"0";"305.81";"0";"3.56";"GNF-Pf-4718";"CCC(=O)N(C)CCCNc1ccnc2cc(Cl)ccc12";"IFI";"'='";"3.738";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600344";"";"0";"467.61";"1";"7.25";"GNF-Pf-4720";"CC(C)(C)CC(C)(C)Nc1c(-c2ccccc2OC(=O)/C=C/c2ccccc2)nc2ccccn12";"IFI";"'='";"8.333";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL584439";"";"0";"573.18";"2";"9.07";"GNF-Pf-4727";"CCCCN(C(=O)Nc1c(C(C)C)cccc1C(C)C)C(CC)c1nc2ccccc2c(=O)n1-c1cccc(Cl)c1";"IFI";"'='";"1.923";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL584861";"";"0";"407.90";"0";"4.87";"GNF-Pf-4735";"COC(=O)C1=C(C)NC2=C(C(=O)CC(c3ccccc3)C2)C1c1ccc(Cl)cc1";"IFI";"'='";"2.299";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600761";"";"0";"368.39";"0";"3.70";"GNF-Pf-4740";"COc1ccc(C2=CC(=Cc3cccc(OC)c3OC)C(=O)O2)cc1OC";"IFI";"";"";"";"";"";"Not applicable";"";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL582741";"";"0";"432.56";"0";"4.74";"GNF-Pf-4751";"CCc1ccc(NC(=O)c2ccc(F)c(S(=O)(=O)NC3CCCC(C)C3C)c2)cc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585264";"";"0";"463.96";"0";"4.65";"GNF-Pf-4758";"COc1cc(OC)c(N(C)C(=O)c2cc3c(s2)-c2ccccc2S(=O)(=O)C3)cc1Cl";"IFI";"'='";"2.778";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL529630";"";"0";"547.66";"2";"6.24";"GNF-Pf-4779";"CCC(c1nc2ccccc2c(=O)n1-c1ccccc1OC)N(CCc1ccccc1)C(=O)c1cccc(OC)c1";"IFI";"'='";"3.67";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL548228";"ETHYLHYDROCUPREINE";"0";"340.47";"0";"3.79";"GNF-Pf-5532";"CCOc1ccc2nccc([C@@H](O)[C@@H]3C[C@@H]4CCN3C[C@@H]4CC)c2c1";"IFI";"";"";"";"";"";"Not applicable";"";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL588802";"";"0";"496.00";"1";"5.67";"GNF-Pf-5540";"CCCOC(=O)C1=C(C)NC2=C(C(=O)CC(c3ccc(OC)c(OC)c3)C2)C1c1ccccc1Cl";"IFI";"'='";"2.353";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600300";"";"0";"432.36";"1";"5.01";"GNF-Pf-5542";"CCOC(=O)C1=C(CC)NC2=C(C(=O)CC(C)(C)C2)C1c1ccc(Br)cc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL580131";"";"0";"354.38";"0";"3.19";"GNF-Pf-5556";"COC(=O)C1=C(C)NC(=Cc2cc(C)n(-c3ccccc3F)c2C)C1=O";"IFI";"";"";"";"";"";"Not applicable";"";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL580139";"";"0";"495.55";"0";"4.39";"GNF-Pf-5560";"COCCOC(=O)C1=C(C)NC2=C(C(=O)CC(c3ccc(OC)c(OC)c3)C2)C1c1ccc(F)cc1";"IFI";"'='";"7.317";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL579154";"";"0";"257.30";"0";"1.86";"GNF-Pf-5567";"Cc1cc(C)nc(/N=C(\N)Nc2ccccc2O)n1";"IFI";"'='";"3.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600913";"";"0";"275.72";"0";"1.36";"GNF-Pf-5569";"Cn1c2c([n+](C)c1CCl)C(=O)c1ccccc1C2=O";"IFI";"'='";"35.71";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL604322";"";"0";"388.30";"0";"4.98";"GNF-Pf-4106";"Cc1cc(C)n(CC(O)Cn2c3ccc(Cl)cc3c3cc(Cl)ccc32)n1";"IFI";"'='";"0.6944";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL604724";"";"0";"327.47";"0";"4.32";"GNF-Pf-4112";"CN1C2CCC1C(=Cc1ccsc1)C(=O)C2=Cc1ccsc1";"IFI";"";"";"";"";"";"Not applicable";"";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL598274";"";"0";"334.38";"0";"2.63";"GNF-Pf-4113";"CCOC(=O)NN=C(C)c1ccc(C(C)=NNC(=O)OCC)cc1";"IFI";"'='";"2.174";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL597464";"";"0";"448.52";"0";"3.84";"GNF-Pf-4118";"CCCCOc1ccc(N(C(C)=O)C2=C(N3CCOCC3)C(=O)c3ccccc3C2=O)cc1";"IFI";"'='";"16.22";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL546398";"";"0";"416.52";"0";"3.93";"GNF-Pf-4121";"CCOc1ccc(-c2nc(NC(=O)CS(=O)(=O)c3ccccc3)sc2C)cc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL596851";"";"0";"424.54";"0";"3.37";"GNF-Pf-4122";"COc1cc(CN2CCC3(CC2)CC3C(=O)NCCc2ccccc2OC)ccc1O";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL530412";"";"0";"273.34";"0";"4.14";"GNF-Pf-4125";"Cc1ccc2cc3c(N)c4cccc(C)c4nc3nc2c1";"IFI";"'='";"12.77";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL599719";"";"0";"377.53";"1";"5.39";"GNF-Pf-4128";"CCN1/C(=C/c2ccc3cc(OC)ccc3[n+]2CC)Sc2cc(C)ccc21";"IFI";"'='";"21.82";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL527963";"";"0";"231.34";"0";"3.13";"GNF-Pf-4145";"CCNC(=O)C=Cc1ccc(C(C)(C)C)cc1";"IFI";"";"";"";"";"";"Not applicable";"";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL528197";"";"0";"319.53";"0";"3.51";"GNF-Pf-4150";"Cc1nc2ccc(Cl)cc2c(O)c1I";"IFI";"'='";"0.7519";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL584490";"";"0";"420.54";"0";"3.62";"GNF-Pf-4160";"CCN(CC)CCNC(=O)c1cc(-c2cc3ccccc3s2)cc(-n2cnnn2)c1";"IFI";"'='";"4.237";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL534131";"";"0";"436.54";"0";"3.71";"GNF-Pf-4171";"CC(=O)c1cccc(S(=O)(=O)NCCCNc2nc3cc(C)cc(C)c3cc2C#N)c1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL597042";"";"0";"394.83";"0";"4.89";"GNF-Pf-4177";"Cc1ccc(F)cc1NC(=O)Cn1c2ccccc2c(=O)c2cc(Cl)ccc21";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL527967";"";"0";"574.77";"3";"5.23";"GNF-Pf-4179";"O=C(NCCCCCCCCCCNC(=O)Nc1ccc(C2=NCCCN2)cc1)Nc1ccc(C2=NCCCN2)cc1";"IFI";"'='";"1.835";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL603896";"";"0";"579.37";"3";"5.21";"GNF-Pf-4196";"COc1ccc(Nc2nc(NN=Cc3cc4c(cc3Br)OCO4)nc(Nc3ccc([N+](=O)[O-])cc3)n2)cc1";"IFI";"'='";"6.494";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL597056";"";"0";"398.48";"1";"6.11";"GNF-Pf-4281";"Cc1ccc2c(c1)NC(c1ccc(F)cc1)C1=C(CC(c3ccccc3)CC1=O)N2";"IFI";"'='";"2.353";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL598056";"";"0";"391.43";"0";"3.78";"GNF-Pf-4321";"CCOc1ccc(C(=O)Cn2ccc(=NCc3ccccc3)cc2)cc1[N+](=O)[O-]";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL527981";"";"0";"576.66";"2";"7.02";"GNF-Pf-4323";"O=C(Nc1nc(-c2ccccn2)cs1)c1ccc(Oc2ccc(C(=O)Nc3nc(-c4ccccn4)cs3)cc2)cc1";"IFI";"'='";"12.64";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL599297";"";"0";"440.50";"0";"1.86";"GNF-Pf-4346";"CCOC(=O)C1CCN(C(=O)C(=O)Nc2ccc3nc4n(c(=O)c3c2)CCCCC4)CC1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL527307";"";"0";"290.25";"0";"2.92";"GNF-Pf-4353";"N=c1c2ccccc2nnn1-c1ccc(C(F)(F)F)cc1";"IFI";"'='";"2.532";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL611663";"";"0";"408.31";"0";"3.73";"GNF-Pf-4361";"C=CC[n+]1c(C=C2C=CN(C)C=C2)sc2ccccc21.[I-]";"IFI";"'='";"15.38";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL528647";"";"0";"299.80";"0";"3.49";"GNF-Pf-4364";"COc1ccc2c(c1)c(C)cc[n+]2Cc1ccccc1.[Cl-]";"IFI";"'='";"6.299";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL597856";"";"0";"445.97";"0";"3.72";"GNF-Pf-4476";"O=C(C(Cc1c[nH]c2ccccc12)NS(=O)(=O)c1ccc(Cl)cc1)N1CCCCC1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL588178";"";"0";"305.74";"0";"3.53";"GNF-Pf-4390";"CCc1nc2nc(C)cc(Nc3ccc(F)c(Cl)c3)n2n1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL598882";"";"0";"324.28";"0";"1.15";"GNF-Pf-4394";"Cc1nc2ccccc2n1S(C)(=O)=O.O=C(O)C(F)(F)F";"IFI";"'='";"1.818";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL529551";"";"0";"260.31";"0";"3.05";"GNF-Pf-4396";"O=c1cc[nH]c2cc(N3CCCCCC3)c(F)cc12";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL611380";"";"0";"501.41";"0";"2.72";"GNF-Pf-4495";"CCCn1c(=O)c(C(=O)NCC[N+](CC)(CC)CC)c(O)c2ccccc21.[I-]";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL598073";"";"0";"486.31";"0";"4.03";"GNF-Pf-4497";"CC(=O)N(C1=C(N2CCCC2)C(=O)c2ccccc2C1=O)c1ccc(I)cc1";"IFI";"'='";"1.333";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL597671";"";"0";"400.54";"0";"3.50";"GNF-Pf-4504";"Cc1ccc(C(=O)NC2CCN(S(=O)(=O)c3c(C)cc(C)cc3C)CC2)cc1";"IFI";"'='";"3.846";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL586025";"";"0";"468.23";"1";"5.32";"GNF-Pf-4512";"CC(C)CCNCC(O)Cn1c2ccc(Br)cc2c2cc(Br)ccc21";"IFI";"'='";"10.07";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL602637";"";"0";"434.33";"0";"4.38";"GNF-Pf-4518";"CCOC(=O)C1=C(CC)NC2=C(C(=O)CCC2)C1c1ccc(OC)c(Br)c1";"IFI";"'='";"3.488";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL526240";"";"0";"414.34";"0";"4.36";"GNF-Pf-4528";"Cl.N=c1n(Cc2ccccc2)c2ccccc2n1CC(O)c1ccc(Cl)cc1";"IFI";"'='";"4.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL526034";"";"0";"281.36";"0";"3.79";"GNF-Pf-4829";"CN(C)Cc1c(O)ccc2oc(Cc3ccccc3)cc12";"IFI";"'='";"0.7299";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL601393";"";"0";"441.91";"0";"4.46";"GNF-Pf-4845";"CCOc1cc(C2CC(=O)NC3=C2C(=O)CC(c2ccc(OC)cc2)C3)cc(Cl)c1O";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL601162";"";"0";"378.45";"1";"5.17";"GNF-Pf-522";"Cc1nc(Oc2ccc3ccc(=O)oc3c2)c2c3c(sc2n1)CCCCC3";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL581909";"";"0";"353.47";"0";"2.17";"GNF-Pf-582";"CNC(=O)[C@@H]1C[C@@H](NCc2ccc(OC)cc2)CN1Cc1ccccc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL603029";"";"0";"363.45";"0";"2.87";"GNF-Pf-589";"Cn1c(=O)n(C)c2cc(C=NN=c3[nH]cc(-c4ccccc4)s3)ccc21";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL583367";"";"0";"519.97";"1";"4.03";"GNF-Pf-944";"COc1ccc(-n2nc(C(=O)NCC(=O)Nc3nc4ccccc4s3)c3ccccc3c2=O)cc1Cl";"IFI";"'='";"4.651";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL584021";"";"0";"284.38";"0";"3.90";"GNF-Pf-957";"Cc1ccc2cc3cc(C(=O)NC(C)C)sc3nc2c1";"IFI";"'='";"4.348";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL583817";"";"0";"264.32";"0";"3.97";"GNF-Pf-968";"C[n+]1c(C=Cc2ccc(F)cc2)ccc2ccccc21";"IFI";"";"";"";"";"";"Not applicable";"";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL583821";"";"0";"383.84";"0";"3.07";"GNF-Pf-973";"CN(C)c1ccc(/C=C2\C(=O)NC(=O)N(Cc3ccccc3Cl)C2=O)cc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585589";"";"0";"443.43";"0";"4.44";"GNF-Pf-977";"OC1(c2ccc(Br)cc2)CCN(C2CCN(CCc3ccccc3)CC2)CC1";"IFI";"'='";"4.098";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL583150";"";"0";"304.40";"0";"3.18";"GNF-Pf-989";"COc1ccc(Cn2c(=S)[nH]c3ccsc3c2=O)cc1";"IFI";"'='";"2.299";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600554";"";"0";"263.30";"0";"3.19";"GNF-Pf-1000";"Cc1cccc(NC(=O)c2ccc3ccccc3n2)n1";"IFI";"'='";"3.226";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL584230";"";"0";"384.14";"0";"2.44";"GNF-Pf-1003";"COc1cc(/C=C/c2nc(O)nc(O)c2[N+](=O)[O-])cc(Br)c1O";"IFI";"'='";"7.692";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600962";"";"0";"298.34";"0";"3.52";"GNF-Pf-1019";"CCOC(=O)c1cnc2c(C)c3[nH]c(C)c(C)c3cc2c1O";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585782";"";"0";"347.80";"0";"4.02";"GNF-Pf-1038";"COc1cc(NC(=O)/C=C/c2ccccc2Cl)cc(OC)c1OC";"IFI";"'='";"1.562";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585032";"";"0";"588.49";"1";"6.28";"GNF-Pf-1041";"CCN1/C(=C\C=C\c2n(CC)c3ccc(C#N)cc3[n+]2CC)Oc2ccc(-c3ccccc3)cc21.[I-]";"IFI";"'='";"10.53";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585980";"";"0";"423.68";"1";"6.17";"GNF-Pf-1044";"COC(=O)c1c(-c2c(Cl)cccc2Cl)noc1C=CNc1ccc(Cl)cc1";"IFI";"";"";"";"";"";"Not applicable";"";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585424";"";"0";"421.57";"1";"5.67";"GNF-Pf-1092";"CCCCOc1ccc(C(=O)Nc2c3c(nn2-c2ccc(C)cc2C)CSC3)cc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600160";"";"0";"334.34";"0";"3.33";"GNF-Pf-1093";"c1cc(NCc2ccc3c(c2)OCO3)n2ncc(-c3ccoc3)c2n1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL607687";"";"0";"288.41";"0";"4.77";"GNF-Pf-1098";"Cc1ccc(-c2cc(C)[n+](C)c(-c3ccc(C)cc3)c2)cc1";"IFI";"'='";"10.61";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL583357";"";"0";"340.40";"0";"4.23";"GNF-Pf-1103";"COc1ccc(/C=C2\SC(=O)NC2=Nc2ccccc2)c(OC)c1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL602022";"";"0";"477.57";"0";"4.88";"GNF-Pf-1107";"CCCN(CC(=O)Nc1cc(C(C)(C)C)nn1-c1cccc(C)c1)C(=O)c1cccc([N+](=O)[O-])c1";"IFI";"'='";"3.604";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585062";"";"0";"378.30";"0";"3.21";"GNF-Pf-1124";"O=C(Oc1ccc(N2C(=O)c3ccc([N+](=O)[O-])cc3C2=O)cc1)c1ccco1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600764";"";"0";"415.80";"0";"3.35";"GNF-Pf-1127";"O=C(CN1CCN(C(=O)c2ccco2)CC1)Nc1cc(C(F)(F)F)ccc1Cl";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585067";"";"0";"403.91";"0";"4.00";"GNF-Pf-1128";"CCCc1ccc(OCCNC(=O)CCNC(=O)Nc2cccc(Cl)c2)cc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL584657";"";"0";"371.44";"0";"4.93";"GNF-Pf-1130";"CCOc1ccc2nc3cc(NC(=O)c4ccc(C)cc4)ccc3c(N)c2c1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL529351";"";"0";"590.28";"2";"7.26";"GNF-Pf-1143";"O=C(Nc1ccc(-c2nc3ccc(NC(=O)c4ccc(Br)cc4)cc3[nH]2)cc1)c1ccc(Br)cc1";"IFI";"'='";"4.918";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL584614";"";"0";"262.32";"0";"3.72";"GNF-Pf-1154";"Cc1nc2ccc(-c3ccc4nc(C)[nH]c4c3)cc2[nH]1";"IFI";"'='";"3.077";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585605";"";"0";"326.35";"0";"2.51";"GNF-Pf-1159";"CCc1ccc(C=NNC(=O)COc2ccc3c(c2)OCO3)cc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585038";"";"0";"377.49";"1";"6.12";"GNF-Pf-1163";"CCCCSc1ncnc2c1c(-c1ccccc1)cn2-c1cccc(F)c1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL84108";"";"0";"334.30";"0";"3.39";"GNF-Pf-1166";"Nc1nc(N)c2c(OCc3ccc(C(F)(F)F)cc3)cccc2n1";"IFI";"'='";"7.634";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585614";"";"0";"304.38";"0";"1.55";"GNF-Pf-1168";"CCCNC(=O)Cn1nc(C)n2c(cc3sccc32)c1=O";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600758";"";"0";"402.52";"0";"3.44";"GNF-Pf-1172";"COc1ccc(CC(=O)Nc2ccc(S(=O)(=O)N3CCCCCC3)cc2)cc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL583561";"";"0";"368.41";"0";"3.46";"GNF-Pf-1174";"Cc1cc(-c2cn[nH]c2C2CCCN(C(=O)Cc3ccccc3F)C2)on1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600155";"";"0";"525.42";"1";"4.50";"GNF-Pf-1180";"CCNC1=C(C(=O)c2ccccc2)N(CC(=O)c2ccc(Br)cc2)S(=O)(=O)c2ccccc21";"IFI";"'='";"7.692";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600897";"";"0";"267.33";"0";"2.22";"GNF-Pf-1182";"O=C1NN=C2C1=NC1(CCCCC1)Cc1ccccc12";"IFI";"'='";"8.333";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL584639";"";"0";"280.28";"0";"2.53";"GNF-Pf-1183";"O=C(O)c1cccc(N2N=C(c3ccccc3)CC2=O)c1";"IFI";"'='";"4.819";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL602024";"";"0";"312.44";"0";"2.48";"GNF-Pf-1186";"S=C(NN=Cc1ccccn1)NC1CC2CC1C1C=CCC21";"IFI";"'='";"32.47";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585064";"";"0";"413.97";"0";"4.50";"GNF-Pf-1197";"O=c1c2c3c(sc2ncn1Cc1cccc(Cl)c1)CC(N1CCCCC1)CC3";"IFI";"'='";"1.754";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL583628";"";"0";"338.54";"0";"4.60";"GNF-Pf-1216";"CC(Cc1ccccc1)NCCCCCNC(C)Cc1ccccc1";"IFI";"'='";"1.852";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL603038";"";"0";"394.50";"0";"4.66";"GNF-Pf-1222";"Cc1cc(C)c2nc(SCC(=O)Nc3ccc4c(c3)OCCO4)cc(C)c2c1";"IFI";"'='";"17.14";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585210";"";"0";"533.50";"0";"3.23";"GNF-Pf-1224";"O=C(COC(c1ccccc1)c1cccnc1)NCCNC(=O)OCc1ccccc1.O=C(O)C(F)(F)F";"IFI";"'='";"0.9091";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600770";"";"0";"358.83";"0";"4.08";"GNF-Pf-1244";"O=C(Nc1ccccc1Cl)C1CCCN1C(=O)OCc1ccccc1";"IFI";"'='";"3.448";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL584218";"";"0";"368.23";"0";"4.22";"GNF-Pf-1256";"Cc1c(C#N)c2ccccc2n1CC(=O)Nc1ccc(Br)cc1";"IFI";"'='";"3.175";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585056";"";"0";"398.85";"0";"2.24";"GNF-Pf-1262";"O=C(NCCCN1CCCC1=O)c1cccn2c(=O)c3ccc(Cl)cc3nc12";"IFI";"'='";"2.778";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585057";"";"0";"479.58";"1";"6.34";"GNF-Pf-1264";"C=CCNC(=O)c1cc(OCc2ccccc2)c(OCc2ccccc2)c(OCc2ccccc2)c1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585254";"";"0";"385.47";"0";"3.58";"GNF-Pf-1272";"Cc1nc2c(-c3ccccc3)c(C)nn2c(C)c1CC(=O)NCc1ccccn1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585070";"";"0";"411.59";"0";"3.83";"GNF-Pf-1284";"CCCCNCCN1CCN(c2cc(OC)cc(OC)c2)C[C@@H]1Cc1ccccc1";"IFI";"'='";"2.439";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585029";"";"0";"402.47";"0";"2.37";"GNF-Pf-1306";"COc1ccc(/C=C/C(=O)Nc2ccc(S(=O)(=O)N3CCOCC3)cc2)cc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL578955";"";"0";"489.71";"0";"4.36";"GNF-Pf-1986";"CCCN1CCC(N2C[C@@H](NCc3ccc4c(c3)c3ccccc3n4CC)C[C@H]2C(=O)NCC)CC1";"IFI";"'='";"4.902";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL603518";"";"0";"448.47";"0";"4.59";"GNF-Pf-1997";"O=C(NCCc1ccc(-c2ccccc2)cc1)c1ccc(NS(=O)(=O)C(F)(F)F)cc1";"IFI";"'='";"2.778";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL578904";"";"0";"348.19";"0";"4.09";"GNF-Pf-2297";"O=C(NNc1nc2ccccc2nc1Cl)Nc1ccc(Cl)cc1";"IFI";"'='";"2.4";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL405668";"";"0";"337.45";"0";"3.95";"GNF-Pf-2036";"Cc1ccc(N=C2NC(=O)/C(=C\c3ccc(N(C)C)cc3)S2)cc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL601366";"";"0";"459.66";"0";"4.88";"GNF-Pf-2047";"Cc1cc(N2CCCC2)nc2ccc(NC(=S)NCCCN3CCc4ccccc4C3)cc12";"IFI";"'='";"11.76";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL577595";"";"0";"367.47";"0";"2.94";"GNF-Pf-2050";"CN(C)C(=O)C1C2NC(=S)N(c3ccccc3)C1(C)Oc1ccccc12";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL602372";"";"0";"319.36";"0";"1.87";"GNF-Pf-2364";"O=C1C2C3c4ccccc4C(c4ccccc43)C2C(=O)N1CCO";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL578269";"";"0";"351.40";"0";"4.63";"GNF-Pf-2367";"FC(F)(F)c1cccc(NC(=S)N2CCCC2c2ccncc2)c1";"IFI";"'='";"1.786";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600939";"";"0";"433.58";"0";"4.95";"GNF-Pf-2375";"CC(C)CNC(=O)c1cc(NC(=O)c2cccs2)ccc1N1CCc2ccccc2C1";"IFI";"'='";"1.087";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL371218";"";"0";"459.38";"1";"5.71";"GNF-Pf-2382";"CCN1/C(=C/c2sc3ccc(I)cc3[n+]2CC)C=Cc2ccccc21";"IFI";"'='";"15.38";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL578917";"";"0";"508.54";"1";"4.08";"GNF-Pf-2385";"O=C1CN(C(=O)c2cc([N+](=O)[O-])c(N3CCCCC3)c([N+](=O)[O-])c2N2CCCCC2)c2ccccc2N1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL601548";"";"0";"148.20";"0";"1.79";"GNF-Pf-2396";"O=C1CCC2C3C=CC(C3)C12";"IFI";"'='";"1.25";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL531507";"";"0";"563.70";"2";"7.34";"GNF-Pf-2091";"COc1cc(NC(C)CCCN(Cc2ccc(OC)c(OC)c2)C(=O)c2ccc3ccccc3c2)c2ncccc2c1";"IFI";"'='";"5.714";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL578306";"";"0";"358.40";"0";"2.67";"GNF-Pf-2410";"O=C(/C=C/c1ccccn1)NCC1Cc2cc(-c3cnccn3)ccc2O1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL521079";"";"0";"517.11";"0";"4.94";"GNF-Pf-138";"CC[C@H]1CN2CCc3cc(OC)c(OC)cc3[C@@H]2C[C@@H]1C[C@@H]1NCCc2cc(OC)c(OC)cc21.Cl";"IFI";"'='";"37.04";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL602580";"";"0";"292.51";"0";"4.08";"GNF-Pf-1379";"CC1CC2=C(CC1CNCCCN(C)C)C(C)(C)CCC2";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL582651";"";"0";"397.29";"0";"3.70";"GNF-Pf-1392";"CCc1nnc2n1N(C(C)=O)C(c1ccc(Cl)c(Cl)c1)=C(C(C)=O)S2";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL578112";"";"0";"316.40";"0";"2.42";"GNF-Pf-1424";"Cc1ccc2c(c1)N(CC(=O)NC1CCCCC1C)C(=O)CO2";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL577018";"";"0";"491.68";"0";"3.51";"GNF-Pf-1432";"COc1ccccc1N1CCN([C@@H]2CCN(Cc3cccnc3)C[C@@H]2CCC(=O)N2CCCC2)CC1";"IFI";"'='";"2.679";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600294";"";"0";"210.19";"0";"-1.74";"GNF-Pf-1443";"Cn1c(=O)[nH]c2c(c1=O)n(C)c(=O)n2C";"IFI";"'='";"1.399";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL578937";"";"0";"433.30";"1";"5.02";"GNF-Pf-2648";"CN(CCCNc1ccnc2cc(Cl)ccc12)C(=O)c1ccc(Cl)c([N+](=O)[O-])c1";"IFI";"'='";"1.869";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL604117";"";"0";"503.47";"2";"5.72";"GNF-Pf-3810";"COc1cc(NC(C)CCCN(Cc2ccc(N(C)C)cc2)C(=O)C(Cl)Cl)c2ncccc2c1";"IFI";"'='";"4.673";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL601962";"";"0";"309.46";"0";"2.58";"GNF-Pf-3873";"CCSc1nc2sc3c(c2c(=O)n1CC)CCN(C)C3";"IFI";"'='";"8.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL599496";"";"0";"590.41";"2";"6.67";"GNF-Pf-3879";"CCCCNC(=O)C1CCC(CN(Cc2c(Cl)cccc2Cl)S(=O)(=O)c2ccc(Br)cc2)CC1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL528486";"";"0";"252.11";"0";"2.91";"GNF-Pf-3921";"Cc1ccc2[nH]c(C)c(Br)c(=O)c2c1";"IFI";"'='";"2.899";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL584250";"";"0";"297.47";"0";"3.12";"GNF-Pf-3928";"CSc1nc(SC)c2c3c(sc2n1)CN(C)CC3";"IFI";"'='";"3.03";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL584466";"";"0";"341.45";"0";"4.45";"GNF-Pf-3936";"COc1ccc(OC)c(-c2ccc(O)c(CN3CCCCCC3)c2)c1";"IFI";"'='";"1.923";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL532552";"";"0";"671.42";"0";"4.96";"GNF-Pf-2696";"CN(C)CCNC(=O)c1ccc(-c2cncc(NCc3ccc(Cl)c(Cl)c3)c2)cc1.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F";"IFI";"'='";"2.128";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL604780";"";"0";"532.64";"1";"4.49";"GNF-Pf-4313";"CCOc1ccc(N(C(=O)C2COc3ccccc3O2)C(C(=O)NC2CCCCC2)c2cn(C)nc2C)cc1";"IFI";"'='";"1.709";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL596653";"";"0";"520.06";"None";"None";"GNF-Pf-4362";"Oc1ccccc1C=Nc1ccccc1[Te]c1ccccc1N=Cc1ccccc1O";"IFI";"'='";"8.209";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585650";"";"0";"306.51";"0";"4.26";"GNF-Pf-4368";"CC(C)(C[N+](C)(C)C)C1OC2CCCCC2C2C=CCCC21";"IFI";"'='";"6.897";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL601826";"";"0";"491.60";"1";"5.93";"GNF-Pf-4381";"CCc1ccc(C2C(C(=O)Nc3ccccc3)=C(C)Nc3c(C(=O)Nc4ccc(C)cc4)cnn32)cc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL596639";"";"0";"378.48";"0";"3.72";"GNF-Pf-4484";"COc1cc2ncnc(NC3CCN(Cc4ccccc4)CC3)c2cc1OC";"IFI";"'='";"2.4";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600092";"";"0";"292.17";"0";"4.50";"GNF-Pf-4490";"Clc1ccc2c(c1)c1cc(Cl)ccc1n2CC1CO1";"IFI";"'='";"16.98";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL603233";"";"0";"512.44";"2";"7.69";"GNF-Pf-4506";"OC(Cn1cnc(-c2ccccc2)c1-c1ccccc1)Cn1c2ccc(Cl)cc2c2cc(Cl)ccc21";"IFI";"'='";"2.326";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585417";"";"0";"346.39";"0";"2.72";"GNF-Pf-4522";"Cc1nnc(SCC(=O)NCc2ccco2)n1-c1ccc(F)cc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL529858";"";"0";"426.35";"1";"5.04";"GNF-Pf-4527";"COc1ccc(-c2c(C(F)(F)F)nn(C)c2NC(=O)Nc2ccc(F)cc2F)cc1";"IFI";"'='";"2.459";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL535960";"";"0";"430.98";"1";"6.36";"GNF-Pf-3962";"CCN(CC)CCNc1nc(C=Cc2ccc(Cl)cc2)nc2cc3ccccc3cc12";"IFI";"";"";"";"";"";"Not applicable";"";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL583844";"";"0";"423.43";"0";"3.39";"GNF-Pf-4010";"O=C(CSc1ccc2nnc(-c3cccc(F)c3)n2n1)Nc1ccc2c(c1)OCO2";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL597461";"";"0";"316.26";"0";"1.63";"GNF-Pf-4045";"O=C(NNC(=O)c1csnn1)c1ccc(C(F)(F)F)cc1";"IFI";"'='";"3.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL584844";"";"0";"503.67";"1";"3.52";"GNF-Pf-1367";"CN(C)CCNC(=O)c1ccc(-c2cccc3c2sc2ccccc23)nc1N1CCN(CCO)CC1";"IFI";"'='";"11.3";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600699";"";"0";"349.46";"0";"2.80";"GNF-Pf-658";"CCN1CC=C2C(C#N)=C(N)C(C#N)(C#N)C(c3ccc(C)s3)C2C1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL588332";"";"0";"341.28";"0";"2.69";"GNF-Pf-1388";"CC1=NN(c2ccc(C(=O)O)cc2)C(=O)/C1=C\c1ccc([N+](=O)[O-])o1";"IFI";"'='";"4.762";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL582450";"";"0";"405.80";"0";"3.63";"GNF-Pf-1394";"CCOC(=O)C1=C(C)N(CCNc2ncc(C(F)(F)F)cc2Cl)C(=O)CC1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL579367";"";"0";"416.70";"1";"7.70";"GNF-Pf-1411";"CCCCCC[P+](N(CCC)CCC)(N(CCC)CCC)N(CCC)CCC";"IFI";"'='";"29.09";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL587096";"";"0";"381.78";"0";"4.83";"GNF-Pf-1440";"O=[N+]([O-])c1ccc(Cl)c(-c2ccc(C=NNc3nc4ccccc4[nH]3)o2)c1";"IFI";"'='";"2.479";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL533470";"";"0";"570.06";"2";"6.78";"GNF-Pf-1466";"CCC(c1nc2ccccc2c(=O)n1-c1ccc(F)c(Cl)c1)N(CCc1ccccc1)C(=O)COc1ccccc1";"IFI";"'='";"1.869";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL582452";"";"0";"409.40";"0";"2.81";"GNF-Pf-1467";"COc1cc(NC(=O)Cn2ncc3c(=O)oc4ccccc4c32)cc(OC)c1OC";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600091";"";"0";"616.67";"2";"7.09";"GNF-Pf-776";"Cc1ccc(N2C(=O)C3C(C2=O)C2(c4ccccc4)C(=O)C3(c3ccccc3)C(c3ccccc3)=C2c2ccccc2)c([N+](=O)[O-])c1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL582458";"";"0";"403.94";"0";"4.32";"GNF-Pf-1469";"Cc1ccc(S(=O)(=O)N(C)CCCNc2ccnc3cc(Cl)ccc23)cc1";"IFI";"'='";"9.677";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600123";"";"0";"426.61";"1";"5.01";"GNF-Pf-1495";"CCCN(CC(=O)Nc1cc(C(C)(C)C)nn1-c1cccc(C)c1C)C(=O)C(C)(C)C";"IFI";"'='";"0.9174";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL599517";"";"0";"234.19";"0";"-1.28";"GNF-Pf-817";"O=C(O)c1nsnc1C(O)C(O)C(=O)O";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL601357";"";"0";"364.45";"0";"3.30";"GNF-Pf-2571";"CCN1CCN(Cc2cc(=O)oc3cc(-c4ccccc4)c(O)cc23)CC1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL583558";"";"0";"269.39";"0";"3.36";"GNF-Pf-1326";"Cc1ccc2c(c1)N(C)/C(=C/c1cccc[n+]1C)S2";"IFI";"'='";"15.38";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL577644";"";"0";"468.80";"0";"4.77";"GNF-Pf-2192";"CN(CCCNc1ccnc2cc(Cl)ccc12)S(=O)(=O)c1ccc(Br)cc1";"IFI";"'='";"7.407";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL601779";"";"0";"371.84";"0";"4.60";"GNF-Pf-2202";"CN(CCCNc1ccnc2cc(Cl)ccc12)C(=O)c1cccc(F)c1";"IFI";"'='";"3.774";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585953";"";"0";"528.01";"2";"7.65";"GNF-Pf-2248";"O=C1c2cccc3c(C4=NN(c5ccccc5)C(c5ccc(Cl)cc5)C4)ccc(c23)C(=O)N1c1ccccc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL601756";"";"0";"319.36";"0";"4.03";"GNF-Pf-2253";"CCOc1ccc(/C=C(/C#N)c2nc3ccccc3[nH]2)cc1OC";"IFI";"'='";"8.421";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL577418";"";"0";"384.50";"1";"6.11";"GNF-Pf-2256";"Cc1ccc(N=C2S/C(=C\c3ccccc3)C(=O)N2c2ccc(C)cc2)cc1";"IFI";"'='";"1.205";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL599927";"";"0";"422.44";"1";"5.85";"GNF-Pf-2275";"Cc1ccc(C(=O)Nc2ccc(-c3nc4cc5ccccc5cc4[nH]3)cc2)cc1[N+](=O)[O-]";"IFI";"'='";"9.091";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL1554";"DACTINOMYCIN";"4";"1255.44";"None";"None";"GNF-Pf-2290";"Cc1c2oc3c(C)ccc(C(=O)N[C@@H]4C(=O)N[C@H](C(C)C)C(=O)N5CCC[C@H]5C(=O)N(C)CC(=O)N(C)[C@@H](C(C)C)C(=O)O[C@@H]4C)c3nc-2c(C(=O)N[C@@H]2C(=O)N[C@H](C(C)C)C(=O)N3CCC[C@H]3C(=O)N(C)CC(=O)N(C)[C@@H](C(C)C)C(=O)O[C@@H]2C)c(N)c1=O";"IFI";"'='";"20.31";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL579335";"";"0";"353.85";"0";"4.46";"GNF-Pf-2311";"CN(CCCNc1ccnc2cc(Cl)ccc12)C(=O)c1ccccc1";"IFI";"'='";"1.869";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL578085";"";"0";"366.37";"0";"2.10";"GNF-Pf-2332";"CC(=O)N(Cc1ccc2c(c1)OCO2)C1CC(=O)N(c2ccccc2)C1=O";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL578305";"";"0";"434.97";"0";"4.99";"GNF-Pf-2338";"CCN1CCN(c2cc(C)c3cc(NC(=O)C=Cc4ccccc4Cl)ccc3n2)CC1";"IFI";"";"";"";"";"";"Not applicable";"";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL578091";"";"0";"404.50";"0";"4.24";"GNF-Pf-2342";"O=C(CSc1nc(NCc2ccccc2)c2ccccc2n1)NCc1ccco1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL578683";"";"0";"435.94";"1";"5.63";"GNF-Pf-2363";"CC1=CC(=C(C#N)c2nc3ccccc3s2)C=C(C)N1c1ccc2c(c1)OCO2.Cl";"IFI";"'='";"3.125";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL579114";"";"0";"405.28";"0";"4.36";"GNF-Pf-2372";"COC(=O)C1=C(C)NC(=Cc2cc(C)n(-c3cc(Cl)ccc3Cl)c2C)C1=O";"IFI";"";"";"";"";"";"Not applicable";"";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL577416";"";"0";"418.55";"0";"3.03";"GNF-Pf-2392";"CN(C)CCNc1ncc(C(=O)NCc2ccccc2)c(NCCc2ccccc2)n1";"IFI";"'='";"1.923";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL602795";"";"0";"498.63";"1";"5.02";"GNF-Pf-2400";"COC(=O)c1sc(-c2ccccc2)cc1NC(=O)c1ccc(S(=O)(=O)N2CCCCCC2)cc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL532965";"";"0";"261.36";"0";"2.98";"GNF-Pf-2406";"COCCCNC(=O)C=Cc1ccc(C(C)C)cc1";"IFI";"";"";"";"";"";"Not applicable";"";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL603003";"";"0";"335.41";"0";"4.12";"GNF-Pf-2409";"CCC(CO)Nc1nccnc1-c1ccccc1Oc1ccccc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL586235";"";"0";"528.65";"2";"6.58";"GNF-Pf-1785";"COc1cc(NC(C)CCCN(Cc2ccccc2OC)C(=O)Nc2ccccc2OC)c2ncccc2c1";"IFI";"'='";"1.887";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL582659";"";"0";"421.95";"1";"5.95";"GNF-Pf-1794";"Cc1ccc(-n2c(C)cc(/C=C3\SC(=Nc4ccc(Cl)cc4)NC3=O)c2C)cc1";"IFI";"'='";"5.814";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL488127";"";"0";"384.53";"1";"5.89";"GNF-Pf-3185";"CCN(CC)CCNc1ccc(Nc2ccnc3cc4ccccc4cc23)cc1";"IFI";"'='";"17.19";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL581864";"";"0";"571.38";"2";"6.72";"GNF-Pf-3190";"O=C(Nc1ccc(Br)cc1C(=O)c1ccccc1)c1cc2nc(-c3cccs3)cc(C(F)(F)F)n2n1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL599937";"";"0";"370.36";"0";"3.17";"GNF-Pf-3202";"CC(=O)N(C1=C(N(C)C)C(=O)c2ccccc2C1=O)c1ccc(F)c(F)c1";"IFI";"'='";"23.08";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600141";"";"0";"380.33";"1";"5.13";"GNF-Pf-3208";"[Br-].c1ccc(-c2c3c(cc4ccccc24)C[N+]2(CCCC2)C3)cc1";"IFI";"'='";"3.03";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL582084";"";"0";"308.29";"0";"2.02";"GNF-Pf-3211";"CCOC(=O)C(=CNc1ccccc1[N+](=O)[O-])C(=O)OCC";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL601588";"";"0";"322.32";"0";"3.43";"GNF-Pf-3365";"CC(=O)C1C(=O)c2c(cccc2[N+](=O)[O-])C1=Nc1ccccc1C";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL579680";"";"0";"432.49";"1";"5.73";"GNF-Pf-3242";"Nc1ccc(-c2nc3cc(Oc4ccc5[nH]c(-c6ccc(N)cc6)nc5c4)ccc3[nH]2)cc1";"IFI";"'='";"15.38";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL582683";"";"0";"468.60";"0";"3.60";"GNF-Pf-3248";"O=C(CN1CCCC1)Nc1nc(-c2ccc3c(c2)CCN3S(=O)(=O)c2ccccc2)cs1";"IFI";"'='";"5.263";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL604777";"";"0";"361.28";"0";"2.82";"GNF-Pf-3251";"CC1=[N+](CC(=O)c2ccc(C)cc2)CCn2c(C)ccc21.[Br-]";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL581869";"";"0";"342.42";"0";"3.11";"GNF-Pf-3266";"O=[N+]([O-])c1ccc(N2CCN(C(=S)Nc3ccccc3)CC2)cc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL582078";"";"0";"418.57";"0";"3.41";"GNF-Pf-3272";"Cc1sc2sc(-c3ccccc3)c(N)[n+]2c1C.O=S(=O)([O-])c1ccccc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL582290";"";"0";"324.30";"0";"2.00";"GNF-Pf-3283";"Cc1nc2ccccc2c(=O)n1NC(=O)c1cccc([N+](=O)[O-])c1";"IFI";"'='";"1.053";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL581880";"";"0";"462.52";"1";"6.52";"GNF-Pf-3286";"CCC(C)(C)c1ccc(OCCCC[n+]2ccc(C)cc2)c(C(C)(C)CC)c1.[Br-]";"IFI";"'='";"7.143";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL582285";"";"0";"425.62";"0";"3.38";"GNF-Pf-3311";"CN1CCC(CCNCc2ccc(OCC(O)CN(C)Cc3ccccc3)cc2)CC1";"IFI";"'='";"7.692";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600752";"";"0";"369.47";"1";"5.46";"GNF-Pf-3313";"Cc1cc(C)c(C(Nc2ccccn2)c2ccc3cccnc3c2O)c(C)c1";"IFI";"'='";"9.524";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL530030";"";"0";"567.36";"2";"4.90";"GNF-Pf-3011";"COc1ccc(Nc2nc(NN=Cc3cc(Br)c(O)cc3O)nc(Nc3ccc([N+](=O)[O-])cc3)n2)cc1";"IFI";"'='";"13.95";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL602414";"";"0";"367.36";"0";"3.11";"GNF-Pf-3013";"CCOC(=O)c1c(-c2ccc3c(c2)OCO3)[nH]c2cccc(OC)c2c1=O";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL582301";"";"0";"458.80";"1";"5.32";"GNF-Pf-3015";"CN(CCCNc1ccnc2cc(Cl)ccc12)S(=O)(=O)c1cc(Cl)ccc1Cl";"IFI";"'='";"7.407";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL280196";"";"0";"254.24";"0";"0.13";"GNF-Pf-3018";"CC(=O)NC(CO)C(O)c1ccc([N+](=O)[O-])cc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL602382";"";"0";"215.30";"0";"1.61";"GNF-Pf-3100";"CSc1nnc(NC(=O)C2CC2)s1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL581042";"";"0";"300.20";"0";"3.47";"GNF-Pf-3106";"C=CC[n+]1cccc2c3ccccc3ccc21.[Br-]";"IFI";"'='";"11.11";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL534288";"";"0";"448.52";"0";"4.30";"GNF-Pf-3125";"O=C(O)C(=O)O.Oc1ccccc1CN1CCN(C(c2ccccc2)c2ccccc2)CC1";"IFI";"'='";"1.818";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL599941";"";"0";"445.51";"1";"6.26";"GNF-Pf-3151";"CSc1ccc(NC(=O)N2CCCn3cccc3C2c2ccc(C(F)(F)F)cc2)cc1";"IFI";"'='";"2.83";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL582716";"";"0";"416.43";"0";"3.34";"GNF-Pf-3152";"COC(=O)C1=C(C)NC2=C(C(=O)c3ccccc32)C1c1ccc(OCC#N)c(OC)c1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL535887";"";"0";"186.26";"0";"2.55";"GNF-Pf-3161";"N#Cc1ccccc1N1CCCCC1";"IFI";"'='";"4.63";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL534579";"";"0";"388.48";"0";"2.46";"GNF-Pf-3164";"O=C(C1CCN(c2nnnn2-c2ccccc2)CC1)N1CCc2ccccc2C1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL582727";"";"0";"391.50";"0";"3.37";"GNF-Pf-3168";"C[N+](C)(C)c1nc(N2CCOCC2)nc(N(c2ccccc2)c2ccccc2)n1";"IFI";"'='";"2.41";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL582264";"";"0";"296.33";"0";"1.71";"GNF-Pf-3172";"COc1ccc2c(c1)C(=NN=C(N)N)c1cc(OC)ccc1-2";"IFI";"'='";"7.692";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL581684";"";"0";"489.30";"1";"5.67";"GNF-Pf-3353";"CC(NC(=O)c1cnn2c(C(F)(F)F)cc(-c3ccc(Br)cc3)nc12)c1ccccc1";"IFI";"'='";"3.226";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL603521";"";"0";"420.56";"1";"5.04";"GNF-Pf-5001";"CCN1/C(=C/c2ccc3cc(OC)ccc3[n+]2CC)Sc2ccc(NC(C)=O)cc21";"IFI";"'='";"5.263";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL599090";"";"0";"463.67";"1";"7.81";"GNF-Pf-4031";"CCCCCCC(=O)Oc1ccccc1-c1nc2cc(C)ccn2c1NC(C)(C)CC(C)(C)C";"IFI";"'='";"2.128";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL602355";"";"0";"309.42";"0";"3.32";"GNF-Pf-4251";"CCN1CCCC1CNc1ncnc2c1[nH]c1ccc(C)cc12";"IFI";"'='";"8.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL604529";"";"0";"548.04";"2";"5.05";"GNF-Pf-4053";"COC(=O)[C@@H]1C[C@H](NC(=O)c2[nH]c3ccc(Cl)cc3c2-c2ccccc2)CN1Cc1cc(OC)cc(OC)c1";"IFI";"'='";"1.77";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL601336";"";"0";"253.31";"0";"3.03";"GNF-Pf-1511";"Cc1cccc(-c2cc3nc(C)c(C)c(O)n3n2)c1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL586146";"";"0";"470.21";"0";"4.44";"GNF-Pf-1593";"CCCNc1nc(OC(C(F)(F)F)C(F)(F)F)nc(OC(C(F)(F)F)C(F)(F)F)n1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL604153";"";"0";"486.59";"1";"5.34";"GNF-Pf-1619";"Cc1ccc(CN2CCC(O)(c3ccc4oc(C(=O)NCCc5cccc(F)c5)cc4c3)CC2)cc1";"IFI";"'='";"3.03";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL528712";"";"0";"333.22";"1";"5.60";"GNF-Pf-1637";"COc1ccc2nc(C)cc(Nc3ccc(Cl)c(Cl)c3)c2c1";"IFI";"'='";"11.94";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600508";"";"0";"225.22";"0";"1.12";"GNF-Pf-1638";"COC(=O)C(C)NC(=O)c1ccc(F)cc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL576601";"";"0";"438.52";"0";"3.15";"GNF-Pf-1418";"COC(=O)[C@@H]1C[C@@H](NC(=O)c2ccc(OC)cc2OC)CN1C/C(C)=C/c1ccccc1";"IFI";"'='";"1.739";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL588622";"";"0";"365.46";"0";"2.36";"GNF-Pf-1445";"O=C1CC(=O)Nc2cc(S(=O)(=O)NC3CCCCCCC3)ccc2N1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL586075";"";"0";"323.35";"0";"3.78";"GNF-Pf-1456";"COc1cccc(OC)c1C(=O)Oc1cccc2ccc(C)nc12";"IFI";"'='";"1.389";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL602011";"";"0";"398.55";"0";"2.04";"GNF-Pf-1464";"CC1(C)CC(NC(=O)C(=O)NC2CC(C)(C)N(O)C(C)(C)C2)CC(C)(C)N1O";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL602834";"";"0";"537.70";"2";"7.93";"GNF-Pf-1492";"Cc1ccc(C(C(=O)NC(C)(C)C)N(C(=O)c2ccc(-c3ccccc3)[nH]2)c2ccc(C3CCCCC3)cc2)o1";"IFI";"'='";"3.158";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL577234";"";"0";"381.52";"0";"2.25";"GNF-Pf-1508";"CCOC(=O)N1CCN(C(=O)C(NC(=O)C2CCC(C)CC2)C(C)C)CC1";"IFI";"'='";"3.846";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585447";"";"0";"390.92";"0";"2.84";"GNF-Pf-1353";"CC(c1nc2ccc(Cl)cc2c(=O)n1C)N1CCN(C(=O)C(C)(C)C)CC1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL587536";"";"0";"343.77";"0";"3.58";"GNF-Pf-1781";"COc1cc(NC2=CC(=O)C(=O)c3ccccc32)c(OC)cc1Cl";"IFI";"'='";"13.51";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL588470";"";"0";"387.52";"1";"5.33";"GNF-Pf-1783";"CC(C)(C)c1ccc(CNC(=O)C(Cc2ccc(O)cc2)c2ccccc2)cc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL582657";"";"0";"455.39";"1";"6.92";"GNF-Pf-1791";"CCOc1ccc2nc(C)cc(Nc3ccc(OCc4ccccc4Cl)cc3)c2c1.Cl";"IFI";"'='";"2.381";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL578095";"";"0";"269.30";"0";"2.24";"GNF-Pf-1806";"COc1ccccc1C(=O)NN=C(C)c1cccnc1";"IFI";"'='";"0.7299";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600522";"";"0";"546.11";"2";"7.03";"GNF-Pf-1818";"CCCCCCN(C(=O)COCc1ccccc1)C(C)c1nc2ccccc2c(=O)n1-c1cccc(Cl)c1C";"IFI";"'='";"0.9346";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL577665";"";"0";"416.49";"0";"3.16";"GNF-Pf-1821";"CN(C)c1cccc(Nc2cc(-c3ccc(CC(N)C(=O)O)cc3)nc3ccnn23)c1";"IFI";"'='";"1.099";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL577231";"";"0";"283.42";"0";"3.75";"GNF-Pf-2897";"CCN1/C(=C/c2cccc[n+]2C)Sc2ccc(C)cc21";"IFI";"";"";"";"";"";"Not applicable";"";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL525840";"";"0";"492.00";"0";"4.80";"GNF-Pf-2898";"O=C(c1ccc(-n2c(SCc3ccc(Cl)cc3)nc3ccccc3c2=O)cc1)N1CCOCC1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL580172";"";"0";"373.34";"0";"4.25";"GNF-Pf-2919";"Brc1cccc(CNC2CCN(CCc3ccccc3)CC2)c1";"IFI";"'='";"2.362";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL495496";"";"0";"231.26";"0";"1.25";"GNF-Pf-3361";"COc1ccc2nc(NC(=N)N)nc(C)c2c1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL582275";"";"0";"502.59";"1";"4.65";"GNF-Pf-3370";"COc1ccccc1N1CCN(c2ccc(NC(=O)c3ccc(F)cc3)cc2C(=O)N2CCCC2)CC1";"IFI";"'='";"0.9174";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL581242";"";"0";"482.54";"1";"5.09";"GNF-Pf-3000";"CCc1ccccc1-n1c(C(C)N(C)C(=O)/C=C/c2ccc([N+](=O)[O-])cc2)nc2ccccc2c1=O";"IFI";"'='";"0.9259";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL597044";"";"0";"510.44";"1";"6.26";"GNF-Pf-3381";"CCN1C(=Cc2ccc3ccccc3[n+]2CC)C=Cc2sc3ccccc3c21.[I-]";"IFI";"'='";"31.43";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL582490";"";"0";"383.31";"0";"4.30";"GNF-Pf-3382";"[Br-].c1ccc(C[n+]2ccc(-c3nc4ccccc4s3)cc2)cc1";"IFI";"'='";"0.9709";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL582491";"";"0";"297.36";"0";"4.19";"GNF-Pf-3384";"CCN(CC)c1ccc(N=Cc2ccccc2[N+](=O)[O-])cc1";"IFI";"'='";"10.32";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL582492";"";"0";"489.73";"0";"3.68";"GNF-Pf-3385";"CCOc1ccc2[nH]c(=O)c(CN(CCN(CC)CC)C(=S)NCCCN(CC)CC)cc2c1";"IFI";"'='";"4.63";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL605334";"";"0";"406.53";"1";"6.42";"GNF-Pf-4018";"COc1ccc(C2N(Cc3ccccc3)c3ccccc3N2Cc2ccccc2)cc1";"IFI";"'='";"20.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600490";"";"0";"282.30";"0";"2.72";"GNF-Pf-4024";"COc1ccc(O)c(C=NNc2nc3ccccc3[nH]2)c1";"IFI";"'='";"8.333";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL609026";"";"0";"416.53";"0";"3.67";"GNF-Pf-4025";"CCn1c(SCc2ccc([N+](=O)[O-])cc2)nc2sc3c(c2c1=O)CCN(C)C3";"IFI";"'='";"4.167";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL7199";"";"0";"252.28";"0";"2.11";"GNF-Pf-4028";"Cc1ccc(C=NNc2ncnc3nc[nH]c23)cc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL599089";"";"0";"293.33";"0";"3.22";"GNF-Pf-4030";"COc1cccc(-c2cncc(-c3cncc(OC)c3)n2)c1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL611660";"";"0";"289.77";"0";"3.26";"GNF-Pf-4051";"Clc1nc(Nc2ccccc2)nc(N2CCCCC2)n1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL596850";"";"0";"583.37";"2";"6.01";"GNF-Pf-4052";"OC(CN1CCN(CC=Cc2ccccc2)CC1)Cn1c2ccc(Br)cc2c2cc(Br)ccc21";"IFI";"";"";"";"";"";"Not applicable";"";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL606160";"";"0";"432.31";"1";"6.22";"GNF-Pf-4288";"Cc1cc2cc(C3C(C#N)=C(N)Oc4c3ccc3ccccc43)c(Cl)nc2cc1Cl";"IFI";"'='";"5.102";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL428695";"";"0";"296.41";"0";"3.39";"GNF-Pf-4292";"CCC1CN2CCC1CC2C(O)c1ccnc2ccccc12";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585464";"";"0";"469.50";"0";"4.18";"GNF-Pf-4293";"COc1ccc(CCNC2(Cc3ccccc3)CC(C)N(C)CC2C)cc1OC.Cl.Cl";"IFI";"'='";"5.455";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585686";"";"0";"422.96";"0";"3.07";"GNF-Pf-4309";"CCCC(c1nnnn1C1CCCCC1)N1CCN(C(=O)c2ccco2)CC1.Cl";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585325";"";"0";"411.53";"0";"3.97";"GNF-Pf-4311";"CCc1noc(C)c1C(=O)NCCN1Cc2ccccc2OC(c2ccsc2)C1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL597254";"";"0";"288.73";"0";"3.58";"GNF-Pf-4315";"Cc1occc1C(=O)NN=C/C(Cl)=C/c1ccccc1";"IFI";"";"";"";"";"";"Not applicable";"";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL597454";"";"0";"268.74";"0";"2.85";"GNF-Pf-4330";"CC(=O)Nc1ccc(NC(=O)C(C)(C)CCl)cc1";"IFI";"'='";"2.532";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL597869";"";"0";"397.59";"1";"6.72";"GNF-Pf-4356";"Cc1cc2c(cc1C)N(C(=O)c1ccccc1)C(C)(C)c1ssc(=S)c1-2";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL606163";"";"0";"498.58";"0";"2.65";"GNF-Pf-4365";"CCOC(=O)C1CCN(C(c2cc3cc(OC)c(OC)cc3[nH]c2=O)c2nnnn2C(C)(C)C)CC1";"IFI";"'='";"5.208";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585649";"";"0";"435.35";"1";"6.73";"GNF-Pf-4367";"OC(CNc1cccc2ccccc12)Cn1c2ccc(Cl)cc2c2cc(Cl)ccc21";"IFI";"'='";"5.769";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL601825";"";"0";"319.43";"0";"3.52";"GNF-Pf-4376";"CCOc1ccc(CCNC(=O)c2cccs2)cc1OCC";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL529107";"";"0";"586.78";"2";"9.13";"GNF-Pf-4482";"CCC(c1nc2ccccc2c(=O)n1-c1cccc(C)c1)N(Cc1ccccc1)C(=O)Nc1c(C(C)C)cccc1C(C)C";"IFI";"'='";"5.376";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL596843";"";"0";"603.51";"2";"6.53";"GNF-Pf-4487";"S=P(OCC1C(COP(=S)(c2ccccc2)c2ccccc2)C1(Cl)Cl)(c1ccccc1)c1ccccc1";"IFI";"'='";"2.778";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL531043";"";"0";"393.45";"0";"3.41";"GNF-Pf-4395";"COCCCNc1nc2cc(OC)c(OC)cc2c2nc(-c3ccccc3)nn12";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL546747";"";"0";"343.34";"0";"3.38";"GNF-Pf-4493";"CCOc1ccc(-c2nonc2NC(=O)c2ccco2)cc1OCC";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL604305";"";"0";"467.95";"0";"4.89";"GNF-Pf-4496";"COC(=O)C1=C(C)NC2=C(C(=O)CC(c3ccccc3Cl)C2)C1c1ccc(OC)c(OC)c1";"IFI";"'='";"3.614";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL597656";"";"0";"342.40";"0";"4.24";"GNF-Pf-4403";"Cc1cccc(NC(c2ccncc2)c2ccc3cccnc3c2O)n1";"IFI";"'='";"7.143";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL599710";"";"0";"399.47";"0";"4.13";"GNF-Pf-4413";"Cc1cc(N2CCN(Cc3ccc(F)cc3)CC2)n2c(nc3ccccc32)c1C#N";"IFI";"'='";"1.176";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL596638";"";"0";"419.87";"0";"4.52";"GNF-Pf-4415";"COc1ccc(C(NC(=O)c2cccnc2)c2cc(Cl)c3cccnc3c2O)cc1";"IFI";"'='";"7.692";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL586028";"";"0";"349.46";"0";"2.80";"GNF-Pf-4515";"CCN1CC=C2C(C#N)=C(N)C(C#N)(C#N)[C@H](c3ccc(C)s3)[C@H]2C1";"IFI";"'='";"3.279";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL528000";"";"0";"232.34";"0";"-0.60";"GNF-Pf-4517";"CC(=NNC(N)=S)C(C)=NNC(N)=S";"IFI";"'='";"1.124";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL206540";"";"0";"245.28";"0";"2.68";"GNF-Pf-4421";"CCOC(=O)c1cnc2ccc(CC)cc2c1O";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL587779";"";"0";"450.95";"1";"5.82";"GNF-Pf-4426";"COc1cc(/C=C2/SC(=Nc3ccccc3)NC2=O)ccc1OCc1ccccc1Cl";"IFI";"";"";"";"";"";"Not applicable";"";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL530067";"";"0";"385.44";"0";"2.25";"GNF-Pf-4526";"CN(C)CCCn1c(N)c(-c2nc3ccccc3[nH]2)c2nc(C#N)c(C#N)nc21";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL596857";"";"0";"412.53";"0";"4.96";"GNF-Pf-4434";"C=C[C@H]1CN2CC[C@H]1C[C@@H]2[C@@H](OC(=O)Cc1ccccc1)c1ccnc2ccccc12";"IFI";"'='";"0.9346";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL601613";"";"0";"408.59";"0";"4.74";"GNF-Pf-4446";"Cc1cnc(C)c(-c2ccc(O)c(CNCC3(N4CCCCC4)CCCCC3)c2)n1";"IFI";"'='";"0.9709";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL602764";"";"0";"274.32";"0";"3.41";"GNF-Pf-4449";"CCCCOc1ccc(C(=O)Nc2cc(C)on2)cc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL601963";"";"0";"297.75";"0";"1.26";"GNF-Pf-4548";"COc1cc2nc(NC(=N)N)nc(C)c2cc1OC.Cl";"IFI";"'='";"3.15";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585308";"";"0";"429.56";"0";"3.42";"GNF-Pf-4458";"CCC1CCCCN1CCCNC(=O)c1cn(CC)c(=O)c2cc(OC)c(OC)cc12";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL583883";"";"0";"420.58";"0";"4.24";"GNF-Pf-4461";"O=C(c1ccc2nc(N3CCCCC3)sc2c1)N1CCN(Cc2ccccc2)CC1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL583806";"";"0";"457.54";"1";"6.59";"GNF-Pf-4559";"c1ccc(Cn2c(N=NNc3nc4ccccc4n3Cc3ccccc3)nc3ccccc32)cc1";"IFI";"'='";"6.034";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL584520";"";"0";"338.37";"0";"3.78";"GNF-Pf-4463";"O=C1Nc2ccccc2C12Nc1ccccc1-c1nc3ccccc3n12";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL583166";"";"0";"392.97";"0";"4.90";"GNF-Pf-4561";"CCCNC(=O)c1ccc(OC2CCN(CC3CCCCC3)CC2)c(Cl)c1";"IFI";"'='";"4.167";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL36654";"ROEMERINE";"0";"279.34";"0";"3.17";"GNF-Pf-4466";"CN1CCc2cc3c(c4c2C1Cc1ccccc1-4)OCO3";"IFI";"'='";"6.173";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL598883";"";"0";"283.76";"0";"0.88";"GNF-Pf-4467";"COc1cccc(N2C(N)=NC(N)=NC2(C)C)c1.Cl";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL601387";"";"0";"428.54";"0";"4.37";"GNF-Pf-4571";"COc1cccc(CCN2Cc3ccc(C(=O)NC(C)C)cc3N=C2c2cccnc2)c1";"IFI";"'='";"1.22";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585979";"";"0";"494.47";"1";"5.79";"GNF-Pf-4575";"OC(CN1CCN(CC=Cc2ccccc2)CC1)Cn1c2ccc(Cl)cc2c2cc(Cl)ccc21";"IFI";"";"";"";"";"";"Not applicable";"";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL524973";"";"0";"341.44";"1";"5.94";"GNF-Pf-4583";"OC1=C2C(=Nc3ccccc3SC2c2ccccc2)c2ccccc21";"IFI";"'='";"2.247";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL577362";"";"0";"468.60";"0";"4.36";"GNF-Pf-2800";"CCOc1ccc2[nH]c(=O)c(CN(CCN3CCCC3)C(=S)Nc3ccc(F)cc3)cc2c1";"IFI";"'='";"3.361";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600131";"";"0";"409.90";"0";"4.72";"GNF-Pf-2843";"Cc1c(C(=O)Nc2ccccc2)sc2ncn(Cc3ccccc3Cl)c(=O)c12";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL576788";"";"0";"490.56";"0";"4.02";"GNF-Pf-2881";"COc1ccc(-c2cc(C3CCN(c4nc(N)c5cc(OC)c(OC)cc5n4)CC3)n[nH]2)cc1OC";"IFI";"'='";"7.407";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585136";"";"0";"344.39";"1";"5.12";"GNF-Pf-4243";"Fc1ccc(Nc2nc(NCc3ccccc3)c3ccccc3n2)cc1";"IFI";"'='";"9.524";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL599503";"";"0";"382.30";"0";"4.39";"GNF-Pf-4264";"Cc1ccc[n+](C(C)C(=O)c2ccc(-c3ccccc3)cc2)c1.[Br-]";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL598895";"";"0";"358.40";"0";"4.54";"GNF-Pf-4266";"O=C(Nc1ccccc1[N+](=O)[O-])C1CC1(c1ccccc1)c1ccccc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL599094";"";"0";"411.33";"0";"4.00";"GNF-Pf-4268";"Cc1nc(Nc2cccc([N+](=O)[O-])c2)nc(Nc2cccc([N+](=O)[O-])c2)c1[N+](=O)[O-]";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL598277";"";"0";"398.46";"0";"4.15";"GNF-Pf-4274";"CC1=C(C(=O)OC(C)C)C(c2ccc([N+](=O)[O-])cc2)C2=C(CC(C)(C)CC2=O)N1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL583556";"";"0";"432.59";"1";"5.89";"GNF-Pf-4863";"CCc1ccccc1NC(=O)C1c2ccccc2C(=O)N(CC(C)C)C1c1cccs1";"IFI";"'='";"3.03";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL604565";"";"0";"374.44";"0";"3.73";"GNF-Pf-4868";"CC(=O)N(C1=C(N2CCCC2)C(=O)c2ccccc2C1=O)c1ccccc1C";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585437";"";"0";"375.47";"0";"4.48";"GNF-Pf-4870";"Oc1ccc(-c2ccc3c(c2)OCO3)cc1CNCC1CC2C=CC1C21CC1";"IFI";"'='";"1.709";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585631";"";"0";"355.31";"0";"1.98";"GNF-Pf-4879";"N=C(NN=Cc1ccc([N+](=O)[O-])cc1)NN=Cc1ccc([N+](=O)[O-])cc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL601752";"";"0";"562.65";"1";"4.80";"GNF-Pf-4880";"CCOC(=O)C1=C(c2ccccc2)N=c2sc(=Cc3ccccc3O)c(=O)n2C1c1c(OC)ccc2ccccc12";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL601395";"";"0";"457.84";"0";"1.54";"GNF-Pf-4886";"O=C(CS(=O)(=O)c1ccc(C(F)(F)F)cn1)NNS(=O)(=O)c1ccc(Cl)cc1";"IFI";"'='";"0.9091";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585412";"";"0";"480.66";"0";"3.72";"GNF-Pf-4913";"CC1CCCCN1CCCNc1ncc(C(=O)NCC2CCCO2)c(NCCc2ccccc2)n1";"IFI";"'='";"2.885";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL602432";"";"0";"449.33";"0";"3.64";"GNF-Pf-4947";"COc1cc(OC)cc(C(=O)NCc2n[nH]c(=S)n2-c2ccc(Br)cc2)c1";"IFI";"'='";"2.299";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585826";"";"0";"393.92";"0";"4.44";"GNF-Pf-4965";"Oc1ccc(-c2ccnc3cc(Cl)ccc23)cc1CNC1CN2CCC1CC2";"IFI";"'='";"0.8547";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL582177";"";"0";"314.82";"0";"3.90";"GNF-Pf-4978";"Cc1cc(NCCc2ccccc2)nc2cc(O)ccc12.Cl";"IFI";"'='";"2.273";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL527141";"";"0";"556.10";"2";"5.96";"GNF-Pf-4980";"Cc1nn(CC(O)Cn2c3ccc(Br)cc3c3cc(Br)ccc32)c(C)c1Br";"IFI";"'='";"3.488";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL598894";"";"0";"443.60";"0";"4.59";"GNF-Pf-4193";"Cc1ccccc1-c1cccc(CN2CCCCC2CCn2cc(C(=O)NC3CC3)nn2)c1";"IFI";"'='";"1.942";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL601113";"";"0";"548.69";"2";"8.29";"GNF-Pf-4194";"Cc1ccc(-n2c(-c3ccccc3)cc(C=NNC(=O)c3cccc(-n4c(C)ccc4C)c3)c2-c2ccccc2)cc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL599952";"";"0";"403.35";"0";"3.94";"GNF-Pf-5004";"CCOc1ccc(-c2c[n+](-c3ccccc3)c3n2CCS3)cc1.[Br-]";"IFI";"'='";"7.692";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL1989853";"";"0";"348.40";"0";"4.07";"GNF-Pf-5007";"O=C1/C(=N\c2cccc(O)c2)C(N2CCCCC2)=C(O)c2ccccc21";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL586188";"";"0";"311.35";"0";"2.51";"GNF-Pf-5024";"CCc1nc2nc(C)cc(Nc3ccc4c(c3)OCCO4)n2n1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585786";"";"0";"373.50";"0";"3.95";"GNF-Pf-5063";"CCOC(=O)c1cnc2ccc(OCC)cc2c1NCCCN(CC)CC";"IFI";"'='";"8.333";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL484307";"";"0";"380.40";"0";"3.01";"GNF-Pf-5072";"COc1cc(Nc2cncc(-c3ccc(C(N)=O)cc3)n2)cc(OC)c1OC";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL601604";"";"0";"557.33";"2";"5.50";"GNF-Pf-5075";"OC(CN1CCN(Cc2ccccc2)CC1)Cn1c2ccc(Br)cc2c2cc(Br)ccc21";"IFI";"'='";"4.082";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL527796";"";"0";"230.27";"0";"1.89";"GNF-Pf-4609";"O=C(N1CCCCC1)n1nnc2ccccc21";"IFI";"'='";"3.333";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL597245";"";"0";"304.40";"0";"1.53";"GNF-Pf-4096";"CCC(=O)NNc1cc(N2CCCC2)nc(N2CCCC2)n1";"IFI";"'='";"4.444";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600901";"";"0";"272.32";"0";"3.84";"GNF-Pf-4099";"Cc1oc(C)c2c(=O)cc(-c3cccs3)cc(O)c12";"IFI";"'='";"2.752";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL596634";"";"0";"433.60";"1";"6.64";"GNF-Pf-4101";"Cc1ccn2c(NC(C)(C)CC(C)(C)C)c(-c3ccccc3OC(=O)C3CCC3)nc2c1";"IFI";"'='";"2.804";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL526199";"";"0";"426.54";"0";"3.48";"GNF-Pf-4109";"Cc1ccc(NC(C)C(=O)Nc2ccc(C#N)cc2)cc1S(=O)(=O)N1CCCCC1";"IFI";"'='";"6.25";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL597463";"";"0";"374.46";"0";"3.38";"GNF-Pf-4116";"CCOC(=O)c1c(N=Cc2cccc(OC)c2O)sc2c1CCN(C)C2";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL599718";"";"0";"355.44";"0";"2.64";"GNF-Pf-4127";"CCOc1ccc2[nH]c3c(NCCCN4CCOCC4)ncnc3c2c1";"IFI";"'='";"4.762";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585392";"";"0";"577.70";"1";"4.69";"GNF-Pf-2628";"COc1ccc(CN(Cc2cc3cc(OC)c(OC)cc3[nH]c2=O)C(=S)NCCc2ccc(OC)c(OC)c2)cc1";"IFI";"'='";"5.405";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL578295";"";"0";"500.54";"1";"4.61";"GNF-Pf-2636";"CCN(CCN1CCN(S(=O)(=O)c2cc(Cl)ccc2Cl)CC1)CC1=CCC2CC1C2(C)C";"IFI";"'='";"1.852";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL602603";"";"0";"524.04";"2";"5.56";"GNF-Pf-2651";"COc1ccc(CCN2C(=O)CC(C(=O)Nc3cccc(Cl)c3)SC2=Nc2ccccc2)cc1OC";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL576770";"";"0";"440.49";"0";"4.57";"GNF-Pf-2695";"COc1cc(C=C2CCC(=Cc3cc(OC)c(OC)c(OC)c3)C2=O)cc(OC)c1OC";"IFI";"";"";"";"";"";"Not applicable";"";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL578720";"";"0";"405.34";"0";"3.30";"GNF-Pf-2715";"CCOc1ccc(C(=O)C[N+]2=C(CC)c3ccc(C)n3CC2)cc1.[Br-]";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL579151";"";"0";"449.56";"1";"5.03";"GNF-Pf-2729";"COc1ccc2c(c1)[nH]c1c(N3CCN(C(c4ccccc4)c4ccccc4)CC3)ncnc12";"IFI";"'='";"8.772";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL610251";"";"0";"351.79";"0";"3.79";"GNF-Pf-2132";"C[n+]1cc(-c2ccc3cccc([N+](=O)[O-])c3n2)cc2ccccc21.[Cl-]";"IFI";"'='";"15.38";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL586078";"";"0";"420.56";"1";"6.03";"GNF-Pf-1529";"Cc1ccccc1OCCSc1nc2ccc(NC(=O)c3ccccc3)cc2s1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL582664";"";"0";"489.57";"1";"6.44";"GNF-Pf-1538";"COc1cc(NC(C)CCCN(Cc2ccc(F)cc2)C(=O)c2ccccc2F)c2ncccc2c1";"IFI";"'='";"2.151";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL581655";"";"0";"411.51";"0";"3.95";"GNF-Pf-3058";"CN(C)S(=O)(=O)c1ccc(C(=O)Nc2nc3c(ccc4ccccc43)s2)cc1";"IFI";"'='";"4.545";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL581449";"";"0";"283.33";"0";"2.91";"GNF-Pf-3060";"CCCc1ccc(C(=O)NC(=O)c2ccccc2O)cc1";"IFI";"'='";"6.107";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL581455";"";"0";"419.93";"0";"4.02";"GNF-Pf-3066";"COc1ccc(S(=O)(=O)N(C)CCCNc2ccnc3cc(Cl)ccc23)cc1";"IFI";"'='";"10.19";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL604562";"";"0";"474.61";"0";"4.42";"GNF-Pf-3075";"CCOC(=O)c1cc(-c2ccccc2)n(CCC(=O)Nc2ccccc2N2CCN(C)CC2)c1C";"IFI";"'='";"2.941";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL582303";"";"0";"404.25";"0";"4.43";"GNF-Pf-3088";"CC(=O)c1ccc(-n2cc(C(=O)C(C)Oc3ccc(Cl)cc3Cl)nn2)cc1";"IFI";"'='";"1.299";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL582096";"";"0";"368.48";"0";"3.67";"GNF-Pf-3095";"CCOC(=O)C1=C(CC)NC2=C(C(=O)CCC2)C1c1ccc(N(C)C)cc1";"IFI";"'='";"1.429";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL582470";"";"0";"343.22";"1";"5.06";"GNF-Pf-3114";"COc1ccc2nc(C)cc(Nc3ccc(Br)cc3)c2c1";"IFI";"'='";"3.03";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL534295";"";"0";"580.68";"2";"7.12";"GNF-Pf-3137";"O=S(=O)(Oc1ccc2ccccc2c1Cc1c(OS(=O)(=O)c2ccccc2)ccc2ccccc12)c1ccccc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL580188";"";"0";"382.25";"1";"5.79";"GNF-Pf-3147";"O=C(Nc1ccc(-c2nc3ccccc3[nH]2)cc1)c1ccc(Cl)c(Cl)c1";"IFI";"'='";"6.818";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL582507";"";"0";"316.32";"0";"2.46";"GNF-Pf-3149";"O=C(Nc1cnc2ccccc2c1)c1cccc(-n2cnnn2)c1";"IFI";"'='";"7.207";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL582517";"";"0";"422.28";"1";"5.01";"GNF-Pf-3166";"Oc1ccc(Br)c(C(Nc2ccccn2)c2ccc3cccnc3c2O)c1";"IFI";"'='";"12.5";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL604977";"";"0";"366.59";"1";"5.38";"GNF-Pf-3173";"CC(Cc1ccccc1)NCCCCCCCNC(C)Cc1ccccc1";"IFI";"'='";"1.852";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL604775";"";"0";"328.45";"1";"5.14";"GNF-Pf-3215";"CCCCCCCc1cc(O)c2c3c(c(=O)oc2c1)CCC(C)C3";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL581670";"";"0";"323.85";"0";"4.40";"GNF-Pf-3219";"Cc1ccccc1C[n+]1cc(-c2ccc(Cl)cc2)n2c1CCC2";"IFI";"'='";"7.143";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL602420";"";"0";"403.23";"0";"3.06";"GNF-Pf-3225";"COc1ccccc1N(CN1C(=O)c2ccc(Br)cc2C1=O)C(C)=O";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL582305";"";"0";"296.37";"0";"2.17";"GNF-Pf-3229";"O=c1cccc2n1CC1CC2CN(Cc2cccc(O)c2)C1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL582509";"";"0";"383.86";"0";"2.37";"GNF-Pf-3232";"COC(=O)NCCNC(=O)COC(c1cccs1)c1cccnc1Cl";"IFI";"'='";"1.942";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL581680";"";"0";"384.47";"0";"2.62";"GNF-Pf-3234";"CCC(C)N1CCN(Cc2cccc(OC)c2OC)CC1.O=CO.O=CO";"IFI";"'='";"3.175";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL579498";"";"0";"267.34";"0";"3.10";"GNF-Pf-4644";"Cc1cc(Nc2ccc(C)c(C)c2)n2nc(C)nc2n1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL603021";"";"0";"362.86";"1";"5.51";"GNF-Pf-3252";"Clc1ccc(OCc2nc3ccccc3n2CCc2ccccc2)cc1";"IFI";"'='";"6.25";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL601369";"";"0";"351.56";"1";"6.58";"GNF-Pf-3258";"CC(C)(C)c1ccc(-c2nc(C34CC5CC(CC(C5)C3)C4)cs2)cc1";"IFI";"'='";"1.099";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL581860";"";"0";"349.22";"0";"4.08";"GNF-Pf-3259";"OCCNc1nc(Nc2ccc(Cl)c(Cl)c2)nc2ccccc12";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL603022";"";"0";"433.60";"0";"4.77";"GNF-Pf-3260";"CSc1nc2sc3c(c2c(=O)n1-c1ccccc1)CCN(CCc1ccccc1)C3";"IFI";"'='";"9.804";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL582076";"";"0";"437.52";"0";"3.37";"GNF-Pf-3269";"COC(=O)c1ccc(S(=O)(=O)N2CCC3(CC2)Nc2ccccc2-n2cccc23)cc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL582080";"";"0";"263.34";"0";"3.27";"GNF-Pf-3275";"NCCNc1cc(-c2ccccc2)nc2ccccc12";"IFI";"'='";"4.425";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL584453";"";"0";"408.33";"1";"5.30";"GNF-Pf-4681";"CCCCOC(=O)C1=C(C)NC2=C(C(=O)CCC2)C1c1ccc(Cl)c(Cl)c1";"IFI";"'='";"2.299";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL581879";"";"0";"318.38";"0";"3.77";"GNF-Pf-3284";"COc1ccc(CCNc2ncnc3c2[nH]c2ccccc23)cc1";"IFI";"'='";"13.73";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL604362";"";"0";"456.58";"1";"6.47";"GNF-Pf-4704";"CCC(Oc1ccc(C(C)(C)CC)cc1C(C)(C)CC)C(=O)Nc1ccc([N+](=O)[O-])cc1O";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585802";"";"0";"540.45";"2";"5.78";"GNF-Pf-4709";"CCCOC(=O)C1=C(C)NC2=C(C(=O)CC(c3ccc(OC)c(OC)c3)C2)C1c1cccc(Br)c1";"IFI";"'='";"8.861";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600149";"";"0";"445.56";"1";"6.75";"GNF-Pf-4716";"Cc1ccn2c(NC(C)(C)CC(C)(C)C)c(-c3ccccc3OC(=O)c3ccco3)nc2c1";"IFI";"'='";"3.738";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL193528";"";"0";"366.51";"0";"4.40";"GNF-Pf-4717";"CC[n+]1c(/C=C/c2ccc(N(C)C)cc2)sc2cc(NC(C)=O)ccc21";"IFI";"";"";"";"";"";"Not applicable";"";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL528586";"";"0";"419.93";"1";"5.32";"GNF-Pf-4719";"CCOC(=O)c1c(CSc2ccccc2)oc2cc(CN(C)C)c(O)c(Cl)c12";"IFI";"'='";"4.615";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL582074";"";"0";"405.50";"0";"4.72";"GNF-Pf-3305";"CCC(C)C(=O)N1CCC(C(=O)Nc2ccc(-c3nc4ccccc4o3)cc2)CC1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL2021449";"";"0";"336.44";"0";"3.74";"GNF-Pf-3318";"C=C[C@H]1CN2CC[C@H]1C[C@@H]2[C@@H](OC(C)=O)c1ccnc2ccccc12";"IFI";"'='";"1.835";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL602631";"";"0";"386.32";"0";"2.38";"GNF-Pf-4762";"COc1ccc(-n2nc([N+](=O)[O-])c(Nc3ccc([N+](=O)[O-])cc3C)[n+]2[O-])cc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600924";"";"0";"563.74";"2";"8.47";"GNF-Pf-3389";"Cc1ccc(C(C(=O)NC2CCCCC2)N(C(=O)c2ccc(-c3ccccc3)[nH]2)c2ccc(C3CCCCC3)cc2)o1";"IFI";"'='";"3.704";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL602004";"";"0";"454.97";"1";"6.67";"GNF-Pf-3340";"COc1cc(CNc2ccc(N3CCCCC3)cc2)cc(Cl)c1OCc1ccc(F)cc1";"IFI";"'='";"5.556";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL546895";"";"0";"432.85";"1";"5.05";"GNF-Pf-3367";"CC(C)OC(=O)c1cccnc1SCC(=O)Nc1ccc(C(F)(F)F)cc1Cl";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600139";"";"0";"392.46";"0";"-0.10";"GNF-Pf-451";"O=C(NCCCN1CCCC1=O)C(=O)NCC(c1ccco1)N1CCOCC1";"IFI";"'='";"2.222";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL602209";"";"0";"393.91";"1";"6.27";"GNF-Pf-3403";"COc1ccc(C)cc1-n1c(-c2ccc(Cl)cc2)cc2c1CC(C)(C)CC2=O";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL602990";"";"0";"284.27";"0";"2.54";"GNF-Pf-3407";"CCOC(=O)c1c(C)oc2c1C(=O)c1ccccc1C2=O";"IFI";"'='";"3.175";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL601600";"";"0";"559.44";"1";"3.28";"GNF-Pf-4017";"CCOC(=O)C1=C(C)N=c2sc(=Cc3cc(Br)ccc3O)c(=O)n2C1c1ccc(OC)c(OC)c1";"IFI";"'='";"2.469";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL578715";"";"0";"449.60";"0";"4.74";"GNF-Pf-2781";"COc1ccc(-n2c(SC)nc3sc4c(c3c2=O)CCN(Cc2ccccc2)C4)cc1";"IFI";"'='";"7.407";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600318";"";"0";"509.47";"1";"4.79";"GNF-Pf-2813";"CCOc1ccccc1C(=O)NC(Nc1sc2c(c1C(N)=O)CCCC2)(C(F)(F)F)C(F)(F)F";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL578245";"";"0";"540.06";"1";"3.26";"GNF-Pf-2828";"COc1ccc(-n2nc(C(=O)NCC(=O)NCCCN3CC(C)CC(C)C3)c3ccccc3c2=O)cc1Cl";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL578680";"";"0";"478.59";"0";"3.50";"GNF-Pf-2836";"COc1cc(OC)cc(-n2nc(C(=O)NCCCN3CC(C)CC(C)C3)c3ccccc3c2=O)c1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL576793";"";"0";"308.30";"0";"3.70";"GNF-Pf-2890";"O=[N+]([O-])c1ccc(-c2ccc(C=NNc3ccccn3)o2)cc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL576723";"";"0";"384.41";"0";"3.49";"GNF-Pf-2896";"COc1ccc(C=C2SC(=N)N(c3ccc4c(c3)OCO4)C2=O)cc1OC";"IFI";"";"";"";"";"";"Not applicable";"";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL373292";"";"0";"390.53";"1";"5.06";"GNF-Pf-2913";"CCN1/C(=C/c2sc3ccccc3[n+]2CC)C=Cc2cc(NC(C)=O)ccc21";"IFI";"'='";"7.692";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL578677";"";"0";"325.86";"0";"5.00";"GNF-Pf-2940";"CN(/C=C/C1=[N+](C)c2ccc(Cl)cc2C1(C)C)c1ccccc1";"IFI";"";"";"";"";"";"Not applicable";"";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL602205";"";"0";"409.44";"0";"3.63";"GNF-Pf-2949";"Cc1ccccc1N1C(=O)C2C3c4ccccc4C(C(=O)O)(c4ccccc43)C2C1=O";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL605611";"";"0";"439.56";"0";"4.32";"GNF-Pf-2957";"Cc1ccccc1Cn1c(N2CCC(C(=O)NCc3ccccn3)CC2)nc2ccccc21";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600946";"";"0";"393.53";"1";"5.94";"GNF-Pf-2980";"CCC(=O)Oc1ccccc1-c1nc2ccccn2c1NC(C)(C)CC(C)(C)C";"IFI";"'='";"2.83";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL580381";"";"0";"279.34";"0";"3.29";"GNF-Pf-2991";"Cc1ccc(-c2cc3nc4c(c(O)n3n2)CCCC4)cc1";"IFI";"'='";"7.143";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600720";"";"0";"307.53";"0";"3.34";"GNF-Pf-2996";"CC(C)=CCCC(C)=CCCC(C)NCCN1CCNCC1";"IFI";"";"";"";"";"";"Not applicable";"";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585275";"";"0";"299.37";"0";"3.79";"GNF-Pf-4147";"CCCCOc1ccc(C=CC(=O)NCc2ccco2)cc1";"IFI";"";"";"";"";"";"Not applicable";"";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL578530";"";"0";"292.33";"0";"2.53";"GNF-Pf-5378";"C[C@@H]1CCC[C@@H](C[C@H]2Cc3cc(O)cc(O)c3C(=O)O2)O1";"IFI";"'='";"1.786";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL587826";"";"0";"341.28";"0";"3.44";"GNF-Pf-5403";"Cl.Cl.Oc1ccc(CN2CCCCC2)nc1-c1ccccc1";"IFI";"'='";"3.03";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL599921";"";"0";"404.39";"0";"4.07";"GNF-Pf-5452";"COC(=O)C1=C(C)NC(=Cc2cc(C)n(-c3ccccc3C(F)(F)F)c2C)C1=O";"IFI";"";"";"";"";"";"Not applicable";"";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL1294";"QUINIDINE";"4";"324.42";"0";"3.17";"GNF-Pf-5459";"C=C[C@H]1CN2CC[C@H]1C[C@@H]2[C@@H](O)c1ccnc2ccc(OC)cc12";"IFI";"'='";"1.667";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL588921";"";"0";"373.88";"0";"4.51";"GNF-Pf-5470";"CCOC(=O)C1=C(C)NC2=C(C(=O)CC(C)(C)C2)C1c1ccc(Cl)cc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL586563";"";"0";"259.39";"0";"3.70";"GNF-Pf-5474";"CC1(C)C2CCC1(C)C(NCc1ccccc1O)C2";"IFI";"'='";"1.493";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL588136";"";"0";"492.53";"0";"4.54";"GNF-Pf-5482";"CCOC(=O)C1=C(C)NC2=C(C(=O)CC(c3ccc(OC)c(OC)c3)C2)C1c1ccc([N+](=O)[O-])cc1";"IFI";"'='";"2.381";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL252518";"ARTENIMOL";"4";"284.35";"0";"2.19";"2, DHA";"C[C@@H]1CC[C@H]2[C@@H](C)[C@@H](O)O[C@@H]3O[C@]4(C)CC[C@@H]1[C@@]23OO4";"IFI";"";"";"";"";"";"Not applicable";"";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL582513";"";"0";"375.47";"0";"3.54";"GNF-Pf-322";"COc1ccc(C(=O)/C(C#N)=C/NC2CCN(Cc3ccccc3)CC2)cc1";"IFI";"'='";"3.333";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600146";"";"0";"431.29";"0";"4.90";"GNF-Pf-324";"COc1c([N+](=O)[O-])cc2c(c1Br)OC1(C=C2)N(C)c2ccccc2C1(C)C";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL581896";"";"0";"452.65";"0";"4.19";"GNF-Pf-325";"CC(C)CNC(=O)c1cnc(NCCCN2CCCCC2C)nc1NCCc1ccccc1";"IFI";"'='";"3.738";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL581653";"";"0";"386.50";"0";"4.24";"GNF-Pf-340";"O=C(Nc1ccc(-n2cccn2)cc1)C1CCN(C/C=C/c2ccccc2)CC1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL581663";"";"0";"429.61";"1";"6.22";"GNF-Pf-350";"C=CCNC(=O)c1ccc2c(c1)N=C(CC(C)c1ccccc1)N(CC1CCCCC1)C2";"IFI";"'='";"2.5";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL534566";"";"0";"733.23";"2";"8.75";"GNF-Pf-360";"O=C(Cc1ccccc1)Nc1ccc(C(=O)Nc2ccc(-c3nc4ccc(NC(=O)c5ccc(NC(=O)Cc6ccccc6)cc5)c(Cl)c4[nH]3)cc2)cc1";"IFI";"'='";"7.576";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL580155";"";"0";"384.53";"1";"5.61";"GNF-Pf-372";"COc1cccc(-n2sc3c(c2=S)-c2cc(OC)ccc2NC3(C)C)c1";"IFI";"'='";"3.676";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL602993";"";"0";"340.22";"0";"4.53";"GNF-Pf-375";"O=C(NCc1ccccc1)c1cccc2c(Br)cccc12";"IFI";"'='";"3.922";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL582064";"";"0";"264.11";"0";"3.93";"GNF-Pf-380";"Clc1ccc(-c2nc3cc(Cl)cnc3[nH]2)cc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL581863";"";"0";"286.29";"0";"1.87";"GNF-Pf-384";"COc1cccc(C=NNC(=O)c2ccccc2O)c1O";"IFI";"'='";"7.692";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL582110";"";"0";"356.47";"0";"3.92";"GNF-Pf-482";"CCCN1CCC(NC2CCCc3c2[nH]c2ccc([N+](=O)[O-])cc32)CC1";"IFI";"'='";"8.333";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL580840";"";"0";"294.35";"0";"2.39";"GNF-Pf-488";"Cc1ccc(OCCCCN2CCOCC2)c([N+](=O)[O-])c1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL579142";"";"0";"348.36";"0";"2.95";"GNF-Pf-2717";"COC(=O)c1c(N)n(-c2ccccc2OC)c2nc3ccccc3nc12";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL602579";"";"0";"326.50";"0";"4.83";"GNF-Pf-2719";"Cc1ccc(C(OCC(C)(C)C[N+](C)(C)C)c2ccccc2)cc1";"IFI";"'='";"2.222";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL536904";"";"0";"295.34";"0";"3.82";"GNF-Pf-2735";"CCOC(=O)c1c(C)n(-c2ccccc2)c2ccc(O)cc12";"IFI";"'='";"2.542";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600731";"";"0";"316.28";"0";"2.91";"GNF-Pf-2760";"Cc1cc(NCCCN(C)C)c2ccccc2n1.Cl.Cl";"IFI";"'='";"7.692";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL577574";"";"0";"351.43";"0";"4.43";"GNF-Pf-2801";"COc1ccccc1C=CC1=NC(=Cc2ccc(SC)cc2)C(=O)O1";"IFI";"";"";"";"";"";"Not applicable";"";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585656";"";"0";"442.49";"0";"4.30";"GNF-Pf-4300";"CC(=O)N(Cc1ccc(F)cc1)C1=C(NCCc2ccccc2)C(=O)c2ccccc2C1=O";"IFI";"'='";"8.333";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585657";"";"0";"360.44";"0";"2.82";"GNF-Pf-4302";"O=C(Nc1ccc(O)cc1)c1cccc(S(=O)(=O)N2CCCCC2)c1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL599505";"";"0";"340.34";"0";"1.65";"GNF-Pf-4340";"CCNc1nc(OC)nc(Oc2ccc(=O)n(-c3ccccc3)n2)n1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL598487";"";"0";"287.75";"0";"4.00";"GNF-Pf-4349";"COc1ccc(NC(=O)C=Cc2ccccc2Cl)cc1";"IFI";"";"";"";"";"";"Not applicable";"";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL604720";"";"0";"324.34";"0";"1.80";"GNF-Pf-4477";"O=c1[nH]n(CC2COC(c3ccccc3)O2)c(=O)c2ccccc12";"IFI";"'='";"1.163";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL606165";"";"0";"496.43";"1";"6.84";"GNF-Pf-4479";"CC1=C(C(=O)OC2CCCC2)C(c2ccc(Cl)cc2)C2=C(CC(c3ccc(Cl)cc3)CC2=O)N1";"IFI";"'='";"4.651";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL1744511";"";"0";"362.50";"1";"5.62";"GNF-Pf-4393";"O=C1/C(=C\c2ccccc2)SC(=Nc2ccccc2)N1C1CCCCC1";"IFI";"";"";"";"";"";"Not applicable";"";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL597655";"";"0";"436.48";"0";"3.41";"GNF-Pf-4400";"COC(=O)c1c(OCc2ccc(F)cc2)cc(=O)n2c1CCN(Cc1ccccc1)CC2";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL599299";"";"0";"267.37";"0";"3.88";"GNF-Pf-4417";"O=C(/C=C/c1cccnc1)C12CC3CC(CC(C3)C1)C2";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL596858";"";"0";"484.62";"1";"6.11";"GNF-Pf-4435";"O=C(C1CCC1)N1CCOc2c(cc(-c3csc4ccccc34)cc2OCCc2ccccn2)C1";"IFI";"'='";"2.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585234";"";"0";"404.88";"0";"3.53";"GNF-Pf-4534";"COc1cc(OC)cc(C(=O)NCc2n[nH]c(=S)n2-c2cccc(Cl)c2)c1";"IFI";"'='";"1.149";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL529555";"";"0";"312.44";"0";"4.51";"GNF-Pf-4452";"CC(C)N(C)Cc1cc(-c2nc3ccccc3s2)ccc1O";"IFI";"'='";"8.036";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL598475";"";"0";"430.51";"0";"3.88";"GNF-Pf-4470";"Cc1cc(C)n(-c2ccc(NC(=O)C3CCN(Cc4ccc5nonc5c4)CC3)cc2)n1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL547947";"";"0";"429.01";"0";"4.08";"GNF-Pf-2818";"Cc1c(CN2CCC(N3CCC(C(=O)NC4CC4)CC3)CC2)[nH]c2c(Cl)cccc12";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL578907";"";"0";"303.43";"0";"4.05";"GNF-Pf-2851";"Cc1ccc(-c2c[n+](Cc3cccc(C)c3)c3n2CCC3)cc1";"IFI";"'='";"7.317";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL576362";"";"0";"429.50";"1";"5.17";"GNF-Pf-2853";"O=C1CC(c2nc3ccccc3n2CCCOc2ccccc2)CN1c1ccc(F)cc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL578068";"";"0";"311.39";"0";"2.93";"GNF-Pf-2858";"Cc1nc(NN=Cc2ccccc2O)cc(N2CCCCC2)n1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL578931";"";"0";"497.29";"1";"6.70";"GNF-Pf-2872";"CCCCCCCCCC[n+]1c(C)n(CC)c2cc(Cl)c(Cl)cc21.[I-]";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL601134";"";"0";"340.25";"0";"3.95";"GNF-Pf-2877";"CC(C)CC(=O)Nc1nnc(-c2ccc(Br)cc2)s1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL602588";"";"0";"237.30";"0";"3.17";"GNF-Pf-2910";"OCCc1cn(-c2ccccc2)c2ccccc12";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL579977";"";"0";"519.50";"2";"5.67";"GNF-Pf-2928";"CC1CN(C(=O)CCCSc2nnc(Cc3ccccc3)n2-c2ccc(Cl)c(Cl)c2)CC(C)O1";"IFI";"'='";"2.727";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600136";"";"0";"278.36";"0";"3.54";"GNF-Pf-2934";"CCN(CC)c1nc(-c2cccnc2)nc2ccccc12";"IFI";"'='";"0.7519";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL603028";"";"0";"371.40";"0";"1.60";"GNF-Pf-2937";"CCOC(=O)c1nnn(-c2nonc2-n2cccc2)c1CN1CCCCC1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL582104";"";"0";"351.43";"0";"2.30";"GNF-Pf-2962";"Cn1c(SCC(=O)Nc2cccc(F)c2)nc2c(c1=O)SCC2";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL582473";"";"0";"419.53";"0";"4.34";"GNF-Pf-2968";"CCOc1ccccc1NC(=O)Nc1ccc2nc(N3CCN(C)CC3)cc(C)c2c1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL582474";"";"0";"440.67";"0";"2.13";"GNF-Pf-2969";"C[n+]1cccc(CNC2=C(Cl)C(=O)c3ccccc3C2=O)c1.[I-]";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL601341";"";"0";"264.59";"0";"3.17";"GNF-Pf-2973";"O=c1cc(C(F)(F)F)c2cc(Cl)c(O)cc2o1";"IFI";"'='";"3.604";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL579956";"";"0";"323.89";"0";"4.04";"GNF-Pf-2976";"CC(Cc1ccccc1Sc1ccccc1O)N(C)C.Cl";"IFI";"'='";"7.143";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL580164";"";"0";"500.54";"1";"2.09";"GNF-Pf-2981";"CC1=CC(=O)OC[C@]23C[C@H](O)C(C)=C[C@H]2O[C@@H]2C[C@@H](OC(=O)C=CC=CC(=O)OCC1)[C@@]3(C)[C@]21CO1";"IFI";"'='";"22.64";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600112";"";"0";"270.28";"0";"3.08";"GNF-Pf-2983";"CCOC(=O)c1cccc(OC(=O)c2ccccc2)c1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL601159";"";"0";"409.96";"1";"5.81";"GNF-Pf-2988";"CC(C)(C)c1ccc(C(=O)NCCCCNc2ccnc3cc(Cl)ccc23)cc1";"IFI";"'='";"3.191";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL599722";"";"0";"365.50";"0";"1.64";"GNF-Pf-4212";"CC(NC(=O)C(=O)N1CCCCC1)C(c1cccs1)N1CCOCC1";"IFI";"'='";"1.408";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585470";"";"0";"467.92";"0";"3.37";"GNF-Pf-4230";"CN1CCN(c2nc(NN=Cc3cccc(Cl)c3)nc(Nc3ccc([N+](=O)[O-])cc3)n2)CC1";"IFI";"'='";"5.195";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL601184";"";"0";"378.71";"1";"5.40";"GNF-Pf-4234";"Clc1ccc(-c2c[n+](Cc3ccc(Cl)c(Cl)c3)c3n2CCC3)cc1";"IFI";"'='";"2.381";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600701";"";"0";"336.80";"0";"2.38";"GNF-Pf-4237";"COc1ccc(Cl)cc1NC(=S)NNC(=O)c1cccnc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585998";"";"0";"254.29";"0";"3.10";"GNF-Pf-4259";"C/C(C=NNC(=O)c1ccco1)=C\c1ccccc1";"IFI";"";"";"";"";"";"Not applicable";"";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL605747";"";"0";"453.50";"0";"3.20";"GNF-Pf-3955";"Cc1cccn2c(=O)c3cc(C(=O)NCc4ccco4)c(=N)n(CCc4ccccc4)c3nc12";"IFI";"'='";"7.812";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL597258";"";"0";"445.05";"1";"6.90";"GNF-Pf-3975";"CC(C)(C)Cc1ccc(OCCCC(=O)Nc2ccc(Cl)c(N)c2)c(CC(C)(C)C)c1";"IFI";"'='";"8.397";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL596646";"";"0";"455.51";"0";"4.44";"GNF-Pf-3981";"COc1cc(/C=C\C(=O)Nc2c3c(nn2-c2ccc(F)cc2)CSC3)cc(OC)c1OC";"IFI";"'='";"4.706";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL596647";"";"0";"490.41";"1";"5.11";"GNF-Pf-3983";"CCN1C(=Cc2sc3ccc(OC)cc3[n+]2CC)C=Cc2ccccc21.[I-]";"IFI";"";"";"";"";"";"Not applicable";"";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL584672";"";"0";"520.47";"2";"7.61";"GNF-Pf-4004";"CC(C)(C)CC(C)(C)Nc1c(-c2ccccc2OC(=O)c2cccc(Br)c2)nc2ccccn12";"IFI";"'='";"4.717";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL584053";"";"0";"453.48";"1";"2.34";"GNF-Pf-4011";"COC(=O)c1ccc2c(=O)n(Cc3ccco3)c(SCC(=O)n3nc(N)cc3C)nc2c1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL599291";"";"0";"264.38";"0";"2.11";"GNF-Pf-4032";"CCNc1nc(NC(C)(C)C)nc(N2CCCC2)n1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL602567";"";"0";"572.58";"1";"4.12";"GNF-Pf-4039";"COc1ccccc1-n1c(C(C)N2CCN(C(=O)c3cc([N+](=O)[O-])cc([N+](=O)[O-])c3)C(C)C2)nc2ccccc2c1=O";"IFI";"'='";"1.869";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600090";"";"0";"232.28";"0";"3.47";"GNF-Pf-4046";"Cc1ccc(NC(=O)ON=C2CCCC2)cc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL584625";"";"0";"321.12";"0";"3.29";"GNF-Pf-4577";"O=c1c2ccccc2[nH]c2ccc(I)cc12";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL578700";"";"0";"645.31";"2";"6.33";"GNF-Pf-2545";"CN(C)c1oc(-c2ccc(Cl)cc2Cl)nc1[P+](c1ccccc1)(c1ccccc1)c1ccccc1.[I-]";"IFI";"'='";"20.37";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL531191";"";"0";"611.78";"1";"3.87";"GNF-Pf-2518";"Cc1cccc(-n2c(CNC(=O)c3ccc(S(=O)(=O)N4CCCCC4)cc3)nnc2SCC(=O)Nc2nccs2)c1";"IFI";"'='";"1.19";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL544227";"CHLORCYCLOGUANIL HYDROCHLORIDE";"0";"288.18";"0";"1.53";"GNF-Pf-2519";"CC1(C)N=C(N)N=C(N)N1c1ccc(Cl)cc1.Cl";"IFI";"'='";"9.63";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL576324";"";"0";"415.50";"0";"3.34";"GNF-Pf-2424";"CCCn1c(=N)c(C(=O)NC(C)c2ccccc2)cc2c(=O)n3cccc(C)c3nc21";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL602762";"";"0";"300.24";"0";"3.86";"GNF-Pf-511";"O=C1c2ccccc2-c2nc3ccc(C(F)(F)F)cc3nc21";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL602970";"";"0";"234.28";"0";"2.16";"GNF-Pf-516";"O=C(COc1ccccc1)Nc1nccs1";"IFI";"'='";"7.477";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL582318";"";"0";"369.37";"0";"2.55";"GNF-Pf-557";"COc1ccc([C@@H]2C[C@H](OC(=O)c3ccc4c(c3)OCO4)C(=O)N2C)cc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL579123";"";"0";"361.36";"0";"2.12";"GNF-Pf-2479";"N#Cc1cc(N2CC3CC(C2)c2cccc(=O)n2C3)c([N+](=O)[O-])cc1C#N";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL581486";"";"0";"424.59";"0";"4.28";"GNF-Pf-566";"CC(C)CNC(=O)c1cnc(NCCCN2CCCCC2C)nc1Nc1ccccc1";"IFI";"'='";"1.852";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL581269";"";"0";"354.50";"0";"4.18";"GNF-Pf-577";"CCCCN1C(=Cc2cccc[n+]2C)Sc2cc(NC(C)=O)ccc21";"IFI";"'='";"7.692";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL577851";"";"0";"523.67";"1";"5.01";"GNF-Pf-2491";"COc1ccccc1N1CCN(C2CCN(C3CCC(c4ccccc4)CC3)CC2)CC1.O=C(O)C(=O)O";"IFI";"'='";"3.448";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600950";"";"0";"383.45";"0";"4.32";"GNF-Pf-584";"Cc1ccc(-c2nn(CC(=O)Nc3cccc(C)c3)c(=O)c3ccccc23)cc1";"IFI";"'='";"1.176";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600510";"";"0";"260.32";"0";"2.09";"GNF-Pf-2506";"CSC1=C(C#N)C(c2ccc(O)cc2)CC(=O)N1";"IFI";"'='";"0.7407";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL601573";"";"0";"343.31";"0";"3.23";"GNF-Pf-2510";"O=C(OC(C(=O)NCc1ccco1)c1ccc(F)cc1)c1ccco1";"IFI";"'='";"5.556";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL581057";"";"0";"380.47";"0";"3.27";"GNF-Pf-593";"COc1ccc(CN2CCc3nnc(CCc4ccccc4)n3CC2)c(F)c1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL596649";"";"0";"445.48";"0";"4.22";"GNF-Pf-2512";"O=C1NN(c2ccccc2)C(=O)/C1=C1/C(=O)N(Cc2cccc3ccccc23)c2ccccc21";"IFI";"";"";"";"";"";"Not applicable";"";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL601767";"";"0";"853.92";"2";"3.74";"GNF-Pf-2533";"CC(=O)O[C@@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C";"IFI";"'='";"11.84";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600284";"";"0";"223.32";"0";"1.82";"GNF-Pf-599";"CCC(C)(C#CCN1CCCC1)OC(C)=O";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL596846";"";"0";"395.55";"0";"4.70";"GNF-Pf-661";"CCN(CC)Cc1cc(Nc2nc3ccccc3[nH]2)cc(CN(CC)CC)c1O";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL586271";"";"0";"410.30";"0";"4.93";"GNF-Pf-1384";"Nc1c(C(=O)c2ccc(Br)cc2)sc2nc(-c3cccnc3)ccc12";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL162";"";"0";"466.54";"0";"4.35";"GNF-Pf-1389";"CN[C@@H]1CC2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4";"IFI";"'='";"41.25";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL586414";"";"0";"483.52";"1";"5.98";"GNF-Pf-1398";"COc1ccccc1Cc1nc2ccccc2nc1SCC(=O)Nc1cccc(C(F)(F)F)c1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL577671";"";"0";"395.48";"0";"4.42";"GNF-Pf-1428";"CCCOc1ccc(C=Nc2ccc(S(=O)(=O)Nc3ccccn3)cc2)cc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL577672";"";"0";"454.60";"0";"4.67";"GNF-Pf-1429";"CCNC(=O)NCCSc1nc(-c2ccc(OC)cc2)c(-c2ccc(OC)cc2)n1CC";"IFI";"'='";"2.752";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL601181";"";"0";"353.21";"0";"2.32";"GNF-Pf-742";"CC1=NNC(=O)C1C(c1ccc(Cl)cc1Cl)C1C(=O)NN=C1C";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL587370";"";"0";"381.45";"0";"4.55";"GNF-Pf-1453";"COc1ccc(OC)c(-c2ccc(O)c(CNCCc3ccccc3F)c2)c1";"IFI";"'='";"1.724";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL611982";"";"0";"330.17";"0";"4.06";"GNF-Pf-771";"Cn1c(=O)c(Cl)c2c3c(c(Cl)ccc31)C(=O)c1ccccc1-2";"IFI";"'='";"3.03";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL598893";"";"0";"434.36";"1";"5.84";"GNF-Pf-796";"CC1=C(C(=O)OC2CCCCC2)C(c2ccc(Cl)c(Cl)c2)C2=C(CCCC2=O)N1";"IFI";"'='";"5.747";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL578537";"";"0";"392.25";"0";"4.81";"GNF-Pf-1499";"CC(C)(C)c1cc(Br)cc(C=NNc2ccc([N+](=O)[O-])cc2)c1O";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL580330";"";"0";"522.39";"1";"3.64";"GNF-Pf-5551";"CCOC(=O)C1=C(C)NC2=C(C(=O)C(C(=O)OC)C(C)C2)C1c1cc(Br)c(OC)c(OC)c1";"IFI";"'='";"4.706";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL580062";"";"0";"373.21";"1";"5.04";"GNF-Pf-4905";"O=C1CSC(=Nc2ccc(F)c(Cl)c2)N1c1ccc(F)c(Cl)c1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585599";"";"0";"381.50";"1";"5.20";"GNF-Pf-4915";"CCCCCc1nnc(NC(=O)c2ccc(-c3ccc(OC)cc3)cc2)s1";"IFI";"'='";"6.557";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL602760";"";"0";"629.82";"2";"5.85";"GNF-Pf-4923";"CC(C)(C)OCCN(CC(O)CN(Cc1ccccc1)C(=O)NC(c1ccccc1)c1ccccc1)S(=O)(=O)c1ccccc1";"IFI";"'='";"0.9346";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL603306";"";"0";"387.96";"1";"5.47";"GNF-Pf-4928";"CCCCN(CCCC)CCCNc1ncnc2c1[nH]c1ccc(Cl)cc12";"IFI";"'='";"4.878";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL578953";"";"0";"457.57";"1";"5.54";"GNF-Pf-5578";"COc1ccc(C2CC(=O)C3=C(C2)NC(C)=C(C(=O)OC2CCCC2)C3c2ccccc2)cc1";"IFI";"'='";"5.814";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL579119";"";"0";"491.58";"0";"4.56";"GNF-Pf-5585";"COCCOC(=O)C1=C(C)NC2=C(C(=O)CC(c3ccc(OC)c(OC)c3)C2)C1c1ccccc1C";"IFI";"'='";"7.595";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL599922";"";"0";"451.49";"0";"4.38";"GNF-Pf-5594";"COC(=O)C1=C(C)NC2=C(C(=O)CC(c3ccc(OC)c(OC)c3)C2)C1c1ccccc1F";"IFI";"'='";"4.762";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL578924";"";"0";"387.57";"1";"5.09";"GNF-Pf-5596";"CCCCNCCN1CCN(c2ccc3ccccc3c2)C[C@@H]1c1ccccc1";"IFI";"'='";"7.317";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL579134";"";"0";"461.56";"0";"4.94";"GNF-Pf-5603";"CCOC(=O)C1=C(C)NC2=C(C(=O)CC(c3ccc(OC)c(OC)c3)C2)C1c1ccccc1C";"IFI";"'='";"5.882";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL577428";"";"0";"499.97";"1";"5.42";"GNF-Pf-5617";"CCOC(=O)C1=C(C)NC2=C(C(=O)CC(c3ccc(OC)c(OC)c3)C2)C1c1c(F)cccc1Cl";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL531108";"";"0";"336.35";"0";"3.68";"GNF-Pf-5636";"CCc1ccccc1N=C1c2c(cccc2[N+](=O)[O-])C(=O)C1C(C)=O";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL578480";"";"0";"530.45";"2";"6.33";"GNF-Pf-5652";"CCCOC(=O)C1=C(C)NC2=C(C(=O)CC(c3ccc(OC)c(OC)c3)C2)C1c1cccc(Cl)c1Cl";"IFI";"'='";"7.143";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL531150";"";"0";"218.31";"0";"-0.99";"GNF-Pf-5664";"CC(C=NNC(N)=S)=NNC(N)=S";"IFI";"'='";"21.77";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL577647";"";"0";"336.42";"0";"3.25";"GNF-Pf-5688";"CCc1c(C#N)c(N)nc(SCC(=O)c2ccc(C)cc2)c1C#N";"IFI";"'='";"3.488";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL1615674";"";"0";"212.64";"0";"0.86";"GNF-Pf-5691";"N=C(N)NN=Cc1cc(Cl)ccc1O";"IFI";"'='";"3.175";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL3144826";"";"0";"318.34";"0";"2.79";"GNF-Pf-5694";"Cc1cc(=O)n(-c2nc(-c3ccccc3O)nc3ccccc23)[nH]1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL586407";"";"0";"503.64";"2";"5.34";"GNF-Pf-5412";"COc1cc(CN(CCCN2CCOCC2)C(=O)Nc2cccc(C)c2)ccc1OCc1ccccc1";"IFI";"'='";"1.77";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL586635";"";"0";"449.47";"1";"6.86";"GNF-Pf-5416";"CC(C)CCN(CCC(C)C)CC(O)Cn1c2ccc(Cl)cc2c2cc(Cl)ccc21";"IFI";"'='";"3.509";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL578322";"";"0";"435.61";"1";"6.89";"GNF-Pf-5451";"Cc1ccn2c(NC(C)(C)CC(C)(C)C)c(-c3ccccc3OC(=O)C(C)(C)C)nc2c1";"IFI";"'='";"2.727";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL524612";"";"0";"464.59";"1";"5.34";"GNF-Pf-5461";"COc1ccc(NC(=O)C2c3ccccc3C(=O)N(CC(C)C)C2c2cccs2)cc1OC";"IFI";"'='";"3.03";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL578966";"";"0";"534.57";"1";"4.32";"GNF-Pf-5464";"CCOC(=O)C1=C(C)NC2=C(C(=O)C(C(=O)OCC)C(c3cccc(OC)c3)C2)C1c1ccc([N+](=O)[O-])cc1";"IFI";"'='";"1.163";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL531990";"";"0";"670.88";"1";"4.27";"GNF-Pf-5471";"CC[C@]1(C2OC(C3O[C@](O)(CO)[C@@H](C)C[C@H]3C)C[C@H]2C)CCC([C@@]2(C)CC[C@@]3(C[C@@H](O)[C@H](C)C([C@H](C)[C@H](OC)C(C)C(=O)O)O3)O2)O1";"IFI";"'='";"8.197";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL602168";"";"0";"301.48";"0";"4.34";"GNF-Pf-5477";"CCCCCCCSc1nsc(NC(=O)CCC)n1";"IFI";"'='";"3.659";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL586982";"";"0";"344.75";"0";"3.96";"GNF-Pf-5478";"COc1cccc(-c2cc(C(=O)Nc3cc(Cl)ccc3O)on2)c1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL588099";"";"0";"422.44";"0";"3.62";"GNF-Pf-5479";"COc1ccc(C2CC(=O)C3=C(C2)NC(=O)CC3c2ccc([N+](=O)[O-])cc2)cc1OC";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL586448";"";"0";"473.59";"1";"7.29";"GNF-Pf-5484";"Cc1ccn2c(NC(C)(C)CC(C)(C)C)c(-c3ccccc3OC(=O)c3ccccc3F)nc2c1";"IFI";"'='";"3.738";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL580752";"";"0";"423.53";"0";"4.68";"GNF-Pf-5486";"CCOC(=O)C1=C(C)NC2=C(C(=O)CC(c3ccc(OC)cc3)C2)C1c1ccsc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL601170";"";"0";"471.61";"0";"3.88";"GNF-Pf-5489";"CCC(C)(C)n1nnnc1C(c1cc2ccc(C)cc2[nH]c1=O)N1CCN(c2ccccc2)CC1";"IFI";"'='";"1.802";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL578741";"";"0";"340.39";"0";"3.94";"GNF-Pf-5510";"Nc1ccc(-c2nc3ccc(-c4nc5ccc(N)cc5[nH]4)cc3[nH]2)cc1";"IFI";"'='";"2.564";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL536918";"";"0";"400.48";"0";"3.75";"GNF-Pf-5516";"COc1ccc(C2(CNCC(O)c3cccc([N+](=O)[O-])c3)CCCC2)cc1OC";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL579171";"";"0";"470.40";"1";"6.31";"GNF-Pf-5324";"CCCOC(=O)C1=C(C)NC2=C(C(=O)CC(c3ccccc3)C2)C1c1ccc(Cl)cc1Cl";"IFI";"'='";"3.659";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL579172";"";"0";"421.58";"0";"3.86";"GNF-Pf-5325";"CCCC(=O)NC(C(=O)N1CCN(C(c2ccccc2)c2ccccc2)CC1)C(C)C";"IFI";"'='";"0.9434";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL588643";"";"0";"534.57";"1";"4.32";"GNF-Pf-5344";"CCOC(=O)C1=C(C)NC2=C(C(=O)C(C(=O)OCC)C(c3ccccc3OC)C2)C1c1ccc([N+](=O)[O-])cc1";"IFI";"'='";"6.977";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL529517";"";"0";"272.38";"0";"1.84";"GNF-Pf-5349";"S=C(NN=Cc1ccccn1)NC1CC2C=CC1C2";"IFI";"'='";"19.67";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL584629";"";"0";"471.99";"1";"5.79";"GNF-Pf-5003";"CC(=O)c1ccc(N2CCN(Cc3cc(-c4ccnc5cc(Cl)ccc45)ccc3O)CC2)cc1";"IFI";"'='";"3.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL579370";"";"0";"312.41";"0";"3.69";"GNF-Pf-5132";"COc1cccc(-c2ccc(O)c(CN3CCC(C)CC3)c2)n1";"IFI";"'='";"1.739";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL608857";"";"0";"366.25";"0";"2.75";"GNF-Pf-5154";"CN(C)c1ccc(C=Cc2cccc[n+]2C)cc1.[I-]";"IFI";"'='";"6.299";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL1493528";"";"0";"409.83";"0";"1.50";"GNF-Pf-5159";"OCC[n+]1c2ccccc2nc2ccc(N3CCOCC3)cc21.[O-][Cl+3]([O-])([O-])[O-]";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL579376";"";"0";"490.43";"1";"5.67";"GNF-Pf-1903";"COc1cc(NC(C)CCCN(Cc2ccccc2OC)C(=O)C(Cl)Cl)c2ncccc2c1";"IFI";"'='";"7.143";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL582648";"";"0";"402.81";"1";"5.01";"GNF-Pf-1949";"COC(=O)c1c(-c2c(F)cccc2Cl)noc1C=CNc1ccc(OC)cc1";"IFI";"";"";"";"";"";"Not applicable";"";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600754";"";"0";"373.39";"0";"1.28";"GNF-Pf-1950";"Cc1oc2c(c1C(=O)NC1CCS(=O)(=O)C1)C(=O)c1ccccc1C2=O";"IFI";"'='";"29.73";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL38827";"LUMEFANTRINE";"4";"528.95";"2";"9.15";"GNF-Pf-1971";"CCCCN(CCCC)CC(O)c1cc(Cl)cc2c1-c1ccc(Cl)cc1/C2=C/c1ccc(Cl)cc1";"IFI";"'='";"1.449";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL579363";"";"0";"373.39";"0";"3.44";"GNF-Pf-1973";"CC(=O)c1c(C)oc2ccc(NS(=O)(=O)c3cccc(C(=O)O)c3)cc12";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL579161";"";"0";"320.37";"0";"4.21";"GNF-Pf-1981";"Cc1ccc2[nH]c3c(NCCc4ccccc4F)ncnc3c2c1";"IFI";"'='";"14.63";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL577887";"";"0";"339.48";"0";"4.09";"GNF-Pf-1991";"Cc1cc(N2CCC(N(C)C3CCCC3)CC2)nc2cc(O)ccc12";"IFI";"'='";"4.545";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL581478";"";"0";"481.45";"1";"8.04";"GNF-Pf-2053";"Cc1ccc(N=C2S/C(=C\c3c(Cl)cccc3Cl)C(=O)N2c2ccc(C)c(C)c2)cc1C";"IFI";"";"";"";"";"";"Not applicable";"";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL395209";"";"0";"393.32";"0";"3.52";"GNF-Pf-2112";"CN(C)CCn1c(=N)n(CC(O)c2ccc(Cl)c(Cl)c2)c2ccccc21";"IFI";"'='";"7.692";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL582515";"";"0";"440.42";"1";"6.15";"GNF-Pf-3036";"COc1cc(-c2nc(-c3ccccc3)c(-c3cccc(C(F)(F)F)c3)[nH]2)cc(OC)c1O";"IFI";"'='";"4.706";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL606162";"";"0";"513.73";"1";"3.89";"GNF-Pf-664";"CC1CCCCN1CCCNc1ncc(C(=O)NCCCN2CCCC2=O)c(NCC2CCCCC2)n1";"IFI";"'='";"3.922";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL581652";"";"0";"389.46";"0";"3.28";"GNF-Pf-3051";"Cc1ccc(C(=O)NNc2nc(Nc3ccccc3)nc(N3CCCC3)n2)cc1";"IFI";"'='";"0.7299";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL529524";"";"0";"299.76";"0";"3.63";"GNF-Pf-716";"Oc1c2c(nc3cc(-c4ccc(Cl)cc4)nn13)CCCC2";"IFI";"'='";"7.143";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL596648";"";"0";"444.58";"0";"4.09";"GNF-Pf-734";"O=C(NCCc1ccccc1)c1cnc(NCCCN2CCCC2)nc1Nc1ccccc1";"IFI";"'='";"0.9615";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL611812";"";"0";"354.43";"0";"3.99";"GNF-Pf-2792";"CCOc1ccc(/C=C2/SC(=Nc3ccccc3)NC2=O)cc1OC";"IFI";"'='";"3.448";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL579091";"";"0";"361.36";"0";"4.29";"GNF-Pf-2806";"COc1ccc(Nc2ncnc3[nH]c(-c4cccc([N+](=O)[O-])c4)cc23)cc1";"IFI";"'='";"7.143";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL576792";"";"0";"453.59";"1";"5.72";"GNF-Pf-2820";"CCN(CC)C(=O)N1CCN(c2ccc(Nc3ccnc4cc5ccccc5cc34)cc2)CC1";"IFI";"'='";"2.299";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL601106";"";"0";"281.79";"0";"1.49";"GNF-Pf-807";"Cc1ccc(N2C(N)=NC(N)=NC2(C)C)c(C)c1.Cl";"IFI";"'='";"1.515";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL578286";"";"0";"444.35";"1";"6.05";"GNF-Pf-2861";"Brc1ccc(-c2n(Cc3ccccc3)c3ccccc3[n+]2Cc2ccccc2)o1";"IFI";"'='";"15.38";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL199659";"";"0";"362.79";"0";"2.52";"GNF-Pf-600";"COc1ccc(-c2ccc(C=C3C(=O)NC(=S)NC3=O)o2)cc1Cl";"IFI";"'='";"7.143";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585427";"";"0";"389.24";"1";"5.52";"GNF-Pf-928";"COC(=O)c1c(-c2c(Cl)cccc2Cl)noc1C=CNc1ccccc1";"IFI";"";"";"";"";"";"Not applicable";"";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585618";"";"0";"566.53";"2";"7.63";"GNF-Pf-932";"CCCCCCN(C(=O)COc1ccc(Cl)cc1)C(CC)c1nc2ccccc2c(=O)n1-c1cccc(Cl)c1";"IFI";"'='";"1.887";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585031";"";"0";"344.42";"0";"4.56";"GNF-Pf-1309";"O=C(c1cccs1)N(Cc1cccs1)c1ccc([N+](=O)[O-])cc1";"IFI";"'='";"1.961";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL531250";"";"0";"302.17";"0";"3.96";"GNF-Pf-1491";"Brc1ccc2c(c1)c1ccccc1n2CC1CO1";"IFI";"'='";"8.333";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL586240";"";"0";"443.50";"0";"4.94";"GNF-Pf-5207";"C=C[C@H]1CN2CC[C@H]1C[C@H]2[C@H](OC(=O)c1cccc([N+](=O)[O-])c1)c1ccnc2ccccc12";"IFI";"'='";"0.9259";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL602000";"";"0";"481.62";"0";"3.11";"GNF-Pf-5210";"CSc1cccc(NC(=O)C2C3C=CC4(O3)C2C(=O)N(C2CC2)C4C(=O)NC2CCCCC2)c1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL534208";"";"0";"360.87";"1";"5.19";"GNF-Pf-5211";"C[n+]1c(C=CNc2ccccc2)n(-c2ccccc2)c2ccc(Cl)cc21";"IFI";"'='";"12.5";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL535281";"";"0";"462.59";"1";"5.67";"GNF-Pf-5289";"CCN(CC)CCCC(C)N=c1cc(C=Cc2ccc([N+](=O)[O-])cc2)[nH]c2ccc(OC)cc12";"IFI";"";"";"";"";"";"Not applicable";"";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600937";"";"0";"526.68";"2";"6.61";"GNF-Pf-5330";"O=C(Cc1cccs1)N1CCOc2c(cc(-c3csc4ccccc34)cc2OCCc2ccccn2)C1";"IFI";"'='";"1.961";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL588602";"";"0";"510.47";"2";"8.15";"GNF-Pf-5339";"CC(C)(C)CC(C)(C)Nc1c(-c2ccccc2OC(=O)c2ccc(Cl)cc2Cl)nc2ccccn12";"IFI";"'='";"2.83";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL532640";"";"0";"417.46";"1";"6.77";"GNF-Pf-5355";"COc1ccc(C2=C(Nc3ccc4oc5ccccc5c4c3)c3ccccc3C2=O)cc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL588746";"";"0";"499.66";"0";"2.80";"GNF-Pf-5404";"O=C(NC1CCN(CC(O)CN(Cc2ccccc2)S(=O)(=O)c2ccccc2)C1)c1ccsc1";"IFI";"'='";"1.905";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL579146";"";"0";"407.00";"1";"5.29";"GNF-Pf-2721";"CCCCNC(=O)c1ccc(OC2CCN(CC3CCCCC3)CC2)c(Cl)c1";"IFI";"'='";"1.408";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600505";"";"0";"332.16";"0";"1.40";"GNF-Pf-2733";"O=C(Cn1nc([N+](=O)[O-])nc1Br)NC1CCCCC1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL579316";"";"0";"320.49";"0";"3.67";"GNF-Pf-2757";"CCC(C)Nc1nc(NC(C)CC)nc(N2CCCCCC2)n1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL579353";"";"0";"517.50";"2";"7.05";"GNF-Pf-2789";"CCN(CC)CCCC(C)Nc1nc(/C=C/c2cc(OC)c(OC)cc2Cl)nc2cc(Cl)ccc12";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL579358";"";"0";"375.94";"1";"5.37";"GNF-Pf-2795";"CCCCC(CC)C(=O)N(C)CCCNc1ccnc2cc(Cl)ccc12";"IFI";"'='";"3.636";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL601157";"";"0";"413.90";"0";"4.48";"GNF-Pf-2817";"COc1cc(OC)cc(C(=O)N(C)CCCNc2ccnc3cc(Cl)ccc23)c1";"IFI";"'='";"1.869";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL579074";"";"0";"460.34";"1";"6.50";"GNF-Pf-2823";"CC(Oc1ccc(Cl)cc1Cl)c1nc(-c2ccc(NC(=O)c3cccs3)cc2)no1";"IFI";"'='";"4.615";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL548758";"";"0";"402.50";"0";"3.54";"GNF-Pf-2884";"COc1ccc(-c2nc(NC(=O)CS(=O)(=O)c3ccccc3)sc2C)cc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL534600";"";"0";"656.85";"1";"4.51";"GNF-Pf-2854";"O=C(NC(c1ccccc1)c1ccccc1)N(Cc1ccccc1)CC(O)CN(CCN1CCOCC1)S(=O)(=O)Cc1ccccc1";"IFI";"'='";"1.942";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL578069";"";"0";"466.75";"1";"5.36";"GNF-Pf-2860";"COC(=O)C1=CN(Cc2ccc(Cl)cc2)C=C(C(=O)OC)C1c1ccc(Cl)c(Cl)c1";"IFI";"'='";"3.529";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL601137";"";"0";"255.37";"0";"3.05";"GNF-Pf-2927";"CN1/C(=C/c2cccc[n+]2C)Sc2ccccc21";"IFI";"'='";"15.38";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL524594";"";"0";"416.40";"0";"4.31";"GNF-Pf-2943";"O=[N+]([O-])c1ccc(C=NNc2nc(Nc3ccccc3)nc(Nc3ccccc3)n2)o1";"IFI";"'='";"6.475";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585957";"";"0";"577.68";"2";"5.77";"GNF-Pf-2641";"COc1ccc(NC(=O)CCCCCn2c(SCc3cc(=O)oc4cc(O)ccc34)nc3ccsc3c2=O)cc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL601965";"";"0";"383.88";"0";"4.23";"GNF-Pf-2646";"CN(CCCNc1ccnc2cc(Cl)ccc12)C(=O)COc1ccccc1";"IFI";"'='";"2.804";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL578940";"";"0";"174.56";"0";"2.18";"GNF-Pf-2650";"O=C(O)c1c(F)cccc1Cl";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL579288";"";"0";"435.27";"0";"3.30";"GNF-Pf-2666";"COc1ccc(OC(C)=O)c(C=NNC(=O)C(C)Oc2ccccc2Br)c1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL584269";"";"0";"370.82";"0";"4.72";"GNF-Pf-4012";"Cl.Fc1ccc(Nc2nc(NCc3ccco3)c3ccccc3n2)cc1";"IFI";"'='";"9.677";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL583650";"";"0";"555.70";"1";"2.51";"GNF-Pf-4016";"CCN(CC)S(=O)(=O)c1ccc2[nH]cc(C(=O)NCCCN3CCN(c4ccc(OC)cc4)CC3)c(=O)c2c1";"IFI";"'='";"6.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL577625";"";"0";"458.67";"0";"4.28";"GNF-Pf-2698";"CCN(CC)CCCNC(=S)N(Cc1cc2ccc(OC)cc2[nH]c1=O)C1CCCCC1";"IFI";"'='";"3.571";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL598903";"";"0";"282.66";"0";"2.60";"GNF-Pf-4057";"O=c1c([N+](=O)[O-])cccn1Cc1ccc(F)cc1Cl";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL534849";"";"0";"301.78";"0";"1.83";"GNF-Pf-5046";"Cl.NC1=NC(c2ccccc2)N(c2ccccc2)C(N)=N1";"IFI";"'='";"1.575";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL584821";"";"0";"517.67";"2";"6.39";"GNF-Pf-5059";"Cc1ccc(-n2c(SCc3ccc(F)cc3)nnc2C(Cc2ccccc2)NC(=O)NC(C)(C)C)cc1";"IFI";"'='";"3.261";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600564";"";"0";"523.60";"2";"8.17";"GNF-Pf-5064";"Cc1ccn2c(NC(C)(C)CC(C)(C)C)c(-c3ccccc3OC(=O)c3ccc(C(F)(F)F)cc3)nc2c1";"IFI";"'='";"7.018";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600161";"";"0";"384.52";"0";"3.17";"GNF-Pf-5086";"COc1ccc(CN2CCOc3ccc(C(C)(O)CN(C)C)cc3C2)cc1C";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL583532";"";"0";"416.57";"0";"2.60";"GNF-Pf-5122";"CC(C)CCN1C(=O)N(CCN(C)C)C(=O)C12CCN(Cc1ccc(O)cc1)CC2";"IFI";"'='";"2.469";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL1744496";"";"0";"364.83";"0";"3.30";"GNF-Pf-5123";"CN(C)c1ccc(C=CC=Cc2cccc[n+]2C)cc1.[O-][Cl+3]([O-])([O-])[O-]";"IFI";"";"";"";"";"";"Not applicable";"";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL319952";"";"0";"367.49";"0";"3.73";"GNF-Pf-5152";"O=C(CCc1ccccc1)c1ccccc1OCC(O)CN1CCCCC1";"IFI";"'='";"1.46";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL1615699";"";"0";"462.59";"1";"6.24";"GNF-Pf-5161";"CCN(CC)CCCC(C)Nc1cc(C=Cc2ccc([N+](=O)[O-])cc2)nc2cc(OC)ccc12";"IFI";"";"";"";"";"";"Not applicable";"";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL601780";"";"0";"429.95";"1";"6.13";"GNF-Pf-5171";"CN(CCCNc1ccnc2cc(Cl)ccc12)C(=O)c1ccc(-c2ccccc2)cc1";"IFI";"'='";"2.83";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL577871";"";"0";"341.45";"0";"4.31";"GNF-Pf-5174";"COc1ccc(OC)c(-c2ccc(O)c(CN3CCCC(C)C3)c2)c1";"IFI";"'='";"1.724";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL533536";"";"0";"354.62";"0";"3.48";"GNF-Pf-5182";"CC(C)C(=O)NC(Nc1ccc([N+](=O)[O-])cc1)C(Cl)(Cl)Cl";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL524242";"";"0";"517.11";"0";"4.94";"GNF-Pf-5190";"CCC1CN2CCc3cc(OC)c(OC)cc3C2CC1CC1NCCc2cc(OC)c(OC)cc21.Cl";"IFI";"'='";"33.33";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600302";"";"0";"684.56";"2";"7.71";"GNF-Pf-2095";"O=C(O)/C=C/C(=O)O.OC1(c2ccc(Cl)c(C(F)(F)F)c2)CCN(CCOC2c3ccccc3CSc3ccc(Cl)cc32)CC1";"IFI";"'='";"2.381";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL203614";"";"0";"356.43";"0";"3.90";"GNF-Pf-2109";"c1ccc(-c2nc(NCCCn3ccnc3)cc(-c3ccncc3)n2)cc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL578673";"";"0";"258.39";"0";"4.38";"GNF-Pf-2129";"Cc1ccc(C)c(Nc2nc3c(s2)CCCC3)c1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL579110";"";"0";"498.58";"1";"5.46";"GNF-Pf-2139";"CCc1ccc(CN2CCC(O)(c3ccc4oc(C(=O)Nc5ccc6c(c5)OCO6)cc4c3)CC2)cc1";"IFI";"'='";"6.897";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL579097";"";"0";"396.40";"0";"5.00";"GNF-Pf-2143";"O=C(C=Cc1ccccc1)c1c(-c2ccccc2)c2cc([N+](=O)[O-])ccc2[nH]c1=O";"IFI";"";"";"";"";"";"Not applicable";"";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL1744505";"";"0";"480.43";"1";"6.37";"GNF-Pf-2149";"Cc1cc(C)cc(-n2c(C)cc(/C=C3\SC(=Nc4ccc(Br)cc4)NC3=O)c2C)c1";"IFI";"";"";"";"";"";"Not applicable";"";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL579315";"";"0";"358.39";"0";"3.93";"GNF-Pf-2150";"COc1ccc(C=C2SC(Nc3ccc(F)cc3)=NC2=O)c(OC)c1";"IFI";"";"";"";"";"";"Not applicable";"";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL576350";"";"0";"484.55";"0";"3.12";"GNF-Pf-2151";"CC1=CC(=O)OC[C@]23CCC(C)=C[C@H]2O[C@@H]2C[C@@H](OC(=O)C=CC=CC(=O)OCC1)[C@@]3(C)[C@]21CO1";"IFI";"'='";"22.64";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL609460";"";"0";"681.79";"3";"5.06";"GNF-Pf-2173";"CCOC(=O)c1sc(NC(=O)C(C)Sc2nnc(CNC(=O)c3ccc(OC)cc3)n2-c2ccccc2OC)c(C(=O)OCC)c1C";"IFI";"'='";"1.351";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL576578";"";"0";"434.49";"1";"5.47";"GNF-Pf-2182";"COc1ccccc1N1C(=N)S/C(=C\c2ccc(OCc3ccccc3F)cc2)C1=O";"IFI";"'='";"2.326";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL586658";"";"0";"280.33";"0";"2.37";"GNF-Pf-1530";"O=C1NCCN1C(=O)C(c1ccccc1)c1ccccc1";"IFI";"'='";"4.545";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL586850";"";"0";"397.45";"0";"4.02";"GNF-Pf-1531";"COC(=O)c1c(NC(=O)c2cc3ccccc3oc2=O)sc2c1CCC(C)C2";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL605187";"";"0";"430.37";"0";"2.07";"GNF-Pf-1534";"CCC(=O)N1CCc2cc(Br)cc(S(=O)(=O)N3CCN(CC)CC3)c21";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL602379";"PHENYL 4-CHLOROPHENYLCARBAMATE";"0";"247.68";"0";"3.95";"GNF-Pf-2315";"O=C(Nc1ccc(Cl)cc1)Oc1ccccc1";"IFI";"'='";"4.8";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL608856";"DIPHENAN";"0";"227.26";"0";"2.73";"GNF-Pf-1544";"NC(=O)Oc1ccc(Cc2ccccc2)cc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585432";"";"0";"287.75";"0";"4.00";"GNF-Pf-930";"COc1ccc(NC(=O)/C=C/c2ccccc2Cl)cc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL584849";"";"0";"399.43";"1";"5.35";"GNF-Pf-1260";"COc1cc(/C=C(\C#N)c2nc3ccccc3[nH]2)ccc1OCc1ccccc1F";"IFI";"'='";"4.762";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585252";"";"0";"388.43";"0";"4.37";"GNF-Pf-1270";"N#Cc1c(N)nc2sc(C(=O)c3ccc(F)cc3)c(N)c2c1-c1ccccc1";"IFI";"'='";"4.167";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585075";"";"0";"496.48";"0";"4.49";"GNF-Pf-1292";"CCOC(=O)c1c(N)n(-c2ccc(NC(=O)c3cccc([N+](=O)[O-])c3)cc2)c2nc3ccccc3nc12";"IFI";"'='";"6.25";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL580253";"";"0";"378.43";"0";"2.03";"GNF-Pf-1296";"O=c1[nH]c(N2CCCC2)nc2c1CCN(Cc1coc3ccccc3c1=O)C2";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL603040";"";"0";"299.42";"0";"3.31";"GNF-Pf-1308";"CCC(NC1CCCCC1)c1nc2ccccc2c(=O)n1C";"IFI";"'='";"2.5";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL541417";"";"0";"425.99";"1";"5.04";"GNF-Pf-1576";"CCN1/C(=C/c2ccc3ccccc3[n+]2CC)Sc2cc(NC(C)=O)ccc21.[Cl-]";"IFI";"'='";"8.333";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL525381";"";"0";"329.48";"0";"4.78";"GNF-Pf-5188";"CCCCCCc1cc(O)c2c(c1)OC(C)(C)C1=C2CCN(C)C1";"IFI";"'='";"5.769";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL579324";"";"0";"379.46";"0";"4.71";"GNF-Pf-5587";"CCOC(=O)c1ccc2c(c1)[C@@H]1C=CC[C@@H]1[C@H](c1cccc(OC)c1OC)N2";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL577391";"";"0";"512.00";"1";"4.91";"GNF-Pf-5644";"COCCOC(=O)C1=C(C)NC2=C(C(=O)CC(c3ccc(OC)c(OC)c3)C2)C1c1ccccc1Cl";"IFI";"'='";"2.326";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL578283";"";"0";"481.98";"1";"5.28";"GNF-Pf-5660";"CCOC(=O)C1=C(C)NC2=C(C(=O)CC(c3ccc(OC)c(OC)c3)C2)C1c1ccccc1Cl";"IFI";"'='";"3.529";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL579341";"";"0";"526.43";"2";"5.39";"GNF-Pf-5670";"CCOC(=O)C1=C(C)NC2=C(C(=O)CC(c3ccc(OC)c(OC)c3)C2)C1c1ccc(Br)cc1";"IFI";"'='";"4.706";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL533376";"";"0";"191.26";"0";"-0.19";"GNF-Pf-5675";"COC(OC)C(C)=NNC(N)=S";"IFI";"'='";"16.81";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585962";"";"0";"561.70";"2";"5.17";"GNF-Pf-5462";"COc1ccc(CCN2C(=S)NC3c4cccc(OC)c4OC2(C)C3C(=O)Nc2ccc(C)cc2C)cc1OC";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL576205";"";"0";"384.58";"1";"5.54";"GNF-Pf-5463";"CCCCCc1ccc(OCCOCC[n+]2ccccc2)c(CCCCC)c1";"IFI";"'='";"4.545";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL586889";"";"0";"526.43";"2";"5.39";"GNF-Pf-5472";"CCOC(=O)C1=C(C)NC2=C(C(=O)CC(c3ccc(OC)c(OC)c3)C2)C1c1cccc(Br)c1";"IFI";"'='";"2.353";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL582645";"";"0";"546.62";"2";"5.85";"GNF-Pf-5487";"COc1ccc(C2CC(=O)C3=C(C2)NC(C)=C(C(=O)OC2CCCCC2)C3c2ccc([N+](=O)[O-])cc2)cc1OC";"IFI";"'='";"4.819";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL580137";"";"0";"400.48";"0";"2.29";"GNF-Pf-5493";"C/C=C/C(C(=O)NCCCC)N1C(=O)c2cc(NC(C)=O)ccc2NC(=O)[C@@H]1C";"IFI";"'='";"1.235";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL578948";"";"0";"417.60";"0";"1.99";"GNF-Pf-5502";"Cn1nc(C(=O)N2CCCCCC2)c2c1CCC(NCC(C)(C)N1CCOCC1)C2";"IFI";"'='";"1.205";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL578534";"";"0";"393.53";"1";"5.86";"GNF-Pf-5514";"CC(=O)Oc1ccccc1-c1nc2cc(C)ccn2c1NC(C)(C)CC(C)(C)C";"IFI";"'='";"4.673";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600724";"";"0";"240.24";"0";"0.47";"GNF-Pf-5518";"NC(=S)NN=Cc1cc([N+](=O)[O-])ccc1O";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL602186";"";"0";"476.53";"0";"4.92";"GNF-Pf-5522";"CCCOC(=O)C1=C(C)NC2=C(C(=O)CC(c3ccc(OC)cc3)C2)C1c1ccc([N+](=O)[O-])cc1";"IFI";"'='";"2.439";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL586694";"";"0";"447.55";"0";"4.06";"GNF-Pf-5332";"Cc1ccc(CN2CCc3nc(N4CCCCC4)sc3C2)s1.O=C(O)C(F)(F)F";"IFI";"'='";"6.944";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL581595";"";"0";"414.51";"0";"0.95";"GNF-Pf-5350";"O=[N+]([O-])c1ccc(S(=O)(=O)N2CCN(C(=S)NCC3CCCO3)CC2)cc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL578527";"";"0";"502.39";"2";"5.55";"GNF-Pf-5373";"COC(=O)C1=C(C)NC2=C(C(=O)CC(c3ccc(OC)c(OC)c3)C2)C1c1cccc(Cl)c1Cl";"IFI";"'='";"4.819";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL578109";"";"0";"281.31";"0";"3.94";"GNF-Pf-5381";"CCOc1ccc(Nc2cc(=O)oc3ccccc23)cc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585399";"";"0";"525.57";"1";"3.48";"GNF-Pf-5383";"CN1CCN=C1c1ccc(NC(=O)c2ccc(C(=O)Nc3ccc(C4=NCCN4C)cc3)c([N+](=O)[O-])c2)cc1";"IFI";"'='";"10.81";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL578965";"";"0";"340.47";"0";"4.67";"GNF-Pf-5400";"COc1cccc(-c2ccc(O)c(CNC3CCCCCCC3)c2)n1";"IFI";"'='";"3.03";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL602828";"";"0";"340.88";"0";"4.73";"GNF-Pf-2906";"CCn1c(/C=C/N(C)c2ccccc2)[n+](CC)c2cc(Cl)ccc21";"IFI";"";"";"";"";"";"Not applicable";"";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL599932";"";"0";"567.16";"2";"7.87";"GNF-Pf-2914";"Cc1ccc(-c2nnc(SCCCC(=O)NC(Cc3ccccc3)c3ccccc3)n2-c2cccc(Cl)c2)cc1";"IFI";"'='";"4.211";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL588710";"";"0";"334.22";"0";"2.85";"GNF-Pf-2915";"CN(C)CCNc1ncnc2c1[nH]c1ccc(Br)cc12";"IFI";"'='";"13.73";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL580173";"";"0";"397.48";"1";"5.41";"GNF-Pf-2922";"C=CCOc1cccc(C(Nc2cccc(C)n2)c2ccc3cccnc3c2O)c1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600331";"";"0";"356.92";"1";"5.21";"GNF-Pf-2925";"CSCCN1CCc2ccc3[nH]cc(-c4cccc(Cl)c4)c3c2C1";"IFI";"'='";"5.556";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL601340";"";"0";"251.31";"0";"1.33";"GNF-Pf-2935";"COc1cc[n+](OC(=O)N2CCCCC2)c(C)c1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL602007";"";"0";"464.97";"0";"4.97";"GNF-Pf-2946";"Cc1ccc(NC(=O)c2ccc(NCCCN3CCCCCC3)c([N+](=O)[O-])c2)cc1F.Cl";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL581677";"";"0";"324.76";"0";"4.31";"GNF-Pf-2947";"CC1=C(CC(=O)c2ccc(Cl)cc2)C(=O)c2ccccc2C1=O";"IFI";"'='";"9.756";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL582722";"";"0";"290.32";"0";"3.66";"GNF-Pf-2954";"CC1=C(CC(=O)c2ccccc2)C(=O)c2ccccc2C1=O";"IFI";"'='";"7.407";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL582102";"";"0";"509.19";"0";"4.08";"GNF-Pf-2959";"Br.O=C(Cn1ccc(=NCc2ccccc2)cc1)c1ccc(I)cc1";"IFI";"'='";"3.03";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL582475";"";"0";"313.40";"0";"3.53";"GNF-Pf-2970";"C(#Cc1ccccc1)CN(Cc1ccccn1)Cc1ccccn1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL579955";"";"0";"441.58";"1";"6.85";"GNF-Pf-2975";"CC(C)(C)CC(C)(C)Nc1c(-c2ccccc2OC(=O)c2ccccc2)nc2ccccn12";"IFI";"'='";"4.202";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL580170";"";"0";"467.53";"0";"3.28";"GNF-Pf-2987";"O=C(Nc1ccc(C2=NCCN2)cc1)Nc1cccc(C(=O)Nc2ccc(C3=NCCN3)cc2)c1";"IFI";"'='";"0.9009";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL530405";"";"0";"567.65";"2";"3.81";"GNF-Pf-4059";"CNC(=O)c1ccc(NC(=O)Nc2ccc(C3=NCCCN3)cc2)cc1NC(=O)Nc1ccc(C2=NCCCN2)cc1";"IFI";"'='";"0.9091";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL579333";"";"0";"450.78";"1";"5.17";"GNF-Pf-2625";"O=C(Nc1cc(Cl)ccc1O)c1cnn2c(C(F)(F)F)cc(-c3ccc(F)cc3)nc12";"IFI";"'='";"2.299";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL578070";"";"0";"475.46";"0";"3.80";"GNF-Pf-2626";"COC(=O)c1cccc(NC(=O)C(=Cc2cccc([N+](=O)[O-])c2)NC(=O)c2ccccc2OC)c1";"IFI";"";"";"";"";"";"Not applicable";"";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600931";"";"0";"340.40";"0";"3.76";"GNF-Pf-2631";"COc1ccc(/C=C2/SC(=N)N(c3ccccc3OC)C2=O)cc1";"IFI";"'='";"2.353";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL528589";"";"0";"297.74";"0";"4.45";"GNF-Pf-2634";"O=C(Nc1cccc(Cl)c1)c1cc2ccccc2cc1O";"IFI";"'='";"9.615";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL578938";"";"0";"434.90";"0";"3.97";"GNF-Pf-2649";"O=[N+]([O-])c1ccc(S(=O)(=O)NCCCCNc2ccnc3cc(Cl)ccc23)cc1";"IFI";"'='";"3.738";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL578264";"";"0";"557.54";"1";"3.89";"GNF-Pf-2679";"CCN(CC)S(=O)(=O)c1cc(S(=O)(=O)c2ccc(Cl)c(S(=O)(=O)N(CC)CC)c2)ccc1Cl";"IFI";"'='";"1.493";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL579112";"";"0";"374.35";"0";"3.56";"GNF-Pf-2683";"Nc1cccc(Oc2ccc3c(c2)C(=O)N(c2cccc(C(=O)O)c2)C3=O)c1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL602192";"";"0";"343.50";"0";"3.70";"GNF-Pf-2685";"COc1ccccc1CN1CCc2nc(N3CCCCC3)sc2C1";"IFI";"'='";"9.722";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL603009";"";"0";"540.45";"2";"5.78";"GNF-Pf-5577";"COc1ccc(C2CC(=O)C3=C(C2)NC(C)=C(C(=O)OC(C)C)C3c2ccccc2Br)cc1OC";"IFI";"'='";"3.529";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL578273";"";"0";"434.35";"0";"2.47";"GNF-Pf-5582";"O=C(O)C(Cc1ccc([N+](=O)[O-])cc1)NS(=O)(=O)c1ccc(OC(F)(F)F)cc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL601359";"";"0";"508.63";"1";"4.44";"GNF-Pf-5638";"CC1N=C(c2ccc(NC(=O)c3ccc(C(=O)Nc4ccc(C5=NC(C)C(C)N5)cc4)cc3)cc2)NC1C";"IFI";"'='";"8.108";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600727";"";"0";"480.98";"1";"5.34";"GNF-Pf-5658";"COc1ccc(-n2c(SCC(=O)Nc3cc(Cl)ccc3OC)nnc2-c2ccccc2)cc1";"IFI";"'='";"4.425";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL579377";"";"0";"397.86";"0";"4.06";"GNF-Pf-5326";"COc1cc(C2CC(=O)NC3=C2C(=O)CC(c2ccccc2Cl)C3)ccc1O";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL531326";"";"0";"315.34";"0";"2.36";"GNF-Pf-5356";"N#Cc1ccc(-c2cnc(N)c(-c3ccc(C(N)=O)cc3)n2)cc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL86304";"MOCLOBEMIDE";"4";"268.74";"0";"1.40";"GNF-Pf-695";"O=C(NCCN1CCOCC1)c1ccc(Cl)cc1";"IFI";"'='";"0.5988";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL598891";"";"0";"387.96";"1";"5.70";"GNF-Pf-718";"CCCCCCC(=O)NC1CCC(Nc2ccnc3cc(Cl)ccc23)CC1";"IFI";"'='";"7.143";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585623";"";"0";"307.35";"0";"-1.11";"GNF-Pf-865";"Cn1c(=O)c2c(ncn2CC(O)CN2CCCC2)n(C)c1=O";"IFI";"'='";"4.274";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600285";"";"0";"248.47";"0";"1.67";"GNF-Pf-886";"O=c1[nH]c2cc(Cl)c(Br)nc2[nH]1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL529569";"";"0";"591.09";"2";"7.59";"GNF-Pf-894";"O=C(CSc1oc(-c2ccc(Cl)cc2)nc1[P+](c1ccccc1)(c1ccccc1)c1ccccc1)c1ccccc1";"IFI";"'='";"21.43";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL603041";"";"0";"400.57";"1";"5.98";"GNF-Pf-908";"CCc1ccc(C(=O)N2CCCn3cccc3C2c2ccc(C(C)(C)C)cc2)cc1";"IFI";"'='";"7.527";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585408";"";"0";"508.57";"1";"2.34";"GNF-Pf-910";"COc1ccc(CCNC(=O)c2cc(S(=O)(=O)N3CCC4(CC3)OCCO4)ccc2F)cc1OC";"IFI";"'='";"2.326";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL584615";"";"0";"315.33";"0";"1.07";"GNF-Pf-915";"COc1ccc(C2C(C(N)=O)=C(C)Nc3ncnn32)cc1OC";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL601823";"";"0";"410.30";"0";"4.13";"GNF-Pf-917";"COc1ccc(N(CCCNC(=O)CCl)C(=O)Nc2cccc(Cl)c2)cc1";"IFI";"'='";"0.9259";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL584624";"";"0";"332.93";"0";"2.87";"GNF-Pf-924";"Cc1cc(C)c(CSC(=N)N)c(C)c1CSC(=N)N.Cl";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL597265";"";"0";"356.38";"0";"3.13";"GNF-Pf-4360";"CCOC(=O)C1=C(C)NC2=C(C(=O)CCC2)C1c1ccc([N+](=O)[O-])cc1";"IFI";"'='";"1.136";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585843";"";"0";"381.27";"1";"6.42";"GNF-Pf-4374";"Clc1ccc(Nc2nc(Nc3ccc(Cl)cc3)c3ccccc3n2)cc1";"IFI";"'='";"3.727";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL611069";"";"0";"421.85";"1";"5.48";"GNF-Pf-4474";"CN(CCCNc1ccnc2cc(Cl)ccc12)C(=O)c1ccc(C(F)(F)F)cc1";"IFI";"'='";"2.727";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL597857";"";"0";"345.83";"0";"2.90";"GNF-Pf-4478";"Clc1ccc2[nH]c3c(NCCCN4CCOCC4)ncnc3c2c1";"IFI";"'='";"11.76";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL604515";"";"0";"534.97";"0";"4.95";"GNF-Pf-4398";"CC(C)(C)c1nn(-c2ccc(Cl)cc2)c2[nH]c(=O)c(CNCc3ccccc3)cc12.O=C(O)C(F)(F)F";"IFI";"'='";"2.564";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL598278";"";"0";"514.63";"2";"7.37";"GNF-Pf-4498";"Cc1ccn2c(NC(C)(C)CC(C)(C)C)c(-c3ccccc3OC(=O)c3ccc(C)c([N+](=O)[O-])c3)nc2c1";"IFI";"'='";"3.738";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL597657";"";"0";"267.34";"0";"3.10";"GNF-Pf-4404";"Cc1cc(C)cc(Nc2cc(C)nc3nc(C)nn23)c1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL2368646";"";"0";"364.83";"0";"3.30";"GNF-Pf-4410";"CN(C)c1ccc(C=CC=Cc2cc[n+](C)cc2)cc1.[O-][Cl+3]([O-])([O-])[O-]";"IFI";"";"";"";"";"";"Not applicable";"";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL586027";"";"0";"458.79";"0";"4.47";"GNF-Pf-4514";"Cl.N=c1n(Cc2ccccc2)c2ccccc2n1CC(O)c1ccc(Br)cc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL597468";"";"0";"268.36";"0";"2.72";"GNF-Pf-4429";"CN(C)CC(O)Cn1c2ccccc2c2ccccc21";"IFI";"'='";"3.817";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585045";"";"0";"532.24";"1";"4.13";"GNF-Pf-4531";"NNC(=O)CNC(c1ccccc1)c1cc(Br)ccc1NC(=O)c1ccccc1Br";"IFI";"'='";"3.077";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL530620";"";"0";"456.85";"1";"5.93";"GNF-Pf-4436";"CCCCCCCn1c(=N)n(CC(O)c2ccc(Cl)c(Cl)c2)c2ccccc21.Cl";"IFI";"'='";"9.259";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585838";"";"0";"224.33";"0";"1.58";"GNF-Pf-4441";"Cc1cc(C)cc(NC(=S)NCCO)c1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL602226";"";"0";"316.40";"0";"2.91";"GNF-Pf-4539";"CCCNC(=O)N1CCC2(CC1)CC(=O)c1cc(C)ccc1O2";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585622";"";"0";"337.43";"1";"5.52";"GNF-Pf-4540";"c1ccc2c(NCCc3c[nH]c4ccccc34)c3ccccc3nc2c1";"IFI";"'='";"5.882";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL602394";"";"0";"322.45";"0";"3.33";"GNF-Pf-2688";"CC(C)NC(=O)CN(C)C1c2ccccc2CCc2ccccc21";"IFI";"'='";"4.587";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL579120";"";"0";"501.90";"2";"7.14";"GNF-Pf-2689";"CCN(CC)CCCC(C)Nc1nc(/C=C/c2ccc(Br)cc2)nc2cc(Cl)ccc12";"IFI";"'='";"3.968";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL579121";"";"0";"482.55";"1";"3.67";"GNF-Pf-2690";"O=C(Nc1ccc(NC(=O)Nc2ccc(C3=NCCN3)cc2)cc1)Nc1ccc(C2=NCCN2)cc1";"IFI";"'='";"0.9091";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL609152";"";"0";"231.25";"0";"2.01";"GNF-Pf-2692";"CCOC(=O)c1c[nH]c2ccc(C)cc2c1=O";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL578071";"";"0";"351.49";"1";"5.92";"GNF-Pf-2701";"CC1CCC(C(C)(C)Oc2ccc(NC(=O)c3ccccc3)cc2)CC1";"IFI";"'='";"0.8333";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL583805";"";"0";"269.39";"0";"3.44";"GNF-Pf-2711";"CCN1/C(=C/c2cccc[n+]2C)Sc2ccccc21";"IFI";"";"";"";"";"";"Not applicable";"";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL578721";"";"0";"363.29";"0";"4.07";"GNF-Pf-2716";"COc1cccc2cc(C(=O)Nc3cccc(C(F)(F)F)c3)c(=O)oc12";"IFI";"'='";"2.326";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL593487";"";"0";"270.21";"0";"3.97";"GNF-Pf-2730";"Cc1oc(-c2cccc(C(F)(F)F)c2)cc1C(=O)O";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL578010";"";"0";"440.63";"0";"4.67";"GNF-Pf-2732";"CCCCCCCCCC(=O)N1CCN(C(CC)c2nc3ccccc3c(=O)n2C)CC1";"IFI";"'='";"4.63";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL576547";"";"0";"384.56";"0";"4.87";"GNF-Pf-2745";"CCN(CC)CCCC(C)NCc1ccc(OC)c(OCc2ccccc2)c1";"IFI";"'='";"7.143";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL578293";"";"0";"437.52";"1";"5.16";"GNF-Pf-2775";"Fc1ccc2[nH]c3c(N4CCN(C(c5ccccc5)c5ccccc5)CC4)ncnc3c2c1";"IFI";"'='";"14.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL579352";"";"0";"395.47";"0";"3.32";"GNF-Pf-2788";"c1ccc(-c2cc(N3CCN(c4ccccn4)CC3)nc(-c3ccccn3)n2)nc1";"IFI";"'='";"15.38";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL579355";"";"0";"416.98";"0";"3.32";"GNF-Pf-2790";"CN(C)CCn1cnc2sc3c(c2c1=O)CCC(NCc1cccc(Cl)c1)C3";"IFI";"'='";"1.961";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL533670";"";"0";"294.19";"0";"4.21";"GNF-Pf-2791";"Cc1nc2ccc(Br)cc2c(O)c1CC(C)C";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL578697";"";"0";"433.57";"0";"4.36";"GNF-Pf-2850";"Cc1ccc(N2CCN(CCNCc3ccc(F)cc3)[C@@H](Cc3ccc(O)cc3)C2)cc1";"IFI";"'='";"2.469";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL578500";"";"0";"526.00";"2";"5.45";"GNF-Pf-2863";"Clc1ccccc1-c1nc([P+](c2ccccc2)(c2ccccc2)c2ccccc2)c(N2CCOCC2)o1";"IFI";"'='";"25.93";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL534535";"";"0";"455.82";"0";"4.06";"GNF-Pf-2864";"Cl.N=c1n(CCN2CCCC2)c2ccccc2n1CC(O)c1ccc(Cl)c(Cl)c1";"IFI";"'='";"8.197";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600307";"";"0";"864.34";"2";"2.86";"GNF-Pf-2867";"CC[C@@]1(O)C[C@H](O[C@@H]2CC(N(C)C)[C@@H](O[C@@H]3C[C@@H](O)[C@@H](O[C@@H]4CCC(=O)[C@@H](C)O4)C(C)O3)[C@@H](C)O2)c2c(cc3c(c2O)C(=O)c2c(O)ccc(O)c2C3=O)[C@H]1C(=O)OC.Cl";"IFI";"'='";"21.43";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL611498";"";"0";"310.38";"0";"3.59";"GNF-Pf-2875";"COc1ccc(/C=C2\SC(=Nc3ccccc3)NC2=O)cc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL601776";"";"0";"410.86";"0";"4.37";"GNF-Pf-2883";"COC(=O)c1ccc(Nc2nc(NCc3ccco3)c3ccccc3n2)cc1.Cl";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL609462";"";"0";"308.85";"0";"3.31";"GNF-Pf-2885";"CC1(C)CC(NC(=O)Cc2ccc(Cl)cc2)CC(C)(C)N1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL579356";"";"0";"406.29";"0";"3.82";"GNF-Pf-2886";"O=C(C[n+]1cc(-c2ccc(F)cc2)n2c1CCC2)Nc1ccc(Cl)cc1.[Cl-]";"IFI";"'='";"2.703";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL604981";"";"0";"408.81";"0";"2.32";"GNF-Pf-4547";"Nc1nonc1-n1nnc(C(=O)NN=Cc2cccc(Cl)c2)c1-c1ccccc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600907";"";"0";"402.98";"0";"4.86";"GNF-Pf-4565";"S=C(Nc1ccccc1)N1CCCN(c2nc3ccc(Cl)cc3s2)CC1";"IFI";"'='";"5.691";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL598265";"";"0";"378.45";"0";"2.02";"GNF-Pf-4469";"CCOC(=O)COc1ccc(C2NC(=S)NC(C)=C2C(C)=O)cc1OC";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL528661";"";"0";"579.65";"1";"4.43";"GNF-Pf-4472";"CCOC(=O)C1=C(C)NC2=C(C(=O)C(C(=O)OCC)C(c3cccc(OC)c3)C2)C1c1cc(OC)c(OC)c(OC)c1";"IFI";"'='";"3.529";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL584826";"";"0";"357.41";"0";"4.88";"GNF-Pf-4570";"COc1ccc(NC2=C(c3ccc(OC)cc3)C(=O)c3ccccc32)cc1";"IFI";"'='";"4.762";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL604105";"";"0";"520.61";"1";"3.47";"GNF-Pf-4473";"C=CCOc1ccc(C2C(C(=O)OCC)=C(C)N=c3sc(=Cc4ccccc4O)c(=O)n32)cc1OCC";"IFI";"'='";"2.353";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600557";"";"0";"529.56";"2";"6.81";"GNF-Pf-4597";"CCC12C(=O)C(CC)(C(c3ccccc3)=C1c1ccccc1)C1C(=O)N(c3cccc(C(F)(F)F)c3)C(=O)C12";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL576753";"";"0";"542.51";"2";"6.85";"GNF-Pf-2677";"OC(CN1CCN(C2c3ccccc3-c3ccccc32)CC1)Cn1c2ccc(Cl)cc2c2cc(Cl)ccc21";"IFI";"'='";"4.615";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL577624";"";"0";"430.55";"0";"4.35";"GNF-Pf-2697";"CCN1CCN(c2cc(C)c3cc(NC(=O)C=Cc4ccc(OC)cc4)ccc3n2)CC1";"IFI";"";"";"";"";"";"Not applicable";"";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL602578";"";"0";"245.29";"0";"1.64";"GNF-Pf-2700";"CCOc1cccc2c(C)nc(NC(=N)N)nc12";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL578292";"";"0";"325.86";"0";"4.95";"GNF-Pf-2704";"CCCCCCCSc1c(O)c2ccc(Cl)cc2[nH]c1=O";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL581853";"";"0";"399.02";"1";"5.33";"GNF-Pf-330";"CCCCCCCCCCCCOCCCNC(=O)c1cccc(N)c1.Cl";"IFI";"'='";"1.974";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL240752";"";"0";"555.59";"1";"2.23";"GNF-Pf-344";"NC(=O)NN=C1c2cc(S(=O)(=O)NCc3ccco3)ccc2-c2ccc(S(=O)(=O)NCc3ccco3)cc21";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL601586";"";"0";"570.61";"1";"4.73";"GNF-Pf-346";"O=C1Nc2ccc(S(=O)(=O)Nc3ccc(NS(=O)(=O)c4ccc5c6c(cccc46)C(=O)N5)cc3)c3cccc1c23";"IFI";"'='";"2.083";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL601560";"";"0";"265.27";"0";"2.61";"GNF-Pf-348";"O=C1C=C(Nc2ccc(O)cc2)c2ccccc2C1=O";"IFI";"'='";"7.752";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL599942";"";"0";"428.99";"1";"5.70";"GNF-Pf-353";"C=CCSC1=NC2(CC(c3ccccc3)c3cc(Cl)c(O)cc3O2)CC(C)(C)N1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL601771";"";"0";"621.78";"2";"7.23";"GNF-Pf-363";"Cc1ccc(N2C3c4ccccc4N(S(=O)(=O)c4ccc(C)cc4)C2c2ccccc2N3S(=O)(=O)c2ccc(C)cc2)cc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL534346";"";"0";"726.47";"2";"7.04";"GNF-Pf-379";"O=S(=O)(NC1=CC2C(=Nc3ccc(NS(=O)(=O)c4ccc(Br)cc4)cc3N2c2ccccc2)C=C1)c1ccc(Br)cc1";"IFI";"'='";"7.143";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL582278";"";"0";"559.73";"2";"5.15";"GNF-Pf-388";"Cc1ccc(C)c(CN2C(=O)c3ccccc3S(=O)(=O)c3ccc(C(=O)NCCCN4CCCC(C)C4)cc32)c1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL581262";"";"0";"270.38";"0";"2.91";"GNF-Pf-393";"Cc1ccc(CN2CCN(Cc3ccccc3)CC2)o1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL602974";"";"0";"267.35";"0";"1.78";"GNF-Pf-394";"COCCCNC(=O)c1c(C)nc2scc(C)n12";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL602202";"";"0";"562.51";"2";"6.94";"GNF-Pf-401";"CCCCCN(C(=O)c1ccc(Br)cc1)C(CC)c1nc2ccccc2c(=O)n1-c1ccccc1OC";"IFI";"'='";"2.885";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL581053";"";"0";"398.49";"0";"1.48";"GNF-Pf-418";"Cc1cc(S(=O)(=O)N2CCN(Cc3ccccc3)CC2)ccc1-n1cnnn1";"IFI";"'='";"1.613";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL581903";"";"0";"418.50";"0";"2.26";"GNF-Pf-423";"O=C(NCC1CCCO1)c1cnc(N2CCN(c3ncccn3)CC2)c2ccccc12";"IFI";"'='";"6.061";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600750";"";"0";"434.61";"1";"6.57";"GNF-Pf-425";"CC[n+]1c(/C=C/C=C2\N(C)c3ccccc3C2(C)C)n(-c2ccccc2)c2ccc(C)cc21";"IFI";"'='";"21.43";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL582525";"";"0";"301.35";"0";"1.81";"GNF-Pf-428";"Cc1noc(C)c1C(=O)N1CCC(O)(c2ccccn2)CC1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL582528";"";"0";"545.89";"2";"6.85";"GNF-Pf-444";"COc1ccc(CN(CC2CCN(C(=O)c3ccccc3Cl)CC2)C(=O)c2ccc(Cl)cc2Cl)cc1";"IFI";"'='";"0.9346";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL601584";"";"0";"389.41";"0";"3.16";"GNF-Pf-446";"COc1ccccc1CNC(=O)CN1C(=O)c2cccnc2Oc2ccccc21";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL580640";"";"0";"484.65";"0";"3.43";"GNF-Pf-447";"COc1ccc(CCNc2nc(NCCCN3CCCC3)ncc2C(=O)NCC(C)C)cc1OC";"IFI";"'='";"0.9524";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL581274";"";"0";"449.56";"0";"2.56";"GNF-Pf-452";"CCN1C(=O)N(CC(N)=O)C(=O)C12CCN(Cc1ccc(N(C)c3ccccc3)cc1)CC2";"IFI";"'='";"3.846";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL582117";"";"0";"425.58";"1";"5.74";"GNF-Pf-457";"CCN1/C(=C/c2sc3ccc(-c4ccccc4)cc3[n+]2CCO)C=Cc2ccccc21";"IFI";"'='";"7.143";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL579556";"";"0";"449.48";"1";"2.43";"GNF-Pf-461";"CN1CCN(c2nc(NN=Cc3ccc(O)cc3)nc(Nc3ccc([N+](=O)[O-])cc3)n2)CC1";"IFI";"'='";"7.692";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL582109";"";"0";"467.57";"0";"4.68";"GNF-Pf-480";"COc1ccccc1CNc1ncc(C(=O)NCc2ccccc2)c(NCCc2ccccc2)n1";"IFI";"'='";"1.923";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL580001";"";"0";"274.39";"0";"4.63";"GNF-Pf-486";"CC[n+]1c(C=Cc2ccc(C)cc2)ccc2ccccc21";"IFI";"";"";"";"";"";"Not applicable";"";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL602822";"";"0";"408.89";"0";"4.42";"GNF-Pf-501";"COc1ccc(C2CC(c3ccccc3Cl)n3ncnc3N2C(=O)C2CC2)cc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL578708";"";"0";"317.39";"0";"3.51";"GNF-Pf-154";"NC(=O)c1ccc2c(c1)N=C(/C=C/c1ccccc1)N(C1CC1)C2";"IFI";"'='";"7.407";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL39664";"SELFOTEL";"0";"223.16";"0";"-0.38";"GNF-Pf-157";"O=C(O)[C@@H]1C[C@H](CP(=O)(O)O)CCN1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585770";"";"0";"583.56";"2";"7.99";"GNF-Pf-179";"O=C(NC(Cc1ccccc1)c1nnc(SCc2ccc(F)cc2)n1-c1ccc(Cl)cc1Cl)C1CCCCC1";"IFI";"'='";"2.083";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL525661";"";"0";"356.17";"0";"3.87";"GNF-Pf-184";"COc1ccc(NC(=O)c2c(Cl)nc(Cl)c([N+](=O)[O-])c2C)cc1";"IFI";"'='";"7.692";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL537813";"";"0";"598.79";"1";"4.76";"GNF-Pf-198";"CCCN1CCC(N2C[C@@H](NCc3ccc(OCc4ccccc4)cc3)C[C@H]2C(=O)NCCc2ccc3c(c2)OCO3)CC1";"IFI";"'='";"9.709";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL602618";"";"0";"553.60";"0";"4.35";"GNF-Pf-201";"COc1ccc(OC)c(-c2csc(N(CCCN(C)C)C(=O)Cc3ccccc3)n2)c1.O=C(O)C(F)(F)F";"IFI";"'='";"9.278";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL601131";"";"0";"532.60";"2";"8.04";"GNF-Pf-204";"O=C(Nc1ccc(-c2nc3ccc(NC(=O)c4cccc5ccccc45)cc3[nH]2)cc1)c1cccc2ccccc12";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL274346";"JATRORRHIZINE CHLORIDE";"0";"373.84";"0";"3.08";"GNF-Pf-220";"COc1cc2c(cc1O)CC[n+]1cc3c(OC)c(OC)ccc3cc1-2.[Cl-]";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL582091";"";"0";"369.47";"1";"5.03";"GNF-Pf-229";"O=[N+]([O-])c1ccc2nc(NC3CCCCC3)c(NC3CCCCC3)nc2c1";"IFI";"'='";"7.692";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL581252";"";"0";"377.40";"0";"2.78";"GNF-Pf-240";"COc1cccc(CNC(=O)Cn2ncc3c(=O)oc4ccc(C)cc4c32)c1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL582308";"";"0";"388.42";"0";"4.84";"GNF-Pf-248";"COc1cc(-c2nc(-c3ccccc3)c(-c3ccc(O)cc3)[nH]2)cc(OC)c1O";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL602182";"";"0";"352.43";"0";"3.18";"GNF-Pf-252";"COCCCNC(=O)CSCc1nc(-c2ccccc2F)oc1C";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL1186409";"";"0";"487.65";"1";"7.32";"GNF-Pf-254";"CC[n+]1c(/C=C/N(C)c2ccccc2)n(-c2ccccc2)c2ccc(-c3nc4ccccc4s3)cc21";"IFI";"'='";"29.25";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600111";"";"0";"313.20";"1";"5.05";"GNF-Pf-268";"Cc1cc(Nc2ccc(Br)cc2)nc2ccccc12";"IFI";"'='";"7.576";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600718";"";"0";"250.21";"0";"0.05";"GNF-Pf-279";"COC(=O)C1=C(OC)C(=O)OC12C=CC(=O)C=C2";"IFI";"'='";"20.45";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL238800";"";"0";"317.35";"0";"3.64";"GNF-Pf-303";"Cc1ccc2nc(Nc3nc(O)c4ccccc4n3)nc(C)c2c1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL578742";"";"0";"428.50";"0";"1.75";"GNF-Pf-2";"COc1ccc(/C=C2\SC(=S)N(CC(=O)NNC(=O)c3ccncc3)C2=O)cc1";"IFI";"'='";"1.163";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL576330";"";"0";"331.46";"0";"4.99";"GNF-Pf-16";"CN(C=Cc1sc2ccc3ccccc3c2[n+]1C)c1ccccc1";"IFI";"'='";"9.091";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL578477";"";"0";"487.36";"0";"4.17";"GNF-Pf-30";"CCCOC(=O)c1c(NC(=O)c2c(I)cnn2C)sc2c1CCCCC2";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL602986";"";"0";"840.97";"3";"-0.94";"GNF-Pf-75";"CC[C@H](C)C[C@H]1CC[C@](O)([C@](C)(O)C(=O)N[C@@H]2C(=O)N3NCCC[C@@H]3C(=O)N(O)[C@@H](C)C(=O)NCC(=O)N3NCCC[C@H]3C(=O)N(O)[C@H](C)C(=O)O[C@H]2C(C)C)O[C@@H]1C";"IFI";"'='";"34.35";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL578696";"";"0";"414.47";"0";"3.66";"GNF-Pf-84";"CCc1nc2ccc(NC(=O)c3ccncc3)cc2c(=O)n1Cc1cccc(OC)c1";"IFI";"'='";"5.128";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL579329";"";"0";"451.21";"1";"5.28";"GNF-Pf-86";"FC(F)(F)c1cccc(Nc2nc3nonc3nc2Nc2ccc(Br)cc2)c1";"IFI";"'='";"22.22";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL533909";"";"0";"593.17";"2";"9.08";"GNF-Pf-87";"CC(C)c1cccc(C(C)C)c1NC(=O)N(Cc1ccccc1)C(C)c1nc2ccccc2c(=O)n1-c1ccc(Cl)cc1";"IFI";"'='";"4.211";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL584673";"";"0";"395.38";"1";"5.89";"GNF-Pf-4072";"COc1ccc(NC2=C(c3ccc(C(F)(F)F)cc3)C(=O)c3ccccc32)cc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL582988";"";"0";"391.31";"0";"2.91";"GNF-Pf-4082";"CCOc1ccc(C(=O)C[N+]2=C(C)c3ccc(C)n3CC2)cc1.[Br-]";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL584482";"";"0";"471.67";"0";"3.82";"GNF-Pf-4083";"CC(C)CN(C(C)C(=O)NC(CN1CCCC1)c1ccccc1)S(=O)(=O)Cc1ccccc1";"IFI";"'='";"1.961";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL528181";"";"0";"324.81";"0";"4.79";"GNF-Pf-4085";"Cc1cc(Nc2ccc(Cl)cc2)nc(NCc2ccccc2)n1";"IFI";"'='";"4.615";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL596836";"";"0";"350.78";"0";"3.11";"GNF-Pf-4102";"COc1cc2nc(Nc3ccc(F)cc3)nc(N)c2cc1OC.Cl";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL601105";"";"0";"316.19";"0";"2.12";"GNF-Pf-4110";"CCc1c2ccc(C)n2cc[n+]1CC.[I-]";"IFI";"'='";"6.024";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL529295";"";"0";"681.81";"2";"7.40";"GNF-Pf-4117";"CCCN(CCC)S(=O)(=O)c1ccc(C(=O)Nc2ccccc2C(=O)Oc2ccc3c(c2)c(C(=O)OCC)c(C)n3-c2ccccc2)cc1";"IFI";"'='";"5.556";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL588394";"";"0";"486.49";"1";"5.80";"GNF-Pf-4144";"CN(CCCNc1ccc(C(=O)Nc2ccc(C(F)(F)F)cc2)cc1[N+](=O)[O-])Cc1ccccc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL599884";"";"0";"579.65";"1";"4.43";"GNF-Pf-4153";"CCOC(=O)C1=C(C)NC2=C(C(=O)C(C(=O)OCC)C(c3ccccc3OC)C2)C1c1cc(OC)c(OC)c(OC)c1";"IFI";"'='";"4.651";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL584905";"";"0";"422.48";"0";"3.58";"GNF-Pf-4157";"COc1cc2c(N3CCOCC3)cc(O)c(CC(=O)Nc3ccccc3)c2cc1OC";"IFI";"'='";"4.412";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL578469";"";"0";"495.62";"0";"2.44";"GNF-Pf-2286";"CC(C)CCn1nc(C(=O)N2CCOCC2)c2c1CCN(C(=O)c1ccc(N3CCOCC3)cc1)C2";"IFI";"'='";"2.564";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL582053";"";"0";"513.64";"2";"6.18";"GNF-Pf-1968";"COc1ccc(C(=O)N(CCCC(C)Nc2cc(OC)cc3cccnc23)Cc2ccccc2OC)cc1";"IFI";"'='";"1.587";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL586955";"";"0";"365.55";"1";"5.40";"GNF-Pf-2009";"CCN1C=C(c2ccc(C)cc2)S/C1=C\c1sc2ccccc2[n+]1C";"IFI";"'='";"14.71";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL524424";"";"0";"290.79";"0";"3.49";"GNF-Pf-2346";"CC(C)C1c2[nH]c3ccccc3c2CCN1C(=O)CCl";"IFI";"'='";"12.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL578464";"";"0";"377.51";"0";"4.02";"GNF-Pf-2361";"O=C1N(Cc2cc3ccccc3s2)CC2CN(Cc3ccccc3)CCN12";"IFI";"'='";"4.286";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL532671";"";"0";"321.42";"0";"3.88";"GNF-Pf-2063";"COc1ccc2nc(-c3ccccc3)cc(NCCN(C)C)c2c1";"IFI";"'='";"3.509";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL602191";"";"0";"346.35";"0";"2.47";"GNF-Pf-2069";"COc1cc(C(=O)Nc2cnc3ccccc3c2)ccc1-n1cnnn1";"IFI";"'='";"5.556";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL577857";"";"0";"497.85";"1";"6.29";"GNF-Pf-2495";"O=C(Nc1ccc(Cl)c(Cl)c1)Nc1cc(C(=O)NCCCN2CCCCCC2)ccc1Cl";"IFI";"'='";"5.714";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL601572";"";"0";"460.57";"1";"5.33";"GNF-Pf-2505";"COc1ccc(NC(=O)c2cc3cc(C4(O)CCN(CC5CC=CCC5)CC4)ccc3o2)cc1";"IFI";"'='";"2.542";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL599087";"";"0";"376.46";"0";"3.20";"GNF-Pf-645";"CN(C)CCCNC(=O)c1ccc(-c2cncc(-c3cccc(O)c3)n2)cc1";"IFI";"'='";"4.167";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL527303";"";"0";"469.70";"0";"4.18";"GNF-Pf-2532";"CC(C)CN1CCN(c2nc(C#N)c3c(c2C(=S)NC2CCCCC2)CC(C)(C)OC3)CC1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL579105";"";"0";"308.36";"0";"4.28";"GNF-Pf-2534";"Cc1cc(Nc2cccc(F)c2)nc(NCc2ccccc2)n1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL578723";"";"0";"224.26";"0";"2.98";"GNF-Pf-2572";"COc1ccc2nc3ccccc3c(N)c2c1";"IFI";"'='";"0.9901";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL578939";"";"0";"326.40";"0";"2.03";"GNF-Pf-2581";"COCCNCC(O)CON=C1c2ccccc2-c2ccccc21";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL584819";"";"0";"470.57";"0";"4.04";"GNF-Pf-1076";"CCOc1ccc(-n2nc(C(=O)NCCCN(C)Cc3ccccc3)c3ccccc3c2=O)cc1";"IFI";"'='";"2.632";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL530361";"";"0";"270.38";"0";"3.61";"GNF-Pf-1083";"CCCCNc1cc(C)nc(NCc2ccccc2)n1";"IFI";"'='";"8.333";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL584622";"";"0";"349.52";"1";"5.94";"GNF-Pf-1086";"C/C(=C\c1ccccc1)CN(C(=O)c1ccc(C(C)(C)C)cc1)C(C)C";"IFI";"'='";"2.151";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL584832";"";"0";"541.71";"2";"8.00";"GNF-Pf-1088";"CCCCCCN(C(=O)c1ccc(C(C)(C)C)cc1)C(CC)c1nc2ccccc2c(=O)n1-c1ccc(F)cc1";"IFI";"'='";"3.883";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585991";"";"0";"370.49";"0";"4.19";"GNF-Pf-1099";"CC(=O)O[C@]1(C(C)=O)CCC2C3C=CC4=CC(=O)CC[C@]4(C)C3CC[C@@]21C";"IFI";"'='";"2.326";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL584431";"";"0";"281.40";"0";"3.73";"GNF-Pf-1105";"C=CC[n+]1c(C=C2C=CC=CN2C)sc2ccccc21";"IFI";"'='";"7.143";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL584648";"";"0";"284.38";"0";"1.22";"GNF-Pf-1119";"CN(CC(=O)NC(C)(C)C)S(=O)(=O)c1ccccc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL578837";"";"0";"375.47";"0";"3.54";"GNF-Pf-2422";"COc1ccc(C(=O)C(C#N)=CNC2CCN(Cc3ccccc3)CC2)cc1";"IFI";"";"";"";"";"";"Not applicable";"";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL578516";"";"0";"232.25";"0";"2.73";"GNF-Pf-2434";"c1ccc2nc3c(nnc4ccccc43)nc2c1";"IFI";"'='";"15.38";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL532750";"";"0";"265.25";"0";"1.88";"GNF-Pf-2441";"N=C1NC(=O)/C(=C/C=C/c2ccc([N+](=O)[O-])o2)S1";"IFI";"'='";"9.677";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL579054";"";"0";"309.82";"0";"4.09";"GNF-Pf-2443";"Clc1ccccc1C[n+]1cc(-c2ccccc2)n2c1CCC2";"IFI";"'='";"4.762";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL578886";"";"0";"478.62";"0";"2.27";"GNF-Pf-2455";"COCCN(C(C)C(=O)NC(CN1CCCC1)c1ccccc1)S(=O)(=O)c1c(C)noc1C";"IFI";"'='";"0.9804";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL530736";"";"0";"696.80";"3";"3.54";"GNF-Pf-2474";"COc1cccc2c1C(=O)C1C(O)=C3C(=C(O)C1C2=O)CC(O)(C(C)=NN=C1CC(C)(C)N(O)C(C)(C)C1)CC3OC1CC(C)(N)C(O)CO1";"IFI";"'='";"21.43";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL578751";"";"0";"409.24";"1";"5.51";"GNF-Pf-1833";"C[n+]1c(-c2ccccc2)cc(-c2ccccc2)cc1-c1ccccc1.F[B-](F)(F)F";"IFI";"'='";"2.532";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL587064";"";"0";"507.59";"1";"4.88";"GNF-Pf-1842";"COc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)CN(C(=O)c2ccc(C)c([N+](=O)[O-])c2)C(C)C)cc1";"IFI";"'='";"0.8197";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL586162";"";"0";"366.40";"0";"3.41";"GNF-Pf-1846";"Cc1cc(NS(=O)(=O)c2ccc(N=Cc3ccc(C#N)cc3)cc2)no1";"IFI";"'='";"7.692";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL577203";"";"0";"290.25";"0";"3.79";"GNF-Pf-2184";"FC(F)(F)c1cccc(Nc2nnnc3ccccc23)c1";"IFI";"'='";"1.299";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL577645";"";"0";"483.52";"1";"6.66";"GNF-Pf-2193";"CC(C)(C)c1ccc(C(=O)Nc2ccc(NC(=O)c3ccc(-c4cccc([N+](=O)[O-])c4)o3)cc2)cc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL601567";"";"0";"349.86";"0";"3.96";"GNF-Pf-2198";"CCOc1c(Cl)cc(CNC(C)C(O)c2ccccc2)cc1OC";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL576611";"";"0";"286.40";"0";"4.50";"GNF-Pf-1922";"Cc1c[n+](Cc2ccccc2)ccc1/C=C/c1ccccc1";"IFI";"'='";"7.143";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL530719";"";"0";"382.49";"0";"4.71";"GNF-Pf-2228";"CCOc1ccc(-c2nc(NC(=O)Cc3cccc(OC)c3)sc2C)cc1";"IFI";"'='";"3.226";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL587918";"";"0";"504.68";"2";"5.97";"GNF-Pf-1939";"COc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)CN(C(=O)c2ccc(C(C)(C)C)cc2)C(C)C)cc1";"IFI";"'='";"1.869";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL588102";"";"0";"426.50";"0";"2.60";"GNF-Pf-1940";"O=C(C1CCN(S(=O)(=O)c2cccc3nonc23)CC1)N1CCCc2ccccc21";"IFI";"'='";"1.852";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL582647";"";"0";"474.97";"1";"5.11";"GNF-Pf-1948";"Cc1ccc(Cl)cc1N1C(=O)[C@@H]2C3c4ccccc4C=CN3[C@H](C(=O)c3cccs3)[C@@H]2C1=O";"IFI";"'='";"9.756";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL576544";"";"0";"428.49";"0";"3.60";"GNF-Pf-2281";"CCOc1ccc2[nH]c(=O)c(CN(CCc3ccccc3)C(=O)c3cnccn3)cc2c1";"IFI";"'='";"3.226";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585078";"";"0";"398.59";"0";"2.89";"GNF-Pf-745";"C[N+]1(CCOC(=O)CCC(=O)OCC[N+]2(C)CCCCCC2)CCCCCC1";"IFI";"'='";"3.448";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585081";"";"0";"435.55";"1";"5.37";"GNF-Pf-747";"COc1ccc2c(c1)C(C)=CC(C)(C)N2C(=O)CSc1nnc(-c2ccc(C)cc2)o1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL601388";"";"0";"304.31";"0";"2.79";"GNF-Pf-757";"COC(=O)c1cn2c(=O)c3ccccc3nc2c2ccccc12";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585276";"";"0";"455.85";"0";"3.22";"GNF-Pf-758";"COc1ccc(-c2ccc(C=NNC(=O)CNC(=O)c3ccc4c(c3)OCO4)o2)cc1Cl";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL584697";"";"0";"387.44";"0";"1.33";"GNF-Pf-762";"Cn1nc(C(C)(C)C)cc1C(=O)N1CCCN1C(=O)CNC(=O)c1ccco1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL597040";"";"0";"445.52";"0";"2.28";"GNF-Pf-778";"O=C(CN1C(=O)C2C3CCC(C3)C2C1=O)N1CCCC(c2ncncc2-c2ccncc2)C1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL602569";"";"0";"571.68";"2";"6.87";"GNF-Pf-794";"O=C1C2C(C(=O)N1Cc1ccccc1)C1(c3ccccc3)C(=O)C2(c2ccccc2)C(c2ccccc2)=C1c1ccccc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL602570";"";"0";"616.67";"2";"7.09";"GNF-Pf-795";"Cc1ccc(N2C(=O)C3C(C2=O)C2(c4ccccc4)C(=O)C3(c3ccccc3)C(c3ccccc3)=C2c2ccccc2)cc1[N+](=O)[O-]";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL597867";"";"0";"407.92";"0";"4.24";"GNF-Pf-801";"COc1cc2c(cc1OC)C(CCCCCl)=NC(C)(C)C2.O=S(=O)(O)O";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL608432";"";"0";"294.65";"0";"3.13";"GNF-Pf-802";"O=C(O)c1cc([N+](=O)[O-])ccc1Oc1cncc(Cl)c1";"IFI";"'='";"0.8333";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585213";"";"0";"399.31";"0";"3.84";"GNF-Pf-841";"O=C(Cn1c(-c2ccccc2)c[n+]2ccsc12)c1ccccc1.[Br-]";"IFI";"'='";"3.175";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL584410";"";"0";"381.44";"1";"5.21";"GNF-Pf-846";"COc1cc(/C=C(\C#N)c2nc3ccccc3[nH]2)ccc1OCc1ccccc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585606";"";"0";"515.53";"1";"5.44";"GNF-Pf-848";"O=C(Nc1cccc(Oc2ccccc2)c1)NC(CN1CCCC1)c1ccccc1.O=C(O)C(F)(F)F";"IFI";"'='";"7.042";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL602227";"";"0";"437.42";"1";"5.37";"GNF-Pf-866";"CCN(CC)CCCC(C)Nc1c2ccc(Cl)cc2nc2ccc(OC)nc12.Cl";"IFI";"'='";"9.756";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL583154";"";"0";"480.51";"0";"2.88";"GNF-Pf-870";"NC(Cc1ccccc1)C(=O)N1CCC(Nc2nsc3ccccc23)C1.O=C(O)C(F)(F)F";"IFI";"'='";"10.14";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600343";"";"0";"352.42";"0";"2.90";"GNF-Pf-874";"COc1ccccc1-n1c(=O)c2c3c(sc2n2c(C)nnc12)CCC3";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL602157";"";"0";"370.88";"1";"6.14";"GNF-Pf-879";"Clc1cccc(C(Nc2cccnc2)(c2ccccc2)c2ccccc2)c1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL584019";"";"0";"492.62";"0";"3.44";"GNF-Pf-883";"COc1ccc(CCNc2nc(NCCCN(C)C)ncc2C(=O)NCc2ccccc2)cc1OC";"IFI";"'='";"2.857";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL581697";"";"0";"440.57";"1";"5.58";"GNF-Pf-508";"COc1ccc(C2NCCc3c2[nH]c2ccccc32)cc1CSc1nc2ccccc2[nH]1";"IFI";"'='";"2.222";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL527454";"";"0";"246.19";"0";"2.15";"GNF-Pf-553";"CC(=O)Nc1cccc(NC(=O)C(F)(F)F)c1";"IFI";"'='";"4.762";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL602816";"";"0";"328.42";"0";"3.50";"GNF-Pf-568";"COc1cccc(N2C(=O)/C(=C/c3cccnc3)SC2=S)c1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL582739";"";"0";"443.53";"0";"4.44";"GNF-Pf-590";"Cc1ccc(S(=O)(=O)Nc2nc3n(n2)C(c2ccccc2)C=C(c2ccccc2)N3)cc1";"IFI";"'='";"2.247";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL577868";"";"0";"473.56";"0";"4.83";"GNF-Pf-2269";"CCc1ccc(NC(=O)c2sc3nc(N)c(C#N)c(-c4ccc(OC)c(OC)c4)c3c2N)cc1";"IFI";"'='";"1.064";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL531781";"";"0";"692.83";"2";"11.49";"GNF-Pf-1972";"c1ccc(-c2nc(-c3ccc4cccnc4c3)n(-n3c(-c4ccc5cccnc5c4)nc(-c4ccccc4)c3-c3ccccc3)c2-c2ccccc2)cc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL579159";"";"0";"264.76";"0";"3.46";"GNF-Pf-1978";"CC(CCCO)Nc1ccnc2cc(Cl)ccc12";"IFI";"'='";"4.878";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600739";"";"0";"442.13";"1";"5.14";"GNF-Pf-2312";"C[n+]1c(/C=C/c2ccc(Cl)c(Cl)c2)ccc2ccccc21.[I-]";"IFI";"'='";"2.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL576980";"";"0";"582.36";"2";"5.33";"GNF-Pf-2317";"COc1ccc(Nc2nc(NN=Cc3cccc(I)c3)nc(Nc3ccc([N+](=O)[O-])cc3)n2)cc1";"IFI";"'='";"5.814";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL578090";"";"0";"413.57";"0";"3.55";"GNF-Pf-2337";"CC(C)CNC(=O)c1cnc(NCCCn2ccnc2)nc1NCC1CCCCC1";"IFI";"'='";"0.9615";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL578092";"";"0";"418.90";"0";"2.35";"GNF-Pf-2343";"C=CCN1CCN(C(c2ccccc2F)c2nnnn2Cc2ccco2)CC1.Cl";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL611500";"";"0";"296.35";"0";"3.72";"GNF-Pf-2351";"CC1=C(CC(=O)c2cccs2)C(=O)c2ccccc2C1=O";"IFI";"'='";"6.579";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL601143";"";"0";"451.32";"1";"6.78";"GNF-Pf-2395";"CCCC[n+]1c(-c2ccccc2)cc(-c2ccccc2)cc1-c1ccccc1.F[B-](F)(F)F";"IFI";"'='";"17.46";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL577636";"";"0";"330.41";"0";"2.10";"GNF-Pf-2397";"O=C(NCC1(c2ccccc2)CCCC1)C(=O)Nc1nncs1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL602799";"";"0";"435.75";"0";"4.73";"GNF-Pf-2408";"Brc1ccc(Nc2nc(NCC3CCCO3)c3ccccc3n2)cc1.Cl";"IFI";"'='";"5.556";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL602031";"";"0";"547.10";"2";"7.39";"GNF-Pf-931";"CCOc1ccc(NC(=O)N(CCC(C)C)C(C)c2nc3ccccc3c(=O)n2-c2cccc(Cl)c2C)cc1";"IFI";"'='";"1.064";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585809";"";"0";"388.56";"0";"3.11";"GNF-Pf-936";"CC(C)CNC(=O)c1cnc(NCCC2CCCN2C)nc1NC1CCCC1";"IFI";"'='";"1.905";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL586424";"";"0";"423.31";"0";"4.13";"GNF-Pf-1855";"COc1ccc(C(=O)C(C)[n+]2cccc3ccc4cccnc4c32)cc1.[Br-]";"IFI";"'='";"7.143";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL530840";"";"0";"611.58";"2";"5.70";"GNF-Pf-1857";"OC(CN1CCN(CC(O)Cn2c3ccccc3c3cc(Br)ccc32)CC1)Cn1c2ccccc2c2ccccc21";"IFI";"'='";"7.143";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL586697";"";"0";"291.46";"0";"3.80";"GNF-Pf-1858";"CCCC1(CCC)NC(=S)N(c2ccc(C)c(C)c2)N1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL577880";"";"0";"348.37";"0";"2.31";"GNF-Pf-1890";"CC1=C(C(=O)Nc2ccccn2)C(c2ccc(O)cc2)n2ncnc2N1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL577230";"";"0";"303.77";"0";"0.48";"GNF-Pf-1915";"NNC(=O)C1CCCN1S(=O)(=O)c1ccc(Cl)cc1";"IFI";"'='";"1.053";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600722";"";"0";"383.54";"0";"3.98";"GNF-Pf-1920";"CC(C)CCNc1ncc(C(=O)NCC(C)C)c(NCCc2ccccc2)n1";"IFI";"'='";"2.913";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL578263";"";"0";"423.45";"0";"4.20";"GNF-Pf-2222";"O=C(/C=C/Nc1ccccc1NS(=O)(=O)c1ccc([N+](=O)[O-])cc1)c1ccccc1";"IFI";"'='";"1.176";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL609154";"";"0";"208.27";"0";"1.86";"GNF-Pf-1932";"Sc1nc2ccc3nsnc3c2[nH]1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL578701";"";"0";"381.50";"1";"6.03";"GNF-Pf-2241";"CC[n+]1c(C=CN(C)c2ccccc2)oc(-c2ccccc2)c1-c1ccccc1";"IFI";"'='";"22.73";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600908";"";"0";"213.62";"0";"1.59";"GNF-Pf-2243";"O=C(CCl)Nc1ccc2c(c1)OCO2";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL577423";"";"0";"392.89";"0";"4.64";"GNF-Pf-2257";"Oc1ccc(-c2ccnc3cc(Cl)ccc23)cc1CNCCCn1ccnc1";"IFI";"'='";"4.31";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600301";"";"0";"297.31";"0";"3.74";"GNF-Pf-1941";"CCOc1ccc2nc3ccc([N+](=O)[O-])cc3c(NC)c2c1";"IFI";"'='";"7.143";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL578455";"";"0";"256.35";"0";"3.98";"GNF-Pf-2278";"CC(C)(C)c1ccc2[nH]c3c(c2c1)CCCC3=NO";"IFI";"'='";"3.175";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL580132";"CLETOQUINE";"0";"307.83";"0";"3.05";"GNF-Pf-1952";"CC(CCCNCCO)Nc1ccnc2cc(Cl)ccc12";"IFI";"'='";"2.439";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL608855";"";"0";"579.12";"2";"9.64";"GNF-Pf-2300";"CC(C)(C)c1ccc(C2CC3=Nc4ccccc4N(C(=O)c4ccccc4Cl)C(c4ccc(F)cc4)C3=C(O)C2)cc1";"IFI";"'='";"7.143";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL603008";"";"0";"472.63";"1";"5.51";"GNF-Pf-2306";"CCCNC(=O)c1ccc(OC2CCN(CC(c3ccccc3)c3ccccc3)CC2)c(OC)c1";"IFI";"'='";"2.778";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL578703";"";"0";"433.27";"0";"3.18";"GNF-Pf-2309";"Cc1cc(S(=O)(=O)NC(Cc2ccc([N+](=O)[O-])cc2)C(=O)O)c(Cl)cc1Cl";"IFI";"'='";"1.031";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL579162";"";"0";"473.73";"0";"3.90";"GNF-Pf-1982";"CCN(CC)CCCNC(=S)N(CCN(CC)CC)Cc1cc2ccc(C)c(C)c2[nH]c1=O";"IFI";"'='";"2.105";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600121";"";"0";"347.29";"0";"4.69";"GNF-Pf-1989";"N=c1c2c(n(Cc3ccc(Cl)c(Cl)c3)c3c1CCC3)CCCC2";"IFI";"'='";"14.29";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL587836";"";"0";"429.32";"0";"3.90";"GNF-Pf-2005";"Cc1cc(N2CCN(C)CC2)nc2ccc(NC(=O)c3ccc(Br)o3)cc12";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL577863";"";"0";"303.22";"0";"4.32";"GNF-Pf-2330";"CCC[n+]1ccc(/C=C/c2ccc(Br)cc2)cc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL586071";"";"0";"384.56";"0";"4.87";"GNF-Pf-2020";"CCN(CC)CCCC(C)NCc1ccc(OCc2ccccc2)c(OC)c1";"IFI";"'='";"7.143";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL581207";"";"0";"332.41";"0";"2.35";"GNF-Pf-2021";"CN1CCN(c2cc(-c3ccncc3)nc(-c3cccnc3)n2)CC1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL598899";"";"0";"535.51";"2";"7.78";"GNF-Pf-2043";"CCOc1ccc(Br)cc1/C=C1\SC(=Nc2ccccc2CC)N(c2ccccc2CC)C1=O";"IFI";"";"";"";"";"";"Not applicable";"";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL579101";"";"0";"466.58";"1";"5.03";"GNF-Pf-2057";"COc1ccc(NC(=O)c2cc3cc(C4(O)CCN(CC(C)(C)C)CC4)ccc3o2)cc1OC";"IFI";"'='";"1.942";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL579102";"";"0";"279.30";"0";"3.37";"GNF-Pf-2058";"COc1ccc(/C=C/c2nc(=O)c3ccccc3o2)cc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL578915";"";"0";"253.69";"0";"1.05";"GNF-Pf-2383";"Cn1c(=O)n(C)c2cc(NC(=O)CCl)ccc21";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL577415";"";"0";"405.84";"0";"3.42";"GNF-Pf-2391";"Cn1nc(C(=O)Nc2ccc(F)c(Cl)c2)c2c1-c1ccccc1S(=O)(=O)C2";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600940";"";"0";"456.87";"0";"2.02";"GNF-Pf-2073";"O=C(NC1CC1)C1CCN(S(=O)(=O)c2ccc(Cl)cc2)CC1.O=C(O)C(F)(F)F";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL578495";"";"0";"330.43";"0";"1.40";"GNF-Pf-2080";"CCC(c1nc2ccccc2c(=O)n1CCOC)N1CCNCC1";"IFI";"'='";"3.306";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL532847";"";"0";"429.40";"0";"4.40";"GNF-Pf-2083";"OC1(c2ccc(Br)cc2)CCN(C2CCN(Cc3ccccc3)CC2)CC1";"IFI";"'='";"1.575";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL579347";"";"0";"360.26";"0";"2.74";"GNF-Pf-2099";"CC[n+]1c(C=CN(C)C)sc2ccccc21.[I-]";"IFI";"'='";"4.615";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL576379";"";"0";"332.32";"0";"2.58";"GNF-Pf-2102";"CCOC(=O)c1ccc2nc3c(nc2c1)C(=O)c1ccccc1C3=O";"IFI";"'='";"21.95";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL577206";"";"0";"365.43";"1";"5.82";"GNF-Pf-2106";"CCCCCCCc1ccc(-c2nnc(-c3ccc([N+](=O)[O-])cc3)o2)cc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL603728";"";"0";"273.34";"0";"4.04";"GNF-Pf-2111";"O=C(c1ccc2ccccc2c1)N1CCc2ccccc21";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600098";"";"0";"308.41";"0";"4.20";"GNF-Pf-2116";"Cc1ccc(/C=C2/SC(=Nc3ccccc3)NC2=O)c(C)c1";"IFI";"'='";"3.409";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL577000";"";"0";"360.42";"0";"4.98";"GNF-Pf-2118";"CCOc1ccc(Nc2nc(NCc3ccco3)c3ccccc3n2)cc1";"IFI";"'='";"3.846";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL577214";"";"0";"400.50";"0";"2.05";"GNF-Pf-2119";"Cn1nc(C(=O)NCc2ccc(F)cc2)c2c1CCC(N1CCC(CO)CC1)C2";"IFI";"'='";"1.25";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600914";"";"0";"328.37";"0";"1.48";"GNF-Pf-2124";"CCN(C(C)=O)C1=C(N2CCOCC2)C(=O)c2ccccc2C1=O";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600129";"";"0";"378.52";"0";"4.91";"GNF-Pf-2125";"C=C[C@H]1CN2CC[C@H]1C[C@H]2[C@H](OC(=O)CCCC)c1ccnc2ccccc12";"IFI";"'='";"4.587";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL602397";"";"0";"442.91";"0";"4.05";"GNF-Pf-2131";"N#C/C(=C\c1cn(Cc2ccccc2Cl)c2ccccc12)c1nn(CCO)c(N)c1C#N";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL579109";"";"0";"420.52";"1";"5.15";"GNF-Pf-2138";"CCCN1CCC(N2CCCC(c3[nH]ncc3-c3cccc(C(F)(F)F)c3)C2)CC1";"IFI";"'='";"1.923";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL577604";"";"0";"306.28";"0";"3.68";"GNF-Pf-2145";"N#CC(=CC=Cc1ccc([N+](=O)[O-])o1)c1nc2ccccc2[nH]1";"IFI";"";"";"";"";"";"Not applicable";"";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL602165";"";"0";"577.73";"2";"6.11";"GNF-Pf-2148";"CCc1ccc(N(C(=O)CCN2CCc3ccccc32)C(C(=O)NCc2ccccc2)c2ccc(OC)c(OC)c2)cc1";"IFI";"'='";"3.333";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL577396";"";"0";"434.47";"0";"3.77";"GNF-Pf-2153";"COc1ccc(S(=O)(=O)N=C2C=C(Nc3ccc(O)cc3)C(=O)c3ccccc32)cc1";"IFI";"'='";"23.08";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585379";"";"0";"600.70";"3";"5.51";"GNF-Pf-2154";"CCOc1cccc2c1N(C(=O)c1cccc([N+](=O)[O-])c1)C(C)(C)C(=S)C2=C1SC(C(=O)OC)=C(C(=O)OC)S1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL577405";"";"0";"406.66";"1";"6.08";"GNF-Pf-2159";"CC1(C)C=C(C23C=CC(C2)C2C(=C4CC(C)(C)NC(C)(C)C4)C=CC23)CC(C)(C)N1";"IFI";"'='";"6.154";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL577838";"";"0";"403.34";"0";"3.17";"GNF-Pf-2163";"CCCCN(CC)S(=O)(=O)c1cc(Br)cc2c1N(C(C)=O)CC2";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL587658";"";"0";"351.24";"0";"3.43";"GNF-Pf-2170";"Cl.OCCNc1nc(Nc2ccc(Cl)cc2)nc2ccccc12";"IFI";"'='";"1.471";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL579339";"";"0";"423.56";"0";"3.22";"GNF-Pf-2176";"CCCCc1nc(CN2CCC3(CC2)C(=O)N(CCc2ccccc2)C(=O)N3C)c[nH]1";"IFI";"'='";"10.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL587655";"";"0";"412.56";"0";"4.50";"GNF-Pf-1513";"COc1cc2nc(CN(C)C(C)c3cccs3)nc(N3CCCC3)c2cc1OC";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL588625";"";"0";"368.39";"0";"3.70";"GNF-Pf-1518";"COc1ccc(C2=C/C(=C/c3cccc(OC)c3OC)C(=O)O2)cc1OC";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL586580";"";"0";"340.42";"0";"2.14";"GNF-Pf-1520";"O=C(CCN1C(=O)C2CCCCC2C1=O)N1CCc2ccccc2C1";"IFI";"'='";"1.562";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL588108";"";"0";"571.04";"2";"8.23";"GNF-Pf-1522";"COc1cc(NC(C)CCCN(Cc2ccc(Cl)cc2)C(=O)Nc2cccc(C(F)(F)F)c2)c2ncccc2c1";"IFI";"'='";"2.703";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL588153";"";"0";"427.44";"0";"3.77";"GNF-Pf-1527";"Cc1cc(C)nc(SCc2cc(=O)c(OC(=O)c3cccc([N+](=O)[O-])c3C)co2)n1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL582442";"";"0";"332.43";"0";"2.20";"GNF-Pf-1532";"CCN(CC)c1ccc2cc(C(C)=NNC(N)=S)c(=O)oc2c1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL581907";"";"0";"326.83";"1";"5.07";"GNF-Pf-509";"Clc1ccc2[nH]c3c(NCCC4=CCCCC4)ncnc3c2c1";"IFI";"'='";"15.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL580849";"";"0";"362.43";"0";"3.41";"GNF-Pf-519";"Cc1cc(C)c2nc(NS(=O)(=O)c3cccc(C(=O)O)c3)sc2c1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL580071";"";"0";"306.39";"0";"1.78";"GNF-Pf-521";"C=CCNC(=S)N1CCN(c2ccc([N+](=O)[O-])cc2)CC1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL582119";"";"0";"465.62";"1";"7.40";"GNF-Pf-528";"CCOc1ccc(-n2cc(-c3ccccc3)c3c(SCc4cc(C)ccc4C)ncnc32)cc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL581479";"";"0";"488.57";"0";"4.64";"GNF-Pf-535";"Cc1c(C(=O)N2CCN(c3ccc([N+](=O)[O-])cc3)CC2)sc2ncnc(N(C)c3ccccc3)c12";"IFI";"'='";"1.163";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600893";"";"0";"231.21";"0";"1.65";"GNF-Pf-545";"CC(=NOC(=O)c1ccco1)c1cnccn1";"IFI";"'='";"2.632";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL582113";"";"0";"480.88";"0";"3.56";"GNF-Pf-567";"COc1ccc(-n2nc(C(=O)NCC(=O)Nc3ccc(F)cc3)c3ccccc3c2=O)cc1Cl";"IFI";"'='";"3.488";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL601591";"";"0";"421.57";"0";"4.28";"GNF-Pf-569";"COC(=O)C1=C(C(=O)OC)SC(=C2C(=S)C(C)(C)Nc3cc(C)ccc32)S1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL584864";"";"0";"423.52";"0";"4.27";"GNF-Pf-1131";"CN(CCCNc1nc2ccccc2c2nc(-c3cccnc3)nn12)Cc1ccccc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL602629";"";"0";"545.51";"2";"6.76";"GNF-Pf-1133";"CCCCCN(CC(=O)Nc1cc(C(C)(C)C)nn1-c1ccc(Cl)c(Cl)c1)C(=O)c1cccc(OC)c1";"IFI";"'='";"1.887";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL584662";"";"0";"359.47";"0";"3.56";"GNF-Pf-1138";"CCOC(=O)c1cnc2ccc(OCC)cc2c1NCCN(CC)CC";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL584612";"";"0";"556.66";"2";"6.72";"GNF-Pf-1152";"O=C(NCCCCCCNC(=O)Nc1nc(-c2ccc(F)cc2)cs1)Nc1nc(-c2ccc(F)cc2)cs1";"IFI";"'='";"3.175";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL601540";"";"0";"291.31";"0";"2.70";"GNF-Pf-1215";"O=C(NN=Cc1cc2ccccc2cc1O)c1cccnc1";"IFI";"'='";"7.143";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL579834";"";"0";"508.66";"2";"5.85";"GNF-Pf-1218";"CCCCNC(=O)N(CCCC(C)Nc1cc(OC)cc2cccnc12)Cc1ccc(OC)c(OC)c1";"IFI";"'='";"2.857";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585797";"";"0";"427.44";"0";"3.66";"GNF-Pf-1243";"COc1ccc(NS(=O)(=O)c2cccc(C(=O)Nc3ccccc3[N+](=O)[O-])c2)cc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL583557";"";"0";"429.31";"0";"4.21";"GNF-Pf-1250";"CCOC(=O)C1=C(C)N/C(=C\c2cc(C)n(-c3cccc(Br)c3)c2C)C1=O";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585059";"";"0";"301.34";"0";"3.35";"GNF-Pf-1266";"CCOc1ccc(C(=O)Nc2cc(OC)ccc2OC)cc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL602225";"";"0";"321.38";"0";"3.32";"GNF-Pf-1273";"Cc1ccccc1CNC(=O)c1oc2c(c1C)-c1[nH]ncc1CC2";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585076";"";"0";"435.46";"0";"3.89";"GNF-Pf-1293";"COc1cccc(NC(=O)c2ccc3oc(=O)c(S(=O)(=O)c4ccccc4)cc3c2)c1";"IFI";"'='";"9.091";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL601337";"";"0";"335.40";"0";"2.60";"GNF-Pf-1558";"CCc1cc(=O)n(C)c(SC(C)C(=O)Nc2ccc(F)cc2)n1";"IFI";"'='";"3.158";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL579373";"";"0";"336.41";"0";"1.98";"GNF-Pf-1565";"Cc1cccc(C)c1N(CC(=O)NCc1ccco1)S(C)(=O)=O";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL607688";"";"0";"460.56";"0";"4.89";"GNF-Pf-1601";"Cc1ccc(S(=O)(=O)c2c(COC(=O)c3cccc(C)c3)c(-c3ccccc3)nn2C)cc1";"IFI";"'='";"3.896";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585586";"";"0";"540.62";"1";"4.34";"GNF-Pf-1641";"COc1cc(C=CC(=O)Nc2ccc3nc(N4CCN(c5ncccn5)CC4)cc(C)c3c2)cc(OC)c1OC";"IFI";"";"";"";"";"";"Not applicable";"";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL601784";"";"0";"527.67";"2";"6.49";"GNF-Pf-1646";"COc1cc(NC(C)CCCN(Cc2ccc(OC)c(OC)c2)C(=O)c2ccccc2C)c2ncccc2c1";"IFI";"'='";"0.9259";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL577457";"";"0";"361.41";"0";"4.46";"GNF-Pf-1650";"COc1ccc(Nc2nc(Nc3ccc(OC)cc3)c3[nH]ccc3n2)cc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL579028";"";"0";"443.50";"0";"4.27";"GNF-Pf-1656";"COc1ccc(NC(=O)Cn2c(-c3ccc(OC)cc3)cn(-c3ccc(C)cc3)c2=O)cc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL588043";"";"0";"529.42";"1";"4.94";"GNF-Pf-1661";"CCC1=NN2C(=N)/C(=C/c3ccc(OCCOc4ccc(Br)cc4)c(OC)c3)C(=O)N=C2S1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL586290";"";"0";"459.54";"0";"3.75";"GNF-Pf-1673";"CCCN(CCC)C(=O)c1c[nH]c2ccc(S(=O)(=O)N(C)c3ccc(F)cc3)cc2c1=O";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL588350";"";"0";"513.09";"0";"2.51";"GNF-Pf-1674";"CC1CCN(S(=O)(=O)c2ccc(C(=O)Nc3sc4c(c3C(N)=O)CCN(C)C4)cc2)CC1.Cl";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL584631";"";"0";"348.49";"0";"3.93";"GNF-Pf-1365";"CCCCN1C(=O)/C(=C/N(C(=O)CC)c2ccccc2)SC1=S";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL586650";"";"0";"516.62";"2";"6.71";"GNF-Pf-1385";"COc1cc(NC(C)CCCN(Cc2ccccc2OC)C(=O)Nc2cccc(F)c2)c2ncccc2c1";"IFI";"'='";"4.808";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL578504";"";"0";"380.27";"0";"3.23";"GNF-Pf-2708";"CC[n+]1ccccc1C=Cc1ccc(N(C)C)cc1.[I-]";"IFI";"'='";"6.569";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL601973";"";"0";"321.31";"0";"1.22";"GNF-Pf-1400";"O=C(NNS(=O)(=O)c1ccccc1[N+](=O)[O-])c1ccccc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL602188";"";"0";"421.57";"1";"5.29";"GNF-Pf-1430";"CN(C)c1ccc(/C=C/c2cc(/C=C/c3ccc(N(C)C)cc3)[n+]3ccccc3n2)cc1";"IFI";"'='";"21.43";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL601379";"";"0";"499.63";"1";"6.62";"GNF-Pf-1471";"COc1cc(NC(C)CCCN(Cc2ccc(F)cc2)C(=O)CCc2ccccc2)c2ncccc2c1";"IFI";"'='";"1.709";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL582670";"";"0";"452.62";"0";"4.90";"GNF-Pf-1472";"CC(C)CN(CC(=O)Nc1cc(C(C)(C)C)nn1-c1ccccc1)C(=O)Cc1cccs1";"IFI";"'='";"0.9346";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL582464";"";"0";"342.49";"0";"4.83";"GNF-Pf-1473";"c1ccc2c(c1)ccc[n+]2CCCCCC[n+]1cccc2ccccc21";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL579371";"";"0";"519.62";"2";"6.59";"GNF-Pf-1493";"Cc1ccc(-n2c(C(C)N(CCc3ccccc3)C(=O)c3cccc(F)c3)nc3ccccc3c2=O)c(C)c1";"IFI";"'='";"0.9434";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL584212";"";"0";"486.66";"0";"4.74";"GNF-Pf-1328";"CC1CCCCN1CCCNc1ncc(C(=O)NCc2ccccc2)c(NCCc2ccccc2)n1";"IFI";"'='";"3.922";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600353";"";"0";"436.38";"0";"4.79";"GNF-Pf-1339";"CCCCCC[n+]1ccccc1C=Cc1ccc(N(C)C)cc1.[I-]";"IFI";"'='";"27.56";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL583361";"";"0";"527.34";"2";"5.21";"GNF-Pf-4648";"CCN1CCN(Cc2c(O)ccc3c(=O)c(Oc4ccccc4Br)c(C(F)(F)F)oc23)CC1";"IFI";"'='";"1.163";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL602222";"";"0";"458.56";"0";"4.03";"GNF-Pf-4666";"CCCCN(C(=O)CCC(=O)Nc1cc(C)on1)C(C(=O)NC1CCCC1)c1ccc(C)o1";"IFI";"'='";"1.818";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL584658";"";"0";"511.61";"1";"3.72";"GNF-Pf-4676";"Cn1c(=O)n(Cc2ccccc2)c(=O)c2c1nc(SCC(=O)Nc1ccccc1)n2Cc1ccccc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL605816";"";"0";"419.99";"0";"4.80";"GNF-Pf-4685";"CCC1(C)CC(CCNCc2ccccc2O)(c2ccc(OC)cc2)CCO1.Cl";"IFI";"'='";"1.887";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600098";"";"0";"308.41";"0";"4.20";"GNF-Pf-4699";"Cc1ccc(/C=C2/SC(=Nc3ccccc3)NC2=O)c(C)c1";"IFI";"";"";"";"";"";"Not applicable";"";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL577448";"";"0";"439.53";"0";"4.30";"GNF-Pf-5453";"COC(=O)C1=C(C)NC2=C(C(=O)CC(c3ccc(OC)c(OC)c3)C2)C1c1cccs1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL582646";"";"0";"485.63";"1";"7.16";"GNF-Pf-5488";"COc1cccc(C(=O)Oc2ccccc2-c2nc3cc(C)ccn3c2NC(C)(C)CC(C)(C)C)c1";"IFI";"'='";"3.738";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL580146";"";"0";"338.45";"0";"3.54";"GNF-Pf-5500";"CC1CCN(C2=C(NC3CCCC3)C(=O)c3ccccc3C2=O)CC1";"IFI";"'='";"14.29";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL578949";"";"0";"298.39";"0";"3.45";"GNF-Pf-5506";"COc1cccc(-c2ccc(O)c(CN3CCCCC3)c2)n1";"IFI";"'='";"1.724";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585216";"";"0";"308.37";"0";"3.30";"GNF-Pf-4774";"Cc1nc2ncccn2c1-c1csc(Nc2ccccn2)n1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL584425";"";"0";"571.94";"2";"8.52";"GNF-Pf-4795";"COc1cc(NC(C)CCCN(Cc2ccc(Cl)cc2)C(=O)Nc2ccc(Cl)cc2Cl)c2ncccc2c1";"IFI";"'='";"1.802";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL604364";"";"0";"411.35";"0";"4.97";"GNF-Pf-4805";"CC[n+]1c(C=C2C=C(C)CC(C)C2)sc2ccccc21.[I-]";"IFI";"";"";"";"";"";"Not applicable";"";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585439";"";"0";"489.58";"0";"3.79";"GNF-Pf-4809";"CCC(C(=O)NCc1ccc(OC)c(OC)c1)n1nc(C)c2c(C)n(-c3ccc(C)cc3)nc2c1=O";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585442";"";"0";"433.60";"1";"6.72";"GNF-Pf-4813";"CC(C)(C)CC(C)(C)Nc1c(-c2ccccc2OC(=O)C2CCCC2)nc2ccccn12";"IFI";"'='";"3.774";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL524251";"";"0";"410.30";"1";"6.15";"GNF-Pf-4822";"Cc1ccnc(NC(c2cccc(Cl)c2Cl)c2ccc3cccnc3c2O)c1";"IFI";"'='";"7.692";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL528968";"";"0";"445.80";"0";"4.93";"GNF-Pf-4847";"Br.CC(=O)Nc1nc(C)c(-c2csc(Nc3ccc(Cl)cc3)n2)s1";"IFI";"'='";"5.814";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585609";"";"0";"416.57";"1";"5.03";"GNF-Pf-4862";"COc1ccc(CNC2CCN(Cc3ccccc3)CC2)cc1OCc1ccccc1";"IFI";"'='";"14.29";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585644";"";"0";"431.54";"1";"5.46";"GNF-Pf-4896";"COc1ccc(-c2nc3ccccc3n2C2CCN(Cc3ccc(C)o3)CC2)cc1OC";"IFI";"'='";"0.9615";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585460";"";"0";"458.61";"0";"4.65";"GNF-Pf-4899";"C=CCNC(=O)c1ccc2c(c1)N=C(CC(C)c1ccccc1)N(CCCN1CCCC1=O)C2";"IFI";"'='";"1.235";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585645";"";"0";"412.54";"1";"5.10";"GNF-Pf-4900";"CC(C)CC1=Nc2cc(C(=O)NCc3ccccc3)ccc2CN1Cc1cccnc1";"IFI";"'='";"3.797";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL1744503";"";"0";"866.10";"3";"4.98";"GNF-Pf-5105";"CC=C[C@H]1O[C@@](O)([C@H](C)C(O)C(C)[C@@H]2OC(=O)C(OC)=CC(C)=C[C@H](C)[C@H](O)[C@H](CC)[C@H](O)C(C)CC(C)=CC=C[C@H]2OC)C[C@@H](O[C@@H]2C[C@H](O)[C@@H](OC(N)=O)[C@H](C)O2)[C@@H]1C";"IFI";"'='";"15.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL586021";"";"0";"395.53";"1";"5.31";"GNF-Pf-5115";"CCN(C(=O)CSc1nc(-c2ccc(C(C)C)cc2)no1)c1cccc(C)c1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL603727";"";"0";"411.51";"0";"1.62";"GNF-Pf-5148";"CCCN1CCN(C(=O)C(=O)Nc2ccc3nc4n(c(=O)c3c2)CCCCC4)CC1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL601971";"";"0";"298.82";"0";"3.65";"GNF-Pf-5273";"N=c1c2c(n(Cc3ccc(Cl)cc3)c3c1CCC3)CCC2";"IFI";"'='";"7.143";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL580533";"";"0";"364.40";"0";"4.37";"GNF-Pf-5281";"CCOC(=O)c1cnc2c(OC)cccc2c1Nc1ccc(C(C)=O)cc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL579939";"";"0";"417.55";"1";"6.25";"GNF-Pf-5295";"COc1ccc2c(c1)-c1c(ssc1=S)C(C)(C)N2C(=O)c1ccccc1F";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL599919";"";"0";"435.61";"1";"6.89";"GNF-Pf-5302";"Cc1ccn2c(NC(C)(C)CC(C)(C)C)c(-c3ccccc3OC(=O)CC(C)C)nc2c1";"IFI";"'='";"4.673";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL583530";"";"0";"626.50";"2";"7.47";"GNF-Pf-5308";"C[N+](C)(CCCC(=O)c1ccc(C(=O)CCC[N+](C)(C)Cc2ccccc2Cl)cc1)Cc1ccccc1Cl.[Cl-].[Cl-]";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL578951";"";"0";"526.46";"2";"6.85";"GNF-Pf-5575";"COc1ccc(C2CC(=O)C3=C(C2)NC(C)=C(C(=O)OC2CCCC2)C3c2ccc(Cl)cc2Cl)cc1";"IFI";"'='";"5.882";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL582322";"";"0";"518.57";"2";"6.93";"GNF-Pf-5581";"COC(=O)c1ccc(C2C3=C(O)CC(c4ccco4)CC3=Nc3ccccc3N2C(=O)c2ccccc2)cc1";"IFI";"'='";"2.41";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL601147";"";"0";"500.42";"2";"6.32";"GNF-Pf-5592";"CCCOC(=O)C1=C(C)NC2=C(C(=O)CC(c3ccc(OC)cc3)C2)C1c1cccc(Cl)c1Cl";"IFI";"'='";"7.143";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL576376";"";"0";"435.50";"0";"4.76";"GNF-Pf-5605";"CCOC(=O)C1=C(C)NC2=C(C(=O)CC(c3ccc(OC)cc3)C2)C1c1ccccc1F";"IFI";"'='";"3.488";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL530973";"";"0";"456.51";"0";"4.03";"GNF-Pf-5607";"CCOC(=O)c1cn(CC)c2cc(N(C)CCc3ccc(OC)c(OC)c3)c(F)cc2c1=O";"IFI";"'='";"4.688";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL499519";"NOCARDIMICIN B";"0";"757.93";"3";"5.91";"GNF-Pf-5618";"CCCCCCCCCCCC(OC(=O)C(CCCCN(O)C(C)=O)NC(=O)c1coc(-c2ccccc2O)n1)C(C)C(=O)NC1CCCCN(O)C1=O";"IFI";"'='";"6.897";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL577213";"";"0";"530.45";"2";"6.32";"GNF-Pf-5621";"COc1ccc(C2CC(=O)C3=C(C2)NC(C)=C(C(=O)OC(C)C)C3c2cccc(Cl)c2Cl)cc1OC";"IFI";"'='";"4.762";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL477328";"";"0";"420.56";"0";"3.35";"GNF-Pf-3071";"O=C(CN1CCCC1)Nc1ccc(Cc2ccc(NC(=O)CN3CCCC3)cc2)cc1";"IFI";"'='";"1.075";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL602177";"";"0";"296.35";"0";"2.82";"GNF-Pf-3074";"O=C1NC(=S)NC1=Cc1cccc(Oc2ccccc2)c1";"IFI";"";"";"";"";"";"Not applicable";"";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL602419";"";"0";"368.31";"0";"4.41";"GNF-Pf-3083";"CN(CCCNc1ccnc2cc(Cl)ccc12)C(=O)C(C)(C)CCl";"IFI";"'='";"4.63";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL601559";"";"0";"189.26";"0";"2.52";"GNF-Pf-3097";"CC(=O)Nc1ccc2c(c1)CCCC2";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL602200";"";"0";"356.47";"0";"2.18";"GNF-Pf-3102";"CC(c1nc2ccccc2c(=O)n1C)N1CCN(C(=O)C(C)(C)C)CC1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL588053";"";"0";"445.52";"1";"5.68";"GNF-Pf-3103";"CCOc1cc(C(=O)Nc2ccc(-c3nc4ccccc4[nH]3)cc2)cc(OCC)c1OCC";"IFI";"'='";"4.706";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL602383";"";"0";"599.78";"1";"3.41";"GNF-Pf-3107";"O=C(CSc1nc2ccccc2c(=O)n1CCCN1CCOCC1)Nc1cccc(S(=O)(=O)N2CCCCCC2)c1";"IFI";"'='";"3.03";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600147";"";"0";"421.59";"1";"6.64";"GNF-Pf-3109";"CCCC(=O)Oc1ccccc1-c1nc2cc(C)ccn2c1NC(C)(C)CC(C)(C)C";"IFI";"'='";"4.63";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL582687";"";"0";"308.17";"0";"3.79";"GNF-Pf-3117";"Cc1cc(Nc2cc(Cl)cc(Cl)c2)n2nc(C)nc2n1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL368715";"";"0";"244.69";"0";"2.53";"GNF-Pf-3118";"Clc1ncnc2ncn(Cc3ccccc3)c12";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL601160";"";"0";"458.48";"0";"1.15";"GNF-Pf-3121";"Cn1c(=O)[nH]c(=O)c2c1nc(N1CCCCCC1)n2CC(O)COc1ccc([N+](=O)[O-])cc1";"IFI";"'='";"2.381";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL601557";"";"0";"233.38";"0";"3.92";"GNF-Pf-3130";"Cc1nc(C23CC4CC(CC(C4)C2)C3)cs1";"IFI";"'='";"2.02";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL581877";"";"0";"398.53";"0";"4.69";"GNF-Pf-3133";"CC(C)Cc1ccc(-c2csc(NC(=O)C3C4CCC(C4)C3C(=O)O)n2)cc1";"IFI";"'='";"4.651";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL1744509";"";"0";"386.40";"0";"3.27";"GNF-Pf-3134";"COC(=O)COc1ccc(/C=C2/SC(=Nc3ccc(F)cc3)NC2=O)cc1";"IFI";"";"";"";"";"";"Not applicable";"";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL579761";"";"0";"300.36";"0";"3.52";"GNF-Pf-3145";"OCCSc1nc(-c2ccccc2)nc2ccc(F)cc12";"IFI";"'='";"1.562";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL581473";"";"0";"503.54";"1";"4.76";"GNF-Pf-3158";"CCOC(=O)c1ccc(NC(=O)c2ccc3nc(NC(=O)c4ccc(C(=O)OC)cc4)sc3c2)cc1";"IFI";"'='";"1.493";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600305";"";"0";"657.77";"2";"7.70";"GNF-Pf-3159";"COc1ccc(C(C)=O)cc1N1C(=O)C2C(C1=O)C1(c3ccccc3)C(=O)C2(c2ccccc2)C(c2ccc(C)cc2)=C1c1ccc(C)cc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600099";"";"0";"351.42";"0";"4.36";"GNF-Pf-5625";"CN(Cc1cc(-c2ccc(F)cc2)ccc1O)CC(O)c1ccccc1";"IFI";"'='";"0.8547";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL535079";"";"0";"426.54";"0";"4.88";"GNF-Pf-5629";"CCOC(=O)c1c(NC(=O)c2ccccc2)sc2c(O)c(CN(CC)CC)ccc12";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL602208";"";"0";"256.33";"0";"3.45";"GNF-Pf-3401";"Cc1sc2ncnc(Nc3ccncc3)c2c1C";"IFI";"'='";"2.703";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600925";"";"0";"406.90";"0";"4.44";"GNF-Pf-3414";"BrC(Br)(Br)c1ncc(-c2ccccc2)cn1";"IFI";"'='";"7.143";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL581856";"";"0";"532.69";"1";"2.34";"GNF-Pf-3429";"Cc1noc(C)c1S(=O)(=O)N(Cc1ccccc1)CC(O)CN1CCC(NC(=O)Cc2cccs2)C1";"IFI";"'='";"0.9615";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600547";"";"0";"479.55";"1";"5.45";"GNF-Pf-3434";"COc1cc2c(cc1OC)C(COc1ccc(F)cc1)N(C(=O)c1ccc(OC(C)C)cc1)CC2";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL533955";"";"0";"442.54";"1";"5.07";"GNF-Pf-3448";"Cc1ccc(NC(=O)c2ccc(NCCCN3CC(C)CC(C)C3)c([N+](=O)[O-])c2)cc1F";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL582707";"";"0";"461.99";"1";"6.02";"GNF-Pf-3461";"COc1cccc(NC(=O)c2ccc(NCCCC3CCCCCC3)c([N+](=O)[O-])c2)c1.Cl";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL598063";"";"0";"458.48";"1";"6.00";"GNF-Pf-3821";"CCOC(=O)c1cc(-c2ccc(C)cc2)n(CCC(=O)Nc2cccc(C(F)(F)F)c2)c1C";"IFI";"'='";"2.703";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL596848";"";"0";"398.93";"0";"4.73";"GNF-Pf-3826";"C=C[C@H]1CN2CC[C@H]1C[C@@H]2[C@@H](OC(=O)CCCCl)c1ccnc2ccccc12";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL597050";"";"0";"432.52";"0";"4.09";"GNF-Pf-3829";"CC(=O)N(C1=C(N2CCOCC2)C(=O)c2ccccc2C1=O)c1ccc(C(C)C)c(C)c1";"IFI";"'='";"7.692";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL528382";"";"0";"328.38";"0";"4.80";"GNF-Pf-3830";"C(=NNc1nc2ccccc2[nH]1)c1cccc(Oc2ccccc2)c1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL598494";"";"0";"348.41";"0";"2.27";"GNF-Pf-3843";"COc1cncc(-c2cncc(N3CCN(c4ccncc4)CC3)n2)c1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL583647";"";"0";"419.91";"1";"5.45";"GNF-Pf-3870";"Cc1cccn2c(NCc3ccccc3)c(-c3ccccc3OC(=O)C(C)Cl)nc12";"IFI";"'='";"4.673";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL599497";"";"0";"407.56";"1";"6.64";"GNF-Pf-3880";"CCN(CC)c1ccc(N=Cc2ccc(Sc3nc4ccccc4s3)o2)cc1";"IFI";"'='";"9.302";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL610503";"";"0";"357.57";"0";"3.98";"GNF-Pf-3887";"S=C(NC1CCCCC1)NC1CC2CCC(C1)N2Cc1ccccc1";"IFI";"'='";"1.266";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL606382";"";"0";"447.44";"1";"6.99";"GNF-Pf-3895";"CCC(C)(C)C1CCc2sc3ncnc(NN=Cc4c(Cl)cccc4Cl)c3c2C1";"IFI";"'='";"4.412";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL598698";"";"0";"561.41";"0";"1.52";"GNF-Pf-3912";"Cn1nccc1C(OCC(=O)N1CCOCC1)c1ccc(F)cc1.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F";"IFI";"'='";"1.961";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL584508";"";"0";"436.56";"0";"4.96";"GNF-Pf-3947";"O=C(NCCCN1CCCCC1)c1ccc2c(c1)sc1nc(-c3ccc(F)cc3)cn12";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL597650";"";"0";"508.50";"2";"2.64";"GNF-Pf-3952";"COc1c(C=NNc2nc(Nc3ccc([N+](=O)[O-])cc3)nc(N3CCN(C)CC3)n2)cccc1[N+](=O)[O-]";"IFI";"'='";"6.494";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585272";"";"0";"374.49";"0";"3.60";"GNF-Pf-4224";"Oc1ccc(-c2cncnc2)cc1CNC1CCN(Cc2ccccc2)CC1";"IFI";"'='";"1.01";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL604978";"";"0";"443.59";"0";"4.94";"GNF-Pf-3322";"COC(=O)c1sc2nc(CN3CCCC(C)C3)ccc2c1NC(=O)c1ccc(C)s1";"IFI";"'='";"0.8696";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL599907";"";"0";"193.23";"0";"2.06";"GNF-Pf-3323";"CC1=NOC(=O)C1=Cc1cccs1";"IFI";"";"";"";"";"";"Not applicable";"";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL535474";"";"0";"582.62";"2";"8.69";"GNF-Pf-3327";"Cc1ccc(C2CC3=Nc4ccccc4N(C(=O)C(F)(F)F)C(c4ccc(OCc5ccccc5)cc4)C3=C(O)C2)cc1";"IFI";"'='";"2.439";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL581883";"";"0";"547.64";"1";"4.49";"GNF-Pf-3329";"CCOC(=O)C1=C(c2ccccc2)N=c2sc(=Cc3cccnc3)c(=O)n2C1c1c(OC)ccc2ccccc12";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL599494";"";"0";"397.60";"1";"5.59";"GNF-Pf-3693";"CCC(C)(C)c1ccc(OCC(O)CNCc2ccccc2)c(C(C)(C)CC)c1";"IFI";"'='";"4.545";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL599495";"";"0";"315.37";"0";"3.54";"GNF-Pf-3694";"O=C1C2C(C(=O)N1c1cccc3ccccc13)C1C=CC2C12CC2";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL576607";"";"0";"333.19";"0";"3.74";"GNF-Pf-3715";"Cc1occc1C(=O)NN=C/C(Br)=C/c1ccccc1";"IFI";"";"";"";"";"";"Not applicable";"";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL602153";"";"0";"252.74";"0";"2.85";"GNF-Pf-3771";"O=C(CCl)Nc1ccc(N2CCCCC2)cc1";"IFI";"'='";"7.692";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL584668";"";"0";"280.33";"0";"3.77";"GNF-Pf-4068";"COc1ccc(-c2cc(-c3ccc(C)cc3)[nH]n2)c(O)c1";"IFI";"'='";"10.61";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL601746";"";"0";"261.41";"0";"4.99";"GNF-Pf-4906";"CCCCCCCCC(=O)Nc1c(C)cccc1C";"IFI";"'='";"0.9615";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL343286";"";"0";"252.28";"0";"2.59";"GNF-Pf-4916";"Nc1nc(N)c2c(Oc3ccccc3)cccc2n1";"IFI";"'='";"14.29";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585611";"";"0";"404.70";"0";"3.27";"GNF-Pf-4924";"Cl.O=C1Nc2ccc(Br)cc2C12NCCc1c2[nH]c2ccccc12";"IFI";"'='";"1.087";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL528746";"";"0";"299.80";"1";"5.12";"GNF-Pf-4929";"CC(C)c1ccc(NC(=O)C=Cc2ccccc2Cl)cc1";"IFI";"";"";"";"";"";"Not applicable";"";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600154";"";"0";"445.53";"1";"5.67";"GNF-Pf-4933";"CC1=C(C(=O)OC2CCCC2)C(c2ccccc2F)C2=C(CC(c3ccccc3)CC2=O)N1";"IFI";"'='";"3.488";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585627";"";"0";"336.39";"0";"3.63";"GNF-Pf-4944";"CCOC(=O)c1ccc(NCc2c(C)[nH]c3ccccc3c2=O)cc1";"IFI";"'='";"4.167";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585813";"";"0";"340.42";"0";"2.53";"GNF-Pf-4949";"O=C1C(NC2CCCCC2)=C(N2CCOCC2)C(=O)c2ccccc21";"IFI";"'='";"3.759";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL602433";"";"0";"479.97";"0";"3.06";"GNF-Pf-4951";"O=C(Nc1ccc2nc3n(c(=O)c2c1)CCCCC3)C(=O)N1CCN(c2cccc(Cl)c2)CC1";"IFI";"'='";"4.348";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585817";"";"0";"320.39";"0";"4.10";"GNF-Pf-4954";"CC(=O)c1c(C)n(CC(=O)Nc2cccc(C)c2)c2ccccc12";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL601394";"";"0";"407.52";"0";"4.17";"GNF-Pf-4955";"N#Cc1c2c(c(N3CCN(Cc4ccccc4)CC3)n3c1nc1ccccc13)CCC2";"IFI";"'='";"1.149";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585822";"";"0";"434.53";"0";"4.48";"GNF-Pf-4956";"CCOc1ccc(NC(=O)c2ccc(F)c(S(=O)(=O)NC3CCCCCC3)c2)cc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL71790";"";"0";"218.26";"0";"3.87";"GNF-Pf-4960";"c1ccc2c(c1)[nH]c1ccc3ccncc3c12";"IFI";"'='";"2.778";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585835";"";"0";"543.49";"0";"3.89";"GNF-Pf-4977";"CCCCCCn1c(=O)c(C(=O)NCC[N+](CC)(CC)CC)c(O)c2ccccc21.[I-]";"IFI";"'='";"5.455";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL601609";"";"0";"332.45";"0";"4.15";"GNF-Pf-4988";"Oc1ccc(-c2cccnc2)cc1CNCC1CC2C=CC1C21CC1";"IFI";"'='";"1.695";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL275177";"";"0";"389.52";"1";"5.26";"GNF-Pf-4992";"CN(C)c1ccc2c(c1)Sc1cc(N(C)C)ccc1N2C(=O)c1ccccc1";"IFI";"'='";"3.876";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL599293";"";"0";"293.37";"0";"3.76";"GNF-Pf-4104";"CCCNC1=C(c2ccc(OC)cc2)C(=O)c2ccccc21";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL611661";"";"0";"352.22";"0";"3.37";"GNF-Pf-4123";"CCC1=[N+](C)c2cccc3cccc(c23)N1C.[I-]";"IFI";"'='";"3.125";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600097";"";"0";"573.68";"2";"6.97";"GNF-Pf-4132";"CCn1c(SCCCCNC(=O)c2cc([N+](=O)[O-])cc([N+](=O)[O-])c2)nc(-c2ccc(C)cc2)c1-c1ccc(C)cc1";"IFI";"'='";"2.857";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL607578";"";"0";"297.38";"0";"4.06";"GNF-Pf-4135";"COc1ccc2nc(C)cc(NN=Cc3cccs3)c2c1";"IFI";"'='";"15.38";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL602829";"";"0";"533.72";"2";"7.63";"GNF-Pf-4136";"Cc1cccc(C)c1-n1c(SCc2cccc(F)c2)nc2c(sc(=S)n2-c2c(C)cccc2C)c1=O";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL584873";"";"0";"241.33";"0";"3.53";"GNF-Pf-4137";"Oc1c(CN2CCCCC2)ccc2ccccc12";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL527403";"";"0";"432.55";"1";"5.11";"GNF-Pf-4142";"Cc1ncc(CN2CCC(C(=O)Nc3ccc(-c4nc5ccccc5o4)cc3)CC2)s1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL602832";"";"0";"381.43";"0";"3.83";"GNF-Pf-4146";"CCCCOc1nc(-c2ccc(OC)cc2)n(C(=O)c2ccccc2OC)n1";"IFI";"'='";"7.407";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585278";"";"0";"266.78";"0";"1.65";"GNF-Pf-4155";"CN(C)CCCNC1=NC=NC2C=C(Cl)C=CC12";"IFI";"'='";"1.235";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL597852";"";"0";"326.44";"0";"4.23";"GNF-Pf-4175";"COc1cccc(-c2ccc(O)c(CN(C)C3CCCCC3)c2)n1";"IFI";"'='";"2.632";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL602155";"";"0";"860.70";"2";"7.60";"GNF-Pf-4178";"CCOc1ccc(C(=O)C(CCC(C[N+]2(C)CCCCCC2)C(=O)c2ccc(OCC)cc2)C[N+]2(C)CCCCCC2)cc1.[I-].[I-]";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL597248";"";"0";"326.40";"0";"4.99";"GNF-Pf-4180";"c1ccc(CNc2nc(Nc3ccccc3)nc3ccccc23)cc1";"IFI";"'='";"8.209";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL609320";"";"0";"312.41";"0";"3.69";"GNF-Pf-4204";"COc1cccc(-c2ccc(O)c(CN3CCCC(C)C3)c2)n1";"IFI";"'='";"2.885";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL587026";"";"0";"475.56";"1";"5.68";"GNF-Pf-5547";"COc1ccc(C2CC(=O)C3=C(C2)NC(C)=C(C(=O)OC2CCCC2)C3c2ccc(F)cc2)cc1";"IFI";"'='";"3.488";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL602170";"";"0";"326.44";"0";"4.13";"GNF-Pf-5557";"COc1cccc(-c2ccc(O)c(CNCC3CCCCC3)c2)n1";"IFI";"'='";"1.98";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL580577";"";"0";"448.59";"1";"5.72";"GNF-Pf-5564";"CCOc1ccc(NC(=O)C2c3ccccc3C(=O)N(CC(C)C)C2c2cccs2)cc1";"IFI";"'='";"6.25";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL578950";"";"0";"475.59";"1";"5.33";"GNF-Pf-5572";"COc1ccc(C2CC(=O)C3=C(C2)NC(C)=C(C(=O)OC(C)C)C3c2cccc(C)c2)cc1OC";"IFI";"'='";"6.024";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL582714";"";"0";"437.54";"0";"3.97";"GNF-Pf-3010";"Cc1cccc(C)c1NC(=O)CN1C(=O)C(C)(C)Oc2ccc(C(=O)NC(C)(C)C)cc21";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL581888";"";"0";"434.97";"0";"4.99";"GNF-Pf-3017";"CCN1CCN(c2cc(C)c3cc(NC(=O)C=Cc4cccc(Cl)c4)ccc3n2)CC1";"IFI";"";"";"";"";"";"Not applicable";"";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL579459";"";"0";"312.19";"0";"2.55";"GNF-Pf-3030";"COc1ccc2c(c1)OC(O)(C(F)(F)C(F)(F)F)CC2=O";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL579554";"";"0";"496.19";"1";"5.09";"GNF-Pf-3031";"CC[n+]1c(/C=C/c2cc(Br)ccc2OC)ccc2ccccc21.[I-]";"IFI";"'='";"7.438";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600945";"";"0";"364.49";"0";"4.37";"GNF-Pf-3048";"C=C[C@H]1CN2CC[C@H]1C[C@@H]2[C@@H](OC(=O)C(C)C)c1ccnc2ccccc12";"IFI";"'='";"1.667";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL580165";"";"0";"418.88";"1";"5.19";"GNF-Pf-3050";"COc1ccc(C=C2N=C(c3ccc(Cl)cc3)N(c3ccccc3)C2=O)cc1OC";"IFI";"";"";"";"";"";"Not applicable";"";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600730";"";"0";"495.55";"0";"4.39";"GNF-Pf-5653";"COCCOC(=O)C1=C(C)NC2=C(C(=O)CC(c3ccc(OC)c(OC)c3)C2)C1c1ccccc1F";"IFI";"'='";"2.353";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL579325";"";"0";"516.42";"2";"5.94";"GNF-Pf-5655";"CCOC(=O)C1=C(C)NC2=C(C(=O)CC(c3ccc(OC)c(OC)c3)C2)C1c1ccc(Cl)cc1Cl";"IFI";"'='";"8.235";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL578706";"";"0";"446.55";"0";"5.00";"GNF-Pf-5662";"CCCCOc1ccc(N(C(C)=O)C2=C(N3CCCCC3)C(=O)c3ccccc3C2=O)cc1";"IFI";"'='";"6.757";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL591861";"";"0";"496.00";"1";"6.51";"GNF-Pf-5673";"COc1ccc(C2CC3=NC(C)=C(C(=O)OC(C)C)C(c4ccccc4Cl)C3=C(O)C2)cc1OC";"IFI";"'='";"4.762";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600119";"";"0";"323.42";"0";"3.64";"GNF-Pf-5692";"CN(C)c1ccc(C=C2SC(=Nc3ccccc3)NC2=O)cc1";"IFI";"";"";"";"";"";"Not applicable";"";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL601807";"";"0";"324.42";"0";"3.17";"GNF-Pf-5423";"C=CC1CN2CCC1CC2[C@H](O)c1ccnc2ccc(OC)cc12";"IFI";"'='";"2.632";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL581074";"";"0";"281.40";"0";"4.44";"GNF-Pf-5427";"Oc1ccc(-c2ccccc2)cc1CN1CCCCCC1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL486232";"";"0";"527.69";"1";"3.55";"GNF-Pf-5434";"CC(C)C[C@H](NC(=O)N1CCOCC1)C(=O)N[C@H](/C=C/S(=O)(=O)c1ccccc1)CCc1ccccc1";"IFI";"'='";"4.444";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585960";"";"0";"549.62";"1";"4.43";"GNF-Pf-5443";"CCOC(=O)C1=C(C)NC2=C(C(=O)C(C(=O)OCC)C(c3ccccc3OC)C2)C1c1ccc(OC)c(OC)c1";"IFI";"'='";"3.488";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL7568";"QUINACRINE";"2";"399.97";"1";"5.97";"GNF-Pf-5448";"CCN(CC)CCCC(C)Nc1c2ccc(Cl)cc2nc2ccc(OC)cc12";"IFI";"'='";"6.952";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL577015";"";"0";"456.37";"1";"5.92";"GNF-Pf-5521";"CCOC(=O)C1=C(C)NC2=C(C(=O)CC(c3ccc(Cl)cc3)C2)C1c1ccc(Cl)cc1";"IFI";"'='";"3.529";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL581026";"";"0";"375.43";"0";"2.94";"GNF-Pf-2929";"c1ccc(-c2cc(N3CCC4(CC3)OCCO4)nc(-c3ccccn3)n2)nc1";"IFI";"'='";"7.692";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL582103";"";"0";"254.24";"0";"2.45";"GNF-Pf-2961";"COC1=CC(=O)c2c(ccc3cc(O)ccc23)C1=O";"IFI";"'='";"7.018";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL586032";"";"0";"282.71";"0";"1.27";"GNF-Pf-3516";"O=C(NNC(=O)c1csnn1)c1ccc(Cl)cc1";"IFI";"'='";"1.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL586035";"";"0";"435.52";"0";"4.81";"GNF-Pf-3524";"CCOC(=O)C1=CN(c2cc(C)ccc2C)C=C(C(=O)OCC)C1c1ccccc1OC";"IFI";"'='";"4.938";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL583399";"";"0";"424.24";"0";"3.46";"GNF-Pf-3525";"Cc1cc(I)ccc1NC(=O)CNC(=O)OCc1ccccc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL581839";"";"0";"340.43";"0";"4.57";"GNF-Pf-3527";"COc1ccc2nc(Nc3nc(-c4ccccn4)cs3)sc2c1";"IFI";"'='";"14.29";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585329";"";"0";"436.56";"0";"3.84";"GNF-Pf-3533";"CCc1ccccc1N(CC(=O)NC1CCCCC1)C(=O)CCC(=O)Nc1ccccn1";"IFI";"'='";"1.562";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585145";"";"0";"368.82";"0";"3.55";"GNF-Pf-3535";"CC(=O)N(C1=C(N(C)C)C(=O)c2ccccc2C1=O)c1ccc(Cl)cc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600113";"";"0";"508.50";"2";"2.64";"GNF-Pf-3536";"COc1ccc([N+](=O)[O-])cc1C=NNc1nc(Nc2ccc([N+](=O)[O-])cc2)nc(N2CCN(C)CC2)n1";"IFI";"'='";"3.947";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL596844";"";"0";"475.81";"0";"4.88";"GNF-Pf-3558";"CCOc1ccc(C(=O)C(C)[n+]2cc(-c3ccc(Cl)cc3)n3c2CCC3)cc1.[Br-]";"IFI";"'='";"5.405";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL578084";"";"0";"305.14";"0";"1.06";"GNF-Pf-2331";"CN(C)[P+](C)(N(C)C)N(C)C.[I-]";"IFI";"'='";"12.36";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585769";"";"0";"266.30";"0";"3.44";"GNF-Pf-1235";"Cc1cccc(NC(=O)/C(C#N)=C/c2ccc(C)o2)c1";"IFI";"'='";"9.091";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL528492";"";"0";"297.79";"0";"1.27";"GNF-Pf-808";"CCOc1ccc(N2C(N)=NC(N)=NC2(C)C)cc1.Cl";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL599946";"";"0";"410.48";"0";"3.82";"GNF-Pf-826";"O=C1C(Nc2ccc(O)cc2)=CC(=NS(=O)(=O)c2cccs2)c2ccccc21";"IFI";"'='";"23.08";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL593254";"";"0";"243.35";"0";"3.18";"GNF-Pf-860";"CC(C)Cc1ccc(/C=C/C(=O)NC2CC2)cc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL583366";"";"0";"488.58";"0";"3.88";"GNF-Pf-875";"COC(=O)[C@@H]1C[C@@H](NC(=O)c2ccc(OC)cc2OC)CN1CC(c1ccccc1)c1ccccc1";"IFI";"'='";"1.439";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585409";"";"0";"371.48";"0";"3.71";"GNF-Pf-911";"CCOC(=O)c1cnc2ccc(OCC)cc2c1NCC1CCCN1CC";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585982";"";"0";"467.53";"0";"2.47";"GNF-Pf-5071";"Nc1cc(C(=O)Nc2ccc(C3=NCCN3)cc2)ccc1C(=O)Nc1ccc(C2=NCCN2)cc1";"IFI";"'='";"2.586";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585434";"";"0";"389.82";"0";"3.60";"GNF-Pf-5084";"O=C(COc1ccc(Cl)cc1)Nc1nnc(-c2ccc3c(c2)OCO3)s1";"IFI";"'='";"1.709";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL601186";"";"0";"583.37";"2";"6.01";"GNF-Pf-5089";"OC(CN1CCN(C/C=C/c2ccccc2)CC1)Cn1c2ccc(Br)cc2c2cc(Br)ccc21";"IFI";"'='";"3.03";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL601781";"";"0";"324.41";"0";"3.83";"GNF-Pf-5176";"CC(=O)Nc1c(NCc2ccccc2)c2ccccc2sc1=O";"IFI";"'='";"2.174";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL599917";"";"0";"447.54";"0";"3.74";"GNF-Pf-5179";"CC(C)CC(N)C(=O)N1CCn2c(nc(-c3ccccc3)c2Nc2ccc3c(c2)OCO3)C1";"IFI";"'='";"4.11";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL601568";"";"0";"433.29";"0";"3.85";"GNF-Pf-5229";"COc1ccc(C=Cc2ccc3ccccc3[n+]2C)cc1OC.[I-]";"IFI";"";"";"";"";"";"Not applicable";"";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL602174";"";"0";"271.32";"0";"3.00";"GNF-Pf-5231";"CCOC(=O)c1cnc2c3c(ccc2c1O)CCCC3";"IFI";"'='";"2.222";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600712";"";"0";"312.41";"0";"4.17";"GNF-Pf-5280";"CC1(C)C(=O)C2(CCCCC2)C(=O)OC1/C=C/c1ccccc1";"IFI";"'='";"1.493";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL582245";"";"0";"530.62";"1";"2.49";"GNF-Pf-5287";"Cc1noc(C)c1S(=O)(=O)N(Cc1ccccc1)CC(O)CN1CCC(NC(=O)c2ccc(F)cc2)C1";"IFI";"'='";"0.9709";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL579724";"";"0";"471.25";"0";"2.57";"GNF-Pf-5293";"Nc1nonc1-n1nnc(-c2ccccc2)c1C(=O)NN=Cc1ccc(F)c(Br)c1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585406";"";"0";"328.38";"0";"3.93";"GNF-Pf-1304";"Oc1c(C(Nc2ccccn2)c2ccncc2)ccc2cccnc12";"IFI";"'='";"15.38";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL528900";"";"0";"617.70";"2";"6.89";"GNF-Pf-949";"COc1ccc(C2=C(c3ccc(OC)cc3)C3(c4ccccc4)C(=O)C2(c2ccccc2)C2C(=O)N(c4ccccc4)C(=O)C23)cc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL587731";"";"0";"389.50";"0";"2.85";"GNF-Pf-1380";"Cn1nc(C(=O)N2CCCC2)c2c1CCC(NCc1cnc3ccccc3c1)C2";"IFI";"'='";"2.469";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL587782";"";"0";"299.37";"0";"3.35";"GNF-Pf-1386";"C=CCNCc1cc(-c2cc(OC)ccc2OC)ccc1O";"IFI";"'='";"0.8475";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL578111";"";"0";"465.53";"1";"5.08";"GNF-Pf-1423";"O=C(CSc1cn(CCNC(=O)c2ccc(F)cc2)c2ccccc12)Nc1ccccc1F";"IFI";"'='";"1.22";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600723";"";"0";"518.66";"1";"3.97";"GNF-Pf-1438";"COc1ccc(CCNc2nc(NCCC3CCCN3C)ncc2C(=O)NCc2ccccc2)cc1OC";"IFI";"'='";"1.923";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL587177";"";"0";"276.36";"0";"3.84";"GNF-Pf-1451";"COc1ccc(C=Cc2ccc3ccccc3[n+]2C)cc1";"IFI";"";"";"";"";"";"Not applicable";"";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL582652";"";"0";"405.32";"0";"2.03";"GNF-Pf-1460";"O=C1NCCN1CCNS(=O)(=O)c1cc(C(F)(F)F)cc(C(F)(F)F)c1";"IFI";"'='";"0.8333";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600771";"";"0";"372.86";"1";"6.12";"GNF-Pf-1054";"Cc1ccc2nc(-c3ccccc3)cc(C(=O)Nc3ccc(Cl)cc3)c2c1";"IFI";"'='";"3.077";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL528025";"";"0";"706.28";"2";"8.39";"GNF-Pf-1068";"COc1cc(CNc2cc(OCCOc3ccc(Cl)cc3)cc(C(=O)NC3CCN(Cc4ccccc4)CC3)c2)ccc1OCc1ccccc1";"IFI";"'='";"7.143";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL577233";"";"0";"367.43";"0";"4.06";"GNF-Pf-1505";"COc1ccc(-c2csc3nc(COc4cccc(C)c4)nn23)c(O)c1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL599958";"";"0";"421.55";"0";"2.84";"GNF-Pf-1085";"CCCCNC(=O)c1ccc2c(c1)N=C(c1cccnc1)N(CCN1CCOCC1)C2";"IFI";"'='";"2.439";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL578420";"";"0";"513.38";"2";"5.79";"GNF-Pf-2442";"COc1cc(C(=O)NC(c2ccccc2Cl)c2cc(Cl)c3cccnc3c2O)cc(OC)c1OC";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL601955";"";"0";"295.30";"0";"2.18";"GNF-Pf-594";"COc1ccccc1NC(=O)c1n[nH]c(=O)c2ccccc12";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL602776";"";"0";"266.77";"0";"3.24";"GNF-Pf-1654";"O=C(CCl)Nc1ccc(N2CCCCCC2)cc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL602412";"";"0";"371.40";"0";"3.21";"GNF-Pf-623";"CCCCCOC(=O)C1=C(C)Nc2ncnn2C1c1cccc([N+](=O)[O-])c1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL582521";"";"0";"453.52";"0";"2.24";"GNF-Pf-627";"CS(=O)(=O)Nc1cccc(-c2cnc(N)c(-c3ccc(C(=O)N4CCOCC4)cc3)n2)c1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL581051";"";"0";"468.77";"1";"8.24";"GNF-Pf-634";"O=C(/C=C/c1ccccc1Cl)Nc1ccc(Oc2ccc3ccccc3c2Cl)c(Cl)c1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL611078";"";"0";"341.52";"1";"5.92";"GNF-Pf-646";"CCCCCc1ccc(-c2cn3nc(CCCCC)sc3n2)cc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL611381";"";"0";"360.48";"0";"3.57";"GNF-Pf-669";"Cc1ccc(S(=O)(=O)Nc2ccc(C(=O)NCCC(C)C)cc2)cc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL598899";"";"0";"535.51";"2";"7.78";"GNF-Pf-2043";"CCOc1ccc(Br)cc1/C=C1\SC(=Nc2ccccc2CC)N(c2ccccc2CC)C1=O";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL584877";"";"0";"432.57";"0";"3.42";"GNF-Pf-674";"CN(C)CCCNc1ncc(C(=O)NCc2ccccc2)c(NCCc2ccccc2)n1";"IFI";"'='";"3.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL582801";"";"0";"398.49";"0";"2.73";"GNF-Pf-694";"CCn1c2cc(C)sc2c2cnn(CC(=O)Nc3c(C)nn(C)c3C)c(=O)c21";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL583021";"";"0";"350.43";"0";"1.95";"GNF-Pf-696";"COc1ccccc1N1CCN(c2c3c(nc4nncn24)CCC3)CC1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL599307";"";"0";"530.69";"1";"3.17";"GNF-Pf-737";"CCOC(=O)c1c(C)[nH]c(C)c1S(=O)(=O)N1CCCC(C(=O)N2CCN(c3cccc(C)c3C)CC2)C1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL583446";"";"0";"386.44";"0";"0.94";"GNF-Pf-766";"CS(=O)(=O)c1cnc2ncnn2c1C1CCCN(C(=O)c2ccccn2)C1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL593253";"";"0";"357.29";"0";"1.93";"GNF-Pf-777";"Cc1cn2c3ccccc3n(CCN3CCOCC3)c2n1.Cl.Cl";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL576530";"";"0";"548.08";"2";"6.84";"GNF-Pf-2425";"COc1cc(OC)cc(C(=O)N(CCCC(C)Nc2cc(OC)cc3cccnc23)Cc2ccc(Cl)cc2)c1";"IFI";"'='";"3.67";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL603005";"";"0";"344.43";"0";"1.38";"GNF-Pf-2437";"CCC(C)NC(=O)CN(c1cc(OC)ccc1OC)S(C)(=O)=O";"IFI";"'='";"4.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL578242";"";"0";"373.39";"0";"3.91";"GNF-Pf-2446";"COc1ccc(NC(=O)CCn2c(=S)oc3ccccc32)c([N+](=O)[O-])c1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL579124";"";"0";"414.38";"0";"4.31";"GNF-Pf-2480";"CCCCCCCn1c2c(c(=N)c3c1CCC3)CCCC2.I";"IFI";"'='";"14.29";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL602798";"";"0";"417.45";"0";"3.28";"GNF-Pf-2500";"O=C(Nc1ccc(F)cc1)N1CCN(c2ccc3nnc(-c4ccccc4)n3n2)CC1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL577157";"";"0";"328.39";"0";"4.28";"GNF-Pf-2525";"COc1ccc(-c2csc(Nc3ccc(O)cc3)n2)cc1OC";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL578911";"";"0";"361.44";"0";"4.20";"GNF-Pf-2546";"COc1ccccc1N1CCN(C(=O)Nc2ccc3ccccc3c2)CC1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL578301";"";"0";"521.41";"1";"4.20";"GNF-Pf-2569";"O=C(Nc1ccc(C2=NCCN2)cc1)c1cc(Cl)c(C(=O)Nc2ccc(C3=NCCN3)cc2)cc1Cl";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL610913";"";"0";"473.73";"0";"3.84";"GNF-Pf-2575";"CCc1ccc2[nH]c(=O)c(CN(CCN(CC)CC)C(=S)NCCCN(CC)CC)cc2c1";"IFI";"'='";"4.63";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL601997";"";"0";"285.39";"0";"2.50";"GNF-Pf-1976";"CN(C)CCCNCc1cc(-c2cccnc2)ccc1O";"IFI";"'='";"1.709";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL579160";"";"0";"389.97";"1";"5.95";"GNF-Pf-1980";"CCCCCCCCC(=O)NCCCCNc1ccnc2cc(Cl)ccc12";"IFI";"'='";"2.857";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL610250";"";"0";"442.30";"0";"4.65";"GNF-Pf-1990";"Cc1ccc(-c2cn3ccccc3[n+]2CC(=O)c2ccc(Cl)cc2)cc1[N+](=O)[O-].[Cl-]";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL577232";"";"0";"312.42";"1";"5.43";"GNF-Pf-1993";"c1ccc(CCCNc2ccnc3cc4ccccc4cc23)cc1";"IFI";"'='";"13.64";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL576207";"";"0";"426.61";"0";"4.28";"GNF-Pf-2003";"CCCCCCCCC(=O)N1CCN(C(CC)c2nc3ccccc3c(=O)n2C)CC1";"IFI";"'='";"2.105";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL139814";"";"0";"306.37";"0";"3.94";"GNF-Pf-2030";"CN(C)c1cc(NC(=O)Nc2ccccc2)c2ccccc2n1";"IFI";"'='";"2.256";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL601365";"";"0";"279.25";"0";"2.13";"GNF-Pf-2041";"O=C(c1ccc([N+](=O)[O-])cc1[N+](=O)[O-])N1CCCCC1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL576392";"";"0";"360.46";"0";"3.81";"GNF-Pf-2042";"COc1ccccc1C(=O)N1CCN(Cc2ccc3ccccc3c2)CC1";"IFI";"'='";"2.326";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL582325";"";"0";"272.32";"0";"0.55";"GNF-Pf-529";"CN(C)c1ccc(C=NNc2nc(N)nc(N)n2)cc1";"IFI";"'='";"7.692";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL581687";"";"0";"326.44";"0";"3.40";"GNF-Pf-538";"CCN1/C(=C/c2cccc[n+]2C)Sc2cc(NC(C)=O)ccc21";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL580842";"";"0";"345.91";"0";"4.40";"GNF-Pf-560";"[Cl-].c1ccc(COCC[N+]2(Cc3ccccc3)CCCCC2)cc1";"IFI";"'='";"0.7692";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL582319";"";"0";"316.36";"0";"3.10";"GNF-Pf-570";"NC(=O)/C(=C\c1cccc2ccccc12)NC(=O)c1ccccc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL581270";"";"0";"466.57";"1";"5.13";"GNF-Pf-579";"O=C(Nc1ccc2c(c1)S(=O)(=O)c1cc(NC(=O)c3cccs3)ccc1-2)c1cccs1";"IFI";"'='";"3.788";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL602610";"";"0";"432.50";"0";"4.93";"GNF-Pf-592";"O=C1NCCCCC1N(Cc1cccc(Oc2ccccc2)c1)C(=O)c1ccc(F)cc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL581058";"";"0";"309.35";"0";"3.43";"GNF-Pf-595";"COc1ccc2nc(NC(=O)c3ccc(C#N)cc3)sc2c1";"IFI";"'='";"1.02";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585260";"";"0";"427.49";"0";"4.71";"GNF-Pf-1361";"O=C1Nc2ccccc2C1=Nc1ccccc1NS(=O)(=O)c1ccc2ccccc2c1";"IFI";"'='";"7.692";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600494";"";"0";"267.74";"0";"3.44";"GNF-Pf-1363";"COC(=O)c1c(-c2ccccc2Cl)csc1N";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL584426";"";"0";"406.42";"0";"3.36";"GNF-Pf-1364";"CCOC(=O)c1c(NC(=O)COc2ccccc2[N+](=O)[O-])sc(C(C)=O)c1C";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL584845";"";"0";"380.45";"0";"3.31";"GNF-Pf-1368";"Cc1cc(-c2cncnc2C2CCN(C(=O)c3cc(C(C)C)n[nH]3)CC2)on1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL586620";"";"0";"287.39";"0";"2.43";"GNF-Pf-1375";"CN(C)CCNc1ccc2ncc(-c3ccsc3)n2n1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL587147";"";"0";"396.31";"0";"4.66";"GNF-Pf-1377";"CC1(C)C2C[C@@H](COC(=O)NC(=O)c3ccccc3)[C@]3(C)[C@H](C21)C3(Cl)Cl";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600755";"";"0";"472.57";"1";"5.15";"GNF-Pf-1391";"CCOC(=O)c1ccc(NC(=O)CSc2nc(NCc3ccccc3)c3ccccc3n2)cc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL576194";"";"0";"265.38";"0";"3.53";"GNF-Pf-1412";"CC(C)c1ccc2c(c1)c1c3c([n+](C)ccn32)CCC1";"IFI";"'='";"4.167";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL601119";"";"0";"318.38";"0";"3.77";"GNF-Pf-1427";"CCCn1c(C=NNc2nc3ccccc3[nH]2)nc2ccccc21";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL602388";"";"0";"404.38";"0";"3.13";"GNF-Pf-1434";"O=C(Oc1ccccc1N1C(=O)C2C3C=CC(C3)C2C1=O)c1ccc([N+](=O)[O-])cc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL582675";"";"0";"323.39";"0";"4.15";"GNF-Pf-1477";"COc1ccc(NC2=CC(=O)CC(c3ccccc3)C2)c(OC)c1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL2308885";"CLOBETASONE BUTYRATE";"4";"478.99";"0";"4.70";"GNF-Pf-1500";"CCCC(=O)O[C@]1(C(=O)CCl)[C@H](C)C[C@@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@]3(F)C(=O)C[C@@]21C";"IFI";"'='";"2.721";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL373330";"";"0";"347.51";"1";"5.49";"GNF-Pf-464";"CCCN1/C(=C/c2sc3ccccc3[n+]2CC)C=Cc2ccccc21";"IFI";"'='";"23.08";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL578936";"";"0";"284.86";"1";"5.26";"GNF-Pf-2647";"CCN(CC)c1scc(-c2ccc(Cl)cc2)[s+]1";"IFI";"'='";"3.077";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL602604";"";"0";"515.65";"2";"7.17";"GNF-Pf-2656";"COc1ccc(C(=O)Oc2ccccc2-c2nc3cc(C)ccn3c2NC(C)(C)CC(C)(C)C)c(OC)c1";"IFI";"'='";"1.064";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL578944";"";"0";"476.54";"1";"6.83";"GNF-Pf-2657";"CCC(C)(C)c1ccc(OCCCC[n+]2cccc(C)c2C)c(C(C)(C)CC)c1.[Br-]";"IFI";"'='";"8.696";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL601972";"";"0";"388.25";"0";"4.78";"GNF-Pf-2773";"O=C(O)CC/C(=C1/C=C(c2ccc(Cl)cc2)NC1=O)c1ccc(Cl)cc1";"IFI";"'='";"7.692";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL602411";"";"0";"470.98";"0";"4.28";"GNF-Pf-3421";"O=C(COC(c1cccs1)c1cccnc1Cl)N1CCN(C(=O)Nc2ccccc2)CC1";"IFI";"'='";"0.9709";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL582269";"";"0";"479.99";"1";"5.82";"GNF-Pf-3424";"CCOC(=O)c1ccc(-n2c(C)cc(/C=C3\SC(=Nc4ccc(Cl)cc4)NC3=O)c2C)cc1";"IFI";"";"";"";"";"";"Not applicable";"";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL580619";"";"0";"381.91";"0";"4.78";"GNF-Pf-3336";"CN(CCCNc1ccnc2cc(Cl)ccc12)C(=O)CCc1ccccc1";"IFI";"'='";"3.738";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL530475";"";"0";"372.45";"0";"3.19";"GNF-Pf-3455";"O=C(c1cccs1)N1CCN(c2ccc([N+](=O)[O-])c(NC3CC3)c2)CC1";"IFI";"'='";"2.5";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL534589";"";"0";"631.73";"2";"7.20";"GNF-Pf-3375";"COc1ccc(C2=C(c3ccc(OC)cc3)C3(c4ccccc4)C(=O)C2(c2ccccc2)C2C(=O)N(c4ccc(C)cc4)C(=O)C23)cc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL582087";"";"0";"425.79";"0";"2.98";"GNF-Pf-3395";"O=[N+]([O-])c1ccc(NCCN(CCO)c2ccc([N+](=O)[O-])cc2[N+](=O)[O-])c(Cl)c1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL596629";"";"0";"311.34";"0";"2.69";"GNF-Pf-3805";"COc1ccc(NC(=O)Cn2ncc3ccccc32)cc1OC";"IFI";"'='";"2.128";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL599101";"";"0";"473.47";"1";"5.74";"GNF-Pf-3840";"CCCN(CCC)[P+](C)(N(CCC)CCC)N(CCC)CCC.[I-]";"IFI";"'='";"7.843";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL576599";"";"0";"492.50";"1";"5.97";"GNF-Pf-3860";"O=[N+]([O-])c1ccc(-c2ccc(C=NNc3nc(Nc4ccccc4)nc(Nc4ccccc4)n3)o2)cc1";"IFI";"'='";"4.651";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL605629";"";"0";"528.01";"2";"6.03";"GNF-Pf-3871";"COc1ccc(NC(=O)C2=C(C)Nc3c(C(=O)Nc4ccc(C)cc4)cnn3C2c2cccc(Cl)c2)cc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL596631";"";"0";"473.00";"0";"4.06";"GNF-Pf-3876";"CN(C)CCCN(Cc1cc2cc3c(cc2[nH]c1=O)OCO3)C(=S)Nc1cccc(Cl)c1";"IFI";"'='";"4.959";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL604119";"";"0";"520.72";"1";"4.21";"GNF-Pf-3881";"Cc1c(C)c2c(c(C)c1O)CC[C@](C)(CN1CCN(c3cc(N4CCCC4)nc(N4CCCC4)n3)CC1)O2";"IFI";"'='";"5.195";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL598287";"";"0";"250.21";"0";"2.00";"GNF-Pf-3919";"O=C1c2ccccc2C(=O)c2c1ccc1nonc21";"IFI";"'='";"30.82";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL598889";"";"0";"467.55";"0";"4.31";"GNF-Pf-3963";"COc1ccc(-n2nc3c(c2NC(=O)/C=C\c2cc(OC)c(OC)c(OC)c2)CSC3)cc1";"IFI";"'='";"3.529";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600700";"";"0";"564.73";"2";"6.35";"GNF-Pf-3980";"COc1cccc(CCNC(=O)c2ccc(OC3CCN(CC(c4ccccc4)c4ccccc4)CC3)c(OC)c2)c1";"IFI";"'='";"2.817";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL603731";"";"0";"334.40";"0";"1.36";"GNF-Pf-4008";"Cn1cnc(S(=O)(=O)Nc2ccccc2C(=O)NCC2CC2)c1";"IFI";"'='";"3.361";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL605422";"";"0";"548.66";"2";"7.71";"GNF-Pf-4026";"COC(=O)c1ccc(C2C3=C(O)CC(c4ccc(C)cc4)CC3=Nc3ccccc3N2C(=O)c2cccs2)cc1";"IFI";"'='";"4.878";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL596849";"";"0";"408.91";"0";"4.02";"GNF-Pf-4050";"O=C(c1ccc(F)cc1Cl)N1CCN(c2nc(-c3cccs3)ns2)CC1";"IFI";"'='";"0.9346";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL582740";"";"0";"426.51";"0";"2.87";"GNF-Pf-3488";"COC(=O)[C@@H]1C[C@@H](NC(=O)c2ccc(OC)cc2OC)CN1Cc1cc(C)ccc1C";"IFI";"'='";"1.709";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600900";"";"0";"630.54";"2";"5.78";"GNF-Pf-3530";"COC(=O)CNC(c1ccccc1)c1cc(Br)ccc1NC(=O)C(Cc1ccccc1)NC(=O)OCc1ccccc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL526981";"";"0";"420.49";"0";"3.68";"GNF-Pf-3531";"COc1ccc(-c2nc(NC(=O)CS(=O)(=O)c3ccc(F)cc3)sc2C)cc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL604927";"";"0";"461.29";"1";"5.14";"GNF-Pf-3569";"O=c1c2cnn(-c3ccccc3)c2nc(-c2ccccc2F)n1-c1ccc(Br)cc1";"IFI";"'='";"2.247";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL583402";"";"0";"438.57";"0";"3.67";"GNF-Pf-3601";"COc1ccc(OC)c(CN2CCC3(CC2)CC3C(=O)NCCc2ccccc2OC)c1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585121";"";"0";"415.88";"1";"5.87";"GNF-Pf-3607";"COc1cc(C=C(C#N)c2nc3ccccc3[nH]2)ccc1OCc1ccccc1Cl";"IFI";"";"";"";"";"";"Not applicable";"";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL605546";"";"0";"530.47";"1";"4.95";"GNF-Pf-3627";"CCC(Sc1nc2ccccc2n1C(C)=O)C(=O)NC1=NN=C(c2ccc(Br)cc2)CS1";"IFI";"'='";"5.714";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL598478";"";"0";"502.31";"1";"3.27";"GNF-Pf-3703";"CC(=O)N(C1=C(N2CCOCC2)C(=O)c2ccccc2C1=O)c1ccc(I)cc1";"IFI";"'='";"18.67";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL596649";"";"0";"445.48";"0";"4.22";"GNF-Pf-735";"O=C1NN(c2ccccc2)C(=O)/C1=C1/C(=O)N(Cc2cccc3ccccc23)c2ccccc21";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL579117";"";"0";"434.49";"1";"5.30";"GNF-Pf-759";"COc1cc(/C=C2/SC(=Nc3ccccc3)NC2=O)ccc1OCc1ccccc1F";"IFI";"";"";"";"";"";"Not applicable";"";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL597041";"";"0";"298.72";"0";"0.84";"GNF-Pf-779";"C/C=C(\Cl)C1=CC(=O)[C@]23C[C@H]2[C@@]2(C)CO[C@@]1(O)[C@@]3(O)O2";"IFI";"'='";"6.863";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL611372";"";"0";"343.42";"0";"3.68";"GNF-Pf-803";"CCCCOc1ccc(C(=O)NCCOc2cccc(OC)c2)cc1";"IFI";"'='";"1.515";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL583811";"";"0";"533.67";"2";"7.33";"GNF-Pf-824";"CCCCCN(C(=O)c1ccc2ccccc2c1)C(CC)c1nc2ccccc2c(=O)n1-c1ccccc1OC";"IFI";"'='";"2.778";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL577444";"";"0";"407.90";"0";"4.87";"GNF-Pf-5186";"COC(=O)C1=C(C)NC2=C(C(=O)CC(c3ccc(Cl)cc3)C2)C1c1ccccc1";"IFI";"'='";"2.299";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL577445";"";"0";"286.33";"0";"3.96";"GNF-Pf-5189";"Cn1c(C(=O)c2cccc3ccccc23)nc2ccccc21";"IFI";"'='";"2.439";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL577883";"";"0";"515.41";"2";"6.86";"GNF-Pf-5240";"CCOc1ccc(C2c3[nH]c4ccccc4c3CCN2C(=O)c2cc3cc(Br)ccc3o2)cc1";"IFI";"'='";"1.163";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL533313";"";"0";"222.72";"0";"2.04";"GNF-Pf-5255";"CC=Cc1n(C)c2ccccc2[n+]1C.[Cl-]";"IFI";"";"";"";"";"";"Not applicable";"";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL578318";"";"0";"388.30";"1";"5.16";"GNF-Pf-5305";"O=C(NCCCCNc1ccnc2cc(Cl)ccc12)c1ccccc1Cl";"IFI";"'='";"2.778";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL582668";"";"0";"490.05";"1";"7.81";"GNF-Pf-5358";"Cc1ccn2c(NC(C)(C)CC(C)(C)C)c(-c3ccccc3OC(=O)c3cccc(Cl)c3)nc2c1";"IFI";"'='";"3.738";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL467886";"";"0";"466.41";"1";"5.14";"GNF-Pf-5364";"CCN1/C(=C/c2sc3ccccc3[n+]2CC)Sc2ccccc21.[I-]";"IFI";"'='";"21.92";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL578529";"";"0";"483.66";"1";"7.72";"GNF-Pf-5377";"CCc1ccc(C(=O)Oc2ccccc2-c2nc3cc(C)ccn3c2NC(C)(C)CC(C)(C)C)cc1";"IFI";"'='";"7.477";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL533063";"";"0";"420.60";"0";"3.63";"GNF-Pf-5384";"O=C(N1CCN(c2ccc(C(F)(F)F)cc2[N+](=O)[O-])CC1)C(Cl)(Cl)Cl";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL602175";"";"0";"300.40";"0";"3.69";"GNF-Pf-5387";"CCCCN(C)Cc1cc(-c2cccc(OC)n2)ccc1O";"IFI";"'='";"3.419";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL602228";"";"0";"510.33";"2";"5.53";"GNF-Pf-5018";"COc1ccc2c(c1OC)C(=O)N1c3ccccc3N=C(c3ccc(I)cc3)CC21";"IFI";"'='";"0.7246";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585896";"";"0";"399.95";"0";"4.94";"GNF-Pf-5049";"CN(CCCNc1ccnc2cc(Cl)ccc12)C(=O)CSc1ccccc1";"IFI";"'='";"3.738";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL588026";"";"0";"311.34";"0";"3.60";"GNF-Pf-1372";"CCOc1ccc(-c2noc(-c3ccncc3)n2)cc1OCC";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585619";"";"0";"535.91";"0";"4.79";"GNF-Pf-980";"O=C(COc1ccc(Cl)cc1)NCc1ccc(CNc2noc3ccccc23)cc1.O=C(O)C(F)(F)F";"IFI";"'='";"5.556";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL582650";"";"0";"359.46";"0";"1.93";"GNF-Pf-1390";"CCc1ccc2c(c1)c1nnc(SCC(=O)NCCOC)nc1n2C";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585804";"";"0";"312.29";"0";"1.57";"GNF-Pf-984";"Cn1cc([N+](=O)[O-])c(C(=O)NN=Cc2c[nH]c3ccccc23)n1";"IFI";"'='";"6.767";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585997";"";"0";"412.56";"0";"3.12";"GNF-Pf-985";"O=C(CCC1CCCN(C(=O)c2ccsc2)C1)N1CCN(c2ccccn2)CC1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL584010";"";"0";"296.35";"0";"3.92";"GNF-Pf-994";"O=C1NC(=Nc2ccccc2)/C(=C/c2ccc(O)cc2)S1";"IFI";"'='";"8.333";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL609437";"";"0";"460.98";"1";"5.53";"GNF-Pf-1002";"CC[n+]1c(C=CC=C2N(C)c3ccccc3C2(C)C)sc2ccccc21.[O-][Cl+3]([O-])([O-])[O-]";"IFI";"";"";"";"";"";"Not applicable";"";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL602159";"";"0";"240.31";"0";"1.13";"GNF-Pf-1004";"C=CCSc1nn2c(=O)c(C)nnc2s1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL584443";"";"0";"290.34";"0";"2.63";"GNF-Pf-1006";"COc1ccc2c(c1OC)C(=O)N(c1ncc(C)s1)C2";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600760";"";"0";"381.91";"1";"5.34";"GNF-Pf-1015";"Cc1ccccc1NC(c1cccc(Cl)c1)c1nnnn1C1CCCCC1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585598";"";"0";"278.21";"0";"3.13";"GNF-Pf-1036";"O=C(Nc1ccc(F)c(F)c1)c1ccccc1[N+](=O)[O-]";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL579282";"";"0";"245.37";"0";"4.23";"GNF-Pf-1049";"CC(=NO)c1ccc2c(c1)C(C)(C)CCC2(C)C";"IFI";"'='";"4.167";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL576799";"";"0";"433.60";"1";"5.12";"GNF-Pf-1482";"c1cc2cc3ccc(OCCN4CCCCC4)cc3nc2cc1OCCN1CCCCC1";"IFI";"'='";"2.679";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL531135";"";"0";"411.28";"0";"4.77";"GNF-Pf-1058";"O=C(Nc1nccs1)c1cc(-c2cccnc2)nc2ccc(Br)cc12";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585972";"";"0";"402.48";"0";"2.92";"GNF-Pf-1078";"O=C1C(Sc2nnc[nH]2)=CC(=NS(=O)(=O)c2cccs2)c2ccccc21";"IFI";"'='";"25.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL584188";"";"0";"241.33";"0";"3.60";"GNF-Pf-1081";"CCC(O)CN(c1ccccc1)c1ccccc1";"IFI";"'='";"1.835";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585425";"";"0";"446.37";"0";"4.35";"GNF-Pf-1095";"CCN(CC)C(=O)c1ccc2c(=O)n(Cc3cccc(Br)c3)c(=S)[nH]c2c1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600348";"";"0";"513.71";"2";"6.56";"GNF-Pf-1110";"Cc1ccc(-n2c(SCc3cccc(C)c3)nnc2C(Cc2ccccc2)NC(=O)NC(C)(C)C)cc1";"IFI";"'='";"1.087";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL601538";"";"0";"688.43";"2";"7.04";"GNF-Pf-1111";"O=C(CC(=NNc1nc(NN=C(CC(=O)C(F)(F)F)C(F)(F)F)nc(N(c2ccccc2)c2ccccc2)n1)C(F)(F)F)C(F)(F)F";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL576598";"";"0";"579.99";"3";"0.00";"GNF-Pf-1145";"COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)C[C@@](O)(C(=O)CO)C[C@@H]3O[C@@H]1C[C@H](N)[C@H](O)[C@H](C)O1.Cl";"IFI";"'='";"25.62";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL601314";"";"0";"343.20";"0";"1.90";"GNF-Pf-1164";"CCOc1cc(Br)cc(/C=C2\NC(=S)NC2=O)c1O";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL602373";"";"0";"345.81";"0";"-0.18";"GNF-Pf-66";"Cl.Nc1nc(N)c2cc(S(=O)(=O)N3CCOCC3)ccc2n1";"IFI";"'='";"9.375";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585933";"";"0";"535.67";"2";"6.17";"GNF-Pf-71";"O=C(NCCC1=CCCCC1)c1ccc2c(=O)n(-c3ccccc3)c(SCc3nc4ccccc4[nH]3)nc2c1";"IFI";"'='";"1.19";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL599923";"";"0";"436.63";"0";"3.97";"GNF-Pf-156";"Cc1ccc(C)c2[nH]c(=O)c(CN(Cc3ccccc3)C(=S)NCCCN(C)C)cc12";"IFI";"'='";"6.186";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL529166";"";"0";"338.63";"0";"4.38";"GNF-Pf-1191";"O=C(c1ccccc1)c1cc(Cl)ccc1NCCBr";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL579137";"";"0";"490.56";"0";"4.84";"GNF-Pf-164";"COc1ccc(C2C(C(=O)Nc3ccc(OC)c(OC)c3)CCC(=O)N2c2ccc(OC)cc2)cc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585256";"";"0";"277.33";"0";"2.22";"GNF-Pf-1201";"Nc1nc(N)nc(C(c2ccccc2)c2ccccc2)n1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585025";"";"0";"395.37";"0";"3.54";"GNF-Pf-1223";"COc1cc(C=NNC(=O)c2ccco2)ccc1OCc1ccc([N+](=O)[O-])cc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL579086";"";"0";"511.97";"0";"0.54";"GNF-Pf-192";"CS(=O)(=O)O.CS(=O)(=O)O.N=C(NCc1ccccc1)NC(=O)c1nc(Cl)c(N)nc1N";"IFI";"'='";"2.222";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL602029";"";"0";"407.58";"1";"5.49";"GNF-Pf-1242";"CCn1c(SCCNC(=O)CC(C)C)nc(-c2ccccc2)c1-c1ccccc1";"IFI";"'='";"3.81";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL579749";"";"0";"423.47";"0";"3.40";"GNF-Pf-213";"COc1cc(C(=O)Nc2ccc3nc4n(c(=O)c3c2)CCCCC4)cc(OC)c1OC";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL579127";"";"0";"330.39";"0";"4.89";"GNF-Pf-2244";"Cc1ccc(Nc2nc(NCc3ccco3)c3ccccc3n2)cc1";"IFI";"'='";"7.143";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL577862";"";"0";"441.33";"0";"3.64";"GNF-Pf-2262";"O=C(N/C(=C/C=C\c1ccccc1)C(=O)N1CCOCC1)c1ccc(Br)cc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL577419";"";"0";"493.86";"1";"6.66";"GNF-Pf-2324";"Cn1nc(C(F)(F)F)c(C(=O)Nc2cccc(C(F)(F)F)c2)c1SCc1ccc(Cl)cc1";"IFI";"'='";"2.532";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL193528";"";"0";"366.51";"0";"4.40";"GNF-Pf-1627";"CC[n+]1c(/C=C/c2ccc(N(C)C)cc2)sc2cc(NC(C)=O)ccc21";"IFI";"'='";"4.688";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL568092";"";"0";"262.44";"0";"4.89";"GNF-Pf-2344";"CCCCCCCCCCCCn1ccc(=N)cc1";"IFI";"'='";"15.38";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL533712";"";"0";"560.53";"2";"6.13";"GNF-Pf-1640";"O=C(Nc1ccc(-c2cnc(-c3ccc(NC(=O)c4cccc([N+](=O)[O-])c4)cc3)nc2)cc1)c1cccc([N+](=O)[O-])c1";"IFI";"'='";"7.143";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL605610";"";"0";"417.42";"0";"3.37";"GNF-Pf-216";"CCOc1ccc(N2C(=O)NC(=O)/C(=C\c3cn(C(C)=O)c4ccccc34)C2=O)cc1";"IFI";"'='";"4.511";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL602001";"";"0";"364.40";"0";"4.63";"GNF-Pf-243";"COc1ccc([C@@H]2Nc3ccc(C(C)=O)cc3[C@@H]3C=CC[C@@H]32)cc1[N+](=O)[O-]";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL601775";"";"0";"260.69";"0";"2.22";"GNF-Pf-246";"Cc1cc(Nc2ccc(Cl)cc2)n2nnnc2n1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL601375";"";"0";"262.33";"0";"3.48";"GNF-Pf-249";"C[n+]1ccc(C2OC2c2ccccc2)c2ccccc21";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL601132";"";"0";"648.68";"2";"8.39";"GNF-Pf-272";"O=C(Nc1ccc(C(c2ccccc2)(c2ccccc2)c2ccc(NC(=O)c3cccc([N+](=O)[O-])c3)cc2)cc1)c1cccc([N+](=O)[O-])c1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL579963";"";"0";"611.79";"2";"5.57";"GNF-Pf-280";"CCOC(=O)c1c(NC(=O)CSc2nnc(CNC(=O)c3cccc(OC)c3)n2C2CCCCC2)sc2c1CCCC2";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL582700";"";"0";"415.88";"1";"5.87";"GNF-Pf-281";"COc1cc(/C=C(\C#N)c2nc3ccccc3[nH]2)ccc1OCc1ccccc1Cl";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL579969";"";"0";"344.37";"0";"0.92";"GNF-Pf-286";"CCOC(=O)N1CCN(C(=O)c2cnc3ccc(C)cn3c2=O)CC1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600134";"";"0";"430.81";"1";"5.47";"GNF-Pf-290";"O=C(Cn1c2ccccc2c(=O)c2cc(Cl)ccc21)Nc1cccc(C(F)(F)F)c1";"IFI";"'='";"3.448";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL582710";"";"0";"387.50";"0";"3.27";"GNF-Pf-299";"CCC(c1ccc(F)cc1)n1cc(C(=O)NCCCN2CCC(C)CC2)nn1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL582300";"";"0";"565.49";"2";"7.46";"GNF-Pf-302";"COc1cc(NC(C)CCCN(Cc2ccc(F)cc2)C(=O)Nc2ccc(Br)cc2)c2ncccc2c1";"IFI";"'='";"3.774";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL578744";"";"0";"380.27";"0";"3.23";"GNF-Pf-4";"CC[n+]1ccc(C=Cc2ccc(N(C)C)cc2)cc1.[I-]";"IFI";"'='";"10.37";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL577668";"";"0";"362.90";"0";"4.95";"GNF-Pf-5";"CCN1C=Cc2ccccc2/C1=C\c1ccc2ccccc2[n+]1CC.[Cl-]";"IFI";"'='";"23.6";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL602983";"";"0";"304.31";"0";"0.83";"GNF-Pf-7";"COc1ccc(OC)c(C=NNC(=O)Cc2cc(O)n[nH]2)c1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL602605";"";"0";"412.52";"0";"4.24";"GNF-Pf-10";"N#CCSc1nc2c(sc(=S)n2-c2ccccc2)c(=O)n1Cc1ccco1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL611211";"";"0";"366.89";"1";"5.51";"GNF-Pf-17";"CC1(C)Cc2nc3ccccc3c(NCc3ccc(Cl)cc3)c2C(O)C1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL578894";"";"0";"418.54";"0";"4.76";"GNF-Pf-27";"O=C(/C=C/c1ccccc1)Nc1ccc(C(=O)OC[C@@H]2CCCN3CCCC[C@H]23)cc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600528";"";"0";"326.40";"0";"2.10";"GNF-Pf-29";"O=C1C(N2CCCCC2)=C(N2CCOCC2)C(=O)c2ccccc21";"IFI";"'='";"7.692";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL609155";"";"0";"635.63";"1";"3.40";"GNF-Pf-35";"Cc1ccc(NC(=O)C2C3C=CC4(O3)C2C(=O)N(CCCN2CCOCC2)C4C(=O)NC2CCCC(C)C2C)cc1Cl.Cl";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL530729";"";"0";"573.65";"1";"3.07";"GNF-Pf-36";"COc1cccc(NC(=O)C2C3C=CC4(O3)C2C(=O)N(CC2COc3ccccc3O2)C4C(=O)NC2CCCCC2)c1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL579322";"";"0";"267.40";"0";"3.54";"GNF-Pf-38";"CC[n+]1cc(C)ccc1C=Cc1ccc(N(C)C)cc1";"IFI";"'='";"7.692";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL601996";"";"0";"473.62";"1";"7.17";"GNF-Pf-43";"Cc1cc(/C=C2\SC(=Nc3ccccc3)N(C3CCCCC3)C2=O)c(C)n1-c1ccc(F)cc1";"IFI";"'='";"1.149";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL601153";"";"0";"482.55";"0";"3.83";"GNF-Pf-44";"CCCOc1ccc(C(=O)C2=C(O)C(=O)N(CCN3CCOCC3)C2c2ccc(F)cc2)c(C)c1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL602167";"";"0";"359.40";"0";"4.98";"GNF-Pf-48";"Cc1cccc(NC(c2cccc(F)c2)c2ccc3cccnc3c2O)n1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL577633";"";"0";"330.44";"0";"3.26";"GNF-Pf-53";"CN(C)c1ccc(/C=C2\SC(=N)N(c3nccs3)C2=O)cc1";"IFI";"'='";"16.67";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL582738";"";"0";"575.67";"2";"2.96";"GNF-Pf-587";"CCOC(=O)c1sc(NC(=O)CSc2nnc(CNC(=O)COc3ccccc3)n2C)c(C(=O)OCC)c1C";"IFI";"'='";"1.19";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL589005";"";"0";"418.49";"0";"4.97";"GNF-Pf-1665";"CCC(=O)N1c2ccccc2NC2=C(C(=O)CC(C)(C)C2)C1c1ccc2c(c1)OCO2";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL588844";"";"0";"529.64";"2";"5.01";"GNF-Pf-1670";"Cc1cccc(NC(=O)N2CCN(C(=O)c3nc(-c4ccccc4)nc(C)c3C(=O)OC(C)C)CC2C)c1C";"IFI";"'='";"1.869";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL580340";"";"0";"366.85";"0";"4.89";"GNF-Pf-1678";"Cc1cccc(Nc2nc(NCc3ccco3)c3ccccc3n2)c1.Cl";"IFI";"'='";"9.434";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL582314";"";"0";"380.52";"None";"None";"GNF-Pf-467";"O=C(O[Si](c1ccccc1)(c1ccccc1)c1ccccc1)c1ccccc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL599935";"";"0";"419.53";"0";"3.46";"GNF-Pf-475";"O=C(NCc1ccccc1)c1cnc(NCCCn2ccnc2)nc1NC1CCCC1";"IFI";"'='";"0.9709";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL576605";"";"0";"288.82";"1";"5.41";"GNF-Pf-1714";"Clc1ccc2c(NC3CCCCCCC3)ccnc2c1";"IFI";"'='";"1.266";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600137";"";"0";"358.36";"0";"4.39";"GNF-Pf-492";"O=C(Nc1cccc(-c2nc3ccccc3[nH]2)c1)c1ccccc1[N+](=O)[O-]";"IFI";"'='";"4.878";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL532383";"";"0";"547.70";"2";"7.72";"GNF-Pf-1747";"CCCCCCN(C(=O)c1ccc2ccccc2c1)C(CC)c1nc2ccccc2c(=O)n1-c1ccccc1OC";"IFI";"'='";"1.887";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL531048";"PHANQUONE";"0";"210.19";"0";"1.52";"GNF-Pf-1759";"O=C1C(=O)c2ncccc2-c2cccnc21";"IFI";"'='";"22.14";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL532167";"";"0";"560.58";"2";"6.64";"GNF-Pf-1769";"COc1ccc(C2c3cccn3-c3ccccc3N2C(=O)CN(C(=O)Nc2ccc(C(F)(F)F)cc2)C2CC2)cc1";"IFI";"'='";"4.202";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL532496";"";"0";"600.77";"2";"9.27";"GNF-Pf-2203";"CN(C)c1ccc(-c2nc(-c3ccc(-c4[nH]c(-c5ccc(N(C)C)cc5)nc4-c4ccccc4)cc3)c(-c3ccccc3)[nH]2)cc1";"IFI";"'='";"12.5";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL579301";"";"0";"515.08";"1";"4.88";"GNF-Pf-2218";"CCN(CC)CCCN(Cc1cc2cc3c(cc2[nH]c1=O)OCCO3)C(=S)Nc1cccc(Cl)c1";"IFI";"'='";"6.897";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL578051";"";"0";"385.39";"0";"3.88";"GNF-Pf-2227";"FC(F)(F)c1cccc(-c2cncc(N3CCN(c4ccccn4)CC3)n2)c1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL533167";"";"0";"566.75";"2";"6.42";"GNF-Pf-2229";"c1ccc2cc3c(N4CCN(CCCN5CCN(c6ccnc7cc8ccccc8cc67)CC5)CC4)ccnc3cc2c1";"IFI";"'='";"7.143";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL588763";"";"0";"266.33";"0";"1.26";"GNF-Pf-1516";"CCOc1ccc(OCc2nnc(S)n2N)cc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL578492";"";"0";"459.80";"0";"3.28";"GNF-Pf-2239";"O=C(O)C(F)(F)F.O=C(c1ccc2c(c1)OCO2)N1CCOC(c2ccc(Cl)cc2)C1";"IFI";"'='";"1.37";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL579312";"";"0";"468.59";"0";"4.40";"GNF-Pf-2609";"CC(C)CC(NC(=O)OC(C)(C)C)C(=O)NC(Cc1ccccc1)C(=O)OCc1ccccc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL579128";"";"0";"342.42";"0";"3.82";"GNF-Pf-2246";"COc1cccc(-c2cc(N=C(NCc3ccco3)SC)n[nH]2)c1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL578060";"";"0";"430.51";"0";"3.68";"GNF-Pf-2617";"Cc1cc(N2CCN(C)CC2)nc2ccc(NC(=O)/C=C/c3ccc4c(c3)OCO4)cc12";"IFI";"'='";"8.333";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL603000";"";"0";"532.08";"2";"6.98";"GNF-Pf-2265";"CCCCCCN(C(=O)COc1ccccc1)C(CC)c1nc2ccccc2c(=O)n1-c1cccc(Cl)c1";"IFI";"'='";"0.9346";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600911";"";"0";"676.78";"2";"10.36";"GNF-Pf-2283";"COc1ccc(-c2nc(-c3ccc4c(c3)-c3cc(-c5[nH]c(-c6ccc(OC)cc6)nc5-c5ccccc5)ccc3C4=O)c(-c3ccccc3)[nH]2)cc1";"IFI";"'='";"1.538";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600296";"";"0";"356.54";"1";"5.03";"GNF-Pf-2308";"CCc1cc2c(cc1-c1csc(NC(=N)N)n1)C(C)(C)CCC2(C)C";"IFI";"'='";"5.155";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL582510";"";"0";"325.42";"0";"2.99";"GNF-Pf-354";"O=C(Nc1ccc(N2CCCCC2)cc1)N1CCc2nc[nH]c2C1";"IFI";"'='";"5.405";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL582067";"";"0";"357.87";"0";"4.30";"GNF-Pf-386";"CN(C)c1ccc(N=C2NC(=O)/C(=C/c3ccc(Cl)cc3)S2)cc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL602820";"";"0";"420.30";"1";"6.51";"GNF-Pf-413";"N#CC(=Cc1ccccc1OCc1ccc(Cl)cc1Cl)c1nc2ccccc2[nH]1";"IFI";"";"";"";"";"";"Not applicable";"";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL580639";"";"0";"427.51";"0";"4.59";"GNF-Pf-445";"Cc1nc([P+](c2ccccc2)(c2ccccc2)c2ccccc2)c(N2CCCCC2)o1";"IFI";"'='";"9.091";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL580641";"";"0";"521.25";"None";"None";"GNF-Pf-448";"";"IFI";"'='";"30.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL611370";"";"0";"307.35";"0";"3.31";"GNF-Pf-3552";"COc1ccc(-c2noc(N3CCc4ccccc4C3)n2)cc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL599892";"";"0";"316.28";"0";"2.83";"GNF-Pf-3594";"Cc1ccc2nc(C)cc(NCCN(C)C)c2c1.Cl.Cl";"IFI";"'='";"4.706";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL604116";"";"0";"394.48";"0";"3.57";"GNF-Pf-3614";"N#Cc1c2c(c(N3CCN(c4ccccn4)CC3)n3c1nc1ccccc13)CCC2";"IFI";"'='";"2.326";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL611075";"";"0";"379.46";"0";"4.37";"GNF-Pf-3621";"COc1ccc(OC)c(-c2ccc(O)c(CNCc3ccccc3OC)c2)c1";"IFI";"'='";"0.8475";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL599714";"";"0";"514.46";"2";"8.28";"GNF-Pf-3636";"Cc1ccc(-c2c3c4n(c(-c5ccc(Cl)cc5)cn4c2C(=O)Nc2ccccc2Cl)CCCC3)cc1";"IFI";"'='";"6.061";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL599097";"";"0";"526.59";"0";"3.48";"GNF-Pf-3640";"O=C(O)/C=C/C(=O)O.O=C(O)/C=C/C(=O)O.c1ccc(CCNC2CCN(Cc3ccccc3)CC2)cc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL598490";"";"0";"452.56";"0";"4.03";"GNF-Pf-3646";"Cc1cccc(-c2cc(C(=O)NC3CCN(Cc4ccccc4)CC3)cc(-n3cnnn3)c2)c1";"IFI";"'='";"1.709";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL602423";"";"0";"411.46";"1";"5.57";"GNF-Pf-3673";"O=C1CC(c2ccccc2)CC2=C1C(c1ccccc1[N+](=O)[O-])Nc1ccccc1N2";"IFI";"'='";"1.075";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL582980";"";"0";"291.35";"0";"4.00";"GNF-Pf-3679";"COc1ccc(C=NNc2cc(C)nc3ccccc23)cc1";"IFI";"'='";"15.38";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585881";"";"0";"429.50";"0";"3.32";"GNF-Pf-3682";"COc1ccc(S(=O)(=O)N2CCC(c3nnc(-c4ccccc4OC)o3)CC2)cc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL583225";"";"0";"362.45";"0";"2.63";"GNF-Pf-3685";"CC1CCN(S(=O)(=O)c2ccc(C(=O)NCc3ccco3)cc2)CC1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL531046";"";"0";"360.50";"1";"5.01";"GNF-Pf-4866";"COc1ccc(C(c2ccc(N(C)C)cc2)c2ccc(N(C)C)cc2)cc1";"IFI";"'='";"13.64";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585967";"";"0";"449.56";"0";"2.74";"GNF-Pf-4912";"O=C(NCC1CCCO1)c1cnc(NCCCn2ccnc2)nc1NCCc1ccccc1";"IFI";"'='";"0.9524";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL587210";"";"0";"507.64";"1";"4.21";"GNF-Pf-5546";"Cc1nc(-c2ccccc2)nc(C(=O)N2CCN(C(=O)NC3CCCCC3)C(C)C2)c1C(=O)OC(C)C";"IFI";"'='";"2.83";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL596643";"";"0";"283.71";"0";"4.01";"GNF-Pf-3717";"O=c1nc(C=Cc2ccc(Cl)cc2)oc2ccccc12";"IFI";"";"";"";"";"";"Not applicable";"";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL599301";"";"0";"437.79";"0";"4.59";"GNF-Pf-3720";"COc1ccc(-[n+]2cc(-c3ccc(Cl)cc3)n3c2SCCC3)cc1.[Br-]";"IFI";"'='";"1.852";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL530698";"";"0";"332.79";"0";"2.48";"GNF-Pf-3400";"Cl.OCCNc1nc(Nc2cccc(O)c2)nc2ccccc12";"IFI";"'='";"3.636";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL581673";"";"0";"342.45";"0";"3.17";"GNF-Pf-3406";"Cc1nc(-c2nc3c(s2)CN(C(=O)c2ccncc2)CC3)cs1";"IFI";"'='";"5.556";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL106525";"";"0";"368.48";"0";"4.88";"GNF-Pf-3427";"CN1CCN(c2ccc(Nc3c4ccccc4nc4ccccc34)cc2)CC1";"IFI";"'='";"15.56";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL560918";"";"0";"448.91";"1";"5.13";"GNF-Pf-3447";"COc1ccc(C(NC(=O)c2cccc(OC)c2)c2cc(Cl)c3cccnc3c2O)cc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL582704";"";"0";"444.54";"0";"4.01";"GNF-Pf-3456";"COc1cccc2c1OCC(CN1CCC(C(=O)Nc3ccc(-n4cccn4)cc3)CC1)=C2";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL580844";"";"0";"464.99";"0";"4.78";"GNF-Pf-3479";"CCCN(CCC)CCCNc1ccc(C(=O)Nc2cccc(OC)c2)cc1[N+](=O)[O-].Cl";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL581487";"";"0";"313.35";"0";"1.90";"GNF-Pf-3481";"O=C(O)CCCNC(=O)C(O)(c1ccccc1)c1ccccc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL581489";"";"0";"353.38";"0";"1.40";"GNF-Pf-3483";"COc1ccccc1CNC(=O)CCn1c(=O)[nH]c2ccccc2c1=O";"IFI";"'='";"1.667";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL603024";"";"0";"404.90";"0";"4.00";"GNF-Pf-3485";"Oc1cccc2ccc[n+](CC(O)Cn3c4ccccc4c4ccccc43)c12.[Cl-]";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL582322";"";"0";"518.57";"2";"6.93";"GNF-Pf-3487";"COC(=O)c1ccc(C2C3=C(O)CC(c4ccco4)CC3=Nc3ccccc3N2C(=O)c2ccccc2)cc1";"IFI";"'='";"4.082";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL524376";"";"0";"316.79";"0";"2.78";"GNF-Pf-3493";"Cl.OCCNc1nc(Nc2ccccc2)nc2ccccc12";"IFI";"'='";"1.439";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL581059";"";"0";"467.35";"1";"6.15";"GNF-Pf-3494";"COc1ccc(C=C2N=C(c3ccc(Cl)cc3)N(c3cc(Cl)ccc3C)C2=O)cc1OC";"IFI";"";"";"";"";"";"Not applicable";"";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600698";"";"0";"222.68";"0";"2.75";"GNF-Pf-3495";"CN(C)/C=C1\Oc2ccccc2N=C1Cl";"IFI";"'='";"2.632";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL581047";"";"0";"377.49";"0";"3.29";"GNF-Pf-3510";"COc1ccc2cc(CNC3CCN(Cc4ccccc4)CC3)c(=O)[nH]c2c1";"IFI";"'='";"3.774";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL608260";"";"0";"190.25";"0";"1.20";"GNF-Pf-3512";"CC(=NNC(=N)N)c1ccc(C)cc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL582105";"";"0";"367.86";"0";"3.93";"GNF-Pf-3514";"COc1ccc(-c2c[n+](CC(=O)c3ccccc3Cl)c3n2CCC3)cc1";"IFI";"'='";"2.5";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL602365";"";"0";"201.23";"0";"1.24";"GNF-Pf-3515";"Cc1nc(NC(=N)N)nc2ccccc12";"IFI";"'='";"0.5848";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL601172";"";"0";"428.62";"1";"6.72";"GNF-Pf-3519";"CC(C)(C)c1ccc(C(=O)N2CCCn3cccc3C2c2ccc(C(C)(C)C)cc2)cc1";"IFI";"'='";"4.587";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL599289";"";"0";"400.36";"0";"4.12";"GNF-Pf-3809";"C(#Cc1ccccc1)C[N+]1(CCOc2ccccc2)CCCCC1.[Br-]";"IFI";"'='";"5.556";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL576406";"";"0";"557.65";"2";"5.11";"GNF-Pf-3813";"CCC(C)NC(=O)c1cc(NC(=O)/C=C/c2ccc([N+](=O)[O-])cc2)ccc1N1CCN(c2ccccc2OC)CC1";"IFI";"'='";"2.752";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL610217";"";"0";"274.39";"0";"4.73";"GNF-Pf-3819";"C=Cc1cc2ccccc2c2cc3c(cc12)C[N+](C)(C)C3";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL604517";"";"0";"490.64";"1";"6.64";"GNF-Pf-3844";"Cc1ccc(NC(=O)C2CSC(c3cccc(F)c3)N2C(=O)c2ccc(C(C)(C)C)cc2)cc1C";"IFI";"'='";"4.255";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL598888";"";"0";"540.45";"2";"5.72";"GNF-Pf-3885";"COc1cc(C2C(C(=O)OCC(C)C)=C(C)NC3=C2C(=O)CC(c2ccccc2)C3)cc(Br)c1O";"IFI";"'='";"4.651";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL599716";"";"0";"440.42";"1";"5.06";"GNF-Pf-3900";"CCn1c(SCc2ccc(Cl)cc2Cl)nc2sc3c(c2c1=O)CCN(C)C3";"IFI";"'='";"11.76";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL584244";"";"0";"561.86";"2";"10.54";"GNF-Pf-3920";"CCCCCCCCCCCCCC(=O)Oc1ccccc1-c1nc2cc(C)ccn2c1NC(C)(C)CC(C)(C)C";"IFI";"'='";"3.704";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL527494";"";"0";"304.38";"0";"2.18";"GNF-Pf-3927";"CC(Cc1ccsc1)Nc1nc2nonc2nc1N(C)C";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL599703";"";"0";"396.39";"0";"3.70";"GNF-Pf-3959";"CC(=O)N(C1=C(N2CCCC2)C(=O)c2ccccc2C1=O)c1ccc(F)c(F)c1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600706";"";"0";"354.81";"1";"5.78";"GNF-Pf-5304";"Cc1ccc(F)cc1NC(=O)c1cc(Cl)ccc1Nc1ccccc1";"IFI";"'='";"2.857";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL581887";"";"0";"373.51";"0";"2.63";"GNF-Pf-309";"CC(C)CNC(=O)c1cnc(NCCCn2ccnc2)nc1NCC(C)C";"IFI";"'='";"0.9804";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL608857";"";"0";"366.25";"0";"2.75";"GNF-Pf-329";"CN(C)c1ccc(C=Cc2cccc[n+]2C)cc1.[I-]";"IFI";"";"";"";"";"";"Not applicable";"";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL582271";"";"0";"396.54";"0";"3.16";"GNF-Pf-335";"NCCCNc1ncc(C(=O)NCc2ccccc2)c(NCC2CCCCC2)n1";"IFI";"'='";"1.942";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL601339";"";"0";"435.46";"0";"3.40";"GNF-Pf-339";"COC(=O)c1ccc(NC(=O)CSc2nc3cc4c(cc3cc2C#N)OCCO4)cc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL581659";"";"0";"528.38";"2";"5.75";"GNF-Pf-347";"COc1ccc2nc(C)cc(N(c3ccc(Br)cc3)S(=O)(=O)c3ccc([N+](=O)[O-])cc3)c2c1";"IFI";"'='";"4.255";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL601587";"";"0";"542.49";"2";"1.10";"GNF-Pf-349";"COc1cc2c(O[C@@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O)c3c(c(-c4ccc5c(c4)OCO5)c2cc1OC)C(=O)OC3";"IFI";"'='";"12.36";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL601812";"";"0";"534.64";"2";"7.40";"GNF-Pf-2805";"COC(=O)c1ccc(C2C3=C(O)CC(c4cccs4)CC3=Nc3ccccc3N2C(=O)c2ccccc2)cc1";"IFI";"'='";"2.5";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL531672";"";"0";"248.31";"0";"1.56";"GNF-Pf-2829";"CC(=O)CSc1nnc(-c2ccncc2)n1C";"IFI";"'='";"1.515";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL579093";"";"0";"363.37";"0";"1.51";"GNF-Pf-2830";"COC(=O)C1=CNC=C(C(=O)OC)C1c1cc(OC)c(OC)cc1OC";"IFI";"'='";"4.878";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL576160";"";"0";"434.57";"0";"4.76";"GNF-Pf-2852";"CCC(SC1=Nc2ccccc2C2=NC(C(C)C)C(=O)N12)C(=O)Nc1cccc(C)c1";"IFI";"'='";"1.163";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL576971";"";"0";"349.35";"0";"2.85";"GNF-Pf-2856";"COC(=O)c1cnn(-c2ccccc2)c1C=NOC(=O)c1ccccc1";"IFI";"'='";"1.075";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL217665";"";"0";"318.42";"0";"3.73";"GNF-Pf-2857";"CN1CCN(c2ccc(Nc3ccnc4ccccc34)cc2)CC1";"IFI";"'='";"7.692";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL601148";"";"0";"373.50";"1";"5.74";"GNF-Pf-4244";"CC[n+]1c(/C=C2\Sc3oc4ccccc4c3N2C)ccc2cc(C)ccc21";"IFI";"'='";"26.15";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL535958";"";"0";"230.22";"0";"0.45";"GNF-Pf-2868";"CCOC(=O)NN=CC=NNC(=O)OCC";"IFI";"'='";"1.087";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL602400";"";"0";"420.52";"0";"3.72";"GNF-Pf-2873";"CCN(CC)CCNc1nc2cc(OC)c(OC)cc2c2nc(-c3ccccc3)nn12";"IFI";"'='";"6.818";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL578452";"";"0";"351.43";"0";"4.43";"GNF-Pf-2900";"COc1ccccc1/C=C/C1=N/C(=C\c2ccc(SC)cc2)C(=O)O1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL579958";"";"0";"496.84";"0";"3.98";"GNF-Pf-2907";"O=C(NCc1ccc(Cl)cc1)C1CNCC1c1ccc(C(F)(F)F)cc1.O=C(O)C(F)(F)F";"IFI";"'='";"1.429";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL580167";"";"0";"431.75";"1";"6.57";"GNF-Pf-2912";"Oc1ccc(Cl)cc1C1CC(c2ccc(Cl)cc2)=NC(c2ccc(Cl)cc2)N1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL604154";"";"0";"355.51";"0";"3.44";"GNF-Pf-2921";"S=C(NCc1ccco1)NC1CC2CCC(C1)N2Cc1ccccc1";"IFI";"'='";"1.235";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL582505";"";"0";"293.41";"0";"3.80";"GNF-Pf-2939";"CCN(CC)C/C=C/C1(O)c2ccccc2-c2ccccc21";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL599304";"";"0";"301.35";"0";"0.61";"GNF-Pf-3909";"NNc1nc(NCc2ccccc2)nc(N2CCOCC2)n1";"IFI";"'='";"3.077";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL599508";"";"0";"421.52";"0";"3.92";"GNF-Pf-4491";"COc1ccc(OC)c(C2CC(=O)N3CN(Cc4ccccc4)CSC3=C2C#N)c1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL531562";"";"0";"263.36";"0";"3.41";"GNF-Pf-3917";"CCN1/C(=C/c2cccc[n+]2C)C=Cc2ccccc21";"IFI";"";"";"";"";"";"Not applicable";"";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600704";"";"0";"575.64";"2";"7.01";"GNF-Pf-4501";"O=C1C2C(C(=O)N1c1ccc(F)cc1)C1(c3ccccc3)C(=O)C2(c2ccccc2)C(c2ccccc2)=C1c1ccccc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL529610";"";"0";"269.35";"0";"2.39";"GNF-Pf-3960";"Cc1ccc2[nH]c3c(NCCN(C)C)ncnc3c2c1";"IFI";"'='";"9.804";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL599890";"";"0";"265.19";"0";"0.64";"GNF-Pf-3971";"Cc1nonc1C(=O)NN=Cc1ccc([N+](=O)[O-])o1";"IFI";"'='";"7.143";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL599305";"";"0";"409.56";"0";"4.10";"GNF-Pf-3985";"Cc1cc(C)n(-c2ccc(NC(=O)C3CCN(Cc4cnc(C)s4)CC3)cc2)n1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL597470";"";"0";"364.45";"0";"2.23";"GNF-Pf-4433";"c1cc(C2=NCCN2)ccc1OCCCOc1ccc(C2=NCCN2)cc1";"IFI";"'='";"1.835";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL1197556";"";"0";"327.45";"1";"5.04";"GNF-Pf-4440";"CCN1/C(=C/c2ccc3ccccc3[n+]2CC)C=Cc2ccccc21";"IFI";"";"";"";"";"";"Not applicable";"";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL598902";"";"0";"319.52";"0";"4.07";"GNF-Pf-3992";"C1CCC(CN2CCc3nc(N4CCCCC4)sc3C2)CC1";"IFI";"'='";"5.556";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL599292";"";"0";"539.41";"2";"7.51";"GNF-Pf-4033";"COc1ccc(-n2c(CNc3cc(C(F)(F)F)ccc3Cl)nnc2SCc2ccccc2Cl)cc1";"IFI";"'='";"1.724";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL598687";"";"0";"395.41";"0";"2.78";"GNF-Pf-4038";"CCOC(=O)C1CCCN(C(=O)c2c(C)oc3c2C(=O)c2ccccc2C3=O)C1";"IFI";"'='";"6.25";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL599513";"";"0";"381.39";"0";"4.59";"GNF-Pf-4054";"O=C(Nc1cccc(-c2nc3ccccc3[nH]2)c1)c1cc(=O)c2ccccc2o1";"IFI";"'='";"2.326";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL306147";"";"0";"404.50";"0";"2.35";"GNF-Pf-4997";"CC(=O)OCC(=O)[C@@]1(O)CCC2C3CCC4=CC(=O)CC[C@]4(C)C3[C@@H](O)C[C@@]21C";"IFI";"'='";"0.7692";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL527634";"";"0";"552.73";"2";"6.03";"GNF-Pf-5002";"c1ccc2cc3c(N4CCN(CCN5CCN(c6ccnc7cc8ccccc8cc67)CC5)CC4)ccnc3cc2c1";"IFI";"'='";"8.197";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL578074";"";"0";"408.33";"0";"4.01";"GNF-Pf-2632";"CCN(CC)c1ccc(C=Cc2cccc[n+]2CC)cc1.[I-]";"IFI";"'='";"8.333";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL534116";"";"0";"722.81";"2";"9.04";"GNF-Pf-2639";"O=C(/C=C/c1ccccc1)Nc1ccccc1C(=O)Nc1ccc(-c2nc3ccc(NC(=O)c4ccccc4NC(=O)/C=C/c4ccccc4)cc3[nH]2)cc1";"IFI";"'='";"15.38";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL578881";"";"0";"296.35";"0";"3.77";"GNF-Pf-2743";"O=C(Nc1nc(-c2ccccc2)cs1)c1ccccc1O";"IFI";"'='";"9.79";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL579338";"";"0";"479.55";"1";"5.16";"GNF-Pf-5668";"CCCOC(=O)C1=C(C)NC2=C(C(=O)CC(c3ccc(OC)c(OC)c3)C2)C1c1ccccc1F";"IFI";"'='";"2.353";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600321";"";"0";"522.04";"2";"6.20";"GNF-Pf-5436";"COc1ccc(C2CC(=O)C3=C(C2)NC(C)=C(C(=O)OC2CCCC2)C3c2ccc(Cl)cc2)cc1OC";"IFI";"'='";"3.571";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL578738";"";"0";"479.55";"1";"5.16";"GNF-Pf-5505";"COc1ccc(C2CC(=O)C3=C(C2)NC(C)=C(C(=O)OC(C)C)C3c2ccc(F)cc2)cc1OC";"IFI";"'='";"4.706";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL586883";"";"0";"516.42";"2";"5.94";"GNF-Pf-5333";"CCOC(=O)C1=C(C)NC2=C(C(=O)CC(c3ccc(OC)c(OC)c3)C2)C1c1ccc(Cl)c(Cl)c1";"IFI";"'='";"5.952";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL579717";"";"0";"425.89";"1";"5.01";"GNF-Pf-5359";"COC(=O)C1=C(C)NC2=C(C(=O)CC(c3ccc(Cl)cc3)C2)C1c1ccc(F)cc1";"IFI";"'='";"3.614";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL579934";"";"0";"488.63";"0";"4.75";"GNF-Pf-5361";"COCCNC(=O)c1ccc(OC2CCN(CC(c3ccccc3)c3ccccc3)CC2)c(OC)c1";"IFI";"'='";"1.37";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL603016";"";"0";"362.47";"0";"4.26";"GNF-Pf-5362";"Cc1cc(-c2ccc(O)c(CN3CCCCC3CO)c2)c2ccccc2n1";"IFI";"'='";"0.8475";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL576610";"";"0";"408.50";"0";"4.15";"GNF-Pf-5390";"COc1cccc(-c2ccc(O)c(CN(C)CCc3ccc(OC)c(OC)c3)c2)n1";"IFI";"'='";"2.564";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL584839";"";"0";"498.56";"0";"2.10";"GNF-Pf-5076";"CSCCC(C(=O)NCC(=O)O)N1C(=O)c2cc(NC(C)=O)ccc2NC(=O)[C@@H]1c1ccccc1";"IFI";"'='";"1.22";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL579118";"";"0";"518.67";"2";"3.67";"GNF-Pf-5584";"O=C(NCCCCCCNC(=O)Nc1ccc(C2=NCCCN2)cc1)Nc1ccc(C2=NCCCN2)cc1";"IFI";"'='";"5.405";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL597668";"";"0";"526.64";"2";"7.46";"GNF-Pf-4278";"Cc1ccn2c(NC(C)(C)CC(C)(C)C)c(-c3ccccc3OC(=O)/C=C/c3ccc([N+](=O)[O-])cc3)nc2c1";"IFI";"'='";"2.804";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL375781";"NEOCUPROINE";"0";"208.26";"0";"3.40";"GNF-Pf-5611";"Cc1ccc2ccc3ccc(C)nc3c2n1";"IFI";"'='";"17.14";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL579326";"";"0";"540.45";"2";"5.78";"GNF-Pf-5656";"CCCOC(=O)C1=C(C)NC2=C(C(=O)CC(c3ccc(OC)c(OC)c3)C2)C1c1ccccc1Br";"IFI";"'='";"3.571";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585655";"";"0";"424.77";"0";"4.22";"GNF-Pf-4298";"CCCCn1c(=N)n(CC(O)c2ccc(Br)cc2)c2ccccc21.Cl";"IFI";"'='";"6.25";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL598677";"";"0";"443.14";"0";"3.37";"GNF-Pf-4317";"CCOc1ccc(N2C(=O)C3C4CC(C(Br)C4Br)C3C2=O)cc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL610789";"";"0";"348.40";"0";"4.67";"GNF-Pf-4319";"CCOC(=O)c1cnc2c(C)cccc2c1Nc1cccc(C(C)=O)c1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL597453";"";"0";"339.18";"0";"2.39";"GNF-Pf-4329";"C[n+]1ccc(C=Cc2ccc(O)cc2)cc1.[I-]";"IFI";"";"";"";"";"";"Not applicable";"";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL604323";"";"0";"380.44";"0";"4.79";"GNF-Pf-4341";"CCOC(=O)c1cnc2c(C)cc(C)cc2c1Nc1ccc(OC)c(OC)c1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585651";"";"0";"321.83";"0";"4.26";"GNF-Pf-4371";"O=C(NC1CC1)c1ccc(CSCc2ccccc2Cl)o1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585844";"";"0";"382.27";"0";"3.08";"GNF-Pf-4377";"CN1C=CC(=Cc2sc3ccccc3[n+]2C)C=C1.[I-]";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL593484";"";"0";"685.79";"1";"4.29";"GNF-Pf-5205";"O=C(CN1CCN(C(=O)c2ccccc2)CC1)Nc1ccc(-c2nc3cc(NC(=O)CN4CCN(C(=O)c5ccccc5)CC4)ccc3o2)cc1";"IFI";"'='";"3.75";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL599960";"";"0";"534.64";"2";"6.06";"GNF-Pf-5226";"O=C(C(Cc1ccc(O)cc1)c1ccccc1)N1CCC(n2c(Cc3ccc(F)cc3)nc3cccnc32)CC1";"IFI";"'='";"7.071";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL577884";"";"0";"534.57";"1";"4.32";"GNF-Pf-5243";"CCOC(=O)C1=C(C)NC2=C(C(=O)C(C(=O)OCC)C(c3ccc(OC)cc3)C2)C1c1ccc([N+](=O)[O-])cc1";"IFI";"'='";"3.571";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL587756";"";"0";"378.26";"0";"4.78";"GNF-Pf-5277";"O=C(Nc1cc(Cl)cc(Cl)c1)Nc1ccccc1C(=O)NCC1CC1";"IFI";"'='";"3.39";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL578107";"";"0";"399.47";"0";"4.84";"GNF-Pf-5309";"C=CCN1Cc2ccc(C(=O)NCc3ccccc3)cc2N=C1c1ccc(F)cc1";"IFI";"'='";"3.896";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL583168";"";"0";"323.35";"0";"3.47";"GNF-Pf-4563";"COc1ccc(NC(C)=C2C(=O)c3ccccc3C2=O)c(OC)c1";"IFI";"'='";"15.38";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL527336";"";"0";"346.43";"0";"4.18";"GNF-Pf-4576";"Cc1ccc(NC2=C(N3CCCCC3)C(=O)c3ccccc3C2=O)cc1";"IFI";"'='";"3.906";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL584441";"";"0";"501.46";"2";"4.63";"GNF-Pf-4593";"COc1ccc(Nc2nc(NN=Cc3cccc([N+](=O)[O-])c3)nc(Nc3ccc([N+](=O)[O-])cc3)n2)cc1";"IFI";"'='";"5.263";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL577425";"";"0";"393.87";"0";"3.69";"GNF-Pf-5679";"CCOC(=O)c1cnc2cc(OCC3CC3)c(OCC3CC3)cc2c1O.Cl";"IFI";"'='";"0.8621";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL44789";"";"0";"178.62";"0";"2.47";"GNF-Pf-5425";"Nc1ccnc2cc(Cl)ccc12";"IFI";"'='";"1.754";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL586875";"";"0";"384.44";"0";"4.47";"GNF-Pf-5028";"COc1cccc(C(NC(=O)c2ccccc2)c2ccc3cccnc3c2O)c1";"IFI";"'='";"10.61";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL582951";"";"0";"253.31";"0";"2.54";"GNF-Pf-5036";"CC(=NNC(=O)c1ccc(C)cc1)c1ccccn1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL602361";"";"0";"668.78";"1";"3.40";"GNF-Pf-5085";"O=C(c1ccc(N2CC3CC(C2)c2cccc(=O)n2C3)c(NS(=O)(=O)c2ccc3c(c2)OCCO3)c1)N1CCN(c2ccccn2)CC1";"IFI";"'='";"1.163";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL578093";"";"0";"334.38";"0";"3.74";"GNF-Pf-2415";"COc1ccc(CNc2ncnc3c2[nH]c2cc(OC)ccc23)cc1";"IFI";"'='";"7.692";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL602374";"";"0";"324.83";"0";"3.69";"GNF-Pf-2489";"CC(=C(Cl)Cl)C(Br)=C(Br)CO";"IFI";"";"";"";"";"";"Not applicable";"";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL578423";"";"0";"367.47";"0";"4.66";"GNF-Pf-2516";"CCCCN1Cc2ccc(C(=O)NC(C)C)cc2N=C1c1ccc(F)cc1";"IFI";"'='";"1.22";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL582530";"";"0";"449.28";"1";"6.34";"GNF-Pf-514";"N#CC(c1ccc(C(F)(F)F)cc1)c1ccc2c(C(F)(F)F)cc(C(F)(F)F)nc2n1";"IFI";"'='";"26.32";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL581491";"";"0";"443.57";"1";"5.90";"GNF-Pf-523";"COc1ccc(-n2cc(-c3ccc(C)cc3)nc2SCC(=O)Nc2ccc(C)cc2)cc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL580834";"";"0";"488.51";"1";"7.08";"GNF-Pf-533";"c1ccc(Oc2ccc(Nc3nc4nonc4nc3Nc3ccc(Oc4ccccc4)cc3)cc2)cc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL581480";"";"0";"343.43";"0";"4.92";"GNF-Pf-536";"O=C1Cc2c([nH]c3ccc(OCc4ccccc4)cc23)C2CC=CCC12";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL581686";"";"0";"519.65";"2";"2.86";"GNF-Pf-537";"CCOC(=O)c1c(NC(=O)CSc2nc3c(c(=O)n(C)c(=O)n3C)n2C(C)C)sc2c1CCCC2";"IFI";"'='";"1.77";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL582520";"";"0";"487.53";"0";"4.74";"GNF-Pf-543";"CCC(c1nc2ccccc2c(=O)n1CC)N1CCN(C(=O)Nc2ccccc2C(F)(F)F)CC1";"IFI";"'='";"2.083";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL581482";"";"0";"323.40";"1";"5.34";"GNF-Pf-549";"O=C(Nc1ccc2c3c(cccc13)CC2)c1cccc2ccccc12";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL582317";"";"0";"376.87";"0";"3.49";"GNF-Pf-555";"COc1ccc(CN2CC(=O)N(c3ccc(Cl)cc3)C2=S)cc1OC";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL527233";"";"0";"312.42";"0";"1.22";"GNF-Pf-578";"CN(C)CCN1CCN(c2cncc(-c3cccnc3)n2)CC1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585996";"";"0";"552.12";"2";"8.37";"GNF-Pf-937";"CCCCCCN(C(=O)c1ccc2ccccc2c1)C(CC)c1nc2ccccc2c(=O)n1-c1cccc(Cl)c1";"IFI";"'='";"3.67";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL583363";"";"0";"470.59";"1";"6.22";"GNF-Pf-940";"COc1ccc(CC(=O)Nc2sc3c(c2C(=O)Nc2cccc4ccccc24)CCCC3)cc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL584024";"";"0";"472.59";"0";"3.07";"GNF-Pf-960";"COC(=O)c1ccccc1NC(=O)CSc1nc2ccsc2c(=O)n1CCN1CCCC1";"IFI";"'='";"2.273";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL584025";"";"0";"495.00";"1";"5.64";"GNF-Pf-961";"COc1ccc(OC)c(NC(=O)CSc2nc(NCc3ccc(Cl)cc3)c3ccccc3n2)c1";"IFI";"'='";"2.222";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585402";"";"0";"487.69";"1";"6.49";"GNF-Pf-975";"CCN(CC)CCCC(C)N(Cc1cccc(OCc2ccccc2)c1)C(=O)NCc1ccccc1";"IFI";"'='";"2.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585616";"";"0";"358.26";"0";"3.67";"GNF-Pf-979";"CCc1n(C)c2ccccc2[n+]1CC(=O)c1ccc(Br)cc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL588051";"";"0";"374.42";"0";"1.43";"GNF-Pf-1844";"NS(=O)(=O)c1ccc(CCNC(=O)/C=C/c2ccc3c(c2)OCO3)cc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL588407";"";"0";"470.55";"0";"3.85";"GNF-Pf-1845";"COc1ccc(N(CC(=O)Nc2cc(OC)ccc2OC)S(=O)(=O)c2ccc(C)cc2)cc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL602778";"";"0";"577.77";"1";"2.99";"GNF-Pf-1847";"CCN1CCN(CCN2C(=O)C3C(C(=O)Nc4ccc(C(C)C)cc4)C4C=CC3(O4)C2C(=O)NC2CCCCC2)CC1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL580127";"";"0";"338.43";"0";"2.28";"GNF-Pf-1867";"Cc1cc2c(cc1S(=O)(=O)N(C)C1CCCCC1)OCC(=O)N2";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL582453";"";"0";"425.80";"0";"4.49";"GNF-Pf-1873";"O=C(Cn1c2ccccc2c(=O)c2cc([N+](=O)[O-])ccc21)Nc1ccc(F)c(Cl)c1";"IFI";"'='";"2.41";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL582454";"";"0";"406.49";"1";"6.59";"GNF-Pf-1874";"c1ccc(OCCOc2ccc(Nc3c4ccccc4nc4ccccc34)cc2)cc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL582461";"";"0";"398.85";"0";"4.42";"GNF-Pf-1877";"O=C(NCCCCNc1ccnc2cc(Cl)ccc12)c1ccc([N+](=O)[O-])cc1";"IFI";"'='";"3.738";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL185912";"";"0";"520.65";"1";"4.64";"GNF-Pf-1887";"CC(C)(C)NC(=O)C(c1ccc(F)cc1)N(CCCN1CCOCC1)C(=O)c1ccc(-c2ccccc2)[nH]1";"IFI";"'='";"3.158";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600705";"";"0";"236.34";"0";"3.64";"GNF-Pf-1895";"C=CC[n+]1ccc(/C=C/c2ccccc2)c(C)c1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600162";"";"0";"542.64";"2";"6.48";"GNF-Pf-1909";"CCCCCCN(C(=O)c1cccc([N+](=O)[O-])c1)C(CC)c1nc2ccccc2c(=O)n1-c1ccccc1OC";"IFI";"'='";"2.857";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL578119";"";"0";"440.91";"0";"4.14";"GNF-Pf-1910";"CCOc1ccccc1-n1c(SCC(=O)c2ccc(Cl)cc2)nc2[nH]ncc2c1=O";"IFI";"'='";"1.163";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL587728";"";"0";"430.51";"0";"3.03";"GNF-Pf-1938";"COc1cccc(OCCN2CCN(c3ncnc4c3cnn4-c3ccccc3)CC2)c1";"IFI";"'='";"9.091";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL587592";"";"0";"482.67";"0";"4.89";"GNF-Pf-1943";"CCN(CC)CCCNC(=S)N(Cc1ccc(F)cc1)Cc1cc2cc(C)cc(C)c2[nH]c1=O";"IFI";"'='";"11.71";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585773";"";"0";"521.57";"2";"6.23";"GNF-Pf-1992";"COc1ccc(Nc2c3c(nc4ccc(NC(=O)c5cc(=O)c6ccccc6o5)cc24)CCCC3)cc1OC";"IFI";"'='";"11.43";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL96051";"SCRIPTAID";"0";"326.35";"0";"2.50";"GNF-Pf-2024";"O=C(CCCCCN1C(=O)c2cccc3cccc(c23)C1=O)NO";"IFI";"'='";"19.42";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL549170";"";"0";"385.35";"0";"3.40";"GNF-Pf-2550";"OC1(C(F)(F)F)CC(c2ccccc2)=NN1c1nncc(-c2ccccc2)n1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL577420";"";"0";"254.79";"0";"3.31";"GNF-Pf-2185";"CC1(C)CN=C(NCc2ccccc2Cl)S1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL601546";"";"0";"236.25";"0";"2.21";"GNF-Pf-2199";"O=[N+]([O-])c1ccc(-c2csc(CO)n2)cc1";"IFI";"'='";"0.8197";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL582250";"";"0";"420.39";"0";"2.57";"GNF-Pf-1798";"COc1ccc([N+](=O)[O-])cc1-c1ccc(/C=C(\C#N)c2nn(CCO)c(N)c2C#N)o1";"IFI";"'='";"1.613";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600932";"";"0";"357.32";"0";"2.57";"GNF-Pf-2703";"O=C(c1ccc([N+](=O)[O-])cc1)c1ccc(N2CCOCC2)c([N+](=O)[O-])c1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600738";"";"0";"214.31";"0";"3.16";"GNF-Pf-2755";"Cc1ccc(C)n1-c1ccc(N(C)C)cc1";"IFI";"'='";"4.762";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL582721";"";"0";"446.82";"1";"5.33";"GNF-Pf-3415";"Cc1ccc(-c2cc(C(F)(F)F)n3ncc(C(=O)Nc4cc(Cl)ccc4O)c3n2)cc1";"IFI";"'='";"4.651";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL602615";"";"0";"386.41";"0";"4.75";"GNF-Pf-3420";"Cc1cccnc1NC(c1ccc([N+](=O)[O-])cc1)c1ccc2cccnc2c1O";"IFI";"'='";"7.692";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL525126";"";"0";"464.49";"1";"5.54";"GNF-Pf-3332";"O=C(Nc1ccc(C(F)(F)F)cc1)c1ccc(NCCCN2CCCCCC2)c([N+](=O)[O-])c1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL537118";"";"0";"290.32";"0";"2.91";"GNF-Pf-3430";"CCOC(=O)c1[nH]c2ccc(OC)cc2c1N=NN(C)C";"IFI";"'='";"6.299";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL582701";"";"0";"341.36";"0";"2.76";"GNF-Pf-3452";"COC(=O)CC(NC(=O)c1ccc(C)cc1)c1ccc2c(c1)OCO2";"IFI";"'='";"1.22";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL582706";"";"0";"272.34";"0";"2.36";"GNF-Pf-3459";"O=S(=O)(Nc1ccc(F)cc1)N1CCCCCC1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL602213";"";"0";"430.33";"0";"4.57";"GNF-Pf-3464";"Cc1ccc(C2CC(=O)N3CN(c4ccc(Br)cc4)CSC3=C2C#N)o1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL528585";"";"0";"549.50";"1";"4.39";"GNF-Pf-3648";"O=C(O)c1cccc(NC(=O)c2ccc(N3C(=O)c4ccc(C(=O)Nc5cccc(C(=O)O)c5)cc4C3=O)cc2)c1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL528154";"";"0";"165.22";"0";"1.73";"GNF-Pf-3697";"O=C1CSc2ccccc2N1";"IFI";"'='";"1.389";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL597256";"";"0";"511.71";"2";"8.50";"GNF-Pf-3710";"CCCCc1ccc(C(=O)Oc2ccccc2-c2nc3cc(C)ccn3c2NC(C)(C)CC(C)(C)C)cc1";"IFI";"'='";"5.263";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL596642";"";"0";"349.45";"0";"3.97";"GNF-Pf-3714";"Fc1ccc(CN2CCc3nc(N4CCCCC4)sc3C2)cc1F";"IFI";"'='";"4.167";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL583831";"";"0";"421.79";"0";"4.89";"GNF-Pf-3745";"Cc1c(-c2ccc(Cl)cc2)[n+]2c(n1-c1ccccc1)SCCC2.[Br-]";"IFI";"'='";"7.692";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585285";"";"0";"386.54";"0";"4.52";"GNF-Pf-3751";"OC(CCN1CCN(C(c2ccccc2)c2ccccc2)CC1)c1ccccc1";"IFI";"'='";"1.515";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL584037";"";"0";"287.75";"0";"3.45";"GNF-Pf-3781";"Cc1cc(Nc2ccc(Cl)c(C)c2)n2nc(C)nc2n1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600107";"";"0";"303.37";"0";"3.66";"GNF-Pf-5242";"Cc1cccc(N(C)c2nc3ccccc3c3nnc(C)n23)c1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL588060";"";"0";"574.79";"2";"6.71";"GNF-Pf-5269";"COc1cc(NC(C)CCCN(Cc2ccc(N(C)C)cc2)S(=O)(=O)c2c(C)cc(C)cc2C)c2ncccc2c1";"IFI";"'='";"2.752";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL586249";"";"0";"405.52";"0";"4.72";"GNF-Pf-5278";"CC(C)CN1C(=O)c2ccccc2C(C(=O)Nc2ccccn2)C1c1cccs1";"IFI";"'='";"2.326";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL604360";"";"0";"267.37";"0";"3.88";"GNF-Pf-5285";"O=C(C=Cc1cccnc1)C12CC3CC(CC(C3)C1)C2";"IFI";"";"";"";"";"";"Not applicable";"";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL577228";"";"0";"335.40";"0";"3.99";"GNF-Pf-5385";"O=C1C(=Cc2ccccc2)Oc2c1ccc(O)c2CN1CCCCC1";"IFI";"";"";"";"";"";"Not applicable";"";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL576609";"";"0";"469.63";"1";"7.46";"GNF-Pf-5389";"Cc1ccn2c(NC(C)(C)CC(C)(C)C)c(-c3ccccc3OC(=O)c3ccccc3C)nc2c1";"IFI";"'='";"3.81";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585033";"";"0";"486.67";"1";"6.73";"GNF-Pf-4623";"COc1ccc2c(c1)N(C(=O)CSc1nc3ccccc3o1)C(C)(C)c1ssc(=S)c1-2";"IFI";"'='";"1.149";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585034";"";"0";"490.58";"0";"3.24";"GNF-Pf-4624";"C=CCc1cc(C=c2sc3n(c2=O)C(c2ccccc2)C(C(=O)OCC)=C(C)N=3)cc(OC)c1O";"IFI";"'='";"1.235";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585042";"";"0";"337.38";"0";"3.71";"GNF-Pf-4635";"COc1ccc2nc(C)cc(NN=Cc3cccc(OC)c3O)c2c1";"IFI";"'='";"7.692";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585043";"";"0";"349.43";"0";"2.99";"GNF-Pf-4636";"CCc1cc(=O)n(C)c(SC(CC)C(=O)Nc2ccc(F)cc2)n1";"IFI";"'='";"3.125";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL578504";"";"0";"380.27";"0";"3.23";"GNF-Pf-4643";"CC[n+]1ccccc1C=Cc1ccc(N(C)C)cc1.[I-]";"IFI";"";"";"";"";"";"Not applicable";"";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585993";"";"0";"319.36";"1";"5.56";"GNF-Pf-4646";"Cc1ccccc1N=Nc1ccc(NC(=O)c2ccco2)c(C)c1";"IFI";"'='";"3.788";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL584219";"";"0";"520.61";"1";"3.32";"GNF-Pf-4649";"CCOc1ccccc1NC(=O)Cn1c(=O)n(Cc2ccccc2)c(=O)c2c(C)c(C(=O)N(C)C)sc21";"IFI";"'='";"6.25";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL603520";"";"0";"525.61";"1";"4.12";"GNF-Pf-4655";"COc1cc(C2c3[nH]c4ccccc4c3C[C@H]3C(=O)N(CCc4ccccc4)CC(=O)N23)cc(OC)c1OC";"IFI";"";"";"";"";"";"Not applicable";"";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL579308";"";"0";"502.39";"2";"5.55";"GNF-Pf-5641";"COC(=O)C1=C(C)NC2=C(C(=O)CC(c3ccc(OC)c(OC)c3)C2)C1c1ccc(Cl)cc1Cl";"IFI";"'='";"6.024";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL579314";"";"0";"501.62";"2";"5.86";"GNF-Pf-5647";"COc1ccc(C2CC(=O)C3=C(C2)NC(C)=C(C(=O)OC2CCCC2)C3c2ccccc2C)cc1OC";"IFI";"'='";"4.762";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL578919";"";"0";"522.04";"2";"6.20";"GNF-Pf-5663";"COc1ccc(C2CC(=O)C3=C(C2)NC(C)=C(C(=O)OC2CCCC2)C3c2ccccc2Cl)cc1OC";"IFI";"'='";"5.952";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL602164";"";"0";"292.39";"1";"-2.69";"GNF-Pf-5666";"CN1C(=O)N(C)C(NNC(N)=S)C1NNC(N)=S";"IFI";"'='";"14.29";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL577200";"";"0";"530.45";"2";"6.32";"GNF-Pf-5674";"COc1ccc(C2CC(=O)C3=C(C2)NC(C)=C(C(=O)OC(C)C)C3c2ccc(Cl)cc2Cl)cc1OC";"IFI";"'='";"4.706";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL588133";"";"0";"447.62";"1";"7.03";"GNF-Pf-5415";"Cc1ccn2c(NC(C)(C)CC(C)(C)C)c(-c3ccccc3OC(=O)C3CCCC3)nc2c1";"IFI";"'='";"3.738";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL602802";"";"0";"559.50";"1";"4.86";"GNF-Pf-5439";"CC(C)NC(=O)N1CCN(C(=O)C(Cc2c[nH]c3ccccc23)NC(=O)Nc2cccc(Cl)c2Cl)CC1C";"IFI";"'='";"1.887";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL578739";"";"0";"517.62";"2";"5.56";"GNF-Pf-5446";"COc1ccc(C2CC(=O)C3=C(C2)NC(C)=C(C(=O)OC2CCCC2)C3c2ccccc2OC)cc1OC";"IFI";"'='";"2.381";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL584301";"";"0";"364.20";"0";"3.47";"GNF-Pf-4700";"Cc1ccc(OCC(=O)Nc2cccc(C(=O)O)c2)c(Br)c1";"IFI";"'='";"7.692";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL584415";"";"0";"400.42";"0";"2.62";"GNF-Pf-4701";"COc1ccccc1-n1nnnc1SCC(=O)Nc1cc([N+](=O)[O-])ccc1C";"IFI";"'='";"2.752";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600689";"";"0";"301.39";"0";"3.80";"GNF-Pf-4706";"CCOC(=O)c1[nH]c(C)c(Cc2ccc(OCC)cc2)c1C";"IFI";"'='";"1.515";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL584659";"";"0";"471.60";"1";"6.86";"GNF-Pf-4743";"COc1cccc(C(=O)Oc2ccccc2-c2nc3ccccn3c2NC(C)(C)CC(C)(C)C)c1";"IFI";"'='";"5.556";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL584660";"";"0";"329.47";"0";"2.28";"GNF-Pf-4744";"N#Cc1ccc(N2CCCN(C(=S)NC3CCCC3)CC2)nc1";"IFI";"'='";"0.7874";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585266";"";"0";"365.39";"0";"3.85";"GNF-Pf-4760";"CCCC(=O)NC(c1cccc([N+](=O)[O-])c1)c1ccc2cccnc2c1O";"IFI";"'='";"11.94";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585420";"";"0";"394.52";"0";"4.33";"GNF-Pf-4783";"CC(=O)N(C1=C(N2CCCCCC2)C(=O)c2ccccc2C1=O)C1CCCCC1";"IFI";"'='";"7.143";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585779";"";"0";"406.28";"1";"5.30";"GNF-Pf-4849";"Oc1c(C(Nc2ccccn2)c2ccc(Br)cc2)ccc2cccnc12";"IFI";"'='";"11.27";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL601773";"DIHYDROERGOCRISTINE";"0";"611.74";"1";"2.72";"GNF-Pf-3462";"CC(C)[C@@]1(NC(=O)[C@@H]2C[C@@H]3c4cccc5[nH]cc(c45)C[C@H]3N(C)C2)O[C@@]2(O)[C@@H]3CCCN3C(=O)[C@H](Cc3ccccc3)N2C1=O";"IFI";"'='";"0.5714";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL598683";"";"0";"436.58";"0";"4.46";"GNF-Pf-3812";"CCC(Sc1nnc(-c2ccc(C)cc2)c(-c2ccc(C)cc2)n1)C(=O)NCCOC";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL598286";"";"0";"388.30";"1";"5.12";"GNF-Pf-3918";"CN(CCCNc1ccnc2cc(Cl)ccc12)C(=O)c1ccc(Cl)cc1";"IFI";"'='";"6.481";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL601176";"";"0";"421.91";"0";"2.60";"GNF-Pf-3923";"Cc1ccc(Cl)cc1N1CCN(S(=O)(=O)c2ccc3c(c2)oc(=O)n3C)CC1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL603035";"";"0";"388.52";"0";"4.31";"GNF-Pf-3938";"N#Cc1ccc(NC(=O)NC2CC3CCCC(C2)N3CCc2ccccc2)cc1";"IFI";"'='";"3.797";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL601530";"";"0";"577.72";"1";"4.78";"GNF-Pf-3939";"CSc1cccc(NC(=O)C2C3C=CC4(O3)C2C(=O)N(Cc2ccc(F)cc2)C4C(=O)NC2CCCC(C)C2C)c1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL528390";"";"0";"369.09";"0";"4.48";"GNF-Pf-3949";"Clc1cccc(Cl)c1C[n+]1ccc2ccccc2c1.[Br-]";"IFI";"'='";"7.692";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL596835";"";"0";"404.47";"0";"4.31";"GNF-Pf-3956";"COc1ccc2ccc(OC)c(C3C(C#N)=C(N)OC4=C3C(=O)CC(C)(C)C4)c2c1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL603689";"";"0";"412.47";"0";"2.65";"GNF-Pf-3965";"COc1ccc(C=NN=C2NC(=O)C(CC(=O)Nc3ccccc3)S2)cc1OC";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL598483";"";"0";"471.91";"0";"4.25";"GNF-Pf-3969";"CCN(CC)CCN1C(=O)c2ccccc2NC1c1ccc(Cl)cc1.O=C(O)C(F)(F)F";"IFI";"'='";"3.659";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL607975";"";"0";"199.25";"0";"2.98";"GNF-Pf-3982";"C=CCc1c(C)nc2ccccc2c1O";"IFI";"'='";"3.077";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL604527";"";"0";"450.54";"0";"4.99";"GNF-Pf-3984";"COc1ccc(CNCc2cc3c(-c4ccc(C)cc4)nn(-c4ccccc4)c3[nH]c2=O)cc1";"IFI";"'='";"8.108";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL604112";"";"0";"418.28";"0";"4.02";"GNF-Pf-3991";"CCc1nnc2sc(-c3ccc(NC(=O)c4ccc(Br)o4)cc3)nn12";"IFI";"'='";"7.692";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL584461";"";"0";"434.54";"0";"4.63";"GNF-Pf-3999";"O=C(Cc1cccs1)N1CCC(n2c(Cc3ccc(F)cc3)nc3cccnc32)CC1";"IFI";"'='";"5.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL602203";"";"0";"553.64";"1";"3.30";"GNF-Pf-3162";"COc1ccc(OC)c(C(C(=O)NC2CCCC2)N(C(=O)c2snc(C(N)=O)c2N)c2ccccc2OC)c1";"IFI";"'='";"6.306";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL581257";"";"0";"414.72";"0";"3.97";"GNF-Pf-3165";"CC1(C)N=C(N)N=C(N)N1c1ccc(Oc2ccc(Cl)cc2)c(Cl)c1.Cl";"IFI";"'='";"10.64";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600743";"";"0";"497.64";"1";"6.61";"GNF-Pf-3180";"Cc1ccc(C2C3=C(CC(C)(C)CC3=O)N(Cc3ccc4c(c3)OCO4)C3=C2C(=O)CC(C)(C)C3)cc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL546591";"";"0";"492.54";"1";"2.10";"GNF-Pf-3195";"COc1cc2nc(N3CCN(c4nc(N)c5cc(OC)c(OC)cc5n4)CC3)nc(N)c2cc1OC";"IFI";"'='";"23.08";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL581870";"";"0";"506.31";"0";"4.45";"GNF-Pf-3199";"Cl.Cl.N=c1n(CCN2CCCCC2)c2ccccc2n1CC(O)c1ccc(Cl)c(Cl)c1";"IFI";"'='";"9.524";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL602178";"";"0";"281.40";"0";"3.91";"GNF-Pf-3207";"Cc1ncc(CCCCN(C)C)c2c1[nH]c1ccccc12";"IFI";"'='";"11.11";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL582718";"";"0";"515.61";"1";"4.70";"GNF-Pf-3226";"Cc1ccc(NC(=O)N2CCN(C(=O)c3nc(-c4ccccc4)nc(C)c3C(=O)OC(C)C)CC2C)cc1";"IFI";"'='";"0.9346";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL602206";"";"0";"393.41";"1";"6.50";"GNF-Pf-3237";"Cc1ccc(NC2=C(c3ccc(C(F)(F)F)cc3)C(=O)c3ccccc32)cc1C";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL581259";"";"0";"424.55";"0";"3.63";"GNF-Pf-3241";"c1ccc(Cn2nnnc2CN2CCN(C(c3ccccc3)c3ccccc3)CC2)cc1";"IFI";"'='";"5.882";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL582682";"";"0";"345.88";"0";"4.30";"GNF-Pf-3247";"CC(C)N(CCNc1ncnc2c1[nH]c1ccc(Cl)cc12)C(C)C";"IFI";"'='";"2.439";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL582077";"";"0";"385.54";"0";"3.76";"GNF-Pf-3271";"Cc1nc(NCCCN(C)C)c2sc3nc4c(cc3c2n1)COC(C)(C)C4";"IFI";"'='";"2.985";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL582081";"";"0";"311.77";"0";"3.07";"GNF-Pf-3276";"O=c1c2ccccc2nc2n1CCN2Cc1ccc(Cl)cc1";"IFI";"'='";"7.576";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600917";"";"0";"228.32";"0";"2.05";"GNF-Pf-3289";"CCn1ccccc1=Nc1cccc[n+]1CC";"IFI";"'='";"7.692";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL581882";"";"0";"383.46";"0";"4.53";"GNF-Pf-3293";"COc1ccc(-n2cnc3cc(NCc4nc5ccccc5n4C)ccc32)cc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL579764";"";"0";"587.91";"2";"7.60";"GNF-Pf-3300";"CC(c1nc2ccccc2c(=O)n1-c1ccccc1Cl)N(Cc1ccccc1)C(=O)Nc1cccc(Br)c1";"IFI";"'='";"5.882";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL601975";"";"0";"634.17";"2";"8.08";"GNF-Pf-3307";"COc1cc(C2C(C(=O)OCCc3ccccc3)=C(C)NC3=C2C(=O)CC(c2ccc(Cl)cc2)C3)ccc1OCc1ccccc1";"IFI";"'='";"4.545";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL601803";"";"0";"285.37";"0";"4.19";"GNF-Pf-3308";"Cc1ccc(-c2cn3ccccc3[n+]2-c2ccccc2)cc1";"IFI";"'='";"6.522";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL582288";"";"0";"341.44";"0";"3.35";"GNF-Pf-3315";"CC(C)c1ccc(NC(=O)C(Cc2cccs2)c2nnn[nH]2)cc1";"IFI";"'='";"4.717";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL584493";"";"0";"575.37";"2";"3.03";"GNF-Pf-4238";"CN1CCN(c2nc(NN=Cc3cc(I)ccc3O)nc(Nc3ccc([N+](=O)[O-])cc3)n2)CC1";"IFI";"'='";"5.263";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL596637";"";"0";"360.67";"0";"3.95";"GNF-Pf-4256";"CN(CCCNc1ccnc2cc(Cl)ccc12)C(=O)C(Cl)Cl";"IFI";"'='";"3.704";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL603759";"";"0";"361.51";"1";"5.17";"GNF-Pf-4267";"CCN(CC)c1ccc(/C=C/c2ccc3ccc(OC)cc3[n+]2CC)cc1";"IFI";"'='";"17.14";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL598276";"";"0";"531.46";"1";"5.37";"GNF-Pf-4271";"CCN1C(=Cc2sc3cc(NC(C)=O)ccc3[n+]2CC)C=Cc2cc(C)ccc21.[I-]";"IFI";"";"";"";"";"";"Not applicable";"";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL470514";"";"0";"267.36";"0";"4.26";"GNF-Pf-3677";"Cc1ccc(Nc2nc(-c3ccccn3)cs2)cc1";"IFI";"'='";"3.623";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL597658";"";"0";"501.64";"1";"3.89";"GNF-Pf-3706";"CCC(C)(C)n1nnnc1C(c1cc2cc(C)cc(C)c2[nH]c1=O)N1CCN(c2ccc(O)cc2)CC1";"IFI";"'='";"2.727";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL583824";"";"0";"231.26";"0";"1.25";"GNF-Pf-3736";"COc1nc(NC(=N)N)nc2ccc(C)cc12";"IFI";"'='";"6.061";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL583434";"";"0";"462.46";"0";"2.64";"GNF-Pf-3752";"COc1cc(C=NNC(=O)c2ccc(C(=O)NN=Cc3ccc(O)c(OC)c3)cc2)ccc1O";"IFI";"'='";"7.143";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL2372413";"";"0";"1264.77";"None";"None";"GNF-Pf-3790";"CCCC[C@@H](C)[C@@H](O)[C@H]1C(=O)N[C@@H](C(C)C)C(=O)N(C)[C@H](SC)C(=O)N(C)[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@H](C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N(C)[C@@H](C(C)C)C(=O)N1C";"IFI";"'='";"4.878";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL597667";"";"0";"303.41";"0";"3.93";"GNF-Pf-4277";"OC1(c2cccc3ccccc23)CCN(Cc2ccccc2)C1";"IFI";"'='";"2.174";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL582659";"";"0";"421.95";"1";"5.95";"GNF-Pf-4289";"Cc1ccc(-n2c(C)cc(/C=C3\SC(=Nc4ccc(Cl)cc4)NC3=O)c2C)cc1";"IFI";"";"";"";"";"";"Not applicable";"";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585466";"";"0";"466.34";"1";"5.32";"GNF-Pf-4297";"COc1cc(C(Nc2ccccn2)c2ccc3cccnc3c2O)cc(Br)c1OC";"IFI";"'='";"12.96";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL598678";"";"0";"432.59";"1";"5.89";"GNF-Pf-4318";"CCc1ccc(NC(=O)C2c3ccccc3C(=O)N(CC(C)C)C2c2cccs2)cc1";"IFI";"'='";"6.061";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL546399";"";"0";"350.77";"0";"4.19";"GNF-Pf-4320";"O=C(Nc1ccon1)c1cc(-c2cccnc2)nc2ccc(Cl)cc12";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL604100";"";"0";"399.47";"0";"3.47";"GNF-Pf-4322";"COC(=O)C1=CN(Cc2ccc(OC)cc2)C=C(C(=O)OC)C1c1cccs1";"IFI";"'='";"2.5";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL598057";"";"0";"371.44";"0";"4.85";"GNF-Pf-4324";"COc1cccc(C(Nc2cc(C)ccn2)c2ccc3cccnc3c2O)c1";"IFI";"'='";"21.43";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL277148";"";"0";"221.26";"0";"3.61";"GNF-Pf-4337";"Oc1cc(-c2ccccc2)nc2ccccc12";"IFI";"'='";"7.092";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL599504";"";"0";"464.99";"1";"5.04";"GNF-Pf-4339";"C=CC1CN2CCC1CC2[C@@H](OC(=O)c1ccc(OC)cc1)c1ccnc2ccccc12.Cl";"IFI";"";"";"";"";"";"Not applicable";"";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL599096";"";"0";"351.79";"0";"2.54";"GNF-Pf-4344";"CCOc1ccc(C2C(C(=O)OC)=CNC=C2C(=O)OC)cc1Cl";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL604310";"";"0";"466.41";"0";"4.95";"GNF-Pf-4351";"CCOC(=O)C1CCN(C(=O)c2cc(C(C)(C)C)nn2Cc2ccc(Cl)cc2Cl)CC1";"IFI";"'='";"1.626";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL597669";"";"0";"355.46";"1";"5.78";"GNF-Pf-4354";"Cc1cccc(C2Sc3ccccc3N=C3c4ccccc4C(=O)C32)c1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL602837";"";"0";"330.30";"0";"1.08";"GNF-Pf-4369";"CCOC(=O)c1nnn(-c2nonc2N)c1-c1ccc(OC)cc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL601537";"";"0";"403.34";"0";"3.17";"GNF-Pf-4375";"CCCN(CCC)S(=O)(=O)c1cc(Br)cc2c1N(C(C)=O)CC2";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL598881";"";"0";"554.51";"2";"7.90";"GNF-Pf-4392";"COc1ccc(OC)c(C2C3=C(CC(C)(C)CC3=O)N(c3ccc(Cl)c(Cl)c3)C3=C2C(=O)CC(C)(C)C3)c1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL482160";"";"0";"463.88";"0";"4.79";"GNF-Pf-4399";"O=C(COc1ccccc1)NC(c1ccc([N+](=O)[O-])cc1)c1cc(Cl)c2cccnc2c1O";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL586024";"";"0";"420.52";"0";"4.98";"GNF-Pf-4510";"Cc1ccc(-c2nn(-c3ccccc3)c3[nH]c(=O)c(CNCc4ccccc4)cc23)cc1";"IFI";"'='";"5.405";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL599506";"";"0";"416.52";"0";"2.76";"GNF-Pf-4419";"CCCCNC(=O)C(CC(C)C)N1C(=O)c2cc(NC(C)=O)ccc2NC(=O)[C@@H]1C";"IFI";"'='";"2.469";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585974";"";"0";"392.43";"0";"3.96";"GNF-Pf-4520";"CC(=O)N(C1=C(N2CCCCC2)C(=O)c2ccccc2C1=O)c1cccc(F)c1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585226";"";"0";"518.67";"2";"3.67";"GNF-Pf-4521";"O=C(NCCCCCCCCNC(=O)Nc1ccc(C2=NCCN2)cc1)Nc1ccc(C2=NCCN2)cc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL598692";"";"0";"429.75";"0";"4.60";"GNF-Pf-4424";"COc1ccc(C[n+]2cc(-c3ccc(Cl)cc3)n3ccccc32)cc1.[Br-]";"IFI";"'='";"2.222";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL598072";"";"0";"451.06";"0";"2.71";"GNF-Pf-4428";"CN(C)[C@@H]1CCN(Cc2cccc(Cl)c2)C[C@@H]1CCC(=O)NCCCN1CCOCC1";"IFI";"'='";"1.818";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL533967";"";"0";"479.55";"1";"5.16";"GNF-Pf-4529";"COc1ccc(C2CC(=O)C3=C(C2)NC(C)=C(C(=O)OC(C)C)C3c2ccccc2F)cc1OC";"IFI";"'='";"4.762";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585044";"";"0";"353.85";"0";"3.10";"GNF-Pf-4530";"Cl.N=c1ccn(CC(=O)N2CCCc3ccccc32)c2ccccc12";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585049";"";"0";"392.97";"0";"4.90";"GNF-Pf-4533";"CC(C)NC(=O)c1ccc(OC2CCN(CC3CCCCC3)CC2)c(Cl)c1";"IFI";"'='";"2.817";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585235";"";"0";"360.33";"1";"1.09";"GNF-Pf-4535";"CCOC(=O)c1nnn(-c2nonc2N)c1-c1ccc(OC)c(OC)c1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585841";"";"0";"432.75";"1";"5.22";"GNF-Pf-4445";"CN(CCCNc1ccnc2cc(Cl)ccc12)C(=O)c1ccc(Br)cc1";"IFI";"'='";"1.852";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL583160";"";"0";"434.79";"1";"5.27";"GNF-Pf-4551";"CCCCCCCC[n+]1c(C)n(CC)c2ccc(Cl)cc21.[I-]";"IFI";"'='";"7.692";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600551";"";"0";"388.47";"0";"4.62";"GNF-Pf-4552";"C=CC1CN2CCC1CC2C(OC(=O)c1ccco1)c1ccnc2ccccc12";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL581456";"";"0";"337.45";"0";"3.95";"GNF-Pf-293";"Cc1cccc(N=C2NC(=O)/C(=C\c3ccc(N(C)C)cc3)S2)c1";"IFI";"";"";"";"";"";"Not applicable";"";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL583807";"";"0";"425.92";"0";"4.30";"GNF-Pf-4560";"O=C(NCc1ccco1)c1ccc(OC2CCN(Cc3ccncc3)CC2)c(Cl)c1";"IFI";"'='";"1.389";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585429";"";"0";"404.47";"0";"4.05";"GNF-Pf-4582";"CCOC(=O)c1ccc(NC2=C(N3CCCCC3)C(=O)c3ccccc3C2=O)cc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL584222";"";"0";"507.53";"2";"2.48";"GNF-Pf-4584";"COC(=O)c1ccc2c(=O)n(Cc3ccc4c(c3)OCO4)c(SCC(=O)n3nc(C)cc3N)nc2c1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL529361";"";"0";"208.24";"0";"2.07";"GNF-Pf-4590";"O=C(NNc1ccccc1F)C1CCC1";"IFI";"'='";"3.448";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL584652";"";"0";"408.31";"0";"3.73";"GNF-Pf-4595";"C=CC[n+]1c(C=C2C=CC=CN2C)sc2ccccc21.[I-]";"IFI";"";"";"";"";"";"Not applicable";"";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL579408";"";"0";"383.53";"0";"4.80";"GNF-Pf-4596";"CCC1(C)CC(CCNCc2ccccc2O)(c2ccccc2OC)CCO1";"IFI";"'='";"2.857";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL584236";"";"0";"432.57";"0";"3.84";"GNF-Pf-4601";"CCCC(=O)N1CCN(c2nc(Cc3ccccc3)c3c(c2C#N)CC(C)(C)OC3)CC1";"IFI";"'='";"4.545";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL601531";"";"0";"549.59";"2";"6.67";"GNF-Pf-4604";"O=C(Nc1ccc(-c2nc3ccccc3[nH]2)cc1)c1cccc(C(=O)Nc2ccc(-c3nc4ccccc4[nH]3)cc2)n1";"IFI";"'='";"11.11";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585818";"";"0";"386.72";"0";"4.96";"GNF-Pf-5025";"Brc1ccc(C=Cc2cc[n+](Cc3ccccc3)cc2)cc1.[Cl-]";"IFI";"";"";"";"";"";"Not applicable";"";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL586010";"";"0";"428.53";"1";"6.37";"GNF-Pf-5030";"COc1cc(-c2nc(-c3ccc(C)c(C)c3)c(-c3ccc(C)c(C)c3)[nH]2)cc(OC)c1O";"IFI";"'='";"8.791";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL584479";"";"0";"385.51";"0";"3.31";"GNF-Pf-4081";"COc1ccc(N2CCN(C(CNC(=O)CC(C)C)c3ccco3)CC2)cc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL576591";"";"0";"418.53";"0";"2.68";"GNF-Pf-2888";"CN1CCN(NC=C2C(=O)N(c3nc4ccccc4s3)N=C2c2ccccc2)CC1";"IFI";"";"";"";"";"";"Not applicable";"";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL576794";"";"0";"420.39";"0";"2.57";"GNF-Pf-2891";"COc1ccc([N+](=O)[O-])cc1-c1ccc(C=C(C#N)c2nn(CCO)c(N)c2C#N)o1";"IFI";"";"";"";"";"";"Not applicable";"";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL582265";"";"0";"397.86";"0";"4.19";"GNF-Pf-2966";"CN(CCCNc1ccnc2cc(Cl)ccc12)C(=O)c1ccc2c(c1)OCO2";"IFI";"'='";"1.869";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL579503";"";"0";"454.37";"0";"4.09";"GNF-Pf-2982";"CCN1CCN(c2cc(C)c3cc(NC(=O)c4cncc(Br)c4)ccc3n2)CC1";"IFI";"'='";"3.333";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL601158";"";"0";"245.32";"0";"3.60";"GNF-Pf-2985";"CCCCc1c(C)nc2c(OC)cccc2c1O";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL536002";"";"0";"277.22";"0";"4.08";"GNF-Pf-2986";"CC(C)(C)NC(=S)Nc1cccc(Cl)c1Cl";"IFI";"'='";"2.273";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL582719";"";"0";"470.53";"1";"5.68";"GNF-Pf-3344";"CCOC(=O)c1c(C)n(-c2ccccc2)c2ccc(OC(=O)c3ccccc3NC(=O)CC)cc12";"IFI";"'='";"2.778";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600747";"";"0";"325.41";"1";"5.48";"GNF-Pf-3350";"Cc1cc(C)cc(NC2=C(c3ccccc3)C(=O)c3ccccc32)c1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL581683";"";"0";"403.48";"0";"4.64";"GNF-Pf-3351";"C=CCCC(=O)N1CCC(C(=O)Nc2ccc(-c3nc4ccccc4o3)cc2)CC1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600306";"";"0";"394.30";"0";"3.54";"GNF-Pf-3352";"CC[n+]1cc(C)ccc1C=Cc1ccc(N(C)C)cc1.[I-]";"IFI";"";"";"";"";"";"Not applicable";"";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL536605";"";"0";"367.53";"1";"5.17";"GNF-Pf-3364";"CCCCOc1ccc(C(O)C(CN2CCCCC2)c2ccccc2)cc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL582068";"";"0";"355.40";"0";"4.19";"GNF-Pf-3368";"O=C(Nc1ccccc1C(F)(F)F)N1CCC(N2CCCCC2)CC1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600751";"";"0";"478.64";"0";"4.50";"GNF-Pf-3378";"CCCC(=O)N(C/C=C/c1ccccc1OC)CCN1CCN(C(=O)Nc2cccc(C)c2)CC1";"IFI";"'='";"2.804";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL525826";"";"0";"346.82";"0";"2.79";"GNF-Pf-3383";"COc1cccc(Nc2nc(NCCO)c3ccccc3n2)c1.Cl";"IFI";"'='";"1.471";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL582495";"";"0";"406.51";"1";"5.01";"GNF-Pf-3388";"CC1CCN(Cc2c(O)ccc3cc(-c4nc5ccccc5s4)c(=O)oc23)CC1";"IFI";"'='";"6.993";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL582497";"";"0";"395.93";"1";"5.39";"GNF-Pf-3394";"CCC(C(=O)NCCCCNc1ccnc2cc(Cl)ccc12)c1ccccc1";"IFI";"'='";"6.604";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL582088";"";"0";"422.74";"1";"5.77";"GNF-Pf-3396";"CN(CCCNc1ccnc2cc(Cl)ccc12)C(=O)c1ccc(Cl)c(Cl)c1";"IFI";"'='";"1.869";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600955";"";"0";"379.50";"0";"3.80";"GNF-Pf-3399";"COc1ccc(CNC2CCN(c3cccc(NC(=O)C4CC4)c3)CC2)cc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600951";"";"0";"349.42";"0";"4.36";"GNF-Pf-3500";"c1ccc(-c2nn(-c3ccccc3)[n+](-c3cccc4ccccc34)n2)cc1";"IFI";"'='";"14.29";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL527181";"";"0";"498.94";"0";"2.89";"GNF-Pf-3502";"CCOC(=O)C1=C(C)N=c2sc(=Cc3cc(Cl)ccc3O)c(=O)n2C1c1ccc2c(c1)OCO2";"IFI";"'='";"2.353";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL581046";"";"0";"411.98";"1";"5.37";"GNF-Pf-3508";"CN(CCCNc1ccnc2cc(Cl)ccc12)C(=O)C12CC3CC(CC(C3)C1)C2";"IFI";"'='";"3.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL601110";"";"0";"269.30";"0";"3.51";"GNF-Pf-3537";"CCOC(=O)c1c(C)[nH]c2c1cc(O)c1ccccc12";"IFI";"'='";"3.106";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL598477";"";"0";"367.29";"0";"4.39";"GNF-Pf-3542";"O=C(Nc1ccc2oc(-c3ccccc3F)nc2c1)c1ccc([N+](=O)[O-])o1";"IFI";"'='";"14.29";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL596845";"";"0";"423.35";"1";"5.27";"GNF-Pf-3559";"O=c1[nH]c(SCC(O)c2ccc(Cl)c(Cl)c2)nc2sc3ccccc3c12";"IFI";"'='";"3.731";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL597046";"";"0";"510.60";"1";"4.36";"GNF-Pf-3560";"CN1CCN=C1c1ccc(NC(=O)Nc2ccc(NC(=O)Nc3ccc(C4=NCCN4C)cc3)cc2)cc1";"IFI";"'='";"0.8929";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL598897";"";"0";"378.41";"0";"4.51";"GNF-Pf-3566";"O=[N+]([O-])c1cccc(C(Nc2nccs2)c2ccc3cccnc3c2O)c1";"IFI";"'='";"7.692";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL598279";"";"0";"356.43";"0";"4.99";"GNF-Pf-3570";"COc1ccc(Nc2nc(NCc3ccccc3)c3ccccc3n2)cc1";"IFI";"'='";"7.299";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL606252";"";"0";"405.50";"0";"3.62";"GNF-Pf-3573";"CCN1CCN(c2c(C(=O)c3ccccc3)cnc3cc(OC)c(OC)cc23)CC1";"IFI";"'='";"2.222";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL597872";"";"0";"471.62";"0";"3.19";"GNF-Pf-3576";"COc1ccc(S(=O)(=O)N2CCCCC2C(=O)NC(CN2CCCC2)c2ccccc2)cc1";"IFI";"'='";"0.9709";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL597268";"";"0";"416.52";"0";"4.54";"GNF-Pf-3580";"Oc1ccc(-c2ccc3c(c2)OCO3)cc1CNC1CCN(Cc2ccccc2)CC1";"IFI";"'='";"1.961";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL581208";"";"0";"315.17";"0";"3.77";"GNF-Pf-3588";"Brc1ccc(C=NNc2nc3ccccc3[nH]2)cc1";"IFI";"'='";"9.016";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL527473";"";"0";"635.16";"2";"6.70";"GNF-Pf-3603";"COc1cc(C(c2c(C)n(C)n(-c3ccccc3)c2=O)c2c(C)n(C)n(-c3ccccc3)c2=O)cc(Cl)c1OCc1ccccc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL532688";"";"0";"429.38";"0";"3.41";"GNF-Pf-3629";"CCC(=O)N1CCc2cc(Br)cc(S(=O)(=O)N3CC(C)CC(C)C3)c21";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL597254";"";"0";"288.73";"0";"3.58";"GNF-Pf-3634";"Cc1occc1C(=O)NN=C/C(Cl)=C/c1ccccc1";"IFI";"'='";"7.692";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL608433";"";"0";"364.46";"0";"1.47";"GNF-Pf-3653";"S=C(NCc1ccco1)NN=CC=NNC(=S)NCc1ccco1";"IFI";"'='";"11.67";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL583599";"";"0";"399.31";"0";"2.53";"GNF-Pf-3661";"O=C(C1CC1)N1CCc2cc(Br)cc(S(=O)(=O)N3CCCC3)c21";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL1615728";"";"0";"234.30";"0";"3.69";"GNF-Pf-3670";"CN1C=CC=CC1=CC=C1C=Nc2ccccc21";"IFI";"";"";"";"";"";"Not applicable";"";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL546162";"";"0";"322.45";"0";"4.08";"GNF-Pf-3683";"OC(CNC1CCCCC1)Cn1c2ccccc2c2ccccc21";"IFI";"'='";"2.128";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL605746";"";"0";"359.49";"0";"4.57";"GNF-Pf-3686";"CC(C)(C)c1ccc(C(=O)C[n+]2cc(-c3ccccc3)n3c2CCC3)cc1";"IFI";"'='";"5.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL598884";"";"0";"392.89";"0";"4.99";"GNF-Pf-3695";"COc1ccccc1Nc1nc(NCc2ccccc2)c2ccccc2n1.Cl";"IFI";"'='";"7.143";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL598885";"";"0";"342.81";"0";"4.26";"GNF-Pf-3696";"Cc1ccc(C#N)c(SCc2nnc(-c3ccc(Cl)cc3)o2)n1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL579640";"";"0";"396.32";"1";"5.03";"GNF-Pf-3704";"Cn1nc(C(F)(F)F)c(-c2ccc(F)cc2)c1NC(=O)Nc1ccc(F)cc1";"IFI";"'='";"3.419";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL598696";"";"0";"406.94";"0";"4.50";"GNF-Pf-3726";"CCCCCNC(=O)C1CSC(c2ccoc2)N1C(=O)c1ccccc1Cl";"IFI";"'='";"0.9434";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL611374";"";"0";"548.21";"1";"4.75";"GNF-Pf-3734";"CC(C)(C)NCC(O)Cn1c2ccc(I)cc2c2cc(I)ccc21";"IFI";"'='";"4.054";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL366240";"";"0";"393.53";"1";"5.12";"GNF-Pf-3742";"CCN1/C(=C/c2sc3cc(OC)c(OC)cc3[n+]2CC)C=Cc2ccccc21";"IFI";"'='";"23.08";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL597242";"";"0";"328.39";"0";"2.95";"GNF-Pf-3759";"Cc1cccc(NS(=O)(=O)c2ccc3[nH]c(=O)ccc3c2)c1C";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL527704";"";"0";"224.33";"0";"1.58";"GNF-Pf-3762";"Cc1ccc(NC(=S)NCCO)cc1C";"IFI";"'='";"3.03";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL597675";"";"0";"295.83";"0";"2.81";"GNF-Pf-3768";"Cl.O[C@@]1(c2cc3ccccc3s2)CN2CCC1CC2";"IFI";"'='";"1.626";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL605551";"";"0";"339.85";"0";"4.10";"GNF-Pf-3769";"COc1ccc(-c2c[n+](Cc3ccccc3Cl)c3n2CCC3)cc1";"IFI";"'='";"2.439";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL528825";"";"0";"675.89";"0";"2.31";"GNF-Pf-3789";"NCCCNC(=O)COC(c1ccccc1)c1cccnc1Cl.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F";"IFI";"'='";"1.942";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL609029";"";"0";"362.43";"0";"2.87";"GNF-Pf-3802";"O=C(N/C(=C/C=C/c1ccccc1)C(=O)N1CCOCC1)c1ccccc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL577003";"";"0";"315.41";"0";"3.82";"GNF-Pf-1479";"COc1ccc(OC)c(-c2ccc(O)c(CNCC(C)C)c2)c1";"IFI";"'='";"2.586";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL601120";"";"0";"282.26";"0";"2.58";"GNF-Pf-1484";"N#Cc1cc2nc3c(nc2cc1C#N)-c1ccccc1C3=O";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600927";"";"0";"397.91";"0";"4.45";"GNF-Pf-1489";"COc1ccc(CC(=O)NCCCCNc2ccnc3cc(Cl)ccc23)cc1";"IFI";"'='";"1.869";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL576412";"";"0";"429.86";"0";"4.54";"GNF-Pf-1509";"CC(C)(C)OC(=O)NCC(=O)Oc1cc2oc(=O)cc(-c3ccccc3)c2cc1Cl";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL528723";"";"0";"622.73";"2";"8.70";"GNF-Pf-1228";"Cc1cccc(-n2c(-c3ccccc3)nc3ccc(-c4ccc5nc(-c6ccccc6)n(-c6cccc(C)c6)c(=O)c5c4)cc3c2=O)c1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL584017";"";"0";"458.52";"0";"2.13";"GNF-Pf-946";"C/C=C/C(C(=O)NCCCC)N1C(=O)c2cc(NC(C)=O)ccc2NC(=O)[C@@H]1CCC(=O)O";"IFI";"'='";"1.235";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL528600";"";"0";"292.34";"0";"3.42";"GNF-Pf-3853";"CN(C)c1ccc(/C=C/c2nc(=O)c3ccccc3o2)cc1";"IFI";"'='";"5.882";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL584476";"";"0";"450.60";"0";"4.90";"GNF-Pf-3864";"CCN1CCC(N2CCC(n3c(Cc4ccccc4OC)nc4cc(F)ccc43)CC2)CC1";"IFI";"'='";"1.695";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL599498";"";"0";"329.36";"0";"3.81";"GNF-Pf-3882";"c1ccc(-c2cc(NCc3ccco3)nc(-c3ccccn3)n2)nc1";"IFI";"'='";"7.692";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL584249";"";"0";"389.28";"0";"4.85";"GNF-Pf-3926";"OC(CNCc1ccco1)Cn1c2ccc(Cl)cc2c2cc(Cl)ccc21";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585097";"";"0";"361.46";"0";"3.84";"GNF-Pf-3940";"CCc1ccc(C(=O)C[n+]2cc(-c3ccc(OC)cc3)n3c2CCC3)cc1";"IFI";"'='";"2.439";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585288";"";"0";"272.38";"0";"3.56";"GNF-Pf-3942";"Cc1cccc2c1[nH]c1nc(SCC(C)C)nnc12";"IFI";"'='";"10.71";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600729";"";"0";"487.62";"0";"3.43";"GNF-Pf-2699";"Cn1nc(C(=O)N2CCc3ccccc3C2)c2c1CCC(N1CCN(Cc3cccc(F)c3)CC1)C2";"IFI";"'='";"1.22";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585465";"";"0";"339.39";"0";"3.22";"GNF-Pf-4296";"CC(=O)N1CCC(N(C(=O)Nc2c(F)cccc2F)C(C)C)CC1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL604779";"";"0";"390.92";"1";"5.60";"GNF-Pf-4301";"Cc1ccc(C)c(Nc2nc(NCc3ccccc3)c3ccccc3n2)c1.Cl";"IFI";"'='";"8.108";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL530216";"";"0";"334.51";"0";"3.71";"GNF-Pf-4348";"C=C(C)CSc1nc(N)c2c3c(sc2n1)CN(CCC)CC3";"IFI";"'='";"14.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL598489";"";"0";"428.44";"0";"3.11";"GNF-Pf-4352";"O=C(Nc1ccc(-n2cnnn2)cc1)C1CCN(Cc2ccc(OC(F)F)cc2)CC1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600971";"";"0";"448.51";"1";"5.82";"GNF-Pf-4370";"Cc1nc(N2CCC(C)CC2)c2c(C)c(C(=O)Nc3ccc(C(F)(F)F)cc3)sc2n1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL597471";"";"0";"409.40";"0";"3.66";"GNF-Pf-4500";"COc1ccc(C(Cc2ccccc2)NC2CN3CCC2CC3)cc1.Cl.Cl";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL597670";"";"0";"306.35";"0";"1.71";"GNF-Pf-4502";"CCOc1ccc(NC(=O)CSc2nncc(O)n2)cc1";"IFI";"'='";"7.692";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL599711";"";"0";"289.21";"0";"2.84";"GNF-Pf-4414";"CCN1CCN(Cc2cc(Cl)cc(Cl)c2O)CC1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585842";"";"0";"563.05";"2";"6.74";"GNF-Pf-4513";"COc1cc(NC(C)CCCN(Cc2ccccc2OC)C(=O)c2ccc(Cl)c([N+](=O)[O-])c2)c2ncccc2c1";"IFI";"'='";"5.435";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL527541";"";"0";"268.14";"0";"4.11";"GNF-Pf-4439";"Cc1nc2ccccc2c(O)c1CC=C(Cl)Cl";"IFI";"'='";"1.961";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585481";"";"0";"453.51";"0";"3.38";"GNF-Pf-3943";"COc1cc2c(cc1OC)C1Cc3ccc(OC)c(OC)c3CN1CC2.O=S(=O)(O)O";"IFI";"'='";"0.6803";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL580767";"";"0";"315.80";"0";"4.01";"GNF-Pf-4019";"Cc1cc(Cl)ccc1OC(C)C(=O)N1CCc2ccccc21";"IFI";"'='";"3.226";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL597038";"";"0";"448.52";"0";"3.40";"GNF-Pf-4023";"COC(=O)[C@@H]1C[C@H](NC(=O)c2ccc(OC)cc2OC)CN1Cc1cccc2ccccc12";"IFI";"'='";"1.852";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL584225";"";"0";"289.85";"0";"4.04";"GNF-Pf-4586";"C=CCC1C=C(Cc2ccccc2)CC(CC=C)N1.Cl";"IFI";"'='";"3.922";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL610249";"";"0";"296.42";"0";"4.00";"GNF-Pf-4589";"CCN(CC)C1SC=C(c2ccc([N+](=O)[O-])cc2)S1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL631";"PROPAFENONE";"4";"341.45";"0";"3.24";"GNF-Pf-4594";"CCCNCC(O)COc1ccccc1C(=O)CCc1ccccc1";"IFI";"'='";"0.5495";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL584237";"";"0";"376.43";"0";"4.97";"GNF-Pf-4602";"Cc1c(C)n(Cc2ccc(F)cc2)c2ccc(C(=O)NCc3ccco3)cc12";"IFI";"'='";"6.25";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL584666";"";"0";"470.42";"1";"6.11";"GNF-Pf-4064";"Nc1c(C(=O)Nc2ccc(Br)cc2)sc2nc3c(c(-c4cccs4)c12)CCC3";"IFI";"'='";"2.326";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL582531";"";"0";"247.25";"0";"2.13";"GNF-Pf-4143";"CCOC(=O)c1cnc2ccc(OC)cc2c1O";"IFI";"'='";"1.163";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL582997";"";"0";"282.30";"0";"2.72";"GNF-Pf-4158";"COc1cc(C=NNc2nc3ccccc3[nH]2)ccc1O";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL597853";"";"0";"480.54";"0";"4.56";"GNF-Pf-4176";"Cc1nc(N2CCN(c3ccccn3)CC2)c2c(C)c(C(=O)Nc3c(F)cccc3F)sc2n1";"IFI";"'='";"2.353";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL582429";"";"0";"238.08";"0";"2.60";"GNF-Pf-4192";"Cc1[nH]c2ccccc2c(=O)c1Br";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL529984";"";"0";"316.79";"0";"4.00";"GNF-Pf-4202";"COc1ccc2nc(C)cc(Nc3cccc(O)c3)c2c1.Cl";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL597466";"";"0";"517.74";"1";"3.06";"GNF-Pf-4205";"CCOc1ccc2[nH]c(=O)c(CN(CCCN3CCOCC3)C(=S)NCCCN(CC)CC)cc2c1";"IFI";"'='";"4.425";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600534";"";"0";"456.57";"1";"5.06";"GNF-Pf-2535";"Cc1ccc(Cn2c(N3CCC(C(=O)NCc4ccc(F)cc4)CC3)nc3ccccc32)cc1";"IFI";"'='";"2.703";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL579331";"";"0";"289.34";"0";"4.03";"GNF-Pf-2551";"Oc1ccc2ccccc2c1CNc1nc2ccccc2[nH]1";"IFI";"'='";"15.38";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL580836";"";"0";"363.51";"0";"4.92";"GNF-Pf-606";"CC(C)CC1=Nc2cc(C(=O)NC(C)C)ccc2CN1Cc1ccccc1";"IFI";"'='";"3.797";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL527909";"";"0";"568.70";"2";"5.16";"GNF-Pf-629";"CCOC(=O)C1=C(C)N=c2sc(=Cc3ccccc3OCc3ccccc3)c(=O)n2C1c1ccccc1OC(C)C";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL599085";"";"0";"381.82";"0";"3.42";"GNF-Pf-643";"CN(C)c1nnc(/C(C#N)=C/c2cc(C(=O)c3cccc(Cl)c3)cn2C)o1";"IFI";"'='";"0.8475";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL605547";"";"0";"407.81";"0";"4.36";"GNF-Pf-657";"O=C(Cn1c2ccccc2c(=O)c2cc([N+](=O)[O-])ccc21)Nc1cccc(Cl)c1";"IFI";"'='";"1.149";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL598900";"";"0";"382.37";"0";"3.63";"GNF-Pf-671";"CCOC(=O)c1oc2cc(O)c(CC)cc2c(=O)c1-c1ccc2c(c1)OCO2";"IFI";"'='";"3.614";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL584879";"";"0";"294.39";"0";"1.34";"GNF-Pf-678";"COc1ccc(OCCOCCN2CCN(C)CC2)cc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL599308";"";"0";"432.45";"0";"2.40";"GNF-Pf-739";"COC(=O)c1cc(NC(=S)NC(=O)c2c(OC)cccc2OC)cc(C(=O)OC)c1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL597261";"";"0";"423.44";"0";"1.75";"GNF-Pf-804";"Cc1cc(CNC(=O)CC2C(=O)NCCN2Cc2ccccc2C(F)(F)F)nn1C";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL604739";"";"0";"446.64";"0";"4.22";"GNF-Pf-814";"CN1CCCN(C(=O)C2CC23CCN(Cc2ccc(N(C)c4ccccc4)cc2)CC3)CC1";"IFI";"'='";"15.38";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL599516";"";"0";"503.05";"2";"6.47";"GNF-Pf-816";"CC(C)N(CC(=O)Nc1cc(C(C)(C)C)nn1-c1ccc(Cl)cc1)C(=O)c1cccc2ccccc12";"IFI";"'='";"0.9804";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL602614";"";"0";"491.46";"1";"5.36";"GNF-Pf-507";"CCC(C)N(CCC(=O)N1CCN(Cc2ccccc2)CC1)C(=O)Nc1cccc(Cl)c1Cl";"IFI";"'='";"1.887";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL579293";"";"0";"375.70";"0";"4.03";"GNF-Pf-2431";"Clc1ccc(-c2cn3c([n+]2-c2ccccc2)CCC3)cc1.[Br-]";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL603025";"";"0";"362.47";"0";"3.01";"GNF-Pf-527";"CC(NC(=O)Cc1ccc(F)cc1)C(c1cccs1)N1CCOCC1";"IFI";"'='";"2.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL578699";"";"0";"273.30";"0";"1.73";"GNF-Pf-2476";"COc1ccc(C(C)=NNc2nnc(C)c(O)n2)cc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL603007";"";"0";"529.64";"2";"5.01";"GNF-Pf-2478";"Cc1ccc(NC(=O)N2CCN(C(=O)c3nc(-c4ccccc4)nc(C)c3C(=O)OC(C)C)CC2C)c(C)c1";"IFI";"'='";"2.885";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL602977";"";"0";"404.26";"0";"3.83";"GNF-Pf-2488";"CCOC(=O)c1c(CNc2ccncc2)n(C)c2cc(Br)c(O)cc12";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600484";"";"0";"625.54";"2";"-0.32";"GNF-Pf-583";"CC(=O)OC1C(NC(=O)c2cc([N+](=O)[O-])c(N(C)C)c([N+](=O)[O-])c2)OC(C(=O)N2CCOCC2)C(OC(C)=O)C1OC(C)=O";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL578513";"";"0";"571.68";"1";"4.52";"GNF-Pf-2502";"CCOC(=O)c1c(NC(=O)c2ccc(S(=O)(=O)N(C)c3ccccc3)cc2)sc2c1CCN(C(=O)OCC)C2";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL601529";"";"0";"295.20";"0";"0.74";"GNF-Pf-588";"CCOC(=O)C[n+]1cc(CC)sc1N.[Br-]";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL579919";"";"0";"356.86";"0";"3.98";"GNF-Pf-2511";"COc1ccc(Nc2nc(N3CCCC3)c3ccccc3n2)cc1.Cl";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL584846";"";"0";"329.23";"0";"3.87";"GNF-Pf-1369";"CC1CN(C)C(C)CC1=NOC(=O)c1ccc(Cl)c(Cl)c1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL579166";"";"0";"395.16";"0";"3.38";"GNF-Pf-1422";"Br.O=[N+]([O-])c1ccc(-c2cn3nc(C(F)(F)F)sc3n2)cc1";"IFI";"'='";"2.817";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL601983";"";"0";"466.58";"0";"3.75";"GNF-Pf-1478";"CCCC(=O)N1CCN(C(=O)c2nc(-c3ccccc3)nc(CCC)c2C(=O)OCC)CC1C";"IFI";"'='";"4.63";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL533082";"";"0";"307.40";"0";"3.13";"GNF-Pf-2555";"c1ccc2cc3c(NCCN4CCOCC4)ccnc3cc2c1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL1615695";"";"0";"451.62";"1";"5.17";"GNF-Pf-833";"CCN(CC)S(=O)(=O)c1ccc(-c2csc(=Nc3cccc4ccccc34)n2C)cc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600127";"";"0";"284.27";"0";"2.46";"GNF-Pf-2580";"COC1=CC(=O)c2c(ccc3c(OC)c(O)ccc23)C1=O";"IFI";"'='";"12.28";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL579262";"";"0";"424.52";"0";"3.18";"GNF-Pf-2591";"COc1ccc2cc(CNCCCO)c(N3CCN(c4ccc(F)cc4)CC3)nc2c1";"IFI";"'='";"1.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585815";"";"0";"495.59";"0";"3.25";"GNF-Pf-5022";"CC1CN=C(c2ccc(NC(=O)c3ccc(C(=O)Nc4ccc(C5=NCC(C)N5)cc4)c(N)c3)cc2)N1";"IFI";"'='";"3.571";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL586015";"";"0";"295.30";"0";"3.90";"GNF-Pf-5039";"Cc1cc(Nc2cccc([N+](=O)[O-])c2)nc2cc(O)ccc12";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585047";"";"0";"435.61";"1";"7.11";"GNF-Pf-5080";"CCCCCC(=O)Oc1ccccc1-c1nc2ccccn2c1NC(C)(C)CC(C)(C)C";"IFI";"'='";"2.857";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL606232";"";"0";"461.65";"1";"7.42";"GNF-Pf-5100";"Cc1ccn2c(NC(C)(C)CC(C)(C)C)c(-c3ccccc3OC(=O)C3CCCCC3)nc2c1";"IFI";"'='";"3.738";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL582952";"";"0";"470.97";"1";"5.88";"GNF-Pf-5101";"FC(F)(F)c1ccccc1NC(=S)N1CCCN(c2nc3ccc(Cl)cc3s2)CC1";"IFI";"'='";"6.195";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL602803";"";"0";"421.92";"1";"5.26";"GNF-Pf-5573";"CCOC(=O)C1=C(C)NC2=C(C(=O)CC(c3ccccc3)C2)C1c1ccccc1Cl";"IFI";"'='";"5.952";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL586363";"";"0";"367.86";"0";"3.93";"GNF-Pf-5197";"COc1ccc(-c2c[n+](CC(=O)c3ccc(Cl)cc3)c3n2CCC3)cc1";"IFI";"'='";"5.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL588276";"";"0";"387.53";"0";"3.51";"GNF-Pf-5203";"c1cc(-c2cccc3cccnc23)nc(N2CCN(CCN3CCCC3)CC2)c1";"IFI";"'='";"4.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL601970";"";"0";"414.96";"0";"3.26";"GNF-Pf-5217";"Cc1cc(Cl)c(S(=O)(=O)N2CCCC2)cc1OCC(=O)NC1CCCCC1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL577012";"";"0";"261.75";"0";"3.90";"GNF-Pf-5245";"CC(NCc1ccccc1)c1cc(Cl)ccc1O";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL602979";"";"0";"575.71";"2";"6.80";"GNF-Pf-2623";"CCc1ccc(-n2c(C(CC)N(CCc3ccccc3)C(=O)c3cc(OC)cc(OC)c3)nc3ccccc3c2=O)cc1";"IFI";"'='";"2.778";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL599959";"";"0";"568.60";"0";"4.02";"GNF-Pf-2635";"Cn1c(C(OCC(=O)N2CCN(Cc3ccccc3)CC2)c2cccnc2)cc2ccccc21.O=C(O)C(F)(F)F";"IFI";"'='";"5.825";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL2368648";"";"0";"406.87";"0";"2.89";"GNF-Pf-2637";"C[n+]1c2ccccc2nc2ccc(NC3CCCCC3N)cc21.[O-][Cl+3]([O-])([O-])[O-]";"IFI";"'='";"23.08";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL578941";"";"0";"340.43";"0";"4.57";"GNF-Pf-2652";"COc1ccc2sc(Nc3nc(-c4ccccn4)cs3)nc2c1";"IFI";"'='";"11.11";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL528186";"";"0";"426.52";"0";"4.39";"GNF-Pf-2675";"COc1cccc(NC(=O)c2ccc(NCCCN3CCC(C)CC3)c([N+](=O)[O-])c2)c1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL582061";"";"0";"571.72";"2";"6.43";"GNF-Pf-3432";"CCOC(=O)C1=C(C(=O)OCC)SC(=C2C(=S)C(C)(C)N(C(=O)c3cccc(F)c3)c3cc(C)ccc32)S1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL602613";"";"0";"509.57";"2";"7.87";"GNF-Pf-3470";"CC(C)(C)CC(C)(C)Nc1c(-c2ccccc2OC(=O)c2cccc(C(F)(F)F)c2)nc2ccccn12";"IFI";"'='";"3.738";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL582320";"";"0";"325.32";"0";"3.50";"GNF-Pf-3471";"Cc1noc(-c2ccc(O)cc2O)c1-c1ccc2c(c1)OCCO2";"IFI";"'='";"6.024";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL601592";"";"0";"440.59";"0";"2.39";"GNF-Pf-3475";"CC(C)N1CCCc2cc(CN3CCC(n4cc(C(=O)NCCCO)nn4)CC3)ccc21";"IFI";"'='";"2.609";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL582485";"";"0";"309.33";"0";"2.13";"GNF-Pf-3379";"c1cc2c(cc1Nc1c3c(nc4nncn14)CCC3)OCCO2";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL582294";"";"0";"303.36";"0";"2.72";"GNF-Pf-3398";"CC1CCCN(c2ccc(C(=O)NC3CC3)cc2[N+](=O)[O-])C1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL597663";"";"0";"390.29";"0";"3.01";"GNF-Pf-3824";"Brc1ccc2[nH]c3c(NCCCN4CCOCC4)ncnc3c2c1";"IFI";"'='";"7.843";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL598077";"";"0";"407.52";"0";"4.50";"GNF-Pf-3847";"Cc1cc(N2CCN(CC=Cc3ccccc3)CC2)n2c(nc3ccccc32)c1C#N";"IFI";"";"";"";"";"";"Not applicable";"";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL584505";"";"0";"292.34";"0";"3.44";"GNF-Pf-3866";"C=CCc1cccc(C=NNc2nc3ccccc3[nH]2)c1O";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL530173";"";"0";"253.31";"0";"2.79";"GNF-Pf-3899";"Cc1cc(C)cc(Nc2cc(C)nc3ncnn23)c1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL583873";"";"0";"431.49";"0";"2.87";"GNF-Pf-3945";"COCCOC(=O)C1=C(C)NC2=C(C(=O)CCC2)C1c1ccc(OC)c(OC)c1OC";"IFI";"'='";"2.899";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL598271";"";"0";"472.63";"1";"5.68";"GNF-Pf-3966";"Cc1cccc(-n2nc(C(C)(C)C)cc2NC(=O)CN(C(=O)/C=C/c2ccccc2)C(C)C)c1C";"IFI";"'='";"0.9259";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL584467";"";"0";"360.42";"0";"3.90";"GNF-Pf-4005";"CCOC(=O)c1c(N)n(-c2ccc(CC)cc2)c2nc3ccccc3nc12";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL597849";"";"0";"435.98";"1";"6.26";"GNF-Pf-4021";"Cc1cc(C)cc(-n2c(C)cc(/C=C3\SC(=Nc4ccc(Cl)cc4)NC3=O)c2C)c1";"IFI";"'='";"4.819";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL598272";"";"0";"471.07";"1";"5.42";"GNF-Pf-4041";"CCN(CC)CCCN(Cc1cc2ccc(C)cc2[nH]c1=O)C(=S)Nc1cccc(Cl)c1";"IFI";"'='";"9.402";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL598273";"";"0";"479.62";"1";"6.19";"GNF-Pf-4042";"CCOC(=O)CCC(=O)Oc1ccccc1-c1nc2cc(C)ccn2c1NC(C)(C)CC(C)(C)C";"IFI";"'='";"4.673";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL582532";"";"0";"344.21";"0";"3.74";"GNF-Pf-3506";"Oc1c2c(nc3cc(-c4ccc(Br)cc4)nn13)CCCC2";"IFI";"'='";"9.524";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL602204";"";"0";"464.50";"0";"1.56";"GNF-Pf-3509";"COc1ccc(NC(=O)CN2CCN(S(=O)(=O)c3cccc([N+](=O)[O-])c3)CC2)c(OC)c1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL601324";"";"0";"265.70";"0";"3.07";"GNF-Pf-3551";"CCOC(=O)c1cnc2ccc(OC)cc2c1Cl";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL597672";"";"0";"355.87";"0";"4.49";"GNF-Pf-3574";"Cc1nc(-c2ccc[n+](C)c2)sc1C(=O)C=Cc1ccc(Cl)cc1";"IFI";"";"";"";"";"";"Not applicable";"";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL584290";"";"0";"316.31";"0";"2.56";"GNF-Pf-3605";"Cn1cnnc1SCC(=O)Nc1ccccc1C(F)(F)F";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL596830";"";"0";"502.73";"1";"4.64";"GNF-Pf-3609";"Cc1cc(N2CCCC2)nc2ccc(NC(=S)NCCCN3CCN(Cc4ccccc4)CC3)cc12";"IFI";"'='";"11.76";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL599286";"";"0";"534.50";"2";"7.92";"GNF-Pf-3615";"Cc1ccn2c(NC(C)(C)CC(C)(C)C)c(-c3ccccc3OC(=O)c3ccccc3Br)nc2c1";"IFI";"'='";"2.128";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL598267";"";"0";"356.49";"1";"5.91";"GNF-Pf-3625";"Cn1cc(C(c2cccs2)c2cn(C)c3ccccc23)c2ccccc21";"IFI";"'='";"17.5";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL546707";"";"0";"405.45";"0";"3.73";"GNF-Pf-3635";"Cc1cccc(OCC(=O)Nc2cccc(NC(=O)COc3cccc(C)c3)n2)c1";"IFI";"'='";"2.941";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL584888";"";"0";"459.29";"0";"2.49";"GNF-Pf-3676";"Nc1nonc1-n1nnc(C(=O)NN=Cc2cc(Br)cs2)c1-c1ccccc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL605549";"";"0";"417.53";"1";"5.83";"GNF-Pf-3708";"CCc1ccc(NC(=O)c2sc3nc4c(c(-c5ccco5)c3c2N)CCCC4)cc1";"IFI";"'='";"1.163";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL607973";"";"0";"296.33";"0";"1.97";"GNF-Pf-839";"COc1ccc(C2(Cc3ccccc3)NC(=O)NC2=O)cc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585984";"";"0";"492.71";"1";"5.12";"GNF-Pf-851";"CC1CCCCN1CCCNc1ncc(C(=O)NCCc2ccccc2)c(NCC2CCCCC2)n1";"IFI";"'='";"2.857";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL584015";"";"0";"496.69";"1";"5.56";"GNF-Pf-877";"COc1ccc(C(=O)C(CCC(CNC(C)(C)C)C(=O)c2ccc(OC)cc2)CNC(C)(C)C)cc1";"IFI";"'='";"7.143";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600773";"";"0";"282.36";"0";"3.13";"GNF-Pf-5051";"N=c1c2c(n(Cc3ccc(F)cc3)c3c1CCC3)CCC2";"IFI";"'='";"4.545";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600521";"";"0";"383.54";"0";"4.08";"GNF-Pf-5181";"O=C1N(Cc2cc3ccccc3s2)CC2CN(Cc3ccsc3)CCN12";"IFI";"'='";"1.389";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL528316";"";"0";"456.46";"1";"7.06";"GNF-Pf-5233";"CCN(CC)CCCC(C)N=c1cc(C=Cc2ccccc2Cl)[nH]c2cc(Cl)ccc12";"IFI";"";"";"";"";"";"Not applicable";"";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL581698";"";"0";"388.45";"0";"3.89";"GNF-Pf-596";"CCOC(=O)c1c(NC(=O)Cc2ccc([N+](=O)[O-])cc2)sc2c1CCCC2";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL601539";"";"0";"273.32";"0";"1.85";"GNF-Pf-1114";"COc1ccc(-c2csc3ncn(N)c(=O)c23)cc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL584833";"";"0";"498.66";"1";"5.07";"GNF-Pf-1160";"CC(C)CC(=O)OC1C(N2CCCCC2)c2c(ccc(/C=C/C(=O)N3CCCCC3)c2O)OC1(C)C";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL577583";"";"0";"319.33";"0";"2.06";"GNF-Pf-2445";"Cc1cc(Nc2ccc(C(=O)n3ccnc3)cc2)n2ncnc2n1";"IFI";"'='";"4.651";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL584215";"";"0";"385.49";"0";"1.81";"GNF-Pf-1177";"OC(CN1CCOCC1)Cn1cnc2c(SCc3ccccc3)ncnc21";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL584852";"BUQUINOLATE";"0";"361.44";"0";"4.19";"GNF-Pf-1188";"CCOC(=O)c1cnc2cc(OCC(C)C)c(OCC(C)C)cc2c1O";"IFI";"'='";"0.6494";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL578713";"";"0";"334.47";"0";"3.07";"GNF-Pf-158";"CN(C)CCN1CCN(c2ccnc3cc4ccccc4cc23)CC1";"IFI";"'='";"5.797";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL347645";"";"0";"135.17";"0";"0.71";"GNF-Pf-1199";"NC(=O)Cc1ccccc1";"IFI";"'='";"2.041";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL579138";"";"0";"383.30";"1";"5.28";"GNF-Pf-165";"COc1ccccc1C1SCCN1C(=O)Nc1ccc(Cl)c(Cl)c1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585257";"";"0";"467.35";"1";"6.15";"GNF-Pf-1203";"COc1ccc(/C=C2\N=C(c3ccc(Cl)cc3)N(c3cc(Cl)ccc3C)C2=O)cc1OC";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL601777";"";"0";"265.25";"0";"1.09";"GNF-Pf-174";"O=C1NC(=S)N/C1=C\C=C\c1ccc([N+](=O)[O-])o1";"IFI";"'='";"10.57";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585789";"";"0";"537.04";"2";"6.97";"GNF-Pf-1234";"CCCCN(C(=O)Nc1ccc(OCC)cc1)C(C)c1nc2ccccc2c(=O)n1-c1ccc(F)c(Cl)c1";"IFI";"'='";"11.7";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL582480";"";"0";"398.58";"0";"3.98";"GNF-Pf-200";"Cn1c(SCC2CCCO2)nnc1C1CCN(C/C=C/c2ccccc2)CC1";"IFI";"'='";"1.709";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585798";"";"0";"477.36";"0";"4.70";"GNF-Pf-1245";"N#C/C(=C\n1cc(Cc2ccc(Cl)cc2Cl)c2ccccc21)c1nn(CCO)c(N)c1C#N";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL602968";"";"0";"268.73";"0";"2.81";"GNF-Pf-1246";"O=C(COc1cccc(Cl)c1)Nc1nccs1";"IFI";"'='";"5.952";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL602023";"";"0";"346.43";"0";"4.19";"GNF-Pf-1259";"Cc1ccc2c(c1)C1CN(C)CCC1N2C(=O)c1cc2ccccc2o1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600563";"";"0";"398.51";"0";"4.94";"GNF-Pf-1277";"Cc1nc(N2CCC(C)CC2)c2c(C)c(C(=O)Nc3ccc(F)cc3)sc2n1";"IFI";"'='";"1.176";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL578499";"";"0";"417.49";"0";"1.07";"GNF-Pf-99";"Cc1ccccc1N(CC(=O)NCC1CCCO1)C(=O)c1snc(C(N)=O)c1N";"IFI";"'='";"3.738";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL578935";"";"0";"317.35";"0";"3.80";"GNF-Pf-109";"Cc1ccc(O)c(C(=O)c2c[nH]c(-c3nc4ccccc4[nH]3)c2)c1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL576181";"";"0";"421.54";"0";"4.73";"GNF-Pf-115";"Cc1ccc(NC(C)c2nc3ccccc3c(=O)n2CCOC2CCCCO2)cc1C";"IFI";"'='";"1.905";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL601130";"";"0";"319.67";"0";"2.24";"GNF-Pf-129";"Cn1ccnc1C(=O)NNc1ncc(C(F)(F)F)cc1Cl";"IFI";"'='";"13.28";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL578686";"";"0";"447.58";"1";"6.95";"GNF-Pf-132";"COc1ccccc1/C=C\CN(C(=O)c1ccc(C)cc1)C(c1ccccc1)c1ccccc1";"IFI";"'='";"2.198";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL578897";"";"0";"532.08";"2";"6.58";"GNF-Pf-135";"CCC(c1nc2ccccc2c(=O)n1-c1cccc(Cl)c1)N(CCC(C)C)C(=O)COCc1ccccc1";"IFI";"'='";"0.9091";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL602180";"";"0";"256.31";"0";"2.15";"GNF-Pf-136";"COc1cnc(-c2ccccn2)nc1N1CCCC1";"IFI";"'='";"8.434";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL578056";"";"0";"305.43";"0";"4.27";"GNF-Pf-139";"CN(C)CCCNc1cc(-c2ccccc2)nc2ccccc12";"IFI";"'='";"3.846";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL577651";"";"0";"459.51";"0";"3.40";"GNF-Pf-2200";"CCOC(=O)c1cccc(NC(=O)CCn2nc(C)c3c(C)n(-c4ccccc4)nc3c2=O)c1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL577655";"";"0";"425.51";"0";"2.81";"GNF-Pf-2206";"CCC(C)NC(=O)c1c[nH]c2ccc(S(=O)(=O)N3CCc4ccccc43)cc2c1=O";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL578468";"";"0";"332.43";"0";"2.40";"GNF-Pf-2225";"CCn1cc(C(=O)N2CCC(C(=O)c3nccs3)CC2)c(C)n1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL581886";"CEPHAELINE HYDROBROMIDE";"0";"547.53";"0";"4.64";"GNF-Pf-307";"Br.CC[C@H]1CN2CCc3cc(OC)c(OC)cc3[C@@H]2C[C@@H]1C[C@H]1NCCc2cc(O)c(OC)cc21";"IFI";"'='";"32.26";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL601346";"";"0";"287.70";"0";"3.13";"GNF-Pf-318";"O=C(Cn1c(=O)oc2cc(Cl)ccc21)c1ccccc1";"IFI";"'='";"1.515";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL581044";"";"0";"246.35";"0";"3.29";"GNF-Pf-321";"CN(C)c1ccc(N/C=C/C(=O)C(C)(C)C)cc1";"IFI";"'='";"4.545";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL529589";"";"0";"286.38";"0";"1.47";"GNF-Pf-327";"CN(C)c1ccc(N2C(N)=NC(N)=NC23CCCC3)cc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL582679";"";"0";"393.44";"0";"4.21";"GNF-Pf-369";"Cc1c(C(=O)Nc2ccccc2)sc2ncn(Cc3ccccc3F)c(=O)c12";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL580154";"";"0";"400.47";"0";"2.24";"GNF-Pf-371";"COc1cc(OC)c(OC)cc1CN1CCN(C(C)C)CC1.O=CO.O=CO";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL582063";"";"0";"313.44";"0";"4.50";"GNF-Pf-377";"CC(C)(C)c1ncccc1OC(=O)C12CC3CC(CC(C3)C1)C2";"IFI";"'='";"3.15";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL528121";"";"0";"266.31";"0";"1.74";"GNF-Pf-405";"O=C(O)CSc1nc2c(ccc3nsnc32)[nH]1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL604361";"";"0";"368.39";"0";"2.31";"GNF-Pf-435";"COCCN1Cc2cccc(C(=O)Nc3ccc4c(c3)OCCO4)c2C1=O";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL579084";"";"0";"582.90";"0";"3.01";"GNF-Pf-2594";"COCCN(C)C(=O)COC(c1cccs1)c1cccnc1Cl.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F";"IFI";"'='";"2.913";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL578059";"";"0";"493.53";"1";"2.74";"GNF-Pf-2615";"COc1ccc(C=NNc2nc(Nc3ccc([N+](=O)[O-])cc3)nc(N3CCN(C)CC3)n2)cc1OC";"IFI";"'='";"5.882";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL610329";"";"0";"431.58";"0";"4.79";"GNF-Pf-2264";"COC(=O)c1sc2nc(CN(C)CC(C)C)ccc2c1NC(=O)c1ccc(C)s1";"IFI";"'='";"0.9615";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL578875";"";"0";"502.52";"2";"5.31";"GNF-Pf-2279";"COC(=O)c1ccc2c(c1)C(=O)c1ccccc1C2C1c2ccccc2C(=O)c2cc(C(=O)OC)ccc21";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600912";"";"0";"295.30";"0";"2.85";"GNF-Pf-2285";"Cc1cc(C)n(-c2ncc(-c3ccc([N+](=O)[O-])cc3)cn2)n1";"IFI";"'='";"7.692";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL577195";"";"0";"301.34";"0";"2.89";"GNF-Pf-2319";"COc1cc(NC(=O)Cc2ccccc2OC)cc(OC)c1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL602158";"";"0";"322.37";"0";"2.77";"GNF-Pf-948";"O=C(CCCc1nc(-c2ccccc2)no1)NCc1cccnc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL584022";"";"0";"445.54";"1";"5.29";"GNF-Pf-959";"COc1ccc(-c2cn(-c3ccc(OC)cc3)c(SCC(=O)Nc3ccccc3)n2)cc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585401";"";"0";"329.34";"0";"1.10";"GNF-Pf-974";"NC(=O)CSc1nnc2ccc(-c3ccc4c(c3)OCO4)nn12";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL6255";"";"0";"261.37";"0";"2.98";"GNF-Pf-983";"COCCCNC(=O)/C=C/c1ccc(C(C)C)cc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL582463";"";"0";"509.09";"2";"6.66";"GNF-Pf-1404";"CCCCc1ccc(C(=O)N(CC(=O)Nc2cc(C(C)(C)C)nn2-c2ccc(Cl)cc2)C(C)C)cc1";"IFI";"'='";"1.905";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585398";"";"0";"564.10";"2";"7.26";"GNF-Pf-1417";"CCCCCCN(C(=O)COCc1ccccc1)C(CC)c1nc2ccccc2c(=O)n1-c1ccc(F)c(Cl)c1";"IFI";"'='";"1.887";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL576411";"";"0";"475.13";"None";"None";"GNF-Pf-1437";"";"IFI";"'='";"14.29";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL601763";"";"0";"191.27";"0";"2.99";"GNF-Pf-1449";"CCCCc1ccc(NC(C)=O)cc1";"IFI";"'='";"2.128";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600507";"";"0";"222.24";"0";"1.58";"GNF-Pf-1457";"Cc1cccnc1NC(=O)CCCC(=O)O";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL258765";"FASCAPLYSIN CHLORIDE";"0";"306.75";"0";"3.14";"GNF-Pf-1458";"O=C1c2ccccc2-[n+]2ccc3c([nH]c4ccccc43)c21.[Cl-]";"IFI";"'='";"41.22";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL580013";"";"0";"304.35";"0";"1.96";"GNF-Pf-1072";"C/C=C1/C[C@H]2[C@@H](OC)Nc3cc(O)c(OC)cc3C(=O)N2C1";"IFI";"'='";"28.57";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL601603";"";"0";"287.79";"0";"3.72";"GNF-Pf-1089";"ClC12CC3CC(C1)CC(n1nnc4ccccc41)(C3)C2";"IFI";"'='";"1.471";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585990";"";"0";"323.35";"0";"2.79";"GNF-Pf-1097";"C=C(C)C(=O)OCCc1ccc(O)c(-n2nc3ccccc3n2)c1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL583562";"";"0";"386.45";"1";"5.76";"GNF-Pf-1176";"CCOc1ccc(C(=O)Nc2cccc(-c3nc4cc(C)ccc4o3)c2C)cc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600280";"";"0";"610.82";"1";"2.40";"GNF-Pf-572";"CC(C)CN(CC(O)CN(CCN1CCOCC1)S(=O)(=O)Cc1ccccc1)C(=O)C1CCCN1C(=O)OC(C)(C)C";"IFI";"'='";"1.961";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL587853";"";"0";"516.76";"1";"4.80";"GNF-Pf-1657";"Cc1cccc(CN2CCC(CNC(=S)Nc3ccc4nc(N5CCN(C)CC5)cc(C)c4c3)CC2)c1";"IFI";"'='";"8.333";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL581912";"";"0";"320.35";"0";"3.48";"GNF-Pf-455";"CCOC(=O)c1[nH]nc(C(=O)c2ccccc2)c1-c1ccccc1";"IFI";"'='";"1.835";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL580141";"";"0";"374.47";"1";"5.22";"GNF-Pf-1687";"Cc1ccc(Sc2cc(C(=O)NCc3ccco3)c3ccccc3n2)cc1";"IFI";"'='";"1.19";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL601166";"";"0";"409.24";"0";"3.77";"GNF-Pf-1695";"O=C1NN(c2ccc(Br)cc2)C(=O)/C1=C\c1c(O)ccc2ccccc12";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL581267";"";"0";"388.43";"1";"5.23";"GNF-Pf-490";"c1cncc(-c2nc3cc(-c4ccc5[nH]c(-c6cccnc6)nc5c4)ccc3[nH]2)c1";"IFI";"'='";"5.556";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL579233";"";"0";"397.57";"1";"6.50";"GNF-Pf-1728";"CC[n+]1c(/C=C/N(C)c2ccccc2)sc(-c2ccccc2)c1-c1ccccc1";"IFI";"'='";"14.29";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL582527";"";"0";"330.27";"0";"0.45";"GNF-Pf-498";"COC(=O)C1N(C(=O)OC)c2ccc([N+](=O)[O-])cc2S1(=O)=O";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL601806";"";"0";"480.59";"1";"5.34";"GNF-Pf-1750";"COc1cc(OC)cc(N2C(=O)N(Cc3ccc(C(C)(C)C)cc3)c3ccccc3S2(=O)=O)c1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL578967";"";"0";"481.56";"0";"3.93";"GNF-Pf-5466";"NC(Cc1ccccc1)C(=O)N1CCn2c(nc(-c3ccccc3)c2Nc2ccc3c(c2)OCO3)C1";"IFI";"'='";"4.11";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL586946";"";"0";"590.57";"1";"3.74";"GNF-Pf-5475";"COc1cc(COc2cc(N)c(Cl)cc2C(=O)CCC2CCN(CCNS(C)(=O)=O)CC2)cc(OC)c1.Cl";"IFI";"'='";"2.564";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL578947";"";"0";"546.45";"2";"5.56";"GNF-Pf-5501";"COCCOC(=O)C1=C(C)NC2=C(C(=O)CC(c3ccc(OC)c(OC)c3)C2)C1c1cccc(Cl)c1Cl";"IFI";"'='";"2.353";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL580959";"";"0";"430.98";"1";"5.29";"GNF-Pf-5353";"O=C(NCc1ccco1)c1ccc(OC2CCN(CC3CCCCC3)CC2)c(Cl)c1";"IFI";"'='";"1.389";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600707";"";"0";"321.40";"0";"4.53";"GNF-Pf-5363";"Oc1ccc(-c2ccccc2)cc1CNCCc1ccc(F)cc1";"IFI";"'='";"3.419";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL584843";"";"0";"505.80";"2";"7.12";"GNF-Pf-5009";"O=C(c1cc2cc(Br)ccc2o1)N1CCc2c([nH]c3ccccc23)C1c1ccc(Cl)cc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL601188";"";"0";"491.57";"1";"6.46";"GNF-Pf-5026";"CCCc1nc2ccc(NC(=O)c3ccccc3F)cc2c(=O)n1Cc1ccc(-c2ccccc2)cc1";"IFI";"'='";"7.273";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL582950";"";"0";"472.89";"1";"5.69";"GNF-Pf-5034";"O=C(Nc1c(C(=O)Nc2cccc(Cl)c2)oc2ccccc12)c1cc(-c2ccccc2O)n[nH]1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL580701";"";"0";"391.34";"1";"5.38";"GNF-Pf-5053";"OC(CNC1CCCCC1)Cn1c2ccc(Cl)cc2c2cc(Cl)ccc21";"IFI";"'='";"6.977";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL584885";"";"0";"410.57";"0";"3.37";"GNF-Pf-685";"CC(C)CNc1nc(NCCC2CCCN2C)ncc1C(=O)NCc1ccccc1";"IFI";"'='";"1.905";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600289";"";"0";"355.35";"0";"3.01";"GNF-Pf-738";"COc1cc(C(=O)Nc2nnc(-c3ccccc3)o2)cc(OC)c1OC";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585088";"";"0";"460.58";"0";"4.35";"GNF-Pf-755";"CCN1CCN(c2cc(C)c3cc(NC(=O)/C=C/c4cc(OC)ccc4OC)ccc3n2)CC1";"IFI";"'='";"8.333";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL602766";"";"0";"548.64";"2";"6.51";"GNF-Pf-832";"COc1cccc(NC(=O)N(Cc2ccccc2)C(C)c2nc3ccccc3c(=O)n2-c2cc(C)ccc2OC)c1";"IFI";"'='";"3.191";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600157";"";"0";"287.36";"0";"4.49";"GNF-Pf-856";"CCCCCCOc1ccc(NC(=O)c2ccco2)cc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL583155";"";"0";"351.17";"0";"3.12";"GNF-Pf-871";"O=C(COc1cccc(Br)c1)NN=Cc1ccccc1F";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600342";"";"0";"452.49";"0";"3.88";"GNF-Pf-872";"C=CCOC(=O)C1=C(C)N=C2SCCC(=O)N2C1c1ccc(OC(=O)c2ccco2)cc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL64894";"GENTIAN VIOLET";"4";"407.99";"0";"4.46";"GNF-Pf-880";"CN(C)c1ccc(C(=C2C=CC(=[N+](C)C)C=C2)c2ccc(N(C)C)cc2)cc1.[Cl-]";"IFI";"'='";"25.68";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL602824";"";"0";"502.62";"1";"3.49";"GNF-Pf-884";"COc1ccccc1CNc1ncc(C(=O)NCCCN2CCCC2=O)c(NCCc2ccccc2)n1";"IFI";"'='";"1.942";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL602017";"";"0";"446.52";"0";"4.00";"GNF-Pf-889";"COC(=O)[C@@H]1C[C@@H](NC(=O)c2ccccc2F)CN1CC(c1ccccc1)c1ccccc1";"IFI";"'='";"2.679";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585233";"";"0";"358.24";"0";"5.00";"GNF-Pf-926";"CCC(=O)c1c(C)n(-c2ccc(Br)cc2)c2ccc(O)cc12";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL577793";"";"0";"335.41";"0";"3.16";"GNF-Pf-2223";"C=CCNC(=O)c1ccc2c(c1)N=CN(CCOc1ccccc1)C2";"IFI";"'='";"2.469";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL602602";"";"0";"495.58";"1";"5.66";"GNF-Pf-2537";"COc1ccc(NC(=O)c2cc3cc(C4(O)CCN(Cc5cc6ccccc6[nH]5)CC4)ccc3o2)cc1";"IFI";"'='";"8.475";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL577836";"";"0";"458.80";"1";"5.37";"GNF-Pf-2543";"O=S(=O)(NCCCCNc1ccnc2cc(Cl)ccc12)c1cc(Cl)ccc1Cl";"IFI";"'='";"3.846";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL602367";"";"0";"590.80";"2";"5.84";"GNF-Pf-2548";"CC[C@@H](C(=O)[C@@H](C)C(O)[C@H](C)CCc1ccc(C)c(O)c1C(=O)O)C1O[C@](CC)(C2CC[C@](O)(CC)[C@H](C)O2)C[C@@H]1C";"IFI";"'='";"9.836";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL579117";"";"0";"434.49";"1";"5.30";"GNF-Pf-2071";"COc1cc(/C=C2/SC(=Nc3ccccc3)NC2=O)ccc1OCc1ccccc1F";"IFI";"'='";"1.136";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL598685";"";"0";"351.28";"0";"4.46";"GNF-Pf-4035";"CC(C)NCC(O)Cn1c2ccc(Cl)cc2c2cc(Cl)ccc21";"IFI";"'='";"4.255";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL548230";"";"0";"390.44";"0";"4.69";"GNF-Pf-4044";"Cc1cc(N2CCCCC2)nc2ccc(NC(=O)c3cccc([N+](=O)[O-])c3)cc12";"IFI";"'='";"8.065";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL611387";"";"0";"343.79";"0";"3.31";"GNF-Pf-4213";"N#Cc1ccc(N2CCN(C(=O)c3ccc(F)cc3Cl)CC2)cc1";"IFI";"'='";"4.255";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585271";"";"0";"568.46";"2";"5.17";"GNF-Pf-4222";"CCOC(=O)C1=C(C)NC2=C(C(=O)C(C(=O)OCC)C(c3cccc(OC)c3)C2)C1c1ccc(Br)cc1";"IFI";"'='";"2.326";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600972";"";"0";"283.42";"0";"4.75";"GNF-Pf-4225";"O=c1c2c([nH]c3ccccc13)CCCCCCCCCC2";"IFI";"'='";"2.941";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL527838";"";"0";"405.46";"0";"3.55";"GNF-Pf-4239";"COc1cc2nc(NCC3CCCO3)n3nc(-c4ccccc4)nc3c2cc1OC";"IFI";"'='";"2.273";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL601148";"";"0";"373.50";"1";"5.74";"GNF-Pf-4244";"CC[n+]1c(/C=C2\Sc3oc4ccccc4c3N2C)ccc2cc(C)ccc21";"IFI";"";"";"";"";"";"Not applicable";"";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL605951";"";"0";"552.43";"2";"7.39";"GNF-Pf-4252";"COc1cc2c(-c3cc(Br)ccc3O)nc3c(c(-c4ccccc4)nn3-c3ccccc3)c2cc1OC";"IFI";"'='";"3.03";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL531932";"";"0";"378.33";"0";"4.89";"GNF-Pf-4260";"Cn1nc(C(F)(F)F)c(-c2ccc(F)cc2)c1NC(=O)Nc1ccccc1";"IFI";"'='";"4.167";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL599295";"";"0";"487.60";"1";"5.55";"GNF-Pf-4262";"COc1ccc(C2CC(=O)C3=C(C2)NC(C)=C(C(=O)OC2CCCC2)C3c2ccc(OC)cc2)cc1";"IFI";"'='";"7.407";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL599296";"";"0";"462.39";"1";"6.92";"GNF-Pf-4263";"COc1ccc(C2Nc3ccc4ccccc4c3C3=C2C(=O)CC(C)(C)C3)cc1Br";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL604114";"";"0";"551.00";"2";"5.80";"GNF-Pf-4061";"COc1ccc(OC)c(NC(=O)COc2cc3ccccc3cc2C(=O)Nc2cc(OC)c(Cl)cc2OC)c1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL599883";"";"0";"236.26";"0";"0.45";"GNF-Pf-4070";"COc1nncc(-c2cnnc(SC)n2)n1";"IFI";"'='";"4.615";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL601178";"";"0";"510.08";"1";"3.83";"GNF-Pf-4071";"COc1ccc2cc(CNCCc3cccc(Cl)c3)c(N3CCC(=O)N(CCN(C)C)CC3)nc2c1";"IFI";"'='";"9.735";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL602830";"";"0";"363.46";"0";"4.41";"GNF-Pf-4074";"COc1ccc(OC)c(-c2ccc(O)c(CNCCc3ccccc3)c2)c1";"IFI";"'='";"0.8475";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL584883";"";"0";"360.28";"0";"2.82";"GNF-Pf-4078";"C[n+]1c2n(c3ccccc31)N=C(c1ccccc1)CS2.[Br-]";"IFI";"'='";"3.704";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL603943";"";"0";"267.34";"0";"3.05";"GNF-Pf-4080";"CCc1ccc(Nc2cc(C)nc3nc(C)nn23)cc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL531760";"";"0";"475.38";"1";"8.55";"GNF-Pf-4087";"COc1ccc2nc(C)cc(Nc3ccc(Oc4ccc5ccccc5c4Cl)c(Cl)c3)c2c1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL365324";"";"0";"339.51";"1";"5.14";"GNF-Pf-4093";"CCN1/C(=C/c2sc3ccccc3[n+]2CC)Sc2ccccc21";"IFI";"";"";"";"";"";"Not applicable";"";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL586912";"";"0";"301.77";"0";"3.70";"GNF-Pf-4108";"CC(Oc1cccc(Cl)c1)C(=O)N1CCc2ccccc21";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL604309";"";"0";"551.64";"2";"6.15";"GNF-Pf-4115";"O=C(c1cc2n(n1)C(C(F)(F)F)CC(c1cccs1)N2)N1CCN(C(c2ccccc2)c2ccccc2)CC1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL597664";"";"0";"491.72";"1";"8.59";"GNF-Pf-4120";"CCCCCCCCC(=O)Oc1ccccc1-c1nc2cc(C)ccn2c1NC(C)(C)CC(C)(C)C";"IFI";"'='";"4.63";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL599105";"";"0";"651.33";"2";"5.18";"GNF-Pf-4130";"OC(CN1CCN(Cc2ccccc2)CC1)Cn1c2ccc(I)cc2c2cc(I)ccc21";"IFI";"'='";"7.547";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL534997";"";"0";"306.77";"0";"4.03";"GNF-Pf-4140";"COc1ccc(-c2csc3ncnc(Cl)c23)cc1OC";"IFI";"'='";"6.154";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585082";"";"0";"414.55";"0";"3.10";"GNF-Pf-4141";"COc1ccc(CN2CCN(Cc3ccc(OC)c(C)c3C)C(CCO)C2)c(O)c1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585468";"";"0";"437.56";"1";"5.79";"GNF-Pf-4149";"CCCC(=O)N(CCCC(C)Nc1cc(OC)cc2cccnc12)Cc1ccc(F)cc1";"IFI";"'='";"1.942";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL602833";"";"0";"377.28";"0";"3.68";"GNF-Pf-4154";"Fc1ccc(-c2cn3c([n+]2-c2ccccc2)SCC3)cc1.[Br-]";"IFI";"'='";"1.042";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL584281";"";"0";"352.49";"0";"2.31";"GNF-Pf-4159";"CCCN1CCc2c(sc3nc(SCC(=O)OC)nc(N)c23)C1";"IFI";"'='";"8.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL111750";"";"0";"428.53";"1";"5.04";"GNF-Pf-4162";"C=C[C@H]1CN2CC[C@H]1C[C@@H]2[C@@H](OC(=O)c1ccc(OC)cc1)c1ccnc2ccccc12";"IFI";"'='";"3.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL527520";"";"0";"1063.11";"None";"None";"GNF-Pf-4168";"COC1C(OC2OC(C)C(O)C(C)(O)C2OC)c2c(cc3c(c2O)C(=O)c2c(ccc4c2OC2OC4(C)C(OC4CC(C)([N+](=O)[O-])C(OC5OC(C)C(O)C(C)(O)C5OC)C(C)O4)C(N(C)C)C2O)C3=O)CC1(C)O";"IFI";"'='";"10.53";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL582493";"";"0";"319.45";"0";"4.51";"GNF-Pf-4170";"Cc1cc(/C=C2\Sc3ccccc3N2C)[n+](C)c2ccccc12";"IFI";"";"";"";"";"";"Not applicable";"";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600491";"";"0";"253.28";"0";"3.82";"GNF-Pf-4186";"Cc1nnc(Nc2ccc(F)cc2)c2ccccc12";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL583431";"";"0";"303.75";"0";"1.67";"GNF-Pf-3529";"O=C(NCc1ccc(Cl)cc1)C(=O)NCc1ccccn1";"IFI";"'='";"1.538";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL599888";"";"0";"311.17";"0";"3.84";"GNF-Pf-3545";"COc1ccc(N)cc1NC(=O)c1ccc(Cl)cc1Cl";"IFI";"'='";"1.515";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL598896";"";"0";"431.51";"0";"3.10";"GNF-Pf-3565";"Cc1cc(C)c(S(=O)(=O)N2CCCC2CNC(=O)c2cccc([N+](=O)[O-])c2)c(C)c1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL604110";"";"0";"508.96";"2";"5.15";"GNF-Pf-3567";"COc1ccccc1C(NC(=O)c1cc(OC)c(OC)c(OC)c1)c1cc(Cl)c2cccnc2c1O";"IFI";"'='";"4.167";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL601111";"";"0";"322.50";"0";"3.54";"GNF-Pf-3572";"CCCSc1nc(N)c2c3c(sc2n1)CN(CCC)CC3";"IFI";"'='";"12.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL529934";"";"0";"651.83";"2";"5.86";"GNF-Pf-3583";"COc1ccc(CN(Cc2ccc(C(C)C)cc2)S(=O)(=O)c2ccc(S(=O)(=O)N3CCN(c4ccccc4F)CC3)cc2)cc1";"IFI";"'='";"1.042";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL588932";"";"0";"464.49";"1";"5.40";"GNF-Pf-3606";"CC1CCN(CCCNc2ccc(C(=O)Nc3ccc(C(F)(F)F)cc3)cc2[N+](=O)[O-])CC1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL596831";"";"0";"319.84";"0";"3.80";"GNF-Pf-3610";"CC(C)C(=O)N(C)CCCNc1ccnc2cc(Cl)ccc12";"IFI";"'='";"2.804";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL598492";"";"0";"391.23";"0";"1.74";"GNF-Pf-3650";"Cc1n(N)c2ccccc2[n+]1CC(=O)c1ccc([N+](=O)[O-])cc1.[Br-]";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL582287";"";"0";"495.79";"0";"4.65";"GNF-Pf-3314";"CCn1c(C=CN(C(C)=O)c2ccccc2)[n+](CC)c2cc(Cl)ccc21.[I-]";"IFI";"";"";"";"";"";"Not applicable";"";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL582291";"";"0";"215.26";"0";"1.55";"GNF-Pf-3319";"Cc1ccc2c(C)nc(NC(=N)N)nc2c1";"IFI";"'='";"2.941";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600954";"";"0";"301.34";"0";"3.93";"GNF-Pf-3320";"O=c1oc(-c2ccccc2F)nc2sc3c(c12)CCCC3";"IFI";"'='";"1.042";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL582086";"";"0";"493.67";"0";"4.09";"GNF-Pf-3325";"C/C(=C\c1csc(C)n1)[C@@H]1C[C@@H]2O[C@@H]2CCC[C@H](C)C(O)[C@@H](C)C(=O)C(C)(C)[C@@H](O)CC(=O)O1";"IFI";"'='";"6.897";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL583997";"";"0";"362.43";"0";"3.88";"GNF-Pf-4867";"COc1ccc(NC2=C(N3CCCCC3)C(=O)c3ccccc3C2=O)cc1";"IFI";"'='";"18.67";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL602973";"";"0";"338.46";"0";"1.57";"GNF-Pf-4892";"CCn1c(CSc2nc(C)cc(C)n2)nnc1SCC(N)=O";"IFI";"'='";"2.703";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL576206";"";"0";"438.98";"1";"5.98";"GNF-Pf-5526";"CC(C)CN1C(=O)c2ccccc2C(C(=O)Nc2cccc(Cl)c2)C1c1cccs1";"IFI";"'='";"6.25";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL586704";"";"0";"409.51";"0";"4.62";"GNF-Pf-5537";"Cc1cc(NC(=O)C2c3ccccc3C(=O)N(CC(C)C)C2c2cccs2)no1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585446";"";"0";"363.51";"0";"4.36";"GNF-Pf-3709";"CC[n+]1c(/C=C2\Sc3cc(C)ccc3N2CCO)ccc2ccccc21";"IFI";"";"";"";"";"";"Not applicable";"";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600334";"";"0";"406.76";"1";"5.17";"GNF-Pf-308";"FC(F)(F)c1cccc(Nc2nc3nonc3nc2Nc2ccc(Cl)cc2)c1";"IFI";"'='";"22.73";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL579768";"";"0";"406.56";"0";"4.59";"GNF-Pf-319";"CC1CCN(C(=O)CSc2nc(NCc3ccccc3)c3ccccc3n2)CC1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL582270";"";"0";"452.64";"1";"6.20";"GNF-Pf-334";"CCOC(=O)NN=C1C=C2C=CC3C4CC5CCCCC5(C(C)=O)[C@@]4(C)CCC3[C@@]2(C)CC1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL582472";"";"0";"397.45";"0";"0.70";"GNF-Pf-336";"O=[N+]([O-])c1cccc2c(S(=O)(=O)NCCCN(CCO)CCO)cccc12";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL593488";"";"0";"586.07";"2";"5.40";"GNF-Pf-3062";"Cc1cccc(NC(=O)c2ccc(N3CC4CC(C3)c3cccc(=O)n3C4)c(NC(=O)Cc3c(F)cccc3Cl)c2)n1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL581451";"";"0";"437.63";"0";"4.85";"GNF-Pf-3063";"C=CC(C)(CCC=C(C)C)c1ccc2c3c(c[nH]c13)CC(CO)NC(=O)C(C(C)C)N2C";"IFI";"'='";"11.32";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL581662";"";"0";"288.35";"0";"1.43";"GNF-Pf-3069";"CC1CN(C2CC(=O)N(c3ccccc3)C2=O)CC(C)O1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL581664";"";"0";"410.47";"0";"4.44";"GNF-Pf-3070";"CC1=C(C(=O)OC2CCCCC2)C(c2cccc([N+](=O)[O-])c2)C2=C(CCCC2=O)N1";"IFI";"'='";"1.449";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL581459";"";"0";"296.76";"0";"4.45";"GNF-Pf-3076";"Cc1cccc(NC(=O)c2cc(Cl)nc3ccccc23)c1";"IFI";"'='";"2.083";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL537911";"";"0";"623.72";"1";"4.04";"GNF-Pf-3078";"CC(CNC(=O)c1ccccc1)C(=O)OCC(=O)[C@@]12OC(C)(C)O[C@@H]1CC1C3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@@]12C";"IFI";"'='";"13.76";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL582506";"";"0";"448.50";"0";"4.16";"GNF-Pf-3091";"CCOc1ccc(S(=O)(=O)N=C2C=C(Nc3ccc(O)cc3)C(=O)c3ccccc32)cc1";"IFI";"'='";"15.38";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL581041";"";"0";"472.67";"1";"5.90";"GNF-Pf-3105";"COc1cccc(CNCCCCCCCCCCCCNCc2cccc(OC)c2O)c1O";"IFI";"'='";"6.015";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL338094";"";"0";"337.18";"0";"4.12";"GNF-Pf-3108";"O=C1c2ccccc2-c2nnc(-c3ccc(Br)cc3)cc21";"IFI";"'='";"5.882";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL582469";"";"0";"513.69";"1";"2.73";"GNF-Pf-3112";"O=C(Cc1ccsc1)NC1CCN(CC(O)CN(Cc2ccccc2)S(=O)(=O)c2ccccc2)C1";"IFI";"'='";"3.03";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL581649";"";"0";"338.39";"0";"4.10";"GNF-Pf-3123";"Fc1ccccc1Nc1nc(NCC2CCCO2)c2ccccc2n1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL581461";"";"0";"415.43";"0";"3.96";"GNF-Pf-3136";"N#Cc1c(N)nc(SCC(=O)c2ccc([N+](=O)[O-])cc2)c(C#N)c1-c1ccccc1";"IFI";"'='";"2.353";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL602987";"";"0";"317.65";"0";"3.40";"GNF-Pf-77";"CN(C)c1cc[n+](Cc2c(Cl)cccc2Cl)cc1.[Cl-]";"IFI";"'='";"7.143";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600542";"";"0";"413.30";"0";"4.73";"GNF-Pf-3142";"CCOC(=O)CCC(=O)Oc1cc(C(C)(C)C)nn1-c1ccc(Cl)c(Cl)c1";"IFI";"'='";"6.364";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL581749";"";"0";"330.44";"0";"3.26";"GNF-Pf-3143";"CN(C)c1ccc(C=C2SC(=N)N(c3nccs3)C2=O)cc1";"IFI";"";"";"";"";"";"Not applicable";"";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL581472";"";"0";"385.51";"0";"3.99";"GNF-Pf-3157";"C=CCn1c(SCC(=O)Nc2ccccc2C)nc2sc(C)cc2c1=O";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL582726";"";"0";"364.46";"1";"5.66";"GNF-Pf-3167";"Cc1cc2c(cc1C)NC(c1ccccc1F)C1=C(CC(C)(C)CC1=O)N2";"IFI";"'='";"2.564";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL581866";"";"0";"410.27";"1";"5.20";"GNF-Pf-3193";"Cc1cc(NC(c2cccc(Br)c2)c2ccc3cccnc3c2O)no1";"IFI";"'='";"4.348";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL599938";"";"0";"378.44";"0";"3.66";"GNF-Pf-3203";"O=[N+]([O-])c1ccc(NCCNc2nc(N3CCCC3)nc3ccccc23)cc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL581668";"";"0";"347.89";"0";"4.58";"GNF-Pf-3212";"CN(CCCNc1ccnc2cc(Cl)ccc12)C(=O)CC(C)(C)C";"IFI";"'='";"7.477";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL581464";"";"0";"494.62";"0";"3.70";"GNF-Pf-3218";"COCCNC(=O)C(c1ccc(C)cc1)N(Cc1ccccc1)C(=O)CCC(=O)Nc1nccs1";"IFI";"'='";"11.32";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL601169";"";"0";"378.46";"1";"5.80";"GNF-Pf-3230";"CCc1cccc(NC(=S)N2CCCC2c2ccccc2C(F)(F)F)c1";"IFI";"'='";"3.704";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL581859";"";"0";"447.47";"0";"3.62";"GNF-Pf-3255";"O=C1CN(C(=O)COC(=O)c2ccccc2NCCc2ccc(F)cc2)c2ccccc2N1";"IFI";"'='";"2.439";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL601590";"";"0";"365.82";"0";"4.07";"GNF-Pf-3263";"COc1ccc(-c2cnc3ccc(NCc4cccc(Cl)c4)nn23)cn1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL582085";"";"0";"380.58";"1";"6.60";"GNF-Pf-3280";"Cc1cc2c(cc1C)-c1c(ssc1=Nc1cccc(C)c1C)C(C)(C)N2";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL581249";"";"0";"484.39";"1";"7.15";"GNF-Pf-3295";"Cc1ccc2nc(C(C#N)=Cc3cn(Cc4ccc(Cl)cc4Cl)nc3-c3ccccc3)[nH]c2c1";"IFI";"";"";"";"";"";"Not applicable";"";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL599708";"";"0";"305.36";"0";"3.64";"GNF-Pf-3296";"CN1/C(=C/C=C/c2oc3ccccc3[n+]2C)Oc2ccccc21";"IFI";"";"";"";"";"";"Not applicable";"";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL601802";"";"0";"295.39";"0";"2.93";"GNF-Pf-3303";"Cc1ccc2[nH]c3c(NCCN4CCCC4)ncnc3c2c1";"IFI";"'='";"8.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL582284";"";"0";"416.46";"0";"3.75";"GNF-Pf-3310";"O=S(=O)(Nc1cc(Sc2nc[nH]n2)c(O)c2ccccc12)c1ccc(F)cc1";"IFI";"'='";"23.08";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL581035";"";"0";"312.41";"0";"4.17";"GNF-Pf-3339";"CC1(C)C(=O)C2(CCCCC2)C(=O)OC1C=Cc1ccccc1";"IFI";"";"";"";"";"";"Not applicable";"";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL579730";"";"0";"427.46";"0";"4.38";"GNF-Pf-3355";"Cc1c(NC(=O)C2c3ccccc3C(=O)N3CCc4ccccc4C23)cccc1[N+](=O)[O-]";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL582272";"";"0";"500.98";"2";"5.91";"GNF-Pf-3366";"Cc1ccc(NC(=O)c2cc(C(=O)c3cc(Cl)ccc3O)cn(-c3ccc(C)cc3C)c2=O)c(C)c1";"IFI";"'='";"6.25";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL582493";"";"0";"319.45";"0";"4.51";"GNF-Pf-3386";"Cc1cc(/C=C2\Sc3ccccc3N2C)[n+](C)c2ccccc12";"IFI";"'='";"20.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL579923";"";"0";"409.30";"0";"3.80";"GNF-Pf-4873";"COc1cccc(C(=O)NCc2nnc(S)n2-c2ccc(Cl)c(Cl)c2)c1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585630";"";"0";"427.53";"0";"1.91";"GNF-Pf-4878";"CCCn1c(SCC(=O)N2c3ccccc3CC2C)nc2c1c(=O)n(C)c(=O)n2C";"IFI";"'='";"3.54";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL581969";"";"0";"518.65";"1";"4.08";"GNF-Pf-4908";"CO[C@H]1CCC=C(C)C(=O)Nc2cc(O)cc(c2)C[C@@H](C)C[C@H](OC)[C@H](O)C(C)C=C(C)[C@@H]1OC(N)=O";"IFI";"'='";"9.615";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585780";"";"0";"449.99";"0";"3.81";"GNF-Pf-4909";"Cn1c(=NC(=O)c2ccc(S(=O)(=O)N3CCCCC3)cc2)sc2cc(Cl)ccc21";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600357";"";"0";"435.75";"1";"5.17";"GNF-Pf-4910";"O=[N+]([O-])c1ccc(-n2ncc(-c3nc(-c4ccc(Cl)cc4)no3)c2C(F)(F)F)cc1";"IFI";"'='";"0.8621";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585413";"";"0";"334.47";"0";"1.98";"GNF-Pf-4914";"CC(C)CNC(=O)c1cnc(NCCCN)nc1NC1CCCC1";"IFI";"'='";"1.905";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL601791";"";"0";"353.43";"0";"2.97";"GNF-Pf-2725";"CCOc1ccc2c(c1)cc(CN(C(C)=O)C1CCCC1)c1nnnn12";"IFI";"'='";"1.818";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600732";"";"0";"449.89";"1";"5.14";"GNF-Pf-2762";"COc1ccc(C2C(C(=O)c3ccccc3)=C(O)C(=O)N2c2cccc(Cl)c2)c(OC)c1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL601356";"";"0";"551.52";"2";"5.83";"GNF-Pf-2779";"O=C(NCCN(CCNc1ccnc2cc(Cl)ccc12)CCNc1ccnc2cc(Cl)ccc12)C1CCC1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL548399";"";"0";"389.80";"0";"3.67";"GNF-Pf-2784";"COc1ccc(C(=O)Nc2nonc2-c2ccc(OC)c(OC)c2)cc1Cl";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL578473";"";"0";"351.45";"0";"3.90";"GNF-Pf-2837";"CCCCN1C=Nc2cc(C(=O)NCc3ccc(OC)cc3)ccc2C1";"IFI";"'='";"1.205";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600947";"";"0";"409.33";"1";"5.04";"GNF-Pf-2911";"CC(=O)Nc1nc(C)c(-c2csc(Nc3ccc(Br)cc3)n2)s1";"IFI";"'='";"4.808";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL582504";"";"0";"340.43";"1";"5.29";"GNF-Pf-2938";"Cc1ccc(Nc2nc(NCc3ccccc3)c3ccccc3n2)cc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL602413";"";"0";"308.39";"0";"3.39";"GNF-Pf-2941";"Cc1ccc(Nc2nc(NCCO)c3ccccc3n2)cc1C";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL581676";"";"0";"368.11";"None";"None";"GNF-Pf-2945";"";"IFI";"'='";"1.818";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL582725";"";"0";"417.62";"0";"2.33";"GNF-Pf-2958";"Cc1cc(C)c2cc(CN(CCN(C)C)C(=S)NCCCN(C)C)c(=O)[nH]c2c1";"IFI";"'='";"3.125";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL534372";"";"0";"472.42";"0";"4.70";"GNF-Pf-2971";"COc1ccc(-c2cc(C(F)(F)F)n3ncc(C(=O)Nc4cc(C)ccc4O)c3n2)cc1OC";"IFI";"'='";"3.448";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL579959";"";"0";"418.47";"0";"4.07";"GNF-Pf-2978";"COc1ccccc1NC1=CC(=NS(=O)(=O)c2ccccc2)c2ccccc2C1=O";"IFI";"'='";"21.43";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL580604";"";"0";"436.46";"0";"4.20";"GNF-Pf-2993";"COc1ccccc1NC1=CC(=NS(=O)(=O)c2ccc(F)cc2)c2ccccc2C1=O";"IFI";"'='";"15.38";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL524403";"";"0";"485.90";"1";"5.06";"GNF-Pf-5398";"O=C(c1cnn(-c2ccccc2)c1C(F)(F)F)N1CCN(c2ccnc3cc(Cl)ccc23)CC1";"IFI";"'='";"6.452";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL584449";"";"0";"330.31";"0";"3.48";"GNF-Pf-4672";"OCCCCCCCCCCC[n+]1ccccc1.[Br-]";"IFI";"'='";"1.22";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL584632";"";"0";"438.43";"0";"3.90";"GNF-Pf-4931";"COc1cc(OC)cc(C(=O)NCc2n[nH]c(=S)n2-c2cccc(C(F)(F)F)c2)c1";"IFI";"'='";"2.381";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL1744495";"";"0";"424.91";"0";"4.32";"GNF-Pf-4942";"CC[n+]1c(C=CN(C)c2ccccc2)sc2ccc(OC)cc21.[O-][Cl+3]([O-])([O-])[O-]";"IFI";"";"";"";"";"";"Not applicable";"";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585628";"";"0";"373.52";"1";"6.00";"GNF-Pf-4945";"Cc1ccc2c(c1)-c1c(ssc1=S)C(C)(C)N2C(=O)c1ccco1";"IFI";"'='";"0.7463";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585265";"";"0";"324.42";"0";"3.04";"GNF-Pf-4759";"CCOc1ccc(C(=O)N2CCN(Cc3ccccc3)CC2)cc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL586012";"";"0";"347.29";"0";"1.54";"GNF-Pf-4959";"Nc1noc2cccc(OC3CCNCC3)c12.O=C(O)C(F)(F)F";"IFI";"'='";"4.167";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL579423";"";"0";"393.74";"0";"4.19";"GNF-Pf-4979";"Clc1ccc(-c2c[n+](-c3ccccc3)c3n2CCS3)cc1.[Br-]";"IFI";"'='";"0.7246";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585969";"";"0";"395.42";"0";"4.48";"GNF-Pf-4984";"O=C(O)C(F)(F)F.Oc1ccc(-c2ccccc2)cc1CNC1CCCCC1";"IFI";"'='";"1.681";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585600";"";"0";"297.40";"0";"3.41";"GNF-Pf-4989";"OCC1CCCCN1Cc1cc(-c2ccccc2)ccc1O";"IFI";"'='";"0.8403";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL582339";"";"0";"297.74";"0";"4.45";"GNF-Pf-4815";"O=C(Nc1ccccc1Cl)c1cc2ccccc2cc1O";"IFI";"'='";"12.31";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL578925";"";"0";"388.51";"0";"4.78";"GNF-Pf-160";"CCC(C)(C)C1CCc2c(sc(NC(=O)c3ccc(F)cc3)c2C(N)=O)C1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL579136";"";"0";"293.84";"0";"3.22";"GNF-Pf-163";"Cc1ccc2nc(C)cc(NCCCN(C)C)c2c1.Cl";"IFI";"'='";"2.326";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL576992";"";"0";"432.55";"1";"5.49";"GNF-Pf-171";"CCCCSc1oc(C)nc1[P+](c1ccccc1)(c1ccccc1)c1ccccc1";"IFI";"'='";"22.22";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL601778";"";"0";"462.59";"1";"6.24";"GNF-Pf-182";"CCN(CC)CCCC(C)Nc1cc(/C=C/c2ccc([N+](=O)[O-])cc2)nc2ccc(OC)cc12";"IFI";"'='";"4.545";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL582487";"";"0";"442.09";"1";"6.11";"GNF-Pf-208";"Clc1ccc(Nc2nc3nonc3nc2Nc2ccc(Cl)c(Cl)c2)cc1Cl";"IFI";"'='";"7.143";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL579972";"";"0";"498.58";"1";"5.33";"GNF-Pf-217";"O=C(Nc1ccc2c(c1)OCO2)c1cc2cc(C3(O)CCN(CCCc4ccccc4)CC3)ccc2o1";"IFI";"'='";"5.217";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL602608";"";"0";"481.60";"0";"3.23";"GNF-Pf-223";"COc1ccc(CCNc2nc(NCCCn3ccnc3)ncc2C(=O)NCC(C)C)cc1OC";"IFI";"'='";"1.923";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL582298";"";"0";"515.69";"2";"6.56";"GNF-Pf-230";"Cc1ccc(-n2c(=S)sc3c(=O)n(-c4ccccc4)c(SCC(=O)c4ccccc4)nc32)cc1C";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600514";"";"0";"618.73";"2";"10.10";"GNF-Pf-236";"CC(C)(c1ccc(Oc2ccc(NC(=O)c3ccccc3)cc2)cc1)c1cccc(Oc2ccc(NC(=O)c3ccccc3)cc2)c1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL579551";"";"0";"388.49";"0";"1.88";"GNF-Pf-244";"O=C(NCCCN1CCCC1=O)c1ccc2nc(N3CCOCC3)sc2c1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL581851";"";"0";"394.44";"0";"4.18";"GNF-Pf-256";"Oc1ccccc1C=NNc1nnc2c3ccccc3n(Cc3ccccc3)c2n1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL601133";"";"0";"282.34";"0";"3.28";"GNF-Pf-275";"CC(C)c1ccc(C=NNC(=O)c2ccccc2O)cc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL271556";"";"0";"353.45";"0";"3.65";"GNF-Pf-276";"COc1ccc(N=C2NC(=O)/C(=C\c3ccc(N(C)C)cc3)S2)cc1";"IFI";"'='";"3.488";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL579974";"";"0";"347.37";"0";"2.58";"GNF-Pf-291";"COC(=O)C1=C(C)Nc2[nH]c(=S)[nH]c(=O)c2C1c1ccccc1F";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL534547";"";"0";"382.45";"0";"4.23";"GNF-Pf-292";"COc1cc(Nc2nccn3c(-c4ccsc4)cnc23)cc(OC)c1OC";"IFI";"'='";"8.333";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL602187";"";"0";"361.20";"0";"3.49";"GNF-Pf-8";"COc1cc(C=NNc2nc3ccccc3[nH]2)cc(Br)c1O";"IFI";"'='";"7.692";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600926";"";"0";"370.50";"1";"5.23";"GNF-Pf-12";"Oc1ccc(C(CCNCCc2c[nH]c3ccccc23)c2ccccc2)cc1";"IFI";"'='";"7.692";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL578893";"";"0";"483.62";"1";"5.76";"GNF-Pf-24";"N#Cc1c2c(c(N3CCN(C(c4ccccc4)c4ccccc4)CC3)n3c1nc1ccccc13)CCC2";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL578476";"";"0";"381.27";"0";"4.23";"GNF-Pf-28";"O=C(Cn1ccc(=NCc2ccccc2)cc1)c1cccc(Br)c1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL579320";"";"0";"453.75";"1";"5.25";"GNF-Pf-33";"COc1ccc(-c2csc(NC(=O)COc3ccccc3Cl)n2)cc1Br";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600132";"";"0";"287.32";"0";"1.31";"GNF-Pf-34";"COc1cc2c(cc1OC)C1=NNC(=O)C1=NC(C)(C)C2";"IFI";"'='";"7.143";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL577413";"";"0";"388.44";"0";"4.39";"GNF-Pf-46";"O=C(CCCn1c2ccccc2c(=O)c2ccccc21)NCc1ccc(F)cc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL296373";"EDATREXATE";"0";"467.49";"0";"1.37";"GNF-Pf-63";"CCC(Cc1cnc2nc(N)nc(N)c2n1)c1ccc(C(=O)N[C@@H](CCC(=O)O)C(=O)O)cc1";"IFI";"'='";"17.89";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL533896";"";"0";"597.23";"2";"8.14";"GNF-Pf-79";"Cc1ccc(Cl)cc1-n1c(SCc2ccccc2)nnc1C(Cc1ccccc1)NC(=O)C12CC3CC(CC(C3)C1)C2";"IFI";"'='";"4.545";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL599943";"";"0";"418.99";"0";"4.81";"GNF-Pf-3343";"CCCN(CCC)CCNC(=O)c1cc2c(-c3ccc(Cl)cc3)nn(C)c2s1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL580151";"";"0";"407.39";"0";"2.99";"GNF-Pf-3357";"O=C(NCc1ccccc1C(F)(F)F)C1CC(O)CN1C(=O)Nc1ccccc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL581862";"";"0";"417.62";"0";"2.28";"GNF-Pf-383";"CCc1ccc2[nH]c(=O)c(CN(CCN(C)C)C(=S)NCCCN(C)C)cc2c1";"IFI";"'='";"3.704";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600691";"";"0";"290.39";"0";"4.33";"GNF-Pf-400";"CC[n+]1c(C=Cc2ccc(OC)cc2)ccc2ccccc21";"IFI";"";"";"";"";"";"Not applicable";"";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL528558";"";"0";"275.35";"0";"2.25";"GNF-Pf-417";"CCN1CCN(C/C=C/c2ccccc2[N+](=O)[O-])CC1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600696";"";"0";"228.18";"0";"2.69";"GNF-Pf-436";"CCOP1(=O)COc2ccccc2OC1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL530572";"";"0";"442.14";"0";"4.95";"GNF-Pf-440";"C[N+](C)(C)c1ccc2cc(Br)c3ccccc3c2c1.[I-]";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL581911";"";"0";"458.58";"1";"5.72";"GNF-Pf-454";"CCC(=O)N1CCOc2c(cc(-c3csc4ccccc34)cc2OCCc2ccccn2)C1";"IFI";"'='";"0.8264";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL582728";"";"0";"407.90";"0";"3.21";"GNF-Pf-459";"CCOC(=O)c1cnc2cc(Cl)c(OC)cc2c1NCCCN1CCOCC1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL528790";"";"0";"586.69";"1";"4.26";"GNF-Pf-469";"COc1ccccc1N1CCN(c2ccc(NC(=O)/C=C/c3ccc([N+](=O)[O-])cc3)cc2C(=O)NCCCN(C)C)CC1";"IFI";"'='";"10.1";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL602814";"";"0";"453.59";"0";"4.40";"GNF-Pf-481";"Cc1nc(N2CCCCC2)c2c(C)c(C(=O)N3CCN(c4ccccc4F)CC3)sc2n1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL580985";"";"0";"519.83";"2";"8.66";"GNF-Pf-499";"COc1ccc2nc(C)cc(Nc3ccc(Oc4ccc(Br)c5ccccc45)c(Cl)c3)c2c1";"IFI";"'='";"13.64";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585845";"";"0";"410.45";"0";"3.59";"GNF-Pf-4378";"CCn1c(=NC(=O)c2cc(=O)c3ccccc3o2)sc2c(OC)ccc(OC)c21";"IFI";"'='";"1.887";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585846";"";"0";"343.20";"0";"1.90";"GNF-Pf-4380";"CCOc1cc(Br)cc(C=C2NC(=S)NC2=O)c1O";"IFI";"";"";"";"";"";"Not applicable";"";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL604324";"";"0";"476.40";"1";"5.76";"GNF-Pf-4489";"O=C(Nc1ccc(OC(F)(F)F)cc1)c1cnn2c1NC(c1cccs1)CC2C(F)(F)F";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL604512";"";"0";"505.75";"2";"8.98";"GNF-Pf-3915";"CCCCCCCCCC(=O)Oc1ccccc1-c1nc2cc(C)ccn2c1NC(C)(C)CC(C)(C)C";"IFI";"'='";"2.174";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL579420";"";"0";"475.22";"1";"5.79";"GNF-Pf-4492";"Cn1nc(C(F)(F)F)c(-c2ccc(Br)cc2)c1NC(=O)Nc1ccc(F)cc1F";"IFI";"'='";"0.8403";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL598693";"";"0";"336.78";"0";"4.34";"GNF-Pf-4494";"O=C(ON=C(c1ccncc1)c1ccc(Cl)cc1)c1ccccc1";"IFI";"'='";"2.542";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600290";"";"0";"369.79";"0";"3.01";"GNF-Pf-4499";"CC(=O)Nc1ccc(NS(=O)(=O)c2cc([N+](=O)[O-])ccc2Cl)cc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585839";"";"0";"413.59";"1";"6.79";"GNF-Pf-4509";"O=C(Nc1ccc(C23CC4CC(CC(c5ccccc5)(C4)C2)C3)cc1)c1cccs1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL586029";"";"0";"395.41";"0";"2.78";"GNF-Pf-4516";"CCOC(=O)C1CCN(C(=O)c2c(C)oc3c2C(=O)c2ccccc2C3=O)CC1";"IFI";"'='";"7.692";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL598691";"";"0";"390.88";"0";"3.77";"GNF-Pf-4420";"Clc1cccc(-c2cn3ccnc3c(N3CCN(c4ccncc4)CC3)n2)c1";"IFI";"'='";"4.396";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL605754";"";"0";"503.03";"2";"6.53";"GNF-Pf-4430";"CCS/C(Cl)=C(/NC(=O)c1ccccc1)[P+](c1ccccc1)(c1ccccc1)c1ccccc1";"IFI";"'='";"3.571";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL598699";"";"0";"514.62";"1";"3.53";"GNF-Pf-3989";"CC(=O)Nc1ccc2c(c1)C(=O)N(C(CC(C)(C)C)C(=O)NC1CCCCC1)[C@@H](CCC(=O)O)C(=O)N2";"IFI";"'='";"1.22";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600975";"";"0";"399.54";"0";"4.30";"GNF-Pf-4448";"N#Cc1c2c(c(N3CCN(C4CCCCC4)CC3)n3c1nc1ccccc13)CCC2";"IFI";"'='";"1.471";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL586033";"";"0";"419.48";"1";"6.33";"GNF-Pf-4451";"Oc1c(C(Nc2ccccn2)c2cccc(Oc3ccccc3)c2)ccc2cccnc12";"IFI";"'='";"12.31";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL423192";"ANISOMYCIN";"0";"265.31";"0";"0.50";"GNF-Pf-4549";"COc1ccc(C[C@H]2NC[C@H](O)[C@H]2OC(C)=O)cc1";"IFI";"'='";"33.6";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL599885";"";"0";"659.69";"2";"6.64";"GNF-Pf-4456";"Cc1cccc(N2C(=O)C3C(C2=O)C2(c4ccccc4)C(=O)C3(c3ccccc3)C(c3ccc4c(c3)OCO4)=C2c2ccc3c(c2)OCO3)c1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL548155";"";"0";"267.76";"0";"1.18";"GNF-Pf-4555";"Cc1ccc(N2C(N)=NC(N)=NC2(C)C)cc1.Cl";"IFI";"'='";"5.303";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL599702";"";"0";"373.48";"0";"4.99";"GNF-Pf-5649";"Cc1cc(/C=C2\SC(=Nc3ccccc3)NC2=O)c(C)n1-c1ccccc1";"IFI";"";"";"";"";"";"Not applicable";"";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL601187";"";"0";"390.96";"0";"4.66";"GNF-Pf-5021";"O=C(NC1CC1)c1ccc(OC2CCN(CC3CCCCC3)CC2)c(Cl)c1";"IFI";"'='";"2.778";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL584838";"";"0";"514.85";"2";"6.42";"GNF-Pf-5074";"CCCOC(=O)C1=C(C)NC2=C(C(=O)CC(c3ccc(Cl)cc3)C2)C1c1ccc(Br)cc1";"IFI";"'='";"3.571";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585811";"";"0";"504.38";"2";"6.29";"GNF-Pf-5090";"CCc1nn(-c2ccccc2)c2nc(-c3cc(Br)ccc3O)c3cc(OC)c(OC)cc3c12";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL578104";"";"0";"415.27";"0";"4.44";"GNF-Pf-5236";"C[n+]1oc(C=Cc2ccccc2)cc1C=Cc1ccccc1.[I-]";"IFI";"";"";"";"";"";"Not applicable";"";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL576405";"";"0";"418.41";"1";"6.26";"GNF-Pf-5252";"FC(F)(F)c1cccc(NC(=S)N2CCCC2c2ccccc2C(F)(F)F)c1";"IFI";"'='";"1.818";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL531222";"";"0";"319.36";"0";"3.47";"GNF-Pf-5336";"COc1cccc(NC(=O)Cn2c(C)c(C#N)c3ccccc32)c1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL535197";"";"0";"509.57";"1";"2.85";"GNF-Pf-5340";"CC(=O)Nc1cc(C(=O)Nc2ccc(C3=NCCN3)cc2)ccc1C(=O)Nc1ccc(C2=NCCN2)cc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL601615";"";"0";"475.68";"1";"7.81";"GNF-Pf-5346";"Cc1ccn2c(NC(C)(C)CC(C)(C)C)c(-c3ccccc3OC(=O)CCC3CCCC3)nc2c1";"IFI";"'='";"2.804";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL579933";"";"0";"344.41";"0";"3.60";"GNF-Pf-5360";"CCOC(=O)c1ccc(NCc2c(C)[nH]c(C(=O)OCC)c2C)cc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL599901";"";"0";"284.19";"0";"3.37";"GNF-Pf-2723";"Clc1ccc(CNCCCn2ccnc2)cc1Cl";"IFI";"'='";"0.9346";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL576326";"";"0";"510.57";"1";"3.12";"GNF-Pf-2736";"O=C(CN1CCN(S(=O)(=O)c2cccc([N+](=O)[O-])c2)CC1)Nc1ccc(OCc2ccccc2)cc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL601990";"";"0";"344.42";"0";"4.41";"GNF-Pf-2753";"CCCCn1nccc1Nc1cc(C)c(C#N)c2nc3ccccc3n12";"IFI";"'='";"3.226";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600930";"";"0";"410.58";"1";"5.13";"GNF-Pf-2767";"CC(C)CN1C(=O)c2ccccc2C(C(=O)NC2CCCCC2)C1c1cccs1";"IFI";"'='";"6.061";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL577845";"";"0";"326.83";"1";"5.65";"GNF-Pf-2770";"CCOc1ccc2nc(C)cc(Nc3ccc(C)c(Cl)c3)c2c1";"IFI";"'='";"7.843";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL579144";"";"0";"549.89";"2";"8.47";"GNF-Pf-2786";"CC1CC(N(C(=O)c2ccc(Cl)cc2Cl)c2ccccc2)c2ccccc2N1C(=O)c1ccc(Cl)cc1";"IFI";"'='";"2.439";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL579278";"";"0";"442.34";"0";"4.57";"GNF-Pf-2824";"CC[n+]1c(/C=C/N2CCCc3ccccc32)ccc2ccccc21.[I-]";"IFI";"'='";"19.51";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL578712";"";"0";"521.41";"1";"4.20";"GNF-Pf-2869";"O=C(Nc1ccc(C2=NCCN2)c(Cl)c1)c1ccc(C(=O)Nc2ccc(C3=NCCN3)c(Cl)c2)cc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL312032";"";"0";"333.41";"0";"2.57";"GNF-Pf-2893";"Cc1ccc(S(=O)(=O)NC(=O)Nc2ccc(N(C)C)cc2)cc1";"IFI";"'='";"3.2";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL601810";"";"0";"367.88";"0";"4.77";"GNF-Pf-2902";"Cc1ccc(C(=O)N(C)CCCNc2ccnc3cc(Cl)ccc23)cc1";"IFI";"'='";"1.869";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL582723";"";"0";"387.26";"0";"4.14";"GNF-Pf-2955";"Cc1ccc(/C=C/c2ccc3ccccc3[n+]2C)cc1.[I-]";"IFI";"'='";"5.983";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL578075";"";"0";"467.57";"1";"5.22";"GNF-Pf-2633";"CCOC(=O)c1c(NC(=O)C(C)Sc2ncnc3c2oc2ccccc23)sc2c1CCC2";"IFI";"'='";"8.571";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL584458";"";"0";"460.38";"0";"4.93";"GNF-Pf-3996";"CCN1C(=Cc2sc3ccccc3[n+]2C)C=Cc2cccc(C)c21.[I-]";"IFI";"";"";"";"";"";"Not applicable";"";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL584460";"";"0";"293.37";"0";"3.71";"GNF-Pf-3997";"Cc1cc(C)nc(Nc2nc(C)c3cc(C)c(C)cc3n2)n1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL578852";"";"0";"464.36";"0";"4.47";"GNF-Pf-2662";"CCCOC(=O)C1=C(C)NC2=C(C(=O)CCC2)C1c1cc(Br)c(O)c(OCC)c1";"IFI";"'='";"3.448";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL528178";"";"0";"295.34";"0";"1.50";"GNF-Pf-4009";"O=C(NCCc1ccccc1)C(=O)NN=Cc1ccccc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL531229";"";"0";"348.18";"0";"2.31";"GNF-Pf-2669";"C=C(C[N+](C)(C)C)c1ccc([N+](=O)[O-])cc1.[I-]";"IFI";"'='";"0.7463";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL603014";"";"0";"339.40";"0";"3.38";"GNF-Pf-2673";"CCOc1ccc2nc(NCCNC(=O)c3ccco3)c(C)cc2c1";"IFI";"'='";"3.896";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL596632";"";"0";"429.31";"0";"4.21";"GNF-Pf-4027";"CCOC(=O)C1=C(C)NC(=Cc2cc(C)n(-c3cccc(Br)c3)c2C)C1=O";"IFI";"";"";"";"";"";"Not applicable";"";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL578072";"";"0";"401.45";"0";"4.81";"GNF-Pf-2702";"CC1=C(C(=O)OC2CCCCC2)C(c2ccc(F)c(F)c2)C2=C(CCCC2=O)N1";"IFI";"'='";"2.353";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585814";"";"0";"480.48";"0";"4.24";"GNF-Pf-5020";"COc1ccc2nc3cc(Cl)ccc3c(NCCCN(CCCN)CCCCN)c2c1.Cl";"IFI";"'='";"2.913";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL578334";"";"0";"320.45";"1";"-1.91";"GNF-Pf-5192";"CCN1C(=O)N(CC)C(NNC(N)=S)C1NNC(N)=S";"IFI";"'='";"4.444";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL588549";"";"0";"364.45";"0";"3.67";"GNF-Pf-5194";"COC(=O)C1=C(C)N/C(=C\c2cc(C)n(-c3cc(C)ccc3C)c2C)C1=O";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL588925";"";"0";"413.26";"0";"3.96";"GNF-Pf-5195";"COC(=O)c1c(-c2c(Cl)cccc2Cl)noc1NC(=O)NN1CCCCC1";"IFI";"'='";"1.681";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL587680";"";"0";"437.58";"0";"4.42";"GNF-Pf-5199";"CC(CNC(=O)c1cn(C2CCCCC2)cc(C(=O)NC(C)(C)C)c1=O)c1ccccc1";"IFI";"'='";"0.9901";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL583163";"";"0";"479.67";"1";"5.52";"GNF-Pf-5031";"c1ccc(CCc2nc3cccnc3n2C2CCN(C3CCN(Cc4ccccc4)CC3)CC2)cc1";"IFI";"'='";"1.923";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL581679";"";"0";"291.79";"0";"2.55";"GNF-Pf-611";"CC1CCCN(Cc2nnnn2-c2ccc(Cl)cc2)C1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL1448140";"";"0";"354.38";"0";"4.03";"GNF-Pf-628";"COC(=O)C1=C(O)/C(=C\c2cc(C)n(-c3ccccc3F)c2C)N=C1C";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL527682";"";"0";"420.58";"1";"5.81";"GNF-Pf-635";"CC(C)Sc1nc2c(c(=O)n1Cc1ccco1)C1(CCCCC1)Cc1ccccc1-2";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL528139";"";"0";"586.66";"2";"3.05";"GNF-Pf-637";"Cc1ccn(C(=O)NCCNC(=O)Nc2ccc(Cc3ccc(NC(=O)NCCNC(=O)n4ccc(C)n4)cc3)cc2)n1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL599086";"";"0";"429.48";"0";"3.57";"GNF-Pf-644";"c1cn2c(-c3ccc(N4CCOCC4)cc3)cnc2c(NCc2ccc3c(c2)OCO3)n1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL598479";"";"0";"458.93";"0";"3.74";"GNF-Pf-647";"Cl.Nc1ccc(-c2cc(N)n(-c3ccc(Oc4ccccc4)c(S(=O)(=O)O)c3)n2)cc1";"IFI";"'='";"1.835";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL597861";"";"0";"406.53";"0";"4.55";"GNF-Pf-655";"Cc1cc(C)n(-c2ccc(NC(=O)C3CCN(Cc4cc(C)c(C)o4)CC3)cc2)n1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL596644";"";"0";"347.42";"0";"3.90";"GNF-Pf-660";"OCC1CCCN1c1nccnc1-c1ccccc1Oc1ccccc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL599510";"";"0";"357.42";"0";"3.57";"GNF-Pf-667";"Cc1cccc(N(C)c2ccnc3c(-c4cccc(C(N)=O)c4)cnn23)c1";"IFI";"'='";"4.348";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL527728";"";"0";"352.25";"0";"4.60";"GNF-Pf-682";"O=C(CSc1nc2ccccc2[nH]1)Nc1ccc(Cl)cc1Cl";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL599706";"";"0";"422.58";"0";"3.66";"GNF-Pf-715";"CN1CCCC1CCNc1ncc(C(=O)NCc2ccccc2)c(NC2CCCC2)n1";"IFI";"'='";"1.942";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600902";"";"0";"722.93";"2";"5.94";"GNF-Pf-721";"OC(COc1ccc(OCC(O)CN2CCN(C3c4ccccc4-c4ccccc43)CC2)cc1)CN1CCN(C2c3ccccc3-c3ccccc32)CC1";"IFI";"'='";"3.03";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL31734";"";"0";"289.72";"0";"2.68";"GNF-Pf-736";"O=C(CNC(=O)c1ccccc1)Oc1ccc(Cl)cc1";"IFI";"'='";"7.143";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600499";"";"0";"675.74";"2";"6.68";"GNF-Pf-743";"COC(=O)c1ccc(N2C(=O)C3C(C2=O)C2(c4ccccc4)C(=O)C3(c3ccccc3)C(c3ccc(OC)cc3)=C2c2ccc(OC)cc2)cc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL606231";"";"0";"490.67";"0";"4.92";"GNF-Pf-760";"O=C(c1cnsn1)N1CCCC(COc2cccc(CN3CCC(Cc4ccccc4)CC3)c2)C1";"IFI";"'='";"1.942";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL580833";"";"0";"363.33";"0";"4.56";"GNF-Pf-783";"Cc1cccc(-c2nc3cc(NC(=O)c4ccc([N+](=O)[O-])o4)ccc3o2)c1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL608258";"";"0";"268.27";"0";"3.42";"GNF-Pf-788";"Cc1ccc2c(c1)N=C(c1ccc([N+](=O)[O-])cc1)CO2";"IFI";"'='";"5.172";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL598690";"";"0";"468.77";"1";"8.24";"GNF-Pf-792";"O=C(C=Cc1ccccc1Cl)Nc1ccc(Oc2ccc3ccccc3c2Cl)c(Cl)c1";"IFI";"";"";"";"";"";"Not applicable";"";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL602571";"";"0";"214.22";"0";"1.51";"GNF-Pf-800";"CC1=C2C(=O)c3ccccc3C2NC(=O)N1";"IFI";"'='";"1.316";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600148";"";"0";"455.03";"1";"6.92";"GNF-Pf-831";"CC[n+]1c(/C=C/C=C2\N(C)c3ccccc3C2(C)C)n(-c2ccccc2)c2ccc(Cl)cc21";"IFI";"'='";"21.43";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL584816";"";"0";"407.47";"0";"3.47";"GNF-Pf-834";"COc1cc(OC)cc(-n2nc(C(=O)NC3CCCCC3)c3ccccc3c2=O)c1";"IFI";"'='";"2.41";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL602638";"";"0";"380.44";"0";"3.48";"GNF-Pf-844";"CCOc1ccc2[nH]c(=O)c(CN(Cc3ccccc3OC)C(C)=O)cc2c1";"IFI";"'='";"3.03";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL577810";"";"0";"332.79";"0";"2.48";"GNF-Pf-2216";"Cl.OCCNc1nc(Nc2ccccc2O)nc2ccccc12";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL578694";"";"0";"498.67";"1";"6.00";"GNF-Pf-2234";"Cc1ccc(-c2cc(-c3ccccc3)c(C#N)c(SCC(O)C[S+]([O-])Cc3ccccc3)n2)cc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600915";"";"0";"298.78";"0";"3.07";"GNF-Pf-2235";"N#Cc1sccc1NS(=O)(=O)c1ccc(Cl)cc1";"IFI";"'='";"0.8475";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL576999";"";"0";"250.32";"0";"1.07";"GNF-Pf-2117";"CN(C)c1cc[n+](OC(=O)N2CCCCC2)cc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL577365";"";"0";"420.58";"0";"4.54";"GNF-Pf-2121";"CCOC(=O)C1(CC2CCCCO2)CCN(C(=O)Nc2cccc(SC)c2)CC1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL588634";"";"0";"557.69";"2";"6.12";"GNF-Pf-1779";"COc1ccc(CC(=O)N(CCCC(C)Nc2cc(OC)cc3cccnc23)Cc2ccc(OC)c(OC)c2)cc1";"IFI";"'='";"3.704";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL586779";"";"0";"437.32";"1";"5.13";"GNF-Pf-1780";"CCOC(=O)c1cnc2c(C)cc(Cl)cc2c1Nc1ccc(OC)c(OC)c1.Cl";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL578681";"";"0";"455.03";"1";"6.92";"GNF-Pf-128";"CC[n+]1c(/C=C/C=C2\N(C)c3ccccc3C2(C)C)n(-c2ccccc2)c2cc(Cl)ccc21";"IFI";"'='";"33.33";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL578891";"";"0";"413.54";"0";"4.75";"GNF-Pf-131";"CCN1C(=O)c2ccccc2Sc2ccc(NC(=O)NCCCOC(C)C)cc21";"IFI";"'='";"2.381";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL576806";"";"0";"419.32";"0";"3.42";"GNF-Pf-1825";"COc1cc(OC)cc(C(=O)N2CCN(Cc3cccc(Br)c3)CC2)c1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL586105";"";"0";"405.50";"0";"2.58";"GNF-Pf-1843";"CCc1ccc(NC(=O)c2ccc(F)c(S(=O)(=O)N3CCN(C)CC3)c2)cc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL588116";"";"0";"306.37";"0";"4.07";"GNF-Pf-1856";"CCN(CC)c1ccc(C=C(C#N)c2nc3ccccc3[nH]2)o1";"IFI";"";"";"";"";"";"Not applicable";"";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL576993";"";"0";"324.21";"0";"4.28";"GNF-Pf-172";"Cc1cccc(C)c1NC(=O)C(O)c1ccc(Cl)cc1Cl";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL577208";"";"0";"423.58";"0";"4.90";"GNF-Pf-175";"Cc1sc2nc(CN(C(=O)CCc3ccccc3)C3CCCCC3)[nH]c(=O)c2c1C";"IFI";"'='";"1.852";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL576995";"";"0";"348.41";"0";"3.33";"GNF-Pf-177";"N#Cc1ccccc1CN1CCC(Oc2cccc3onc(N)c23)CC1";"IFI";"'='";"4.167";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL601140";"";"0";"340.38";"0";"3.29";"GNF-Pf-186";"COc1ccc(C)cc1Nc1nc(N)c2cc(OC)c(OC)cc2n1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL576725";"";"0";"411.48";"0";"3.67";"GNF-Pf-187";"O=C(O)/C=C/C(=O)O.O=C1Cc2ccccc2C(=C2CCNCC2)c2ccsc21";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL578873";"";"0";"436.96";"0";"3.16";"GNF-Pf-189";"CC(C)NC(=O)N1CCN(C(=O)COC(c2cccs2)c2cccnc2Cl)CC1";"IFI";"'='";"1.942";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL582477";"";"0";"433.56";"0";"3.50";"GNF-Pf-195";"O=C(NCCc1ccccc1)c1cnc(NCCCn2ccnc2)nc1NC1CCCC1";"IFI";"'='";"0.9615";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL582479";"";"0";"459.62";"1";"5.63";"GNF-Pf-199";"CCc1ccc(CSc2nc3cc(OC)c(OC)cc3c(=N)n2CCc2ccccc2)cc1";"IFI";"'='";"2.597";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL602015";"";"0";"452.46";"0";"3.17";"GNF-Pf-202";"COc1ccccc1CN1CCc2nc(-c3cnccn3)sc2C1.O=C(O)C(F)(F)F";"IFI";"'='";"9.859";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL602991";"";"0";"281.11";"0";"3.00";"GNF-Pf-205";"Cc1cc(NC(=O)c2ccc(Br)cc2)no1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL579960";"";"0";"371.45";"0";"4.38";"GNF-Pf-206";"CC1=C(C(=O)OC(C)C)C(c2ccccc2F)C2=C(CC(C)(C)CC2=O)N1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL579750";"";"0";"378.47";"0";"3.67";"GNF-Pf-215";"CC1(C)Oc2ccc(C(=O)N3CCCC3)cc2N(CCc2ccccc2)C1=O";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL582498";"";"0";"359.73";"0";"4.63";"GNF-Pf-225";"COc1cccc(OC)c1C(=O)Nc1cc(C(F)(F)F)ccc1Cl";"IFI";"'='";"1.449";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL601167";"";"0";"386.40";"0";"3.27";"GNF-Pf-231";"COC(=O)COc1ccc(/C=C2\SC(=Nc3ccc(F)cc3)NC2=O)cc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL581253";"";"0";"450.33";"0";"4.08";"GNF-Pf-241";"CCOC(=O)C1=C(C)NC2=C(C(=O)CCC2)C1c1cc(Br)c(O)c(OCC)c1";"IFI";"'='";"3.448";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL582307";"";"0";"553.73";"2";"5.51";"GNF-Pf-247";"COc1ccc(-c2ccc(C(=O)N(C)Cc3cscn3)c(N3CCC(N4CCc5ccccc5C4)CC3)n2)cc1";"IFI";"'='";"3.846";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL582481";"";"0";"431.62";"1";"6.59";"GNF-Pf-269";"CCCCNC(=O)c1ccc2c(c1)N=C(CC(C)c1ccccc1)N(C1CCCCC1)C2";"IFI";"'='";"2.469";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL1615698";"";"0";"337.21";"0";"3.39";"GNF-Pf-270";"N=C(N)NN=Cc1cccc(OCc2ccc(Cl)c(Cl)c2)c1";"IFI";"'='";"2.83";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL599931";"";"0";"380.28";"0";"2.60";"GNF-Pf-274";"O=C(c1ccncc1)N1N=C(C(F)(F)F)CC1(O)c1cccc([N+](=O)[O-])c1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL577621";"";"0";"356.30";"0";"1.99";"GNF-Pf-147";"Cl.Cl.OCCNCCNCc1ccc2[nH]c3ccccc3c2c1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL534283";"";"0";"294.45";"0";"3.50";"GNF-Pf-14";"CCCCNc1nc(NC(C)(C)C)nc(NC(C)(C)C)n1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL601574";"";"0";"280.28";"0";"2.75";"GNF-Pf-25";"Cc1ccc(NC(=O)c2cc3ccccc3oc2=O)nc1";"IFI";"'='";"9.195";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL578489";"";"0";"362.50";"1";"5.62";"GNF-Pf-42";"O=C1/C(=C/c2ccccc2)SC(=Nc2ccccc2)N1C1CCCCC1";"IFI";"'='";"4.598";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL578081";"";"0";"520.30";"0";"3.00";"GNF-Pf-60";"Cc1cccc(OCC(O)CN2CCN(CC(=O)c3ccc(Br)cc3)CC2)c1.Cl.Cl";"IFI";"'='";"3.077";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL579318";"";"0";"346.34";"0";"2.69";"GNF-Pf-78";"Cc1oc2c(c1C(=O)NCc1cccnc1)C(=O)c1ccccc1C2=O";"IFI";"'='";"17.5";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL602598";"";"0";"395.32";"1";"5.22";"GNF-Pf-149";"O=[N+]([O-])c1cc(C(F)(F)F)cc([N+](=O)[O-])c1Sc1cccc2cccnc12";"IFI";"'='";"14.29";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL578308";"";"0";"421.52";"0";"3.92";"GNF-Pf-2417";"COc1ccc(CN2CSC3=C(C#N)C(c4cccc(OC)c4)CC(=O)N3C2)cc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL578630";"";"0";"375.45";"0";"4.84";"GNF-Pf-2420";"O=C(Nc1ccc(-c2noc(CCc3ccccc3)n2)cc1)c1cccs1";"IFI";"'='";"4.545";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL576323";"";"0";"423.99";"1";"6.24";"GNF-Pf-2423";"CCCCCc1ccc(C(=O)NCCCCNc2ccnc3cc(Cl)ccc23)cc1";"IFI";"'='";"3.158";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL579089";"";"0";"490.95";"1";"6.53";"GNF-Pf-2428";"O=C(Oc1ccccc1-c1nc2ccccn2c1NC1CCCCC1)c1ccc([N+](=O)[O-])cc1Cl";"IFI";"'='";"2.804";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600299";"";"0";"321.81";"0";"2.80";"GNF-Pf-2447";"COCC(=O)N(C)CCCNc1ccnc2cc(Cl)ccc12";"IFI";"'='";"0.9346";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL602805";"";"0";"496.55";"0";"-0.36";"GNF-Pf-2452";"CCC(C)(O)C(=O)O[C@H]1C(=O)OC2CC3C(C)=C[C@H](O)[C@@H](O)[C@]3(C)C3C24CO[C@]3(O)[C@H](O)[C@H](C)C14";"IFI";"'='";"7.692";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL577885";"";"0";"409.53";"1";"5.03";"GNF-Pf-9";"Oc1ccccc1CNC(Cc1ccccc1)C(O)(c1ccccc1)c1ccccc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL576525";"";"0";"526.94";"2";"6.94";"GNF-Pf-11";"O=[N+]([O-])c1ccc(C2OC3C(c4ccc(Cl)cc4)=Nc4ccccc4N3C2c2ccc([N+](=O)[O-])cc2)cc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL578726";"";"0";"535.73";"2";"7.09";"GNF-Pf-2507";"CCCCC(CC)C(=O)N(CCCC(C)Nc1cc(OC)cc2cccnc12)Cc1ccc(OC)c(OC)c1";"IFI";"'='";"1.852";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL578519";"";"0";"298.39";"0";"3.87";"GNF-Pf-2509";"CCN(CC)c1ccc(NCc2ccc3c(c2)OCO3)cc1";"IFI";"'='";"2.985";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL584736";"";"0";"597.54";"2";"7.88";"GNF-Pf-2522";"COc1cc(NC(C)CCCN(Cc2ccc(OC)c(OC)c2)C(=O)Nc2cccc(Cl)c2Cl)c2ncccc2c1";"IFI";"'='";"6.422";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL601360";"";"0";"483.59";"0";"2.34";"GNF-Pf-2530";"O=C(NC1CCN(CC(O)CN(Cc2ccccc2)S(=O)(=O)c2ccccc2)C1)c1ccco1";"IFI";"'='";"2.941";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL579106";"";"0";"513.64";"2";"6.19";"GNF-Pf-2536";"CCCCCN(C(=O)c1cccc(OC)c1)C(CC)c1nc2ccccc2c(=O)n1-c1ccccc1OC";"IFI";"'='";"1.961";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL579116";"";"0";"331.42";"1";"5.22";"GNF-Pf-32";"Cc1ccc(N=C(Nc2ccc(C)cc2)Nc2ccccc2O)cc1";"IFI";"'='";"3.297";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL579332";"";"0";"371.39";"0";"4.36";"GNF-Pf-2553";"CCOC(=O)c1ccc(-c2c(-c3cc(CC)c(OC)cc3O)noc2C)o1";"IFI";"'='";"2.439";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL577627";"";"0";"466.53";"0";"2.92";"GNF-Pf-47";"COc1ccc(C2C(C(=O)c3ccc(C)cc3)=C(O)C(=O)N2CCN2CCOCC2)c(OC)c1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL601142";"";"0";"337.40";"0";"3.51";"GNF-Pf-52";"O=C1CCC(=O)N1c1ccc(CSc2nc3ccccc3[nH]2)cc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL601759";"";"0";"316.54";"0";"3.62";"GNF-Pf-2587";"Cc1cc(Br)cc(Cl)c1OC(=O)c1ccno1";"IFI";"'='";"1.653";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL581268";"";"0";"341.48";"1";"5.27";"GNF-Pf-2590";"CC[n+]1c(/C=C2\C=Cc3cc(C)ccc3N2C)ccc2cc(C)ccc21";"IFI";"";"";"";"";"";"Not applicable";"";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL601144";"";"0";"491.69";"1";"5.27";"GNF-Pf-61";"CC1=CC[C@@H](/C(C)=C/c2csc(C)n2)OC(=O)C[C@H](O)C(C)(C)C(=O)[C@H](C)[C@@H](O)[C@@H](C)CCC1";"IFI";"'='";"5.66";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL487518";"";"0";"291.31";"0";"3.04";"GNF-Pf-85";"Cc1cc(Nc2cc3ccccc3cc2O)n2ncnc2n1";"IFI";"'='";"4.167";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL597262";"";"0";"260.35";"0";"0.94";"GNF-Pf-805";"CN(C)c1ccc(N2C(N)=NC(N)=NC2(C)C)cc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL596650";"";"0";"315.35";"0";"2.96";"GNF-Pf-810";"COc1ccc(C(=O)Nc2ccc3nsnc3c2)cc1OC";"IFI";"'='";"4.225";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL527516";"";"0";"636.62";"2";"7.80";"GNF-Pf-815";"O=C(Nc1ccc(-c2cc(-c3ccccc3)nc(-c3ccc(NC(=O)c4cccc([N+](=O)[O-])c4)cc3)n2)cc1)c1cccc([N+](=O)[O-])c1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585079";"";"0";"395.37";"0";"4.30";"GNF-Pf-818";"CCOc1cc([N+](=O)[O-])cc(C=Nc2cccc(NC(=O)c3ccco3)c2)c1O";"IFI";"'='";"7.143";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL193869";"";"0";"333.48";"0";"4.93";"GNF-Pf-843";"CCN1C(=Cc2sc3ccccc3[n+]2C)C=Cc2ccc(C)cc21";"IFI";"'='";"23.81";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585236";"";"0";"421.29";"0";"4.45";"GNF-Pf-859";"COc1cc(NC(=O)C(F)(F)F)c(C(=O)c2ccc(C(F)(F)F)cc2)cc1OC";"IFI";"'='";"1.961";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL528672";"";"0";"329.38";"0";"3.40";"GNF-Pf-863";"CCOc1ccc(S(=O)(=O)Oc2cccc3cccnc23)cc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585807";"";"0";"403.57";"0";"4.87";"GNF-Pf-867";"CCN(CC)c1ccc(/C=C/C23NC(=O)CCN2c2ccc(C)cc2C3(C)C)cc1";"IFI";"'='";"7.692";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL586001";"";"0";"262.40";"0";"3.40";"GNF-Pf-869";"CCCN[P+](CC(C)C)(NCCC)NCCC";"IFI";"'='";"10.91";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL601115";"";"0";"353.43";"0";"3.99";"GNF-Pf-891";"CC(=O)Nc1sc(C)c(C)c1N=Nc1ccc(S(=O)(=O)O)cc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL602019";"";"0";"304.35";"0";"3.92";"GNF-Pf-896";"CC1(c2ccccc2)CC(c2ccccc2)=Nc2nonc2N1";"IFI";"'='";"1.22";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL583592";"";"0";"440.45";"0";"3.25";"GNF-Pf-898";"COc1cc(OC)cc(-n2c(=O)c3sccc3n(CC(=O)c3ccc(F)cc3)c2=O)c1";"IFI";"'='";"1.961";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL583596";"";"0";"492.94";"0";"3.56";"GNF-Pf-903";"O=C(Cc1ccc(F)cc1Cl)N1CCN(c2cccc3c2C(=O)N(Cc2ccccn2)C3=O)CC1";"IFI";"'='";"1.724";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL583597";"";"0";"341.37";"0";"3.25";"GNF-Pf-904";"CC(C)c1ccc(OCC(=O)NN=Cc2cccc([N+](=O)[O-])c2)cc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585208";"";"0";"444.67";"0";"4.53";"GNF-Pf-905";"CC(C)CNC(=O)c1cnc(NCCCN2CCCCC2C)nc1NCC1CCCCC1";"IFI";"'='";"2.885";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL601606";"";"0";"486.50";"1";"5.42";"GNF-Pf-909";"N#Cc1nc(-c2ccccc2)c(-c2ccc(-c3nc(C#N)c(C#N)nc3-c3ccccc3)cc2)nc1C#N";"IFI";"'='";"7.143";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL599956";"";"0";"418.88";"1";"5.19";"GNF-Pf-912";"COc1ccc(/C=C2\N=C(c3ccc(Cl)cc3)N(c3ccccc3)C2=O)cc1OC";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL603036";"";"0";"459.54";"0";"3.66";"GNF-Pf-914";"CCN(c1ccc(F)cc1)S(=O)(=O)c1ccc2[nH]cc(C(=O)NCCC(C)C)c(=O)c2c1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL601813";"";"0";"531.61";"1";"8.67";"GNF-Pf-922";"CCCCCCN(CCCCCC)CC(O)c1cc(-c2ccc(Cl)cc2)nc2c(C)cc(C)cc12.Cl";"IFI";"'='";"4.545";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585232";"";"0";"535.62";"2";"6.13";"GNF-Pf-925";"CCC(c1nc2ccccc2c(=O)n1-c1ccc(F)cc1)N(CCc1ccccc1)C(=O)COc1ccccc1";"IFI";"'='";"1.075";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL113999";"";"0";"355.40";"0";"2.43";"GNF-Pf-607";"COc1cc(CNc2ccc3nc(N)nc(N)c3c2)cc(OC)c1OC";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL581897";"";"0";"566.66";"1";"3.94";"GNF-Pf-612";"COc1ccc(CN2CCN(C(=O)c3sc4ncn(Cc5ccccc5F)c(=O)c4c3C)CC2)c(OC)c1OC";"IFI";"'='";"1.149";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL527461";"";"0";"292.30";"0";"-0.14";"GNF-Pf-620";"N#Cc1nc(C(=O)N2CCOCC2)oc1N1CCOCC1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL581050";"";"0";"570.62";"1";"4.94";"GNF-Pf-621";"CCOC(=O)c1ccc(NC(=O)c2sc(NC(=O)c3cc(OC)c(OC)c(OC)c3)c(C(=O)OCC)c2C)cc1";"IFI";"'='";"2.326";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL584874";"";"0";"350.44";"0";"1.21";"GNF-Pf-672";"CN(C)C(=O)CN(C)C(=O)c1cnc2scc(C(C)(C)C)n2c1=O";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL603732";"";"0";"406.66";"0";"3.88";"GNF-Pf-675";"N#Cc1cn(-c2ccc(Cl)cc2)c(=O)n(Cc2c(Cl)cccc2Cl)c1=O";"IFI";"'='";"3.478";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585087";"";"0";"388.56";"0";"3.11";"GNF-Pf-687";"CC(C)CNC(=O)c1cnc(NCCCN2CCCC2)nc1NC1CCCC1";"IFI";"'='";"1.905";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL598052";"";"0";"424.59";"0";"3.41";"GNF-Pf-700";"CC(C)CNc1nc(NCCCN2CCCC2)ncc1C(=O)NCCc1ccccc1";"IFI";"'='";"1.905";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL598890";"";"0";"458.61";"0";"3.96";"GNF-Pf-717";"O=C(NCc1ccccc1)c1cnc(NCCCN2CCCC2)nc1NCCc1ccccc1";"IFI";"'='";"1.905";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL598485";"";"0";"411.53";"0";"2.98";"GNF-Pf-720";"Cc1nccn1CC(C)C(=O)N1CCCC(n2nc(-c3cccs3)ccc2=O)C1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL598486";"";"0";"370.50";"0";"2.28";"GNF-Pf-723";"CC(C)CNc1nc(NCCCN)ncc1C(=O)NCCc1ccccc1";"IFI";"'='";"1.905";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL597665";"";"0";"494.93";"1";"5.35";"GNF-Pf-725";"CC(C)C1N=C2c3ccccc3N=C(SCC(=O)Nc3cc(C(F)(F)F)ccc3Cl)N2C1=O";"IFI";"'='";"3.529";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL604736";"";"0";"407.25";"0";"4.10";"GNF-Pf-740";"COc1ccc(OC)c(NC2=C(Cl)C(=O)N(c3ccc(C)c(Cl)c3)C2=O)c1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL601182";"";"0";"371.49";"0";"2.87";"GNF-Pf-749";"CCCN1CCC(c2nc(N3CCOCC3)ncc2-c2cc(C)no2)CC1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL601183";"";"0";"440.53";"0";"1.57";"GNF-Pf-752";"CN(C)CCNC(=O)c1c[nH]c2ccc(S(=O)(=O)N3CCc4ccccc43)cc2c1=O";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585273";"";"0";"433.51";"1";"6.12";"GNF-Pf-753";"N#CC(C#N)C(/C(Sc1ccc([N+](=O)[O-])cc1)=C(/O)c1ccccc1)c1cccs1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL584062";"";"0";"419.52";"1";"5.48";"GNF-Pf-761";"CCOC(=O)C1=C(C)N(c2ccc(OCC)cc2)C(=O)C1=Cc1ccc(C(C)C)cc1";"IFI";"";"";"";"";"";"Not applicable";"";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL598053";"";"0";"428.56";"0";"4.99";"GNF-Pf-768";"CN(Cc1ccccc1)C(=O)CSc1nc(NCc2ccccc2)c2ccccc2n1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL268356";"";"0";"289.34";"0";"1.05";"GNF-Pf-785";"CCOC(=O)c1cccc(N2C(N)=NC(N)=NC2(C)C)c1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL1744508";"";"0";"294.38";"0";"3.89";"GNF-Pf-791";"Cc1ccccc1/C=C1\SC(=Nc2ccccc2)NC1=O";"IFI";"";"";"";"";"";"Not applicable";"";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585250";"";"0";"298.25";"0";"3.17";"GNF-Pf-1347";"CC1=NOC(=O)/C1=C/c1ccc(-c2ccc([N+](=O)[O-])cc2)o1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL577436";"";"0";"484.56";"1";"6.53";"GNF-Pf-2204";"O=C(/C=C\c1ccccc1)Nc1ccc2[nH]c(-c3ccc(NC(=O)/C=C/c4ccccc4)cc3)nc2c1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL576527";"";"0";"363.51";"0";"4.07";"GNF-Pf-2210";"O=C(NCc1ccccc1)NC1CC2CCCC(C1)N2Cc1ccccc1";"IFI";"'='";"3.947";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL577368";"";"0";"430.37";"0";"-0.80";"GNF-Pf-2212";"CC(=O)OCN1C(=O)N(COC(C)=O)C2C1N(COC(C)=O)C(=O)N2COC(C)=O";"IFI";"'='";"1.136";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL577589";"";"0";"395.55";"0";"4.19";"GNF-Pf-2215";"Cc1ccc(CN2CCN(Cc3cn(C(C)C)c4ccccc34)CC2CCO)o1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL579302";"";"0";"428.66";"1";"6.72";"GNF-Pf-2220";"CCCCCCCCOC(=O)NCCCCCCNC(=O)OCCCCCCCC";"IFI";"'='";"5.882";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600105";"";"0";"317.37";"0";"1.70";"GNF-Pf-2221";"CC1(C)Oc2ccc3ccc(=O)oc3c2CC1=NNC(N)=S";"IFI";"'='";"3.846";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL578050";"";"0";"305.39";"0";"3.45";"GNF-Pf-2226";"CCN(CC)c1cc(-c2ccccn2)nc(-c2ccccn2)n1";"IFI";"'='";"15.38";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL602392";"";"0";"366.38";"0";"3.79";"GNF-Pf-2237";"O=C1C(Nc2ccccc2)=C(n2nnc3ccccc32)C(=O)c2ccccc21";"IFI";"'='";"9.091";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL610330";"";"0";"386.88";"0";"4.72";"GNF-Pf-2238";"O=C(c1ccccc1)N1CCc2nc(Cc3ccc(F)cc3Cl)sc2C1";"IFI";"'='";"1.389";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600936";"";"0";"410.30";"0";"3.33";"GNF-Pf-2240";"CCOC(=O)c1sc(Nc2c(Cl)cc(S(N)(=O)=O)cc2Cl)nc1C";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL601154";"";"0";"442.56";"0";"3.35";"GNF-Pf-2245";"C=C(C)[C@@H]1CC=C(CN2C[C@H](NC(=O)c3ccc(OC)cc3OC)C[C@H]2C(=O)OC)CC1";"IFI";"'='";"1.739";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL577417";"";"0";"352.43";"1";"5.13";"GNF-Pf-2255";"FC(F)(F)c1cccc(-c2nc3c(s2)CN(C2CCCC2)CC3)c1";"IFI";"'='";"2.778";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL609749";"";"0";"524.73";"1";"4.50";"GNF-Pf-2258";"CCN(CC)CCCNC(=S)N(CCc1cccc(C)c1)Cc1cc2cc(OC)c(OC)cc2[nH]c1=O";"IFI";"'='";"11.43";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL577869";"";"0";"396.64";"1";"6.92";"GNF-Pf-2270";"CCCCCc1ccc(OCCCC[n+]2cccc(C)c2C)c(CCCCC)c1";"IFI";"'='";"7.143";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL579078";"";"0";"467.51";"0";"3.52";"GNF-Pf-2273";"CCC(=O)N1CCc2cc(S(=O)(=O)N3CCN(c4cccc(C(F)(F)F)c4)CC3)ccc21";"IFI";"'='";"5.714";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL579079";"";"0";"344.21";"0";"3.15";"GNF-Pf-2274";"O=C1C2C(C(=O)N1c1ccc(Br)cc1)C1C=CC2C12CC2";"IFI";"'='";"0.9346";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL577163";"";"0";"502.58";"1";"4.04";"GNF-Pf-2282";"O=C(Nc1ccc(C2=NCCN2)cc1)c1cccc2c(C(=O)Nc3ccc(C4=NCCN4)cc3)cccc12";"IFI";"'='";"1.681";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600916";"";"0";"580.80";"1";"3.92";"GNF-Pf-2287";"CSc1cccc(NC(=O)C2C3C=CC4(O3)C2C(=O)N(CCN2CCCCC2)C4C(=O)NC2CCCC(C)C2C)c1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL578052";"";"0";"461.65";"1";"5.74";"GNF-Pf-2291";"O=C(NCCc1ccccc1)c1cnc(NCCC2=CCCCC2)nc1NCC1CCCCC1";"IFI";"'='";"3.846";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL578062";"";"0";"383.95";"0";"4.22";"GNF-Pf-2303";"CN1C[C@@H](CSc2ccccn2)C=C2c3cccc4[nH]cc(c34)C[C@H]21.Cl";"IFI";"'='";"4.878";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL582665";"";"0";"444.47";"0";"1.32";"GNF-Pf-1540";"COC(=O)CNC(=O)c1sc2ncn(CC(=O)Nc3ccccc3OC)c(=O)c2c1C";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL577640";"";"0";"380.89";"0";"4.11";"GNF-Pf-2326";"COc1cc(CNCCCN(C)C)ccc1OCc1ccc(F)cc1Cl";"IFI";"'='";"7.143";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL582677";"";"0";"338.78";"0";"2.43";"GNF-Pf-1548";"COC(=O)CSc1nnc2c(n1)[nH]c1c(OC)ccc(Cl)c12";"IFI";"'='";"3.191";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL578089";"";"0";"344.50";"0";"3.70";"GNF-Pf-2336";"CCOc1ccccc1CN1CCCC(C(=O)N2CCCCCC2)C1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL576478";"";"0";"430.55";"0";"4.14";"GNF-Pf-2345";"Cc1cccc(C2c3[nH]c4ccccc4c3CCN2C(=O)CCCN2CCCCC2=O)n1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL579283";"";"0";"521.66";"2";"5.64";"GNF-Pf-2348";"COc1ccc(NC(=O)CCCCCn2c(SCC(=O)c3ccccc3)nc3ccsc3c2=O)cc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL532511";"";"0";"328.36";"0";"3.55";"GNF-Pf-2365";"O=C(C1CC1)N1CCN=C1SCc1ccc(C(F)(F)F)cc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600315";"";"0";"339.79";"0";"1.78";"GNF-Pf-1577";"N#Cc1cc(C#N)c(N2CCN(c3cccc(Cl)n3)CC2)nc1N";"IFI";"'='";"6.579";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL587711";"";"0";"513.51";"2";"5.56";"GNF-Pf-1596";"CCCCCCCC(=O)N1CCN(C(=O)C(NC(=O)Nc2ccc(Cl)cc2Cl)C(C)CC)CC1";"IFI";"'='";"3.738";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL579496";"";"0";"325.44";"0";"3.86";"GNF-Pf-1612";"CCc1ccc(NC(=O)CSc2nc(C)cc(C)c2C#N)cc1";"IFI";"'='";"3.704";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL601124";"";"0";"420.04";"1";"5.44";"GNF-Pf-1618";"CCC(C)(C)c1ccc(OCCOCC[n+]2ccccc2)c(C(C)(C)CC)c1.[Cl-]";"IFI";"'='";"6.522";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL577221";"";"0";"416.40";"1";"1.70";"GNF-Pf-1630";"Cc1cc(Oc2ncnc(N(C)CC(=O)OC(C)(C)C)c2[N+](=O)[O-])c2nncn2n1";"IFI";"'='";"7.143";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL578328";"";"0";"402.39";"0";"2.94";"GNF-Pf-1648";"Cc1cc(NS(=O)(=O)c2ccc(NC(=O)c3ccc([N+](=O)[O-])cc3)cc2)no1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL577674";"";"0";"445.50";"0";"4.02";"GNF-Pf-1651";"CC(=O)Nc1ccc(NC2=CC(=NS(=O)(=O)c3ccccc3)c3ccccc3C2=O)cc1";"IFI";"'='";"7.692";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL588086";"";"0";"360.33";"0";"3.63";"GNF-Pf-1662";"O=C1Nc2ccccc2C1=NN=Cc1ccc(-c2ccccc2[N+](=O)[O-])o1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL602779";"";"0";"282.19";"0";"3.07";"GNF-Pf-1669";"CC(C)(C)NS(=O)(=O)c1cc(Cl)ccc1Cl";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL394752";"";"0";"150.15";"0";"-0.36";"GNF-Pf-1671";"NNc1ncnc2[nH]cnc12";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL581196";"";"0";"383.42";"0";"4.01";"GNF-Pf-1680";"COc1ccc(NC(=O)NCc2cccn2Cc2ccc(F)cc2)cc1OC";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL579932";"";"0";"360.44";"0";"2.58";"GNF-Pf-1682";"CCOC(=O)c1cnc(SCC(=O)Nc2cc(C)ccc2C)nc1N";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL580140";"";"0";"362.44";"0";"4.50";"GNF-Pf-1686";"FC(F)(F)c1cccc(CNC2CCN(CCc3ccccc3)CC2)c1";"IFI";"'='";"1.613";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL582048";"";"0";"315.46";"0";"3.79";"GNF-Pf-1690";"Cc1cccc(C)c1NC(=O)N1CCN(C2CCCCC2)CC1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL513104";"";"0";"313.40";"0";"3.71";"GNF-Pf-1694";"CC(C)(C)NCC(O)COc1cccc2oc3ccccc3c12";"IFI";"'='";"7.692";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600313";"";"0";"300.36";"0";"2.14";"GNF-Pf-1702";"CCC(=O)N(C1=C(NC)C(=O)c2ccccc2C1=O)C(C)C";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL577223";"";"0";"328.80";"0";"2.93";"GNF-Pf-1706";"CC(=O)N1c2ccccc2CC1C(=O)NCc1cccc(Cl)c1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600710";"";"0";"259.33";"0";"3.19";"GNF-Pf-1712";"CCCC1=NN(c2nc3ccccc3s2)C(=O)C1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL587560";"";"0";"418.03";"0";"4.61";"GNF-Pf-1743";"O=C1CCC(CCNCc2ccc(Cl)cc2)N1CC1(N2CCCCC2)CCCC1";"IFI";"'='";"0.9709";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL586483";"";"0";"399.95";"0";"4.99";"GNF-Pf-1746";"O=C(CSc1ccccc1)NCCCCNc1ccnc2cc(Cl)ccc12";"IFI";"'='";"3.738";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL587436";"";"0";"410.47";"0";"3.58";"GNF-Pf-1748";"O=C(Nc1ccccc1)C1Cc2ccccc2CN1S(=O)(=O)c1ccc(F)cc1";"IFI";"'='";"1.149";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL601614";"";"0";"505.57";"1";"3.05";"GNF-Pf-1749";"COc1ccc([C@]23Oc4cc(OC)cc(OC)c4[C@@]2(O)[C@@H](O)C(C(=O)N(C)C)[C@@H]3c2ccccc2)cc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL576606";"";"0";"479.17";"0";"1.97";"GNF-Pf-1754";"CCOC(=O)C1(CC)CC(C)(C(=O)C[n+]2cccc(Br)c2)OC1=O.[Br-]";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL588539";"";"0";"315.44";"0";"4.57";"GNF-Pf-1768";"CC[n+]1c(/C=C/N2CCCc3ccccc32)ccc2ccccc21";"IFI";"";"";"";"";"";"Not applicable";"";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL588543";"";"0";"367.47";"0";"3.62";"GNF-Pf-1771";"O=C1N(Cc2cc3ccccc3s2)CC2CN(Cc3ccoc3)CCN12";"IFI";"'='";"1.408";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL602406";"";"0";"478.93";"0";"4.90";"GNF-Pf-283";"COc1ccc(C(NC(=O)COc2ccccc2)c2cc(Cl)c3cccnc3c2O)cc1OC";"IFI";"'='";"12.5";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL601345";"";"0";"283.71";"0";"4.01";"GNF-Pf-287";"O=c1nc(/C=C/c2ccc(Cl)cc2)oc2ccccc12";"IFI";"'='";"2.381";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL582711";"";"0";"423.85";"0";"4.03";"GNF-Pf-300";"C=CCNC(=O)CSc1ccc(C(=O)Nc2ccc(Cl)cc2F)cc1[N+](=O)[O-]";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600128";"";"0";"425.96";"1";"5.45";"GNF-Pf-2592";"CCOC(=O)c1ccc2nc(C)cc(Nc3ccc(N4CCCCC4)cc3)c2c1.Cl";"IFI";"'='";"1.124";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL579286";"";"0";"414.47";"0";"2.90";"GNF-Pf-2596";"O=C(CCn1c(=O)[nH]c2ccccc21)NCC1Cc2cccc(-c3ccncc3)c2O1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL579100";"";"0";"215.30";"0";"3.51";"GNF-Pf-2604";"CCCc1c(C)nc2ccc(C)cc2c1O";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL578901";"";"0";"459.59";"1";"5.48";"GNF-Pf-2612";"CCOc1ccc(C2C(C(=O)OCCc3ccccc3)=C(C)NC3=C2C(=O)CC(C)(C)C3)cc1";"IFI";"'='";"3.571";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL599903";"";"0";"856.97";"3";"-1.41";"GNF-Pf-91";"CCCCCCC1CCC(O)(C(C)(O)C(=O)NC2C(=O)N3NCCCC3C(=O)N(O)C(COC)C(=O)NCC(=O)N3NCCCC3C(=O)N(O)C(C)C(=O)OC2C)OC1C";"IFI";"'='";"39.29";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL578716";"";"0";"470.61";"0";"3.35";"GNF-Pf-105";"CC1=C(CO)C(=O)O[C@@H]([C@@H](C)[C@H]2CC[C@H]3[C@@H]4C[C@H]5O[C@]56[C@@H](O)C=CC(=O)[C@]6(C)C4CC[C@@]32C)C1";"IFI";"'='";"32.14";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL578717";"";"0";"474.56";"1";"5.80";"GNF-Pf-106";"CCCCc1ccc(C(=O)NCCCN(C(=O)Nc2ccc([N+](=O)[O-])cc2)c2ccccc2)cc1";"IFI";"'='";"2.083";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL578929";"";"0";"489.65";"0";"4.64";"GNF-Pf-108";"CC1CC(C)CC(C)C(O)C(C#N)=CC=CCC(C2CCCC2C(=O)O)OC(=O)CC(O)C(C)C1";"IFI";"'='";"25.76";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585583";"";"0";"522.48";"2";"5.55";"GNF-Pf-118";"O=C(Nc1ccc(-c2nc3cc(NC(=O)c4cccc([N+](=O)[O-])c4)ccc3[nH]2)cc1)c1cccc([N+](=O)[O-])c1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL578871";"";"0";"245.28";"0";"3.24";"GNF-Pf-121";"CCOc1ccc(NC(=O)c2ccc(C)o2)cc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL576945";"";"0";"570.20";"2";"6.45";"GNF-Pf-127";"O=C(Nc1ccc(-c2nc3cc(NC(=O)c4ccc(Br)o4)ccc3[nH]2)cc1)c1ccc(Br)o1";"IFI";"'='";"7.692";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600503";"";"0";"320.82";"0";"3.35";"GNF-Pf-1796";"CN(C)C(=O)NCCCCNc1ccnc2cc(Cl)ccc12";"IFI";"'='";"0.9174";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL577879";"";"0";"215.25";"0";"3.05";"GNF-Pf-1816";"COc1ccc2cc(C(C)=NO)ccc2c1";"IFI";"'='";"1.613";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL587856";"";"0";"382.46";"0";"3.01";"GNF-Pf-146";"COc1cc(-c2nc3ccc(N4CCN(C)CC4)cc3[nH]2)cc(OC)c1OC";"IFI";"'='";"6.024";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL579489";"";"0";"429.38";"0";"3.70";"GNF-Pf-1865";"CCC(=O)N1CCc2cc(Br)cc(S(=O)(=O)N3CCCCC3CC)c21";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL601354";"";"0";"449.58";"0";"3.19";"GNF-Pf-1883";"CCOc1cc(S(=O)(=O)N2CCCC3(CCCCC3)C2)c(OCC)cc1-n1cnnn1";"IFI";"'='";"4.098";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL578100";"";"0";"452.56";"0";"3.53";"GNF-Pf-1886";"CCCC(=O)N1CCN(C(=O)c2nc(-c3ccccc3)nc(C(C)C)c2C(=O)OC)CC1C";"IFI";"'='";"2.778";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL578103";"";"0";"357.44";"0";"3.78";"GNF-Pf-1892";"CCOc1ccc2c(c1)sc(=NC(=O)Nc1ccc(OC)cc1)n2C";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL601563";"";"0";"418.48";"0";"4.89";"GNF-Pf-1898";"Cc1cc(/C=C2/SC(=Nc3ccccc3)NC2=O)c(C)n1-c1cccc([N+](=O)[O-])c1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL602185";"";"0";"536.88";"1";"4.23";"GNF-Pf-1900";"CCc1c(C(=O)N2CCN(C(=O)CCl)C(C)C2)cnn1-c1nc(-c2ccc(Br)cc2)cs1";"IFI";"'='";"4.762";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL578332";"";"0";"417.60";"0";"4.33";"GNF-Pf-1911";"O=C(C1CCCCN1)N1CC(c2ccccc2)c2ccccc2C1CN1CCCCC1";"IFI";"'='";"8.571";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL579174";"";"0";"431.54";"0";"2.09";"GNF-Pf-1924";"O=C1NC(=O)C(Cc2ccc(S(=O)(=O)N3CCN(c4ccccc4)CC3)cc2)S1";"IFI";"'='";"1.235";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL579381";"";"0";"329.31";"1";"5.37";"GNF-Pf-1928";"CCN(CC)c1scc(-c2ccc(Br)cc2)[s+]1";"IFI";"'='";"7.692";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL587277";"";"0";"362.82";"0";"3.36";"GNF-Pf-1929";"COc1cc(CNNc2nc3cc(Cl)ccc3[nH]2)cc(OC)c1OC";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL588987";"";"0";"443.98";"1";"6.03";"GNF-Pf-1934";"O=C(NCCCCNc1ccnc2cc(Cl)ccc12)C(c1ccccc1)c1ccccc1";"IFI";"'='";"3.774";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL587221";"";"0";"312.84";"0";"4.04";"GNF-Pf-1944";"N=c1c2c(n(Cc3ccc(Cl)cc3)c3c1CCC3)CCCC2";"IFI";"'='";"14.29";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL510650";"ECHINOMYCIN";"0";"1101.28";"None";"None";"GNF-Pf-1958";"CS[C@H]1SC[C@H]2C(=O)N(C)[C@@H](C(C)C)C(=O)OC[C@@H](NC(=O)c3cnc4ccccc4n3)C(=O)N[C@@H](C)C(=O)N(C)[C@@H]1C(=O)N(C)[C@@H](C(C)C)C(=O)OC[C@@H](NC(=O)c1cnc3ccccc3n1)C(=O)N[C@@H](C)C(=O)N2C";"IFI";"'='";"34.62";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600733";"";"0";"423.22";"1";"5.76";"GNF-Pf-1984";"N#Cc1cc(-c2cccc(C(F)(F)F)c2)cn(Cc2c(Cl)cccc2Cl)c1=O";"IFI";"'='";"5.263";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL578956";"";"0";"416.74";"1";"9.50";"GNF-Pf-1987";"CC(C)(C)C1=CC(=C2C=C(C(C)(C)C)SC(C(C)(C)C)=C2)C=C(C(C)(C)C)S1";"IFI";"'='";"3.659";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL576613";"";"0";"395.93";"1";"5.34";"GNF-Pf-1998";"CCC(C(=O)N(C)CCCNc1ccnc2cc(Cl)ccc12)c1ccccc1";"IFI";"'='";"2.97";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL579382";"";"0";"431.99";"0";"3.73";"GNF-Pf-2000";"Cc1nc(CC(=O)N2CCCC(CNC(=O)C3(c4ccc(Cl)cc4)CC3)C2)cs1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600910";"";"0";"309.33";"0";"2.76";"GNF-Pf-2002";"CCOC(=O)c1ccc(NC(=O)c2cc3ccccn3n2)cc1";"IFI";"'='";"7.692";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL587087";"";"0";"268.81";"0";"2.74";"GNF-Pf-2004";"CC[n+]1c(C=CN(C)C)sc2ccccc21.[Cl-]";"IFI";"";"";"";"";"";"Not applicable";"";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL586764";"";"0";"431.54";"1";"6.44";"GNF-Pf-2012";"CC(C)(C)CC(C)(C)Nc1c(-c2ccccc2OC(=O)c2ccco2)nc2ccccn12";"IFI";"'='";"4.762";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL588835";"";"0";"413.55";"1";"6.11";"GNF-Pf-2013";"CCC(Sc1nc(C)cc(-c2ccccc2)n1)C(=O)Nc1cccc2ccccc12";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL469912";"PUROMYCIN";"0";"471.52";"1";"-0.79";"GNF-Pf-2016";"COc1ccc(C[C@H](N)C(=O)N[C@@H]2[C@@H](CO)O[C@@H](n3cnc4c(N(C)C)ncnc43)[C@@H]2O)cc1";"IFI";"'='";"30.77";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL608557";"";"0";"309.41";"0";"2.97";"GNF-Pf-2027";"C=CCOc1ccccc1CN1CCN(c2ccccn2)CC1";"IFI";"'='";"2.985";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL603026";"";"0";"425.27";"0";"2.72";"GNF-Pf-2031";"COc1cc(CN2CCN(c3ccccn3)CC2)cc(I)c1O";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL582258";"";"0";"432.51";"1";"5.20";"GNF-Pf-2037";"Cc1ccc(N=C2NC(=O)/C(=C\c3cc(C)n(-c4cccc([N+](=O)[O-])c4)c3C)S2)cc1";"IFI";"'='";"2.353";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600144";"";"0";"449.62";"1";"5.05";"GNF-Pf-2040";"COc1ccc(CN(Cc2cc3cccc(C)c3[nH]c2=O)C(=S)NC2CCCCC2)cc1";"IFI";"'='";"3.604";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL577382";"";"0";"459.49";"0";"3.13";"GNF-Pf-2049";"COc1ccccc1CN1CCC(S(=O)(=O)c2ccccc2)CC1.O=C(O)C(F)(F)F";"IFI";"'='";"4.11";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL578672";"";"0";"311.43";"0";"2.14";"GNF-Pf-2052";"CN1CCc2c(C#N)c(N3CCCC3)nc(N3CCCC3)c2C1";"IFI";"'='";"3.509";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL530907";"";"0";"666.69";"2";"7.36";"GNF-Pf-2056";"COc1ccc(CCN2C(=O)c3ccc(Oc4ccc(NC(=O)c5oc(=O)c6ccccc6c5-c5ccccc5)cc4)cc3C2=O)cc1OC";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL599898";"";"0";"207.27";"0";"2.15";"GNF-Pf-2068";"CCCCOC(=O)Cc1ccc(N)cc1";"IFI";"'='";"7.087";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL601332";"";"0";"285.73";"0";"4.68";"GNF-Pf-2072";"Cc1ccc(-c2cc(-c3cc(Cl)ccc3O)on2)cc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL577842";"";"0";"350.33";"0";"3.48";"GNF-Pf-2077";"O=C(Nc1ccccc1C(=O)O)c1cccc(NC(=O)c2ccco2)c1";"IFI";"'='";"7.692";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL532466";"";"0";"590.80";"2";"5.84";"GNF-Pf-2082";"CC[C@@H](C(=O)[C@@H](C)[C@@H](O)[C@H](C)CCc1ccc(C)c(O)c1C(=O)O)[C@H]1O[C@](CC)([C@H]2CC[C@](O)(CC)[C@@H](C)O2)C[C@@H]1C";"IFI";"'='";"26.92";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL602196";"";"0";"406.49";"0";"2.58";"GNF-Pf-2087";"CC(C)(C)C1=NN(CC(=O)NCCc2c[nH]cn2)C(=O)c2cc3ccccc3n2C1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL588768";"";"0";"401.54";"0";"3.57";"GNF-Pf-2088";"COc1cc2nc(SCC(C)C)n(CCCn3ccnc3)c(=N)c2cc1OC";"IFI";"'='";"2.381";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL578927";"";"0";"340.30";"0";"2.49";"GNF-Pf-2090";"COc1ccc(-c2cnnc(NN=Cc3ccc([N+](=O)[O-])o3)n2)cc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL599899";"";"0";"303.37";"0";"4.51";"GNF-Pf-2092";"C/C=C/[P+](c1ccccc1)(c1ccccc1)c1ccccc1";"IFI";"'='";"11.76";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL534037";"";"0";"582.77";"2";"6.93";"GNF-Pf-2093";"COc1cc(NC(C)CCCN(Cc2ccc(N(C)C)cc2)S(=O)(=O)c2cccc3ccccc23)c2ncccc2c1";"IFI";"'='";"3.704";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL601544";"";"0";"687.79";"2";"6.40";"GNF-Pf-2101";"CCOC(=O)C1=C(c2ccccc2)N=c2sc(=Cc3c(C)n(Cc4ccc(F)cc4)c4ccccc34)c(=O)n2C1c1cccc(OC)c1OC";"IFI";"'='";"4.598";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL577209";"";"0";"527.46";"2";"5.79";"GNF-Pf-2108";"CCOC(=O)C1=C(C)N(c2ccc(N(C)C)cc2)C(C)=C(C(=O)OCC)C1c1ccc(Br)cc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL601334";"";"0";"548.52";"3";"5.48";"GNF-Pf-2161";"O=[N+]([O-])c1cccc(C=NNc2nc(NN=Cc3cccc([N+](=O)[O-])c3)nc(Nc3cccc4ccccc34)n2)c1";"IFI";"'='";"2.299";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL578920";"";"0";"419.52";"1";"5.48";"GNF-Pf-2171";"CCOC(=O)C1=C(C)N(c2ccc(OCC)cc2)C(=O)/C1=C\c1ccc(C(C)C)cc1";"IFI";"'='";"3.529";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL273081";"";"0";"357.87";"0";"4.30";"GNF-Pf-62";"CN(C)c1ccc(/C=C2/SC(=Nc3ccccc3Cl)NC2=O)cc1";"IFI";"'='";"12.64";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL602581";"";"0";"316.11";"0";"2.52";"GNF-Pf-2454";"O=C(CCl)NCCNc1ncc(C(F)(F)F)cc1Cl";"IFI";"'='";"1.37";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL296419";"ASTEMIZOLE";"4";"458.58";"1";"5.35";"GNF-Pf-2461";"COc1ccc(CCN2CCC(Nc3nc4ccccc4n3Cc3ccc(F)cc3)CC2)cc1";"IFI";"'='";"2.367";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL578082";"";"0";"483.66";"1";"6.19";"GNF-Pf-2497";"Cc1ccc(-n2c(SCc3cccc4ccccc34)nc3sc4c(c3c2=O)CCN(C)C4)cc1";"IFI";"'='";"10.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL602172";"";"0";"574.68";"2";"9.15";"GNF-Pf-22";"COc1ccc(-c2nc(-c3ccc(-c4[nH]c(-c5ccc(OC)cc5)nc4-c4ccccc4)cc3)c(-c3ccccc3)[nH]2)cc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL578690";"";"0";"405.54";"0";"3.40";"GNF-Pf-2539";"Cc1cccc(CC(=O)N2CCC[C@@H]3CN(C(=O)CCc4cccnc4)CC[C@@H]32)c1";"IFI";"'='";"0.9804";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL577853";"";"0";"409.96";"1";"5.85";"GNF-Pf-2562";"CCCCc1ccc(C(=O)NCCCCNc2ccnc3cc(Cl)ccc23)cc1";"IFI";"'='";"2.128";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600933";"";"0";"348.75";"0";"2.90";"GNF-Pf-2566";"NC(=N[N+](=O)[O-])Nc1ccc(NC(=O)Nc2ccc(Cl)cc2)cc1";"IFI";"'='";"2.857";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL578508";"";"0";"290.25";"0";"2.92";"GNF-Pf-2570";"N=c1c2ccccc2nnn1-c1cccc(C(F)(F)F)c1";"IFI";"'='";"2.532";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL578730";"";"0";"499.59";"1";"5.05";"GNF-Pf-2584";"CCOC(=O)N1CCc2c(sc(NCc3ccc(C)o3)c2C(=O)Nc2ccc(OC)cc2OC)C1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL529241";"";"0";"244.39";"0";"1.09";"GNF-Pf-526";"CSc1nnc(CN2CCSCC2)n1C";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL581268";"";"0";"341.48";"1";"5.27";"GNF-Pf-2590";"CC[n+]1c(/C=C2\C=Cc3cc(C)ccc3N2C)ccc2cc(C)ccc21";"IFI";"'='";"15.38";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL582737";"";"0";"424.55";"0";"2.59";"GNF-Pf-574";"CCOC(=O)N1CCN(C(=O)CCCCn2c(=S)[nH]c3ccsc3c2=O)CC1";"IFI";"'='";"2.299";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL581271";"";"0";"418.48";"0";"3.58";"GNF-Pf-581";"CCOc1ccc2cc(C#N)c(SCC(=O)N3CC(=O)Nc4ccccc43)nc2c1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL581469";"";"0";"304.74";"0";"2.78";"GNF-Pf-311";"Cc1ccc(Nc2nc3nonc3nc2N(C)C)cc1Cl";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL581471";"";"0";"275.74";"0";"3.91";"GNF-Pf-313";"COC(C(=NO)c1ccc(Cl)cc1)c1ccccc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL602002";"";"0";"372.47";"0";"3.38";"GNF-Pf-315";"Cc1cc(C=C2SC(=S)N(CC(=O)O)C2=O)c(C)n1-c1ccccc1";"IFI";"";"";"";"";"";"Not applicable";"";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL579767";"";"0";"365.43";"0";"1.60";"GNF-Pf-317";"O=C1NN=C(CC(=O)N2CC[C@@H](c3ccccc3)[C@H](O)C2)C2C=CC=CC12";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL582512";"";"0";"271.28";"0";"1.17";"GNF-Pf-320";"COc1ccccc1C(=O)NNC(=O)c1ccccn1";"IFI";"'='";"12.12";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL370933";"";"0";"355.51";"0";"4.11";"GNF-Pf-370";"CC[n+]1c(C=C2Sc3ccccc3N2CCO)sc2ccccc21";"IFI";"'='";"4.688";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600742";"";"0";"452.64";"1";"5.54";"GNF-Pf-373";"CCCN(CC(=O)Nc1cc(C(C)(C)C)nn1-c1cccc(C)c1C)C(=O)C1CCCCC1";"IFI";"'='";"0.9091";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL579559";"";"0";"326.44";"0";"3.22";"GNF-Pf-399";"CCN(CC)C(=O)COc1ccccc1CNCc1ccccc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL525709";"";"0";"417.14";"1";"6.68";"GNF-Pf-419";"O=C(Nc1cc(C(F)(F)F)cc(C(F)(F)F)c1)Nc1ccc(Cl)c(Cl)c1";"IFI";"'='";"18.8";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL581490";"";"0";"323.85";"0";"3.74";"GNF-Pf-453";"Cc1cc(C)c(S(=O)(=O)NCc2ccc(Cl)cc2)c(C)c1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600952";"";"0";"341.41";"1";"5.36";"GNF-Pf-456";"O=C(O)c1ccc([C@@H]2Nc3c(ccc4ccccc34)[C@@H]3C=CC[C@@H]32)cc1";"IFI";"'='";"5.882";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL599934";"";"0";"473.36";"0";"3.11";"GNF-Pf-462";"COc1ccc2c(c1)c1c3n2CCN(Cc2ccccc2)C3=[N+](C)CC1.[I-]";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL582315";"";"0";"613.86";"3";"5.79";"GNF-Pf-468";"Cc1ccc(Nc2nc(NN=Cc3ccc(-c4ccc(Cl)c([N+](=O)[O-])c4)o3)nc(N3CCOCC3)n2)c(Br)c1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL579562";"";"0";"465.64";"0";"2.54";"GNF-Pf-471";"COC(=O)c1c(S(=O)(=O)NCCN(C)C)sc2c1CCN(CC(C)c1ccccc1)C2";"IFI";"'='";"2.913";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL579778";"";"0";"421.91";"0";"2.23";"GNF-Pf-473";"CCCn1c(SCC(=O)Nc2ccccc2Cl)nc2c1c(=O)n(C)c(=O)n2C";"IFI";"'='";"3.704";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585072";"";"0";"532.63";"1";"2.39";"GNF-Pf-1210";"CC1=C[C@H]2O[C@@H]3C[C@H]4OC(=O)C=CC=C[C@H]([C@@H](C)O)OCC[C@@H](C)[C@H](O)C(=O)OC[C@@]2(CC1)[C@]4(C)[C@@]31CO1";"IFI";"'='";"24.53";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL602630";"";"0";"331.31";"0";"0.74";"GNF-Pf-1213";"CCOC(=O)Cn1cnc2c(nnn2Cc2ccc(F)cc2)c1=O";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL581530";"";"0";"440.96";"1";"5.16";"GNF-Pf-1219";"CCOC(=O)c1cnn(-c2ccnc3cc(Cl)ccc23)c1CNC(C)c1cccs1";"IFI";"'='";"2.632";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL604567";"";"0";"500.02";"1";"4.63";"GNF-Pf-1279";"CN(c1ccc(Cl)cc1)S(=O)(=O)c1ccc2[nH]cc(C(=O)NCCC3=CCCCC3)c(=O)c2c1";"IFI";"'='";"7.692";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600286";"";"0";"297.38";"0";"1.71";"GNF-Pf-955";"COC(=O)C1CCCCN1S(=O)(=O)c1ccc(C)cc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL99";"TRICHOSTATIN";"1";"302.37";"0";"2.58";"GNF-Pf-1011";"CC(/C=C/C(=O)NO)=C\[C@@H](C)C(=O)c1ccc(N(C)C)cc1";"IFI";"'='";"22.64";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL603032";"";"0";"361.32";"0";"4.34";"GNF-Pf-1014";"O=[N+]([O-])c1cc([N+](=O)[O-])c2cccnc2c1Nc1cccc2cccnc12";"IFI";"'='";"10.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL584027";"";"0";"497.64";"1";"6.49";"GNF-Pf-1022";"CCCCCN(C(=O)c1ccc(C)cc1)C(CC)c1nc2ccccc2c(=O)n1-c1ccccc1OC";"IFI";"'='";"1.887";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585992";"";"0";"299.38";"0";"4.84";"GNF-Pf-1060";"c1ccc(-c2ccc(CNc3ccc4cn[nH]c4c3)cc2)cc1";"IFI";"'='";"15.38";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL583542";"";"0";"508.71";"1";"4.53";"GNF-Pf-1080";"CCN1CCN(C2CCN(Cc3cc4ccc(F)cc4n(CCSc4ccccc4)c3=O)CC2)CC1";"IFI";"'='";"3.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL2310925";"NONACTIN";"0";"736.94";"3";"6.02";"GNF-Pf-1094";"C[C@H]1C[C@@H]2CC[C@@H](O2)[C@@H](C)C(=O)O[C@H](C)C[C@H]2CC[C@@H](O2)[C@H](C)C(=O)O[C@@H](C)C[C@@H]2CC[C@@H](O2)[C@@H](C)C(=O)O[C@H](C)C[C@H]2CC[C@H](O2)[C@H](C)C(=O)O1";"IFI";"'='";"12.5";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600288";"";"0";"284.77";"0";"2.65";"GNF-Pf-1096";"CC1(C)Cc2c(sc(NC(=O)CCl)c2C#N)CO1";"IFI";"'='";"8.333";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL1744494";"";"0";"287.30";"0";"0.62";"GNF-Pf-1136";"CC(=O)Oc1cccc(C=c2sc3ncnn3c2=O)c1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL602821";"";"0";"310.38";"0";"4.22";"GNF-Pf-485";"COc1ccc(/C=C2\SC(=O)NC2=Nc2ccccc2)cc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL602364";"";"0";"324.45";"0";"4.65";"GNF-Pf-496";"Oc1ccc(-c2nc3ccccc3s2)cc1CN1CCCCC1";"IFI";"'='";"11.97";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL582465";"";"0";"364.43";"0";"3.85";"GNF-Pf-1476";"Cc1nc2cc(-c3ccc(F)cc3)nn2c(NCCCn2ccnc2)c1C";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL577859";"";"0";"430.89";"1";"5.72";"GNF-Pf-2401";"COc1ccc(C2CC(c3c(-c4ccccc4)c4cc(Cl)ccc4[nH]c3=O)=NO2)cc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL583818";"";"0";"295.27";"0";"-0.55";"GNF-Pf-969";"O=C(NNC(=O)c1cccc(F)c1)C(=O)N1CCOCC1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL584012";"";"0";"421.85";"1";"5.48";"GNF-Pf-995";"CN(CCCNc1ccnc2cc(Cl)ccc12)C(=O)c1cccc(C(F)(F)F)c1";"IFI";"'='";"3.738";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL602424";"";"0";"447.56";"0";"3.63";"GNF-Pf-1008";"CCOC(=O)N1CCC(NC(=O)CSCc2nc(-c3cccc(OC)c3)oc2C)CC1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL588450";"";"0";"412.45";"0";"3.97";"GNF-Pf-5204";"COc1cc2nc(NCc3cccnc3)n3nc(-c4ccccc4)nc3c2cc1OC";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL582635";"";"0";"437.49";"0";"3.81";"GNF-Pf-5279";"CCOc1cc(C2CC(=O)NC3=C2C(=O)CC(c2cc(OC)ccc2OC)C3)ccc1O";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL602793";"";"0";"288.42";"0";"3.13";"GNF-Pf-5317";"CCN1C(=S)NC2c3cc(C)ccc3OC13CCCC23";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL580956";"";"0";"469.51";"0";"4.21";"GNF-Pf-5351";"CCOC(=O)c1cccc(NC(=O)CC2C(=O)N(c3ccc(F)cc3)C(=O)N2CCC(C)C)c1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL578506";"";"0";"382.47";"1";"5.65";"GNF-Pf-2710";"Cc1ccc(C(CCNc2ncnc3c2[nH]c2ccccc23)c2ccco2)cc1";"IFI";"'='";"9.091";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL579113";"";"0";"409.57";"0";"2.67";"GNF-Pf-2754";"OC(COc1ccccc1CNCCN1CCCC1)CN1CCc2ccccc2C1";"IFI";"'='";"7.692";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL602401";"";"0";"433.94";"1";"5.85";"GNF-Pf-2785";"Cc1cccn2c(NCc3ccccc3)c(-c3ccccc3OC(=O)CCCCl)nc12";"IFI";"'='";"3.81";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL527773";"";"0";"424.43";"0";"4.92";"GNF-Pf-2847";"FC(F)(F)c1cccc(-c2cc(NCCCn3ccnc3)nc(-c3ccncc3)n2)c1";"IFI";"'='";"2.041";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL531018";"";"0";"416.49";"1";"5.60";"GNF-Pf-2870";"Nc1ccc(-c2nc3cc(-c4ccc5[nH]c(-c6ccc(N)cc6)nc5c4)ccc3[nH]2)cc1";"IFI";"'='";"27.27";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL601578";"";"0";"315.42";"0";"2.82";"GNF-Pf-2876";"CCCCOc1ccc(NC2=NC3(CCCC3)NC(N)=N2)cc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL580166";"";"0";"273.34";"0";"4.14";"GNF-Pf-2909";"Cc1ccc2nc3nc4c(C)cccc4c(N)c3cc2c1";"IFI";"'='";"8.955";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL580169";"";"0";"333.35";"0";"3.47";"GNF-Pf-2917";"CC(=O)Nc1cccc(-c2cncc(-c3ccc(C(=O)O)cc3)n2)c1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL582503";"";"0";"273.38";"0";"4.51";"GNF-Pf-2936";"c1ccc2c(c1)c1c(c3ccccc32)CN2CCCC2C1";"IFI";"'='";"3.509";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL596855";"";"0";"305.34";"0";"1.68";"GNF-Pf-4209";"CCCn1nc(Oc2nc(NCC)cc(OC)n2)ccc1=O";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL604926";"";"0";"509.57";"2";"7.87";"GNF-Pf-4273";"CC(C)(C)CC(C)(C)Nc1c(-c2ccccc2OC(=O)c2ccc(C(F)(F)F)cc2)nc2ccccn12";"IFI";"'='";"3.81";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL584216";"";"0";"377.26";"0";"4.80";"GNF-Pf-1252";"COc1cc(Br)c(/C=C2\Sc3ccccc3C2=O)cc1OC";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585061";"";"0";"442.00";"1";"5.17";"GNF-Pf-1269";"CCOc1ccc(C2=NC3(CCN(C(C)C)CC3)NC(c3cc(Cl)ccc3O)C2)cc1";"IFI";"'='";"3.125";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600766";"";"0";"434.61";"1";"6.32";"GNF-Pf-1283";"CC[n+]1c(/C=C/C=C2\N(C)c3ccccc3C2(C)C)n(Cc2ccccc2)c2ccccc21";"IFI";"'='";"32.61";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600959";"";"0";"360.42";"0";"3.17";"GNF-Pf-939";"O=C1N(c2ccccc2)C[C@@H]2C[C@@H](c3ccc4nonc4c3)N3CCC[C@@]123";"IFI";"'='";"7.692";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585998";"";"0";"254.29";"0";"3.10";"GNF-Pf-988";"C/C(C=NNC(=O)c1ccco1)=C\c1ccccc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL603034";"";"0";"487.07";"0";"4.76";"GNF-Pf-1020";"CCN(CC)CCCC(C)NC(=O)CSc1nc2ccccc2c(=O)n1-c1cccc(Cl)c1";"IFI";"'='";"3.67";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL584030";"";"0";"343.81";"0";"4.10";"GNF-Pf-1024";"O=C(NCCCCNc1ccnc2cc(Cl)ccc12)c1ccco1";"IFI";"'='";"0.9434";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL584032";"";"0";"441.51";"0";"3.70";"GNF-Pf-1026";"COc1cccc2cc(-c3csc(NC(=O)CCC(=O)NC4CCCC4)n3)c(=O)oc12";"IFI";"'='";"2.353";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585776";"";"0";"385.47";"0";"3.97";"GNF-Pf-1033";"Cc1ccc(-c2ccc(C#N)c(OCC(=O)NCCc3ccccc3)n2)c(C)c1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL601534";"";"0";"645.20";"2";"6.86";"GNF-Pf-1034";"COc1cc2c3cc1Oc1c(OC)c(OC)cc4c1C(Cc1ccc(O)c(c1)Oc1ccc(cc1)CC3N(C)CC2)N(C)CC4.Cl";"IFI";"'='";"7.143";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL535464";"";"0";"288.35";"0";"3.77";"GNF-Pf-1039";"c1ccc2c(NCCc3c[nH]cn3)c3ccccc3nc2c1";"IFI";"'='";"9.091";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL602838";"";"0";"518.92";"2";"8.21";"GNF-Pf-1043";"CC(C)(C)C(/C=C/c1ccc(Cl)cc1Cl)n1nnnc1C1(Nc2ccc(Cl)cc2)CCCCC1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL528024";"";"0";"603.77";"2";"5.41";"GNF-Pf-1059";"CCOC(=O)c1c(NC(=O)CSc2nnc(CNC(=O)c3cccc(C)c3)n2Cc2ccccc2)sc2c1CCCC2";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL583359";"";"0";"380.85";"1";"5.12";"GNF-Pf-1064";"Cl.Fc1ccccc1Nc1nc(NCc2ccccc2)c2ccccc2n1";"IFI";"'='";"7.143";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600757";"";"0";"491.59";"1";"6.82";"GNF-Pf-1074";"CCOc1cc(C(Nc2cc(C)ccn2)c2ccc3cccnc3c2O)ccc1OCc1ccccc1";"IFI";"'='";"7.143";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL584432";"";"0";"384.54";"0";"4.56";"GNF-Pf-1106";"CCN1CCC(N2CCC(n3c(C4CCC4)nc4cc(F)ccc43)CC2)CC1";"IFI";"'='";"2.655";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL584433";"";"0";"405.28";"0";"4.36";"GNF-Pf-1108";"COC(=O)C1=C(C)N/C(=C\c2cc(C)n(-c3cc(Cl)ccc3Cl)c2C)C1=O";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL584643";"";"0";"392.53";"0";"2.51";"GNF-Pf-1113";"CCCCN(C)C(=O)c1sc2ncn(CC(=O)N(CC)CC)c(=O)c2c1C";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL584646";"";"0";"272.69";"0";"3.17";"GNF-Pf-1115";"N#Cc1ccc(NC(=O)c2cc(Cl)ccc2O)cc1";"IFI";"'='";"24.74";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL528716";"";"0";"638.60";"2";"7.09";"GNF-Pf-1140";"O=C(Nc1ccc(-c2nc3ccc(-c4nc5ccc(NC(=O)c6ccccc6[N+](=O)[O-])cc5[nH]4)cc3[nH]2)cc1)c1ccccc1[N+](=O)[O-]";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL584613";"";"0";"394.43";"0";"4.53";"GNF-Pf-1153";"Cc1cc(N2CCC(C)CC2)nc2ccc(NC(=O)c3ccc([N+](=O)[O-])o3)cc12";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585603";"";"0";"307.40";"0";"3.42";"GNF-Pf-1156";"CCC(=O)NCc1nc2ccccc2n1Cc1ccc(C)cc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL602428";"";"0";"387.36";"1";"5.24";"GNF-Pf-1204";"O=C(Nc1cc(C(F)(F)F)ccc1OCc1ccccc1)c1ccccc1O";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL584865";"";"0";"510.64";"1";"4.52";"GNF-Pf-1205";"COc1ccc(CNC(=O)c2ccc3c(c2)N=C(/C=C/c2ccccc2)N(CCN2CCOCC2)C3)cc1";"IFI";"'='";"8.537";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL529615";"";"0";"279.77";"0";"3.11";"GNF-Pf-1207";"Cc1c(Cl)cccc1NCC(=O)NN=C1CCCC1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL585068";"";"0";"372.78";"1";"5.00";"GNF-Pf-1208";"COC(=O)c1c(-c2c(F)cccc2Cl)noc1C=CNc1ccccc1";"IFI";"";"";"";"";"";"Not applicable";"";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL580837";"";"0";"544.70";"1";"4.05";"GNF-Pf-474";"COc1ccc(NC(=O)CCCCCn2c(SCC(=O)NCC3CCCO3)nc3ccsc3c2=O)cc1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL588167";"";"0";"420.49";"0";"4.17";"GNF-Pf-1371";"COc1ccccc1NC(=O)CSc1nc2cccnc2n1-c1ccccc1OC";"IFI";"'='";"7.692";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL588079";"";"0";"350.81";"1";"5.50";"GNF-Pf-1378";"COc1ccc2nc3cc(Cl)ccc3c(Nc3ccc(O)cc3)c2c1";"IFI";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL588461";"";"0";"441.54";"0";"3.89";"GNF-Pf-1381";"O=C(NCCc1ccccc1)c1cnc(NCCCn2ccnc2)nc1Nc1ccccc1";"IFI";"'='";"2.857";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL581614";"";"0";"562.69";"1";"4.41";"GNF-Pf-1462";"Cc1nc(-c2ccccc2)nc(C(=O)N2CCN(S(=O)(=O)/C=C/c3ccccc3)C(C)C2)c1C(=O)OCC(C)C";"IFI";"'='";"1.887";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL602584";"";"0";"303.29";"0";"4.70";"GNF-Pf-1474";"Cc1ccc2ncnc(Nc3cccc(C(F)(F)F)c3)c2c1";"IFI";"'='";"4.412";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL577005";"";"0";"364.40";"0";"3.17";"GNF-Pf-1555";"COc1ccc(Cn2cccc(C(=O)Nc3ccc(OC)cc3)c2=O)cc1";"IFI";"'='";"5.263";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL577007";"";"0";"418.55";"0";"3.57";"GNF-Pf-1562";"CC(C)CNC(=O)c1cnc(NCCc2ccncc2)nc1NCCc1ccccc1";"IFI";"'='";"0.9615";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL601582";"";"0";"500.98";"1";"1.78";"GNF-Pf-1563";"CS(=O)(=O)c1ccccc1S(=O)(=O)N1CCC(NC(=O)c2ccccc2Cl)(C(=O)O)CC1";"IFI";"'='";"2.941";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600295";"";"0";"723.96";"3";"11.37";"GNF-Pf-1498";"C1CCC(NP2(NC3CCCCC3)=NP(NC3CCCCC3)(NC3CCCCC3)=NP(NC3CCCCC3)(NC3CCCCC3)=N2)CC1";"IFI";"'='";"3.125";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL577635";"";"0";"287.31";"0";"0.75";"GNF-Pf-2394";"O[C@H]1C=C2CCN3Cc4cc5c(cc4[C@@H]([C@@H]23)[C@H]1O)OCO5";"IFI";"'='";"10.61";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL583364";"";"0";"394.43";"1";"5.92";"GNF-Pf-941";"CCC(C)(C)c1ccc(Oc2ccc(NC(=O)c3ccc([N+](=O)[O-])o3)cc2)cc1";"IFI";"'='";"15.15";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
"CHEMBL600759";"";"0";"549.67";"1";"4.37";"GNF-Pf-953";"CCCN(CC1CC1)C(=O)C1CCCN(c2cccc3c2C(=O)N(Cc2cc(OC)c(OC)c(OC)c2)C3=O)C1";"IFI";"'='";"5.455";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL1040694";"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1156829";"3";"Novartis Malaria Screening";"Proc. Natl. Acad. Sci. U.S.A.";"2008";"None";""
